Citrus Sinensis ID: 046493
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 679 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWZ5 | 821 | G-type lectin S-receptor- | yes | no | 0.976 | 0.807 | 0.544 | 0.0 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.944 | 0.735 | 0.340 | 1e-102 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.951 | 0.740 | 0.346 | 4e-92 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.882 | 0.723 | 0.346 | 7e-86 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.877 | 0.718 | 0.353 | 5e-82 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.908 | 0.755 | 0.314 | 3e-77 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.849 | 0.723 | 0.317 | 3e-73 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.880 | 0.718 | 0.311 | 3e-62 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.877 | 0.718 | 0.300 | 1e-61 | |
| Q94C25 | 452 | Probable receptor-like pr | no | no | 0.375 | 0.564 | 0.464 | 4e-61 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/674 (54%), Positives = 473/674 (70%), Gaps = 11/674 (1%)
Query: 13 CLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALD-VQFFL 71
CL+ + AG IG + PGF +QM +INN+G+FL SNNS FGFGF T D V F
Sbjct: 11 CLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGFGFVTTQDSVTLFT 70
Query: 72 LVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQ 131
L +IH SS K++W+ANR + +SDKFVF+ NGN ++ E W + SG+ +EL+
Sbjct: 71 LSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVME--GTEVWRLDNSGKNASRIELR 128
Query: 132 DSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVL 191
DSGNLV++ V+G+ +W+SF HPTDTL+ Q F EGM+L S P+S+NM+ LE KSGD+VL
Sbjct: 129 DSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTYALEIKSGDMVL 188
Query: 192 YAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDEN 251
T Q YWS+AN + V S+SL+ N+W F+D ++ LLWQF+FS+N D+N
Sbjct: 189 SVNSLTPQVYWSMANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDN 248
Query: 252 ATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCYFDNWCQCPTSL 311
TW A+LG+NG I+FSNL +G +A + KIP C PEPC PY+VC C C + L
Sbjct: 249 TTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSKVCGCVSGL 308
Query: 312 -RSQLNCRPPVASTCNVSMNSA----KLFYLGERLDYFALGFVSPF-PRYDLNTCKEACL 365
R++ +C+ + S C + ++A +L G+ +DYFALG+ PF + DL++CKE C
Sbjct: 309 SRARSDCKTGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCH 368
Query: 366 HNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGK 425
+NCSC LFF+NS+ NCFLFD IGS + S G +G+VSY+KI+S + K
Sbjct: 369 NNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGGGDNGEDDG--K 426
Query: 426 PIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYD 485
+V+IVV T+ +IA L++ H ++K + + QE EEDNFLE +SGMP RF+Y
Sbjct: 427 HFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYK 486
Query: 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL 545
DL AT NFS KLGQGGFGSVY G LPDG ++AVKKLE IGQGKKEF AEV+ IG++HHL
Sbjct: 487 DLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL 546
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
HLV+L+GFC EGAHRLLAYE+L GSL++WIF + L W+TRFNIALG AKGLAYL
Sbjct: 547 HLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYL 606
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
HE+C+ +IVHCDIKPEN+LLDDNF AKVSDFGLAKLM RE+S V+TT+RGTRGYLAPEWI
Sbjct: 607 HEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWI 666
Query: 666 TNNPISEKSDVYSY 679
TN ISEKSDVYSY
Sbjct: 667 TNYAISEKSDVYSY 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 241/707 (34%), Positives = 365/707 (51%), Gaps = 66/707 (9%)
Query: 16 LVFKTCIAGSQHIGKLYPGFEATQMEWINNN-GLFLISNNSVFGFGFYTA---LDVQFFL 71
VF +C + + + YP F A+ + +++++ G FL+S NS+F G ++ F
Sbjct: 18 FVFVSCASSIEFV---YPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFY 74
Query: 72 LVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGE--AWSANTSGQKVECME 129
V+H+ S +W++NR + S G + ++ G + WS V+ +
Sbjct: 75 FSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLR 134
Query: 130 LQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSV----YLEFK 185
L D+GNL+LL LW+SF PTD+++ GQ+ GM L + ++ S +L +
Sbjct: 135 LTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGE 194
Query: 186 SGDLVLYAGYQTSQTYWSLANDSRKTNTS------VAAKVHSASLVSNAWNFYDIRKALL 239
S L+ + G Q YW L R S + +L++ +R AL
Sbjct: 195 SDGLMQWRG----QNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALP 250
Query: 240 WQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVC 299
F A + S+G+ S +GK +E P SC +P C +C
Sbjct: 251 PSSDFR---------VAKMDSSGKFIVSRF-SGKNLVTE-FSGPMDSCQIPFVCGKLGLC 299
Query: 300 YFDNW-----CQCPTSLRSQLN---CRPPVAS-TCNVSMNSAKLFYL--GERLDYFALGF 348
DN C CP +R C P S + VS + + YL G + YF+ F
Sbjct: 300 NLDNASENQSCSCPDEMRMDAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHF 359
Query: 349 VSPFPR-YDLNTCKEACLHNCSCSVLFFENSTKNCFLF-DQIGSLQRSQQGSTGY--VSY 404
P L C + C NCSC +F+EN++++C+L D GSL + + + Y
Sbjct: 360 TDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGY 419
Query: 405 MKISSGNEVLNSKSRESDGGK--PIVLIVVIVVATILVIASLLYAGL--WHHNKRKRLTK 460
+K+S + GG P++ +V++ + ++ +L GL W R +
Sbjct: 420 VKLSIRKTNAQPPGNNNRGGSSFPVIALVLLPCSGFFLLIAL---GLLWWRRCAVMRYSS 476
Query: 461 FSQEDLEEDNFLEK-------ISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD 513
++ + E I G+P +F +++L +AT+NF ++G GGFGSVY G LPD
Sbjct: 477 IREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPD 536
Query: 514 GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572
+AVKK+ + G G++EF E+ IGN+ H +LVKL+GFC G LL YEY+ +GSL
Sbjct: 537 ETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSL 596
Query: 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632
+K +F+ L W RF+IALG A+GLAYLH C+ KI+HCD+KPEN+LL D+F K
Sbjct: 597 EKTLFSGN--GPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPK 654
Query: 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
+SDFGL+KL+N+EES ++TT+RGTRGYLAPEWITN ISEK+DVYSY
Sbjct: 655 ISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSY 701
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 257/741 (34%), Positives = 370/741 (49%), Gaps = 95/741 (12%)
Query: 1 MGLFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQ--MEWINNNGLFLISNNSVFG 58
+GLF + FC LV +A HIG L +A++ W++ NG F I G
Sbjct: 11 VGLFSF-----FCFFLV---SLATEPHIG-LGSKLKASEPNRAWVSANGTFAI------G 55
Query: 59 FGFYTALDVQFFLLVVIHIS---SAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA 115
F + D FLL + +VW+ NR + E GN L N
Sbjct: 56 FTRFKPTDR--FLLSIWFAQLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVV 113
Query: 116 WSANTSGQKVECMELQDSGNLVLLGVN---GSILWQSFSHPTDTLLPGQQFVEGMRLKSF 172
W++NTS VE + +SGN +LLG G +WQSFS P+DTLLP Q + L S
Sbjct: 114 WTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSN 173
Query: 173 PNSNNMSVY-LEFKSGDLVLYAGY--------QTSQTYWSLANDSRKTNTSVAAKVHSAS 223
P+ + Y L+ L G + +YWS + S T V A +
Sbjct: 174 PSPSRHGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTG-DVTAVLDDTG 232
Query: 224 LVSNAWNFYDIRKALLWQFIFSENNDENAT-----------WAAILGSNGEITFSNLRNG 272
+ I +++ +N + N + +L +NG + N
Sbjct: 233 SFKIVYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDND 292
Query: 273 KAATSEAIKIPQISCSVPEPCNPYF-----VCYFDNW-----CQC-PTSLR--SQLNCR- 318
+S+ + P+ + +V PC+ VC D C C P S++ Q N +
Sbjct: 293 MNGSSQWV--PEWA-AVSNPCDIAGICGNGVCNLDRTKKNADCLCLPGSVKLPDQENAKL 349
Query: 319 ----PPVASTCNVSMN---SAKL-------FYLGERLDYFALGFVSPFPRYDLNTCKEAC 364
+ C ++N S K+ +Y ER + +S ++ C E C
Sbjct: 350 CSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDIS-----NVRKCGEMC 404
Query: 365 LHNCSC--SVLFFENSTKNCFLFDQIGSLQRSQQGSTGYV---SYMKISSGNEVLNSKSR 419
L +C C SV ++ C++ + GST +V + S + +SKSR
Sbjct: 405 LSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKSR 464
Query: 420 ESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMP 479
+S G + VL++ IVV +LV+ +LL L+++ RKR K + + N L + P
Sbjct: 465 KSHGLRQKVLVIPIVVG-MLVLVALLGMLLYYNLDRKRTLKRAAK-----NSL-ILCDSP 517
Query: 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLE-SIGQGKKEFSAEVTT 538
F+Y DL T NFS LG GGFG+VY G + VAVK+L+ ++ G++EF EV T
Sbjct: 518 VSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNT 577
Query: 539 IGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM 598
IG++HH++LV+L G+C E +HRLL YEY+ NGSLDKWIF+S + + L W TRF IA+
Sbjct: 578 IGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVAT 637
Query: 599 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 658
A+G+AY HE+C +I+HCDIKPEN+LLDDNF KVSDFGLAK+M RE S V T +RGTRG
Sbjct: 638 AQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRG 697
Query: 659 YLAPEWITNNPISEKSDVYSY 679
YLAPEW++N PI+ K+DVYSY
Sbjct: 698 YLAPEWVSNRPITVKADVYSY 718
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 234/675 (34%), Positives = 337/675 (49%), Gaps = 76/675 (11%)
Query: 50 LISNNSVFGFGFYT-ALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFE-KNGNAY 107
++S++ + GF+ F++ + S ++W ANR + D + VF+ NGN
Sbjct: 38 IVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 108 LQRGNGEA--WSAN-TSGQKVECME--LQDSGNLVLL----GVNGSILWQSFSHPTDTLL 158
L GN + WS S V +E LQD GNLVL ++ ++LWQSF HP DT L
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWL 157
Query: 159 PG------QQFVEGMRLKSF-----PNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA-- 205
PG ++ + RL S+ P+ S+ L+ + +L+ G S YWS
Sbjct: 158 PGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNG---SNEYWSSGPW 214
Query: 206 NDSRKTNTSVAAK----VHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSN 261
N + SV +++ S SN + Y F +S N N + ++ +
Sbjct: 215 NPQSRIFDSVPEMRLNYIYNFSFFSNTTDSY---------FTYSIYNQLNVS-RFVMDVS 264
Query: 262 GEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVC--YFDNWCQCPTSLR--SQLN- 316
G+I G A + P+ C V C + +C + +C+CP R SQ +
Sbjct: 265 GQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDW 324
Query: 317 --------CRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSP-FPRYDLNTCKEACLHN 367
C C S F+ RL L S R L+ C AC +
Sbjct: 325 DLKDYSAGCVRKTELQC--SRGDINQFF---RLPNMKLADNSEVLTRTSLSICASACQGD 379
Query: 368 CSCSVLFFENSTKNCFLF--DQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGK 425
CSC ++ + C ++ D + Q + S G + Y+++++ ++V N + K
Sbjct: 380 CSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAA-SDVPNVGASGKSNNK 438
Query: 426 PIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYD 485
L+ ++L + + + + EK G + FSY
Sbjct: 439 G------------LIFGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDGTLSAFSYR 486
Query: 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL 545
+L ATKNFS KLG GGFGSV+ G LPD +AVK+LE I QG+K+F EV TIG + H+
Sbjct: 487 ELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHV 546
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIF-NSTEESRFLSWNTRFNIALGMAKGLAY 604
+LV+L+GFC EG+ +LL Y+Y+ NGSLD +F N EE L W RF IALG A+GLAY
Sbjct: 547 NLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAY 606
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH+EC I+HCDIKPEN+LLD F KV+DFGLAKL+ R+ S V TT+RGTRGYLAPEW
Sbjct: 607 LHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEW 666
Query: 665 ITNNPISEKSDVYSY 679
I+ I+ K+DVYSY
Sbjct: 667 ISGVAITAKADVYSY 681
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 233/660 (35%), Positives = 330/660 (50%), Gaps = 64/660 (9%)
Query: 52 SNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRG 111
S NS F F + FL V S + W+A + +G+ L G
Sbjct: 44 SPNSTFSVSFVPSPSPNSFLAAVSFAGSVPI-WSAG---TVDSRGSLRLHTSGSLRLTNG 99
Query: 112 NGEA-WSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLK 170
+G W + T V ++D+G +LL +W SF +PTDT++ Q F G L+
Sbjct: 100 SGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKILR 159
Query: 171 SFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLAND------------SRKTNTSVAAK 218
S S LE +SG+L L + TS YW+ + S +TN V+
Sbjct: 160 S----GLYSFQLE-RSGNLTLR--WNTSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVS-- 210
Query: 219 VHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSE 278
+ ++L+ A Y F F + +D+ N I S RN +
Sbjct: 211 IFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDG---------NLRIYSSASRNSGPVNAH 261
Query: 279 AIKIPQISCSVPEPCNPYFVCYFDNW---CQCPTSL-------RSQLNCRPPVASTCNVS 328
+ Q C V C + +C +++ C CP+ + C+ V + + S
Sbjct: 262 WSAVDQ--CLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRKGCKRKVELS-DCS 318
Query: 329 MNSAKLFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSC-SVLFFENSTKNCFLFDQ 387
N+ L + RL + S + C+ CL + C + + + + NC+
Sbjct: 319 GNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQKHP 378
Query: 388 IGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGKPIVLIVVIVVATILVIASLL-- 445
Q S SY+K+ G V N+ R + G + + +VA + VIA LL
Sbjct: 379 GSFFTGYQWPSVPSTSYVKVC-GPVVANTLERATKGDDNNSKVHLWIVA-VAVIAGLLGL 436
Query: 446 ---YAGLWHHNKRK--RLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQ 500
GLW RK R S LE SG P +F+Y +L + TK+F KLG
Sbjct: 437 VAVEIGLWWCCCRKNPRFGTLSSHY----TLLEYASGAPVQFTYKELQRCTKSFKEKLGA 492
Query: 501 GGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560
GGFG+VY G+L + VAVK+LE I QG+K+F EV TI + HHL+LV+L GFC +G HR
Sbjct: 493 GGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHR 552
Query: 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKP 620
LL YE++ NGSLD ++F +T+ ++FL+W RFNIALG AKG+ YLHEEC IVHCDIKP
Sbjct: 553 LLVYEFMRNGSLDNFLF-TTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKP 611
Query: 621 ENVLLDDNFTAKVSDFGLAKLMN-REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
EN+L+DDNF AKVSDFGLAKL+N ++ +++RGTRGYLAPEW+ N PI+ KSDVYSY
Sbjct: 612 ENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSY 671
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 216/687 (31%), Positives = 326/687 (47%), Gaps = 70/687 (10%)
Query: 50 LISNNSVFGFGFYTALDVQFFLLVVIHISSAK------VVWTAN--RGLLIRDSDKFVFE 101
L S++ F GFY F V + A +VW+AN R + R S +
Sbjct: 48 LQSSDGTFSSGFYEVYTHAFTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRS-ALTLQ 106
Query: 102 KNGNAYLQRGNGEA-WSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLP 159
K+GN L +G A W A+ + V+ L D+GNLV+ G+ +WQSF PTDT LP
Sbjct: 107 KDGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLP 166
Query: 160 GQQFVEGMRLKSFPNSNNMSVYLEFKSGDL----VLYAGYQTSQTYW-----SLANDSRK 210
Q RL S + Y+ F+ DL ++Y Q S YW +L D R
Sbjct: 167 TQLITAATRLVPTTQSRSPGNYI-FRFSDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRN 225
Query: 211 TNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLR 270
S + + S V + +F D Q + + + L +G + ++
Sbjct: 226 QYNSTRLGMLTDSGVLASSDFAD------GQALVASDVGPGVKRRLTLDPDGNLRLYSMN 279
Query: 271 NGKAATSEAIKIPQISCSVPEPCNPYFVCYFDNW--CQCPTSLRSQ------LNCRPPVA 322
+ + S ++ C++ C P +C++ C CP ++ C V
Sbjct: 280 DSDGSWSVSMVAMTQPCNIHGLCGPNGICHYSPTPTCSCPPGYATRNPGNWTEGCMAIVN 339
Query: 323 STCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFFENSTKNC 382
+TC+ + F D++ L TC++ C+ +C+C ++ T +C
Sbjct: 340 TTCDRYDKRSMRFVRLPNTDFWG-SDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSC 398
Query: 383 FLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESD-------------------- 422
+ + S R+ S Y+K+ +G V N+ SD
Sbjct: 399 YPKAYLFS-GRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIRE 457
Query: 423 ---------GGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLE 473
GG+ +A V+ + W ++ L + S+ E +
Sbjct: 458 PFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKREL-RPSELWASEKGYKA 516
Query: 474 KISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFS 533
S R+SY +L KAT+ F +LG+G G+VY G+L D VAVKKLE++ QGK+ F
Sbjct: 517 MTSNF-RRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQ 575
Query: 534 AEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN 593
AE++ IG ++H++LV++ GFC EG+HRLL EY+ NGSL +F S + L W RFN
Sbjct: 576 AELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILF-SEGGNILLDWEGRFN 634
Query: 594 IALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT- 652
IALG+AKGLAYLH EC ++HCD+KPEN+LLD F K++DFGL KL+NR S +
Sbjct: 635 IALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSH 694
Query: 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679
+RGT GY+APEW+++ PI+ K DVYSY
Sbjct: 695 VRGTLGYIAPEWVSSLPITAKVDVYSY 721
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 212/668 (31%), Positives = 315/668 (47%), Gaps = 91/668 (13%)
Query: 50 LISNNSVFGFGFYTALDVQ---FFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNA 106
++S ++F GF++ + + + + + VW ANR + D D E
Sbjct: 33 ILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTG 92
Query: 107 YLQRGN---GEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQF 163
YL N G W + Q ++GNL+L+ +GS +WQSF +PTDT LPG
Sbjct: 93 YLIVSNLRDGVVWQTDNK-QPGTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNV 151
Query: 164 VEGMRLKSF-------PNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVA 216
+ S+ P ++ + F LV Y+ + YWS N + + V
Sbjct: 152 TGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLV----YKGTTPYWSTGNWTGEAFVGVP 207
Query: 217 A-------KVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNL 269
+ H + + +F+ I L ++ E ++G+NG++
Sbjct: 208 EMTIPYIYRFHFVNPYTPTASFWYIVPPL-------DSVSEPRLTRFMVGANGQLKQYTW 260
Query: 270 RNGKAATSEAIKIPQISCSVPEPCNPYFVCYFD--NWCQCPTSLRSQLNC---RPPVAST 324
+ + P+ C V C C + C C R + + +
Sbjct: 261 DPQTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRNDAAWRSDDYSDG 320
Query: 325 CNVSMNSAKLFYLGERLDYF-ALGFVSPFPRYDLN-----------TCKEACLHNCSCSV 372
C + GE+ D F A+G + RYD + +C + CL N SC
Sbjct: 321 CRRENGDS-----GEKSDTFEAVGDL----RYDGDVKMSRLQVSKSSCAKTCLGNSSCVG 371
Query: 373 LFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGKPIVLIVV 432
+ + + C + + S N + NSK S ++I+
Sbjct: 372 FYHKEKSNLCKIL---------------------LESPNNLKNSKGNISKS----IIILC 406
Query: 433 IVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATK 492
VV +I V+ L L + ++ K ++D ED F + + FS+ +L AT
Sbjct: 407 SVVGSISVLGFTLLVPLILLKRSRKRKKTRKQD--EDGF--AVLNLKV-FSFKELQSATN 461
Query: 493 NFSTKLGQGGFGSVYLGMLPDGIQ-VAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
FS K+G GGFG+V+ G LP VAVK+LE G G+ EF AEV TIGN+ H++LV+L+
Sbjct: 462 GFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLR 521
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
GFC E HRLL Y+Y+ GSL ++ S + LSW TRF IALG AKG+AYLHE C
Sbjct: 522 GFCSENLHRLLVYDYMPQGSLSSYL--SRTSPKLLSWETRFRIALGTAKGIAYLHEGCRD 579
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
I+HCDIKPEN+LLD ++ AKVSDFGLAKL+ R+ S V T+RGT GY+APEWI+ PI+
Sbjct: 580 CIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPIT 639
Query: 672 EKSDVYSY 679
K+DVYS+
Sbjct: 640 TKADVYSF 647
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 214/688 (31%), Positives = 307/688 (44%), Gaps = 90/688 (13%)
Query: 57 FGFGFYTALDVQFFLLVV--IHISSAKVVWTAN----RGLLIRDSDKFVFEKNGNAYLQR 110
F FGF F L + IS +VW A L+ + K +G +
Sbjct: 57 FAFGFRKIQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIAD 116
Query: 111 GNG-EAWSANTSGQKVECMELQDSGNLVLLGVNGS-----ILWQSFSHPTDTLLPGQQFV 164
G E W A SG V D GN VL +GS +LW SF +PTDTLLP Q
Sbjct: 117 PRGQELWRA-LSGGSVSRGRFTDDGNFVLFR-DGSEDSDEVLWSSFENPTDTLLPNQNIE 174
Query: 165 EGMRLKSFPNSNNM-----SVYLEFKSGDLVLYA-GYQT-------SQTYWSLANDS--- 208
G L S + S+ LE G+L L++ +T SQ Y S ND
Sbjct: 175 VGRNLSSRRTETSFKKGRFSLRLE-DDGNLQLHSLNAETASESDIYSQYYESNTNDPNNP 233
Query: 209 ---------------RKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENAT 253
++ N+ K S A FY LL I E
Sbjct: 234 GIQLVFNQSGEIYVLQRNNSRFVVKDRDPDF-SIAAPFYISTGFLLSTIIPKEA--RRIV 290
Query: 254 WAAILG------SNGEITFSNLRNGKAATSEAIKIPQISCSVPE------PCNPYFVCYF 301
+LG + + N+ G + C PE P N Y C
Sbjct: 291 GGCLLGLCRDNMCSPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLP 350
Query: 302 DNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTCK 361
D Q CRP T N +N + L E+ ++ G + YD CK
Sbjct: 351 DFEMQ---------TCRPE-NQTANSDVNLYEFITL-EKTNW-PFGDYESYANYDEERCK 398
Query: 362 EACLHNCSCS-VLFFENSTKNCFLFD-QIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSR 419
+CL +C C+ V+F N C+ + +RS +G + ++ S +V + +R
Sbjct: 399 ASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNR 458
Query: 420 ESDGGKPIVLIVVIVVATILVI--ASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISG 477
I+ V++ + VI S Y K K + K D+ +
Sbjct: 459 AKKLDWLIIACSVLLGTSAFVIFDTSCSYR---KTKKSKNMMKNQARDIGRTTATTTANE 515
Query: 478 MPTR-FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG-QGKKE 531
+ R F+Y +L +AT++F+ +LG+G FG VY G L + VAVKKL+ + +KE
Sbjct: 516 LNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKE 575
Query: 532 FSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTR 591
F EV IG +HH +LV+L GFC EG +++ YE+L G+L ++F S W R
Sbjct: 576 FKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPS----WEDR 631
Query: 592 FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
NIA+ +A+G+ YLHEEC +I+HCDIKP+N+LLD+ +T ++SDFGLAKL+ ++ T
Sbjct: 632 KNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLT 691
Query: 652 TLRGTRGYLAPEWITNNPISEKSDVYSY 679
+RGT+GY+APEW N+PI+ K DVYSY
Sbjct: 692 NIRGTKGYVAPEWFRNSPITSKVDVYSY 719
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 209/696 (30%), Positives = 323/696 (46%), Gaps = 100/696 (14%)
Query: 50 LISNNSVFGFGFYTALDV--QFFLLVVIHISSAKVVWTANRGLLIRDSDKFV-FEKNGNA 106
++SN+S F FGF++ ++ ++ + +I VVW AN I DS V K GN
Sbjct: 37 VVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSPINDSSGMVSISKEGNL 96
Query: 107 YLQRGNGEA-WSANT---SGQKVECMELQDSGNLVLLGVNGS---ILWQSFSHPTDTLLP 159
+ G G+ WS N L ++GNLVLLG + ILW+SF HP + LP
Sbjct: 97 VVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTNTGDEILWESFEHPQNIYLP 156
Query: 160 GQQFV------EGMRLKSF-----PNSNNMS---VYLEFKS-----GDLVLY-AGYQTSQ 199
++L+S+ P+ S + L F DL+++ +G Q
Sbjct: 157 TMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQ 216
Query: 200 TYWSLANDSRKTNT---SVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAA 256
+ L N + N ++++ + +S A N LL+ F+
Sbjct: 217 YFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGN------TLLYHFL------------- 257
Query: 257 ILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCYFDNW----CQCPTSLR 312
L S G + + +K+P C C + C F+ C C +
Sbjct: 258 -LDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGFK 316
Query: 313 SQ-----------LNC--RPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNT 359
Q C + P+ + + ++ R+ + +
Sbjct: 317 PQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANEQD 376
Query: 360 CKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGS-TGYVSYMKISSGNEVLNSKS 418
C E+CL NCSC+ F+ C L+ G+L Q+ S TG V Y++++ K
Sbjct: 377 CPESCLKNCSCTAYSFDRGI-GCLLWS--GNLMDMQEFSGTGVVFYIRLADSE----FKK 429
Query: 419 RESDGGKPIVLIVVIVVATILVIASLLYAGLWH---HNKRKRLTKFSQEDLEEDNFLE-- 473
R + + IV+ V ++V L +++ A LW H ++ R T+ E +E + +
Sbjct: 430 RTN---RSIVITVTLLVGAFLFAGTVVLA-LWKIAKHREKNRNTRLLNERMEALSSNDVG 485
Query: 474 -------KISGMPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKL-E 523
K+ +P F + L AT NFS KLGQGGFG+VY G L +G+ +AVK+L
Sbjct: 486 AILVNQYKLKELPL-FEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSR 544
Query: 524 SIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEES 583
+ GQG +EF EV I + H +LV+L GFCIEG R+L YE++ LD ++F+ ++
Sbjct: 545 TSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQ- 603
Query: 584 RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643
R L W TRFNI G+ +GL YLH + +KI+H D+K N+LLD+N K+SDFGLA++
Sbjct: 604 RLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQ 663
Query: 644 REESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYS 678
E V T + GT GY+APE+ SEKSDV+S
Sbjct: 664 GNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFS 699
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 124/267 (46%), Positives = 175/267 (65%), Gaps = 12/267 (4%)
Query: 425 KPIVLIVVIVVATILVIASLLYAGLWHHNKRKRL-TKFSQEDLE---EDNFLEKISGMPT 480
K LI + ++ IL + L ++ +RK L ++F+ E E E +FL K++G+PT
Sbjct: 32 KTFYLIAGVDISLILAVICFLIIRSRYNKERKLLVSRFASEGRELRIEYSFLRKVAGVPT 91
Query: 481 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIG 540
+F +DL +AT F + +G+GG GSV+ G+L DG QVAVK++E +G++EF +EV I
Sbjct: 92 KFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEEKGEREFRSEVAAIA 151
Query: 541 NVHHLHLVKLKGFCIEGAH---RLLAYEYLGNGSLDKWIFNSTEESRF-----LSWNTRF 592
+V H +LV+L G+ + R L Y+Y+ N SLD WIF LSW R+
Sbjct: 152 SVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIFPDRGNRGRSGGGCLSWEQRY 211
Query: 593 NIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652
+A+ +AK LAYLH +C KI+H D+KPEN+LLD+NF A V+DFGL+KL+ R+ES V T
Sbjct: 212 QVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARDESRVLTD 271
Query: 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679
+RGTRGYLAPEW+ + ISEKSDVYSY
Sbjct: 272 IRGTRGYLAPEWLLEHGISEKSDVYSY 298
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 679 | ||||||
| 255553179 | 774 | s-receptor kinase, putative [Ricinus com | 0.938 | 0.822 | 0.728 | 0.0 | |
| 225442967 | 828 | PREDICTED: G-type lectin S-receptor-like | 0.997 | 0.817 | 0.630 | 0.0 | |
| 357455241 | 815 | S-locus-specific glycoprotein S6 [Medica | 0.966 | 0.804 | 0.609 | 0.0 | |
| 356557243 | 814 | PREDICTED: G-type lectin S-receptor-like | 0.983 | 0.820 | 0.602 | 0.0 | |
| 356550614 | 813 | PREDICTED: G-type lectin S-receptor-like | 0.983 | 0.821 | 0.603 | 0.0 | |
| 297743455 | 896 | unnamed protein product [Vitis vinifera] | 0.938 | 0.710 | 0.592 | 0.0 | |
| 224092482 | 816 | predicted protein [Populus trichocarpa] | 0.992 | 0.825 | 0.579 | 0.0 | |
| 449437142 | 776 | PREDICTED: G-type lectin S-receptor-like | 0.936 | 0.819 | 0.587 | 0.0 | |
| 225430295 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.961 | 0.801 | 0.572 | 0.0 | |
| 356562038 | 812 | PREDICTED: G-type lectin S-receptor-like | 0.988 | 0.826 | 0.552 | 0.0 |
| >gi|255553179|ref|XP_002517632.1| s-receptor kinase, putative [Ricinus communis] gi|223543264|gb|EEF44796.1| s-receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 990 bits (2560), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/640 (72%), Positives = 536/640 (83%), Gaps = 3/640 (0%)
Query: 40 MEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFV 99
M+WI+ GLFL+SNNSVFGFGFYTALD + FLLVVIH+ SAKVVWTANRGLL+ DSD+FV
Sbjct: 1 MDWIDKEGLFLLSNNSVFGFGFYTALDARSFLLVVIHMKSAKVVWTANRGLLVSDSDQFV 60
Query: 100 FEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLP 159
F KNGN YLQRG+G AWS NT GQ+V MEL DSGNLVLLG NG ILWQSFSHPTDTLLP
Sbjct: 61 FGKNGNVYLQRGDGIAWSTNTEGQRVTSMELMDSGNLVLLGDNGGILWQSFSHPTDTLLP 120
Query: 160 GQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKV 219
GQ+FVEGM+LKSF N N ++ YLE K GDLVLYAGY Q YWSLANDSRKTN SV KV
Sbjct: 121 GQEFVEGMKLKSFQNKNGLNNYLEIKYGDLVLYAGYIPPQVYWSLANDSRKTNNSVNGKV 180
Query: 220 HSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEA 279
HS SLVSN+WNFYD+ + LLWQFIF E++D NATWA LGS+G I F NL+ G++ EA
Sbjct: 181 HSLSLVSNSWNFYDVNRVLLWQFIFFESSDPNATWAVKLGSDGAIEFYNLQKGRSVAPEA 240
Query: 280 IKIPQISCSVPEPCNPYFVCYFDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGE 339
KIPQ SC +PEPC+ Y+VCYFDNWCQCP L+S+ +C+PPVASTCN S NS +LFY+GE
Sbjct: 241 TKIPQNSCGIPEPCDRYYVCYFDNWCQCPPPLKSEFDCKPPVASTCNGSKNSVELFYVGE 300
Query: 340 RLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGST 399
+LDYFA+GFV P + +LN+CKEACL NCSC VLFFE ST CFLFDQ+GS R Q GS
Sbjct: 301 KLDYFAVGFVKPLLKSNLNSCKEACLDNCSCIVLFFEESTGRCFLFDQLGSFTRIQAGSP 360
Query: 400 GYVSYMKISSGNEVLNSKSRESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLT 459
GYVSYMK+S+ + NSKS S+GG+ +LI VI++AT+ VIA +Y G+W++ ++ R
Sbjct: 361 GYVSYMKVSTSKQ--NSKSG-SNGGREALLIAVIIIATVFVIAGFIYLGVWYNRRKHRFL 417
Query: 460 KFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAV 519
+F Q++LEEDNF + +SGMP R+S+ DLC ATKNFS K+GQGGFGSVYLGMLPDG Q+AV
Sbjct: 418 EFPQDNLEEDNFWDSLSGMPARYSFSDLCTATKNFSMKVGQGGFGSVYLGMLPDGAQLAV 477
Query: 520 KKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS 579
KKLE IGQGKKEF AEV+ IG+VHH+HLVKLKGFC EGAHRLL YE++ GSLDKWIF +
Sbjct: 478 KKLEGIGQGKKEFRAEVSIIGSVHHVHLVKLKGFCAEGAHRLLVYEFMEKGSLDKWIFKN 537
Query: 580 TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639
EES L WNTRFNIA+GMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA
Sbjct: 538 NEESSSLDWNTRFNIAIGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 597
Query: 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
KLMNRE+SLVYTT+RGTRGYLAPEWITNNPISEKSDVYSY
Sbjct: 598 KLMNREDSLVYTTVRGTRGYLAPEWITNNPISEKSDVYSY 637
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442967|ref|XP_002265931.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 910 bits (2352), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/682 (63%), Positives = 537/682 (78%), Gaps = 5/682 (0%)
Query: 1 MGLFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFG 60
MG FR+ C CL+LV K C+A +Q+ G++YPGF+ +QMEW +N G+FL+SN+S F G
Sbjct: 8 MGWFRFLRTFCLCLILVLKICMASTQNTGQIYPGFQGSQMEWKDNKGMFLLSNSSTFALG 67
Query: 61 FYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANT 120
F L+ F+LVVIH++S+K VWTANR LI++SDKFVFEKNGNAYL+ G+ WS +T
Sbjct: 68 FLNTLE-GLFVLVVIHVASSKAVWTANRSFLIQNSDKFVFEKNGNAYLKGGDKIIWSTDT 126
Query: 121 SGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSV 180
+GQ V MELQD+GNLV+LG NG ILWQSFSHPTDTLL GQ+FVEGM+LK F N +N+
Sbjct: 127 AGQGVTAMELQDTGNLVVLGENGRILWQSFSHPTDTLLSGQEFVEGMKLKGFSNRDNLFN 186
Query: 181 YLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLW 240
YLE KSGDL+LYAG+QT QTYWS++N+SRKT KVHSAS++SN+WNFYD +AL+W
Sbjct: 187 YLEMKSGDLILYAGFQTPQTYWSMSNESRKTIYKGHGKVHSASMMSNSWNFYDQNQALVW 246
Query: 241 QFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCY 300
QF FSEN D N TWA +L S G I+F +L+ G A +E+ KIPQ SCSVPEPC PY+VC
Sbjct: 247 QFNFSENLDPNVTWAGVLDSEGSISFYDLQKGNLAPAESTKIPQNSCSVPEPCEPYYVCS 306
Query: 301 FDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTC 360
DN CQCP++L S +NC+P + S CNVS NS +L ++G+ L+YFALGFV+P + DLN C
Sbjct: 307 VDNRCQCPSALNSSVNCKPQITSVCNVSKNSVELLHVGDSLNYFALGFVAPSLKSDLNGC 366
Query: 361 KEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSR- 419
+EAC NCSC VLFFENS+ NCFLFDQIGS QRS S+G++SY+K+S+ ++ ++R
Sbjct: 367 REACFGNCSCLVLFFENSSGNCFLFDQIGSFQRSNWYSSGFISYVKVSNNGDLDGGQNRS 426
Query: 420 --ESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISG 477
E GGK I++IV+I VAT+LVI ++Y G + + + K + + S ++LEED+FL+ ISG
Sbjct: 427 REERKGGKIILVIVLIAVATVLVIFGVVYLG-FRYRREKEIQECSPDNLEEDDFLDSISG 485
Query: 478 MPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVT 537
MP RF Y +L AT NFS KLGQGGFGSVY G+LPDG Q+AVKKLE +GQGKKEF AEV
Sbjct: 486 MPIRFRYKELQNATSNFSEKLGQGGFGSVYKGVLPDGTQLAVKKLEGVGQGKKEFRAEVC 545
Query: 538 TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALG 597
TIG++HH+HLVKLKGFC EGAHRLL YE+LG GSLDK IF + + L W TRF+IALG
Sbjct: 546 TIGSIHHVHLVKLKGFCNEGAHRLLVYEFLGKGSLDKLIFKNNRKDLLLDWETRFSIALG 605
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
AKGLAYLHEEC+ KI+HCDIKPENVLLDDN+ AKVSDFGLAKLMNR++S V+TT+RGTR
Sbjct: 606 TAKGLAYLHEECDPKIIHCDIKPENVLLDDNYLAKVSDFGLAKLMNRDQSHVFTTVRGTR 665
Query: 658 GYLAPEWITNNPISEKSDVYSY 679
GYLAPEWI N+ ISEKSDV+S+
Sbjct: 666 GYLAPEWIANHAISEKSDVFSF 687
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455241|ref|XP_003597901.1| S-locus-specific glycoprotein S6 [Medicago truncatula] gi|355486949|gb|AES68152.1| S-locus-specific glycoprotein S6 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2202), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/665 (60%), Positives = 506/665 (76%), Gaps = 9/665 (1%)
Query: 19 KTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHIS 78
+T A QHI K+YPGF A++++W +NNG FL+SNNS F FGF+T LDV F+LVVIH+S
Sbjct: 21 RTYQAKDQHIQKIYPGFSASRLDWNDNNGFFLLSNNSAFAFGFFTTLDVSLFVLVVIHLS 80
Query: 79 SAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVL 138
S KVVWTANRGLL+++SDK VF +GN YL+ GNG W NT+GQKV MEL DSGNLVL
Sbjct: 81 SYKVVWTANRGLLVKNSDKCVFNHSGNIYLESGNGFVWETNTAGQKVRDMELLDSGNLVL 140
Query: 139 LGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTS 198
G NG +WQSFSHPTDTLLPGQ FVEGM LKSFPN N+ +L + GDLVLYAG++T+
Sbjct: 141 FGENGKAIWQSFSHPTDTLLPGQSFVEGMTLKSFPNRMNLFHFLGYIQGDLVLYAGFETT 200
Query: 199 QTYWSL----ANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATW 254
Q YWSL N +RK T KVH ASLVSN+WNFYD L+W+ +FS+++D + +
Sbjct: 201 QLYWSLMGEVGNRTRKNVTGKTNKVHYASLVSNSWNFYDKNGILVWKTVFSDHSDPKSFY 260
Query: 255 AAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCYFDNWCQCPTSLRSQ 314
AAIL NG I+F +L GK+ E K+PQ C VPEPC+PY+VC+F NWC+CP+ LRS+
Sbjct: 261 AAILDPNGAISFYDLNKGKSTNPEVFKLPQDPCGVPEPCDPYYVCFFANWCECPSLLRSR 320
Query: 315 LNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLF 374
NC+PP S C+ +S +L Y+GE LDYFAL + +P + LN+CK+AC+ NCSC VLF
Sbjct: 321 FNCKPPNISACS-PRSSTELLYVGEHLDYFALKYDAPVLKSTLNSCKDACVKNCSCLVLF 379
Query: 375 FENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGKPIVLIVVIV 434
+ENST CF FDQ GS QR + + GYVSYMK+S+ + + S K ++L+ VIV
Sbjct: 380 YENSTGRCFHFDQTGSFQRFKGSTGGYVSYMKVSTDSGGNDGSSSGK---KNMLLVFVIV 436
Query: 435 VATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNF 494
+ T+LVIA L+ G W + K+K ++ QE LEED+F + +S MP RF+Y L +ATK+F
Sbjct: 437 ILTVLVIAGLI-TGFWCYKKKKSFDEYPQETLEEDDFFDGLSNMPARFTYSALARATKDF 495
Query: 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
STK+G+GGFGSVYLG+L D Q+AVKKLE +GQG KEF AEV+ IG++HH+HLVKLKGFC
Sbjct: 496 STKIGEGGFGSVYLGLLEDDTQLAVKKLEGVGQGAKEFKAEVSIIGSIHHVHLVKLKGFC 555
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
EG HRLL YEY+ GSLDKWIF ++E + L+W TR+NIA+G AKGLAYLHEECEV+I+
Sbjct: 556 AEGPHRLLVYEYMARGSLDKWIFKNSENTLLLTWETRYNIAIGTAKGLAYLHEECEVRII 615
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 674
HCDIKP+NVLLDDNF AKVSDFGLAKLM+RE+S V+TTLRGTRGYLAPEWITN ISEKS
Sbjct: 616 HCDIKPQNVLLDDNFMAKVSDFGLAKLMSREQSHVFTTLRGTRGYLAPEWITNYAISEKS 675
Query: 675 DVYSY 679
DV+SY
Sbjct: 676 DVFSY 680
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557243|ref|XP_003546927.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/690 (60%), Positives = 533/690 (77%), Gaps = 22/690 (3%)
Query: 1 MGLFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFG 60
MG+FR GAL F +LL+F+TC+A QH+ ++YPGF A+Q +W ++NG FL+SN+S F FG
Sbjct: 1 MGIFR-CGALFFYVLLLFRTCLAKDQHVSQIYPGFSASQPDWSDHNGFFLLSNSSAFAFG 59
Query: 61 FYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANT 120
F+T LDV F+LVV+H+SS KVVWTANRGLL+ SDKFV +++GNAYL+ GN W+ NT
Sbjct: 60 FFTTLDVSSFVLVVMHLSSYKVVWTANRGLLVGTSDKFVLDRDGNAYLEGGNSVVWATNT 119
Query: 121 SGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSV 180
+GQK+ MEL DSGNLVLLG NG+ +WQSFSHPTDTLLP Q FV+GM LKSF NS NM
Sbjct: 120 TGQKIRSMELLDSGNLVLLGENGTAIWQSFSHPTDTLLPRQDFVDGMTLKSFHNSLNMCH 179
Query: 181 YLEFKSGDLVLYAGYQTSQTYWSL----ANDSRKTNTSVAAKVHSASLVSNAWNFYDIRK 236
+L +K+GDLVLYAG++T Q YWSL A S + NT KVHSASLVSN+ +FYDI +
Sbjct: 180 FLSYKAGDLVLYAGFETPQVYWSLSGEQAQGSSRNNT---GKVHSASLVSNSLSFYDINR 236
Query: 237 ALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPY 296
ALLW+ +FSE++D + WAA L G ITF +L G+A EA+K+PQ C +P+PC+PY
Sbjct: 237 ALLWKVVFSEHSDPKSLWAATLDPTGAITFYDLNKGRAPNPEAVKVPQDPCGIPQPCDPY 296
Query: 297 FVCYFDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYD 356
+VC+F+NWC CP LR++ NC+PP STC S +S +L Y+GE LDYFAL + +P + +
Sbjct: 297 YVCFFENWCICPKLLRTRFNCKPPNISTC--SRSSTELLYVGEELDYFALKYTAPVSKSN 354
Query: 357 LNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGST--GYVSYMKIS---SGN 411
LN CKE CL NCSC VLFFENST CF FDQ GS QR ++G+ GYVS+MK+S + +
Sbjct: 355 LNACKETCLGNCSCLVLFFENSTGRCFHFDQTGSFQRYKRGAGAGGYVSFMKVSISSASD 414
Query: 412 EVLNSKSRESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKR-LTKFSQEDLEEDN 470
+ +K+R +D +V++V+ V+ + +I G W+ KRK+ + K+ Q+DL+ED+
Sbjct: 415 DGHGNKNRRNDAVLVVVIVVLTVLVIVGLIM-----GFWYFYKRKKNVAKYPQDDLDEDD 469
Query: 471 FLEKI-SGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK 529
SGMP RF++ LC+ATK+FSTK+G+GGFGSVYLG+L DGIQ+AVKKLE +GQG
Sbjct: 470 DFLDSLSGMPARFTFAALCRATKDFSTKIGEGGFGSVYLGVLEDGIQLAVKKLEGVGQGA 529
Query: 530 KEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWN 589
KEF AEV+ IG++HH+HLVKLKGFC EG HRLL YEY+ GSLDKWIF +++ + L+W+
Sbjct: 530 KEFKAEVSIIGSIHHVHLVKLKGFCAEGPHRLLVYEYMARGSLDKWIFKNSDNTFLLNWD 589
Query: 590 TRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649
TR+NIA+G AKGLAYLHEECEV+I+HCDIKP+NVLLDDNFTAKVSDFGLAKLM+RE+S V
Sbjct: 590 TRYNIAIGTAKGLAYLHEECEVRIIHCDIKPQNVLLDDNFTAKVSDFGLAKLMSREQSHV 649
Query: 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
+TTLRGTRGYLAPEWITN ISEKSDV+SY
Sbjct: 650 FTTLRGTRGYLAPEWITNYAISEKSDVFSY 679
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550614|ref|XP_003543680.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2170), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/689 (60%), Positives = 529/689 (76%), Gaps = 21/689 (3%)
Query: 1 MGLFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFG 60
MG+FR G L F +LL+F+TC+A QH+ ++YPGF A+Q +W ++NG FL+SN+S F FG
Sbjct: 1 MGIFR-CGTLFFHVLLLFRTCLAKDQHVSQIYPGFSASQPDWSDHNGFFLLSNSSAFAFG 59
Query: 61 FYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANT 120
F+T LDV F+LVV+H+SS KVVWTANRGLL+ SDKFV + +GNAYL+ GNG W+ NT
Sbjct: 60 FFTTLDVSSFVLVVMHLSSYKVVWTANRGLLVGTSDKFVLDHDGNAYLEGGNGVVWATNT 119
Query: 121 SGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSV 180
GQK+ MEL +SGNLVLLG NG+ +WQSFSHPTDTLLPGQ FVEGM LKSF NS NM
Sbjct: 120 RGQKIRSMELLNSGNLVLLGENGTTIWQSFSHPTDTLLPGQDFVEGMTLKSFHNSLNMCH 179
Query: 181 YLEFKSGDLVLYAGYQTSQTYWSL----ANDSRKTNTSVAAKVHSASLVSNAWNFYDIRK 236
+L +K+GDLVLYAG++T Q YWSL A S K NT KVHSASLVSN+ +FYDI +
Sbjct: 180 FLSYKAGDLVLYAGFETPQVYWSLSGEQAQGSSKNNT---GKVHSASLVSNSLSFYDISR 236
Query: 237 ALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPY 296
ALLW+ +FSE++D + WAA L G ITF +L G+A EA+K+PQ C +P+PC+PY
Sbjct: 237 ALLWKVVFSEDSDPKSLWAATLDPTGAITFYDLNKGRAPNPEAVKVPQDPCGIPQPCDPY 296
Query: 297 FVCYFDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYD 356
+VC+F+NWC CP LR++ NC+PP STC S +S +L Y+GE LDYFAL + +P + +
Sbjct: 297 YVCFFENWCICPKLLRTRYNCKPPNISTC--SRSSTELLYVGEELDYFALKYTAPVSKSN 354
Query: 357 LNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGST--GYVSYMKISSGNEVL 414
LN CKE CL NCSC VLFFENST CF FDQ GS QR ++G+ GYVS+MK+S +
Sbjct: 355 LNACKETCLGNCSCLVLFFENSTGRCFHFDQTGSFQRYKRGAGAGGYVSFMKVS-----I 409
Query: 415 NSKSRESDGGKPIV--LIVVIVVATILVIASLLYAGLWHHNKRKR-LTKFSQEDLEEDNF 471
+S S + G K +++V+V+ +++ L G W+ KRK+ + K+ Q+DL+ED+
Sbjct: 410 SSASDDGHGNKNGRNDMVLVVVIVLTVLVIVGLITGFWYLFKRKKNVAKYPQDDLDEDDD 469
Query: 472 LEKI-SGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK 530
SGMP RF++ LC+ATK+FS+K+G+GGFGSVYLG+L DG Q+AVKKLE +GQG K
Sbjct: 470 FLDSLSGMPARFTFAALCRATKDFSSKIGEGGFGSVYLGVLEDGTQLAVKKLEGVGQGAK 529
Query: 531 EFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNT 590
EF AEV+ IG++HH+HLVKLKGFC EG HRLL YEY+ GSLDKWIF ++E + L+W+T
Sbjct: 530 EFKAEVSIIGSIHHVHLVKLKGFCAEGPHRLLVYEYMARGSLDKWIFKNSENTFLLNWDT 589
Query: 591 RFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650
R+NIA+G AKGLAYLHEEC+V+I+HCDIKP+NVLLDDNFTAKVSDFGLAKLM+RE+S V+
Sbjct: 590 RYNIAIGTAKGLAYLHEECDVRIIHCDIKPQNVLLDDNFTAKVSDFGLAKLMSREQSHVF 649
Query: 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679
TTLRGTRGYLAPEWITN ISEKSDV+SY
Sbjct: 650 TTLRGTRGYLAPEWITNYAISEKSDVFSY 678
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743455|emb|CBI36322.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2158), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/682 (59%), Positives = 505/682 (74%), Gaps = 45/682 (6%)
Query: 1 MGLFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFG 60
MG FR+ C CL+LV K C+A +Q+ G++YPGF+ +QMEW +N G+FL+SN+S F G
Sbjct: 93 MGWFRFLRTFCLCLILVLKICMASTQNTGQIYPGFQGSQMEWKDNKGMFLLSNSSTFALG 152
Query: 61 FYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANT 120
F L+ F+LVVIH++S+K VWTANR LI++SDKFVFEKNGNAYL+ G+ WS +T
Sbjct: 153 FLNTLE-GLFVLVVIHVASSKAVWTANRSFLIQNSDKFVFEKNGNAYLKGGDKIIWSTDT 211
Query: 121 SGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSV 180
+GQ V MELQD+GNLV+LG NG ILWQSFSHPTDTLL GQ+FVEGM+LK F N +N+
Sbjct: 212 AGQGVTAMELQDTGNLVVLGENGRILWQSFSHPTDTLLSGQEFVEGMKLKGFSNRDNLFN 271
Query: 181 YLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLW 240
YLE KSGDL+LYAG+QT QTYWS++N+SRKT KVHSAS++SN+WNFYD +AL+W
Sbjct: 272 YLEMKSGDLILYAGFQTPQTYWSMSNESRKTIYKGHGKVHSASMMSNSWNFYDQNQALVW 331
Query: 241 QFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCY 300
QF FSEN D N TWA +L S G I+F +L+ G A +E+ KIPQ SCSVPEPC PY+VC
Sbjct: 332 QFNFSENLDPNVTWAGVLDSEGSISFYDLQKGNLAPAESTKIPQNSCSVPEPCEPYYVCS 391
Query: 301 FDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTC 360
DN CQCP++L S +NC+P + S CNVS NS +L +
Sbjct: 392 VDNRCQCPSALNSSVNCKPQITSVCNVSKNSVELLH------------------------ 427
Query: 361 KEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSR- 419
NS+ NCFLFDQIGS QRS S+G++SY+K+S+ ++ ++R
Sbjct: 428 ----------------NSSGNCFLFDQIGSFQRSNWYSSGFISYVKVSNNGDLDGGQNRS 471
Query: 420 --ESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISG 477
E GGK I++IV+I VAT+LVI ++Y G + + + K + + S ++LEED+FL+ ISG
Sbjct: 472 REERKGGKIILVIVLIAVATVLVIFGVVYLG-FRYRREKEIQECSPDNLEEDDFLDSISG 530
Query: 478 MPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVT 537
MP RF Y +L AT NFS KLGQGGFGSVY G+LPDG Q+AVKKLE +GQGKKEF AEV
Sbjct: 531 MPIRFRYKELQNATSNFSEKLGQGGFGSVYKGVLPDGTQLAVKKLEGVGQGKKEFRAEVC 590
Query: 538 TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALG 597
TIG++HH+HLVKLKGFC EGAHRLL YE+LG GSLDK IF + + L W TRF+IALG
Sbjct: 591 TIGSIHHVHLVKLKGFCNEGAHRLLVYEFLGKGSLDKLIFKNNRKDLLLDWETRFSIALG 650
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
AKGLAYLHEEC+ KI+HCDIKPENVLLDDN+ AKVSDFGLAKLMNR++S V+TT+RGTR
Sbjct: 651 TAKGLAYLHEECDPKIIHCDIKPENVLLDDNYLAKVSDFGLAKLMNRDQSHVFTTVRGTR 710
Query: 658 GYLAPEWITNNPISEKSDVYSY 679
GYLAPEWI N+ ISEKSDV+S+
Sbjct: 711 GYLAPEWIANHAISEKSDVFSF 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092482|ref|XP_002309629.1| predicted protein [Populus trichocarpa] gi|222855605|gb|EEE93152.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/677 (57%), Positives = 488/677 (72%), Gaps = 3/677 (0%)
Query: 3 LFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFY 62
L R+ G++ +LL+ + C AG QH+G +YPGF+ +QM WIN NGLFLISNNS F FGF
Sbjct: 6 LIRFMGSISLFVLLLPEGCKAGVQHVGTIYPGFQGSQMTWINLNGLFLISNNSNFAFGFS 65
Query: 63 TALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSG 122
T DV FLLVV+H+ S+KV+W+ANRG + SDKF+F +G LQ+G W+A+T G
Sbjct: 66 TTQDVTQFLLVVVHMGSSKVIWSANRGSPVSYSDKFIFGGDGKVSLQKGEAVVWTADTGG 125
Query: 123 QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVYL 182
++V +E+QDSGNLVLLG GS+LWQSFSHPTDTL+ Q FV+GM+L S PNSN ++ L
Sbjct: 126 KRVSAIEMQDSGNLVLLGNGGSVLWQSFSHPTDTLISNQDFVDGMKLVSDPNSNKLTHIL 185
Query: 183 EFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQF 242
E KSGD++L AG+QT Q YWS+ + R T K ASL N+W FYD K L QF
Sbjct: 186 EIKSGDMMLSAGFQTPQPYWSIQKERRMTIDKGGGKPAVASLSGNSWKFYDGNKVFLSQF 245
Query: 243 IFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCYFD 302
IFS++ D N TW A+LG++G I+F NL +G + KIP CS PEPC+ ++VC +
Sbjct: 246 IFSDSTDANGTWIAVLGNDGFISFYNLDDG--GSDSQTKIPSDPCSRPEPCDAHYVCSGN 303
Query: 303 NWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTCKE 362
N CQCP+ L ++LNC+ V S+C+ S S +L G+RL+YFALGFV P DL CK
Sbjct: 304 NVCQCPSGLSNRLNCQTEVVSSCDGSNGSTELVSAGDRLNYFALGFVPPSSITDLEGCKS 363
Query: 363 ACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESD 422
AC NCSC FF NS+ NCFLF IGS Q S GS+ +V+Y+K+SS ++ +
Sbjct: 364 ACHGNCSCLAFFFHNSSGNCFLFSDIGSFQNSNAGSS-FVAYIKVSSDGGSGSNAGGDGS 422
Query: 423 GGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRF 482
G K ++V+IV+ T++VI LLY +H K+K++ + E+DNFLE +SGMP RF
Sbjct: 423 GEKSFPIVVIIVIGTLIVICGLLYMAFRYHRKKKKMLESPPNTSEDDNFLETLSGMPIRF 482
Query: 483 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV 542
SY DL AT NFS KLGQGGFGSVY G LPDG Q+AVKKLE +GQGKKEF AEV+ IG++
Sbjct: 483 SYRDLQTATNNFSVKLGQGGFGSVYQGALPDGTQLAVKKLEGMGQGKKEFRAEVSIIGSI 542
Query: 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
HH HLV++KGFC EG HRLLAYE++ NGSLDKWIF +E L W TRFNIA+G AKGL
Sbjct: 543 HHHHLVRIKGFCAEGTHRLLAYEFMANGSLDKWIFKRNKEEFLLDWETRFNIAVGTAKGL 602
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 662
AYLHE+C+VKI+HCDIKPENVLLD F AKVSDFGLAKLMNRE+S V+TTLRGTRGYLAP
Sbjct: 603 AYLHEDCDVKIIHCDIKPENVLLDGQFLAKVSDFGLAKLMNREQSHVFTTLRGTRGYLAP 662
Query: 663 EWITNNPISEKSDVYSY 679
EWITN ISEKSDVYSY
Sbjct: 663 EWITNYAISEKSDVYSY 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437142|ref|XP_004136351.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/643 (58%), Positives = 472/643 (73%), Gaps = 7/643 (1%)
Query: 40 MEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFV 99
M WI+NNGLFL+SNNS FGFGF T DV FLL VIH SS +VVW+ANR + +SD+F
Sbjct: 1 MNWIDNNGLFLMSNNSKFGFGFVTTQDVTMFLLAVIHTSSLRVVWSANRAFPVANSDEFT 60
Query: 100 FEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGS--ILWQSFSHPTDTL 157
F++ GNA L++G+ WS N+S + V +ELQ+SGNLVL N I+W+SFSHPTDTL
Sbjct: 61 FDEKGNAMLKKGSVVVWSTNSSDKGVSSLELQNSGNLVLRANNSDNEIVWESFSHPTDTL 120
Query: 158 LPGQQFVEGMRLKS-FPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVA 216
L GQ FVEGMRL S N+NNMS +LE KSGD+ L AG+Q+ QTYWS+A ++RKT
Sbjct: 121 LSGQDFVEGMRLVSDLSNNNNMSYFLEMKSGDMTLSAGFQSPQTYWSMAKENRKTVNKNG 180
Query: 217 AKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAAT 276
V+SA+L +N+W FYD K LLWQFIFS +ENATW A+LG +G ++F NL++ AA+
Sbjct: 181 GAVYSATLDTNSWKFYDRSKVLLWQFIFSNVANENATWIAVLGDDGFVSFYNLQDSGAAS 240
Query: 277 SEAIKIPQISCSVPEPCNPYFVCYFDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFY 336
+ +IP+ SCS PEPC PYF+CY N CQCP+ L + +C+P + S C+ S S KL Y
Sbjct: 241 T--TRIPEDSCSTPEPCGPYFICYSGNKCQCPSVLSTNPSCQPGIVSPCHQSNGSIKLAY 298
Query: 337 LGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQ 396
+ YFAL F+ DLN CK AC+ NCSC LFFEN T NCFL D +GS Q S +
Sbjct: 299 -ATGVKYFALEFLPSTSTTDLNGCKNACMSNCSCRALFFENLTGNCFLLDDVGSFQNSNE 357
Query: 397 GSTGYVSYMKISSGNEVLNSKSRESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRK 456
S +VSY+K+S+ ++ +GG ++ +I+V T VI LLY ++ ++K
Sbjct: 358 DSN-FVSYIKVSNNGGSGDNNGGSRNGGMNSHIVAIIIVFTGFVICGLLYLAFCYYKRKK 416
Query: 457 RLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQ 516
+L E E+DNFL+ ++G P R+SYD+L AT NFS KLGQGGFGSVY G+LPDG +
Sbjct: 417 KLPGTPHETSEDDNFLDGLTGAPIRYSYDNLQTATNNFSMKLGQGGFGSVYQGLLPDGTR 476
Query: 517 VAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI 576
VAVKKLE++GQGKKEF AEV+ IG++HH+HLV+LKG+C EG+H+LLAYEY+GNGSLDKWI
Sbjct: 477 VAVKKLEAVGQGKKEFRAEVSIIGSIHHVHLVRLKGYCAEGSHKLLAYEYMGNGSLDKWI 536
Query: 577 FNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636
F +E L WNTRFNIALG AKGLAYLHE+C+VKI+HCDIKPENVLLDD F AKVSDF
Sbjct: 537 FRKNKEDFLLDWNTRFNIALGTAKGLAYLHEDCDVKIIHCDIKPENVLLDDKFLAKVSDF 596
Query: 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
GLAKLM RE+S V+TTLRGTRGYLAPEWITN ISEKSDVYSY
Sbjct: 597 GLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSDVYSY 639
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430295|ref|XP_002282684.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/664 (57%), Positives = 473/664 (71%), Gaps = 11/664 (1%)
Query: 19 KTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHIS 78
+TC+A Q GK+ PGFE +QM WI+N+G FL+SNNS F FGF DVQ FLLVVIH++
Sbjct: 23 ETCMASVQRHGKVEPGFEGSQMNWIDNDGHFLLSNNSDFAFGFEATNDVQLFLLVVIHLA 82
Query: 79 SAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVL 138
+ K++WTANRG +++SDKFVF+ G +LQ+GN WS +T+G+ V +E+QDSGNLVL
Sbjct: 83 AKKIIWTANRGSPVQNSDKFVFDDKGRVFLQKGNRTVWSPDTAGKAVSAIEMQDSGNLVL 142
Query: 139 LGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTS 198
+G G +WQSF HPTDTLL Q F EGM+L+S ++N+S YLE KSG+++LYAGY+T
Sbjct: 143 VGNEGQPIWQSFDHPTDTLLSYQNFKEGMKLESDLTNDNISYYLEIKSGNMILYAGYRTP 202
Query: 199 QTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAIL 258
Q YWS+ ++ K V SAS+ N+W FYD KALLWQF+ S+N D N+TWAA L
Sbjct: 203 QPYWSMKKENLKIVEKDGDPV-SASIEGNSWRFYDRNKALLWQFVLSQNGDTNSTWAATL 261
Query: 259 GSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCYFDNWCQCPTSLRSQLNCR 318
GS+G I+F+ L +G + + +IP SCS P C Y++C N CQCP+ L S+ NC
Sbjct: 262 GSDGFISFTTLSDGGISQVQK-QIPGDSCSSPGFCEAYYICS-SNRCQCPSVLSSRPNCN 319
Query: 319 PPVASTCNVSMNSAKLFYLGERLDYFALGFVSP-FPRYDLNTCKEACLHNCSCSVLFFEN 377
+ S C +S +L G+ +YFA+ F+SP P DLN CK +CL NCSC FF+N
Sbjct: 320 TGIVSPCK---DSTELVNAGDGFNYFAIEFISPSLPDTDLNGCKNSCLSNCSCLASFFKN 376
Query: 378 STKNCFLFDQIGSLQRSQQGSTGYVSYMKISS--GNEVLNSKSRESDGGKPIVLIVVIVV 435
ST NCFLFD +G LQ + G+ Y+K+SS G++V K +V+I V
Sbjct: 377 STGNCFLFDSVGGLQSTD--GQGFAMYIKVSSSGGSDVNPGGDGGGGSKKHFPYVVIIAV 434
Query: 436 ATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFS 495
+T+LVI L+Y G + ++K EEDNFLE +SGMP RFSY DL AT NFS
Sbjct: 435 STVLVIIGLVYVGFRYSRRKKSPESPHDHTSEEDNFLESLSGMPIRFSYKDLQTATDNFS 494
Query: 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
KLGQGGFGSVY G LPDG Q+AVKKLE IGQGKKEF AEV+ IG++HHLHLVKLKGFC
Sbjct: 495 VKLGQGGFGSVYRGALPDGTQLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVKLKGFCA 554
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
EG+HRLLAYE++ NGSLD+WIF E L WNTRFNIALG AKGL+YLHE+C+ KI+H
Sbjct: 555 EGSHRLLAYEFMANGSLDRWIFRKNREGFMLDWNTRFNIALGTAKGLSYLHEDCDAKIIH 614
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSD 675
CDIKPENVLLDDN+ AKVSDFGLAKLM RE+S V+TTLRGTRGYLAPEWITN ISEKSD
Sbjct: 615 CDIKPENVLLDDNYHAKVSDFGLAKLMTREQSHVFTTLRGTRGYLAPEWITNYAISEKSD 674
Query: 676 VYSY 679
VYSY
Sbjct: 675 VYSY 678
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356562038|ref|XP_003549282.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/680 (55%), Positives = 483/680 (71%), Gaps = 9/680 (1%)
Query: 3 LFRYTGALCFCLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFY 62
LF L C+LL + + Q++GK+YPG E +QM WI+ G+ L S N FGFG
Sbjct: 7 LFSAMDTLLLCILLSSEVVLTSYQNVGKVYPGIEGSQMNWIDRYGILLESYNGEFGFGLV 66
Query: 63 T-ALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTS 121
T A D FLL ++H+ + K+VW ANR L + +SDKFVF++ GN L +G WS TS
Sbjct: 67 TTANDSTLFLLAIVHMHTPKLVWVANRELPVSNSDKFVFDEKGNVILHKGESVVWSTYTS 126
Query: 122 GQKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVY 181
G+ V MEL+D+GNLVLLG + ++WQSFSHPTDTLLP Q F+EGM+L S P NN++
Sbjct: 127 GKGVSSMELKDTGNLVLLGNDSRVIWQSFSHPTDTLLPMQDFIEGMKLVSEPGPNNLTYV 186
Query: 182 LEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKV-HSASLVSNAWNFYDIRKALLW 240
LE +SG ++L G QT Q YWS+ DSRK + V SA+L +N+W FYD K+LLW
Sbjct: 187 LEIESGSVILSTGLQTPQPYWSMKKDSRKKIVNKNGDVVASATLDANSWRFYDETKSLLW 246
Query: 241 QFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCY 300
+ F+E +D NATW A+LGS+G ITFSNL +G + + +IPQ SCS PEPC+PY +C
Sbjct: 247 ELDFAEESDANATWIAVLGSDGFITFSNLLSGGSIVASPTRIPQDSCSTPEPCDPYNICS 306
Query: 301 FDNWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTC 360
+ C CP+ L S+ NC+P S CN S ++ +L +RL+YFALGFV P + DL C
Sbjct: 307 GEKKCTCPSVLSSRPNCKPGFVSPCN-SKSTIELVKADDRLNYFALGFVPPSSKTDLIGC 365
Query: 361 KEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRE 420
K +C NCSC +FF +S+ NCFLFD+IGS ++S + S G VSY+K+ S +R+
Sbjct: 366 KTSCSANCSCLAMFFNSSSGNCFLFDRIGSFEKSDKDS-GLVSYIKVVSSE----GDTRD 420
Query: 421 SDGGK-PIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMP 479
S K +++V+IV+ T+ VI+ +L+ K++ L + QED E+D+FLE ++GMP
Sbjct: 421 SGSSKMQTIVVVIIVIVTLFVISGMLFVAHRCFRKKEDLLESPQEDSEDDSFLESLTGMP 480
Query: 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTI 539
R+SY DL AT NFS +LG+GGFGSVY G+LPDG Q+AVKKLE IGQGKKEF EV+ I
Sbjct: 481 IRYSYTDLETATSNFSVRLGEGGFGSVYKGVLPDGTQLAVKKLEGIGQGKKEFRVEVSII 540
Query: 540 GNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMA 599
G++HH HLV+LKGFC EG+HR+LAYEY+ NGSLDKWIFN +E L W+TR+NIALG A
Sbjct: 541 GSIHHHHLVRLKGFCAEGSHRVLAYEYMANGSLDKWIFNKNKEEFVLDWDTRYNIALGTA 600
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
KGLAYLHE+C+ KI+HCDIKPENVLLDDNF KVSDFGLAKLM RE+S V+TTLRGTRGY
Sbjct: 601 KGLAYLHEDCDSKIIHCDIKPENVLLDDNFRVKVSDFGLAKLMTREQSHVFTTLRGTRGY 660
Query: 660 LAPEWITNNPISEKSDVYSY 679
LAPEWITN ISEKSDVYSY
Sbjct: 661 LAPEWITNCSISEKSDVYSY 680
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 679 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.976 | 0.807 | 0.537 | 1.3e-194 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.893 | 0.733 | 0.346 | 6e-87 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.888 | 0.727 | 0.355 | 4.5e-82 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.521 | 0.405 | 0.414 | 1.6e-72 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.450 | 0.368 | 0.377 | 1.4e-67 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.907 | 0.768 | 0.290 | 6.4e-60 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.452 | 0.381 | 0.346 | 1.2e-59 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.455 | 0.382 | 0.350 | 1.5e-59 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.561 | 0.464 | 0.337 | 6.1e-59 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.891 | 0.747 | 0.297 | 7.3e-59 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1885 (668.6 bits), Expect = 1.3e-194, P = 1.3e-194
Identities = 362/674 (53%), Positives = 462/674 (68%)
Query: 13 CLLLVFKTCIAGSQHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALD-VQFFL 71
CL+ + AG IG + PGF +QM +INN+G+FL SNNS FGFGF T D V F
Sbjct: 11 CLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGFGFVTTQDSVTLFT 70
Query: 72 LVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQ 131
L +IH SS K++W+ANR + +SDKFVF+ NGN ++ G E W + SG+ +EL+
Sbjct: 71 LSIIHKSSTKLIWSANRASPVSNSDKFVFDDNGNVVME-GT-EVWRLDNSGKNASRIELR 128
Query: 132 DSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVL 191
DSGNLV++ V+G+ +W+SF HPTDTL+ Q F EGM+L S P+S+NM+ LE KSGD+VL
Sbjct: 129 DSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMTYALEIKSGDMVL 188
Query: 192 YAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDEN 251
T Q YWS+AN + V S+SL+ N+W F+D ++ LLWQF+FS+N D+N
Sbjct: 189 SVNSLTPQVYWSMANARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDN 248
Query: 252 ATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVPEPCNPYFVCYFDNWCQCPTSL 311
TW A+LG+NG I+FSNL +G +A + KIP C PEPC PY+VC C C + L
Sbjct: 249 TTWIAVLGNNGVISFSNLGSGASAADSSTKIPSDLCGTPEPCGPYYVCSGSKVCGCVSGL 308
Query: 312 -RSQLNCRPPVASTCNVSMNSA----KLFYLGERLDYFALGFVSPFPRY-DLNTCKEACL 365
R++ +C+ + S C + ++A +L G+ +DYFALG+ PF + DL++CKE C
Sbjct: 309 SRARSDCKTGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFCH 368
Query: 366 HNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGK 425
+NCSC LFF+NS+ NCFLFD IGS + S G +G+VSY+KI+S D GK
Sbjct: 369 NNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGS--GGGDNGEDDGK 426
Query: 426 PXXXXXXXXXXXXXXXXXXXYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYD 485
+ H ++K + + QE EEDNFLE +SGMP RF+Y
Sbjct: 427 HFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYK 486
Query: 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL 545
DL AT NFS KLGQGGFGSVY G LPDG ++AVKKLE IGQGKKEF AEV+ IG++HHL
Sbjct: 487 DLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL 546
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
HLV+L+GFC EGAHRLLAYE+L GSL++WIF + L W+TRFNIALG AKGLAYL
Sbjct: 547 HLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYL 606
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
HE+C+ +IVHCDIKPEN+LLDDNF AKVSDFGLAKLM RE+S V+TT+RGTRGYLAPEWI
Sbjct: 607 HEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWI 666
Query: 666 TNNPISEKSDVYSY 679
TN ISEKSDVYSY
Sbjct: 667 TNYAISEKSDVYSY 680
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 869 (311.0 bits), Expect = 6.0e-87, P = 6.0e-87
Identities = 231/667 (34%), Positives = 333/667 (49%)
Query: 50 LISNNSVFGFGFYT-ALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFE-KNGNAY 107
++S++ + GF+ F++ + S ++W ANR + D + VF+ NGN
Sbjct: 38 IVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 108 LQRGNGEA--WSAN-TSGQKVECME--LQDSGNLVLL----GVNGSILWQSFSHPTDTLL 158
L GN + WS S V +E LQD GNLVL ++ ++LWQSF HP DT L
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWL 157
Query: 159 PG------QQFVEGMRLKSF-----PNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLAND 207
PG ++ + RL S+ P+ S+ L+ + +L+ G S YWS +
Sbjct: 158 PGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNG---SNEYWS--SG 212
Query: 208 SRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFS 267
+ + V L + +NF F +S N N + ++ +G+I
Sbjct: 213 PWNPQSRIFDSVPEMRL-NYIYNFSFFSNTTDSYFTYSIYNQLNVS-RFVMDVSGQIKQF 270
Query: 268 NLRNGKAATSEAIKIPQISCSVPEPCNPYFVCY--FDNWCQCPTSLR--SQLNCR-PPVA 322
G A + P+ C V C + +C + +C+CP R SQ + +
Sbjct: 271 TWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPFCRCPQGFRPMSQKDWDLKDYS 330
Query: 323 STC------NVSMNSAKLFYLGERLDYFALGFVSP-FPRYDLNTCKEACLHNCSCSVLFF 375
+ C S F+ RL L S R L+ C AC +CSC +
Sbjct: 331 AGCVRKTELQCSRGDINQFF---RLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAY 387
Query: 376 ENSTKNCFLF--DQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESDGGKPXXXXXXX 433
+ + C ++ D + Q + S G + Y+++++ ++V N + K
Sbjct: 388 DEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAA-SDVPNVGASGKSNNKGLIFGAVL 446
Query: 434 XXXXXXXXXXXXYAGLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKN 493
+ + +RKR+ EK G + FSY +L ATKN
Sbjct: 447 GSLGVIVLVLLVVILILRYRRRKRMRG------------EKGDGTLSAFSYRELQNATKN 494
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
FS KLG GGFGSV+ G LPD +AVK+LE I QG+K+F EV TIG + H++LV+L+GF
Sbjct: 495 FSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGF 554
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIF-NSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
C EG+ +LL Y+Y+ NGSLD +F N EE L W RF IALG A+GLAYLH+EC
Sbjct: 555 CSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDC 614
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
I+HCDIKPEN+LLD F KV+DFGLAKL+ R+ S V TT+RGTRGYLAPEWI+ I+
Sbjct: 615 IIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITA 674
Query: 673 KSDVYSY 679
K+DVYSY
Sbjct: 675 KADVYSY 681
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 232/653 (35%), Positives = 334/653 (51%)
Query: 52 SNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRG 111
S NS F F + FL V S + W+A + +G+ L G
Sbjct: 44 SPNSTFSVSFVPSPSPNSFLAAVSFAGSVPI-WSAGT---VDSRGSLRLHTSGSLRLTNG 99
Query: 112 NGEA-WSANTSGQKVECMELQDSGNLVLLGVNGSI-LWQSFSHPTDTLLPGQQFVEGMRL 169
+G W + T V ++D+G +LL N S+ +W SF +PTDT++ Q F G L
Sbjct: 100 SGTTVWDSKTDRLGVTSGSIEDTGEFILLN-NRSVPVWSSFDNPTDTIVQSQNFTAGKIL 158
Query: 170 KSFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA-NDSRKTNTSVAAKVHSASLVSNA 228
+S S LE +SG+L L + TS YW+ N S +N S + ++ SL +N
Sbjct: 159 RS----GLYSFQLE-RSGNLTLR--WNTSAIYWNHGLNSSFSSNLS-SPRL---SLQTNG 207
Query: 229 W-NFYDIRKALLWQFIFSENNDENATWAAI-LGSNGEITF--SNLRNGKAATSEAIKIPQ 284
+ ++ + ++S + ++ T+ + L +G + S RN + + Q
Sbjct: 208 VVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQ 267
Query: 285 ISCSVPEPCNPYFVCYFDNW---CQCPTSLRS--QLN-----CRPPVA-STCNVSMNSAK 333
C V C + +C +++ C CP+ +N C+ V S C S N+
Sbjct: 268 --CLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDC--SGNTTM 323
Query: 334 LFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSC-SVLFFENSTKNCFLFDQIGSLQ 392
L + RL + S + C+ CL + C + + + + NC+ GS
Sbjct: 324 LDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQ-KHPGSFF 382
Query: 393 RSQQG-STGYVSYMKISSGNEVLNSKSRESDG----GKPXXXXXXXXXXXXXXXXXXXYA 447
Q S SY+K+ G V N+ R + G K
Sbjct: 383 TGYQWPSVPSTSYVKVC-GPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEI 441
Query: 448 GLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVY 507
GLW RK +F LE SG P +F+Y +L + TK+F KLG GGFG+VY
Sbjct: 442 GLWWCCCRKN-PRFGTLS-SHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVY 499
Query: 508 LGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567
G+L + VAVK+LE I QG+K+F EV TI + HHL+LV+L GFC +G HRLL YE++
Sbjct: 500 RGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFM 559
Query: 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD 627
NGSLD ++F +T+ ++FL+W RFNIALG AKG+ YLHEEC IVHCDIKPEN+L+DD
Sbjct: 560 RNGSLDNFLF-TTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDD 618
Query: 628 NFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
NF AKVSDFGLAKL+N +++ +++RGTRGYLAPEW+ N PI+ KSDVYSY
Sbjct: 619 NFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSY 671
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 733 (263.1 bits), Expect = 1.6e-72, P = 1.6e-72
Identities = 158/381 (41%), Positives = 222/381 (58%)
Query: 320 PVASTCN--VSMNSAKLFYL--GERLDYFALGFVSPFPR-YDLNTCKEACLHNCSCSVLF 374
PV+ + + VS + + YL G + YF+ F P L C + C NCSC +F
Sbjct: 327 PVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVF 386
Query: 375 FENSTKNCFLF-DQIGSLQRSQQGSTGY--VSYMKISSGNEVLNSKSRESDGGKPXXXXX 431
+EN++++C+L D GSL + + + Y+K+S + GG
Sbjct: 387 YENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIA 446
Query: 432 XXXXXXXXXXXXXXYAGLWHHN---------KRKRLTK---FSQEDLEEDNFLEKISGMP 479
LW + K++T+ F DL +F I G+P
Sbjct: 447 LVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDL--GSF--HIPGLP 502
Query: 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTT 538
+F +++L +AT+NF ++G GGFGSVY G LPD +AVKK+ + G G++EF E+
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAI 562
Query: 539 IGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM 598
IGN+ H +LVKL+GFC G LL YEY+ +GSL+K +F+ L W RF+IALG
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGN--GPVLEWQERFDIALGT 620
Query: 599 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 658
A+GLAYLH C+ KI+HCD+KPEN+LL D+F K+SDFGL+KL+N+EES ++TT+RGTRG
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRG 680
Query: 659 YLAPEWITNNPISEKSDVYSY 679
YLAPEWITN ISEK+DVYSY
Sbjct: 681 YLAPEWITNAAISEKADVYSY 701
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 1.4e-67, Sum P(3) = 1.4e-67
Identities = 127/336 (37%), Positives = 180/336 (53%)
Query: 360 CKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGS-TGYVSYMKISSGNEVLNSKS 418
C E+CL NCSC+ F+ C L+ G+L Q+ S TG V Y++++ ++
Sbjct: 377 CPESCLKNCSCTAYSFDRGI-GCLLWS--GNLMDMQEFSGTGVVFYIRLADSE--FKKRT 431
Query: 419 RESDGGKPXXXXXXXXXXXXXXXXXXXYAGLWH---HNKRKRLTKFSQEDLE--EDNFLE 473
S LW H ++ R T+ E +E N +
Sbjct: 432 NRS------IVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVG 485
Query: 474 -------KISGMPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLE- 523
K+ +P F + L AT NFS KLGQGGFG+VY G L +G+ +AVK+L
Sbjct: 486 AILVNQYKLKELPL-FEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSR 544
Query: 524 SIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEES 583
+ GQG +EF EV I + H +LV+L GFCIEG R+L YE++ LD ++F+ ++
Sbjct: 545 TSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQ- 603
Query: 584 RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643
R L W TRFNI G+ +GL YLH + +KI+H D+K N+LLD+N K+SDFGLA++
Sbjct: 604 RLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQ 663
Query: 644 REESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYS 678
E V T + GT GY+APE+ SEKSDV+S
Sbjct: 664 GNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFS 699
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
Identities = 193/665 (29%), Positives = 294/665 (44%)
Query: 47 GLFLISNNSVFGFGFYTALDVQFFLLVVIH--ISSAKVVWTANRGLLIRDSDK-FVFEKN 103
G L S N +F GF++ + + + + I VVW ANR + D+ N
Sbjct: 30 GQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGIIPRTVVWVANRENSVTDATADLAISSN 89
Query: 104 GNAYLQRG-NGEAWSAN-TSGQKVECMELQDSGNLVLLG-VNGSILWQSFSHPTDTLLPG 160
G+ L G + WS T EL DSGNL+++ V+G LWQSF H DT+LP
Sbjct: 90 GSLLLFDGKHSTVWSTGETFASNGSSAELSDSGNLLVIDKVSGITLWQSFEHLGDTMLPY 149
Query: 161 QQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVH 220
+ ++ Y + G+ V Y Q + + + AK
Sbjct: 150 SSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYITTQVPPQGFIMRGSKPYWRSGPWAKTR 209
Query: 221 --SASLVSNAWNF-YDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATS 277
L ++ + +++ FS +L S G + ++ NG
Sbjct: 210 FTGVPLTDESYTHPFSVQQDANGSVYFSHLQRNFKRSLLVLTSEGSLKVTH-HNGTDWVL 268
Query: 278 EAIKIPQISCSVPEPCNPYFVCYFD--NWCQCPTSLRSQLNCRPPVASTCNVSMNSAKLF 335
I +P +C C P+ +C C+C Q + + + +L
Sbjct: 269 N-IDVPANTCDFYGVCGPFGLCVMSIPPKCKCFKGFVPQFSEEWKRGNWTGGCVRRTELL 327
Query: 336 Y----LGERLDYF-ALGFVSPFPRYDL------NTCKEACLHNCSCSVLFFENSTKNCFL 384
G ++ F + + P Y+ C ++CLHNCSC + N C +
Sbjct: 328 CQGNSTGRHVNVFHPVANIKPPDFYEFVSSGSAEECYQSCLHNCSCLAFAYINGI-GCLI 386
Query: 385 FDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESD-GGKPXXXXXXXXXXXXXXXXX 443
++Q + M+ S G E+L+ + S+ GG
Sbjct: 387 WNQ------------ELMDVMQFSVGGELLSIRLASSEMGGNQRKKTIIASIVSISLFVT 434
Query: 444 XXYA--GLWHHNKRKR--LTKFS-QEDLEEDNFLEKISGMPTRFSYDDLCKATKNFS--T 496
A G W + + ++K S Q D E +SG+ F + AT NFS
Sbjct: 435 LASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSEDVSGLYF-FEMKTIEIATNNFSLVN 493
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
KLGQGGFG VY G L DG ++AVK+L S GQGK+EF E+ I + H++LV++ G CI
Sbjct: 494 KLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCI 553
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
EG RLL YE++ N SLD +IF+S + + W RF+I G+A+GL YLH + ++I+H
Sbjct: 554 EGEERLLVYEFMVNKSLDTFIFDSRKRVE-IDWPKRFSIIQGIARGLLYLHRDSRLRIIH 612
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISEKS 674
D+K N+LLDD K+SDFGLA++ + T + GT GY++PE+ SEKS
Sbjct: 613 RDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVGTLGYMSPEYAWTGVFSEKS 672
Query: 675 DVYSY 679
D YS+
Sbjct: 673 DTYSF 677
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 1.2e-59, Sum P(2) = 1.2e-59
Identities = 115/332 (34%), Positives = 181/332 (54%)
Query: 356 DLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLN 415
D C ++CLHNCSC + + C +++Q + ++ S+G E+L+
Sbjct: 364 DAEECHQSCLHNCSCLAFAYIHGI-GCLIWNQ------------NLMDAVQFSAGGEILS 410
Query: 416 SKSRESD-GGKPXXXXXXXXXXXXXXXXXXXYA--GLWHHNKRKRLTKFSQEDLEEDNFL 472
+ S+ GG A G W + + + ++ +D ++
Sbjct: 411 IRLAHSELGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKA--YTLKDAWRNDLK 468
Query: 473 EK-ISGMPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQG 528
K + G+ F + + AT NFS KLGQGGFGSVY G L DG ++AVK+L S GQG
Sbjct: 469 SKEVPGLEF-FEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQG 527
Query: 529 KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSW 588
K+EF E+ I + H +LV++ G CIEG +LL YE++ N SLD ++F++ ++ + W
Sbjct: 528 KEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLE-VDW 586
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
RF+I G+A+GL YLH + +K++H D+K N+LLD+ K+SDFGLA++ +
Sbjct: 587 PKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQ 646
Query: 649 VYTT-LRGTRGYLAPEWITNNPISEKSDVYSY 679
T + GT GY++PE+ SEKSD+YS+
Sbjct: 647 DKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSF 678
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 1.5e-59, Sum P(2) = 1.5e-59
Identities = 117/334 (35%), Positives = 174/334 (52%)
Query: 356 DLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLN 415
++ C+++CLHNCSC + D IG L +Q + ++ S G E+L+
Sbjct: 364 NVEECQKSCLHNCSCLAFAY---------IDGIGCLMWNQD----LMDAVQFSEGGELLS 410
Query: 416 SKSRESD-GGKPXXXXXXXXXXXXXXXXXXXYAGL--WHHNKRKRL---TKFSQEDLEED 469
+ S+ GG + W + + T SQ D
Sbjct: 411 IRLARSELGGNKRKKAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITTDASQVSWRND 470
Query: 470 NFLEKISGMPTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-G 526
+ + G+ F + AT NFS KLGQGGFG VY G L DG ++AVK+L S G
Sbjct: 471 LKPQDVPGLDF-FDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSG 529
Query: 527 QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFL 586
QGK+EF E+ I + H +LV++ G CIEG +LL YE++ N SLD ++F+S + +
Sbjct: 530 QGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLE-I 588
Query: 587 SWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646
W R +I G+A+G+ YLH + +K++H D+K N+LLD+ K+SDFGLA++ E
Sbjct: 589 DWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTE 648
Query: 647 SLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSY 679
T + GT GY+APE+ SEKSD+YS+
Sbjct: 649 YQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSF 682
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 6.1e-59, Sum P(2) = 6.1e-59
Identities = 144/427 (33%), Positives = 217/427 (50%)
Query: 283 PQISCSVPEPCNPYFVCYFDN--WCQC-----PTS---LRSQLNCRPPVASTCNVS-MNS 331
P SC + C P+ +C CQC P S RS R V T N+S +
Sbjct: 276 PLTSCDLYGRCGPFGLCVRSGTPMCQCLKGFEPKSDEEWRSGNWSRGCVRRT-NLSCQGN 334
Query: 332 AKLFYLGERLD-YFALGFVSPFPRYDLNT------CKEACLHNCSCSVLFFENSTKNCFL 384
+ + G+ D ++ + + P Y+L + C + CL NCSC+ + +
Sbjct: 335 SSVETQGKDRDVFYHVSNIKPPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSG------ 388
Query: 385 FDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESD--GGKPXXXXXXXXXXXXXXXX 442
IG L +Q+ + +K G E L+ + S+ G K
Sbjct: 389 ---IGCLVWNQE----LLDTVKFIGGGETLSLRLAHSELTGRKRIKIITVATLSLSVCLI 441
Query: 443 XXXYA-GLWHHN-KRKRLTKFSQEDLE----EDNFLEKISGMPTRFSYDDLCKATKNFST 496
A G W + K+ + S++++E D + +SG+ F DL AT NFS
Sbjct: 442 LVLVACGCWRYRVKQNGSSLVSKDNVEGAWKSDLQSQDVSGL-NFFEIHDLQTATNNFSV 500
Query: 497 --KLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLGQGGFG+VY G L DG ++AVK+L S QG +EF E+ I + H +L++L G
Sbjct: 501 LNKLGQGGFGTVYKGKLQDGKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGC 560
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
CI+G +LL YEY+ N SLD +IF+ ++ + W TRFNI G+A+GL YLH + +++
Sbjct: 561 CIDGEEKLLVYEYMVNKSLDIFIFDLKKKLE-IDWATRFNIIQGIARGLLYLHRDSFLRV 619
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNPISE 672
VH D+K N+LLD+ K+SDFGLA+L + + T ++ GT GY++PE+ SE
Sbjct: 620 VHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSE 679
Query: 673 KSDVYSY 679
KSD+YS+
Sbjct: 680 KSDIYSF 686
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 202/678 (29%), Positives = 302/678 (44%)
Query: 47 GLFLISNNSVFGFGFYTALDVQ--FFLLVVIHISSAKVVWTANRGLLIRDSD-KFVFEKN 103
G L S+N V+ GF++ + Q + + I VVW ANR + DS N
Sbjct: 35 GKTLSSSNGVYELGFFSFNNSQNQYVGIWFKGIIPRVVVWVANREKPVTDSAANLTISSN 94
Query: 104 GNAYLQRGNGEA-WS-ANTSGQKVECMELQDSGNLVLLGVN-GSILWQSFSHPTDTLLPG 160
G+ L N WS T EL D+GNLV++ N G LW+SF H DT+LP
Sbjct: 95 GSLLLFNENHSVVWSIGETFASNGSRAELTDNGNLVVIDNNSGRTLWESFEHFGDTMLPF 154
Query: 161 QQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQT---------SQTYWSLANDSRKT 211
+ + + + + GD + Q S+TYW ++
Sbjct: 155 SNLMYNLATGEKRVLTSWKSHTDPSPGDFTVQITPQVPSQACTMRGSKTYWRSGPWAKTR 214
Query: 212 NTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRN 271
T + V + S D + F + E N + + ++ S G + N
Sbjct: 215 FTGIP--VMDDTYTSPFSLQQDTNGS--GSFTYFERNFKLSY--IMITSEGSLKIFQ-HN 267
Query: 272 GKAATSEAIKIPQISCSVPEPCNPYFVCYFD--NWCQC-----PTSLRSQLN------CR 318
G + P+ SC + C P+ +C C+C P S+ C
Sbjct: 268 GMDWELN-FEAPENSCDIYGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRGNWTDGCV 326
Query: 319 PPVASTCNVSMNSAKL--FYLGERL---DYFALGFVSPFPRYDLNTCKEACLHNCSCSVL 373
C + N + FY + D++ F S F D C + CLHNCSC
Sbjct: 327 RHTELHCQGNTNGKTVNGFYHVANIKPPDFYE--FAS-F--VDAEGCYQICLHNCSCLAF 381
Query: 374 FFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKISSGNEVLNSKSRESD-GGKPXXXXXX 432
+ N C +++Q + ++ S+G E+L+ + S+ GG
Sbjct: 382 AYINGI-GCLMWNQ------------DLMDAVQFSAGGEILSIRLASSELGGNKRNKIIV 428
Query: 433 XXXXXXXXXXXXXYAGLWH------HNKRKRLTKF-SQEDLEEDNFLEKISGMPTRFSYD 485
+A H +++K S+E D + +SG+ F +
Sbjct: 429 ASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAWNNDLEPQDVSGLKF-FEMN 487
Query: 486 DLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTTIGNV 542
+ AT NFS KLGQGGFGSVY G L DG ++AVK+L S GQGK+EF E+ I +
Sbjct: 488 TIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKL 547
Query: 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
H +LV++ G CIEG RLL YE+L N SLD ++F+S + + W RFNI G+A+GL
Sbjct: 548 QHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLE-IDWPKRFNIIEGIARGL 606
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLA 661
YLH + ++++H D+K N+LLD+ K+SDFGLA++ E T + GT GY+A
Sbjct: 607 HYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMA 666
Query: 662 PEWITNNPISEKSDVYSY 679
PE+ SEKSD+YS+
Sbjct: 667 PEYAWTGMFSEKSDIYSF 684
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWZ5 | SD25_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5445 | 0.9764 | 0.8075 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 679 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-23 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-19 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-08 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd01100 | 73 | cd01100, APPLE_Factor_XI_like, Subfamily of PAN/AP | 5e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| smart00605 | 94 | smart00605, CW, CW domain | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 0.004 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 7e-47
Identities = 67/188 (35%), Positives = 94/188 (50%), Gaps = 13/188 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTTIGNVHHLHLVKLKG 552
KLG G FG+VY G VAVK L+ + K+ E+ + + H ++V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ H L EY G L ++ LS + IAL + +GL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TNNPIS 671
I+H D+KPEN+LLD+N K++DFGLAK + + S TT GT Y+APE + N
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 672 EKSDVYSY 679
K DV+S
Sbjct: 178 PKVDVWSL 185
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 72/186 (38%), Positives = 103/186 (55%), Gaps = 12/186 (6%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
LG+GGFG+VYL G +VA+K + E +E E+ + ++H ++VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ H L EY GSL + E LS + I L + +GL YLH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 615 HCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WITNNPISE 672
H D+KPEN+LLD DN K++DFGL+KL+ ++SL T+ GT Y+APE + SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 673 KSDVYS 678
KSD++S
Sbjct: 174 KSDIWS 179
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 58/185 (31%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLG+G FG VYL G VA+K + + I + ++ E+ + + H ++V+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ L EY G L + + R RF + L YLH + I
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLHSK---GI 118
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
VH D+KPEN+LLD++ K++DFGLA+ ++ E TT GT Y+APE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 674 SDVYS 678
D++S
Sbjct: 177 VDIWS 181
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 494 FSTKLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLH 546
KLG+G FG VY G L ++VAVK L ++ Q +EF E + + H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+VKL G C E ++ EY+ G L + + LS + + AL +A+G+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLD--YLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPE 663
+ +H D+ N L+ +N K+SDFGL++ + ++ Y ++G + ++APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAPE 174
Query: 664 WITNNPISEKSDVYSY 679
+ + KSDV+S+
Sbjct: 175 SLKEGKFTSKSDVWSF 190
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 19/196 (9%)
Query: 494 FSTKLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLH 546
KLG+G FG VY G L ++VAVK L ++ Q +EF E + + H +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+VKL G C E + EY+ G L ++ + + LS + + AL +A+G+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLE 119
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPE 663
+ +H D+ N L+ +N K+SDFGL++ + ++ Y RG + ++APE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAPE 173
Query: 664 WITNNPISEKSDVYSY 679
+ + KSDV+S+
Sbjct: 174 SLKEGKFTSKSDVWSF 189
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 18/196 (9%)
Query: 494 FSTKLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLH 546
KLG+G FG VY G L +VAVK L + + ++EF E + + + H +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+V+L G C +G + EY+ G L ++ + L+ +AL +AKG+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPE 663
VH D+ N L+ +N K+SDFGL++ + ++ Y G + ++APE
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY--YRKRGGGKLPIKWMAPE 174
Query: 664 WITNNPISEKSDVYSY 679
+ + + KSDV+S+
Sbjct: 175 SLKDGKFTSKSDVWSF 190
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 497 KLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
KLG+G FG VY G L +VAVK L ++ + +K+F E + + H ++V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDK-----WIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
G C E L EY+ G L + E LS + A+ +AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAP 662
K VH D+ N L+ ++ K+SDFGL++ + ++ Y G + ++AP
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD--YYRKKTGGKLPIRWMAP 176
Query: 663 EWITNNPISEKSDVYSY 679
E + + + KSDV+S+
Sbjct: 177 ESLKDGIFTSKSDVWSF 193
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 26/195 (13%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLKG 552
LG+G FGSVYL + D G +AVK +E G ++E A E+ + ++ H ++V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 553 FCI--EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIAL------GMAKGLAY 604
E + EY+ GSL S L + + + +GLAY
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSL----------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPE 663
LH IVH DIK N+L+D + K++DFG AK + E+ T ++RGT ++APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 664 WITNNPISEKSDVYS 678
I +D++S
Sbjct: 174 VIRGEEYGRAADIWS 188
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFS-AEVTTIGNVHHLHLVKLKG 552
++G+G FG VYL DG +K+ L ++ + ++E + EV + ++H +++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLS----WNTRFNIALGMAKGLAYLHEE 608
E + EY G L + I +E + + + L L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKYLHSR 122
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
KI+H DIKP+N+ L N K+ DFG++K+++ + T+ GT YL+PE N
Sbjct: 123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPELCQNK 178
Query: 669 PISEKSDVYS 678
P + KSD++S
Sbjct: 179 PYNYKSDIWS 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
K+G+GGFG VY G +VA+K + + K++ E+ + H ++VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLAYLHEE 608
++ + E+ GSL + ST N + + KGL YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKST--------NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
I+H DIK N+LL + K+ DFGL+ ++ ++ T+ GT ++APE I
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGK 172
Query: 669 PISEKSDVYS 678
P K+D++S
Sbjct: 173 PYDYKADIWS 182
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 22/194 (11%)
Query: 494 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTTIGNVHHLHLVK 549
+G+G FG VY G+ L G VA+K++ + K E+ + N+ H ++VK
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWI-----FNSTEESRFLSWNTRFNIALGMAKGLAY 604
G + EY NGSL + I F + + ++ + +GLAY
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY---------QVLQGLAY 114
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LHE+ ++H DIK N+L + K++DFG+A +N + + GT ++APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEV 170
Query: 665 ITNNPISEKSDVYS 678
I + S SD++S
Sbjct: 171 IEMSGASTASDIWS 184
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (282), Expect = 5e-27
Identities = 69/197 (35%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKL----ESIGQGKKEFSAEVTTIGNV-HHLHLVKLK 551
KLG+G FG VYL D VA+K L ES + + F E+ + ++ H ++VKL
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
F + L EY+ GSL+ + LS + I + L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL-KKIGRKGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 612 KIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLV-----YTTLRGTRGYLAPEWI 665
I+H DIKPEN+LLD D K+ DFGLAKL+ S +T GT GY+APE +
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 666 T---NNPISEKSDVYSY 679
S SD++S
Sbjct: 181 LGLSLAYASSSSDIWSL 197
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 60/186 (32%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G FG V LG G +VAVK L+ + F AE + + + H +LV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
++G + EY+ GSL ++ + ++ + AL + +G+ YL E+
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
VH D+ NVL+ ++ AKVSDFGLAK E S + + + APE + S K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 180 SDVWSF 185
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/186 (31%), Positives = 91/186 (48%), Gaps = 11/186 (5%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
KLG G FG V++G +VAVK L+ + F E + + H LV+L C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ GSL F + E + L ++A +A+G+AYL +H
Sbjct: 73 EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D+ N+L+ +N K++DFGLA+L+ +E YT G + + APE + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 185 SDVWSF 190
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLP-----DGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLH 546
F +LG+G FG V L G QVAVK L Q + +F E+ + + H +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 547 LVKLKGFCIEGAHR---LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
+VK KG C E L EYL +GSL ++ ++ + + KG+
Sbjct: 68 IVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMD 123
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG----Y 659
YL + + +H D+ N+L++ K+SDFGLAK++ E Y ++ +
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP--EDKDYYYVKEPGESPIFW 178
Query: 660 LAPEWITNNPISEKSDVYSY 679
APE + + S SDV+S+
Sbjct: 179 YAPECLRTSKFSSASDVWSF 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/186 (32%), Positives = 99/186 (53%), Gaps = 11/186 (5%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK-KEFSAEVTTIGNVHHLHLVKLKGFCI 555
KLG G FG V+ G+ + ++VA+K L+S K ++F EV + + H HL+ L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
G + E + GSL F + E + L + ++A +A+G+AYL E+ +H
Sbjct: 73 VGEPVYIITELMEKGSLL--AFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY--LAPEWITNNPISEK 673
D+ N+L+ ++ KV+DFGLA+L+ + VY + Y APE ++ S K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKED---VYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 185 SDVWSF 190
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 17/191 (8%)
Query: 498 LGQGGFGSVYLGML----PDGIQVAVKKLESIGQGKK--EFSAEVTTIGNVHHLHLVKLK 551
+G G FG V G L I VA+K L++ K+ +F E + +G H ++++L+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G + ++ EY+ NGSLDK++ + + + + G+A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNN 668
VH D+ N+L++ N KVSDFGL++ + E+ YTT +G + + APE I
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYTT-KGGKIPIRWTAPEAIAYR 183
Query: 669 PISEKSDVYSY 679
+ SDV+S+
Sbjct: 184 KFTSASDVWSF 194
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 63/195 (32%), Positives = 103/195 (52%), Gaps = 25/195 (12%)
Query: 498 LGQGGFGSVYLGM-LPDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG G FG+VY G+ +P+G I VA+K L E+ + KE E + +V H H+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESR---FLSWNTRFNIALGMAKGLAYLHE 607
G C+ +L+ + + G L ++ N + L+W + +AKG++YL E
Sbjct: 75 LGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 664
++VH D+ NVL+ K++DFGLAKL++ +E + G + ++A E
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKVPIKWMALES 182
Query: 665 ITNNPISEKSDVYSY 679
I + + KSDV+SY
Sbjct: 183 ILHRIYTHKSDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 68/193 (35%), Positives = 93/193 (48%), Gaps = 22/193 (11%)
Query: 498 LGQGGFGSVYLG--MLPDG--IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG G FGSV G ++ G ++VAVK L E I GKKEF E + + + H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTE--ESRFLSWNTRFNIALGMAKGLAYLHEEC 609
G C +G +L E G L K++ E S + +A+GMA YL E
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ--VAMGMA----YL-ESK 114
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 666
VH D+ NVLL + AK+SDFG+++ + Y R + APE I
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECIN 171
Query: 667 NNPISEKSDVYSY 679
S KSDV+SY
Sbjct: 172 YGKFSSKSDVWSY 184
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 7e-23
Identities = 45/83 (54%), Positives = 53/83 (63%), Gaps = 3/83 (3%)
Query: 82 VVWTANRGLLIRDSD-KFVFEKNGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGNLVL 138
VVW ANR + DS + + +GN L GNG WS+NTSG+ C LQD GNLVL
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLVL 63
Query: 139 LGVNGSILWQSFSHPTDTLLPGQ 161
+G +LWQSF HPTDTLLPGQ
Sbjct: 64 YDNSGKVLWQSFDHPTDTLLPGQ 86
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 11/186 (5%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
KLG G FG V+ G+ + VAVK L+ K+F AE + + H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ E + GSL +++ R L ++A +A G+AYL + +H
Sbjct: 73 EEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D+ NVL+ +N KV+DFGLA+++ + Y G + + APE N S K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 185 SDVWSF 190
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 59/186 (31%), Positives = 102/186 (54%), Gaps = 10/186 (5%)
Query: 497 KLGQGGFGSVYL-GMLPDGIQVAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKLKG 552
KLG+G +GSVY L D A+K+ L S+ Q ++E + E+ + +V+H +++ K
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
++G + EY G L K I ++ + + + I + + +GL LHE+ K
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
I+H D+K N+LL N K+ D G++K++ ++++ T + GT Y+APE P S
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWKGRPYSY 180
Query: 673 KSDVYS 678
KSD++S
Sbjct: 181 KSDIWS 186
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 496 TKLGQGGFGSVYLGMLPD------GIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLH 546
+LGQG FG VY G+ +VA+K + S+ + + EF E + + + H
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-RIEFLNEASVMKEFNCHH 70
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF------LSWNTRFNIALGMAK 600
+V+L G G L+ E + G L ++ + E+ + +A +A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
G+AYL + K VH D+ N ++ ++ T K+ DFG+ + + E+ Y +G +G L
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYR--KGGKGLL 183
Query: 661 -----APEWITNNPISEKSDVYSY 679
APE + + + KSDV+S+
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSF 207
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 64/195 (32%), Positives = 93/195 (47%), Gaps = 23/195 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
K+G G FG VY + L G +AVK++ ++ + KE + E+ + + H +LVK G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 553 FCIEGAHR---LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+E HR + EY G+L E R L + L + +GLAYLH
Sbjct: 67 --VE-VHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH- 118
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT---TLRGTRGYLAPEWIT 666
IVH DIKP N+ LD N K+ DFG A + + + +L GT Y+APE IT
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 667 NNPISEK---SDVYS 678
+D++S
Sbjct: 177 GGKGKGHGRAADIWS 191
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 9/190 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTTIGNVHHLHLVKLKG 552
+G+G FG+V DG + K+++ +KE +EV + + H ++V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 553 -FCIEGAHRLLAY-EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH--EE 608
L EY G L + I +E +++ + I + L H +
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
++H D+KP N+ LD N K+ DFGLAK++ + S T GT Y++PE + +
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYVGTPYYMSPEQLNHM 185
Query: 669 PISEKSDVYS 678
EKSD++S
Sbjct: 186 SYDEKSDIWS 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 20/193 (10%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
F +LG G FG V+LG I VA+K + + +F E + + H +LV+L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMA----KGLAYLHEEC 609
C + + EY+ NG L ++ + + L M + + YL
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL--RERKGKL-----GTEWLLDMCSDVCEAMEYLESNG 120
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 666
+H D+ N L+ ++ KVSDFGLA+ + ++ YT+ +GT+ + PE
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174
Query: 667 NNPISEKSDVYSY 679
+ S KSDV+S+
Sbjct: 175 YSRFSSKSDVWSF 187
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 58/186 (31%), Positives = 95/186 (51%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
KLG G FG V++G +VA+K L+ + F AE + + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
++ EY+ NGSL F T E L+ N ++A +A+G+A++ + +H
Sbjct: 73 EPIYIIT-EYMENGSLVD--FLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D++ N+L+ + K++DFGLA+L+ E YT G + + APE I + K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 184 SDVWSF 189
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 497 KLGQGGFGSVYL-GMLPDGIQVAVKKLES-IGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
++G+G G V+ G VA+KK+ +G A E+ + H ++VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
G+ +L EY+ L + + +E R L + + KG+AY+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I+H D+KP N+L+ + K++DFGLA+L + EE +Y+ TR Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 36/208 (17%)
Query: 498 LGQGGFGSVYLG----MLPDG--IQVAVKKLE--SIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG+G FG V+LG + P+ VAVK L+ + +K+F E + N H ++VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWN----TRFN------IALGMA 599
G C EG ++ +EY+ +G L+K++ + ++ FL IA+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT----LRG 655
G+ YL + VH D+ N L+ + K+ DFG M+R+ VYTT + G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG----MSRD---VYTTDYYRVGG 182
Query: 656 TR----GYLAPEWITNNPISEKSDVYSY 679
++ PE I + +SDV+S+
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSF 210
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 54/189 (28%), Positives = 98/189 (51%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G G FG V+LG + +VA+K + +++F E + + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
C E + L +E++ +G L ++ + +F S T + L + +G+AYL +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL--RAQRGKF-SQETLLGMCLDVCEGMAYLESSN---V 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
+H D+ N L+ +N KVSDFG+ + + ++ YT+ GT+ + +PE + +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 671 SEKSDVYSY 679
S KSDV+S+
Sbjct: 179 SSKSDVWSF 187
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 59/190 (31%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 496 TKLGQGGFGSVYLGML-PDGIQVAVKK--LESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
LGQG G VY P G A+KK ++ + +K+ E+ T+ + ++VK G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 553 -FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKGLAYLHEEC 609
F EG + EY+ GSL + + IA + KGL YLH +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK- 118
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNN 668
I+H DIKP N+L++ K++DFG++K++ E +L T GT Y++PE I
Sbjct: 119 -RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 669 PISEKSDVYS 678
S +D++S
Sbjct: 176 SYSYAADIWS 185
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 14/190 (7%)
Query: 498 LGQGGFGSVYLGMLP----DGIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLK 551
+G G FG V+ G+L + VA+K L+ + +++F +E + +G H ++++L+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G + ++ EY+ NG+LDK++ + E G+A G+ YL ++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SDM 126
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG--YLAPEWITNNP 669
VH D+ N+L++ N KVSDFGL++++ + YTT G + APE I
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 670 ISEKSDVYSY 679
+ SDV+S+
Sbjct: 187 FTSASDVWSF 196
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHH 544
++ + KLG G +G VY G+ + VAVK L+ +EF E + + H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 545 LHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
+LV+L G C + E++ G+L ++ + ++ +A ++ + Y
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEY 119
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLA 661
L ++ +H D+ N L+ +N KV+DFGL++LM + YT G + + A
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTA 173
Query: 662 PEWITNNPISEKSDVYSY 679
PE + N S KSDV+++
Sbjct: 174 PESLAYNKFSIKSDVWAF 191
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 62/188 (32%), Positives = 92/188 (48%), Gaps = 15/188 (7%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLE--SIGQGKKE--FSAEVTTIGNVHHLHLVKLKG 552
LG+G FG V L D ++ A+K L+ I + K+ E + ++H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ + +L L EY G L + ++E RF RF A + L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAA-EIVLALEYLHSL--- 112
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
I++ D+KPEN+LLD + K++DFGLAK ++ E S T GT YLAPE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGTPEYLAPEVLLGKGYG 171
Query: 672 EKSDVYSY 679
+ D +S
Sbjct: 172 KAVDWWSL 179
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
K+G+G FG VY G+L +VAVK + K++F E + H ++VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
++ + E + GSL F +++R L+ ++L A G+ YL + +
Sbjct: 62 VQKQPIYIVMELVPGGSL--LTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTR----GYLAPEWITNNP 669
H D+ N L+ +N K+SDFG M+REE +YT G + + APE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 670 ISEKSDVYSY 679
+ +SDV+SY
Sbjct: 172 YTSESDVWSY 181
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 58/190 (30%), Positives = 91/190 (47%), Gaps = 21/190 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
KLG+G +GSVY + G VA+K + + + +E E++ + ++VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 556 EGAHRLLAYEYLGNGS-LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ + EY G GS D I T ++ L+ I KGL YLH K +
Sbjct: 69 KNTDLWIVMEYCGAGSVSD--IMKITNKT--LTEEEIAAILYQTLKGLEYLHS---NKKI 121
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLAPEWITNNP 669
H DIK N+LL++ AK++DFG++ L T T+ GT ++APE I
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 670 ISEKSDVYSY 679
+ K+D++S
Sbjct: 176 YNNKADIWSL 185
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 42/112 (37%), Positives = 62/112 (55%), Gaps = 2/112 (1%)
Query: 43 INNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEK 102
++G L+S NS+F GF+T + + L++ SS VVW ANR + DS +
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQS 62
Query: 103 NGNAYLQRGNG-EAWSANTSGQK-VECMELQDSGNLVLLGVNGSILWQSFSH 152
+GN L G+G WS+NT+G + L D GNLV+ +G+ LWQSF +
Sbjct: 63 DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-19
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 3/114 (2%)
Query: 43 INNNGLFLISNNSVFGFGFYT-ALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFE 101
++G L+S+ S+F GF+ + + + L++ SS VVW ANR S +
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQ 62
Query: 102 KNGNAYLQRGNG-EAWSANTSGQK-VECMELQDSGNLVLLGVNGSILWQSFSHP 153
+GN + G+G WS+NT+ + L D GNLVL +G+ LWQSF +P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 492 KNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
KN K+G+G G VY G +VA+KK+ Q K+ E+ + + H ++V
Sbjct: 22 KNLE-KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWN-TRFN------IALGMAKGLA 603
+ G + EY+ GSL T+ ++ N R N + + +GL
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSL-------TD---IITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
YLH + ++H DIK +N+LL + + K++DFG A + +E+S ++ GT ++APE
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPE 186
Query: 664 WITNNPISEKSDVYS 678
I K D++S
Sbjct: 187 VIKRKDYGPKVDIWS 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 60/194 (30%), Positives = 88/194 (45%), Gaps = 25/194 (12%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGF 553
+LG+G GSV L + + K + +K+ E+ + ++VK G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 554 CIEGAHRLL--AYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLAYL 605
++ + + A EY GSLD I+ + R IA + KGL+YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDS-IYK-----KVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEW 664
H KI+H DIKP N+LL K+ DFG++ +L+N T GT Y+APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG----TFTGTSFYMAPER 174
Query: 665 ITNNPISEKSDVYS 678
I P S SDV+S
Sbjct: 175 IQGKPYSITSDVWS 188
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 56/177 (31%), Positives = 87/177 (49%), Gaps = 24/177 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA--------EVTTIGNV-HHLH 546
+LG G FGSVYL G VA+KK+ KK+F + EV ++ + H +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+VKLK E +EY+ G+L + + + + S + +I + +GLA++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLM--KDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+ H D+KPEN+L+ K++DFGLA+ + YT TR Y APE
Sbjct: 117 K---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 497 KLGQGGFGSVYLGML--PDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
+LG G G V +L P G +AVK +LE +K+ E+ + + ++V G
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEE---SRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ EY+ GSLDK I + R L IA+ + KGL YLHE+
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILG-----KIAVAVLKGLTYLHEK- 119
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNN 668
KI+H D+KP N+L++ K+ DFG++ +L+N + T GT Y+APE I N
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGN 174
Query: 669 PISEKSDVYS 678
S KSD++S
Sbjct: 175 DYSVKSDIWS 184
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 498 LGQGGFGSVYLGMLP----DGIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLK 551
+G G FG V G L I VA+K L++ + +++F +E + +G H +++ L+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G + ++ EY+ NGSLD F + +F + G+A G+ YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQL-VGMLRGIASGMKYL---SDM 125
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNN 668
VH D+ N+L++ N KVSDFGL++++ + YTT RG + + APE I
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYR 184
Query: 669 PISEKSDVYSY 679
+ SDV+SY
Sbjct: 185 KFTSASDVWSY 195
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 31/201 (15%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLE--SIG-QGKKEFSA-------EVTTIGNVHHLH 546
+G G FGSVYLGM G +AVK++E S+ K + E+ + + H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAY 604
+V+ G ++ H + EY+ GS+ + + + EE+ N + KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR------NFVRQILKGLNY 121
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG------ 658
LH I+H DIK N+L+D+ K+SDFG++K + E + + T G R
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSV 176
Query: 659 -YLAPEWITNNPISEKSDVYS 678
++APE + + K+D++S
Sbjct: 177 FWMAPEVVKQTSYTRKADIWS 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLGQG FG V++G +VA+K L+ + F E + + H LV+L
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
E ++ EY+ GSL F E ++L ++A +A G+AY+ +
Sbjct: 70 VSEEPIYIVT-EYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
VH D++ N+L+ +N KV+DFGLA+L+ E YT +G + + APE
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 671 SEKSDVYSY 679
+ KSDV+S+
Sbjct: 181 TIKSDVWSF 189
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 34/206 (16%)
Query: 497 KLGQGGFGSVYLG----MLP--DGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
+LG+G FG V+L + P D I VAVK L ++ +K+F E + N+ H H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF---------LSWNTRFNIALGMAK 600
G C+EG ++ +EY+ +G L+K++ ++ L+ + +IA +A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG-- 658
G+ YL + VH D+ N L+ +N K+ DFG M+R+ VY+T G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG----MSRD---VYSTDYYRVGGH 181
Query: 659 ------YLAPEWITNNPISEKSDVYS 678
++ PE I + +SDV+S
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWS 207
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 57/193 (29%), Positives = 101/193 (52%), Gaps = 21/193 (10%)
Query: 498 LGQGGFGSVYLGM-LPDG----IQVAVKKLE--SIGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG G FG+V+ G+ +P+G I VA+K ++ S Q +E + + +G++ H ++V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIF---NSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
G C GA L + GSL + +S + R L+W + +AKG+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWIT 666
+VH ++ N+LL + +++DFG+A L+ ++ Y+ + ++A E I
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 667 NNPISEKSDVYSY 679
+ +SDV+SY
Sbjct: 185 FGRYTHQSDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 10/186 (5%)
Query: 497 KLGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLKG 552
K+G+G FG V+ + +V A+K+++ ++E E + + ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
++ + EY NG L K + + R L + + + + GLA+LH + K
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
I+H DIK N+ LD K+ D G+AKL++ + + T+ GT YL+PE + P +E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 673 KSDVYS 678
KSDV++
Sbjct: 181 KSDVWA 186
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 494 FSTKLGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA----EVTTIGNVHHLH 546
F +G+G F +V L + A+K L+ + + KK EV T N H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPG 63
Query: 547 LVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
++KL + + L EY NG L ++I + L A + L YL
Sbjct: 64 IIKLY-YTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR----------- 654
H I+H D+KPEN+LLD + K++DFG AK+++ S
Sbjct: 119 HS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 655 --------GTRGYLAPEWITNNPISEKSDVYSY 679
GT Y++PE + P + SD+++
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWAL 208
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 22/197 (11%)
Query: 498 LGQGGFGSVYLGMLPDGIQ--VAVKKLE----SIGQGKKEFS-------AEVTTIG-NVH 543
LG G FG VY + Q +A+K++ + G+ K+E +EVT I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 544 HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEES--RFLSWNTRFNIALGMAKG 601
H ++V+ +E RL L G+ FNS +E RF + +NI + M
Sbjct: 68 HPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKKQRF-TEERIWNIFVQMVLA 125
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 661
L YLH+E +IVH D+ P N++L ++ ++DFGLAK E L T++ GT Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYSC 181
Query: 662 PEWITNNPISEKSDVYS 678
PE + N P EK+DV++
Sbjct: 182 PEIVKNEPYGEKADVWA 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 494 FSTKLGQGGFGSVYL---GMLPD--GIQVAVKKLE-SIGQGKKEFSAEVTTIGNVHHLHL 547
F +LG+G FGSV L L D G VAVKKL+ S + ++F E+ + ++ H ++
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 548 VKLKGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEE---SRFLSWNTRFNIALGMAKGL 602
VK KG C R L EYL GSL ++ E + L + ++ + KG+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------ICKGM 121
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYL 660
YL + + VH D+ N+L++ K+ DFGL K++ ++E V +
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178
Query: 661 APEWITNNPISEKSDVYSY 679
APE +T + S SDV+S+
Sbjct: 179 APESLTESKFSVASDVWSF 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
KLG G FG V++G +VAVK L+ + F E + + H LV+L E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
++ EY+ GSL F E R L ++A +A G+AY+ + +H
Sbjct: 73 EPIYIVT-EYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D++ N+L+ D K++DFGLA+L+ E YT +G + + APE + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 184 SDVWSF 189
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 57/195 (29%), Positives = 100/195 (51%), Gaps = 23/195 (11%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKKLE----SIGQGKKEFSA---EVTTIGNVHHLHLVKL 550
LG+G +G+VY G+ G +AVK++E ++ +KE+ EV + ++ H+++V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
G C++ + E++ GS+ + F E F + + + G+AYLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ------ILDGVAYLHNN 121
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-----NREESLVYTTLRGTRGYLAPE 663
C +VH DIK NV+L N K+ DFG A+ + + S + ++ GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 664 WITNNPISEKSDVYS 678
I + KSD++S
Sbjct: 179 VINESGYGRKSDIWS 193
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 63/191 (32%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 497 KLGQGGFGSVYLGMLP-DGIQVAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKLKG 552
K+G+G FG +YL D +K+ L + +KE S EV + + H ++V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNST----EESRFLSWNTRFNIALGMAKGLAYLHEE 608
E + EY G L K I E + LSW + I+LG L ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG----LKHIHDR 120
Query: 609 CEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
KI+H DIK +N+ L N AK+ DFG+A+ +N L YT + GT YL+PE N
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQN 176
Query: 668 NPISEKSDVYS 678
P + K+D++S
Sbjct: 177 RPYNNKTDIWS 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 50/187 (26%), Positives = 93/187 (49%), Gaps = 9/187 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
K+G+G F VY + L DG VA+KK++ + +++ E+ + + H +++K
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
IE + E G L + I + ++ R + T + + + L ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+I+H DIKP NV + K+ D GL + + + + + +L GT Y++PE I N +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPERIHENGYN 184
Query: 672 EKSDVYS 678
KSD++S
Sbjct: 185 FKSDIWS 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 16/192 (8%)
Query: 498 LGQGGFGSVYLGML-PDG---IQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLK 551
+G G FG V G L G I VA+K L+S + +++F +E + +G H +++ L+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G + ++ E++ NG+LD F + +F + + G+A G+ YL E+
Sbjct: 72 GVVTKSRPVMIITEFMENGALDS--FLRQNDGQF-TVIQLVGMLRGIAAGMKYL---SEM 125
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTR---GYLAPEWITN 667
VH D+ N+L++ N KVSDFGL++ + + S YT+ G + + APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 668 NPISEKSDVYSY 679
+ SDV+SY
Sbjct: 186 RKFTSASDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
F +LG G FG V G VA+K ++ + EF E + + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
C + + EY+ NG L ++ E + + + + +G+AYL + +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
+H D+ N L+DD KVSDFGL++ + +E YT+ G++ + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 671 SEKSDVYSY 679
S KSDV+++
Sbjct: 179 SSKSDVWAF 187
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
KLG G FG V++G + +VAVK L+ + F E + + H LV+L +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ GSL F ++E + + + +A+G+AY+ + +H
Sbjct: 73 EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D++ NVL+ ++ K++DFGLA+++ E YT G + + APE I + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 185 SDVWSF 190
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 48/175 (27%), Positives = 73/175 (41%), Gaps = 19/175 (10%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
+G+G +G V G VA+KK E KK EV + + H ++V LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L +EY+ L+ + + R W + + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHSH 119
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I+H DIKPEN+L+ ++ K+ DFG A+ + + T TR Y APE
Sbjct: 120 ---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 498 LGQGGFGSVY----LGMLPDGIQ--VAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
+GQG FG V+ G+LP VAVK L E+ + +F E + H ++VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLD--------KWIFNSTEESRF----------LSWNTR 591
L G C G L +EY+ G L+ + + + + LS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 592 FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
IA +A G+AYL E K VH D+ N L+ +N K++DFGL++ + + Y
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YY 186
Query: 652 TLRGTRG----YLAPEWITNNPISEKSDVYSY 679
++ PE I N + +SDV++Y
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAY 218
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 23/194 (11%)
Query: 498 LGQGGFGSVYLGM-LPDG----IQVAVKKLESIGQGK--KEFSAEVTTIGNVHHLHLVKL 550
LG G FG+VY G+ +P+G I VA+K+L K KE E + +V + H+ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE--SRFLSWNTRFNIALGMAKGLAYLHEE 608
G C+ +L+ + + G L ++ + S++L N + +AKG+ YL E
Sbjct: 75 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEER 128
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 665
++VH D+ NVL+ K++DFGLAKL+ +E + G + ++A E I
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGGKVPIKWMALESI 183
Query: 666 TNNPISEKSDVYSY 679
+ + +SDV+SY
Sbjct: 184 LHRIYTHQSDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 21/191 (10%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK------KEFSAEVTTIGNVHHLHLVKL 550
LG G FGSVY G+ L DG AVK++ G+ K+ E+ + + H ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
G E + + E + GSL K + + S E + TR + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTR-----QILLGLEYLHDR 121
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TN 667
VH DIK N+L+D N K++DFG+AK + E + +G+ ++APE I
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 668 NPISEKSDVYS 678
+D++S
Sbjct: 177 GGYGLAADIWS 187
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/189 (30%), Positives = 93/189 (49%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLGQG FG V++G +VA+K L+ + F E + + H LV L
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
E ++ E++G GSL F + ++L ++A +A G+AY+ +
Sbjct: 70 VSEEPIYIVT-EFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
+H D++ N+L+ DN K++DFGLA+L+ E YT +G + + APE
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 671 SEKSDVYSY 679
+ KSDV+S+
Sbjct: 181 TIKSDVWSF 189
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 59/186 (31%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
+G+G FG+V G G +VAVK K + Q F E + +HH +LV+L G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 555 I-EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ G + + E + G+L F T +S +L +A+G+ YL + K+
Sbjct: 69 LHNGLY--IVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
VH D+ N+L+ ++ AKVSDFGLA++ S+ + + APE + + S K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSK 177
Query: 674 SDVYSY 679
SDV+SY
Sbjct: 178 SDVWSY 183
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 21/193 (10%)
Query: 498 LGQGGFGSVYLGM-LPDG----IQVAVKKL-ESIG-QGKKEFSAEVTTIGNVHHLHLVKL 550
LG G FG+VY G+ +P+G I VA+K L E+ G + EF E + ++ H HLV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE--SRFLSWNTRFNIALGMAKGLAYLHEE 608
G C+ +L+ + + +G L ++ + S+ L N + +AKG+ YL E
Sbjct: 75 LGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEER 128
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR--GYLAPEWIT 666
++VH D+ NVL+ K++DFGLA+L+ +E Y G ++A E I
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK-EYNADGGKMPIKWMALECIH 184
Query: 667 NNPISEKSDVYSY 679
+ +SDV+SY
Sbjct: 185 YRKFTHQSDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKG 552
+ +G +G V+L G A+K K + I + + + E + ++VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ +G L L EYL G L + S +E R IA + L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYLHS-- 111
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAK--LMNREESLVYTTLR-----GTRGYLAP 662
I+H D+KP+N+L+D N K++DFGL+K L+ R+ +L GT Y+AP
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 663 EWITNNPISEKSDVYS 678
E I S+ D +S
Sbjct: 171 EVILGQGHSKTVDWWS 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 497 KLGQGGFGSVYLG----MLP--DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVK 549
+LG+G FG V+L + P D + VAVK L+ +K+F E + N+ H H+VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF------------LSWNTRFNIALG 597
G C +G ++ +EY+ +G L+K++ ++ L + +IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
+A G+ YL + VH D+ N L+ N K+ DFG M+R+ VY+T
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFG----MSRD---VYSTDYYRV 181
Query: 658 G--------YLAPEWITNNPISEKSDVYSY 679
G ++ PE I + +SDV+S+
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 24/196 (12%)
Query: 498 LGQGGFGSVYLGML--PDG--IQVAVKKLESIGQGKK--EFSAEVTTIGNVHHLHLVKLK 551
+G+G FG VY G L DG I AVK L I ++ +F E + + H +++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 552 GFCI--EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
G C+ EG+ L+ Y+ +G L +I + E+ + L +AKG+ YL +
Sbjct: 63 GICLPSEGS-PLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG------YLAPE 663
K VH D+ N +LD++FT KV+DFGLA+ + +E Y ++ G ++A E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE---YYSVHNHTGAKLPVKWMALE 172
Query: 664 WITNNPISEKSDVYSY 679
+ + KSDV+S+
Sbjct: 173 SLQTQKFTTKSDVWSF 188
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 16/190 (8%)
Query: 498 LGQGGFGSVYLG--MLPDG--IQVAVKKLESIGQGKKE--FSAEVTTIGNVHHLHLVKLK 551
LG G FG + G LP + VA+ L + K+ F AE T+G H ++V+L+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G G ++ EY+ NG+LD F E + L + G+A G+ YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEM 126
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL--APEWITNNP 669
VH + VL++ + K+S F +L + +YTT+ G L APE I +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 670 ISEKSDVYSY 679
S SDV+S+
Sbjct: 185 FSSASDVWSF 194
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 60/185 (32%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
+G+G FG V LG G +VAVK K ++ Q F AE + + + H +LV+L G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 556 EGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
E L + EY+ GSL ++ + L + +L + + + YL V
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 674
H D+ NVL+ ++ AKVSDFGL K E S T + + APE + S KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 675 DVYSY 679
DV+S+
Sbjct: 181 DVWSF 185
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 25/179 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTI------GNVHHLHLVK 549
++G+G +G VY G VA+KK+ + K+ F +T I + H ++V+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFP--ITAIREIKLLQKLRHPNIVR 62
Query: 550 LKGFCIEGAHR--LLAYEYLG---NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
LK + +EY+ G LD + E +F + + +GL Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKC-YMKQLLEGLQY 115
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
LH I+H DIK N+L++++ K++DFGLA+ + S YT T Y PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 479 PTRFSYDDLCKATKN---FSTKLGQGGFGSVY------LGMLPDGIQVAVKKLESIGQG- 528
PT+ YD + +N F LG G FG V L ++VAVK L+
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 529 -KKEFSAEV---TTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESR 584
++ +E+ + +GN H ++V L G C G L+ EY G L ++ E
Sbjct: 81 EREALMSELKIMSHLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--S 136
Query: 585 FLSWNTRFNIALGMAKGLAYL-HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LM 642
FL+ + + +AKG+A+L + C +H D+ NVLL K+ DFGLA+ +M
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIM 192
Query: 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
N +V R ++APE I N + +SDV+SY
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 17/189 (8%)
Query: 497 KLGQGGFGSVYLGML----PDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G+G FG VY G+ + I VAVK K + +++F E + H H+VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G E ++ E G L ++ L + + ++ LAYL
Sbjct: 73 IGVITENPVWIV-MELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR--GYLAPEWITNN 668
+ VH DI NVL+ K+ DFGL++ + E+ Y +G ++APE I
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFR 183
Query: 669 PISEKSDVY 677
+ SDV+
Sbjct: 184 RFTSASDVW 192
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 30/200 (15%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGK-------KEFSAEVTTIGNVHHL 545
+G+G +G VYL + + G +AVK++E G+ K +E+ T+ ++ HL
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI--FNSTEES--RFLSWNTRFNIALGMAKG 601
++V+ GF + + EY+ GS+ + + EE RF + +G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--------LEG 120
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-NREESLVYTTLRGTRGYL 660
LAYLH + I+H D+K +N+L+D + K+SDFG++K + ++ +++G+ ++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 661 APEWITNNP--ISEKSDVYS 678
APE I + S K D++S
Sbjct: 178 APEVIHSYSQGYSAKVDIWS 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 498 LGQGGFGSVYLGMLPD-------GIQVAVKKLE--SIGQGKKEFSAEVTTIGNVHHLHLV 548
LG G FG VY G D I+VAVK L + Q KKEF E + N +H ++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESR---FLSWNTRFNIALGMAKGLAYL 605
KL G C+ + + E + G L ++ ++ E L+ +I L +AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 606 HEECEVKIVHCDIKPENVLL-----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTR--- 657
++ +H D+ N L+ D + K+ DFGLA+ + + + Y G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD---YYRKEGEGLLP 176
Query: 658 -GYLAPEWITNNPISEKSDVYSY 679
++APE + + + +SDV+S+
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSF 199
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 36/209 (17%)
Query: 497 KLGQGGFGSVYLG----MLP--DGIQVAVKKLESIGQ-GKKEFSAEVTTIGNVHHLHLVK 549
+LG+G FG V+L +LP D + VAVK L+ + +++F E + + H H+V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF-----------LSWNTRFNIALGM 598
G C EG L+ +EY+ +G L++++ + +++ L+ IA +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 599 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT---LRG 655
A G+ YL + VH D+ N L+ K+ DFG M+R+ +Y+T G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFG----MSRD---IYSTDYYRVG 181
Query: 656 TRG-----YLAPEWITNNPISEKSDVYSY 679
R ++ PE I + +SD++S+
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSF 210
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 498 LGQGGFGSVYLGML--PDGIQ--VAVK--KLESIGQGK-KEFSAEVTTIGNVHHLHLVKL 550
LG+G FGSV G L DG Q VAVK KL+ + +EF +E + + H +++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 551 KGFCIEGAHR------LLAYEYLGNGSLDKWIFNS--TEESRFLSWNTRFNIALGMAKGL 602
G C E + ++ ++ +G L ++ S L T + +A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GY 659
YL +H D+ N +L ++ T V+DFGL+K + + Y R + +
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD--YYRQGRIAKMPVKW 181
Query: 660 LAPEWITNNPISEKSDVYSY 679
+A E + + + KSDV+++
Sbjct: 182 IAIESLADRVYTSKSDVWAF 201
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 497 KLGQGGFGSVYL-GMLPDGIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLKG 552
K+G+G FG L DG Q +K++ KE EV + N+ H ++V+ +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNST----EESRFLSWNTRFNIALGMAKGLAYLHEE 608
E + + +Y G L K I E + L W + +AL ++H+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHDR 120
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
KI+H DIK +N+ L + T K+ DFG+A+++N L T + GT YL+PE N
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 669 PISEKSDVYS 678
P + KSD+++
Sbjct: 177 PYNNKSDIWA 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
F +LG G FG V+LG I+VA+K + +++F E + + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
C + + E++ NG L ++ + LS + ++ + +G+ YL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
+H D+ N L+ KVSDFG+ + + +E YT+ G + + PE +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 671 SEKSDVYSY 679
S KSDV+S+
Sbjct: 179 SSKSDVWSF 187
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 498 LGQGGFGSVYLGML-PDGI----QVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG+G FG V L P+G QVAVK L ES G + E+ + N++H ++VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 551 KGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
KG C E L E+L +GSL +++ + + ++ + A+ + KG+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLGSR 128
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAPEWIT 666
+ VH D+ NVL++ K+ DFGL K + ++E V L + APE +
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 667 NNPISEKSDVYSY 679
+ SDV+S+
Sbjct: 186 QSKFYIASDVWSF 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (184), Expect = 1e-14
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 26/178 (14%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA----EVTTIGNVHHLHLVKLK 551
KLG+G +G VY G VA+KK+ + ++ + E++ + + H ++VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKGLAYLHEEC 609
L +EY L K++ + R + +I + +GLAY H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYCHS-- 116
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL----MNREESLVYTTLRGTRGYLAPE 663
+I+H D+KP+N+L++ + K++DFGLA+ + YT T Y APE
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-----YTHEVVTLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/179 (35%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 498 LGQGGFGSVYLGMLP-DGIQVAVKKL--ESIGQGK--KEFSAEVTT-IGNVHHLHLVKLK 551
+G+G FG V L DG AVK L ++I + K K AE + NV H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ + A +L +Y+ G L F+ E F RF A +A L YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHS--- 114
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+ I++ D+KPEN+LLD ++DFGL K E S +T GT YLAPE + P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 12/185 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G FG VY + VA+K LE ++ E+ + ++ K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
++G+ + EY G GS + + + F I + GL YLHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAF-ILREVLLGLEYLHEE---GK 119
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
+H DIK N+LL + K++DFG++ + S T + GT ++APE I + EK
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 674 SDVYS 678
+D++S
Sbjct: 179 ADIWS 183
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 34/199 (17%)
Query: 493 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE--FSAEVTTIGNVHHLHLVK 549
NF K+G+G G V + G QVAVKK++ Q ++E F+ EV + + H ++V+
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVE 80
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLA 603
+ + G + E+L G+L + + TR N + L + K L+
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALS 129
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGY 659
+LH + ++H DIK +++LL + K+SDFG ++K + R +SLV GT +
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYW 181
Query: 660 LAPEWITNNPISEKSDVYS 678
+APE I+ P + D++S
Sbjct: 182 MAPEVISRLPYGTEVDIWS 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 489 KATKNFSTKLGQGGFGSVYLG--MLPDG----IQVAVKKL--ESIGQGKKEFSAEVTTIG 540
+ F +LG+G FG VY G P+ VA+K L + + ++EF E +
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 541 NVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKW-IFNS-----------TEESRFLSW 588
++ H ++V L G C + + +EYL +G L ++ + NS L
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
+ +IA+ +A G+ YL VH D+ N L+ + T K+SDFGL++ + S
Sbjct: 124 SDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDI---YSA 177
Query: 649 VYTTLRGTR----GYLAPEWITNNPISEKSDVYSY 679
Y ++ ++ PE I + +SD++S+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 20/189 (10%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF---SAEVTTIGNVHHLHLVKLKGF 553
++G+G FG V+ G+ QV K+ + + + E E+T + ++ K G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 554 CIEGAHRLLAYEYLGNGS-LDKWIFNSTEESRFLSWNTRFNIALGMA---KGLAYLHEEC 609
++G + EYLG GS LD +E F IA + KGL YLH E
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDE---------FQIATMLKEILKGLDYLHSE- 120
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
K +H DIK NVLL + K++DFG+A + + + T GT ++APE I +
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 670 ISEKSDVYS 678
K+D++S
Sbjct: 178 YDSKADIWS 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 23/194 (11%)
Query: 498 LGQGGFGSVYLGM-LPDG----IQVAVKKLE--SIGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG G FG+VY G+ +PDG I VA+K L + + KE E + V ++ +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE--SRFLSWNTRFNIALGMAKGLAYLHEE 608
G C+ +L+ + + G L ++ + + S+ L N + +AKG++YL E
Sbjct: 75 LGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKGMSYLEE- 127
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 665
V++VH D+ NVL+ K++DFGLA+L++ +E+ + G + ++A E I
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD--GGKVPIKWMALESI 183
Query: 666 TNNPISEKSDVYSY 679
+ + +SDV+SY
Sbjct: 184 LHRRFTHQSDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 14/186 (7%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF---SAEVTTIGNVHHLHLVKLKGF 553
++G+G FG VY G+ +V K+ + + + E E+T + ++ + G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 554 CIEGAHRLLAYEYLGNGS-LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
++G + EYLG GS LD EE+ + I + KGL YLH E +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHSE---R 121
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
+H DIK NVLL + K++DFG+A + + + T GT ++APE I +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 673 KSDVYS 678
K+D++S
Sbjct: 181 KADIWS 186
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 26/201 (12%)
Query: 498 LGQGGFGSVYLGML------PDGIQVAVKKLESIGQGKKE--FSAEVTTIGNVHHLHLVK 549
LG G FG VY G+ +QVAVK L + E F E + +H ++V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWI---FNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
L G E R + E + G L ++ E L+ A +AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 607 EECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL--- 660
E +H DI N LL AK++DFG+A+ + R Y +G R L
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS--YYR--KGGRAMLPIK 186
Query: 661 --APEWITNNPISEKSDVYSY 679
PE + + K+DV+S+
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSF 207
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 30/198 (15%)
Query: 497 KLGQGGFGSVYLG---MLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL----HLVK 549
+LG G FG V G M I VA+K L++ + +K E+ + H ++V+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN--ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM---AKGLAYLH 606
+ G C E +L E G L+K++ +E T N+ M + G+ YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI------TVSNVVELMHQVSMGMKYLE 112
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG-----YLA 661
+ VH D+ NVLL + AK+SDFGL+K + ++S Y R + G + A
Sbjct: 113 GK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKAR-SAGKWPLKWYA 166
Query: 662 PEWITNNPISEKSDVYSY 679
PE I S +SDV+SY
Sbjct: 167 PECINFRKFSSRSDVWSY 184
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 59/192 (30%), Positives = 86/192 (44%), Gaps = 24/192 (12%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-------AVKKLESI----GQGKKEFSAEVTTIGNVHHLH 546
LG+GGFG V +QV A KKL+ G+K E + V+
Sbjct: 1 LGKGGFGEVC------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+V L H L + G L I+N E R L + + + G+ +LH
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH 112
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
+ IV+ D+KPENVLLDD ++SD GLA + +++ T GT GY+APE +
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILK 167
Query: 667 NNPISEKSDVYS 678
P S D ++
Sbjct: 168 EEPYSYPVDWFA 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 18/191 (9%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTI-------GNVHHLHLVK 549
LGQG FG VYL D G ++AVK++ E EV + N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
G + + EY+ GS+ + + L+ + +G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN- 123
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN--REESLVYTTLRGTRGYLAPEWITN 667
IVH DIK N+L D K+ DFG +K + ++ GT +++PE I+
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 668 NPISEKSDVYS 678
K+DV+S
Sbjct: 182 EGYGRKADVWS 192
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 496 TKLGQGGFGSV------YLGMLPDGIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLH 546
LG+G FG V L VAVK L+ E E + V+H H
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPH 64
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS--------------------TEESRFL 586
++KL G C + LL EY GSL ++ S + R L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 587 SWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646
+ + A +++G+ YL E+K+VH D+ NVL+ + K+SDFGL++ + E+
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 647 SLVYTTLRGTRG-----YLAPEWITNNPISEKSDVYSY 679
S V + ++G ++A E + ++ + +SDV+S+
Sbjct: 182 SYV----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 9/187 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLK 551
K+G+G F VY L DG+ VA+KK++ + + + E+ + ++H +++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
IE + E G L + I + ++ R + T + + + L ++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--- 125
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+++H DIKP NV + K+ D GL + + + + + +L GT Y++PE I N +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPERIHENGYN 184
Query: 672 EKSDVYS 678
KSD++S
Sbjct: 185 FKSDIWS 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 57/188 (30%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKKL-ESIGQGKK-EFSAEVTTIGNVHHLHLVKLKGFCI 555
LG+G FG V+ G L D VAVK E + Q K +F +E + H ++VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
+ + E + G ++ +E L AL A G+AYL + +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK---NCIH 116
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR----GYLAPEWITNNPIS 671
D+ N L+ +N K+SDFG+++ +E+ +Y++ G + + APE + S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSS-SGLKQIPIKWTAPEALNYGRYS 172
Query: 672 EKSDVYSY 679
+SDV+SY
Sbjct: 173 SESDVWSY 180
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 493 NFSTKLGQGGFGSVYL----------------GMLPDG-IQVAVKKL--ESIGQGKKEFS 533
NF KLG+G FG V+L D + VAVK L ++ +++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 534 AEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIF-------NSTEESRFL 586
EV + + ++ +L G C + EY+ NG L++++ S+ L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 587 SWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE- 645
S++T +A +A G+ YL + VH D+ N L+ N+T K++DFG M+R
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG----MSRNL 180
Query: 646 ESLVYTTLRGTRGYLAPEWITNNPI-----SEKSDVYSY 679
S Y ++G R L W+ + + KSDV+++
Sbjct: 181 YSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAF 218
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 21/194 (10%)
Query: 498 LGQGGFGSVYLGMLP-----DGIQVAVKKLES-IGQGKKE-FSAEVTTIGNVHHLHLVKL 550
LG+G FG V L G VAVK L+ GQ + E+ + ++H ++VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 551 KGFCIEGAHR--LLAYEYLGNGSLDKWI-FNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
KG C E + L EY+ GSL ++ + ++ L + A + +G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQICEGMAYLHS 125
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG--YLAPEWI 665
+ +H D+ NVLLD++ K+ DFGLAK + G + A E +
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 666 TNNPISEKSDVYSY 679
N S SDV+S+
Sbjct: 183 KENKFSYASDVWSF 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 49/186 (26%), Positives = 94/186 (50%), Gaps = 12/186 (6%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLKGF 553
+G+G FG V+L D V +K++ K E A E + + H ++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+E ++ EY G+L ++I L +T + + + L ++H + I
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 614 VHCDIKPENVLLDDNFTA-KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
+H D+K +N+LLD + K+ DFG++K+++ +S YT + GT Y++PE P ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGKPYNQ 180
Query: 673 KSDVYS 678
KSD+++
Sbjct: 181 KSDIWA 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
LG+G +G VY L +++A+K++ E + + E+ + H ++V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 556 EGAHRLLAYEYLGNGSLD-----KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
E + E + GSL KW E + + + + +GL YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEGLKYLHDN-- 127
Query: 611 VKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+IVH DIK +NVL++ + K+SDFG +K + T GT Y+APE I P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGP 185
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLV 548
+ + KLG G FG V++ +VAVK ++ + F AE + + H LV
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
KL + ++ E++ GSL F ++E + + +A+G+A++ +
Sbjct: 65 KLHAVVTKEPIYIIT-EFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 665
+H D++ N+L+ + K++DFGLA+++ E YT G + + APE I
Sbjct: 122 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAI 175
Query: 666 TNNPISEKSDVYSY 679
+ KSDV+S+
Sbjct: 176 NFGSFTIKSDVWSF 189
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 19/188 (10%)
Query: 497 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEF-SAEVTTIGNVHHLHLVKLKGFC 554
K+G+G G V + G QVAVKK++ Q ++E EV + + HH ++V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ G + E+L G+L + ++ ++ + L + + L+YLH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQ---GVI 140
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNRE----ESLVYTTLRGTRGYLAPEWITNNPI 670
H DIK +++LL + K+SDFG +++E +SLV GT ++APE I+ P
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLPY 195
Query: 671 SEKSDVYS 678
+ D++S
Sbjct: 196 GTEVDIWS 203
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 16/186 (8%)
Query: 498 LGQGGFGSVYL-GMLPDGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGF 553
LG G GSV +P G +A KK+ IG +K+ E+ + ++V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ + + E++ GSLD+ I+ ++ + IA+ + +GL YL+ +I
Sbjct: 72 FLNENNICMCMEFMDCGSLDR-IY---KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRI 125
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
+H DIKP N+L++ K+ DFG++ +L+N + T GT Y++PE I +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTV 181
Query: 673 KSDVYS 678
KSDV+S
Sbjct: 182 KSDVWS 187
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF---SAEVTTIGNVHHLHLVKLKGF 553
K+G+G FG V+ G+ +V K+ + + + E E+T + ++ K G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 554 CIEGAHRLLAYEYLGNGS-LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
++ + EYLG GS LD +E++ + I + KGL YLH E K
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLHSE---K 121
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
+H DIK NVLL ++ K++DFG+A + + + T GT ++APE I +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 673 KSDVYS 678
K+D++S
Sbjct: 181 KADIWS 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 18/198 (9%)
Query: 496 TKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHL 547
T LG+G FG V+L V VK L+ + EF E+ + H ++
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS-----TEESRFLSWNTRFNIALGMAKGL 602
V+L G C E + EY G L +++ + + LS + + +A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLA 661
+L + VH D+ N L+ KVS L+K + N E + L R +LA
Sbjct: 131 DHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-WLA 186
Query: 662 PEWITNNPISEKSDVYSY 679
PE + + S KSDV+S+
Sbjct: 187 PEAVQEDDFSTKSDVWSF 204
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 50/221 (22%)
Query: 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGML--PDGIQVAVKKLESIGQGK--KEFSAEVT 537
F+ +DL + +G+G FG+V ML P G +AVK++ S K K ++
Sbjct: 1 FTAEDLKDLGE-----IGRGAFGTVN-KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 538 TIGNVHHL-HLVKLKG---------FCIEGAHRLLAYEYLGNGSLDKW------IFNSTE 581
+ ++VK G C+E L + SLDK+ + S
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICME----------LMDISLDKFYKYVYEVLKSVI 104
Query: 582 ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-K 640
L IA+ K L YL EE +KI+H D+KP N+LLD N K+ DFG++ +
Sbjct: 105 PEEILG-----KIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157
Query: 641 LMNREESLVYTTLRGTRGYLAPEWITNN---PISEKSDVYS 678
L++ S+ T G R Y+APE I + +SDV+S
Sbjct: 158 LVD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWS 195
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/185 (34%), Positives = 88/185 (47%), Gaps = 16/185 (8%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLE--SIGQGKKE---FSAEVTTIGNVHHLHLVKLK 551
+G+G FG V L + AVK L+ +I + K+E S + NV H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
F + A +L +Y+ G L ++ E FL RF A +A L YLH
Sbjct: 63 -FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLHS--- 114
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+ IV+ D+KPEN+LLD ++DFGL K N E + +T GT YLAPE + P
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 671 SEKSD 675
D
Sbjct: 174 DRTVD 178
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 16/192 (8%)
Query: 496 TKLGQGGFGSV---YLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVK 549
+LG G FG+V M VAVK L++ K E E + + + ++V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ G C E +L E G L+K++ ++++ ++ + ++ G+ YL E
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGT--RGYLAPEWITN 667
VH D+ NVLL AK+SDFGL+K + +E+ G + APE +
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 668 NPISEKSDVYSY 679
S KSDV+S+
Sbjct: 173 YKFSSKSDVWSF 184
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 21/194 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTTIGNVHHL---HLVKLK 551
+LG+G +GSVY + P G+ +A+K++ + + K F+ + + +H ++V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFY 65
Query: 552 G-FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G F IEGA + EY+ GSLDK ++ + + + I + KGL +L EE
Sbjct: 66 GAFFIEGA-VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-- 121
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI----- 665
I+H D+KP NVL++ N K+ DFG++ N SL T + G + Y+APE I
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGGP 178
Query: 666 TNNPI-SEKSDVYS 678
NP + +SDV+S
Sbjct: 179 NQNPTYTVQSDVWS 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 11/184 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-EVTTIGNVHHLHLVKLKGFC 554
K+GQG G+VY + + G +VA+K++ Q KKE E+ + H ++V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ G + EYL GSL + + + ++ R + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QVI 137
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 674
H DIK +N+LL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 675 DVYS 678
D++S
Sbjct: 197 DIWS 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 494 FSTKLGQGGFGSV----------YLGMLPDG-----IQVAVKKLES--IGQGKKEFSAEV 536
KLG+G FG V +LG + VAVK L + + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 537 TTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF--------LSW 588
+ + + ++++L G C+ + EY+ NG L++++ ES F +S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
+A+ +A G+ YL + VH D+ N L+ +++T K++DFG+++ + +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD-- 183
Query: 649 VYTTLRGTRGYLAPEWITNNPI-----SEKSDVYSY 679
Y ++G R L W+ I + SDV+++
Sbjct: 184 -YYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAF 217
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 16/185 (8%)
Query: 498 LGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTT-----IGNVHHLHLVKLK 551
+G+G FG V L DG AVK L+ KK+ + + N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ + A +L +Y+ G L F+ E FL RF A +A + YLH
Sbjct: 63 -YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLHS--- 114
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+ I++ D+KPEN+LLD ++DFGL K E +T GT YLAPE + P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 671 SEKSD 675
D
Sbjct: 174 DRTVD 178
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 9/187 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLK 551
K+G+G F VY L D VA+KK++ + +++ E+ + ++H +++K
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
IE + E G L + I ++ R + T + + + + ++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--- 125
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+++H DIKP NV + K+ D GL + + + + + +L GT Y++PE I N +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SLVGTPYYMSPERIHENGYN 184
Query: 672 EKSDVYS 678
KSD++S
Sbjct: 185 FKSDIWS 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 590 TRFNIA-LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
+F I + +A L YLH + I+H DIKP+N+LLD+ ++DF +A + +
Sbjct: 102 VKFWICEIVLA--LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156
Query: 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
T+ GT GY+APE + S D +S
Sbjct: 157 --TSTSGTPGYMAPEVLCRQGYSVAVDWWS 184
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 494 FSTKLGQGGFGSVYL----GMLP-------------DGIQVAVKKLESIG--QGKKEFSA 534
F KLG+G FG V+L GM + VAVK L + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 535 EVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN-------STEESRFLS 587
E+ + + ++++L CI + EY+ NG L++++ + +S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 588 WNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647
++T +A +A G+ YL + VH D+ N L+ N+T K++DFG+++ + +
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD- 184
Query: 648 LVYTTLRGTRGYLAPEWITNNPI-----SEKSDVYSY 679
Y ++G R L W++ I + SDV+++
Sbjct: 185 --YYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAF 218
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 31/182 (17%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKK--EFSA--EVTTIGNVHHLHLVK 549
KLG+G + VY G VA+KK L + K F+A E+ + + H +++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 550 L-----KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
L I L +E++ L+K I + + + + L +GL Y
Sbjct: 67 LLDVFGHKSNIN-----LVFEFME-TDLEKVIKDK--SIVLTPADIK-SYMLMTLRGLEY 117
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM---NREESLVYTTLRGTRGYLA 661
LH I+H D+KP N+L+ + K++DFGLA+ NR+ T TR Y A
Sbjct: 118 LHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK----MTHQVVTRWYRA 170
Query: 662 PE 663
PE
Sbjct: 171 PE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 16/192 (8%)
Query: 497 KLGQGGFGSVYLG--MLPDG--IQVAVKKLESIGQGK--KEFSAEVTTIGNVHHLHLVKL 550
KLG G FG V G G I VAVK L+S +F E + ++ H +L++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 551 KGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
G + H L + E GSL + + +T + A+ +A G+ YL +
Sbjct: 62 YGVVL--THPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYLESK- 116
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGL--AKLMNREESLVYTTLRGTRGYLAPEWITN 667
+ +H D+ N+LL + K+ DFGL A N + ++ L+ + APE +
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 668 NPISEKSDVYSY 679
S SDV+ +
Sbjct: 175 RTFSHASDVWMF 186
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 62/185 (33%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 498 LGQGGFGSVYLGMLP-DG----IQVAVKKLESIGQGKKEFSAEVTTI-GNVHHLHLVKLK 551
+G+G FG V L DG ++V KK+ + +K AE + NV H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ + +L +++ G L F+ E F RF A +A L YLH
Sbjct: 63 -YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+ IV+ D+KPEN+LLD ++DFGL K +S TT GT YLAPE I P
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 671 SEKSD 675
D
Sbjct: 174 DNTVD 178
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 51/189 (26%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEF-SAEVTTIGNVHHLHLVKLKGFC 554
K+G+G G V + + G VAVKK++ Q ++E EV + + H ++V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ G + E+L G+L + ++ ++ + L + K L+ LH + ++
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQ---GVI 138
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNRE----ESLVYTTLRGTRGYLAPEWITNNPI 670
H DIK +++LL + K+SDFG +++E +SLV GT ++APE I+ P
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPELISRLPY 193
Query: 671 SEKSDVYSY 679
+ D++S
Sbjct: 194 GPEVDIWSL 202
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 56/187 (29%), Positives = 94/187 (50%), Gaps = 23/187 (12%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG-F 553
LG G G+VY L +AVK L+ + +K+ +E+ + +++ G F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 554 CIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+E +R+ + E++ GSLD ++ E + IA+ + KGL YL +K
Sbjct: 69 FVE--NRISICTEFMDGGSLD--VYRKIPE------HVLGRIAVAVVKGLTYL---WSLK 115
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
I+H D+KP N+L++ K+ DFG++ +L+N + T GT Y+APE I+
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYG 171
Query: 672 EKSDVYS 678
SDV+S
Sbjct: 172 IHSDVWS 178
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 6e-12
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 468 EDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIG 526
++ LEK+ + S D K F K+GQG G+VY + + G +VA+K++
Sbjct: 1 DEEILEKLRSI---VSVGDPKKKYTRFE-KIGQGASGTVYTAIDIATGQEVAIKQMNLQQ 56
Query: 527 QGKKEFSA-EVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF 585
Q KKE E+ + + ++V + G + EYL GSL + + +
Sbjct: 57 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116
Query: 586 LSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645
++ R + + L +LH +++H DIK +N+LL + + K++DFG + E
Sbjct: 117 IAAVCRECL-----QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168
Query: 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+S +T+ GT ++APE +T K D++S
Sbjct: 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 31/208 (14%)
Query: 494 FSTKLGQGGFGSVYLGML-PDGIQV--AVKKLESIGQ--GKKEFSAEVTTIGNV-HHLHL 547
F +G+G FG V + DG+++ A+K+++ ++F+ E+ + + HH ++
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA------------ 595
+ L G C + LA EY +G+L ++ +SR L + F IA
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 596 ----LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
+A+G+ YL ++ + +H D+ N+L+ +N+ AK++DFGL++ +E + T
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 181
Query: 652 TLRGTRGYLAPEWITNNPISEKSDVYSY 679
R ++A E + + + SDV+SY
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSY 209
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 61/191 (31%), Positives = 97/191 (50%), Gaps = 19/191 (9%)
Query: 498 LGQGGFGSVYLG---MLPDGIQV-AVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKL 550
LGQG FG V+L PD Q+ A+K L+ + + E + V+H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 551 K-GFCIEGAHRLLAYEYLGNGSLDKWIFNS-TEESRFLSWNTRFNIALGMAKGLAYLHEE 608
F EG L+ ++L G L F ++E F + +F +A +A L +LH
Sbjct: 64 HYAFQTEGKLYLI-LDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALALDHLHS- 116
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
+ I++ D+KPEN+LLD+ K++DFGL+K E Y + GT Y+APE +
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRR 173
Query: 669 PISEKSDVYSY 679
++ +D +S+
Sbjct: 174 GHTQSADWWSF 184
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 19/194 (9%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCI 555
+G G +G VY G + G A+K ++ G ++E E+ + HH ++ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 556 EGA------HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ L E+ G GS+ I N+ + W I + +GL++LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT--N 667
K++H DIK +NVLL +N K+ DFG++ ++R T GT ++APE I
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 187
Query: 668 NPISE---KSDVYS 678
NP + KSD++S
Sbjct: 188 NPDATYDFKSDLWS 201
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 51/184 (27%), Positives = 93/184 (50%), Gaps = 11/184 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-EVTTIGNVHHLHLVKLKGFC 554
K+GQG G+V+ + + G +VA+K++ Q KKE E+ + + + ++V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ G + EYL GSL + + + ++ R + + L +LH +++
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 674
H DIK +NVLL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 675 DVYS 678
D++S
Sbjct: 197 DIWS 200
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 15/188 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
K+G+G +G VY G VA+KK+ ES G K E+ + ++H +++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLL 64
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
L +E++ + L K I + R L + + + +GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI- 670
I+H D+KPEN+L++ K++DFGLA+ YT TR Y APE + +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 671 SEKSDVYS 678
S D++S
Sbjct: 177 STPVDIWS 184
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 16/190 (8%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCI 555
+G+G +G VY G VA+K ++ I ++E E + +H ++ G I
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 556 E-----GAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ +L L E G GS+ + ++ + L I +GLAYLHE
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN- 132
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
K++H DIK +N+LL N K+ DFG++ ++ T + GT ++APE I
Sbjct: 133 --KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIA--- 186
Query: 670 ISEKSDVYSY 679
++ SY
Sbjct: 187 -CDEQPDASY 195
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 34/191 (17%)
Query: 490 ATKNFS-----TKLGQGGFGSVYLGM-LPDGIQVAVKKL-----ESIGQGKKEFSAEVTT 538
A K+ S ++G G G+VY + P G A+K + +++ +++ E+
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICREIEI 125
Query: 539 IGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM 598
+ +V+H ++VK + E++ GSL+ +FL+ ++A +
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLA-----DVARQI 177
Query: 599 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLR 654
G+AYLH IVH DIKP N+L++ K++DFG LA+ M+ S V
Sbjct: 178 LSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----- 229
Query: 655 GTRGYLAPEWI 665
GT Y++PE I
Sbjct: 230 GTIAYMSPERI 240
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 16/190 (8%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G+G FG V+ G L D VAVK K +F E + H ++V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
C + + E + G D F TE R L + A G+ YL +
Sbjct: 62 CTQKQPIYIVMELVQGG--DFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---C 115
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR----GYLAPEWITNNP 669
+H D+ N L+ + K+SDFG+++ EE VY + G + + APE +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 670 ISEKSDVYSY 679
S +SDV+S+
Sbjct: 173 YSSESDVWSF 182
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 15/192 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G G VY + LP+ +VA+K+ LE E EV + +H ++VK
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 554 CIEGAHRLLAYEYLGNGS-LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ G L YL GS LD I S+ L + + KGL YLH ++
Sbjct: 68 FVVGDELWLVMPYLSGGSLLD--IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI- 124
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEWITN- 667
H DIK N+LL ++ + K++DFG LA +R V T GT ++APE +
Sbjct: 125 --HRDIKAGNILLGEDGSVKIADFGVSASLADGGDR-TRKVRKTFVGTPCWMAPEVMEQV 181
Query: 668 NPISEKSDVYSY 679
+ K+D++S+
Sbjct: 182 HGYDFKADIWSF 193
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 37/201 (18%)
Query: 498 LGQGGFGSVY-LGMLPDGIQVAVKKLESI--GQGKKEFSAEV-TTIGNVHHLHLVKLKG- 552
LG+G +G V + +P G +AVK++ + Q +K ++ ++ +V + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 553 --------FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
C+E + + SLDK+ ++ + + IA+ + K L Y
Sbjct: 69 LFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPE 663
LH + + ++H D+KP NVL++ N K+ DFG++ L++ S+ T G + Y+APE
Sbjct: 119 LHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPE 173
Query: 664 WITNNPISE------KSDVYS 678
I NP KSDV+S
Sbjct: 174 RI--NPELNQKGYDVKSDVWS 192
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 43/202 (21%)
Query: 498 LGQGGFGSVYL-GMLPDGIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLK-- 551
+G+G +G V L DG Q +KKL ++E A E + + H ++V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 552 ------------GFCIEGA---HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIAL 596
GFC EG H+L + G L E++ + W + +
Sbjct: 68 WEGEDGLLYIVMGFC-EGGDLYHKLKEQK----GKL-------LPENQVVEWF----VQI 111
Query: 597 GMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGT 656
MA L YLHE+ I+H D+K +NV L KV D G+A+++ + + +TL GT
Sbjct: 112 AMA--LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA-STLIGT 165
Query: 657 RGYLAPEWITNNPISEKSDVYS 678
Y++PE +N P + KSDV++
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWA 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 55/180 (30%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 496 TKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKL 550
++G G FG+VY + VA+KK+ G+ E EV + + H + ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 551 KGFCIEGAHRLLAYEY-LGNGS----LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
KG + L EY LG+ S + K E + I G +GLAYL
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---------ICHGALQGLAYL 131
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
H + H DIK N+LL + T K++DFG A L++ S V GT ++APE I
Sbjct: 132 HSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 32/205 (15%)
Query: 497 KLGQGGFGSVYLGMLPDGIQ------VAVKKL-ESIGQGKK-EFSAEVTTIGNVHHLHLV 548
+LGQG FG VY G D I+ VAVK + ES ++ EF E + + H+V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESR------FLSWNTRFNIALGMAKGL 602
+L G +G L+ E + +G L ++ + E+ + +A +A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT---LRGTRG- 658
AYL+ + K VH D+ N ++ +FT K+ DFG M R+ +Y T +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG----MTRD---IYETDYYRKGGKGL 182
Query: 659 ----YLAPEWITNNPISEKSDVYSY 679
++APE + + + SD++S+
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSF 207
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 468 EDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIG 526
++ LEK+ + S D K F K+GQG G+VY M + G +VA++++
Sbjct: 2 DEEILEKLRSI---VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 527 QGKKEFSA-EVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF 585
Q KKE E+ + + ++V + G + EYL GSL + + +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117
Query: 586 LSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645
++ R + + L +LH +++H DIK +N+LL + + K++DFG + E
Sbjct: 118 IAAVCRECL-----QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+S +T+ GT ++APE +T K D++S
Sbjct: 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 24/195 (12%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTTIGNVHHLHLVKL 550
LGQG FG VYL D G ++AVK+++ + KE +A E+ + N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 551 KGFCIEGAHRLLA--YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
G + R L+ E++ GS I + + L+ N + +G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLAPE 663
IVH DIK N+L D K+ DFG +K R +++ + ++ GT +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 664 WITNNPISEKSDVYS 678
I+ K+D++S
Sbjct: 180 VISGEGYGRKADIWS 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 494 FSTKLGQGGFGSVYLGMLP-DGIQV--AVKKLESIG--QGKKEFSAEVTTIGNV-HHLHL 547
F +G+G FG V M+ DG+++ A+K L+ ++F+ E+ + + HH ++
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--------------- 592
+ L G C + +A EY G+L ++ +SR L + F
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 593 -NIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
A +A G+ YL E+ + +H D+ NVL+ +N +K++DFGL++ EE V
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 652 TL-RGTRGYLAPEWITNNPISEKSDVYSY 679
T+ R ++A E + + + KSDV+S+
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSF 204
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 18/188 (9%)
Query: 498 LGQGGFGSVYLGML-PDGIQVAVKKL--ESIGQGKKE---FSAEVTTIGNVHHLHLVKLK 551
LG GGFG V L + A+K + I + ++ FS E + +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ + + EY G L + + F + RF IA + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIA-CVVLAFEYLHNR--- 112
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEWITNNPI 670
I++ D+KPEN+LLD N K+ DFG AK L + +++ T GT Y+APE I N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGY 169
Query: 671 SEKSDVYS 678
D +S
Sbjct: 170 DFSVDYWS 177
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 24/194 (12%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKG-F 553
+LG G FG VY + G A K +E+ + + E + E+ + +H ++VKL G F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+G ++ E+ G++D + E R L+ I M + L YLH KI
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPEWI---- 665
+H D+K NVLL + K++DFG++ K + R +S + GT ++APE +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 666 -TNNPISEKSDVYS 678
+ P K+D++S
Sbjct: 187 MKDTPYDYKADIWS 200
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 495 STKLGQGGFGSVYLGMLPDGIQ------VAVKKLESIGQGKK--EFSAEVTTIGNVHHLH 546
S +LGQG FG VY G+ ++ VA+K + ++ EF E + + + H
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWI--FNSTEESRFL----SWNTRFNIALGMAK 600
+V+L G +G L+ E + G L ++ E+ + S +A +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT---LRGTR 657
G+AYL+ K VH D+ N ++ ++FT K+ DFG M R+ +Y T +G +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRD---IYETDYYRKGGK 180
Query: 658 G-----YLAPEWITNNPISEKSDVYSY 679
G +++PE + + + SDV+S+
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSF 207
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 53/204 (25%), Positives = 80/204 (39%), Gaps = 51/204 (25%)
Query: 493 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE---FSA--EVTTIGNVHHLH 546
KLG+G FG VY + G VA+KK+ + +K+ +A E+ + + H +
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLKHPN 68
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE------SRFLSWNTRFN------- 593
+V L I+ +A E + S L N
Sbjct: 69 VVPL----ID-----MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIK 118
Query: 594 -IALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL----------- 641
L + +G+ YLHE I+H DIK N+L+D+ K++DFGLA+
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 642 --MNREESLVYTTLRGTRGYLAPE 663
+ YT L TR Y PE
Sbjct: 176 GGGGTRK---YTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 28/197 (14%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTTIGNVHHLHLVKL 550
LGQG FG VYL D G ++A K+++ + KE SA E+ + N+ H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 551 KGFCIEGAHRLLA--YEYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
G + A + L EY+ GS+ + + + ES + + + +G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLA 661
IVH DIK N+L D K+ DFG +K R +++ + ++ GT +++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMS 177
Query: 662 PEWITNNPISEKSDVYS 678
PE I+ K+DV+S
Sbjct: 178 PEVISGEGYGRKADVWS 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 56/186 (30%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 498 LGQGGFGSVY-LGMLPDGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
LG+GGFG V + G A KKL+ +G++ E + V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ E L L NG K+ + E F F A + GL +LH+ +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQR---R 115
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
IV+ D+KPENVLLDD+ ++SD GLA + + + GT GY+APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRAGTPGYMAPEVLQGEVYDF 173
Query: 673 KSDVYS 678
D ++
Sbjct: 174 SVDWFA 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 28/195 (14%)
Query: 497 KLGQGGFGSVYLG-MLPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G G +G VY + G VA+K KLE G + E++ + H ++V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ + EY G GSL I+ T +++ R + KGLAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPEWIT 666
+H DIK N+LL ++ K++DFG++ + + +S + GT ++APE
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAA 174
Query: 667 NNPIS---EKSDVYS 678
K D+++
Sbjct: 175 VERKGGYDGKCDIWA 189
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 19/188 (10%)
Query: 497 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEF-SAEVTTIGNVHHLHLVKLKGFC 554
K+G+G G V + G QVAVK ++ Q ++E EV + + H ++V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ G + E+L G+L + ++R L+ + + + L YLH + ++
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTR-LNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 615 HCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
H DIK +++LL + K+SDFG ++K + + +SLV GT ++APE I+ P
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPY 194
Query: 671 SEKSDVYS 678
+ D++S
Sbjct: 195 GTEVDIWS 202
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 33/205 (16%)
Query: 498 LGQGGFGSVYLGMLP-DGIQV--AVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLK 551
+G+G FG V + DG+++ A+K+++ ++F+ E+ + + HH +++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF----------------NIA 595
G C + LA EY +G+L ++ +SR L + F + A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL-R 654
+A+G+ YL ++ + +H D+ N+L+ +N+ AK++DFGL++ +E V T+ R
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 172
Query: 655 GTRGYLAPEWITNNPISEKSDVYSY 679
++A E + + + SDV+SY
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSY 197
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 16/189 (8%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK--EFSAEVTTIGNVHHLHLVKL-KGFC 554
LG G FG VY + A K+ I ++ +F E+ + H ++V L + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
E +L E+ G+LD + E R L+ + M + L +LH K++
Sbjct: 73 YENKLWIL-IEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-----TNNP 669
H D+K N+LL + K++DFG++ N+ T GT ++APE + +NP
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 670 ISEKSDVYS 678
K+D++S
Sbjct: 185 YDYKADIWS 193
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCI 555
+G G +G VY G + G A+K ++ ++E E+ + HH ++ G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 556 EGA------HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ + L E+ G GS+ + N+ + W I + +GLA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH- 140
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT--N 667
K++H DIK +NVLL +N K+ DFG++ ++R T GT ++APE I
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 197
Query: 668 NPISE---KSDVYS 678
NP + +SD++S
Sbjct: 198 NPDATYDYRSDIWS 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 497 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKE--FSAEVTTIGNVHHLHLVKLK 551
++G G FG V LG G+ +V VK+L + ++ F EV ++H ++++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSW-NTRFNIALGMAKGLAYLHEECE 610
G CIE LL E+ G L ++ ++ ++ + +A +A GL +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-----YTTLRGTRGYLAPEWI 665
+H D+ N L + + K+ D+GLA E+ + LR +LAPE +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELV 174
Query: 666 TN-------NPISEKSDVYSY 679
++KS+++S
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSL 195
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 494 FSTKLGQGGFGSVYLG--MLP--DGIQ-VAVKKLESIGQGKK--EFSAEVTTIGNVHHLH 546
F +LG+ FG +Y G LP D Q VA+K L+ I ++ EF E + + +HH +
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF-------------LSWNTRFN 593
+V L G + + +EYL G L +++ + S L +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 594 IALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE--SLVYT 651
IA+ +A G+ YL VH D+ N+L+ + K+SD GL++ + + +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 652 TLRGTRGYLAPEWITNNPISEKSDVYSY 679
+L R ++ PE I S SD++S+
Sbjct: 186 SLLPIR-WMPPEAIMYGKFSSDSDIWSF 212
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-------FSAEVTTIGNVHHLHLVK 549
LG G F S Y + G +AVK++ + E E+ + ++H H+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF--LSWNTRFNIALGMAKGLAYLHE 607
+ G E +H L E++ GS+ S S++ N + +GL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSV------SHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 608 ECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNRE---ESLVYTTLRGTRGYLAPE 663
+I+H D+K N+L+D +++DFG A + + L GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 664 WITNNPISEKSDVYS 678
+ DV+S
Sbjct: 179 VLRGEQYGRSCDVWS 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 35/116 (30%), Positives = 68/116 (58%), Gaps = 11/116 (9%)
Query: 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVL 624
E++ GSLD+ + +++ + N I++ + +GL YL E+ KI+H D+KP N+L
Sbjct: 79 EHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNIL 132
Query: 625 LDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
++ K+ DFG++ +L++ S+ + GTR Y++PE + + +SD++S
Sbjct: 133 VNSRGEIKLCDFGVSGQLID---SMA-NSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 60/178 (33%), Positives = 81/178 (45%), Gaps = 22/178 (12%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLES---IGQGKKE-FSAEVTTIGNVHHLHLVKLKG 552
LG G FG V L + A+K L + + E E + ++ H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF---NIALGMAKGLAYLHEEC 609
+ ++ L EY+ G L + S RF RF + L L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLA----LEYLHSL- 120
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
IV+ D+KPEN+LLD + K++DFG AK R + Y TL GT YLAPE I +
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGRTY-TLCGTPEYLAPEIILS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 62/180 (34%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 498 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
LG+GGFG V + G A K+LE I + K E A E + V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKGLAYLHE 607
+ E L L + G L I+N EE R L + A + GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCGLEDLHR 120
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
E V+ D+KPEN+LLDD ++SD GLA + ES+ GT GY+APE + N
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 497 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLK 551
++G G FG V LG + G QV VK+L Q + +F E ++ H +L++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKGLAYLHEEC 609
G C E LL E+ G L ++ S ++ ++ + +A +A GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-----YTTLRGTRGYLAPE 663
+H D+ N LL + T K+ D+GL+ +E+ V + LR ++APE
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 51/189 (26%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGI-QVAVKKLESIGQGK------KEFSAEVTTIGNVHHLHLVK 549
+LG+G FG+VYL + + +K L+ I G+ + + E + + H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+E + EY LD + + LS N + + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+I+H D+K +N+ L +N K+ DFG+++L+ L TT GT Y++PE + +
Sbjct: 126 --RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA-TTFTGTPYYMSPEALKHQG 181
Query: 670 ISEKSDVYS 678
KSD++S
Sbjct: 182 YDSKSDIWS 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 52/172 (30%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 498 LGQGGFGSVY-LGMLPDGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKG 552
LG+GGFG V M G A KKL +G + E + VH +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L + G L I+N EE+ + GL +LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPE 663
I++ D+KPENVLLD++ ++SD GLA +L + + GT G++APE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAGTPGFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 24/255 (9%)
Query: 429 LIVVIVVATILVIASLLYAGLWHHNKRK-RLTKFSQED--LEEDNFLEKISGMPTRFSYD 485
+ + LV+A + + ++ + L + ED E F K+S + +
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVS---KSITIN 686
Query: 486 DLCKATKNFSTKLGQGGFGSVYLG-MLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH 544
D+ + K + +G G+ Y G + +G+Q VK++ + A+ +G + H
Sbjct: 687 DILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQH 742
Query: 545 LHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
++VKL G C L +EY+ +L +E R LSW R IA+G+AK L +
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNL-------SEVLRNLSWERRRKIAIGIAKALRF 795
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH C +V ++ PE +++D + L L+ + T + Y+APE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPET 849
Query: 665 ITNNPISEKSDVYSY 679
I+EKSD+Y +
Sbjct: 850 RETKDITEKSDIYGF 864
|
Length = 968 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 48/187 (25%), Positives = 95/187 (50%), Gaps = 14/187 (7%)
Query: 496 TKLGQGGFGSVY-LGMLPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
++LG G G V + P G+ +A K LE + + E+ + + ++V G
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ E++ GSLD+ + +E++ + +++ + +GLAYL E+ +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREKHQ-- 124
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
I+H D+KP N+L++ K+ DFG++ +L++ + + GTR Y++PE + S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 180
Query: 672 EKSDVYS 678
+SD++S
Sbjct: 181 VQSDIWS 187
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 61/175 (34%), Positives = 83/175 (47%), Gaps = 12/175 (6%)
Query: 498 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
LG+GGFG V + G A KKLE I + K E A E + V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ E L L NG K+ E+ F F A + GL LH+E +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQE---R 122
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
IV+ D+KPEN+LLDD+ ++SD GLA ++ E GT GY+APE + N
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 498 LGQGGFGSVYLGMLPDG------IQVAVKKLESIGQGKKEFS---AEVTTIGNVHHLHLV 548
LG+GG+G V+ G + V K +I + +K+ + AE + V H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTE-ESRFLSWNTRFNIA-LGMAKGLAYLH 606
L G L EYL G L F E E F+ F ++ + +A L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLA--LEHLH 117
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
++ I++ D+KPEN+LLD K++DFGL K + E V T GT Y+APE +
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM 173
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 44/188 (23%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 498 LGQGGFGSVYL-GMLPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
LG+G FG L D V K++ + +++ E+ + + H +++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECE 610
++ L+ EY G+L I E + W + ++Y+H+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA-- 120
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
I+H DIK N+ L K+ DFG++K++ E S+ T + GT Y++PE
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 671 SEKSDVYS 678
+ KSD+++
Sbjct: 179 NFKSDIWA 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 51/175 (29%), Positives = 91/175 (52%), Gaps = 18/175 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKLKG 552
K+G+G +G VY G G VA+KK LES +G + E++ + + H ++V L+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 553 FCIEGAHRLLAYEYLGNGSLD-KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
++ + L +E+L S+D K +S + +++ + + +G+ + H
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTRGYLAPE 663
+++H D+KP+N+L+D+ K++DFGLA+ R VYT T Y APE
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 39/211 (18%)
Query: 498 LGQGGFGSVYLGML------PDGIQVAVKKLESIGQGKKEFSAEVT------TIGNVHHL 545
LG+G FG V + VAVK L+ +K+ S V+ IG H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGK--HK 76
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNI------- 594
+++ L G C + + EY +G+L ++ S +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 595 -ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 653
A +A+G+ +L + K +H D+ NVL+ ++ K++DFGLA+ ++ + T
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191
Query: 654 RGTRGYL-----APEWITNNPISEKSDVYSY 679
T G L APE + + + +SDV+S+
Sbjct: 192 --TNGRLPVKWMAPEALFDRVYTHQSDVWSF 220
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKL-ESIGQGKKE---FSAEVTTIGNVHHLHLVKL 550
T++GQGG+G V+L D G VA+K++ +S+ E E + LVKL
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWN-TRFNIALGMAKGLAYLHEEC 609
+ + LA EY+ G + N LS + RF +A M + + LHE
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMA-EMFEAVDALHE-- 119
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPE 663
+ +H D+KPEN L+D + K++DFGL+K ++ S+V G+ Y+APE
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 51/193 (26%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-----EVTTIGNVHHLHLVKLK 551
+G G +G V + G +VA+KK+ ++ A E+ + ++ H +++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGL- 64
Query: 552 GFCIEGAHRLLAYEYLGNGS------------LDKWIFN----STEESRFLSWNTRFNIA 595
+L + + L K I + + + ++ +
Sbjct: 65 -------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ------ 111
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-----Y 650
+ +GL YLH ++H D+KP N+L++ N K+ DFGLA+ ++ +E Y
Sbjct: 112 --ILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 651 TTLRGTRGYLAPE 663
TR Y APE
Sbjct: 167 VV---TRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 481 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDG--IQVAVKKLES---IGQGKKEFS-A 534
+ Y+D NF LG G FG V L + VA+K+ E I Q + + +
Sbjct: 26 KMKYEDF-----NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 535 EVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF-- 592
E + ++H V L G + ++ L E++ G E FL N RF
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG----------EFFTFLRRNKRFPN 130
Query: 593 NIALGMAKGLAYLHEECE-VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
++ A + + E + + IV+ D+KPEN+LLD + K++DFG AK++ ++ Y
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTY- 186
Query: 652 TLRGTRGYLAPEWITN 667
TL GT Y+APE + N
Sbjct: 187 TLCGTPEYIAPEILLN 202
|
Length = 340 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 74/213 (34%)
Query: 500 QGGFGSVYLG------------MLPDGIQVAVKKLESI--------GQGKKEFSAEV-TT 538
+G FGSVYL +L +A ++ ++ QG+ + A++ +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 539 IGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL-----------DKWIFNSTEESRFLS 587
+ +L+LV EYL G + W E
Sbjct: 66 FQSKDYLYLV---------------MEYLNGGDCASLIKTLGGLPEDWAKQYIAE----- 105
Query: 588 WNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK--LMNRE 645
+ G+ LH+ I+H DIKPEN+L+D K++DFGL++ L N++
Sbjct: 106 ----------VVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152
Query: 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
GT YLAPE I + SD +S
Sbjct: 153 FV-------GTPDYLAPETILGVGDDKMSDWWS 178
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 54/173 (31%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 497 KLGQGGFGSVYLGMLPDGIQ-VAVKK-LESIGQG--KKEFSAEVTTIGNVHHLHLVKLKG 552
+G+G +G V + Q VA+KK LES KK E+ + + H +LV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 553 FCIEGAHRLLAYEYLGNGSLDKW--IFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
L +E++ + LD N +ESR F I +G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR--VRKYLFQIL----RGIEFCHSH-- 119
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I+H DIKPEN+L+ + K+ DFG A+ + VYT TR Y APE
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 63/183 (34%), Positives = 86/183 (46%), Gaps = 28/183 (15%)
Query: 498 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
LG+GGFG V + G A KKLE I + K E A E + V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKGLAYLHE 607
+ E L L + G L I+N +E R + + A + GL LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY------AAEITCGLEDLHR 120
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR---GTRGYLAPEW 664
E +IV+ D+KPEN+LLDD ++SD GLA + E T+R GT GY+APE
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TIRGRVGTVGYMAPEV 172
Query: 665 ITN 667
+ N
Sbjct: 173 VKN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 63/183 (34%), Positives = 85/183 (46%), Gaps = 28/183 (15%)
Query: 498 LGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
LG+GGFG V + G A KKLE I + K E A E + V+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKGLAYLHE 607
+ E L L + G L I+N +E R + + A + GL L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELCCGLEDLQR 120
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR---GTRGYLAPEW 664
E +IV+ D+KPEN+LLDD ++SD GLA + E T+R GT GY+APE
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-----TVRGRVGTVGYMAPEV 172
Query: 665 ITN 667
I N
Sbjct: 173 INN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/186 (30%), Positives = 78/186 (41%), Gaps = 33/186 (17%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF----------SAEVTTIGNVHHLHL 547
LG+G FG V L + A K ++ KKE E + N H L
Sbjct: 3 LGKGTFGKVILVR-----EKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 548 VKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
LK + + RL EY G L F+ + E F RF A + L YLH
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY----TTLRGTRGYLAP 662
+V+ D+K EN++LD + K++DFGL K E + T GT YLAP
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAP 164
Query: 663 EWITNN 668
E + +N
Sbjct: 165 EVLEDN 170
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/177 (33%), Positives = 82/177 (46%), Gaps = 15/177 (8%)
Query: 498 LGQGGFGSVYL-GMLPDGIQVAVKKL-ESIGQGKKEFSAEVT---TIGNVHHLHLVKLKG 552
LG+G FG V L G A+K L + + K E + VT + N H L LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ + RL EY G L F+ + E F RF A + L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSR--- 114
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
+V+ DIK EN++LD + K++DFGL K + + + T GT YLAPE + +N
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDN 170
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/184 (33%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 498 LGQGGFGSVYL-GMLPDGIQVAVKKLE-SIGQGKKEFSAEVT---TIGNVHHLHLVKLKG 552
LG+G FG V L G A+K L+ + K E + +T + N H L LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ + RL EY+ G L F+ + E F TRF A + L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
KIV+ D+K EN++LD + K++DFGL K ++ T GT YLAPE + +N
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 672 EKSD 675
D
Sbjct: 174 RAVD 177
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKK---LESIGQGKKEFSAEVTTIGNVHHLHLVKLK-GF 553
+G+G FG L + Q K L ++ E + + H ++V K F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+G H + EY G L + I + + +T + M G+ ++HE+ ++
Sbjct: 68 EADG-HLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RV 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
+H DIK +N+ L N K+ DFG A+L+ + T + GT Y+ PE N P + K
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNK 180
Query: 674 SDVYS 678
SD++S
Sbjct: 181 SDIWS 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 48/199 (24%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 498 LGQGGFGSVYLGMLPDG---IQVAVKKLESIGQGKKE---FSAEVTTIGNVHHLHLVKLK 551
LG+G FGSV G L ++VAVK ++ + E F +E + H ++++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 552 GFCIEGAHR------LLAYEYLGNGSLDKWIFNST--EESRFLSWNTRFNIALGMAKGLA 603
G C++ ++ ++ +G L ++ S + ++L +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYL 660
YL + +H D+ N +L++N V+DFGL+K + + Y R + ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD--YYRQGRIAKMPVKWI 181
Query: 661 APEWITNNPISEKSDVYSY 679
A E + + + KSDV+S+
Sbjct: 182 AIESLADRVYTTKSDVWSF 200
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 530 KEFSAEVTTIGNVHHLHLVKL--KGFCIEGAHRLLA-YEYLGNGSLDKWIFNSTEESRFL 586
F E ++H ++V L G G L A +EY+ +L + + L
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEYVPGRTLREVLAADGA----L 76
Query: 587 SWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLM- 642
+ L + LA H + IVH D+KP+N+++ AKV DFG+ L+
Sbjct: 77 PAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP 133
Query: 643 NREESLVYTTLR-----GTRGYLAPEWITNNPISEKSDVYSY 679
++ V T R GT Y APE + P++ SD+Y++
Sbjct: 134 GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 32/202 (15%)
Query: 498 LGQGGFGSVYLGML---PDG--------IQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH 546
LGQG F ++Y G+L D + V +K L S + F + + + H H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
LVKL G C+ + ++ EY+ G LD ++ + + + L W + ++A +A L YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 607 EECEVKIVHCDIKPENVLL---DDNFT----AKVSDFGLAKLMNREESLVYTTLRGTRGY 659
++ K+VH ++ +N+L+ N K+SD G+ + E V R +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERIP--W 170
Query: 660 LAPEWITN--NPISEKSDVYSY 679
+APE I N ++ +D +S+
Sbjct: 171 IAPECIRNGQASLTIAADKWSF 192
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 24/195 (12%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLE---SIGQGKKEFSA---EVTTIGNVHHLHLVKL 550
LG+G FG VYL D G ++AVK++ + KE +A E+ + N+ H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 551 KGFCIEGAHRLLA--YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
G + + L+ EY+ GS I + + L+ N + +G++YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----TLRGTRGYLAPE 663
IVH DIK N+L D K+ DFG +K R +++ + ++ GT +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 664 WITNNPISEKSDVYS 678
I+ K+DV+S
Sbjct: 180 VISGEGYGRKADVWS 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 62/180 (34%), Positives = 86/180 (47%), Gaps = 28/180 (15%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA--EVT-TIGNVHHL-------- 545
+G+G FG VY D ++ A+K L KKE A EV TIG + L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-----KKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 546 -HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
+V LK F + L L +Y+ G L ++ +E RF +F IA + L
Sbjct: 56 PFIVGLK-FSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIA-ELVLALE 110
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+LH+ IV+ D+KPEN+LLD + DFGL+K N ++ T GT YLAPE
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 53/218 (24%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 486 DLCKATKNFSTKLGQGGFGSVYL----GMLPD----GIQVAVKKLESIGQGK--KEFSAE 535
+L + LG+G FG V + G+ D + VAVK L+ K + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 536 VTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI-----------FNSTE-E 582
+ + + H +++ L G C + + EY G+L +++ F++ +
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 583 SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-L 641
L++ + A +A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
N + T R ++APE + + + +SDV+S+
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 44/181 (24%), Positives = 85/181 (46%), Gaps = 37/181 (20%)
Query: 494 FSTKLGQGGFGSVYLGMLPD-----------------GIQVAVKKL--ESIGQGKKEFSA 534
F KLG+G FG V+L + + + VAVK L ++ + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 535 EVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI-----FNSTEESR----- 584
EV + + ++++L G C++ + EY+ NG L++++ + E
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 585 -----FLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639
+S+++ ++AL +A G+ YL + VH D+ N L+ +N T K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 640 K 640
+
Sbjct: 186 R 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 31/181 (17%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKLKG 552
K+G+G +G VY G VA+KK LE+ +G + E++ + ++H ++V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESR-------FLSWNTRFNIALGMAKGLAYL 605
L +E+L + L K++ +S +L + +G+AY
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY---------QLLQGIAYC 115
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTRGYLAP 662
H +++H D+KP+N+L+D K++DFGLA+ R YT T Y AP
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR----TYTHEVVTLWYRAP 168
Query: 663 E 663
E
Sbjct: 169 E 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 30/80 (37%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+GL YLH I+H DIKP N+L++ N K+ DFGLA++ +ES T T+ Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 660 LAPEWITNNP-ISEKSDVYS 678
APE + + + D++S
Sbjct: 171 RAPEILMGSRHYTSAVDIWS 190
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 482 FSYDDLCKATKNFSTKLGQGGFGSVY----LGMLPD----GIQVAVKKLESIGQGK--KE 531
FS D L LG+G FG V LG+ D + VAVK L+ K +
Sbjct: 12 FSRDKL-----TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD 66
Query: 532 FSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI-------------F 577
+E+ + + H +++ L G C + + EY G+L +++
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126
Query: 578 NSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637
+ + +++ + +A+G+ YL + K +H D+ NVL+ +N K++DFG
Sbjct: 127 ARVPDEQ-MTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 182
Query: 638 LAKLMNREESLVYTTL-RGTRGYLAPEWITNNPISEKSDVYSY 679
LA+ +N + TT R ++APE + + + +SDV+S+
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 498 LGQGGFGSVYL----GM---LPDGI-QVAVKKLESIGQGK--KEFSAEVTTIGNV-HHLH 546
LG+G FG V + G+ P+ + +VAVK L+S K + +E+ + + H +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWI-----------FNSTE-ESRFLSWNTRFNI 594
++ L G C + + EY G+L +++ +N T+ LS+ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL- 653
A +A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ ++ + TT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 654 RGTRGYLAPEWITNNPISEKSDVYSY 679
R ++APE + + + +SDV+S+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 27/179 (15%)
Query: 497 KLGQGGFGSVYLGMLPDGIQ-VAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLK 551
++G G FG+VY + VAVKK+ G+ E EV + + H + ++ K
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 552 GFCIEGAHRLLAYEY-LGNGS----LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
G ++ L EY LG+ S + K E + I G +GLAYLH
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLH 138
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
++H DIK N+LL + K++DFG A + S V GT ++APE I
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 59/186 (31%), Positives = 82/186 (44%), Gaps = 38/186 (20%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH----------- 546
+G G FG V+L K+ +I EV + H+H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAI--------PEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 547 --LVKLKGFCIEGAHRLL--AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
+++L F E R L EY+ G L ++ NS RF + F A + L
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLF-YASEIVCAL 114
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLA 661
YLH + +IV+ D+KPEN+LLD K++DFG AK L +R TL GT YLA
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLA 166
Query: 662 PEWITN 667
PE I +
Sbjct: 167 PEVIQS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 62/197 (31%), Positives = 87/197 (44%), Gaps = 32/197 (16%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF-----SAEVTTIGN------VHHL 545
LG+G FG V L L + A+K L KK+ E T + H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL------KKDVVLEDDDVECTMVERRVLALAWEHP 56
Query: 546 HLVKLKGFCI--EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
L L FC H EYL G L +F+ RF RF A + GL
Sbjct: 57 FLTHL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARF-YAAEIICGLQ 110
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL-MNREESLVYTTLRGTRGYLAP 662
+LH++ I++ D+K +NVLLD + K++DFG+ K MN E +T GT Y+AP
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAP 165
Query: 663 EWITNNPISEKSDVYSY 679
E + +E D +S+
Sbjct: 166 EILKGQKYNESVDWWSF 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 24/194 (12%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKL-KGF 553
+LG G FG VY + G+ A K +++ + + E + E+ + + H ++VKL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
E +L E+ G++D + E R L+ + + L YLHE KI
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPEWI---- 665
+H D+K N+L + K++DFG++ + + R +S + GT ++APE +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCET 179
Query: 666 -TNNPISEKSDVYS 678
+ P K+DV+S
Sbjct: 180 SKDRPYDYKADVWS 193
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 34/212 (16%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKL-ESIGQG---KKEFSAEVTTIGNVHHLHLVKLK 551
+G+GG G VYL P +VA+KK+ E + + KK F E ++ H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFL--------SWNTRFNIALGMAKGLA 603
C +G Y+ +L K + S + L S +I + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-----------SLVYTT 652
Y+H + ++H D+KP+N+LL + D+G A EE ++ Y++
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 653 LR------GTRGYLAPEWITNNPISEKSDVYS 678
+ GT Y+APE + P SE +D+Y+
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYA 216
|
Length = 932 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/177 (33%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 498 LGQGGFGSVYL-GMLPDGIQVAVKKLE-SIGQGKKEFSAEVT---TIGNVHHLHLVKLKG 552
LG+G FG V L G A+K L+ + K E + +T + N H L LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ + RL EY G L F+ + E F RF A + L YLH E V
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV 117
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
V+ D+K EN++LD + K++DFGL K ++ T GT YLAPE + +N
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDN 171
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 48/187 (25%), Positives = 94/187 (50%), Gaps = 14/187 (7%)
Query: 496 TKLGQGGFGSVY-LGMLPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
++LG G G V+ + P G+ +A K LE + + E+ + + ++V G
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ E++ GSLD+ + +++ + +++ + KGL YL E+ K
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--K 124
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
I+H D+KP N+L++ K+ DFG++ +L++ + + GTR Y++PE + S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 180
Query: 672 EKSDVYS 678
+SD++S
Sbjct: 181 VQSDIWS 187
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 490 ATKNFSTKLGQGGFGSVYLGML---PDGIQ---VAVKKLESIGQG--KKEFSAEVTTIGN 541
+T F +LG+ FG VY G L G Q VA+K L+ +G ++EF E
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64
Query: 542 VHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIF--------NSTEESRFLSWNTR-- 591
+ H ++V L G + + + Y + L +++ ST++ + +
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 592 --FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE--S 647
+I +A G+ +L +VH D+ NVL+ D K+SD GL + + +
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
L+ +L R +++PE I S SD++SY
Sbjct: 182 LMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSY 212
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 493 NFSTKLGQGGFGSVYLGML---PDGIQVAVKKLESIGQGKKEFSA----EVTTIGNVHHL 545
+G+G +G VY DG + A+KK + + S E+ + + H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 546 HLVKLKGFCIEGAHRL--LAYEYLGNGSLDKW--I-FNSTEESRFLSWNTRFNIALGMAK 600
++V L +E A + L ++Y D W I F+ + + + ++ +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDY---AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 601 GLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMN 643
G+ YLH ++H D+KP N+L+ + K+ D GLA+L N
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 15/172 (8%)
Query: 498 LGQGGFGSVYLGMLPDGIQV----AVKKLESIGQGKKEFS-AEVTTIGNVHHLHLVKLKG 552
+G+G FG V D ++ ++K + + + + AE T + V+ +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
F + +L L ++ G L + E RF RF A + L LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTA-ELLCALENLHK---F 112
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+++ D+KPEN+LLD + DFGL KL N ++ T GT YLAPE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 52/188 (27%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHL---HLVKLK 551
+G+G +G+VY G +P G VA+K L++ + EV + + ++ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G ++G + EY GS+ + +++S R + L Y+H+ V
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHK---V 120
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
++H DIK N+L+ + K+ DFG+A L+N + S +T GT ++APE IT
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 672 E-KSDVYS 678
+ K+D++S
Sbjct: 180 DTKADIWS 187
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 488 CKATKNFS--TKLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTTIGN 541
C++ F ++G+G +G VY G VA+KK +++ G S E+T + N
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 542 VHHLHLVKLKGFCIEGAHR---LLAYEYLGN--GSLDKWIFNSTEESRFLSWNTRFNIAL 596
+ H ++V+LK + G H L EY SL + ES+ + L
Sbjct: 63 LRHPNIVELKE-VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC------LML 115
Query: 597 GMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
+ +GL YLHE I+H D+K N+LL D K++DFGLA+
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 59/199 (29%), Positives = 86/199 (43%), Gaps = 36/199 (18%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL-----------ESIGQGKKEFSAEVTTIGNVHHL 545
LG+G FG V L L ++ AVK L E K+ + G H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLA----LAGK--HP 56
Query: 546 HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
L +L C + RL EY+ G L +F+ RF RF A + GL +
Sbjct: 57 FLTQLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARF-YAAEIVLGLQF 111
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY----TTLRGTRGYL 660
LHE I++ D+K +NVLLD K++DFG+ K E ++ +T GT Y+
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDYI 163
Query: 661 APEWITNNPISEKSDVYSY 679
APE ++ P D ++
Sbjct: 164 APEILSYQPYGPAVDWWAL 182
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 27/179 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLK 551
++G G FG+VY + + VA+KK+ G+ E EV + + H + ++ +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 552 GFCIEGAHRLLAYEY-LGNGS----LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
G + L EY LG+ S + K E + + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------VTHGALQGLAYLH 132
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
++H D+K N+LL + K+ DFG A +M V GT ++APE I
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 498 LGQGGFGSVYLGMLP----DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG+G FGSV L +VAVK L++ +EF E + H +++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 551 KGFCIEGAHR------LLAYEYLGNGSLDKWIFNST--EESRFLSWNTRFNIALGMAKGL 602
G + + ++ ++ +G L ++ S EE L T + +A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-----NREESLVYTTLRGTR 657
YL + +H D+ N +L++N T V+DFGL+K + R+ ++
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK--- 180
Query: 658 GYLAPEWITNNPISEKSDVYSY 679
+LA E + +N + SDV+++
Sbjct: 181 -WLALESLADNVYTTHSDVWAF 201
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 22/177 (12%)
Query: 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
+K+G+G +G V+ + G VA+KK E KK E+ + + H +LV L
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL- 65
Query: 552 GFCIEGAHRL----LAYEYLGNGSLDKWIFNSTEES-RFLSWNTRFNIALGMAKGLAYLH 606
IE R L +EY D + N E++ R + + I + + + H
Sbjct: 66 ---IEVFRRKRKLHLVFEYC-----DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+ +H D+KPEN+L+ K+ DFG A+++ YT TR Y APE
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 594 IALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 653
+ + + K L YL E+ V +H D+KP N+LLD + K+ DFG++ + +S T
Sbjct: 119 MTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRS 174
Query: 654 RGTRGYLAPEWIT-NNPISE---KSDVYS 678
G Y+APE I +P + ++DV+S
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWS 203
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 27/179 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLK 551
++G G FG+VY + VA+KK+ G+ E EV + + H + ++ K
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 552 GFCIEGAHRLLAYEY-LGNGS----LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
G + L EY LG+ S + K E + I G +GLAYLH
Sbjct: 92 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLH 142
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
++H DIK N+LL + K++DFG A + + S V GT ++APE I
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-08
Identities = 17/53 (32%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 356 DLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYMKIS 408
L C+EACL NCSC+ + N + C L++ + + RS G Y++++
Sbjct: 33 SLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSG-GGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 29/62 (46%), Positives = 39/62 (62%), Gaps = 7/62 (11%)
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
YLH + I++ D+KPEN+LLD+ KV+DFG AK + + + TL GT YLAPE
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF---TLCGTPEYLAPE 185
Query: 664 WI 665
I
Sbjct: 186 VI 187
|
Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 29/79 (36%), Positives = 47/79 (59%), Gaps = 5/79 (6%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+GL +LH C IVH D+KPEN+L+ K++DFGLA++ + + +L T + T Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWY 173
Query: 660 LAPEWITNNPISEKSDVYS 678
APE + + + D++S
Sbjct: 174 RAPEVLLQSTYATPVDMWS 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 28/200 (14%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEF------------SAEVTTIG 540
NF LG+G FG V L + +L +I KK+ V +
Sbjct: 3 NFLMVLGKGSFGKVMLAE-----RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 541 NVHHLHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMA 599
L +L C + RL EY+ G L +++ + +F + F A +A
Sbjct: 58 GKPPF-LTQLHS-CFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVF-YAAEIA 111
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
GL +LH + I++ D+K +NV+LD K++DFG+ K N T GT Y
Sbjct: 112 IGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDY 167
Query: 660 LAPEWITNNPISEKSDVYSY 679
+APE I P + D +++
Sbjct: 168 IAPEIIAYQPYGKSVDWWAF 187
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 17/180 (9%)
Query: 497 KLGQGGFGSVYLGML---PDGIQVAVKKLESIGQGKK--EFSAEVTTIGNVHHLHLVKLK 551
++G G FG V L + +V VK+L++ K+ EF + + H ++++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G C+E LL +EY G L ++ R +A +A G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-----VYTTLRGTRGYLAPEWIT 666
+H D+ N L + T KV D+G+ +E+ + LR +LAPE +
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVG 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 35/187 (18%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSA----EVTTIGNVHHLHLVKLKG 552
+G+G +G VY D G VA+KK+ + K+ F E+ + ++H ++V LK
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 553 FCIEGAHRL----------LAYEYLGN---GSLDKWIFNSTEESRFLSWNTRFNIALGMA 599
+ L L +EY+ + G L+ + + +E+ +I M
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED----------HIKSFMK 123
Query: 600 K---GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGT 656
+ GL Y H++ +H DIK N+LL++ K++DFGLA+L N EES YT T
Sbjct: 124 QLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 657 RGYLAPE 663
Y PE
Sbjct: 181 LWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 33/159 (20%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKLKG 552
K+G+G +G+V+ + VA+K+ L+ +G + E+ + + H ++V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 553 FCIEGAHRL-LAYEYLG----------NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKG 601
+ +L L +EY NG +D I S F+ + KG
Sbjct: 67 -VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS-----FM---------FQLLKG 111
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
LA+ H ++H D+KP+N+L++ N K++DFGLA+
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 13/181 (7%)
Query: 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557
L G G V++ P V K IGQ K E + NV+H ++++K + G
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLK---IGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVSG 129
Query: 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCD 617
A + L + S D + + T+ SR L + I + +GL YLH + +I+H D
Sbjct: 130 AITCMV---LPHYSSDLYTY-LTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRD 182
Query: 618 IKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVY 677
+K EN+ ++D + D G A+ + + L GT APE + + + K+D++
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPA--FLGLAGTVETNAPEVLARDKYNSKADIW 240
Query: 678 S 678
S
Sbjct: 241 S 241
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 498 LGQGGFGSVY----LGMLPD----GIQVAVKKLESIGQGK--KEFSAEVTTIGNV-HHLH 546
LG+G FG V G+ + VAVK L+ K + +E+ + + H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWI-----------FNSTEESR-FLSWNTRFNI 594
++ L G C + + EY G+L +++ F+ T+ LS+ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL- 653
A +A+G+ YL + +H D+ NVL+ ++ K++DFGLA+ ++ + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 654 RGTRGYLAPEWITNNPISEKSDVYSY 679
R ++APE + + + +SDV+S+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSF 222
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
+ K + + H+ IVH DIKPEN+L+ N K+ DFG A+ ++ + YT TR
Sbjct: 109 LIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165
Query: 658 GYLAPEWITNNPISEKSDVYS 678
Y +PE + P + D++S
Sbjct: 166 WYRSPELLLGAPYGKAVDMWS 186
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 497 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
KLG+G + +V+ G L + + VA+K++ + +A EV+ + N+ H ++V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L +EYL + L +++ N +S + + +GL+Y H+ K
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAK 640
I+H D+KP+N+L+++ K++DFGLA+
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 27/68 (39%), Positives = 38/68 (55%), Gaps = 7/68 (10%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK----LMNREESLVYTTLRG 655
K L Y+H ++H D+KP N+LL+ + K++DFGLA+ L E+ V T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 656 TRGYLAPE 663
TR Y APE
Sbjct: 175 TRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M G+ +LH I+H D+KP N+++ + T K+ DFGLA+ S + T TR
Sbjct: 127 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTR 181
Query: 658 GYLAPEWITNNPISEKSDVYS 678
Y APE I E D++S
Sbjct: 182 YYRAPEVILGMGYKENVDIWS 202
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYLHEECEVKIVHCD 617
+ L EY G L + + E +F +F +A L +A +H ++ VH D
Sbjct: 75 NLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA-----IHSVHQMGYVHRD 127
Query: 618 IKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
IKPENVL+D K++DFG A + + + GT Y+APE +T
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 32/184 (17%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSA--EVTT---IGNVHHLHLVKL 550
+G+G +G+VY L G VA+KK+ + + S E+ + + H ++V+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 551 KGFCI-----EGAHRLLAYEYLGNGSLDKWIFN------STEESRFLSWNTRFNIALGMA 599
C L +E++ + L ++ E + L +
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ--------LL 117
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+G+ +LH IVH D+KP+N+L+ + K++DFGLA++ + E +L T++ T Y
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWY 172
Query: 660 LAPE 663
APE
Sbjct: 173 RAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 6/67 (8%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR---EESLVYTTLRGT 656
+GL Y+H ++H D+KP N+L++++ ++ DFG+A+ ++ E T T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 657 RGYLAPE 663
R Y APE
Sbjct: 175 RWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 59/190 (31%), Positives = 76/190 (40%), Gaps = 33/190 (17%)
Query: 493 NFSTKLGQGGFGSVYLGML-PDGIQVAVKKL-----------ESIGQGKKEFSAEVTTIG 540
LG+G FG V L G A+K L ES+ K+ F T
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFE----TAN 57
Query: 541 NVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAK 600
+ H LV L H EY G L I F F A +
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAAC-VVL 112
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY----TTLRGT 656
GL YLHE KIV+ D+K +N+LLD K++DFGL K E + + +T GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGT 164
Query: 657 RGYLAPEWIT 666
+LAPE +T
Sbjct: 165 PEFLAPEVLT 174
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 7/70 (10%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
+ +GL Y+H I+H D+KP N+ ++++ K+ DFGLA+ + E T TR
Sbjct: 127 ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATR 179
Query: 658 GYLAPEWITN 667
Y APE + N
Sbjct: 180 WYRAPEIMLN 189
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 554 CIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
C + RL EY+ G L +++ + +F F A ++ GL +LH
Sbjct: 69 CFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVF-YAAEISVGLFFLHRR---G 121
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
I++ D+K +NV+LD K++DFG+ K + + + T GT Y+APE I P +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 673 KSDVYSY 679
D ++Y
Sbjct: 181 SVDWWAY 187
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 25/179 (13%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+G G FG VY + D +VA+KK+ Q K E+ + N++H++++ LK +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYT 130
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM----------AKGLAYLH 606
+ N ++ F +++ R N AL + + LAY+H
Sbjct: 131 ECFKKNEKNIFLNVVME---FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 607 EECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPE 663
+ I H D+KP+N+L+D N T K+ DFG AK L+ + S+ Y +R Y APE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPE 240
|
Length = 440 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 41/147 (27%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKGF 553
KLG+G + +VY G G VA+K++ + +A E++ + + H ++V+L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+L +EY+ + L K++ ++ L NT + + KG+A+ HE ++
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAK 640
+H D+KP+N+L++ K++DFGLA+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 15/189 (7%)
Query: 498 LGQGGFGSVY-LGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCI 555
+G+G +G VY + DG AVK L+ I +E AE + ++ +H ++VK G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 556 E-----GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ G L E GS+ + + + L I G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+I+H D+K N+LL K+ DFG++ + L T GT ++APE I
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIA---- 201
Query: 671 SEKSDVYSY 679
E+ YSY
Sbjct: 202 CEQQYDYSY 210
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 57/205 (27%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 495 STKLGQGGFGSV-YLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKL 550
S LG G G+V + DG AVK ++ G K AEV + N +VK
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 551 KGFCIEGAHRLLAY----------------EYLGNGSLDKWIFNSTEESRFLSWNTRFNI 594
C H A +Y G L + I + + +R
Sbjct: 96 ---C----HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR---EHEA 145
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTL 653
L + L +H ++H DIK N+LL N K+ DFG +K+ S V T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 654 RGTRGYLAPEWITNNPISEKSDVYS 678
GT Y+APE P S+K+D++S
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFS 230
|
Length = 496 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 46/197 (23%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 500 QGGFGSVYLGMLPDGI-----QVAVKKLESIGQGKKE-----FSAEVTTIGNVHHLHLVK 549
+G FG ++ G+L D +V VK ++ E E + + H +++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK---TVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 550 LKGFCIE-GAHRLLAYEYLGNGSLDKWIFNSTE----ESRFLSWNTRFNIALGMAKGLAY 604
+ CIE G + Y Y+ G+L ++ + LS ++A+ +A G++Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAP 662
LH+ ++H DI N ++D+ K++D L++ + L R + ++A
Sbjct: 133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WMAL 188
Query: 663 EWITNNPISEKSDVYSY 679
E + N S SDV+S+
Sbjct: 189 ESLVNKEYSSASDVWSF 205
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+GL Y+H +VH D+KP N+L+++N K+ DFGLA++ + + T TR Y
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYY 171
Query: 660 LAPE-WITNNPISEKSDVYS 678
APE +T + D++S
Sbjct: 172 RAPEIMLTWQKYDVEVDIWS 191
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFS-AEVTTIGNVHH-LHLVKLK 551
K+G+G +G VY G VA+KK LE +G + E++ + + +++V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 552 GFCIE------GAHRL-LAYEYLGNGSLDKWI-FNSTEESRFLSWNTRFNIALGMAKGLA 603
+E G L L +EYL + L K++ N R L T + + KG+A
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTA-KVSDFGLAK 640
+ H+ ++H D+KP+N+L+D K++D GL +
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 16/173 (9%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLES---IGQGKKEFSAEVTTIGNVHHLH--LVKLK 551
LG+G FG V L L + ++ AVK L+ + E + I ++ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 552 GFCIEGAHRLL-AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
C + RL E++ G L +F+ + RF RF A + L +LH++
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARF-YAAEITSALMFLHDK-- 115
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I++ D+K +NVLLD K++DFG+ K +T GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT-STFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFS---AEVTTIGNVHHLHLVKLKGF 553
++G G +G VY ++A K+ + G +FS E+ + H ++V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ + EY G GSL I++ T LS + +GLAYLH + ++
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGP---LSELQIAYVCRETLQGLAYLHSKGKM-- 128
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLA----KLMNREESLVYTTLRGTRGYLAPE 663
H DIK N+LL DN K++DFG+A + + +S + GT ++APE
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGN----------- 541
NF LG+G FG V L ++ K+ ++ E T +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 542 VHHLHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAK 600
+ LH C + RL EY+ G L ++ + RF + F A +A
Sbjct: 63 LTQLH------SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVF-YAAEIAI 112
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
GL +LH + I++ D+K +NV+LD K++DFG+ K N + + T GT Y+
Sbjct: 113 GLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYI 168
Query: 661 APEWITNNPISEKSDVYSY 679
APE I P + D +++
Sbjct: 169 APEIIAYQPYGKSVDWWAF 187
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 580 TEESRFLSWNTRFNIALGMAKGLAYL-HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638
TE+S L + + +A+G+ +L + C +H D+ NVLL D AK+ DFGL
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGL 258
Query: 639 AK-LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
A+ +MN +V R ++APE I + + +SDV+SY
Sbjct: 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 300
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 497 KLGQGGFGSVYLGMLPDGIQ---VAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKL 550
K+G+G +G VY D + +A+KK LE +G + E++ + + H ++V+L
Sbjct: 9 KIGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKGLAYLHEE 608
+ L +EYL + L K + +S + ++ N R + +G+AY H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAK----NPRLIKTYLYQILRGIAYCHSH 121
Query: 609 CEVKIVHCDIKPENVLLDDNFTA-KVSDFGLAK 640
+++H D+KP+N+L+D A K++DFGLA+
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 45/203 (22%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS--AEVTTIGNV-------HHLH 546
K+G+G F V G A+K + KK F +V + + H +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM------KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 547 LVKLKGFCIEGAHRLLA----------YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIAL 596
+++L + LA YE + R L +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG------------RKRPLPEKRVKSYMY 107
Query: 597 GMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGT 656
+ K L ++H I H DIKPEN+L+ D+ K++DFG + + + YT T
Sbjct: 108 QLLKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYIST 161
Query: 657 RGYLAPEWI-TNNPISEKSDVYS 678
R Y APE + T+ K D+++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWA 184
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 24/154 (15%)
Query: 497 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
KLG+G + +VY G L D + VA+K++ + +A EV+ + ++ H ++V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 553 FCIEGAHRLLAYEYLGNGSLDKW------IFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
L +EYL + L ++ N FL + +GL Y H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL---------FQLLRGLNYCH 121
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
K++H D+KP+N+L+++ K++DFGLA+
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 41/159 (25%), Positives = 81/159 (50%), Gaps = 25/159 (15%)
Query: 532 FSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF-LSWNT 590
F + + V H+HL + G C+ G+ ++ E++ +G LD + E+ R ++W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAW-- 118
Query: 591 RFNIALGMAKGLAYLHEECEVKIVHCDIKPENVL-----LDDNFTA--KVSDFGLA-KLM 642
+ +A +A L+YL ++ +VH ++ +N+L L + + K+SD G++ +
Sbjct: 119 KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 643 NREESLVYTTLRGTR-GYLAPEWITN-NPISEKSDVYSY 679
+REE R R ++APE + N +S +D +S+
Sbjct: 176 SREE-------RVERIPWIAPECVPGGNSLSTAADKWSF 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 26/70 (37%), Positives = 40/70 (57%), Gaps = 4/70 (5%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
+ +GL Y+H ++H D+KP N+LL+ N K+ DFGLA+ + + + T TR
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVTR 172
Query: 658 GYLAPEWITN 667
Y APE + N
Sbjct: 173 WYRAPELLLN 182
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 40/148 (27%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 497 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
KLG+G + +V+ G L + + VA+K++ + +A EV+ + ++ H ++V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L +EYL + L +++ + +S + + +GLAY H K
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAK 640
++H D+KP+N+L+++ K++DFGLA+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 38/166 (22%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-------------- 542
LG+G +G V G VA+KK++ I + + + + +G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 543 --HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------I 594
H +++ L +EG L + + L K + + R I
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDR---------KIRLTESQVKCI 124
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
L + GL LH+ +H D+ P N+ ++ K++DFGLA+
Sbjct: 125 LLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 55/223 (24%), Positives = 87/223 (39%), Gaps = 58/223 (26%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSA------EVTTIGN---VHHLHL 547
+G+G FG V+L D QV A+K L K+ A ++ + + L+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 548 VKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNS---TEESRFLSWNTRFNIALGMAKGLA 603
+ + L L EY+ G L + EE+ RF IA + L
Sbjct: 68 -----YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIA-ELVLALD 115
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR--------- 654
+H+ + +H DIKP+N+L+D + K++DFGL K MN+ + Y
Sbjct: 116 SVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 655 -------------------GTRGYLAPEWITNNPISEKSDVYS 678
GT Y+APE + P + D +S
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 40/148 (27%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA-EVTTIGNVHHLHLVKLKG 552
K+G+G +G VY G VA+KK L++ +G + E++ + ++H ++VKL
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L +E+L + L K++ S + + + +GLA+ H +
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSG--IPLPLIKSYLFQLLQGLAFCHSH---R 120
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAK 640
++H D+KP+N+L++ K++DFGLA+
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/188 (28%), Positives = 76/188 (40%), Gaps = 30/188 (15%)
Query: 495 STKLGQGGFGSVYLG--MLPDGIQVAVKKLESIGQGKKEFSA----EVTTIGNVHHLHLV 548
K+GQG FG V+ I VA+KK+ + K+ F E+ + + H ++V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQI-VALKKVL-MENEKEGFPITALREIKILQLLKHENVV 74
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE--SRFLSWNTRFNIALGMAK------ 600
L C R A Y +F E + LS N L K
Sbjct: 75 NLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLS-NKNVKFTLSEIKKVMKML 128
Query: 601 --GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK---LMNREESLVYTTLRG 655
GL Y+H KI+H D+K N+L+ + K++DFGLA+ L + YT
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 656 TRGYLAPE 663
T Y PE
Sbjct: 186 TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 496 TKLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+ +G G +GSV G++VAVKKL +SI K+ + E+ + ++ H +++ L
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 81
Query: 551 KG-FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
F + YL + + N + + + +F I + +GL Y+H
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS-- 138
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE + N
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN 191
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G G +G VY + G A+K KLE G+ E+ + + H ++V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ + E+ G GSL I++ T LS + ++ +GL YLH + ++
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGP---LSESQIAYVSRETLQGLYYLHSKGKM-- 128
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMN----REESLVYTTLRGTRGYLAPE 663
H DIK N+LL DN K++DFG++ + + +S + GT ++APE
Sbjct: 129 -HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 497 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKGF 553
KLG+G + +VY G +G VA+K + + F+A E + + + H ++V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
L +EY+ D + N + + + +GL+Y+H+ I
Sbjct: 72 IHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQR---YI 124
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAK 640
+H D+KP+N+L+ D K++DFGLA+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 3/64 (4%)
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 661
L +LH+ + I++ DIK EN+LLD ++DFGL+K EE + GT Y+A
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 662 PEWI 665
PE I
Sbjct: 175 PEVI 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 26/66 (39%), Positives = 38/66 (57%), Gaps = 5/66 (7%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE--SLVYTTLRGTR 657
+GL Y+H ++H D+KP N+LL+ N K+ DFGLA++ + E + T TR
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 658 GYLAPE 663
Y APE
Sbjct: 174 WYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 26/86 (30%), Positives = 52/86 (60%), Gaps = 5/86 (5%)
Query: 593 NIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652
++ + +GL +LH ++VH D+KP+N+L+ + K++DFGLA++ + + +L T+
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TS 168
Query: 653 LRGTRGYLAPEWITNNPISEKSDVYS 678
+ T Y APE + + + D++S
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWS 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 26/186 (13%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKGFC 554
LG G G V+ + D +VAVKK+ + + A E+ I + H ++VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI-VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 555 IEGAHRL---------LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
L L Y+ ++ + N E+ + R + +GL Y+
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKYI 130
Query: 606 HEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNRE--------ESLVYTTLRGT 656
H ++H D+KP NV ++ ++ K+ DFGLA++++ E LV R
Sbjct: 131 HS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 657 RGYLAP 662
R L+P
Sbjct: 188 RLLLSP 193
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M G+ +LH I+H D+KP N+++ + T K+ DFGLA+ S + T TR
Sbjct: 128 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTR 182
Query: 658 GYLAPEWITNNPISEKSDVYS 678
Y APE I E D++S
Sbjct: 183 YYRAPEVILGMGYKENVDIWS 203
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 22/68 (32%), Positives = 38/68 (55%), Gaps = 5/68 (7%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRG 655
+ + L Y+H + H D+KP+N+L + + K+ DFGLA++ + ++ +T
Sbjct: 112 LLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 656 TRGYLAPE 663
TR Y APE
Sbjct: 169 TRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 52/176 (29%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVK--KLESIGQGKKEFSAEVTTIGN------VHHLHLV 548
LG+G FG V L L +V A+K K + I Q + + T H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLT 59
Query: 549 KLKGFCIEGAHRLL-AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
L C + RL EY+ G L +F +F +RF A + L +LH
Sbjct: 60 ALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF-YAAEVTLALMFLHR 114
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+++ D+K +N+LLD K++DFG+ K + TT GT Y+APE
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 19/50 (38%), Positives = 30/50 (60%)
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+H D+KP+N+LLD + K++DFG M+ + T GT Y++PE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 35/121 (28%), Positives = 61/121 (50%), Gaps = 8/121 (6%)
Query: 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDI 618
H E+L G L +F+ ++ RF + F A + GL +LH + I++ D+
Sbjct: 70 HLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVC-GLQFLHSK---GIIYRDL 122
Query: 619 KPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
K +NV+LD + K++DFG+ K ++ +T GT Y+APE + + D +S
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYIAPEILQGLKYTFSVDWWS 181
Query: 679 Y 679
+
Sbjct: 182 F 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 28/70 (40%), Positives = 39/70 (55%), Gaps = 7/70 (10%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M KGL Y+H I+H D+KP N+ ++++ K+ DFGLA+ + E T TR
Sbjct: 127 MLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTR 179
Query: 658 GYLAPEWITN 667
Y APE I N
Sbjct: 180 WYRAPEVILN 189
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 19/173 (10%)
Query: 514 GIQVAVKKLESIGQGK---KEFSAEVTTIGNVHHLHLVKLKGF-----CIEGAHRLLAYE 565
GI VAVKKL Q + K E+ + V+H +++ L +E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL 625
L + +L + I + R +S+ + M G+ +LH I+H D+KP N+++
Sbjct: 106 ELMDANLCQVIHMELDHER-MSY-----LLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 156
Query: 626 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ T K+ DFGLA+ + + T TR Y APE I E D++S
Sbjct: 157 KSDCTLKILDFGLARTAC--TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 26/86 (30%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TL 653
+ +A+G+ +L K +H D+ N+LL +N K+ DFGLA+ + ++ V
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 654 RGTRGYLAPEWITNNPISEKSDVYSY 679
R ++APE I + + +SDV+S+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSF 261
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 498 LGQGGFGSVYLGM---LPDGIQ-----VAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLV 548
LGQG F ++ G+ + D + V +K L+ + E F + + + H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY-LHE 607
G C+ G ++ EY+ GSLD ++ + +SW L +AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWK------LEVAKQLAWALHF 115
Query: 608 ECEVKIVHCDIKPENVLL 625
+ + H ++ +NVLL
Sbjct: 116 LEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 576 IFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635
+F + S L I + + LAYLH I+H D+K EN+ LD+ A + D
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGD 228
Query: 636 FGLA-KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
FG A KL ++ GT +PE + +P K+D++S
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWS 272
|
Length = 392 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 7/82 (8%)
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTR 657
GL Y+H ++H D+KP N+L++ + K+ DFGLA+ + E + T TR
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 658 GYLAPE-WITNNPISEKSDVYS 678
Y APE ++ ++ DV+S
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWS 195
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 34/169 (20%)
Query: 483 SYDDLCKATKNFSTKLGQGGFGSVYLGM--LPDGIQVAVKKLESIGQGKKEFSA--EVTT 538
+Y L K LG+G + +VY G L + VA+K++ + F+A E +
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASL 56
Query: 539 IGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF----NI 594
+ ++ H ++V L L +EYL T+ +++ N+
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYL-----------DTDLKQYMDDCGGGLSMHNV 105
Query: 595 ALGM---AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
L + +GLAY H+ +++H D+KP+N+L+ + K++DFGLA+
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 23/59 (38%), Positives = 37/59 (62%)
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+H ++ VH DIKP+NVLLD N +++DFG MN++ ++ + GT Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 7/70 (10%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M GL Y+H I+H D+KP N+ ++++ K+ DFGLA+ + E T TR
Sbjct: 126 MLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTR 178
Query: 658 GYLAPEWITN 667
Y APE I N
Sbjct: 179 WYRAPEVILN 188
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 52/155 (33%), Positives = 72/155 (46%), Gaps = 26/155 (16%)
Query: 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLKG 552
+G+G FG V L D G A+KKL +KE AE + + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY- 67
Query: 553 FCIEGAHRL-LAYEYLGNGSL-----DKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYL 605
+ + + L L EYL G + K F TEE TRF IA +A + +
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--TEEE------TRFYIAETILA--IDSI 117
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
H+ + +H DIKP+N+LLD K+SDFGL
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M G+ +LH I+H D+KP N+++ + T K+ DFGLA+ S + T TR
Sbjct: 135 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTR 189
Query: 658 GYLAPEWITNNPISEKSDVYS 678
Y APE I E D++S
Sbjct: 190 YYRAPEVILGMGYKENVDIWS 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 497 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLKGF 553
KLG+G + +VY G+ +G VA+K + + F+A E + + + H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+EY+ D + +N R + +GLAY+H + I
Sbjct: 72 IHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HI 124
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAK 640
+H D+KP+N+L+ K++DFGLA+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 554 CIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
C + RL L EY+ G L +F+ + + + RF A + L +LHE
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARF-YAAEICIALNFLHER---G 116
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I++ D+K +NVLLD + K++D+G+ K +T GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 36/131 (27%), Positives = 55/131 (41%), Gaps = 18/131 (13%)
Query: 541 NVHHL-----HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA 595
VH L + +KL +L +Y+ +G L F+ ++ LS I
Sbjct: 60 MVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKII 115
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESLVYTTLR 654
+ + L LH+ I+H DIK ENVL D + D+GL K++ +
Sbjct: 116 RQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD 167
Query: 655 GTRGYLAPEWI 665
GT Y +PE I
Sbjct: 168 GTLDYFSPEKI 178
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 31/161 (19%)
Query: 500 QGGFGSVYLGMLPD-----GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
+G FG VYLG + ++V VKK + I K +V + L L K F
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKV-VKKADMI---NKNMVHQVQAERDA--LALSK-SPFI 66
Query: 555 IEGAHRL-------LAYEYLGNGSLDKW--IFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
+ + L L EYL G + I+ +E I+ +A L YL
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM-----AVKYIS-EVALALDYL 120
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL-MNRE 645
H I+H D+KP+N+L+ + K++DFGL+K+ +NRE
Sbjct: 121 HRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
GL ++H +V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 661 APE 663
APE
Sbjct: 163 APE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 57/184 (30%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 498 LGQGGFGSVYL----GMLPDGIQVAVKKLESIGQGKKEFSAEVT-TIGNVHHLHLVKLKG 552
LG G +G V+L G A+K L+ +K + E T T NV L V+
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LEHVRQSP 65
Query: 553 FCIE-------GAHRLLAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKG 601
F + A L +Y+ G + ++ S +E RF S I L
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE----IILA---- 117
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 661
L +LH+ + IV+ DIK EN+LLD ++DFGL+K EE + GT Y+A
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 662 PEWI 665
PE I
Sbjct: 175 PEII 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 4/83 (4%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGT 656
+AKG+ +L K +H D+ N+LL +N K+ DFGLA+ + ++ V R
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 657 RGYLAPEWITNNPISEKSDVYSY 679
++APE I + + +SDV+S+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSF 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 23/63 (36%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
GL ++H +V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 661 APE 663
APE
Sbjct: 163 APE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 50/205 (24%), Positives = 75/205 (36%), Gaps = 38/205 (18%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLE--SIGQGKK--EFSAEVTTIGNVHHLHLVKLK 551
LG+G G V+L L G A+K L+ + + K E + + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ L +Y G L + + RF A + L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLL--- 122
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKL------------------MNREESLVYT-- 651
IV+ D+KPEN+LL ++ +SDF L+K + T
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 652 ---TLR-----GTRGYLAPEWITNN 668
+ R GT Y+APE I+ +
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGD 207
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 7/70 (10%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
+ +GL Y+H I+H D+KP NV ++++ ++ DFGLA+ + E T TR
Sbjct: 127 LLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATR 179
Query: 658 GYLAPEWITN 667
Y APE + N
Sbjct: 180 WYRAPEIMLN 189
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 26/83 (31%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGT 656
+A+G+ +L K +H D+ N+LL +N K+ DFGLA+ + ++ V + R
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 657 RGYLAPEWITNNPISEKSDVYSY 679
++APE I + + +SDV+S+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSF 262
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 582 ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641
ES LS+ + +A G+ +L + VH D+ NVL+ + K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 642 MNREESLV-----YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
+ R+ + + + L+ ++APE I NN + SDV+S+
Sbjct: 289 IMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSF 327
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 40/201 (19%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF-----SAEVTTIGNV------HHL 545
LG+G FG V+L L Q A+K L KK+ E T + H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL------KKDVVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 546 HLVKLKGFCI--EGAHRLLAYEYLGNGSLDKWIFNSTEESRF-LSWNTRFNIALGMAKGL 602
L L +C + EYL G L +F+ +F L T + A + GL
Sbjct: 57 FLTHL--YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFY--AAEIICGL 109
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV----YTTLRGTRG 658
+LH + IV+ D+K +N+LLD + K++DFG+ K E+++ T GT
Sbjct: 110 QFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPD 161
Query: 659 YLAPEWITNNPISEKSDVYSY 679
Y+APE + + D +S+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSF 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 10/122 (8%)
Query: 543 HHLHLVKLKGFCIEGAHRLL-AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKG 601
+H LV L C + RL EY+ G L +F+ + + + RF A ++
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLA 108
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 661
L YLHE I++ D+K +NVLLD K++D+G+ K R +T GT Y+A
Sbjct: 109 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIA 164
Query: 662 PE 663
PE
Sbjct: 165 PE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 21/50 (42%), Positives = 32/50 (64%)
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+H D+KP+N+LLD + K++DFG MN+E + T GT Y++PE
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 498 LGQGGFGSVY-LGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGF-- 553
+G+G +G V+ + +G + AVK L+ I +E AE + + H ++VK G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 554 ---CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN---IALGMAK---GLAY 604
G L E GS+ + FL R IA + + GL +
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLV------KGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL-AKLMNREESLVYTTLRGTRGYLAPE 663
LH K +H D+K N+LL K+ DFG+ A+L + L T GT ++APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPE 194
Query: 664 WIT-----NNPISEKSDVYS 678
I ++ + DV+S
Sbjct: 195 VIACEQQLDSTYDARCDVWS 214
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 20/50 (40%), Positives = 30/50 (60%)
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
VH DIKP+NVLLD N +++DFG + + ++ GT Y++PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 10/121 (8%)
Query: 544 HLHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
H LV L C + RL E++ G L +F+ + + + RF + ++ L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLAL 109
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 662
+LHE I++ D+K +NVLLD K++D+G+ K R +T GT Y+AP
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT-STFCGTPNYIAP 165
Query: 663 E 663
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 28/78 (35%), Positives = 40/78 (51%), Gaps = 17/78 (21%)
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK--LMNREESL----------- 648
L YLH IVH D+KP+N+L+ K++DFGL+K LM+ +L
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 649 -VYTTLRGTRGYLAPEWI 665
+ + GT Y+APE I
Sbjct: 171 FLDKQVCGTPEYIAPEVI 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
L +LH+ + I++ DIK EN+LLD N ++DFGL+K + +E + GT Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 661 APE 663
AP+
Sbjct: 174 APD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 469 DNFLEKISGMPTRFSYDDLCKATKNFSTK---------LGQGGFGSVYLGMLPDGIQV-A 518
DNFL + Y+ + + + K +G+G FG V L +V A
Sbjct: 22 DNFLNR---------YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYA 72
Query: 519 VKKLESIGQGKKEFSA----EVTTIGNVHHLHLVKLKGFCI--EGAHRLLAYEYLGNGSL 572
+K L K+ SA E + + +V+L FC + + + EY+ G L
Sbjct: 73 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL 130
Query: 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632
+ N + W + + +A L +H + ++H D+KP+N+LLD + K
Sbjct: 131 VNLMSNYDVPEK---WAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLK 182
Query: 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
++DFG M+ + T GT Y++PE
Sbjct: 183 LADFGTCMKMDETGMVRCDTAVGTPDYISPE 213
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK-LMNREESLVYTTLRGT 656
+AKG+++L + +H D+ N+LL K+ DFGLA+ + N +V R
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 657 RGYLAPEWITNNPISEKSDVYSY 679
++APE I N + +SDV+SY
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSY 302
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 26/161 (16%)
Query: 498 LGQGGFGSVYLGMLPDGIQV---AVKKLESIGQG-------------KKEFSAEVTTIGN 541
+G GGFG VY + AV K+E++ + A I N
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 542 VHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE-SRFLSWNTRF--NIALGM 598
+ HL + K G C + Y ++ L+K + N+ E R N + NI M
Sbjct: 80 IDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIMKDM 135
Query: 599 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639
L Y+HE I H DIKPEN+++D N + D+G+A
Sbjct: 136 LTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 23/84 (27%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 542 VHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKG 601
V H H+V L G C+ ++ E++ G LD ++ ++ L+ +F +A +A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASA 117
Query: 602 LAYLHEECEVKIVHCDIKPENVLL 625
L+YL ++ +VH ++ +N+LL
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 32/119 (26%), Positives = 58/119 (48%), Gaps = 8/119 (6%)
Query: 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622
+Y+ + + + S + S L+ + +A+G+ +L + VH D+ N
Sbjct: 213 SYKGSNDSEVKNLL--SDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267
Query: 623 VLLDDNFTAKVSDFGLAKLMNREESLVY--TTLRGTRGYLAPEWITNNPISEKSDVYSY 679
VLL K+ DFGLA+ + + + V +T + ++APE I +N + SDV+SY
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK-WMAPESIFDNLYTTLSDVWSY 325
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 4/119 (3%)
Query: 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKP 620
LL EY G L+K I +E + + L + + L E K++H D+K
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 621 ENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
N+ L K+ DFG +K + SL V ++ GT YLAPE S+K+D++S
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256
|
Length = 478 |
| >gnl|CDD|238533 cd01100, APPLE_Factor_XI_like, Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 5e-04
Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 1/69 (1%)
Query: 335 FYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIGSLQRS 394
F G +D+ + F C+ AC + C + +K CFL G+L +S
Sbjct: 6 FRQGSNVDFRGGDLSTVFAS-SAEQCQAACTADPGCLAFTYNTKSKKCFLKSSEGTLTKS 64
Query: 395 QQGSTGYVS 403
+G
Sbjct: 65 TGAVSGPRL 73
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 73 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 29/140 (20%), Positives = 63/140 (45%), Gaps = 16/140 (11%)
Query: 546 HLVKLKGFCIEGAHRL----LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKG 601
+++K+ GF I+ L L EY G L + + + LS+ T+ ++A+ KG
Sbjct: 79 NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKG 134
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 661
L L++ + ++ + L+ +N+ K+ GL K+++ + Y +
Sbjct: 135 LYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFS 188
Query: 662 PEWITN--NPISEKSDVYSY 679
+ + + + + K D+YS
Sbjct: 189 YKMLNDIFSEYTIKDDIYSL 208
|
Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 11/115 (9%)
Query: 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623
Y ++ + + D W + R L TR I + + Y+H++ K++H DIK EN+
Sbjct: 250 YSFMYDEAFD-W------KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENI 298
Query: 624 LLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
L+ + + DFG A +E GT +PE + + E +D++S
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
|
Length = 501 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 4/63 (6%)
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
G+A+LH+ I+H D+K N+LL++ K+ DFGLA+ YT L T Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYR 173
Query: 661 APE 663
APE
Sbjct: 174 APE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|214742 smart00605, CW, CW domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 14/59 (23%), Positives = 30/59 (50%), Gaps = 4/59 (6%)
Query: 356 DLNTCKEACLHNCSCSVLFFENSTKNCFLF--DQIGSLQRSQQGSTGYVSYMKISSGNE 412
+ C + C + +C VL + NS++ C+LF + ++++ S V+ K+S+
Sbjct: 23 SWDECIQKCYEDSNC-VLAYGNSSETCYLFSYGTVLTVKKLSSSSGKKVA-FKVSTDQP 79
|
Length = 94 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 11/171 (6%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLKG 552
+G+G FG V + L + +V A+K L K+ F E + N + + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ + L +Y G L + S E R RF +A M + +H+ +
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLA-EMVIAIDSVHQ---LH 122
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
VH DIKP+N+L+D N +++DFG + + ++ + GT Y++PE
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 36.4 bits (84), Expect = 0.004
Identities = 17/51 (33%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 356 DLNTCKEACL-HNCSCSVLFFENSTKNCFLFDQIGSLQRSQQGSTGYVSYM 405
L C CL NCSC + N TK C L+ SL ++ +G V
Sbjct: 26 SLEECASKCLNSNCSCRSFTYNNGTKGCLLWS-ESSLGDARLFPSGGVDLY 75
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLKG 552
+G+G FG V L D V A+K L +KE AE + L +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNS---TEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ + L E+L G + + TEE T+F IA + + +H+
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE------TQFYIAETVL-AIDSIHQ-- 119
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGL 638
+ +H DIKP+N+LLD K+SDFGL
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 679 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.98 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.95 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.93 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.93 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.92 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.92 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.92 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.92 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.92 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.92 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.91 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.91 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.91 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.9 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.87 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.87 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.86 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.52 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.49 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.32 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.32 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.27 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.18 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.94 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.66 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.17 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.15 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.13 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.13 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.98 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.76 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.6 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.35 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.24 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| PLN02236 | 344 | choline kinase | 97.1 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.06 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.05 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.9 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.63 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 96.61 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.88 Aligned_cols=197 Identities=54% Similarity=0.919 Sum_probs=178.2
Q ss_pred CCCcCHHHHHHHhhhhh--hhcCcccceEEEEEEeCCCcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 479 PTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG-KKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 479 ~~~~~~~~l~~~~~~~~--~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
...|++.++.+++.+|. ..||+|+||.||+|.++++..||||++...... ..+|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 46699999999999998 689999999999999999999999999775544 677999999999999999999999999
Q ss_pred eCC-eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEe
Q 046493 556 EGA-HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 634 (679)
Q Consensus 556 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 634 (679)
+.+ +++||||||++|+|.++|+..... +++|..|++|+.++|+||+|||+.+.+.||||||||+|||||+++++||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 999 599999999999999999875432 78999999999999999999999998899999999999999999999999
Q ss_pred eccCCccccc-CCceeeecc-cCccccccccccccCCCCcccceeeC
Q 046493 635 DFGLAKLMNR-EESLVYTTL-RGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||+|+.... .... ... .||.+|+|||++..+..+.|+|||||
T Consensus 220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySF 264 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSF 264 (361)
T ss_pred CccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccc
Confidence 9999976654 3222 222 89999999999998899999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=316.65 Aligned_cols=180 Identities=29% Similarity=0.474 Sum_probs=160.6
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|.+.++||+|+|++||+|+++. +..||||.+.... ...+.+..|+++|+.++|||||++++++.+++..+|||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 35667889999999999999865 8999999986542 3446678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC------CcEEEeeccCCc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN------FTAKVSDFGLAK 640 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kL~DFg~a~ 640 (679)
|.||+|.+||++. +.+++..+..++.||+.||++||++ +||||||||+||||+.. -.+||+|||+|+
T Consensus 91 C~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 91 CNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999764 3699999999999999999999999 99999999999999864 468999999999
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+.... ...+.+|++-|||||++..++|+.|+|+||.
T Consensus 164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSi 200 (429)
T KOG0595|consen 164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSI 200 (429)
T ss_pred hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHH
Confidence 887543 2366899999999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=296.01 Aligned_cols=177 Identities=29% Similarity=0.414 Sum_probs=159.7
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-eeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-HRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 568 (679)
+..+.||+|..|+||+++++. ++.+|+|.+.. .....+++.+|++++++.+||+||+++|.|..+. ...|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 345789999999999999874 88999999943 3445678999999999999999999999999998 5999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+|+|++++... +.+++...-+|+.+|++||.|||+ + +||||||||+||||+..|++||+|||.++.+...
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999998653 459999999999999999999996 5 9999999999999999999999999999987665
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+.+||..|||||.+.+..|+.++|||||
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL 263 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSL 263 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecc
Confidence 3467899999999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=292.47 Aligned_cols=192 Identities=27% Similarity=0.432 Sum_probs=167.8
Q ss_pred HHHHhhhhhhhcCcccceEEEEEE-eCCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEE-EEEeCCe-e
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKG-FCIEGAH-R 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~ 560 (679)
...+.|++.++||+|.||+||++. +.+|..||.|.+.-. ....+....|+.+|++|+|||||++++ -+.++++ .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 344668889999999999999998 457999999998642 334567889999999999999999998 5555555 7
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV-KIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
+|||||+..|+|..+++...++.+.+++..+++++.|++.||..+|.+.+. -|+||||||.||+|+.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 899999999999999998888888999999999999999999999994321 3999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.+...... ....+|||.||+||.+.+.+|+.||||||+
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 998776543 355789999999999999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=295.03 Aligned_cols=183 Identities=30% Similarity=0.481 Sum_probs=157.4
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
.+..|.+.+.||+|+||.|-+|..+ +++.||||++.+.. ......++|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5566788899999999999999965 59999999996521 12234679999999999999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC---CcEEEee
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSD 635 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~D 635 (679)
..|+||||++||+|.+.+-. .+.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999865 34577778889999999999999999 99999999999999755 7899999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCC---CcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI---SEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDvwSl 679 (679)
||+|+..... ....+.+|||.|.|||++.+... ..++|+||+
T Consensus 323 FGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 323 FGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred cchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeec
Confidence 9999987643 33477899999999999987653 348899996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.01 Aligned_cols=192 Identities=30% Similarity=0.494 Sum_probs=173.6
Q ss_pred CHHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 483 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 483 ~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
...++......+.++||+|-||.|+.|.+.....||+|.++......+.|.+|+++|++|+|+|||+++++|..++.++|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 33456677778899999999999999999777899999999877788999999999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|||||+.|+|.+||+.. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+..
T Consensus 279 VtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 99999999999999873 356799999999999999999999999 9999999999999999999999999999966
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.++.........-+..|.|||.+....++.|||||||
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF 390 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF 390 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence 6665544444556789999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.91 Aligned_cols=186 Identities=27% Similarity=0.381 Sum_probs=168.6
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe-CCCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
|....+|...+.||+|+|+++|+++. ..|+.||+|++.+ .....+.+.+|+++.++|+|||||+++++|++.++.
T Consensus 14 D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 14 DPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV 93 (592)
T ss_pred cCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce
Confidence 33336688889999999999999998 6799999999976 445667899999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
|||.|+|+.++|.+++.+ .+++++.++..+++||+.||.|||++ +|+|||||..|++|+++.++||+|||+|.
T Consensus 94 YivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred EEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceee
Confidence 999999999999999963 56799999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+..+... ..+.+|||.|+|||++....++..+||||+
T Consensus 167 ~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSl 204 (592)
T KOG0575|consen 167 QLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSL 204 (592)
T ss_pred eecCcccc-cceecCCCcccChhHhccCCCCCchhhhhh
Confidence 88765332 356899999999999999999999999995
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.37 Aligned_cols=181 Identities=35% Similarity=0.579 Sum_probs=158.4
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCcceEEEEEEeCC-eeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-HRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 568 (679)
.+.+.||+|+||+||+|.+.....||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. ..+||||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 445669999999999999965555999999763322 568999999999999999999999999988 7899999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeEeCCCC-cEEEeeccCCcccccCC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK-IVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREE 646 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~ 646 (679)
+|+|.++++.. ....+++..+++++.||++||.|||++ + ||||||||+||||+.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999774 255799999999999999999999999 7 99999999999999997 99999999998766532
Q ss_pred ceeeecccCccccccccccc--cCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWIT--NNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwSl 679 (679)
...+...||+.|||||++. ..+|+.|+|||||
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF 232 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF 232 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence 1223468999999999999 5689999999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.71 Aligned_cols=182 Identities=27% Similarity=0.362 Sum_probs=162.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..+++.+.||+|+||+||+++.++ ++.+|+|++++.. .+.+..++|..+|.+++||.||+++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 345678999999999999999765 8999999997632 34567889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+.||.|..+|++ ...+++..+.-++..|+.||.|||++ +||||||||+|||||++|.++|+|||+++..-.
T Consensus 105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999965 34589999999999999999999999 999999999999999999999999999996544
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ...+.+||+.|||||++.+..|+..+|.|||
T Consensus 178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred CCC-ccccccCCccccChHHHhcCCCCcccchHhH
Confidence 432 2355899999999999999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=284.15 Aligned_cols=186 Identities=25% Similarity=0.331 Sum_probs=162.6
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--Cee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHR 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 560 (679)
.....|+..++||+|.||.||+|+.. +|+.||+|+++-.. ....-..+|+.+|++|.||||+++.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34455677789999999999999964 59999999986533 3345678999999999999999999999887 689
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
|||+|||+. +|.-++... .-.+++.++..++.||+.||+|+|.+ +|+|||||.+|||||.+|.+||+|||+|+
T Consensus 194 YlVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999999986 888887543 34599999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
++........+..+-|.-|+|||++.|. .|+.++|+||.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~ 306 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSV 306 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhh
Confidence 8887776667778889999999999886 59999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.58 Aligned_cols=191 Identities=26% Similarity=0.447 Sum_probs=167.6
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..|+.+....|.++||+|-||.|.++....+..||||.++... ....+|.+|+++|.+|+||||++++|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 5677777788899999999999999999778999999998733 45688999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+|+|||++|+|.+|+..+..+ .+....-.+|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++-
T Consensus 612 mI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999876432 245566778999999999999998 999999999999999999999999999996
Q ss_pred cccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+-..... .....+-.++|||||.+..++++.+||||+|
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWaf 725 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAF 725 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhh
Confidence 5554433 2234566889999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.14 Aligned_cols=195 Identities=28% Similarity=0.497 Sum_probs=166.8
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEE
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGF 553 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~ 553 (679)
....++......+.++||+|+||+||+|+.. +...||||.+++.. +..++|++|+++++.++|||||+++|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3345667777788899999999999999953 35679999998743 357899999999999999999999999
Q ss_pred EEeCCeeeEEEeccCCCCHhHHhhccCC------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTE------E----SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 554 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
|.+++..++|+|||..|+|.+||..... . ..+++..+.+.|+.|||.||+||-++ .+|||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence 9999999999999999999999974321 1 23488999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCceeee-cccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||.++..|||+|||+++..-..+..... ...-.++|||||.|..++||.+||||||
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 9999999999999999976544433222 2344779999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=264.89 Aligned_cols=177 Identities=32% Similarity=0.392 Sum_probs=160.3
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+++.+.||.|+||+|.+++.+. |..+|+|+++... ...+...+|..+|+.+.||+++++.+.+.+.+..++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 3567889999999999999764 8899999997532 2346678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
.+||.|..+|++ .+++++..+.-++.||+.||+|||+. +|++|||||+|||||.+|.+||+|||.|+.....
T Consensus 126 v~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 126 VPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred cCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999965 34699999999999999999999999 9999999999999999999999999999977654
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.-+.+|||.|+|||++..+++..++|.|||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWal 227 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWAL 227 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHH
Confidence 356799999999999999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=258.75 Aligned_cols=180 Identities=27% Similarity=0.392 Sum_probs=158.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|...++||+|.||.||+|++. .|+.||||+++.... ......+|++.|+.++|+||+.++++|.+.+..-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5667789999999999999965 499999999976432 245678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
|+. +|+..+++. ...++...+..++.++++||+|||++ .|+||||||.|+||+++|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 975 999999764 45699999999999999999999999 99999999999999999999999999999887654
Q ss_pred ceeeecccCccccccccccccC-CCCcccceee
Q 046493 647 SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYS 678 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS 678 (679)
... +..+-|.-|+|||.+.|. .|+..+||||
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWa 187 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWA 187 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhh
Confidence 432 334789999999999876 5899999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=267.31 Aligned_cols=181 Identities=26% Similarity=0.361 Sum_probs=156.3
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|+...++|+|++|.||+++.++ |+.||||++...+.+ .+-..+|+++|++|+|+|+|.++++|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 35566789999999999999876 999999999664432 35578999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
++..-|.+ |.+. ...++.+.+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+..+
T Consensus 83 ~dhTvL~e-Le~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 83 CDHTVLHE-LERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred cchHHHHH-HHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 98744444 4332 34589999999999999999999999 9999999999999999999999999999988753
Q ss_pred ceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
...++..+.|..|+|||.+.| .+|...+||||.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi 188 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAI 188 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence 233567788999999999988 579999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=293.96 Aligned_cols=193 Identities=31% Similarity=0.575 Sum_probs=167.7
Q ss_pred CcCHHHHHHHhhh-----------hhhhcCcccceEEEEEEeCC----CcEEEEEEecc--cccCHHHHHHHHHHHHhhc
Q 046493 481 RFSYDDLCKATKN-----------FSTKLGQGGFGSVYLGMLPD----GIQVAVKKLES--IGQGKKEFSAEVTTIGNVH 543 (679)
Q Consensus 481 ~~~~~~l~~~~~~-----------~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~ 543 (679)
.++|+|..++-.+ +.++||.|.||.|++|+++- ...||||.++. .+....+|..|+.||.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 4667665555444 34679999999999999763 46799999987 3455678999999999999
Q ss_pred CCCcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 544 HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 544 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
||||++|.|+.......+||.|||++|+|+.||+.+. ..+++.+...++++|+.||.||-+. ++|||||.++||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence 9999999999999999999999999999999998765 3489999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCceeeecccC--ccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESLVYTTLRG--TRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+.+..+|++|||+++.+.++.....++..| ..+|.|||.+...+++.+||||||
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSy 820 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSY 820 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhcccc
Confidence 99999999999999999887665444444434 568999999999999999999997
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-33 Score=281.29 Aligned_cols=184 Identities=30% Similarity=0.446 Sum_probs=161.9
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHH--HHHHHHHHHhhc-CCCcceEEEEEEeCC-eee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKE--FSAEVTTIGNVH-HLHLVKLKGFCIEGA-HRL 561 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 561 (679)
+...+|.+.++||.|.||.||+|+-. .+..||||++++.-...++ -.+|++.|++|+ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34568999999999999999999954 5899999999875444444 467999999998 999999999999988 899
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+|||||+ .+|.+++.+. .+.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 9999996 5999999765 56799999999999999999999999 999999999999999888999999999998
Q ss_pred cccCCceeeecccCccccccccccc-cCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSl 679 (679)
..... .++..+.|+.|+|||++. ..-|+.+.||||+
T Consensus 160 v~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~ 196 (538)
T KOG0661|consen 160 VRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAV 196 (538)
T ss_pred cccCC--CcchhhhcccccchHHhhhccccCCchHHHHH
Confidence 76654 357788999999999875 5568999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=282.18 Aligned_cols=181 Identities=28% Similarity=0.418 Sum_probs=159.8
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 565 (679)
+.|.+.||+|+|++|++|+..+ ++.+|||++.+. +...+-+..|-..|.+| .||.|++|+..|+|+..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 5678899999999999999664 899999998652 23334567888899999 89999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.++|.+. +.+++..+..++.+|+.||+|||++ |||||||||+|||||+++++||+|||.|+.+...
T Consensus 155 ~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999763 4699999999999999999999999 9999999999999999999999999999987653
Q ss_pred Cce------------eeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESL------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ....++||..|.+||++.+...++.+|||+|
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl 273 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL 273 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence 221 1134789999999999999999999999996
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=271.94 Aligned_cols=184 Identities=26% Similarity=0.427 Sum_probs=166.8
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEe-CCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
-.+.+|++.+.||+|.||.|-++.. ..|+.||||.+++. +++.-.+++|+++|..|+||||+.++.+|+..+...
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3567899999999999999999996 56999999998763 344556899999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
|||||..+|.|.+|+.+ ...+++.++.++++||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++..
T Consensus 130 ivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999965 45699999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCceeeecccCccccccccccccCCCC-cccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSl 679 (679)
+..... ..+++|++-|.+||++.|.+|. +.+|-|||
T Consensus 203 y~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsL 239 (668)
T KOG0611|consen 203 YADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSL 239 (668)
T ss_pred hccccH--HHHhcCCcccCCccccCCCCCCCCccchhhH
Confidence 876543 3678999999999999999985 88999996
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=284.08 Aligned_cols=179 Identities=29% Similarity=0.462 Sum_probs=161.7
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCH-HHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGK-KEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
|.--++||+|+.|.||.++.. .++.||||++....+.. +-+.+|+.+|+..+|+|||.+++.+...++.++|||||++
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 444578999999999999954 58899999998766554 5578999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
|+|.+.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||+|..+......
T Consensus 355 gsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 355 GSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred Cchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 9999988543 499999999999999999999999 9999999999999999999999999999988776543
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..+.+||+.|||||++....|.+|.|||||
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSL 455 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSL 455 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhh
Confidence 367899999999999999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=279.21 Aligned_cols=180 Identities=32% Similarity=0.482 Sum_probs=162.6
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCH---HHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGK---KEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|.+.+.||+|+||.||+|+-+. .+.||+|.+.+....+ +.+++|++++++++||||+.+++.|+...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 46677889999999999999764 7899999997654444 5588999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+.| +|..+|.. ...++++.+..|+.|++.||.|||+. +|+|||+||+|||++..+.+|++|||+|+.+....
T Consensus 83 a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 83 AVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 987 99999965 34599999999999999999999999 99999999999999999999999999999887754
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ..+...|||.|||||+..+++|+..+|+|||
T Consensus 155 ~-vltsikGtPlYmAPElv~e~pyd~~sDlWsl 186 (808)
T KOG0597|consen 155 S-VLTSIKGTPLYMAPELVEEQPYDHTSDLWSL 186 (808)
T ss_pred e-eeeeccCcccccCHHHHcCCCccchhhHHHH
Confidence 4 3467899999999999999999999999996
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=281.39 Aligned_cols=184 Identities=29% Similarity=0.439 Sum_probs=160.9
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-----c-cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-----G-QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 559 (679)
....|.+.+.||+|+||+|++|... +++.||+|++... . ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3456788899999999999999865 5899999977542 1 23456778999999999 9999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcEEEeeccC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGL 638 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~ 638 (679)
.++||||+.+|+|.+++.+ ..++.+.++.++++|++.|++|+|++ +|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999965 34688999999999999999999999 99999999999999999 9999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCC-CC-cccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNP-IS-EKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDvwSl 679 (679)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~ 209 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL 209 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence 99874 1222346789999999999999987 86 78999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=268.66 Aligned_cols=186 Identities=24% Similarity=0.354 Sum_probs=161.8
Q ss_pred HHhhhhhhhcCcccceEEEEEEe-CCCcEEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
...|++.++||.|..++||+|+. +.++.||||++.- ...+.+++++|+..+..++||||++++..|..++..++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 34578889999999999999995 4589999999964 33446889999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
||.+|++.+.++.... ..+++..+..|++++++||.|||.+ |.||||||+.||||+++|.+||+|||....+...
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999987653 3499999999999999999999999 9999999999999999999999999987665443
Q ss_pred Cce---eeecccCccccccccccccC--CCCcccceeeC
Q 046493 646 ESL---VYTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 646 ~~~---~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
..+ .....+||+.|||||++... .|+.|+|||||
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSf 218 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSF 218 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhh
Confidence 322 12557899999999996543 58999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=266.42 Aligned_cols=182 Identities=35% Similarity=0.487 Sum_probs=153.7
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC--eeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA--HRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~ 567 (679)
+...+.||+|+||.||++...+ |+..|||.+.... ...+.+.+|+++|.+++|||||+++|.....+ .+++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4556789999999999999865 8999999886532 12566899999999999999999999855444 688999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCccccc--
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNR-- 644 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~-- 644 (679)
++|+|.+++.+.. . .+++..+.++.+||++||+|||++ +||||||||+||||+. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999997653 2 599999999999999999999999 9999999999999999 79999999999987763
Q ss_pred CCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
..........||+.|||||++.++ ....++|||||
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl 208 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL 208 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence 111222357899999999999853 33459999997
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=271.60 Aligned_cols=179 Identities=34% Similarity=0.512 Sum_probs=149.9
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHh--hcCCCcceEEEEEEeCC----eeeEEEec
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGN--VHHLHLVKLKGFCIEGA----HRLLAYEY 566 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~ 566 (679)
++.+.||+|+||.||+|.+ +++.||||++.. +..+.|.+|-++... ++|+||++++++-.... +++||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4567899999999999999 569999999974 445667777776554 58999999999876555 78999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
.+.|+|.+||..+ .++|....+|+..+++||+|||+.. +++|+|||||.+||||..|+.+.|+|||+|.
T Consensus 290 h~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999654 4999999999999999999999854 4689999999999999999999999999999
Q ss_pred ccccCCce-eeecccCccccccccccccCC-CC-----cccceeeC
Q 046493 641 LMNREESL-VYTTLRGTRGYLAPEWITNNP-IS-----EKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDvwSl 679 (679)
.+...... .....+||.+|||||++.+.. +. .+.||||+
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam 410 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM 410 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH
Confidence 88754432 123378999999999998753 22 36899985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.49 Aligned_cols=181 Identities=25% Similarity=0.324 Sum_probs=157.4
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+++.++||+|+||.||+|+-++ |..+|+|++++.. ...+.++.|-.+|....+|.||+++..|++.+++||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 4567889999999999999765 9999999998743 3456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC-
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE- 645 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~- 645 (679)
++||++..+|.+ ...|++..+..++.+++.|+..||+. |+|||||||+|+|||..|++||+|||++.-+...
T Consensus 223 lPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 223 LPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred cCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999965 45699999999999999999999999 9999999999999999999999999998532110
Q ss_pred ---------------------Cce-----e-------------------eecccCccccccccccccCCCCcccceeeC
Q 046493 646 ---------------------ESL-----V-------------------YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ---------------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.. . ....+|||.|||||++.+..|+..+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 0 002469999999999999999999999996
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=257.79 Aligned_cols=185 Identities=27% Similarity=0.377 Sum_probs=157.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCC-cceEEEEEEeCC------
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLH-LVKLKGFCIEGA------ 558 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 558 (679)
..+...++||+|.||+||+|+.. +|+.||+|+++.... ......+|+.++++|+|+| |+++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999965 589999999975332 4466789999999999999 999999999877
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..++|+||++ .+|..++.........++...+..+++||+.||+|||++ +|+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7889999996 499999977553224577789999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
|+...-+.. ..+..++|.-|.|||++.+. .|+...||||+
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL 207 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence 996654332 24556789999999999887 68999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=253.39 Aligned_cols=180 Identities=24% Similarity=0.310 Sum_probs=155.0
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 565 (679)
|+...+|++|.||.||+|+++. ++.||+|+++-... -.-.-.+|+.+|.+.+|||||.+-.+.... +..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 4556789999999999999864 88999999975332 123467999999999999999999987743 57899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|++. +|..++..- ..++...++..+..|+++||+|||.+ .|+||||||+|+|+...|.+||+|||+|+.+...
T Consensus 158 ~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 158 YVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9986 999988654 35689999999999999999999999 9999999999999999999999999999998876
Q ss_pred CceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
.. ..+..+-|..|+|||++.+.+ |+.+.|+||+
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv 264 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV 264 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence 33 356678899999999998864 8999999994
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=276.34 Aligned_cols=187 Identities=29% Similarity=0.464 Sum_probs=157.7
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC--C---cEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD--G---IQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~---~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 556 (679)
++......+.++||+|+||.||+|++.. + ..||||..+. ......+|.+|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3444444566899999999999999753 2 2389998874 23456789999999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeec
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 636 (679)
....+||||++.||+|.++|.... ..++..+++.++.+.+.||+|||++ ++|||||.++|+|++.++.+||+||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999997653 2599999999999999999999999 9999999999999999999999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+++........ .....-...|+|||.+....++.++|||||
T Consensus 307 GLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 307 GLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred ccccCCcceeec-cccccCcceecChhhhccCccccccchhhe
Confidence 998865421111 111235679999999999999999999997
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.04 Aligned_cols=188 Identities=26% Similarity=0.401 Sum_probs=153.5
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHH--hhcCCCcceEEEEEEeCC---
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIG--NVHHLHLVKLKGFCIEGA--- 558 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~--- 558 (679)
.+.....+..+.+.||+|.||.||+|++ .|+.||||++.. .++..+.+|.++.+ .|+|+||+.+++.-..++
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4445556667788999999999999999 688999999975 34555666666655 569999999998865443
Q ss_pred -eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeEeCCCCcEE
Q 046493 559 -HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE-----CEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 559 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
+++||++|.+.|+|.|||.+. .++.+..++++..+|.||++||.. ..|.|.|||||++||||..++.+.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 679999999999999999653 489999999999999999999963 357899999999999999999999
Q ss_pred EeeccCCcccccCCce---eeecccCccccccccccccCC----CC--cccceeeC
Q 046493 633 VSDFGLAKLMNREESL---VYTTLRGTRGYLAPEWITNNP----IS--EKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~s--~~sDvwSl 679 (679)
|+|+|+|......... ..+..+||.+|||||++...- +. ..+|||||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf 412 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF 412 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence 9999999876654321 245678999999999996542 22 46899997
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=245.83 Aligned_cols=180 Identities=28% Similarity=0.400 Sum_probs=161.1
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.++.+.||+|-||.||+|+.+. +..||+|++.+. ...+.++++|+++...|+||||+++++++.++...||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 4678999999999999999654 788999999653 34567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
.+.|.|...|.... ...+++.....++.|+|.||.|+|.+ +++||||||+|+|++.++..||+|||-+.....+.
T Consensus 104 a~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 104 APRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred cCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 99999999997544 45689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..+.+||..|.|||...+..++..+|+|++
T Consensus 179 ---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~l 208 (281)
T KOG0580|consen 179 ---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSL 208 (281)
T ss_pred ---ceeeecccccCCHhhcCCCCccchhhHHHH
Confidence 356789999999999999999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=260.09 Aligned_cols=175 Identities=30% Similarity=0.409 Sum_probs=147.6
Q ss_pred hhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eeeEEEeccC
Q 046493 495 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRLLAYEYLG 568 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~ 568 (679)
.+.+|+|+||.||+|.+.. ++.||||+.-.... .-.+|+++|+++.|||||+++.++.... ...+|||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 4789999999999999765 79999998854322 2347999999999999999999887532 2358999998
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcEEEeeccCCcccccCCc
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~~~~~~ 647 (679)
. +|.++++........++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.+...+.
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 6 99999876544456688888899999999999999998 99999999999999965 9999999999999877664
Q ss_pred eeeecccCccccccccccccC-CCCcccceee
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYS 678 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS 678 (679)
. ....-|+.|+|||.+.|. .|+.+.||||
T Consensus 182 n--iSYicSRyYRaPELifga~~Yt~~IDiWS 211 (364)
T KOG0658|consen 182 N--ISYICSRYYRAPELIFGATEYTTSIDIWS 211 (364)
T ss_pred c--eeEEEeccccCHHHHcCccccCceeEEhh
Confidence 3 344568899999998876 5999999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=274.45 Aligned_cols=188 Identities=29% Similarity=0.484 Sum_probs=160.4
Q ss_pred CHHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 483 SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 483 ~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
.+.||......+.+.||+|+||+||+|++.. .||||+++... ...+.|++|+..+++-+|.||+-++|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4556666667788999999999999999854 69999996532 345789999999999999999999999998887
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.||+.+|+|.+|..+|+..+ ..++..+.+.|++||++|+.|||.+ +|||||||..||++.++++|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999997754 3488899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCC-ceeeecccCcccccccccccc---CCCCcccceeeC
Q 046493 640 KLMNREE-SLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSl 679 (679)
..-..-. ........|...|||||+++. .+|+..+|||||
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF 579 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF 579 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence 7544321 112234568889999999864 469999999997
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=260.13 Aligned_cols=182 Identities=26% Similarity=0.370 Sum_probs=150.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---------------CHHHHHHHHHHHHhhcCCCcceEEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------------GKKEFSAEVTTIGNVHHLHLVKLKGF 553 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~~ 553 (679)
..|++.+.||+|.||.|-+|+.. +++.||||++.+.+. ..+..++|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 45788899999999999999965 589999999854211 12578999999999999999999999
Q ss_pred EEeC--CeeeEEEeccCCCCHhHHhhccCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc
Q 046493 554 CIEG--AHRLLAYEYLGNGSLDKWIFNSTEESRF-LSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 630 (679)
Q Consensus 554 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 630 (679)
..+. +..|||+|||..|.+...= ..++ +++.++++++++++.||+|||.+ +||||||||+|+||+++|.
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 8764 5789999999988875432 1233 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCCcccccCCc----eeeecccCccccccccccccCC----CCcccceeeC
Q 046493 631 AKVSDFGLAKLMNREES----LVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSl 679 (679)
+||+|||.+........ ......+|||.|+|||...++. .+.+.||||+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 99999999986633211 1123468999999999887732 3468899996
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=269.64 Aligned_cols=179 Identities=26% Similarity=0.360 Sum_probs=158.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+... ++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 346778999999999999999864 8999999986522 23456889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998653 3588999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 201 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTM 201 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeech
Confidence 32 23468999999999999999999999997
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=273.00 Aligned_cols=184 Identities=22% Similarity=0.270 Sum_probs=158.1
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
....|++.+.||+|+||.||+++... ++.+|+|.+... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 34567888999999999999999764 889999998642 2234567889999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998542 378899999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCceeeecccCccccccccccccCC----CCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSl 679 (679)
............||+.|+|||++.+.. ++.++|||||
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence 543332234567999999999987643 7889999996
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.59 Aligned_cols=184 Identities=28% Similarity=0.445 Sum_probs=165.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe-eeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH-RLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 564 (679)
..|+..+++|+|+||.++.++.+ ++..+++|++.... .......+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35778899999999999999976 47899999986533 344567899999999999999999999999988 89999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
+|++||+|.+.|...+ +..++++.+..++.||+.|+.|||++ .|+|||||+.||+++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 56799999999999999999999998 999999999999999999999999999999887
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ..+.+||+.||.||++.+.+|..|+|||||
T Consensus 159 ~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 159 EDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred chhh-hheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 6533 356789999999999999999999999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.42 Aligned_cols=180 Identities=28% Similarity=0.366 Sum_probs=158.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 564 (679)
...+.++||+|+||+|+++..+. ++.+|||.+++. ..+.+..+.|.+++... +||.+++++.++++.++.|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 34678899999999999999875 889999999873 35567788899988877 5999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+.||++..+.+ ...+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|.+||+|||+++..-.
T Consensus 449 ey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 449 EYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999544432 34599999999999999999999999 999999999999999999999999999997543
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ..++.+|||.|||||++.+..|+.++|.|||
T Consensus 521 ~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~l 554 (694)
T KOG0694|consen 521 QGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGL 554 (694)
T ss_pred CCC-ccccccCChhhcChhhhccCcccchhhHHHH
Confidence 332 3577999999999999999999999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=270.44 Aligned_cols=178 Identities=28% Similarity=0.417 Sum_probs=159.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+++++.||.|+.|.|-+|++. +|+.+|||++.+. ......+.+|+-+|+.+.||||+++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456788999999999999965 5999999999653 22345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|.|.++|.+ .+++.+.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|.....+.
T Consensus 94 v~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999965 45699999999999999999999999 99999999999999999999999999998755443
Q ss_pred ceeeecccCccccccccccccCCCC-cccceee
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYS 678 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwS 678 (679)
...+.+|++.|.|||++.|.+|. .++||||
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccch
Confidence 34667999999999999999985 7999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=266.13 Aligned_cols=176 Identities=28% Similarity=0.331 Sum_probs=152.8
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.||+|+||.||+++.. +++.||||+++... .....+.+|++++++++||||+++++++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999975 58999999987522 23356778999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 99998864 34589999999999999999999999 999999999999999999999999999875432221 12
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCccc
Confidence 34579999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=271.48 Aligned_cols=190 Identities=26% Similarity=0.419 Sum_probs=156.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+...++++.++||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3456788889999999999999974 135689999987532 2345688999999999 899999999998765
Q ss_pred C-eeeEEEeccCCCCHhHHhhccCCC------------------------------------------------------
Q 046493 558 A-HRLLAYEYLGNGSLDKWIFNSTEE------------------------------------------------------ 582 (679)
Q Consensus 558 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 582 (679)
+ ..+++|||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 578999999999999998653210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-eeecccCcc
Q 046493 583 ----SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTR 657 (679)
Q Consensus 583 ----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~ 657 (679)
...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999 9999999999999999999999999999865433221 112345678
Q ss_pred ccccccccccCCCCcccceeeC
Q 046493 658 GYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 658 ~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.|+|||++.+..++.++|||||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwsl 262 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSF 262 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHH
Confidence 8999999999899999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=272.33 Aligned_cols=181 Identities=25% Similarity=0.316 Sum_probs=156.0
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.+.||+|+||+||+++... ++.||||+++... .....+++|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 5667899999999999998764 8999999996522 2335678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999864 34589999999999999999999999 99999999999999999999999999987543211
Q ss_pred c----------------------------------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 S----------------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .......||+.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 0 00123479999999999999999999999996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=261.72 Aligned_cols=181 Identities=30% Similarity=0.369 Sum_probs=156.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.+.||+|+||.||++... +++.||||.+.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 455688999999999999964 58999999986422 2234578899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998886432 33589999999999999999999999 99999999999999999999999999998754332
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....|++.|+|||++.+..++.++|||||
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 187 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhH
Confidence 1 234578999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=272.70 Aligned_cols=181 Identities=23% Similarity=0.296 Sum_probs=154.5
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.++||+|+||+||+|+... ++.||||+++... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 5567889999999999999754 8899999996522 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998653 3588999999999999999999999 99999999999999999999999999976432100
Q ss_pred c----------------------------------------------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 S----------------------------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .......||+.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 00123469999999999998889999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=266.47 Aligned_cols=178 Identities=29% Similarity=0.357 Sum_probs=156.8
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 3567789999999999999976 48999999986422 234568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 82 YVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998653 3589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....|++.|+|||++.+..++.++|||||
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 184 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWAL 184 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHH
Confidence 2 23468999999999999889999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=265.03 Aligned_cols=189 Identities=26% Similarity=0.447 Sum_probs=157.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-----------------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLV 548 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv 548 (679)
....|.+.++||+|+||.||++.+.+ +..||+|.+.... ....++.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45667888999999999999998532 3469999987532 2346789999999999999999
Q ss_pred eEEEEEEeCCeeeEEEeccCCCCHhHHhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 046493 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTE---------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613 (679)
Q Consensus 549 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i 613 (679)
++++++.+.+..++||||+++++|.+++..... ....+++..+++++.||+.||.|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 999999999999999999999999999864321 123478889999999999999999999 99
Q ss_pred eecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 614 vH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+||||||+|||+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 226 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHH
Confidence 999999999999999999999999998654433221 123456789999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=267.53 Aligned_cols=180 Identities=28% Similarity=0.383 Sum_probs=157.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC--CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
...|++.+.||+|+||.||+|.... +..||+|++... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3457788999999999999998644 368999998642 2334568899999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999998653 3589999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ....||+.|+|||++.+..++.++|||||
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTL 214 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccch
Confidence 4322 34578999999999998889999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=289.41 Aligned_cols=191 Identities=31% Similarity=0.532 Sum_probs=163.5
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC--C----cEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD--G----IQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
++......+.+.||+|.||.||+|...+ + ..||||.++.. .+...+|.+|..+|++++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3445556677889999999999999654 3 35999999773 56678899999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEe
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 634 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 634 (679)
...+|++|||++|+|..||++.+. ....++..+.+.++.|||+|+.||+++ ++|||||.++|+||++...+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 999999999999999999987532 245689999999999999999999999 99999999999999999999999
Q ss_pred eccCCcccccCCceeeec-ccCccccccccccccCCCCcccceeeC
Q 046493 635 DFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||+|+.+.+.+...... ..-...|||||.+..+.++.|+|||||
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence 999999554444332222 244678999999999999999999997
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=271.63 Aligned_cols=182 Identities=25% Similarity=0.307 Sum_probs=156.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||.||+++.. +++.||||+++... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 3566789999999999999976 48999999996532 234567889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 82 YLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998652 3589999999999999999999999 9999999999999999999999999998754321
Q ss_pred Cce-------------------------------------eeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESL-------------------------------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 100 0012468999999999999899999999997
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=267.33 Aligned_cols=178 Identities=29% Similarity=0.372 Sum_probs=157.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||.||+|+..+ ++.||||+++... .....+.+|++++.+++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 36678899999999999999864 8999999996532 234568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 82 YVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 9999999999954 33588999999999999999999999 9999999999999999999999999999865441
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 184 (333)
T cd05600 155 ----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSL 184 (333)
T ss_pred ----cCCcccCccccChhHhcCCCCCCccceecc
Confidence 234578999999999999999999999997
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=262.70 Aligned_cols=174 Identities=25% Similarity=0.322 Sum_probs=152.2
Q ss_pred cCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||+|+||.||+++..+ ++.||+|+++.. ......+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999764 889999998642 23345678899999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 9998652 3589999999999999999999999 999999999999999999999999999986433222 1234
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..||+.|+|||++.+..++.++|||||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~Dvwsl 179 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTL 179 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceech
Confidence 578999999999999999999999996
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=270.85 Aligned_cols=182 Identities=22% Similarity=0.297 Sum_probs=155.1
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||.||+++... ++.||||++... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 36678899999999999999754 899999998642 2234668899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999998652 3588899999999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 E------------------------------------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 0 000112469999999999999999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=264.16 Aligned_cols=176 Identities=30% Similarity=0.355 Sum_probs=153.0
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.||+|+||.||+++.. +++.||||++... ......+.+|+++++.++||||+++++++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999975 4899999999652 233456788999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 99988854 33589999999999999999999999 999999999999999999999999999875433221 12
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 181 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCcccc
Confidence 34578999999999998899999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=264.45 Aligned_cols=179 Identities=30% Similarity=0.550 Sum_probs=157.0
Q ss_pred CCcCHHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
..+.|++|.+- +=||+|+.|.||+|++ .++.||||+++... +.+++-|++|+||||+.+.|+|.....
T Consensus 119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 34556666542 4499999999999999 66899999886422 357888999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
++||||||..|.|.+.|+. +..+.......+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-+
T Consensus 187 yCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred eEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999965 45688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+...... ..-.+.||..|||||++++.+.+.|+|||||
T Consensus 260 ~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSf 297 (904)
T KOG4721|consen 260 KELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSF 297 (904)
T ss_pred Hhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehh
Confidence 8776542 2234789999999999999999999999997
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=270.97 Aligned_cols=181 Identities=24% Similarity=0.293 Sum_probs=154.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|.+.++||+|+||.||+++.. +++.||||++... ....+.+++|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 566789999999999999875 5899999998642 22345688899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999864 34588999999999999999999999 99999999999999999999999999996432110
Q ss_pred ce----------------------------------------------eeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SL----------------------------------------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999999899999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=270.95 Aligned_cols=181 Identities=22% Similarity=0.294 Sum_probs=154.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.++||+|+||+||+|+.. +++.||+|++.... .....+.+|++++++++||||+++++.+.+++..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 566789999999999999975 48899999986532 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998653 3588999999999999999999999 99999999999999999999999999975321100
Q ss_pred ----------------------------------------------ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 ----------------------------------------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........||+.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 000112468999999999999999999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.00 Aligned_cols=185 Identities=23% Similarity=0.277 Sum_probs=158.5
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
+....|++.+.||+|+||.||+++... ++.+|+|++... ......+.+|+.+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 345678888999999999999999764 889999998642 223455788999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999998542 378889999999999999999999 999999999999999999999999999987
Q ss_pred cccCCceeeecccCccccccccccccCC----CCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSl 679 (679)
.............||+.|+|||++.+.. ++.++|||||
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl 233 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence 6544332234567999999999987543 7889999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=263.99 Aligned_cols=176 Identities=28% Similarity=0.340 Sum_probs=152.3
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.||+|+||.||+++.. +++.||+|+++.. ......+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999975 5899999998652 223455778999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99988854 33589999999999999999999999 999999999999999999999999999875432221 12
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhh
Confidence 34568999999999999899999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=265.41 Aligned_cols=183 Identities=23% Similarity=0.261 Sum_probs=158.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 3567789999999999999976 48999999997532 244568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 82 YQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999654 23589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CceeeecccCccccccccccc------cCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWIT------NNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwSl 679 (679)
.........||+.|+|||++. +..++.++|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 195 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence 433333457899999999986 4567899999997
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=268.90 Aligned_cols=184 Identities=22% Similarity=0.274 Sum_probs=157.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
....|++.++||+|+||.||+++.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456778899999999999999976 4889999998642 2234557889999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998542 478889999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCceeeecccCccccccccccccC----CCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNN----PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwSl 679 (679)
............||+.|+|||++.+. .++.++|||||
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeeh
Confidence 54332222446799999999998654 37889999996
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=261.93 Aligned_cols=176 Identities=28% Similarity=0.344 Sum_probs=151.8
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999975 5899999998652 223456778999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99988854 3358999999999999999999997 6 999999999999999999999999999875432221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccc
Confidence 234569999999999999899999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=261.28 Aligned_cols=180 Identities=27% Similarity=0.411 Sum_probs=161.4
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
|.-.+.||+|.||.||+|.+.. ++.||+|++.. ...+.+++++|+.++.+++++||.++++.+..+..++++|||+.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 3444789999999999999754 89999999865 44556789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+|++.+.|.. ...+++..+.-++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 95 gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 95 GGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred Ccchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999854 34458888888999999999999999 9999999999999999999999999999988776554
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .+++||+.|||||++.+..|+.|+|||||
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSL 197 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSL 197 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhh
Confidence 4 67899999999999998899999999997
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=263.05 Aligned_cols=183 Identities=23% Similarity=0.279 Sum_probs=157.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||.||+++.. +++.||+|.+... ......+.+|..++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 3667789999999999999976 4789999998642 2233457889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 y~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 82 YYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred CCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999653 23588999999999999999999999 9999999999999999999999999999876554
Q ss_pred CceeeecccCcccccccccccc-----CCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSl 679 (679)
.........|++.|+|||++.+ ..++.++|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSl 194 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEee
Confidence 3333334579999999999875 457889999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=262.55 Aligned_cols=183 Identities=23% Similarity=0.287 Sum_probs=156.1
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||.||+++... ++.||+|++... ....+.+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 36678899999999999999764 899999998642 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 82 YYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred cCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999643 33589999999999999999999999 9999999999999999999999999999765543
Q ss_pred CceeeecccCcccccccccccc-----CCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSl 679 (679)
.........||+.|+|||++.. ..++.++|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 194 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehh
Confidence 3222233468999999999863 357889999996
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=267.24 Aligned_cols=182 Identities=27% Similarity=0.380 Sum_probs=159.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
+|++.+.||+|+||+||+|+.. +++.||||+++.. ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4667889999999999999976 5899999998652 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 82 YMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999653 4589999999999999999999998 9999999999999999999999999999876543
Q ss_pred C----------------------------ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 E----------------------------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 216 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence 3 111233568999999999999999999999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=259.69 Aligned_cols=176 Identities=30% Similarity=0.386 Sum_probs=151.6
Q ss_pred hhcCcccceEEEEEEeC----CCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG-----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
++||+|+||.||+++.. .++.||||+++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 47899999986421 2334578899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ...+.+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999854 33578889999999999999999999 99999999999999999999999999987543322
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......|++.|+|||++.+..++.++|||||
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 186 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSL 186 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceeccc
Confidence 2 1234578999999999998889999999996
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=255.86 Aligned_cols=187 Identities=27% Similarity=0.435 Sum_probs=157.5
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
+....+++.+.||+|+||.||+|.+. .+..||+|.++... .....+.+|+..+++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34566788899999999999999853 36789999987632 2345688999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++++|.+++... ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+|++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999998653 23589999999999999999999999 99999999999999999999999999876
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..............++..|+|||.+.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHH
Confidence 543222111112345678999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=255.53 Aligned_cols=178 Identities=29% Similarity=0.411 Sum_probs=154.0
Q ss_pred cCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||+|+||+||++... +++.+|+|++.... ...+.+..|++++++++|+||+++.+++.+++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999975 58899999986422 2235677899999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.........+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988865443455689999999999999999999999 9999999999999999999999999999766543321 233
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..|++.|+|||++.+..++.++|||||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~Dvwsl 183 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFAL 183 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHH
Confidence 578999999999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=262.25 Aligned_cols=181 Identities=27% Similarity=0.308 Sum_probs=154.5
Q ss_pred hhhhhhcCcccceEEEEEEeC----CCcEEEEEEeccc-----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeee
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 561 (679)
|++.++||+|+||.||+++.. +++.||+|++... ....+.+.+|+++++++ +|+||+++++++.+++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 567789999999999999853 4789999998642 12335678899999999 5999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999864 33589999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.............||+.|+|||++.+. .++.++|||||
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 193 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccc
Confidence 544333222345799999999999875 47889999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=264.57 Aligned_cols=185 Identities=29% Similarity=0.376 Sum_probs=162.0
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhc-CC-----CcceEEEEEEeC
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HL-----HLVKLKGFCIEG 557 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 557 (679)
.|....+|++.+.||+|.||+|.+|.+.. ++.||||+++....-..+-..|+++|..|+ |. |+|++++++...
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 44444588999999999999999999764 999999999987776777888999999997 43 899999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC--CcEEEee
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN--FTAKVSD 635 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~D 635 (679)
++.|||+|.++ .+|.++|+.+. -..++...+..|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|
T Consensus 261 ~HlciVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence 99999999995 59999998765 44599999999999999999999999 99999999999999743 4799999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||.+......- ....-++.|+|||++.|.+|+.+.|||||
T Consensus 335 FGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSL 374 (586)
T KOG0667|consen 335 FGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSL 374 (586)
T ss_pred cccccccCCcc----eeeeeccccccchhhccCCCCCccceeeh
Confidence 99998765432 24566889999999999999999999997
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=264.62 Aligned_cols=181 Identities=24% Similarity=0.296 Sum_probs=155.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.+.||+|+||.||+++.. +++.||||+++.. ......+++|++++.+++||||+++++.+.+++..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 556788999999999999976 4899999998642 22345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999864 34589999999999999999999999 99999999999999999999999999987543211
Q ss_pred c----------------------------------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 S----------------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .......||+.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 0 00113469999999999999999999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=242.44 Aligned_cols=182 Identities=27% Similarity=0.452 Sum_probs=157.7
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
....|++.+.||+|.|+.|+++... .|+.+|+|++.. ...+.+++.+|+++-+.|+||||+++++...+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3455788899999999999998864 589999998743 345778899999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~ 640 (679)
+|+|.|++|-.-+-. +..+++..+-..++||+++|.|+|.+ +|||||+||+|+++-. .--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999765533 24588999999999999999999999 9999999999999953 3468999999999
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceee
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS 678 (679)
.+... .......|||+|||||+++..+|+..+||||
T Consensus 162 ~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~ 197 (355)
T KOG0033|consen 162 EVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 197 (355)
T ss_pred EeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhh
Confidence 88732 2335578999999999999999999999997
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=252.47 Aligned_cols=187 Identities=26% Similarity=0.449 Sum_probs=163.0
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
....+++.++||+|++|.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 44567788999999999999999888889999998765555678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999986543 34588899999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......++..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 190 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhh
Confidence 22223346778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=260.61 Aligned_cols=173 Identities=31% Similarity=0.444 Sum_probs=152.1
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.+.||.|+||.||-+++. +.+.||||++.-... .-.++..|++.|++++|||++.+.|++..+...+||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 467999999999999975 478899999965332 22568999999999999999999999999999999999996
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
|+-.+++... .+++.+.++..|..+.+.||+|||+. +.||||||+.|||+.+.|.+||+|||.|.+....
T Consensus 110 GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 110 GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 5777777554 45699999999999999999999999 9999999999999999999999999999876543
Q ss_pred eecccCccccccccccc---cCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
+.++|||.|||||++. .+.|+-++|||||
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSL 211 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 211 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeec
Confidence 5678999999999874 4579999999997
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=260.98 Aligned_cols=183 Identities=22% Similarity=0.282 Sum_probs=155.8
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||.||+++... ++.+|+|++... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 35677899999999999999765 788999998642 2233457889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++.+. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 82 YYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999653 23589999999999999999999999 9999999999999999999999999999765443
Q ss_pred CceeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
.........||+.|+|||++. ...++.++|||||
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSl 194 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEee
Confidence 332223457999999999986 3457899999996
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=258.58 Aligned_cols=176 Identities=26% Similarity=0.311 Sum_probs=151.3
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
++||+|+||.||+|+... ++.||||+++.. ....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999764 789999998652 22345577888888876 799999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 9999888543 3588999999999999999999999 999999999999999999999999999875433222 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWAL 182 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceech
Confidence 234568999999999999899999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.79 Aligned_cols=176 Identities=25% Similarity=0.326 Sum_probs=151.1
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+++... ++.||+|+++.. ......+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 789999998752 12335577888888777 799999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999988854 24589999999999999999999999 999999999999999999999999999975432221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecc
Confidence 234578999999999999999999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=258.96 Aligned_cols=183 Identities=31% Similarity=0.442 Sum_probs=163.2
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 560 (679)
-....|++.+.||.|.||.||+++.+. |+.+|+|.+.+.. ...+.+.+|+++|+++. ||||+.+.+.+++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 344567888999999999999999876 9999999996533 23468999999999998 99999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC----CcEEEeec
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN----FTAKVSDF 636 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DF 636 (679)
++|||++.||.|.+.+... .+++..+..++.||+.++.|||+. +|+||||||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999654 299999999999999999999998 99999999999999633 57999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++..... .......+||+.|+|||++...+|+..+||||+
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~ 224 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSI 224 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHH
Confidence 99998877 334567899999999999999999999999984
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=259.08 Aligned_cols=176 Identities=24% Similarity=0.306 Sum_probs=151.9
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+++.. +++.||||+++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999976 48899999997522 2335578899999998 699999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence 999988854 24589999999999999999999999 999999999999999999999999999875322211 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceech
Confidence 234578999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=257.78 Aligned_cols=176 Identities=30% Similarity=0.372 Sum_probs=149.5
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+|+..+ ++.||||+++.. ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 789999998652 22334556677776654 899999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-K 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-c
Confidence 9999988542 3589999999999999999999999 999999999999999999999999999986433221 2
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSF 182 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhH
Confidence 234578999999999999899999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=251.27 Aligned_cols=188 Identities=30% Similarity=0.451 Sum_probs=162.7
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+....+++.+.||+|++|.||+|...+++.||+|.++......+++.+|++++++++||||+++++++...+..+++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 44566788899999999999999987788999999987666678899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999996543 34689999999999999999999999 99999999999999999999999999998765332
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........+..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 190 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHH
Confidence 211111223458999999998899999999996
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=249.69 Aligned_cols=184 Identities=27% Similarity=0.442 Sum_probs=159.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..+++.+.||+|+||.||+++..++..+|+|.++......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 34667788999999999999998888999999876556677899999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999986532 3488999999999999999999999 99999999999999999999999999998654433222
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~ 187 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHH
Confidence 222345678999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=267.01 Aligned_cols=178 Identities=22% Similarity=0.298 Sum_probs=153.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
...|++.++||+|+||.||++.+. .++.||+|... ...+.+|++++++++||||+++++++..+...++|+|++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 345788899999999999999975 48899999754 234688999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
. ++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 688888754 23588999999999999999999999 999999999999999999999999999975433222
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......||+.|+|||++.+..++.++|||||
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 269 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence 22234579999999999999899999999996
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=265.26 Aligned_cols=191 Identities=27% Similarity=0.464 Sum_probs=158.6
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
++....+++.++||+|+||.||+|+. ..+..||||+++... ...+.+.+|+++++.+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34455688899999999999999973 236689999996532 3345688999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCC-------------------------------------------------------
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTE------------------------------------------------------- 581 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 581 (679)
.+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 582 ----------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 582 ----------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 112478899999999999999999999 9999999999999999999999999999866543
Q ss_pred Ccee-eecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....++..|+|||++.+..++.++|||||
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl 302 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 302 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence 3211 122345678999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=257.36 Aligned_cols=176 Identities=28% Similarity=0.373 Sum_probs=152.8
Q ss_pred hhcCcccceEEEEEEe----CCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 496 TKLGQGGFGSVYLGML----PDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+.||+|+||.||+++. .+++.+|+|+++... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999885 247899999997532 234557789999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999854 23589999999999999999999999 9999999999999999999999999999865443221
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....|++.|+|||++.+..++.++|||||
T Consensus 155 -~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 184 (318)
T cd05582 155 -AYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184 (318)
T ss_pred -eecccCChhhcCHHHHcCCCCCCccceecc
Confidence 234578999999999998889999999997
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=251.83 Aligned_cols=176 Identities=32% Similarity=0.483 Sum_probs=154.4
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 571 (679)
+.||+|-||+||-|+.+ +|+.||||++.+ ....+..+++|+.+|++++||.||.+...|++.+..++|||-+.| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence 68999999999999976 599999999865 345567899999999999999999999999999999999999954 6
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC---CcEEEeeccCCcccccCCce
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DFg~a~~~~~~~~~ 648 (679)
+.++|.... ...+++..-..++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||+|||.|+.+.....+
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 666665433 45689999999999999999999999 99999999999999744 47999999999998765433
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+||+.|+|||++.++.|...-|+||.
T Consensus 724 --rsVVGTPAYLaPEVLrnkGyNrSLDMWSV 752 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNKGYNRSLDMWSV 752 (888)
T ss_pred --hhhcCCccccCHHHHhhccccccccceee
Confidence 56789999999999999999999999983
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.71 Aligned_cols=176 Identities=27% Similarity=0.340 Sum_probs=151.4
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+|+... ++.||||+++.. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 368999999999999764 889999998642 23345677888888877 699999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 9999988653 3589999999999999999999999 999999999999999999999999999875432221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAM 182 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhh
Confidence 234578999999999998899999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.49 Aligned_cols=176 Identities=31% Similarity=0.413 Sum_probs=148.7
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHH-HHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVT-TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||+||+|+.. +++.||||++.... ....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999976 58999999986421 22334455544 56778999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-T 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-c
Confidence 999998864 34588999999999999999999999 999999999999999999999999999875432221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182 (323)
T ss_pred cccccCChhhcChhhhcCCCCCcccccccc
Confidence 234568999999999999999999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=257.99 Aligned_cols=180 Identities=27% Similarity=0.321 Sum_probs=153.5
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCC-CcceEEEEEEeCCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHL-HLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e 565 (679)
|++.+.||+|+||.||+|+..+ ++.||||+++.. ....+.+..|.+++..++|+ +|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 5677899999999999999764 789999998652 23445678899999999764 68889999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988543 3588999999999999999999999 9999999999999999999999999998753222
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhh
Confidence 21 1234578999999999999999999999996
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.33 Aligned_cols=176 Identities=30% Similarity=0.404 Sum_probs=148.3
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHH-HHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVT-TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+|+.. +++.||+|++.... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 48899999986422 22334555554 57888999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++.. ...+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence 999888854 34588899999999999999999999 999999999999999999999999999875432222 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCccccc
Confidence 234578999999999998899999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=272.89 Aligned_cols=186 Identities=24% Similarity=0.259 Sum_probs=159.4
Q ss_pred hhhhhhhcCcccceEEEEEEeCC--CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|.+.+.||+|++|.||+|.... ++.||+|.+.... .....+++|+++++.++||||+++++++.+++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 37788999999999999998543 5788888765432 33356788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++|+|.+++........++++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865443455689999999999999999999999 999999999999999999999999999987654322
Q ss_pred e-eeecccCccccccccccccCCCCcccceeeC
Q 046493 648 L-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......||+.|+|||++.+..++.++|||||
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 257 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHH
Confidence 1 1234569999999999999899999999996
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=255.76 Aligned_cols=182 Identities=25% Similarity=0.347 Sum_probs=156.4
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.+.||+|+||.||+++... ++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 46778899999999999999864 7899999986532 2346688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
++++.+..+... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 82 VEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 998777655422 34589999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........|++.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 187 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSV 187 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhH
Confidence 322334578999999999998889999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=255.27 Aligned_cols=181 Identities=26% Similarity=0.396 Sum_probs=153.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|++.++||+|+||.||+|+.. +++.||+|+++.. ......+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 4677889999999999999976 4889999998642 233456789999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 86 DS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred Cc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 75 899888543 33578999999999999999999999 999999999999999999999999999976543221
Q ss_pred eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
......+++.|+|||++.+ ..++.++|||||
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHH
Confidence 1233567899999998865 468999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.45 Aligned_cols=179 Identities=30% Similarity=0.358 Sum_probs=151.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHH---HhhcCCCcceEEEEEEeCCeeeEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTI---GNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
|++.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|.+++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 356788999999999999975 4899999999642 22334566676655 466799999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|..++.. ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988743 3589999999999999999999999 99999999999999999999999999987543
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......|++.|+|||++.+..++.++|||||
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGL 187 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhH
Confidence 3222 1234578999999999999899999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=255.97 Aligned_cols=176 Identities=27% Similarity=0.348 Sum_probs=150.7
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+|+... ++.||+|.++.. .........|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999864 889999999753 23345567788887765 899999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence 999998854 23588999999999999999999999 999999999999999999999999999875322221 2
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhh
Confidence 244678999999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=259.36 Aligned_cols=183 Identities=23% Similarity=0.345 Sum_probs=158.5
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
....|++.++||+|+||.||+++.. ++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3456777889999999999999976 48889999886532 23467899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.|++.||.|||++ .+|+||||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999998653 3588999999999999999999985 1699999999999999999999999999976543
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....|++.|+|||++.+..++.++|||||
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 22 234568999999999999899999999996
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.69 Aligned_cols=184 Identities=24% Similarity=0.356 Sum_probs=159.1
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+....|++.++||+|+||.||++... ++..+|+|.+.... .....+.+|++++++++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 45567888999999999999999986 48889999886532 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999864 23588999999999999999999974 169999999999999999999999999997654
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....|+..|+|||++.+..++.++|||||
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 188 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence 321 133568999999999998889999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=257.29 Aligned_cols=180 Identities=27% Similarity=0.324 Sum_probs=153.0
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 565 (679)
|++.+.||+|+||.||+|+... ++.||||+++... ...+.+..|.+++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 4567889999999999999764 7899999986522 2234566788888777 58999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988543 3588999999999999999999999 9999999999999999999999999999754322
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 187 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhch
Confidence 21 1234578999999999999999999999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=250.21 Aligned_cols=186 Identities=27% Similarity=0.458 Sum_probs=160.5
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
...+.+.++||+|++|.||+|...+ ++.||+|.++.......++.+|++++++++|+||+++++++..++..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3456778899999999999999764 889999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999986543 34589999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......++..|+|||.+.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 191 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 191 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHH
Confidence 21122334668999999999899999999996
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=256.71 Aligned_cols=176 Identities=30% Similarity=0.390 Sum_probs=147.7
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHH-HHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVT-TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+++... ++.||+|++.... ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 7889999986422 22334444444 56778999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.. ...+.+..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999999864 23478888999999999999999999 999999999999999999999999999975433221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccc
Confidence 234579999999999999999999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=256.75 Aligned_cols=176 Identities=32% Similarity=0.409 Sum_probs=148.7
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHH-HHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVT-TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||+||+++.. +++.+|+|++... .....++..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 5899999998642 122344555554 46778999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 999988854 34589999999999999999999999 999999999999999999999999999875432221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....|++.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCL 182 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccc
Confidence 234578999999999999999999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=255.07 Aligned_cols=176 Identities=27% Similarity=0.364 Sum_probs=150.3
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+|+..+ ++.||||+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 368999999999999765 789999998753 23345566788887764 899999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999854 23588999999999999999999999 999999999999999999999999999875332221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhH
Confidence 234578999999999999899999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=249.52 Aligned_cols=186 Identities=28% Similarity=0.465 Sum_probs=159.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
...+|++.++||+|++|.||+|+..+...||+|+++......+.+.+|++++++++||||+++++.+. .+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 34568889999999999999999877778999999875556678999999999999999999999874 45678999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999996532 34578999999999999999999999 999999999999999999999999999987654432
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......++..|+|||++.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 189 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHH
Confidence 22223446778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=247.99 Aligned_cols=183 Identities=27% Similarity=0.440 Sum_probs=158.6
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
.+++.+.||+|++|.||++..+++..+|+|.+........++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46678899999999999999877788999998765556678899999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++..........
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999986542 3589999999999999999999999 999999999999999999999999999986644322211
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 187 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSF 187 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHH
Confidence 22234568999999998899999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=248.41 Aligned_cols=184 Identities=27% Similarity=0.443 Sum_probs=159.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..+++.+.||+|++|.||+++..++..+|+|.++......+++.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 34677889999999999999987777899999876555677899999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999986532 2589999999999999999999999 99999999999999999999999999998665433222
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl 187 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence 122345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=255.97 Aligned_cols=176 Identities=24% Similarity=0.298 Sum_probs=151.9
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+++... ++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 7899999997532 2335578899999888 699999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 9999888542 3589999999999999999999999 999999999999999999999999999875332221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehh
Confidence 234679999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=243.64 Aligned_cols=180 Identities=29% Similarity=0.417 Sum_probs=163.1
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.+.++||+|++|.||++.++. |+.+|||.+.. ..+.+++.+|+.++++.+.|++|+++|.+.....+++|||||.-|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 5667899999999999999765 99999999865 456788999999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+..+.++.. ++++++.++..+++..++||+|||.. .-||||||+.|||++.+|.+||+|||.|..+.+.-.. .
T Consensus 114 SiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-R 186 (502)
T KOG0574|consen 114 SISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-R 186 (502)
T ss_pred cHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-h
Confidence 999999764 46799999999999999999999998 8999999999999999999999999999877665433 3
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++..||+-|||||++..-.|..++|||||
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSL 215 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSL 215 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhh
Confidence 56789999999999999899999999997
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=256.75 Aligned_cols=180 Identities=27% Similarity=0.336 Sum_probs=153.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 565 (679)
+++.+.||+|+||+||+|+.. +++.||+|+++.. ....+.+..|.++++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456788999999999999975 4889999998652 223456778888888885 6788899999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998542 3589999999999999999999999 9999999999999999999999999998754332
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhh
Confidence 21 1234568999999999999899999999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=251.46 Aligned_cols=181 Identities=30% Similarity=0.371 Sum_probs=156.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.++||+|+||+||++... +++.||||++.... .....+.+|++++++++||||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 566788999999999999975 58999999986422 2234567899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998886532 34589999999999999999999999 99999999999999999999999999998754332
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....|++.|+|||++.+..++.++|||||
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~ 187 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGL 187 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhH
Confidence 2 133468999999999998889999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.63 Aligned_cols=193 Identities=26% Similarity=0.427 Sum_probs=172.9
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
..-.|+.+......++||-|-||.||.|.++. .-.||||.++.+....++|..|..+|+.++|||+|+++|+|..+...
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 35566777777778999999999999999876 77899999998888899999999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
|||+|||..|+|.+||++.. ...++.-..+.++.||..||.||..+ ++|||||.++|+|+.++..+|++|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999998765 33477778899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++..+.........-.+.|.|||-+....++.|+|||+|
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAF 452 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF 452 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHH
Confidence 998765443333445778999999999999999999997
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=271.35 Aligned_cols=188 Identities=27% Similarity=0.328 Sum_probs=154.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCC-cEEEEEEecc-cccCHHHHHHHHHHHHhhc-CCCcceEEEE-EEe------CC
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDG-IQVAVKKLES-IGQGKKEFSAEVTTIGNVH-HLHLVKLKGF-CIE------GA 558 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~-~~vavK~l~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~ 558 (679)
..+.++.+.|.+|||+.||+|.+..+ .++|+|++-. .+...+.+++|+++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 33456778999999999999998775 9999998744 5566788999999999997 9999999993 221 12
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
+.+|.||||++|.|-+++.... ...|++.++++|+.|+++|+++||.. +++|||||||-+||||+.+++.||+|||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 5689999999999999997543 33499999999999999999999996 66899999999999999999999999999
Q ss_pred CcccccCCce--e------eecccCcccccccccc---ccCCCCcccceeeC
Q 046493 639 AKLMNREESL--V------YTTLRGTRGYLAPEWI---TNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~--~------~~~~~gt~~y~aPE~~---~~~~~s~~sDvwSl 679 (679)
|......... . .-....|+.|+|||++ .+.++++|+|||||
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWAL 244 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWAL 244 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHH
Confidence 8643322110 0 0013479999999976 57789999999996
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=242.01 Aligned_cols=186 Identities=25% Similarity=0.290 Sum_probs=158.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
-...++.+.||.|.-|+||++++.+ +...|+|++.+.. ......+.|-+||+.+.||.++.++..++.++..+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3445678899999999999999876 6899999997633 2335567799999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
||||+||+|...++++. .+.+++..+.-++..++.||+|||.. |||.|||||+||||.++|.+-|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999887654 66799999999999999999999999 99999999999999999999999999875321
Q ss_pred c---------------------------------C-Cc---------------------eeeecccCccccccccccccC
Q 046493 644 R---------------------------------E-ES---------------------LVYTTLRGTRGYLAPEWITNN 668 (679)
Q Consensus 644 ~---------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~ 668 (679)
. . .. ......+||-.|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 0 00 001125799999999999999
Q ss_pred CCCcccceeeC
Q 046493 669 PISEKSDVYSY 679 (679)
Q Consensus 669 ~~s~~sDvwSl 679 (679)
.++.++|+|+|
T Consensus 311 GHgsAVDWWtf 321 (459)
T KOG0610|consen 311 GHGSAVDWWTF 321 (459)
T ss_pred CCCchhhHHHH
Confidence 99999999986
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=262.20 Aligned_cols=191 Identities=29% Similarity=0.473 Sum_probs=157.9
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
.+....+++.+.||+|+||.||+|+.. ++..||||+++... ...+.+.+|+++++.+ +|+||+++++++.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345667888999999999999998842 24579999997532 2345688999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCC-------------------------------------------------------
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTE------------------------------------------------------- 581 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 581 (679)
.+..++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 582 -----------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 582 -----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
...++++.++++++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 113478889999999999999999999 999999999999999999999999999986544332211
Q ss_pred -ecccCccccccccccccCCCCcccceeeC
Q 046493 651 -TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 -~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||++.+..++.++|||||
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 300 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSY 300 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHH
Confidence 22345678999999988899999999996
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=247.12 Aligned_cols=188 Identities=28% Similarity=0.481 Sum_probs=163.1
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++....+++.++||+|+||.||+|..++++.||+|.+.........+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4566788899999999999999999988999999999876666788999999999999999999999864 556899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999986543 34689999999999999999999998 9999999999999999999999999999876533
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........++..|+|||.+.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl 189 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHH
Confidence 3222223346778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=246.78 Aligned_cols=187 Identities=28% Similarity=0.456 Sum_probs=160.4
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+....+++.++||+|++|.||+|..+++..+|+|.++......+.+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 344568889999999999999999888889999999876666778999999999999999999999875 4567899999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999986532 34589999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........++..|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 189 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHH
Confidence 222222345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=234.86 Aligned_cols=180 Identities=31% Similarity=0.447 Sum_probs=154.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-----cC----HHHHHHHHHHHHhh-cCCCcceEEEEEEeCCe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-----QG----KKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 559 (679)
.|+-++.||.|..+.|-++..+ .+.+.|+|++.... .. .++-..|+.+|+++ .||+|+++.++++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 3455678999999999988865 48899999885421 11 24466799999999 59999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++|+|.|+.|.|.++|.. ...++++...+|++|+.+|+.|||.+ +||||||||+|||++++.++||+|||++
T Consensus 98 ~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999954 44699999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCcccccccccccc------CCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITN------NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwSl 679 (679)
..+...+. ....+|||+|+|||.+.- ..|+..+|+||.
T Consensus 171 ~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 171 CQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred eccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 98877654 366899999999998853 247889999983
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.87 Aligned_cols=182 Identities=24% Similarity=0.347 Sum_probs=153.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|++.++||+|+||.||+|+.. +++.||||+++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34677899999999999999976 58899999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
++ ++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 96 5887777543 24588999999999999999999999 99999999999999999999999999997543322
Q ss_pred ceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. ......+++.|+|||++.+. .++.++|||||
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (303)
T cd07869 158 H-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190 (303)
T ss_pred c-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence 1 12345689999999998654 57889999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=260.79 Aligned_cols=179 Identities=29% Similarity=0.472 Sum_probs=155.6
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------eeeEEEe
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------HRLLAYE 565 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 565 (679)
.+.||+|+||.||+|+.+ .|+.||||.++. .....+...+|++++++|+|+|||+++++=.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999999999999965 599999999876 3345677889999999999999999999865433 5689999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC--CCC--cEEEeeccCCcc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD--DNF--TAKVSDFGLAKL 641 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~DFg~a~~ 641 (679)
||.+|+|...|.+..+ ...+++.+.+.++.++..||.|||++ +|+||||||.||++. ++| ..||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999987654 45699999999999999999999999 999999999999984 333 469999999998
Q ss_pred cccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+.++. .....+||+.|++||+... +.|+..+|.|||
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~ 210 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSF 210 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence 87766 4577899999999999985 788999999997
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=253.10 Aligned_cols=176 Identities=28% Similarity=0.352 Sum_probs=151.3
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||+||+++... ++.||||+++.. ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 789999999753 23345677888888888 699999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 9999888543 3589999999999999999999999 999999999999999999999999999875322221 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....|++.|+|||++.+..++.++|||||
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 182 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhH
Confidence 233568999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=260.85 Aligned_cols=189 Identities=28% Similarity=0.408 Sum_probs=156.7
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCC
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGA 558 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 558 (679)
....+.+.++||+|+||.||+|+... +..||||+++... ...+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34567788999999999999998532 3479999996532 23467899999999996 999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCC---------------------------------------------------------
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTE--------------------------------------------------------- 581 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 581 (679)
..++||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864321
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 582 -----------------------------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 582 -----------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
....+++..+..++.||++||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 012478888999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 627 DNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 9999999999999865433221 1123456788999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=248.12 Aligned_cols=188 Identities=29% Similarity=0.516 Sum_probs=159.6
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
..++.+.+.||+|+||.||+|+..+ ++.||||.++.... ..+.+.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567888999999999999998643 47899999876433 357899999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNST----------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 630 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 630 (679)
+++|||+++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997542 1234578999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 631 AKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+||+|||+++........ ......+++.|+|||++.+..++.++|||||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence 999999999765332211 1123345788999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=246.16 Aligned_cols=188 Identities=29% Similarity=0.484 Sum_probs=163.7
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+....+.+.++||+|++|.||++..++++.||||.+.......+++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 44567788899999999999999988888999999987666778899999999999999999999999998999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999996543 34589999999999999999999999 99999999999999999999999999998765422
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........+..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 190 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence 211122334678999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=245.48 Aligned_cols=175 Identities=33% Similarity=0.452 Sum_probs=151.2
Q ss_pred cCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||+|+||.||+++.. +++.+|+|++.... .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999975 48999999986421 2234566799999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence 98886532 34588999999999999999999999 999999999999999999999999999987654322 234
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..|+..|+|||++.+..++.++|||||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Dvwsl 180 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAM 180 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHH
Confidence 568999999999998889999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=259.44 Aligned_cols=178 Identities=25% Similarity=0.460 Sum_probs=152.9
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEec-----ccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe--eeEEE
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLE-----SIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH--RLLAY 564 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 564 (679)
++..+||+|+|-+||+|.+.. |.+||--.++ +.....+.|..|+++|+.|+||||++++..+.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 456789999999999999864 7778744332 233345789999999999999999999999998765 67889
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEEEeeccCCcccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~ 643 (679)
|.+..|+|..|+.+. +.++...+..|++||++||.|||++ .|+|||||||.+||+|+ ..|.+||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999764 4588999999999999999999998 56899999999999998 56899999999999887
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ....|||.|||||+.. ..|+..+|||||
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaF 229 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAF 229 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhh
Confidence 6553 3368999999999987 679999999998
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=248.86 Aligned_cols=181 Identities=24% Similarity=0.384 Sum_probs=149.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC--CCcEEEEEEecccc---cCHHHHHHHHHHHHhh---cCCCcceEEEEEEe-----C
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIG---QGKKEFSAEVTTIGNV---HHLHLVKLKGFCIE-----G 557 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 557 (679)
+|++.++||+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++++ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 4677889999999999999863 36889999886422 2234566788777766 69999999999863 3
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
...++||||++ ++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 46789999996 58999886543 34589999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++...... ......|++.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 195 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 195 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHH
Confidence 998654432 2234568999999999988889999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=268.27 Aligned_cols=187 Identities=28% Similarity=0.343 Sum_probs=158.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-------
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------- 558 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 558 (679)
.+|.+.+.||+|+||+||+++.. +++.||||++.... .....+.+|+..+..++|+||++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 46788899999999999999865 58999999986532 33456788999999999999999988775432
Q ss_pred -eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 559 -HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 559 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 35799999999999999976544456799999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++........ ......||+.|+|||++.+..++.++|||||
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSl 231 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHH
Confidence 99876443211 1234579999999999999999999999996
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=244.27 Aligned_cols=186 Identities=28% Similarity=0.466 Sum_probs=158.9
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
....+++.++||+|++|.||++....+..+|+|++.......+.+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34567788899999999999999877778999998765556678899999999999999999999875 45678999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999996532 34588999999999999999999999 999999999999999999999999999987644332
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 189 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHH
Confidence 22223346778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=256.11 Aligned_cols=176 Identities=25% Similarity=0.412 Sum_probs=148.0
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+++.++||+|+||.||+++.. +++.||||++.... .....+.+|++++++++|+||+++++++.+++..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 456788999999999999975 58999999986432 234678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+. ....+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 156 ~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9998643 2356778889999999999999999 999999999999999999999999999987654321
Q ss_pred eeecccCcccccccccccc-----CCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITN-----NPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSl 679 (679)
......||..|+|||++.. ...+.++|||||
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl 259 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHH
Confidence 1234578999999998743 234568999996
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=256.13 Aligned_cols=180 Identities=23% Similarity=0.409 Sum_probs=150.5
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 562 (679)
|++.++||+|+||.||+|+.. +++.||||+++.. ......+.+|++++++++||||+++++++...+ ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 667889999999999999975 5899999998642 223456889999999999999999999886432 4799
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||++ ++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 689888854 23589999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCc--eeeecccCcccccccccccc--CCCCcccceeeC
Q 046493 643 NREES--LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSl 679 (679)
..... .......|++.|+|||++.+ ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSl 194 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHH
Confidence 33221 11234578999999999876 578999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=243.67 Aligned_cols=185 Identities=30% Similarity=0.530 Sum_probs=162.1
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+..|.+.++||.|++|.||+|...+++.+++|.+..... ...++.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 455788899999999999999998899999999876443 4677899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..+..++.||+.||.|||++ +++|+||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999997643 34589999999999999999999999 999999999999999999999999999987654322
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....++..|+|||.+.+..++.++|||||
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 190 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSF 190 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence 2 123446778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=251.07 Aligned_cols=174 Identities=26% Similarity=0.304 Sum_probs=145.2
Q ss_pred cCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhh---cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 498 LGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNV---HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
||+|+||+||+|+.. +++.||||++.... ........|..++.++ +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 48999999986422 1223345566666655 699999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999998854 34589999999999999999999999 999999999999999999999999999875433222 1
Q ss_pred eecccCccccccccccccC-CCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+. .++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 183 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceecc
Confidence 2345799999999998765 47899999997
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=272.15 Aligned_cols=186 Identities=26% Similarity=0.401 Sum_probs=156.5
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
+|++.++||+|+||.||+|+... ++.||||+++... ...+++.+|++++++++||||+++++++.+++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 46778899999999999999764 8999999986532 224568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 566 YLGNGSLDKWIFNSTE-------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
|+++++|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999864211 123456778899999999999999999 999999999999999999999999999
Q ss_pred CcccccCCc-----------------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREES-----------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++....... .......||+.|+|||++.+..++.++|||||
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSL 217 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHH
Confidence 986622110 00112468999999999999999999999996
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=252.24 Aligned_cols=180 Identities=26% Similarity=0.421 Sum_probs=159.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|.+.+.||+|.|+.|.++++. .+..||||.+.+... ....+.+|+++|+.|+|||||+++.+.......|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 4677889999999999999976 489999999976433 234588999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
..+|.+.+|+.++ ..+.+..+..++.|+.+|++|||++ .|||||||++||||+.+.++||+|||++..+....
T Consensus 137 a~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 137 ASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred ccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999764 3466788999999999999999999 99999999999999999999999999999887443
Q ss_pred ceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
...+..|++.|.|||++.+.+| .+++|+||+
T Consensus 210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl 241 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL 241 (596)
T ss_pred --cccccCCCCCccChHhhcCcccCCcceehhhh
Confidence 2366889999999999999886 489999996
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=243.90 Aligned_cols=188 Identities=24% Similarity=0.441 Sum_probs=161.4
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++...++++.++||+|+||.||++...++..+++|.++......+.+.+|++++++++|+||+++++++.+ ...+++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34566788899999999999999998778889999987655556788999999999999999999999887 77899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999996543 34578899999999999999999998 9999999999999999999999999999866543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........++..|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 189 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHH
Confidence 3222223345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=247.23 Aligned_cols=181 Identities=36% Similarity=0.615 Sum_probs=151.7
Q ss_pred hhhhcCcccceEEEEEEeC-----CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 494 FSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 494 ~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.+.||.|.||.||+|.+. .+..|+||.++... ...+++.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999986 26789999996532 2357899999999999999999999999988889999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.++|.... ...+++..+..|+.||++||+|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999997752 34589999999999999999999999 99999999999999999999999999998773322
Q ss_pred ce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ..........|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysf 191 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSF 191 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 22 1223456789999999999889999999996
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-29 Score=230.22 Aligned_cols=191 Identities=28% Similarity=0.347 Sum_probs=160.9
Q ss_pred HHHhhhhhhhcCcccceEEEEEE-eCCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----ee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 560 (679)
.+.+|++.++||+|||+-||+++ ..+++.+|+|++.-.. .+.+..++|++..++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45678899999999999999999 5568999999986544 66788999999999999999999999876443 48
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
||+++|+..|+|.+.+.....++..+++.+.++|+.+|++||++||+. .+.++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999988777777899999999999999999999998 3359999999999999999999999999987
Q ss_pred ccccCCcee--------eecccCccccccccccc---cCCCCcccceeeC
Q 046493 641 LMNREESLV--------YTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
...-.-... -.....|..|+|||.+. +..++.++|||||
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 653221100 01235789999999885 3457899999997
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=246.09 Aligned_cols=173 Identities=20% Similarity=0.339 Sum_probs=148.9
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeEEEecc
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG----KKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLLAYEYL 567 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 567 (679)
..|++|+++.||+|.. +++.||||+++..... .+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4689999999999998 7899999999764332 3567799999999999999999999877 34678999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++|+|.+++... ..+++..+..++.|++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999653 3588999999999999999999973 178899999999999999999999999998654322
Q ss_pred eeeecccCcccccccccccc--CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN--NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSl 679 (679)
....++..|+|||++.+ ..++.++|||||
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~Sl 208 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL 208 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHH
Confidence 23467899999999976 678999999996
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=245.68 Aligned_cols=181 Identities=29% Similarity=0.365 Sum_probs=155.5
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|+..+.||+|+||.||++... +++.||||.+.... .....+.+|+.++++++|++|+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 455678999999999999976 48899999986532 1234577899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886532 33589999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....|+..|+|||++.+..++.++|||||
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 187 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHH
Confidence 2 123468999999999999899999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=284.61 Aligned_cols=181 Identities=29% Similarity=0.520 Sum_probs=150.3
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
++++++... +...+.||+|+||.||+|+.. +++.||||+++..... ..+|++.+++++||||++++++|.+++..
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 455555443 344578999999999999974 6899999998653322 23568899999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++|+|.++++ .++|..+.+++.||++||+|||..+.++|+||||||+||+++.++.+++. |+...
T Consensus 759 ~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred EEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999984 27899999999999999999996666699999999999999999888875 66554
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ....+++.|+|||++.+..++.++|||||
T Consensus 831 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 831 LLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred ccccC-----CCccccccccCcccccCCCCCcccchhhH
Confidence 33221 22367899999999999999999999996
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=250.66 Aligned_cols=185 Identities=29% Similarity=0.449 Sum_probs=154.2
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-Cc----EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
....|+..+.||+|+||.||+|++.. ++ .||+|.++... ...+++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 44567778899999999999998643 33 48999986432 3356788999999999999999999999865 56
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++++||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 7999999999999998654 23488999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... .....++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 197 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHH
Confidence 765443221 122334678999999999899999999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=245.67 Aligned_cols=190 Identities=26% Similarity=0.456 Sum_probs=157.4
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
+...+|++.++||+|++|.||+|... .+..||||++.... ....++.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34566888899999999999999853 25679999986432 23456889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEE------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
..++||||+++++|.+++...... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653221 23467888999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+++......... .....+++.|+|||++.+..++.++|||||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence 99999987654332211 112345778999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=244.61 Aligned_cols=181 Identities=30% Similarity=0.362 Sum_probs=155.3
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|+..+.||+|+||+||++... +++.+|+|.++... .....+.+|++++++++|+||+++.+.+.+++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 345578999999999999975 58899999986532 2234577899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 34589999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....|+..|+|||.+.+..++.++|||||
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~sl 187 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGL 187 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHH
Confidence 1 233568999999999998889999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=245.38 Aligned_cols=189 Identities=30% Similarity=0.525 Sum_probs=158.2
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
.+..+.+.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3455677889999999999999852 24668999886533 3456789999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcE
Q 046493 561 LLAYEYLGNGSLDKWIFNST---------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 631 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 631 (679)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 1223589999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||+++........ ......++..|+|||++.+..++.++|||||
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 208 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHH
Confidence 99999999865433221 1122345778999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=241.93 Aligned_cols=184 Identities=29% Similarity=0.497 Sum_probs=156.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
..+++.+.||+|+||.||+|++.. ...||||.++... ....++.+|+.++++++||||+++++.+.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 446778899999999999999743 4579999986533 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+|+||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999986542 3589999999999999999999998 99999999999999999999999999998775
Q ss_pred cCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl 194 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF 194 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHH
Confidence 22221 1122345678999999998889999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=259.16 Aligned_cols=179 Identities=24% Similarity=0.265 Sum_probs=153.5
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
...|.+.+.||+|+||.||+++... ++.||||... ...+.+|++++++++|+||+++++++..++..++|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 3357778899999999999999865 7899999643 234578999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
. ++|.+++... ...+++.+++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 6888887543 23589999999999999999999999 999999999999999999999999999986543322
Q ss_pred e-eeecccCccccccccccccCCCCcccceeeC
Q 046493 648 L-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......||+.|+|||++.+..++.++|||||
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl 348 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence 1 1123569999999999999999999999996
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=243.38 Aligned_cols=180 Identities=33% Similarity=0.522 Sum_probs=155.7
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHH---HHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKK---EFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||+|+||+||+++... ++.+|+|++........ ...+|+.++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4677899999999999999875 67899999976543333 2345999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.. ...+++..+..++.||++||++||++ +|+|+||||+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 99999999972 34589999999999999999999999 9999999999999999999999999999864222 2
Q ss_pred eeeecccCccccccccccc-cCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSl 679 (679)
.......++..|+|||++. +..++.++|||||
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL 185 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 2234567899999999998 7789999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=244.46 Aligned_cols=181 Identities=25% Similarity=0.346 Sum_probs=161.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
-|.+.+.||+|.|..|-++++- .|+.||||++.+.. .....+.+|++.|+.++|||||+++.+......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3677888999999999999853 69999999997643 3446788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEEEeeccCCcccccC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~~ 645 (679)
-++|+|.+||..+. ..+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- +-|-+||+|||++..+...
T Consensus 99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999997764 3499999999999999999999999 999999999999774 6789999999999887766
Q ss_pred CceeeecccCccccccccccccCCCC-cccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSl 679 (679)
+. .++.+|+..|-|||++.|..|+ +++|||||
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSL 205 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSL 205 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHH
Confidence 54 3678999999999999999987 67899996
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=244.50 Aligned_cols=187 Identities=28% Similarity=0.484 Sum_probs=156.1
Q ss_pred HhhhhhhhcCcccceEEEEEEe-----CCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
..+++.++||+|+||.||+|.. .++..|++|.++... ....++.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999984 246789999997533 233578899999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC
Q 046493 563 AYEYLGNGSLDKWIFNSTE-------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 629 (679)
+|||+++++|.+++..... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123478899999999999999999999 999999999999999999
Q ss_pred cEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 630 TAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 630 ~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+||+|||+++........ ......++..|+|||++.+..++.++|||||
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 9999999999865443221 1223445778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=246.95 Aligned_cols=190 Identities=24% Similarity=0.406 Sum_probs=157.2
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC---------------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcce
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD---------------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVK 549 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~ 549 (679)
+.+.+|++.++||+|+||.||+++... ...||+|.++... .....+.+|++++++++|+||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 345678889999999999999988642 2358999986532 23456889999999999999999
Q ss_pred EEEEEEeCCeeeEEEeccCCCCHhHHhhccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 046493 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTE--------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPE 621 (679)
Q Consensus 550 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~ 621 (679)
+++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999854321 112468899999999999999999999 9999999999
Q ss_pred CeEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 622 NVLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 622 NIll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||++++++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 9999999999999999997654332211 122345778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=244.82 Aligned_cols=187 Identities=28% Similarity=0.527 Sum_probs=156.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..+++.+.||+|++|.||+|.... ...|++|.++... ....++.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 356778999999999999998643 2579999986532 23456899999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC
Q 046493 562 LAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 629 (679)
++|||+++++|.+++..... ....+++..++.++.|+++||.|||++ +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999965321 114588999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCCcccccCCc-eeeecccCccccccccccccCCCCcccceeeC
Q 046493 630 TAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 630 ~~kL~DFg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 999999999986543321 11223456788999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=238.45 Aligned_cols=178 Identities=29% Similarity=0.411 Sum_probs=151.9
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHh
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLD 573 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 573 (679)
++||+|++|.||+|...++..+|+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999986533 22346889999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecc
Q 046493 574 KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 653 (679)
Q Consensus 574 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~ 653 (679)
+++... ...+++..+..++.|++.+|.|||++ +++||||||+||++++++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998543 23478999999999999999999999 999999999999999999999999999975443322111223
Q ss_pred cCccccccccccccCCCCcccceeeC
Q 046493 654 RGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 654 ~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.++..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~sl 180 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSY 180 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHH
Confidence 44678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=237.33 Aligned_cols=177 Identities=25% Similarity=0.386 Sum_probs=151.0
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-----CCeeeEEEe
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-----GAHRLLAYE 565 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 565 (679)
.+.||+|++|.|..+... +|+.||||++.. .....++..+|+++++.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999976 489999999864 33445778899999999999999999999875 346799999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
+|+ .+|...++. +..++...+..++.||++||.|+|+. +|+||||||+|++++.+..+||+|||+|+.....
T Consensus 107 lMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 994 589998854 34499999999999999999999999 9999999999999999999999999999987643
Q ss_pred Cce-eeecccCccccccccccc-cCCCCcccceeeC
Q 046493 646 ESL-VYTTLRGTRGYLAPEWIT-NNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~-~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSl 679 (679)
... ..+..+-|..|.|||++. ...|+.+.||||.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 111 235567899999999875 4579999999984
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=242.18 Aligned_cols=185 Identities=30% Similarity=0.486 Sum_probs=156.1
Q ss_pred HHhhhhhhhcCcccceEEEEEEe-----CCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--Ce
Q 046493 489 KATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AH 559 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 559 (679)
+..+.+.++||+|+||.||+++. .++..||+|.++... .....+.+|++++++++||||+++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34567788999999999999984 247889999986532 3346789999999999999999999998875 56
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 78999999999999998543 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+........ ......++..|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 198 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhh
Confidence 876543321 1123456778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=261.83 Aligned_cols=181 Identities=29% Similarity=0.467 Sum_probs=156.2
Q ss_pred hhhhhhcCcccceEEEEEEe-CC----CcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGML-PD----GIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~-~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+-.++||+|+||+||+|.+ ++ +.+||+|++... ....+++.+|+.+|.+++|||+++++++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34457899999999999995 33 457999998653 345788999999999999999999999999877 77999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
+||+.|.|.+|++.++ ..+..+..+.|..||++||.|||++ .+|||||..+||||.+-..+||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998754 4588999999999999999999999 999999999999999999999999999998876
Q ss_pred CCceee-ecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVY-TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ....-.+.|||-|.+....|+.++|||||
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsf 886 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSF 886 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhh
Confidence 544321 22334678999999999999999999997
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=255.03 Aligned_cols=180 Identities=28% Similarity=0.373 Sum_probs=152.0
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 562 (679)
+++.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+++++.++|+||+++++++...+ ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 356788999999999999975 58999999986532 23457889999999999999999999998776 7899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|+||++ ++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 82 v~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 82 VTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred Eeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 999997 578877743 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
............+++.|+|||++.+. .++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV 191 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence 54333223345678999999998875 47899999996
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=242.04 Aligned_cols=185 Identities=25% Similarity=0.424 Sum_probs=158.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||.||+|+.. +++.||||.++.. ......+.+|++++++++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 4677889999999999999975 5899999987542 2223568889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.........+++..+..++.|+++||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999998865443345689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....+++.|+|||.+.+..++.++|||||
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 192 (267)
T cd08228 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred hHH-HhcCCCCccccChhhhccCCCCchhhHHHH
Confidence 221 123468889999999988889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=238.66 Aligned_cols=178 Identities=25% Similarity=0.401 Sum_probs=150.4
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
++||+|+||.||+|+.. +++.+|+|.+... ......+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 5889999987643 23346789999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee-e
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-T 651 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~-~ 651 (679)
.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998643 33588999999999999999999999 999999999999999999999999999876543211110 1
Q ss_pred cccCccccccccccccCCCCcccceeeC
Q 046493 652 TLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 652 ~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....+..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 182 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSF 182 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHH
Confidence 1123457999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=271.34 Aligned_cols=198 Identities=23% Similarity=0.357 Sum_probs=159.7
Q ss_pred CCcCHHHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
..+...+.....|.+.++||+|+||+||+++... +..+|+|.+.... .....+..|+.++++|+||||+++++++.
T Consensus 3 ~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 3444455666678899999999999999999765 7789999886422 23466889999999999999999999886
Q ss_pred eC--CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeecCCCCCCeEeCC--
Q 046493 556 EG--AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE----VKIVHCDIKPENVLLDD-- 627 (679)
Q Consensus 556 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----~~ivH~Dlkp~NIll~~-- 627 (679)
+. ...+|||||+++++|.++|.........+++..++.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 53 56899999999999999997644334569999999999999999999998521 25999999999999964
Q ss_pred ---------------CCcEEEeeccCCcccccCCceeeecccCcccccccccccc--CCCCcccceeeC
Q 046493 628 ---------------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN--NPISEKSDVYSY 679 (679)
Q Consensus 628 ---------------~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSl 679 (679)
...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 23589999999986644321 234578999999999864 458899999996
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=246.96 Aligned_cols=181 Identities=25% Similarity=0.388 Sum_probs=152.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+|.+.++||+|+||.||+|+.. +++.||+|+++.. ......+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4667789999999999999976 4788999998642 233456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 75 888887543 33588999999999999999999999 999999999999999999999999999976543322
Q ss_pred eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
. .....+++.|+|||++.+ ..++.++|||||
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (309)
T cd07872 160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGV 191 (309)
T ss_pred c-cccccccccccCCHHHhCCCCCCcHHHHHHH
Confidence 1 223467899999998865 458899999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=242.91 Aligned_cols=188 Identities=26% Similarity=0.392 Sum_probs=156.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
-..+++.++||+|+||.||+|+..+ ++.||+|+++.... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3457888999999999999998632 57899999975332 235688999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC
Q 046493 561 LLAYEYLGNGSLDKWIFNST------------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN 628 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 628 (679)
++++||+++++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999985321 1123578889999999999999999999 99999999999999999
Q ss_pred CcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 629 FTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 629 ~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 99999999998866443221 1223456789999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=252.48 Aligned_cols=179 Identities=28% Similarity=0.318 Sum_probs=150.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------ 558 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 558 (679)
..+|++.+.||+|+||.||+++.. .++.||||++... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 356788899999999999999975 4899999998642 233466789999999999999999999987543
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..++||||+++ +|.+.+. ..+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 5666552 2378899999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++....... .....||+.|+|||++.+..++.++|||||
T Consensus 170 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 208 (359)
T cd07876 170 ARTACTNFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSV 208 (359)
T ss_pred ccccccCcc--CCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence 976543221 234578999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=244.53 Aligned_cols=182 Identities=30% Similarity=0.367 Sum_probs=162.5
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++..-++||+|+||.|+-++..+ |+.+|.|++.+ ....+....+|-++|.+++.+.||.+-..+++.+..++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 34445789999999999999764 99999998854 23456667899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
.|.||+|.-+|++.. ...++++.+.-++.+|+.||++||.+ .||.|||||+|||+|+.|+++|+|+|+|..+...
T Consensus 266 lMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred eecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999998765 35699999999999999999999999 9999999999999999999999999999988776
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.. ...+||.+|||||++.++.|+...|.|||
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l 372 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSL 372 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHH
Confidence 543 44589999999999999999999999986
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=250.06 Aligned_cols=190 Identities=27% Similarity=0.433 Sum_probs=155.6
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+...+|++.+.||+|+||.||+|... .++.||+|+++... ...+.+.+|+++++++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34567889999999999999999742 24789999987532 2235677899999999 799999999988754
Q ss_pred -CeeeEEEeccCCCCHhHHhhccCCC------------------------------------------------------
Q 046493 558 -AHRLLAYEYLGNGSLDKWIFNSTEE------------------------------------------------------ 582 (679)
Q Consensus 558 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 582 (679)
...++++||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678999999999999998643210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-eeecccCccc
Q 046493 583 ---SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRG 658 (679)
Q Consensus 583 ---~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~ 658 (679)
...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12588999999999999999999999 9999999999999999999999999999876433221 1223456778
Q ss_pred cccccccccCCCCcccceeeC
Q 046493 659 YLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 659 y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||++.+..++.++|||||
T Consensus 241 y~aPE~~~~~~~~~~~Di~Sl 261 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSF 261 (337)
T ss_pred ccCcHHhcCCCCCccccHHHH
Confidence 999999999999999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=258.83 Aligned_cols=181 Identities=25% Similarity=0.387 Sum_probs=148.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--------Cee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--------AHR 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~ 560 (679)
..|++.++||+|+||.||+|... .++.||||++.... ....+|+.++++++||||+++++++... ...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 45778899999999999999975 48899999885432 2345799999999999999999887532 245
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCC
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLA 639 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a 639 (679)
++||||+++ +|.+++.........+++..+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999975 78777755433455689999999999999999999999 999999999999999664 7999999999
Q ss_pred cccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+....... .....||+.|+|||++.+. .++.++|||||
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 87654322 1335689999999998764 68999999996
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=252.62 Aligned_cols=192 Identities=29% Similarity=0.443 Sum_probs=158.4
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVH-HLHLVKLKGFCI 555 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 555 (679)
.++....+.+.++||+|+||.||+|++. .++.||||+++... ...+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455566778899999999999999853 24689999997532 22356889999999997 999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCC------------------------------------------------------
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTE------------------------------------------------------ 581 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 581 (679)
+.+..++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 046493 582 ----------------------------------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPE 621 (679)
Q Consensus 582 ----------------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~ 621 (679)
....+++..++.++.||+.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467788899999999999999998 9999999999
Q ss_pred CeEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 622 NVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 622 NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 327 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHH
Confidence 999999999999999999865432211 1122356788999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=238.90 Aligned_cols=185 Identities=30% Similarity=0.460 Sum_probs=156.8
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC------Cee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG------AHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~ 560 (679)
...|++.+.||+|+||.||+|+..+ ++.||+|++........++.+|+.++.++ +|+||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 3457778899999999999999764 88999999976666677889999999999 699999999998753 457
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
+++|||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 89999999999999986532 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
....... ......|++.|+|||++. +..++.++|||||
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 202 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHH
Confidence 6543322 123456899999999986 3357889999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=250.07 Aligned_cols=176 Identities=30% Similarity=0.443 Sum_probs=154.2
Q ss_pred hcCcccceEEEEEEeCC-CcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHhH
Q 046493 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDK 574 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 574 (679)
+||+|.+|+||.|++.+ ...+|||.+.. .....+.+..|+.+-++|+|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765 67899999865 44556778999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEEEeeccCCcccccCCceeee
Q 046493 575 WIFNSTEESRFL--SWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYT 651 (679)
Q Consensus 575 ~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~~~~~~~~ 651 (679)
+|+.. -+++ ++.++-.+.+||++||.|||++ .|||||||-+||||+ -.|.+||+|||-++.+..-... ..
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-cc
Confidence 99653 3445 7888888999999999999999 999999999999997 5789999999999877654433 35
Q ss_pred cccCccccccccccccCC--CCcccceeeC
Q 046493 652 TLRGTRGYLAPEWITNNP--ISEKSDVYSY 679 (679)
Q Consensus 652 ~~~gt~~y~aPE~~~~~~--~s~~sDvwSl 679 (679)
++.||..|||||++..++ |..++|||||
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~ 764 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSF 764 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhc
Confidence 678999999999997654 8899999997
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=242.45 Aligned_cols=190 Identities=26% Similarity=0.448 Sum_probs=159.2
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
+....+.+.+.||+|+||.||+|...+ +..||+|.+.... ....++.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445567788999999999999998643 4689999986533 23457889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEE------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 999999999999999999653321 23478899999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 9999999865443221 1123456789999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=237.71 Aligned_cols=183 Identities=27% Similarity=0.491 Sum_probs=158.5
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
.+++.+.||+|++|.||++...++..+|+|.++.......++.+|++++++++||||+++++++.+....++++||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 45677899999999999999877889999998766666778999999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++.... ..++++.+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 85 CLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999986532 3478999999999999999999999 999999999999999999999999999876543322111
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl 187 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHH
Confidence 22335678999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=237.58 Aligned_cols=182 Identities=24% Similarity=0.350 Sum_probs=156.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+++.++||||+++++.+.+.+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46788899999999999999975 48899999986532 33456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999998854 33589999999999999999999999 999999999999999999999999999876543321
Q ss_pred eeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
......|+..|+|||++. ...++.++|||||
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl 195 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence 123456899999999874 4558899999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=243.39 Aligned_cols=188 Identities=28% Similarity=0.473 Sum_probs=158.3
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcce
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-----------------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVK 549 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~ 549 (679)
...|++.++||+|+||.||+++..+ +..||+|.+.... ...+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4567888999999999999998643 2468999986532 34567889999999999999999
Q ss_pred EEEEEEeCCeeeEEEeccCCCCHhHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTE-------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 550 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
+++++..++..++++||+++++|.+++..... ....+++..++.++.|+++||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976431 123589999999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++++++.++|+|||+++........ ......+++.|+|||.+.+..++.++|||||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 99999999999999999865433221 1223456788999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=244.69 Aligned_cols=191 Identities=25% Similarity=0.450 Sum_probs=158.9
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC--------CCcEEEEEEeccc--ccCHHHHHHHHHHHHhh-cCCCcceEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESI--GQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 554 (679)
++....+.+.+.||+|+||.||+++.. ++..||+|.+... .....++.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 355667788899999999999999741 2457999988653 23346788999999999 899999999999
Q ss_pred EeCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 555 IEGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 555 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
...+..+++|||+++++|.+++..... ....+++.++..++.||++||.|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999975421 123578889999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++++++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHH
Confidence 999999999999999998765432211 122345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=240.06 Aligned_cols=185 Identities=26% Similarity=0.453 Sum_probs=159.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|++|.||+++.. +++.++||.+.... ....++.+|+++++.++|+||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4677889999999999999964 68999999875421 234578899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.........+++..+..++.||++||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999875433345689999999999999999999999 9999999999999999999999999998866543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....++..|+|||.+.+..++.++|||||
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 192 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHH
Confidence 321 233468899999999998889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=242.44 Aligned_cols=190 Identities=25% Similarity=0.423 Sum_probs=158.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+....+++.+.||+|++|.||++.... ...+|+|.+.... ....++.+|+++++++ +|+||+++++++.++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344556778899999999999998642 3689999987532 2335688999999999 799999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNST------------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL 625 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll 625 (679)
+..+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 99999999999999999986532 2245689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 626 DDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 626 ~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 999999999999998765433211 122345678999999988889999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=250.94 Aligned_cols=179 Identities=24% Similarity=0.352 Sum_probs=152.6
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
+....|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++||||+++++++.+.+..++|+|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 334457888999999999999999764 788999975432 23569999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
++. ++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 5888887543 34589999999999999999999999 9999999999999999999999999999754332
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....||+.|+|||++.+..++.++|||||
T Consensus 211 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 242 (357)
T PHA03209 211 PA--FLGLAGTVETNAPEVLARDKYNSKADIWSA 242 (357)
T ss_pred cc--cccccccccccCCeecCCCCCCchhhHHHH
Confidence 21 233568999999999999899999999996
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=210.90 Aligned_cols=178 Identities=23% Similarity=0.357 Sum_probs=154.0
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.-.++||+|.+|+||+|+..+ ++.||+|+++... .-.....+|+-+++.++|.|||+++++...++...+|+||+.
T Consensus 5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd 84 (292)
T KOG0662|consen 5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_pred HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence 345789999999999999765 8899999986533 234667899999999999999999999999999999999996
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
. +|..|.... ...++.+.+..++.|+++||.|+|++ ++.||||||+|.||+.+|+.||+|||+++.+..+-.
T Consensus 85 q-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 85 Q-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred H-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 4 888887554 44589999999999999999999999 999999999999999999999999999998765432
Q ss_pred eeecccCccccccccccccCC-CCcccceee
Q 046493 649 VYTTLRGTRGYLAPEWITNNP-ISEKSDVYS 678 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwS 678 (679)
..+..+-|..|.+|.++.|.+ |+...|+||
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmws 187 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhh
Confidence 234556789999999998875 788999998
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=242.09 Aligned_cols=180 Identities=27% Similarity=0.398 Sum_probs=149.1
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhh---cCCCcceEEEEEEeC-----Ce
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNV---HHLHLVKLKGFCIEG-----AH 559 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~ 559 (679)
|++.+.||+|+||+||+|+.. +++.||+|.++... .....+.+|+++++++ +||||+++++++.+. ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 567789999999999999976 48899999886422 2234566787777766 699999999988652 45
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.+++|||+++ +|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7899999975 8988886532 34589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+....... .....++..|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 193 (288)
T cd07863 156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSV 193 (288)
T ss_pred ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhH
Confidence 87653321 234568899999999998889999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=237.34 Aligned_cols=182 Identities=29% Similarity=0.439 Sum_probs=158.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|.+.+.||+|++|.||++... +++.|++|.+... ....+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456788999999999999976 4899999998642 234567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999997642 34689999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....+++.|+|||++.+..++.++|||||
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 187 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHH
Confidence 2 233468899999999998889999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=237.39 Aligned_cols=181 Identities=32% Similarity=0.546 Sum_probs=158.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
...+++.+.||+|++|.||++.. .++.||+|.++......+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 34567788999999999999997 47899999997755556789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||.++......
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 84 KGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999999986543 23589999999999999999999999 99999999999999999999999999998764322
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+..|+|||.+.+..++.++|||||
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~sl 185 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHH
Confidence 12334678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=235.66 Aligned_cols=182 Identities=26% Similarity=0.399 Sum_probs=157.5
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
|++.++||+|++|.||++... +++.+|+|.++. .....+.+.+|+.++++++|+||+++++.+.+++..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 566789999999999999976 488999998854 23345678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 82 GGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999886432 34578999999999999999999999 9999999999999999999999999999766443221
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||++.+..++.++|||||
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 186 (255)
T cd08219 157 -ACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186 (255)
T ss_pred -cccccCCccccCHHHHccCCcCchhhhhhh
Confidence 233568899999999998889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=238.35 Aligned_cols=185 Identities=26% Similarity=0.449 Sum_probs=160.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|++|.||+|... +++.||+|.++.. ....+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4677889999999999999987 6899999988531 2235678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.........+++.++..++.|+++||.|||+. +|+||||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999876544455689999999999999999999999 9999999999999999999999999998865443
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....+++.|+|||.+.+..++.++|||||
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 192 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHH
Confidence 221 123468889999999988889999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=244.49 Aligned_cols=185 Identities=27% Similarity=0.487 Sum_probs=152.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-Cc--EEEEEEeccc--ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GI--QVAVKKLESI--GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 563 (679)
..+++.+.||+|+||.||+|++.+ +. .+++|.++.. ......+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 346778899999999999999753 43 4678877642 23345788999999999 899999999999999999999
Q ss_pred EeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcE
Q 046493 564 YEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 631 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 631 (679)
|||+++++|.+++..... ....+++.+++.++.||++||+|||++ +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999965321 123588999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||++....... ......++..|+|||++.+..++.++|||||
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhh
Confidence 999999986432111 1112234668999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=239.04 Aligned_cols=184 Identities=30% Similarity=0.524 Sum_probs=155.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
..+++.+.||+|+||.||+|+.. .+..+|+|.++... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677889999999999999864 23479999886532 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... ...+++.++..++.|++.||+|||++ +++||||||+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999653 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCceeeec--ccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTT--LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... ..++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 195 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY 195 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHH
Confidence 433221111 223568999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=238.08 Aligned_cols=183 Identities=27% Similarity=0.373 Sum_probs=156.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
...|++.++||+|+||.||+|+.. +++.||+|++... ......+++|+.++++++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 456788899999999999999974 5889999998643 23456688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998854 23589999999999999999999999 99999999999999999999999999998664322
Q ss_pred ceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
. ......+++.|+|||.+. ...++.++|||||
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~ 195 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence 1 113346889999999884 3457889999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=242.41 Aligned_cols=190 Identities=26% Similarity=0.444 Sum_probs=156.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
+...+|++.++||+|+||.||+|..++ +..||+|.+.... .....+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345678888999999999999997532 4589999886433 22346788999999999999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTE------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
..++||||+++++|.+++..... .....++..+..++.|++.||.|||++ +|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999965321 123456788899999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvwsl 207 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF 207 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHH
Confidence 99999998654332211 122345678999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=235.62 Aligned_cols=176 Identities=29% Similarity=0.480 Sum_probs=147.1
Q ss_pred hcCcccceEEEEEEeC---CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCC
Q 046493 497 KLGQGGFGSVYLGMLP---DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 571 (679)
.||+|+||.||+|.+. .+..||+|++.... ...+++.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35679999986532 23466899999999999999999999875 456789999999999
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee-
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY- 650 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~- 650 (679)
|.+++... ...+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998643 34589999999999999999999999 999999999999999999999999999986544332211
Q ss_pred -ecccCccccccccccccCCCCcccceeeC
Q 046493 651 -TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 -~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSY 184 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHH
Confidence 11233578999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-28 Score=251.95 Aligned_cols=182 Identities=24% Similarity=0.410 Sum_probs=157.0
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
..++...||.|+||.||++..++ +...|.|++.. .....+++.-|++||+...||+||++++.+..++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35677889999999999999875 45556787764 34556789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
||-.+..+... ++.+.+.++.-+++|++.||.|||++ +|||||||+.|||+.-+|.++|+|||.+........
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q- 185 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ- 185 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh-
Confidence 99999887543 56799999999999999999999999 999999999999999999999999998865433222
Q ss_pred eeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
....+.|||.|||||+.. ..+|+.++|||||
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl 221 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL 221 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence 235678999999999864 5689999999997
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=242.76 Aligned_cols=189 Identities=25% Similarity=0.425 Sum_probs=156.4
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-----------------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-----------------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLV 548 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv 548 (679)
...+|++.++||+|+||.||+++.. +...||+|.++... .....+.+|++++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3456788899999999999998632 23468999987532 2346789999999999999999
Q ss_pred eEEEEEEeCCeeeEEEeccCCCCHhHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 046493 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTE-------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPE 621 (679)
Q Consensus 549 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~ 621 (679)
++++++.+++..+++|||+++++|.+++..... ....+++.++..++.|++.||+|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999875321 123478889999999999999999999 9999999999
Q ss_pred CeEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 622 NVLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 622 NIll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||++++++.++|+|||+++.+....... .....++..|+|||...+..++.++|||||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 9999999999999999998654432211 122334678999999888889999999996
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=241.76 Aligned_cols=188 Identities=29% Similarity=0.508 Sum_probs=157.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
...+.+.+.||+|+||.||+++.. ++..+++|.++... ...+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 345667789999999999999842 34568999886533 33467899999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC
Q 046493 562 LAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 629 (679)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999965321 123488999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 630 TAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 630 ~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.++|+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 9999999999765443221 1123456788999999999899999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=236.40 Aligned_cols=181 Identities=28% Similarity=0.379 Sum_probs=155.0
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
+++.+.||+|++|.||++... +++.+++|.+.... .....+.+|++++++++||||+++++++.+++..++++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 566789999999999999975 48999999886422 12346888999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999998653 3588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCceee--ecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVY--TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ....++..|+|||++.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHH
Confidence 221111 23457889999999999889999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=248.16 Aligned_cols=190 Identities=26% Similarity=0.440 Sum_probs=154.6
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+...+|++.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4456788999999999999999973 246889999997532 2345688999999999 689999999988654
Q ss_pred -CeeeEEEeccCCCCHhHHhhccCCC------------------------------------------------------
Q 046493 558 -AHRLLAYEYLGNGSLDKWIFNSTEE------------------------------------------------------ 582 (679)
Q Consensus 558 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 582 (679)
...+++|||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4678999999999999998643210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-eeec
Q 046493 583 ---------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTT 652 (679)
Q Consensus 583 ---------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~ 652 (679)
...+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999 9999999999999999999999999999865332211 1122
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..++..|+|||.+.+..++.++|||||
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~sl 267 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSF 267 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHH
Confidence 345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=236.58 Aligned_cols=181 Identities=26% Similarity=0.412 Sum_probs=154.5
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
|++.++||+|+||.||++.... +..+++|.+... ....+.+.+|+++++.++||||+++++++.+++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6778899999999999999765 778899988653 23456788999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|..++.+. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999887542 24589999999999999999999999 999999999999999999999999999876543221 1
Q ss_pred eecccCccccccccccc-----cCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
.....++..|+|||++. +..++.++|||||
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 23356899999999884 3457889999996
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=238.82 Aligned_cols=181 Identities=26% Similarity=0.415 Sum_probs=146.7
Q ss_pred hhcCcccceEEEEEEeCC---CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
++||+|+||.||+|...+ ...+++|.+.... .....+.+|++.++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4578888876432 23456889999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-
Q 046493 571 SLDKWIFNSTEE-SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 648 (679)
Q Consensus 571 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~- 648 (679)
+|.+++...... ....++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765422 23356788899999999999999999 9999999999999999999999999998754333211
Q ss_pred eeecccCcccccccccccc-------CCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITN-------NPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSl 679 (679)
......+++.|+|||++.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHH
Confidence 1122345778999998743 356789999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=253.28 Aligned_cols=184 Identities=23% Similarity=0.289 Sum_probs=156.8
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeC---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
...+...+|++.++||+|+||.||++... .++.|++|.+... ....+|++++++++||||+++++++...+..
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34455667889999999999999999753 3578999988642 2356899999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
+++||++. ++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 162 ~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 99999996 688888832 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ ......||+.|+|||++.+..++.++|||||
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 66543221 1224579999999999999999999999996
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=250.82 Aligned_cols=178 Identities=26% Similarity=0.285 Sum_probs=150.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ce
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 559 (679)
.+|++.+.||+|+||.||++... .++.||||++.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 46777889999999999999975 48899999986532 2345677899999999999999999988643 35
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 97 ~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 6899999975 6766663 2478899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+....... .....+|+.|+|||++.+..++.++|||||
T Consensus 167 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 204 (355)
T cd07874 167 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_pred ccCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHH
Confidence 86543321 234578999999999999899999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=244.12 Aligned_cols=191 Identities=26% Similarity=0.424 Sum_probs=157.5
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC--------CcEEEEEEeccc--ccCHHHHHHHHHHHHhh-cCCCcceEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESI--GQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 554 (679)
++....|.+.++||+|+||.||+++... ...+|+|.++.. .....++.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3445678889999999999999998532 357999998753 23345688899999999 799999999999
Q ss_pred EeCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 555 IEGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 555 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
.+.+..++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999976432 123588999999999999999999998 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++++++.+||+|||.++......... .....+++.|+|||.+.+..++.++|||||
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 999999999999999987654322111 112234578999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=250.71 Aligned_cols=178 Identities=26% Similarity=0.287 Sum_probs=150.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ce
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 559 (679)
.+|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 46778899999999999999975 4889999998653 22345678899999999999999999987643 35
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++ +|.+++. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 6999999975 7777763 2378899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+....... .....+|+.|+|||++.+..++.++|||||
T Consensus 174 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 211 (364)
T cd07875 174 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSV 211 (364)
T ss_pred cccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence 86544321 234578999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=236.74 Aligned_cols=172 Identities=28% Similarity=0.463 Sum_probs=147.7
Q ss_pred hhcCcccceEEEEEEeCCC-----------cEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 496 TKLGQGGFGSVYLGMLPDG-----------IQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~-----------~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
+.||+|+||.||+|.+.+. ..+++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 4699999999999998653 257888876544447788999999999999999999999988 7789999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-------cEEEeecc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-------TAKVSDFG 637 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kL~DFg 637 (679)
||+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999996543 2589999999999999999999999 999999999999999887 79999999
Q ss_pred CCcccccCCceeeecccCccccccccccccC--CCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
++...... ....++..|+|||++.+. .++.++|||||
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 192 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSF 192 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence 99865442 223567789999999876 78999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=239.80 Aligned_cols=186 Identities=26% Similarity=0.356 Sum_probs=155.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEE-----eCCeeeE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCI-----EGAHRLL 562 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~l 562 (679)
.+|++.+.||+|+||.||+++... ++.+|+|+++.......++.+|+.+++++ +||||+++++++. .++..++
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 345677889999999999999754 78999999876544557788999999999 6999999999884 3456899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999998865433345688999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCceeeecccCcccccccccccc-----CCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSl 679 (679)
...... .....|++.|+|||++.. ..++.++|||||
T Consensus 175 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 215 (286)
T cd06638 175 TSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215 (286)
T ss_pred ccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence 433211 233468999999998853 447889999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=243.44 Aligned_cols=180 Identities=23% Similarity=0.371 Sum_probs=146.1
Q ss_pred hhhcCcccceEEEEEEeC---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeEEEeccCC
Q 046493 495 STKLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLLAYEYLGN 569 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 569 (679)
.++||+|+||.||+|+.. +++.+|+|.++... ....+.+|++++++++||||+++++++.+ +...++++||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 367999999999999965 46789999987543 24557889999999999999999999864 4567899999864
Q ss_pred CCHhHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe----CCCCcEEEeeccCCc
Q 046493 570 GSLDKWIFNST-----EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAK 640 (679)
Q Consensus 570 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a~ 640 (679)
+|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8888775322 1123588999999999999999999999 99999999999999 456789999999998
Q ss_pred ccccCCce--eeecccCccccccccccccC-CCCcccceeeC
Q 046493 641 LMNREESL--VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
........ ......+|+.|+|||++.+. .++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence 76543221 12345789999999998774 58899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=239.48 Aligned_cols=187 Identities=27% Similarity=0.402 Sum_probs=156.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..+++.+.||+|+||.||+|+.+ +.+.|++|.+..... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 44566788999999999999964 246799998865333 3467999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeec
Q 046493 562 LAYEYLGNGSLDKWIFNSTEES-----RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 636 (679)
+||||+++++|.+++....... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997544211 2589999999999999999999999 9999999999999999999999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++...............++..|+|||.+.+..++.++|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 204 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF 204 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHH
Confidence 9987544332222233456778999999988888999999996
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=238.11 Aligned_cols=174 Identities=28% Similarity=0.386 Sum_probs=151.9
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+++.+.||+|++|.||+|+.. +++.||+|.+... ....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 466788999999999999964 5889999998643 2234678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99997542 367888999999999999999999 99999999999999999999999999998654332
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 179 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSL 179 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHH
Confidence 234578999999999998889999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=239.37 Aligned_cols=183 Identities=28% Similarity=0.442 Sum_probs=150.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-Cc----EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
..+++.+.||+|+||.||+|.... ++ .+++|.+.... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 345667889999999999999643 43 47888875422 23356778888999999999999999875 455678
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
++||+++++|.+++... ...+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999653 24589999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......++..|+|||.+.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 197 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY 197 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence 433221 1233457789999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=227.05 Aligned_cols=187 Identities=25% Similarity=0.425 Sum_probs=155.0
Q ss_pred CHHHHHHHhhhhhhhcCcccceEEEEEE-eCCCcEEEEEEecc-cccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCe
Q 046493 483 SYDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLES-IGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAH 559 (679)
Q Consensus 483 ~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 559 (679)
+++|+.+-+. +.||+|+++.|--+. +.++.++|||++.+ .........+|++++.+.+ |+||++++++|+++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3556544443 569999999999887 56799999999976 4456778899999999996 9999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEEEeec
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDF 636 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DF 636 (679)
.|||||-|.||+|..+|+. .+.+++.++.++.++|+.||.|||.+ +|.||||||+|||-.+.. -+||+||
T Consensus 151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999965 44699999999999999999999999 999999999999987544 5799999
Q ss_pred cCCcccccCCc------eeeecccCccccccccccc---cC--CCCcccceeeC
Q 046493 637 GLAKLMNREES------LVYTTLRGTRGYLAPEWIT---NN--PISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~---~~--~~s~~sDvwSl 679 (679)
.++.-+..... ....+.+|+..|||||+.. ++ .|+.+.|.|||
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSL 277 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSL 277 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHH
Confidence 88764432211 1223468899999999763 32 47899999996
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=241.89 Aligned_cols=179 Identities=25% Similarity=0.357 Sum_probs=154.3
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
|++.++||+|+||.||+++.. ++..+|+|.+.... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 567789999999999999975 47889999886432 223568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++... ..+++..+..++.|+++||.|||+. .+++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 83 GGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999653 4588999999999999999999973 189999999999999999999999999987653322
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||.+.+..++.++|||||
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 184 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHH
Confidence 134568899999999988889999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.71 Aligned_cols=181 Identities=29% Similarity=0.422 Sum_probs=148.4
Q ss_pred hhcCcccceEEEEEEeCC---CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4679999887533 23357888999999999999999999999999999999999999
Q ss_pred CHhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 571 SLDKWIFNSTE-ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 571 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
+|.+++..... .....++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 223467788889999999999999999 99999999999999999999999999997544332211
Q ss_pred -eecccCccccccccccccC-------CCCcccceeeC
Q 046493 650 -YTTLRGTRGYLAPEWITNN-------PISEKSDVYSY 679 (679)
Q Consensus 650 -~~~~~gt~~y~aPE~~~~~-------~~s~~sDvwSl 679 (679)
.....++..|+|||++.+. .++.++|||||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSL 195 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHH
Confidence 1234567889999988642 35789999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=239.65 Aligned_cols=183 Identities=31% Similarity=0.495 Sum_probs=152.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-----CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLL 562 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 562 (679)
.+++.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4667789999999999999842 47899999986533 335678999999999999999999998754 346789
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|+||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999998653 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .....++..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHH
Confidence 5433211 111233456999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=239.31 Aligned_cols=189 Identities=24% Similarity=0.401 Sum_probs=158.5
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-----CcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-CCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-GAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 559 (679)
...+|.+.+.||+|+||.||+|...+ +..|++|+++.. ....+.+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45667788999999999999999765 688999988653 2334668899999999999999999998876 467
Q ss_pred eeEEEeccCCCCHhHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEee
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEE----SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 635 (679)
.++++||+++++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764322 14689999999999999999999999 999999999999999999999999
Q ss_pred ccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++.+...... ......++..|+|||++.+..++.++|||||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 205 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence 9999866443322 1122346778999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=242.88 Aligned_cols=190 Identities=24% Similarity=0.416 Sum_probs=156.2
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC--------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCI 555 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 555 (679)
+...++.+.++||+|+||.||+++.. ....+|+|.++... ....++.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456778899999999999999742 24579999887532 2345688999999999 6999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
+.+..+++|||+++++|.+++..... ....+++.++..++.||+.||.|||++ +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 99999999999999999999965321 124588999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 99999999999999998664322111 112234567999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=235.17 Aligned_cols=173 Identities=26% Similarity=0.441 Sum_probs=145.0
Q ss_pred hhcCcccceEEEEEEeCC-------------CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 496 TKLGQGGFGSVYLGMLPD-------------GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
+.||+|+||.||+|+..+ ...|++|.+.... .....+.+|+.+++.++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899876532 33456888999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc-------EEEe
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-------AKVS 634 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kL~ 634 (679)
++|||+++++|..++... ...+++..++.++.||++||+|||++ +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988543 23589999999999999999999999 9999999999999987664 8999
Q ss_pred eccCCcccccCCceeeecccCccccccccccc-cCCCCcccceeeC
Q 046493 635 DFGLAKLMNREESLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSl 679 (679)
|||++...... ....++..|+|||.+. +..++.++|||||
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSF 195 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHH
Confidence 99998755332 2345788999999886 4568999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=239.41 Aligned_cols=178 Identities=31% Similarity=0.392 Sum_probs=156.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|.+.+.||+|++|.||+++.. +++.+|+|.++... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 3567789999999999999976 48999999986422 234668899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 82 YVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998653 4589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||.+.+...+.++|||||
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWAL 184 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHH
Confidence 133468899999999988888999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=234.06 Aligned_cols=181 Identities=33% Similarity=0.539 Sum_probs=157.1
Q ss_pred hhcCcccceEEEEEEeCC----CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQG--KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+++... +..|++|.++..... .+.+.+|++.+++++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 789999999764433 57889999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 570 GSLDKWIFNSTEE-----SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 570 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
++|.+++...... ...+++..+..++.|+++||+|||++ +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764221 35689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCc-eeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .......++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF 193 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHH
Confidence 432 11233467889999999988889999999995
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=261.83 Aligned_cols=190 Identities=20% Similarity=0.304 Sum_probs=149.8
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC--CcEEEE------------------EEecccccCHHHHHHHHHHHHhhcCC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD--GIQVAV------------------KKLESIGQGKKEFSAEVTTIGNVHHL 545 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vav------------------K~l~~~~~~~~~~~~E~~~l~~l~h~ 545 (679)
+.....|++.++||+|+||+||++..+. +...++ |.+.........+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3345678899999999999999987542 222222 22222223345688999999999999
Q ss_pred CcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 046493 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE-SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVL 624 (679)
Q Consensus 546 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIl 624 (679)
||+++++++.+.+..++++|++. ++|.+++...... ........+..++.||+.||+|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999985 5777776543211 12234667788999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 625 LDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 625 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 9999999999999998765443322234579999999999999999999999996
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.49 Aligned_cols=179 Identities=31% Similarity=0.487 Sum_probs=152.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEE-eCCeeeEEEeccC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI-EGAHRLLAYEYLG 568 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 568 (679)
..+++.+.||+|++|.||++.. .+..|++|.++.. ...+.+.+|+.++++++|+|++++++++. +++..++++||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4567788999999999999987 4788999998653 33567899999999999999999999765 4567899999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999986543 33588999999999999999999999 99999999999999999999999999987654322
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||++.+..++.++|||||
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 185 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHH
Confidence 22334668999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=246.71 Aligned_cols=177 Identities=26% Similarity=0.347 Sum_probs=149.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ce
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 559 (679)
.+|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45777889999999999999975 57899999986532 2345677899999999999999999987643 35
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++++|++ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 68999988 6799887742 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+...... ....||+.|+|||++.+ ..++.++|||||
T Consensus 166 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 166 RQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred eecCCCc----CCccccccccCchHhcCCccCCchhhhHhH
Confidence 8654322 34568999999999877 468899999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=244.88 Aligned_cols=191 Identities=25% Similarity=0.445 Sum_probs=157.9
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC--------CcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 554 (679)
++...+|++.+.||+|+||.||+++... ...||+|.++... ...+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 4555678889999999999999997421 2468999886532 2346788999999999 799999999999
Q ss_pred EeCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 555 IEGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 555 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
.+++..++++||+++++|.+++..... ....+++.++..++.|+++||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999975321 123588899999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 999999999999999998654332111 122334568999999999899999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=235.86 Aligned_cols=181 Identities=24% Similarity=0.389 Sum_probs=146.2
Q ss_pred hhcCcccceEEEEEEeCCC---cEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
++||+|+||.||+++..++ ..+++|.++... ...+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985443 356677765432 34567899999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc-ee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LV 649 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~-~~ 649 (679)
+|.+++..........++..+..++.||++||+|||+. +++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976433334567778889999999999999998 999999999999999999999999999864322211 11
Q ss_pred eecccCcccccccccccc-------CCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITN-------NPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSl 679 (679)
.....++..|+|||++.. ..++.++|||||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 194 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence 123467889999998753 235789999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=239.07 Aligned_cols=188 Identities=26% Similarity=0.491 Sum_probs=156.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
...+.+.++||+|+||.||++... ++..+++|.++.. ....+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 345567889999999999999742 3568999988653 334567999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc
Q 046493 562 LAYEYLGNGSLDKWIFNSTE-----------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 630 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 630 (679)
++|||+++++|.+++..... ....+++..++.++.||+.||+|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999865421 113488999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 631 AKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+||+|||++.......... .....+++.|+|||.+.+..++.++|||||
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 9999999997654332211 122345678999999999899999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=237.54 Aligned_cols=179 Identities=32% Similarity=0.449 Sum_probs=150.6
Q ss_pred hhhhhcCcccceEEEEEEe-----CCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEE
Q 046493 493 NFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLA 563 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 563 (679)
.+.+.||+|+||+||++.. .++..||+|.++... .....+.+|++++++++||||+++++++.+. ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988653 357889999987532 2456788999999999999999999988764 357899
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... .+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998542 489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......++..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl 196 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSF 196 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHH
Confidence 43221 1122345667999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.28 Aligned_cols=181 Identities=26% Similarity=0.408 Sum_probs=156.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+|++.+.||+|++|.||+|+.. +++.|++|.+... ....+.+.+|+.+++.++|+||+++++.+.++...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 35677788999999999999964 5889999988653 334567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999853 2478999999999999999999999 999999999999999999999999999886544322
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....+++.|+|||.+.+..++.++|||||
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~ 202 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHH
Confidence 1 133468899999999998889999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.94 Aligned_cols=188 Identities=29% Similarity=0.464 Sum_probs=158.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+....+.+.+.||+|+||.||++... .+..||||.++... ...+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44456788899999999999999742 25579999887532 2345688999999999 799999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
+..+++|||+++++|.+++.... ...+++.++..++.|++.||+|||++ +|+|+||||+||++++++.++|+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999996533 23489999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 229 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH
Confidence 99866443221 1122346788999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.82 Aligned_cols=181 Identities=26% Similarity=0.403 Sum_probs=157.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+|.+.++||+|++|.||++... +++.||+|.+... ....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56777889999999999999964 5899999998653 334566889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999853 2478899999999999999999999 999999999999999999999999999986544322
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....+++.|+|||.+.+..++.++|||||
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 201 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHH
Confidence 1 233468889999999998889999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=236.57 Aligned_cols=183 Identities=27% Similarity=0.401 Sum_probs=155.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.++||+|++|.||+|+... ++.+++|.+.... ...+.+.+|++++++++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 457888999999999999999765 8899999986533 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|..++.+. ...+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999998887543 23589999999999999999999999 999999999999999999999999999875433211
Q ss_pred eeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
......+++.|+|||++. ...++.++|||||
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 123346788999999985 3456889999996
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=236.41 Aligned_cols=183 Identities=26% Similarity=0.397 Sum_probs=156.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.++||.|++|.||++... ++..+|+|.++... ...+.+.+|++++++++||||+++++.+.+++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45788899999999999999975 58899999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998653 24589999999999999999999999 999999999999999999999999999876543222
Q ss_pred eeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
......+++.|+|||.+. ...++.++|||||
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl 194 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence 123346889999999875 3457789999996
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=234.57 Aligned_cols=184 Identities=26% Similarity=0.461 Sum_probs=152.2
Q ss_pred hhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe------
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH------ 559 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 559 (679)
.+.+.||+|+||.||+|.... +..||+|+++... .....+.+|++.++.++||||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456889999999999998643 3679999987532 234578899999999999999999999876554
Q ss_pred eeEEEeccCCCCHhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTE--ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
.++++||+++++|..++..... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 6899999999999999865431 234689999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++......... ......+..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 998664432211 112234678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=236.38 Aligned_cols=184 Identities=31% Similarity=0.535 Sum_probs=154.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-C---cEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-G---IQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
..+++.+.||+|+||.||+|+... + ..||||.++.. .....++..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778899999999999999753 3 36999998653 23346799999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... ...+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998653 23589999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCcee-eec-cc--CccccccccccccCCCCcccceeeC
Q 046493 644 REESLV-YTT-LR--GTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~-~~~-~~--gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ... .. .+..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 197 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY 197 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhh
Confidence 432211 111 11 2457999999998899999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.69 Aligned_cols=185 Identities=26% Similarity=0.398 Sum_probs=154.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
.+.++.+.++||+|++|.||+|...+ ...|+||...... ...+.+.+|++++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34557778899999999999998643 3578999886532 345678999999999999999999998875 4578
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999999653 23489999999999999999999998 999999999999999999999999999986
Q ss_pred cccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.............++..|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 194 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHH
Confidence 65443222222334568999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=232.88 Aligned_cols=182 Identities=29% Similarity=0.437 Sum_probs=160.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
..|++.++||+|++|.||+++..+ ++.+++|.++.... .+++.+|++++++++|+||+++++++.++...++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 456778899999999999999875 78999999876433 6789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998543 34589999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......++..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~ 185 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHH
Confidence 1233457889999999998899999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=235.79 Aligned_cols=183 Identities=25% Similarity=0.484 Sum_probs=149.7
Q ss_pred hhhhcCcccceEEEEEEeCC-C--cEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ceee
Q 046493 494 FSTKLGQGGFGSVYLGMLPD-G--IQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AHRL 561 (679)
Q Consensus 494 ~~~~Lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 561 (679)
+.++||+|+||.||+|+..+ + ..+|+|.++.. ....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56789999999999999765 3 26899988653 23346788899999999999999999987532 2468
Q ss_pred EEEeccCCCCHhHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 562 LAYEYLGNGSLDKWIFNST--EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
+++||+++++|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999875322 1234589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+......... .....+++.|+|||.+.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 8765433211 122345778999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=237.30 Aligned_cols=185 Identities=29% Similarity=0.446 Sum_probs=152.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCc----EEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGI----QVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
....+++.++||+|+||+||+|+.. +++ .||+|.++.. ....+++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3445677789999999999999853 343 5899998642 23356788999999999999999999998754 56
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++++||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 7999999999999998653 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... .....+++.|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence 765433211 112234678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=262.19 Aligned_cols=185 Identities=24% Similarity=0.260 Sum_probs=165.9
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
....|++.+.||+|+||.|..++.+. ++.+|+|++.+ .......|..|-.+|..-..+-|+.++-.|+++++.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 44557888999999999999999865 88899999976 23456778999999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|||||+||+|-.+|.+.. .+++..+..++..|+.||.-||+- |+|||||||+|||||..|++||+|||.|..+
T Consensus 153 VMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999996542 589999999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCceeeecccCccccccccccc----c-CCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWIT----N-NPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDvwSl 679 (679)
..+........+|||.|++||++. + +.|++.+|.||+
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSl 267 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSL 267 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhh
Confidence 877777777789999999999985 2 468999999996
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=231.90 Aligned_cols=175 Identities=31% Similarity=0.474 Sum_probs=147.5
Q ss_pred hcCcccceEEEEEEeC---CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 497 KLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+||+|+||.||+|.++ ++..+|+|+++.... ..+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 478899999865332 3467889999999999999999999875 45678999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999998542 3589999999999999999999999 999999999999999999999999999987654432211
Q ss_pred --ecccCccccccccccccCCCCcccceeeC
Q 046493 651 --TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 --~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||.+.+..++.++|||||
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSF 184 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHH
Confidence 12234578999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=239.15 Aligned_cols=184 Identities=28% Similarity=0.478 Sum_probs=151.5
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-C--cEEEEEEeccc--ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-G--IQVAVKKLESI--GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.|++.+.||+|+||.||+|...+ + ..+++|.++.. ....+.+.+|+++++++ +||||+++++++.+.+..++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35677899999999999999754 3 35788888642 23346788999999999 7999999999999999999999
Q ss_pred eccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 565 EYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
||+++++|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence 99999999999965321 123588999999999999999999998 999999999999999999999
Q ss_pred EeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||++....... .......+..|+|||++.+..++.++|||||
T Consensus 160 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 204 (297)
T cd05089 160 IADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSF 204 (297)
T ss_pred ECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHH
Confidence 99999986432211 1111233567999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=236.94 Aligned_cols=182 Identities=29% Similarity=0.415 Sum_probs=156.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.+.|...+.||+|++|.||+|.+. +++.||+|.++.. ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 345677788999999999999875 4789999988642 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.. ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 83 YLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999999998843 3588999999999999999999999 9999999999999999999999999999866543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......++..|+|||.+.+..++.++|||||
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (277)
T cd06642 155 QI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187 (277)
T ss_pred ch-hhhcccCcccccCHHHhCcCCCchhhhHHHH
Confidence 21 1123467889999999998889999999996
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=242.47 Aligned_cols=187 Identities=28% Similarity=0.479 Sum_probs=162.5
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC---C--cEEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD---G--IQVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~---~--~~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
+|.+....+.+.||.|-||.||+|...+ | -.||||.-+. .....+.|..|..+|++++||||++++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 4556666778899999999999999543 2 4588998876 33557889999999999999999999999976 4
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..+||||.++-|.|..||+.+. ..++......++.||..||+|||+. .+|||||..+|||+....-+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 6799999999999999998754 3488899999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++.+........+...-++.|||||.+.-..++.+||||-|
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMF 578 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMF 578 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHH
Confidence 99988876655555566789999999999999999999954
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=237.40 Aligned_cols=187 Identities=28% Similarity=0.444 Sum_probs=154.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..+.+.+.||+|++|.||+|.+.+ +..|++|.+.... .....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 456677899999999999999753 5678999886432 23456899999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEEEee
Q 046493 562 LAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSD 635 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~D 635 (679)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||++++++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999975431 123589999999999999999999999 999999999999998654 599999
Q ss_pred ccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++......... ......+..|+|||++.+..++.++|||||
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 207 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence 99998764322111 112233568999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=239.58 Aligned_cols=188 Identities=30% Similarity=0.498 Sum_probs=156.3
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
...+++.+.||+|+||.||+++.. ++..||+|.+.... ...+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 445677889999999999999863 36789999986532 2346788999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 561 LLAYEYLGNGSLDKWIFNST------------------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
++++||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996421 1123478899999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 99999999999999998765433211 1122334678999999988899999999996
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=229.06 Aligned_cols=185 Identities=23% Similarity=0.340 Sum_probs=153.3
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-----CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe-CCeee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-GAHRL 561 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 561 (679)
.|+...+||+|.+|.||+|.-.+ .+.+|+|+++... .-....-+|+.+++.++||||+.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46778899999999999996432 2379999997642 223556789999999999999999999987 77889
Q ss_pred EEEeccCCCCHhHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC----CcEEEeec
Q 046493 562 LAYEYLGNGSLDKWIFNST-EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN----FTAKVSDF 636 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DF 636 (679)
+++||.+. +|.+.|+-++ ...+.++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999986 7877775433 2345789999999999999999999999 99999999999999866 99999999
Q ss_pred cCCcccccCCcee--eecccCccccccccccccC-CCCcccceeeC
Q 046493 637 GLAKLMNREESLV--YTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
|+++.+...-... ....+-|.-|+|||.+.|. .||++.||||.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAi 226 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAI 226 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHH
Confidence 9999887654322 2345679999999999886 48999999983
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=232.36 Aligned_cols=182 Identities=23% Similarity=0.362 Sum_probs=158.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||.|++|.||.++.. +++.+++|.+... ....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 567789999999999999865 4889999987642 234567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++.++..++.|++++|+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999986543 34589999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......+++.|+|||.+.+..++.++|||||
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~sl 187 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWAL 187 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHH
Confidence 1234568999999999988888999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=241.49 Aligned_cols=181 Identities=20% Similarity=0.226 Sum_probs=149.4
Q ss_pred hhhhcCcc--cceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 494 FSTKLGQG--GFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 494 ~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+.++||+| +|++||+++.. +++.||+|+++... ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999875 58999999986532 22356778999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986542 23489999999999999999999999 999999999999999999999999986554322111
Q ss_pred ee------eecccCcccccccccccc--CCCCcccceeeC
Q 046493 648 LV------YTTLRGTRGYLAPEWITN--NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~------~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSl 679 (679)
.. .....++..|+|||++.+ ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence 00 112346778999999876 458899999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=232.31 Aligned_cols=182 Identities=27% Similarity=0.427 Sum_probs=155.2
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe-CCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-GAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 566 (679)
|++.+.||+|++|.||++.... ++.||+|++.... ...+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 6678899999999999999764 7899999986432 334568899999999999999999998764 4467899999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999987532 34589999999999999999999999 99999999999999999999999999998764432
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....+++.|+|||++.+..++.++|||||
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 188 (257)
T cd08223 157 DM-ASTLIGTPYYMSPELFSNKPYNYKSDVWAL 188 (257)
T ss_pred Cc-cccccCCcCccChhHhcCCCCCchhhhHHH
Confidence 21 234568899999999999889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=238.36 Aligned_cols=185 Identities=30% Similarity=0.451 Sum_probs=153.3
Q ss_pred hhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+++.+.||+|+||.||+|+... ...+++|.+.... ...+.+.+|+.+++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 4567889999999999998532 3578898886533 2345788999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 564 YEYLGNGSLDKWIFNSTE--------------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 999999999999864321 123588999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 9999999999999999865433221 1122345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=235.93 Aligned_cols=172 Identities=25% Similarity=0.416 Sum_probs=142.8
Q ss_pred hcCcccceEEEEEEeCC-------------------------CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceE
Q 046493 497 KLGQGGFGSVYLGMLPD-------------------------GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKL 550 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l 550 (679)
.||+|+||.||+|.+.. ...|++|.+.... ....++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 2458999886532 234568889999999999999999
Q ss_pred EEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-
Q 046493 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF- 629 (679)
Q Consensus 551 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~- 629 (679)
++++.++...++||||+++++|..++... ...+++..+..++.||++||+|||++ +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998643 34588999999999999999999999 999999999999997643
Q ss_pred ------cEEEeeccCCcccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 630 ------TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 630 ------~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.+||+|||.+...... ....++..|+|||.+.+ ..++.++|||||
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 4899999988644322 22356788999998865 468999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=236.43 Aligned_cols=182 Identities=26% Similarity=0.410 Sum_probs=153.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||+|++|.||+|+.. +++.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456788999999999999976 5899999998642 223467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++..... ...+++..+..++.||++||+|||++ +++|+||||+||++++++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 689888865332 35689999999999999999999999 999999999999999999999999999976543321
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
......+++.|+|||++.+. .++.++|||||
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSI 188 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHH
Confidence 12334578899999988654 47889999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=233.59 Aligned_cols=181 Identities=29% Similarity=0.438 Sum_probs=154.9
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
|.+.+.||+|+||.||+|...+++.+|||.++.... ....+.+|++++++++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 456788999999999999988899999998864221 1245888999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 82 EFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999543 3478999999999999999999999 999999999999999999999999999876532
Q ss_pred CC-----ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EE-----SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ........++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 194 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHH
Confidence 11 111223468899999999998889999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=233.38 Aligned_cols=179 Identities=27% Similarity=0.493 Sum_probs=147.9
Q ss_pred hhcCcccceEEEEEEeCC-Cc--EEEEEEeccc--ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD-GI--QVAVKKLESI--GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|+||.||+|++.+ +. .+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999764 33 5788888642 23446788999999999 799999999999999999999999999
Q ss_pred CCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 570 GSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 570 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
++|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 123478999999999999999999998 99999999999999999999999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++....... .......+..|+|||++.+..++.++|||||
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHH
Confidence 986322111 1111234567999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=235.85 Aligned_cols=184 Identities=27% Similarity=0.349 Sum_probs=158.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+....|++.++||+|++|+||++... +++.||+|++... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 44567888999999999999999975 4889999987543 23356789999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++.. ...+++..+..++.+++.+|.|||+. .+++||||+|+||++++++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 82 MEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999999998854 23589999999999999999999973 189999999999999999999999999987543
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....|+..|+|||++.+..++.++|||||
T Consensus 156 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 188 (284)
T cd06620 156 NSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188 (284)
T ss_pred hhc---cCccccCcccCCHHHHccCCCCccchHHHH
Confidence 322 123568999999999988889999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=234.85 Aligned_cols=184 Identities=30% Similarity=0.531 Sum_probs=154.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-C---cEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-G---IQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
..++..+.||+|++|.||+|+... + ..+++|.++... ...+++.+|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 455667899999999999999753 3 379999986532 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998653 24589999999999999999999999 99999999999999999999999999998665
Q ss_pred cCCceeeec--ccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTT--LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... ...+..|+|||++.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 196 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF 196 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHH
Confidence 432221111 223457999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=238.62 Aligned_cols=181 Identities=24% Similarity=0.378 Sum_probs=152.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|.+.++||+|+||.||+|+.. +++.||+|.++.. ......+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4677789999999999999976 4789999998642 233456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++... ...+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 87 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 5898888653 33588999999999999999999999 999999999999999999999999999976543222
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. .....+++.|+|||.+.+. .++.++|||||
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 1 1234578899999988654 47889999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=230.03 Aligned_cols=178 Identities=29% Similarity=0.460 Sum_probs=152.5
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHh
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLD 573 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 573 (679)
++||+|++|.||++.+.+++.|++|.++.... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999875332 3567899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee-ec
Q 046493 574 KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-TT 652 (679)
Q Consensus 574 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~-~~ 652 (679)
+++... ...+++..+..++.+++.+|+|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998653 23578999999999999999999999 999999999999999999999999999986543221111 11
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~sl 181 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSY 181 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHH
Confidence 234567999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=237.31 Aligned_cols=180 Identities=26% Similarity=0.419 Sum_probs=156.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+|++.++||.|++|.||+|... +++.|++|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 3667788999999999999864 5899999988653 3345678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 100 GGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999998853 2489999999999999999999999 9999999999999999999999999998865443221
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 201 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence 133468889999999998889999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=255.40 Aligned_cols=179 Identities=22% Similarity=0.321 Sum_probs=147.6
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCC------CcceEEEEEEeC-Cee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL------HLVKLKGFCIEG-AHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~-~~~ 560 (679)
..+|++.++||+|+||+||+|.+.. ++.||||+++.......+...|++++++++|. +++++++++..+ .+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 3567888999999999999999754 78899999975444455677788888887654 588888888764 478
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCC----------
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNF---------- 629 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~---------- 629 (679)
++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccc
Confidence 8999988 67888888542 358999999999999999999997 5 899999999999998765
Q ss_pred ------cEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 630 ------TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 630 ------~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 331 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331 (467)
T ss_pred cCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence 4999999988643222 234679999999999999999999999996
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=232.96 Aligned_cols=180 Identities=28% Similarity=0.388 Sum_probs=158.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+|++.+.||.|++|.||+|+.. +++.||+|.+... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4677889999999999999976 4889999998653 233467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998542 589999999999999999999999 999999999999999999999999999987754422
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......+++.|+|||.+.+..++.++|||||
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~sl 184 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSL 184 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHH
Confidence 1234568889999999998889999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=235.61 Aligned_cols=186 Identities=28% Similarity=0.379 Sum_probs=155.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC-----CeeeE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG-----AHRLL 562 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~l 562 (679)
..|++.+.||+|+||.||++... +++.+|+|.+.........+.+|+.+++++ +||||+++++++... +..++
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 34667788999999999999975 588999999876544567788999999999 799999999998754 35799
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|+||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 9999999999998865433345689999999999999999999999 9999999999999999999999999998865
Q ss_pred ccCCceeeecccCccccccccccccC-----CCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNN-----PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwSl 679 (679)
...... .....++..|+|||.+... .++.++|||||
T Consensus 179 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 179 TSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred cccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 433221 1234688999999988643 26889999996
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=234.20 Aligned_cols=184 Identities=32% Similarity=0.492 Sum_probs=154.1
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-C----cEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-G----IQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~----~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
...+++.+.||+|+||.||+|...+ + ..+|+|.+.... ....++.+|++++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4556778999999999999999643 3 368999886543 234678899999999999999999999987 7889
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+|+||+++++|.+++.... ..+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999996542 3489999999999999999999998 999999999999999999999999999987
Q ss_pred cccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ .....++..|+|||.+....++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSY 197 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHH
Confidence 65433221 111224568999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=231.35 Aligned_cols=183 Identities=26% Similarity=0.377 Sum_probs=158.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.+.||+|++|.||++... +++.+++|.+... ....+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 34677789999999999999975 4788999998653 234578899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ...+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||.+........
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999988653 24589999999999999999999999 999999999999999999999999999986554321
Q ss_pred eeeecccCccccccccccccC---CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN---PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSl 679 (679)
......++..|+|||.+.+. .++.++|||||
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~sl 190 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHH
Confidence 12335678899999999776 78999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=231.50 Aligned_cols=178 Identities=29% Similarity=0.432 Sum_probs=152.3
Q ss_pred hhcCcccceEEEEEEeCC--C--cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD--G--IQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
++||+|++|.||+|.+.+ + ..||||.++.... ..+.+.+|++.+++++||||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 2 3699999976433 45678999999999999999999999988 888999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.+... ..+++..+..++.|+++||+|||++ +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 4689999999999999999999999 99999999999999999999999999998765432211
Q ss_pred --eecccCccccccccccccCCCCcccceeeC
Q 046493 650 --YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 --~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~sl 186 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMF 186 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHH
Confidence 112456789999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=232.78 Aligned_cols=181 Identities=28% Similarity=0.382 Sum_probs=151.4
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 562 (679)
|++.+.||+|+||.||++...+ ++.||||.+.... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 5567889999999999999754 8999999875321 1235678899999999999999999998764 46789
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+|||+++++|.+++... ..+++..+++++.|++.||+|||++ +++|+||||+||++++++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999998643 3478899999999999999999999 9999999999999999999999999998865
Q ss_pred ccCCc--eeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .......++..|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence 43211 11123458889999999988889999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=238.83 Aligned_cols=179 Identities=23% Similarity=0.373 Sum_probs=145.1
Q ss_pred hhcCcccceEEEEEEeCC---CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 570 (679)
.+||+|+||.||+|+..+ +..||+|.++... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999653 5789999987543 34567899999999999999999999854 4577899999875
Q ss_pred CHhHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe----CCCCcEEEeeccCCcc
Q 046493 571 SLDKWIFNST-----EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKL 641 (679)
Q Consensus 571 sL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a~~ 641 (679)
+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777764321 1223588999999999999999999999 99999999999999 5667999999999987
Q ss_pred cccCCce--eeecccCccccccccccccC-CCCcccceeeC
Q 046493 642 MNREESL--VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
....... ......+|+.|+|||++.+. .++.++|||||
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 6543221 12345689999999998764 57899999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=235.34 Aligned_cols=181 Identities=28% Similarity=0.402 Sum_probs=156.8
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||+|++|.||+|+.. +++.|++|++.... .....+.+|+.++++++||||+++++++.+++..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 567789999999999999975 58999999986532 23467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+++|.+++.... ..+++.++..++.||++||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999986543 4589999999999999999999999 999999999999999999999999999987655433
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.......++..|+|||.+.+. .++.++|||||
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAV 187 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHH
Confidence 223445789999999988654 46899999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=230.58 Aligned_cols=182 Identities=31% Similarity=0.559 Sum_probs=156.5
Q ss_pred hhhhhcCcccceEEEEEEeCC-----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++.+.||.|+||.||+++..+ +..||+|.++.... ..+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999999764 38899999976443 46789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999986533 12289999999999999999999999 9999999999999999999999999999876554
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........+++.|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHH
Confidence 3222222346789999999988889999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=229.75 Aligned_cols=176 Identities=36% Similarity=0.529 Sum_probs=148.4
Q ss_pred hhcCcccceEEEEEEeCC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
++||+|+||.||+|+... +..+|+|.+..... ..+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998533 26899999876443 4567899999999999999999999876 4567999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999653 2589999999999999999999999 99999999999999999999999999998765433221
Q ss_pred e--ecccCccccccccccccCCCCcccceeeC
Q 046493 650 Y--TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~--~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....++..|+|||.+.+..++.++|||||
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSY 184 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHH
Confidence 1 11223568999999998889999999996
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=231.59 Aligned_cols=181 Identities=30% Similarity=0.462 Sum_probs=153.8
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
+.+.+.||+|++|.||+|... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456678999999999999975 478999998854221 124678899999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999543 3588899999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCce-----eeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESL-----VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ ......++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 198 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSL 198 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHH
Confidence 76532111 1122457889999999998889999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=236.33 Aligned_cols=176 Identities=27% Similarity=0.424 Sum_probs=152.9
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
..+||+|+||.||++... +++.||+|.+... ....+.+.+|+.+++.++||||+++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999975 5899999998642 33456788999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.. ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......... ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 176 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 176 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccc
Confidence 998743 3488999999999999999999999 9999999999999999999999999998765433221 233
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..++..|+|||++.+..++.++|||||
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~sl 203 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSL 203 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHH
Confidence 568899999999998889999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=234.07 Aligned_cols=181 Identities=26% Similarity=0.361 Sum_probs=154.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|++.+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4667788999999999999986 48999999886432 2345678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 82 CDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred cCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999888887643 23489999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
. ......++..|+|||.+.+ ..++.++|||||
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAI 187 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHH
Confidence 2 1223457889999999876 457899999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=231.50 Aligned_cols=181 Identities=28% Similarity=0.412 Sum_probs=156.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|+..++||+|++|.||+|... ++..||+|.++.. ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 44666788999999999999975 4889999988643 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998853 3488899999999999999999999 99999999999999999999999999997664432
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......++..|+|||++.+..++.++|+|||
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~sl 187 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHH
Confidence 2 1223457889999999988889999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=237.96 Aligned_cols=184 Identities=27% Similarity=0.313 Sum_probs=156.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 35667889999999999999865 89999999865322 34568899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999986432 34689999999999999999999999 9999999999999999999999999998754322
Q ss_pred Cce----------------------------eeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESL----------------------------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......|+..|+|||++.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 110 0112467889999999998889999999996
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=231.89 Aligned_cols=186 Identities=28% Similarity=0.426 Sum_probs=157.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCC------eee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGA------HRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~ 561 (679)
.+|++.+.||+|++|.||+|... +++.+++|++.......+.+.+|+++++++ +|+||+++++++.+.. ..+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 56778899999999999999986 478999999877665667899999999999 6999999999997654 479
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++.........+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999999876443345689999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCceeeecccCcccccccccccc-----CCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSl 679 (679)
....... .....++..|+|||++.. ..++.++|||||
T Consensus 163 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 204 (275)
T cd06608 163 LDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSL 204 (275)
T ss_pred cccchhh-hcCccccccccCHhHhcccccccCCccccccHHHh
Confidence 5433221 233568899999998754 346789999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=236.42 Aligned_cols=176 Identities=28% Similarity=0.461 Sum_probs=152.3
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
...||+|+||.||++... ++..||||.+.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999975 48899999986532 3346688999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||++++++.++|+|||++......... ...
T Consensus 107 ~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 177 (292)
T cd06658 107 TDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKS 177 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cce
Confidence 998843 2488999999999999999999999 9999999999999999999999999998765433221 123
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..++..|+|||.+.+..++.++|||||
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~sl 204 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSL 204 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHH
Confidence 468899999999988889999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=233.70 Aligned_cols=183 Identities=28% Similarity=0.419 Sum_probs=154.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+++.+.||+|++|.||+++.. .++.||+|.++.. ......+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4678899999999999999986 5899999988643 223457889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|..++.... ....+++..+..++.|++.||.|||++ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999886532 133589999999999999999999963 189999999999999999999999999997654322
Q ss_pred eeeecccCccccccccccccCC------CCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNP------ISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwSl 679 (679)
.....+++.|+|||.+.+.. ++.++|||||
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 193 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence 12345788999999986543 4789999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=229.35 Aligned_cols=178 Identities=30% Similarity=0.492 Sum_probs=152.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..|++.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++||||+++++++..+ ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4577889999999999999986 6788999998653 2356789999999999999999999998754 47899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999996543 34588999999999999999999998 99999999999999999999999999987643321
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+..|+|||.+.+..++.++|||||
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHH
Confidence 22334578999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=229.48 Aligned_cols=182 Identities=29% Similarity=0.437 Sum_probs=156.8
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.++||+|+||.+|+++.. +++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 567789999999999999975 4889999998642 233467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999886532 23578999999999999999999999 999999999999999999999999999986644322
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....|++.|+|||++.+..++.++|+|||
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 187 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWAL 187 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHH
Confidence 1 123457889999999998889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=232.27 Aligned_cols=185 Identities=29% Similarity=0.450 Sum_probs=154.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe------CCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE------GAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~ 560 (679)
...|++.+.||+|+||.||+|+.. +++.+|+|.+........++..|+.+++++ +|+||+++++++.. .+..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 346777889999999999999975 488999999876555567788999999999 69999999999863 4577
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
+++|||+++++|.+++.... ...+++..+..++.||++||.|||+. +|+|+||+|+||++++++.++|+|||++.
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 99999999999999986543 34578888999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCceeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
....... ......|++.|+|||.+. +..++.++|||||
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvwsl 212 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHH
Confidence 6543221 123356889999999886 3457889999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=229.57 Aligned_cols=179 Identities=29% Similarity=0.404 Sum_probs=155.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
|+..+.||+|++|.||+|... +++.|++|.+.... ...+.+.+|++++++++|+||+++++++.+++..++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455678999999999999986 68999999885432 23467889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998643 3488999999999999999999999 999999999999999999999999999886544
Q ss_pred CCceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
.. ......++..|+|||.+.... ++.++|+|||
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~sl 188 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSL 188 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHH
Confidence 33 123456889999999987766 8999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=234.82 Aligned_cols=182 Identities=26% Similarity=0.363 Sum_probs=156.4
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.++||+|++|.||+|...+ ++.|+||+++.. ....+.+.+|++++++++|+||+++++++.+++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 46778899999999999999764 889999988653 23346789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
++++.+..++.. ...+++..+..++.||+.||+|||++ +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998777665533 23489999999999999999999999 99999999999999999999999999998766544
Q ss_pred ceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
........++..|+|||++.+. .++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~sl 188 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHH
Confidence 3223345678899999999888 78999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=234.46 Aligned_cols=181 Identities=25% Similarity=0.389 Sum_probs=151.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|++.+.||+|++|.||+|... +++.||||.+.... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4667789999999999999976 58999999986422 22345778999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++ +|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 86 DT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 85 9999886542 3588999999999999999999999 999999999999999999999999999875432221
Q ss_pred eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
. .....++..|+|||++.+ ..++.++|||||
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence 1 122346889999998876 457899999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=231.82 Aligned_cols=179 Identities=25% Similarity=0.328 Sum_probs=157.5
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.+.||.|+||.||+++.. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 567789999999999999986 48999999986422 3457789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++... ..+++..+..++.||++||.|||++ +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999998553 3589999999999999999999999 99999999999999999999999999988765432
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....++..|+|||.+.+..++.++|+|||
T Consensus 155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 185 (258)
T cd05578 155 L--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSL 185 (258)
T ss_pred c--ccccCCChhhcCHHHHcccCCCCcccchhh
Confidence 1 234568889999999988889999999996
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=236.32 Aligned_cols=180 Identities=23% Similarity=0.335 Sum_probs=151.8
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.++||+|++|.||+|+.. +|+.||+|+++... .....+.+|++++++++||||+++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566788999999999999976 48999999986422 22356788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 7 4788877543 24589999999999999999999999 999999999999999999999999999986543322
Q ss_pred eeeecccCccccccccccccCC-CCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
. .....+++.|+|||++.+.. ++.++|||||
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 186 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 186 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHH
Confidence 1 23345788999999987654 7899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=235.46 Aligned_cols=180 Identities=27% Similarity=0.347 Sum_probs=153.1
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
|++.+.||+|++|.||+|... +++.|+||+++.... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 556778999999999999975 589999999965332 2345778999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+ +++|.+++.... ..+++..+..++.||++||+|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 889999996532 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.... .....+++.|+|||.+.+ ..++.++|||||
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 189 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSV 189 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence 3221 233456788999998865 457899999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=231.96 Aligned_cols=183 Identities=27% Similarity=0.391 Sum_probs=150.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHH-HHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTT-IGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+++.+.||+|+||.||+++.. +++.||+|+++... .....+..|+.. ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 566788999999999999976 48999999987532 234456666665 55668999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++.........+++..++.++.||+.||+|||+++ +++||||||+||++++++.+||+|||++........
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 7 6888888654433456899999999999999999999852 799999999999999999999999999986543221
Q ss_pred eeeecccCcccccccccccc----CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN----NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+ ..++.++|+|||
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 193 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhh
Confidence 133467889999998865 446889999996
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=228.22 Aligned_cols=181 Identities=24% Similarity=0.419 Sum_probs=155.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||+|++|.||++... +++.+|||.+... ....+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 566788999999999999975 4889999998643 233567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcEEEeeccCCcccccCC
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~~~~~ 646 (679)
++++|.+++.... ...+++..+..++.|++++|+|||++ +++|+||+|+||+++++ +.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999996543 34589999999999999999999999 99999999999999855 468999999998765433
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ....++..|+|||.+.+..++.++|||||
T Consensus 157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (256)
T cd08220 157 KA--YTVVGTPCYISPELCEGKPYNQKSDIWAL 187 (256)
T ss_pred cc--cccccCCcccCchhccCCCCCcccchHHH
Confidence 21 23467889999999998889999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=229.35 Aligned_cols=181 Identities=33% Similarity=0.493 Sum_probs=156.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|.+.+.||+|++|.||++... +++.|++|.++.... ..+.+.+|++++++++|+||+++++.+.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 566789999999999999975 588999999875433 4577899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998642 3478899999999999999999999 999999999999999999999999999987654332
Q ss_pred ee---eecccCccccccccccccCC---CCcccceeeC
Q 046493 648 LV---YTTLRGTRGYLAPEWITNNP---ISEKSDVYSY 679 (679)
Q Consensus 648 ~~---~~~~~gt~~y~aPE~~~~~~---~s~~sDvwSl 679 (679)
.. .....+++.|+|||++.+.. ++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~ 192 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL 192 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHH
Confidence 21 11346788999999998766 8899999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=222.98 Aligned_cols=181 Identities=29% Similarity=0.330 Sum_probs=157.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.+++.+.||+|.||.|.+++-+ .++.+|+|++++.. .....-..|-++|+..+||.+..+-..++..++.|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 3467899999999999999965 48999999997632 233445678899999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|..||.|.-+|.+ .+.+++.....+-..|+.||.|||++ +||.||||.+|.|+|.+|.+||+|||+++.--..
T Consensus 249 yanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 249 YANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999888855 34588888888999999999999999 9999999999999999999999999999864333
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....+.+|||.|+|||++....|..++|.|.+
T Consensus 322 g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~ 354 (516)
T KOG0690|consen 322 G-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGV 354 (516)
T ss_pred c-ceeccccCChhhcCchhhccccccceeehhhh
Confidence 2 23467899999999999999999999999963
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=234.84 Aligned_cols=181 Identities=23% Similarity=0.297 Sum_probs=153.2
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
|++.+.||+|+||.||++.... ++.|++|.+.... ...+.+.+|+++++.++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 5667889999999999999764 7899999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999543 3589999999999999999999999 99999999999999999999999999987421110
Q ss_pred c--------------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 S--------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .......++..|+|||.+.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 0 00112457889999999988889999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=230.53 Aligned_cols=184 Identities=30% Similarity=0.517 Sum_probs=156.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-----CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHR 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 560 (679)
..+++.+.||+|+||.||+++.. .++.+|||.++.... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 44667789999999999999853 368899999976554 36789999999999999999999999887 5578
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999996543 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... .....++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl 198 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSF 198 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHH
Confidence 776332211 112345567999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=230.02 Aligned_cols=183 Identities=28% Similarity=0.462 Sum_probs=154.8
Q ss_pred hhhhhhcCcccceEEEEEEeCC--CcEEEEEEeccc-----------ccCHHHHHHHHHHHHh-hcCCCcceEEEEEEeC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESI-----------GQGKKEFSAEVTTIGN-VHHLHLVKLKGFCIEG 557 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~-----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 557 (679)
|++.+.||+|+||.||+|.... ++.+|+|.+... .....++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5667889999999999999765 688999987531 1123456778887765 6899999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeec
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 636 (679)
+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||++++++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999886543334568999999999999999999996 5 8999999999999999999999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|.+....... ......++..|+|||.+.+..++.++|||||
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 199 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAF 199 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHH
Confidence 9998765543 2244568899999999998889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=231.45 Aligned_cols=180 Identities=31% Similarity=0.424 Sum_probs=157.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+++.+.||+|++|.||++... +++.+++|++.... ...+++.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 3567789999999999999986 48899999986532 34467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
++++|.+++.... ..+++..+..++.|+++||+|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999986542 468899999999999999999999 7 99999999999999999999999999987654332
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ...++..|+|||.+.+..++.++|||||
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 185 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSL 185 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHH
Confidence 21 2568889999999999899999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=209.46 Aligned_cols=182 Identities=26% Similarity=0.374 Sum_probs=152.6
Q ss_pred hhhhhcCcccceEEEEEEeC-CCcEEEEEEecc--cccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES--IGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.-...||+|++|.|-+-++. +|...|+|+++. ..+..+...+|+.+..+- .+|.+|+++|...+....++.||.|.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 44578999999999888864 599999999975 345556778888876655 69999999999999999999999995
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
-+|+.+-.+.-..+..+++..+-+|+..+.+||.|||++ ..+||||+||+||||+.+|++||+|||.+-.+.+.-..
T Consensus 129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 488887665555577799999999999999999999998 48999999999999999999999999999877654322
Q ss_pred eeecccCcccccccccccc----CCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITN----NPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwSl 679 (679)
+...|-..|||||.+.. ..|+-+||||||
T Consensus 206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSL 238 (282)
T KOG0984|consen 206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSL 238 (282)
T ss_pred --HHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence 33568889999998854 358899999997
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=230.88 Aligned_cols=175 Identities=30% Similarity=0.393 Sum_probs=150.7
Q ss_pred cCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||+|+||+||++... +++.+|+|.+... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 4899999998642 22344567899999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence 99986543 24589999999999999999999999 999999999999999999999999999876543221 233
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..++..|+|||.+.+..++.++|||||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~sl 180 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFAL 180 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHH
Confidence 467889999999988889999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=229.37 Aligned_cols=178 Identities=33% Similarity=0.530 Sum_probs=146.1
Q ss_pred hhcCcccceEEEEEEeCC----CcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-CCeeeEEEeccC
Q 046493 496 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-GAHRLLAYEYLG 568 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 568 (679)
+.||+|+||.||+|...+ ...||+|++... ....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 457999988542 2234678899999999999999999998764 556789999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.... ...++..+..++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999986532 2367788899999999999999999 9999999999999999999999999999865432211
Q ss_pred e---eecccCccccccccccccCCCCcccceeeC
Q 046493 649 V---YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~---~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 188 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSF 188 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHH
Confidence 1 112345778999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=228.58 Aligned_cols=181 Identities=27% Similarity=0.378 Sum_probs=151.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 562 (679)
|+..+.||+|++|.||++... .+..|++|+++... .....+.+|+.++++++||||+++++++.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 456788999999999999975 48999999885421 1234688899999999999999999988763 56789
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
++||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++..
T Consensus 84 ~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999998642 3488999999999999999999998 9999999999999999999999999999765
Q ss_pred ccCCc--eeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .......++..|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence 43211 11123458889999999998889999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=229.46 Aligned_cols=181 Identities=29% Similarity=0.412 Sum_probs=155.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|++.++||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34667788999999999999865 58899999876422 3346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999999853 3488999999999999999999999 99999999999999999999999999987654432
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......++..|+|||.+.+..++.++|+|||
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 187 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187 (277)
T ss_pred h-hhccccCCccccChhhhccCCCCchhhHHHH
Confidence 1 1233467889999999988888999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-27 Score=203.41 Aligned_cols=100 Identities=44% Similarity=0.741 Sum_probs=69.1
Q ss_pred CCeEEEEeCCCCCCCCC---CceEEeeCCcEEEEeCCc-eeEEe-ccCCC--ceeEEEEecCCCEEEEccCCceeeecCC
Q 046493 79 SAKVVWTANRGLLIRDS---DKFVFEKNGNAYLQRGNG-EAWSA-NTSGQ--KVECMELQDSGNLVLLGVNGSILWQSFS 151 (679)
Q Consensus 79 ~~tvVWvANr~~p~~~~---~~~~~~~~g~lvl~~~~~-~vWst-~~~~~--~~~~a~LldsGNLVl~~~~~~~lWQSFD 151 (679)
++||||+|||+.|+... ..|.|+.||+|+|.+.++ .+|++ ++.+. ....|+|+|+|||||+|..+.++|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 47999999999999532 348999999999999886 69999 55543 4789999999999999999999999999
Q ss_pred CCccccCCCCccCCCc------eeecCCCCCCc
Q 046493 152 HPTDTLLPGQQFVEGM------RLKSFPNSNNM 178 (679)
Q Consensus 152 ~PTDTlLpgqkl~~~~------~l~S~~~~g~~ 178 (679)
|||||+||||+|+.+. .++|+.+..++
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDP 113 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS---
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCC
Confidence 9999999999997642 24555554444
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=229.85 Aligned_cols=184 Identities=27% Similarity=0.450 Sum_probs=156.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 565 (679)
|++.+.||.|++|.||++... +++.+|+|++.... ...+.+.+|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 566788999999999999865 57899999986422 234568889999999999999999998764 346789999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH-----EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
|+++++|.+++.........+++..++.++.||++||+||| +. +++|+||+|+||++++++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999999765444567999999999999999999999 66 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ .....+++.|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~sl 196 (265)
T cd08217 159 ILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSL 196 (265)
T ss_pred cccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHH
Confidence 76554321 234568999999999998889999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=230.45 Aligned_cols=181 Identities=26% Similarity=0.415 Sum_probs=154.0
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
|+..+.||+|++|.||+++.. +++.||+|.++.... ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 455678999999999999964 589999999864221 246788999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLM 642 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~ 642 (679)
+||+++++|.+++.+. .++++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .+||+|||.+...
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 82 VEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998642 3588999999999999999999999 999999999999998775 6999999999876
Q ss_pred ccCCce---eeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESL---VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 194 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHH
Confidence 543211 1123467889999999988889999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=227.11 Aligned_cols=173 Identities=29% Similarity=0.346 Sum_probs=151.9
Q ss_pred cCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||.|++|.||+++... ++.+++|++.... ...+.+.+|++++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999864 8999999986522 3346789999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.+. ..+++..+..++.||+.||+|||++ +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999653 3488999999999999999999998 99999999999999999999999999998765432 1123
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..+++.|+|||.+.+..++.++|+|||
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~sl 178 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSL 178 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhh
Confidence 467889999999988889999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=232.09 Aligned_cols=181 Identities=31% Similarity=0.504 Sum_probs=151.1
Q ss_pred hhcCcccceEEEEEEeCC-------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPD-------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.||+|++|.||+|+..+ ++.+++|.+.... ....++.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999999643 2579999886532 3456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-----cEEEeeccC
Q 046493 567 LGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-----TAKVSDFGL 638 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~DFg~ 638 (679)
+++++|.+++.+... ....+++.+++.++.|++.||+|||+. +++|+||||+||++++++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 124478999999999999999999998 999999999999999877 899999999
Q ss_pred CcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++........ ......++..|+|||.+.+..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 9765433211 1122345788999999998899999999996
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=231.66 Aligned_cols=181 Identities=24% Similarity=0.299 Sum_probs=152.9
Q ss_pred hhhhhhcCcccceEEEEEEe----CCCcEEEEEEecccc-----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeee
Q 046493 492 KNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESIG-----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 561 (679)
|++.+.||+|+||.||+++. .+++.||+|+++... ...+.+.+|+++++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45678899999999999986 368899999986421 2346678899999999 5999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+|+||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998642 3588999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCceeeecccCccccccccccccC--CCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
.............|+..|+|||.+.+. .++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl 194 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHH
Confidence 654332222345688999999998753 46789999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=228.20 Aligned_cols=177 Identities=28% Similarity=0.408 Sum_probs=149.3
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHh
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLD 573 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 573 (679)
..||+|+||.||+|++. ++..|++|.+.... ...+.+.+|++++++++|+||+++++++.+++..++++||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999965 47889999886533 34567899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccccCCceee
Q 046493 574 KWIFNSTEESRFL--SWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 574 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+++.... ..+ ++..+..++.||+.||+|||++ +|+||||||+||+++. ++.++|+|||++........ ..
T Consensus 94 ~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~ 166 (268)
T cd06624 94 ALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CT 166 (268)
T ss_pred HHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cc
Confidence 9996532 224 7888899999999999999999 9999999999999986 67999999999876543222 12
Q ss_pred ecccCccccccccccccCC--CCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNP--ISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~--~s~~sDvwSl 679 (679)
....+++.|+|||++.+.. ++.++|||||
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl 197 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHH
Confidence 2345789999999986643 7889999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=231.05 Aligned_cols=173 Identities=25% Similarity=0.432 Sum_probs=145.4
Q ss_pred hhcCcccceEEEEEEeCC--------CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.||+|+||.||+|.... ...+++|.+.... ...+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 2348888875432 3346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc--------EEEeeccC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--------AKVSDFGL 638 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kL~DFg~ 638 (679)
+++++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999996542 3588999999999999999999999 9999999999999987765 69999998
Q ss_pred CcccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+...... ....+++.|+|||++.+. .++.++|||||
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSF 191 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHH
Confidence 8754332 234578899999999864 57899999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=235.01 Aligned_cols=181 Identities=26% Similarity=0.375 Sum_probs=153.9
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.++||+|++|.||+|...+ ++.||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 35677899999999999999864 8999999886422 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.++... ...+++..++.++.||++||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999887643 23489999999999999999999999 99999999999999999999999999998654433
Q ss_pred ceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. ......++..|+|||++.+. .++.++|||||
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAV 187 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHH
Confidence 2 22334678899999988754 47889999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=232.02 Aligned_cols=182 Identities=32% Similarity=0.398 Sum_probs=154.8
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 566 (679)
+++.++||.|++|.||++.+. +++.+|+|.+.... .....+.+|++++++++||||+++++++.+. +..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 455688999999999999986 48899999986532 2456789999999999999999999998654 367999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.........+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999998765433345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....++..|+|||.+.+..++.++|||||
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 189 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSL 189 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHH
Confidence 1 23457889999999998899999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=231.46 Aligned_cols=181 Identities=24% Similarity=0.344 Sum_probs=150.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|.+.+.||+|+||.||+|... +++.|++|++.... .....+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 4667789999999999999875 58899999986532 33356788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++... ...+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 86 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 86 H-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred c-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 6 6777776443 23478888999999999999999999 999999999999999999999999999976433221
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. .....+++.|+|||++.+. .++.++|||||
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHH
Confidence 1 1234578899999998764 47889999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=234.88 Aligned_cols=184 Identities=30% Similarity=0.493 Sum_probs=150.8
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCc----EEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGI----QVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
...++..+.||+|+||.||+|... +++ .||+|.+..... ...++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 334556688999999999999864 343 578898865322 234688999999999999999999998754 467
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 899999999999998653 23588999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ .....++..|+|||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl 197 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHH
Confidence 65432211 122345678999999998899999999996
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=227.61 Aligned_cols=181 Identities=28% Similarity=0.393 Sum_probs=152.0
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc------ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI------GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 562 (679)
|++.+.||+|++|.||+++.. +++.|++|.+... ......+++|++++++++|+||+++++++.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 567789999999999999975 4899999987431 12335788999999999999999999998764 45789
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
++||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999998542 3478999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCc--eeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .......++..|+|||.+.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 195 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence 43211 11123468899999999998889999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=228.90 Aligned_cols=181 Identities=28% Similarity=0.413 Sum_probs=152.3
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----c-------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----Q-------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
|...+.||+|++|.||+|... +++.||+|.++... . ..+.+.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 445678999999999999865 58999999875311 1 12457889999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||+|+||++++++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998653 4588999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCce-eeecccCccccccccccccCC--CCcccceeeC
Q 046493 640 KLMNREESL-VYTTLRGTRGYLAPEWITNNP--ISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSl 679 (679)
......... ......++..|+|||.+.... ++.++|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~sl 198 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL 198 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHH
Confidence 865432211 123346889999999987654 7899999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=230.31 Aligned_cols=181 Identities=25% Similarity=0.318 Sum_probs=152.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 564 (679)
.|++.+.||+|++|.||+|... +++.+++|.++... .....+.+|+.++++++||||+++++++... +..++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5677889999999999999986 48899999986432 2234567899999999999999999999877 8899999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++ +|.+++.... ..+++..+..++.||++||+|||++ +++|+||||+||++++++.+||+|||++.....
T Consensus 86 e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99974 9988886532 3589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
... ......+++.|+|||.+.+.. ++.++|||||
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 193 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHH
Confidence 421 123345788999999987654 6899999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=231.44 Aligned_cols=181 Identities=27% Similarity=0.414 Sum_probs=157.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+|.+.+.||+|+||.||++... +++.|++|.+.. .....+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46777889999999999999864 578999999864 2334567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.+ ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999854 2478899999999999999999999 999999999999999999999999999876544332
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....+++.|+|||.+.+..++.++|||||
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 201 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHH
Confidence 1 233468889999999988889999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=228.55 Aligned_cols=182 Identities=28% Similarity=0.429 Sum_probs=159.1
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.|++.+.|++|++|.||++... ++..+++|+++......+.+.+|++++++++|+||+++++.+...+..++++||+++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 3566788999999999999987 588999999976444567789999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999997642 3689999999999999999999998 999999999999999999999999999876544322 1
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 202 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHH
Confidence 133457889999999988889999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=228.00 Aligned_cols=173 Identities=25% Similarity=0.339 Sum_probs=142.4
Q ss_pred hcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHh---hcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 497 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGN---VHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.||+|+||.||++... +++.+|+|.+.... .....+.+|..+++. .+||||+.+++++.+++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 48899999886432 112334445444433 479999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 99999988542 3589999999999999999999999 999999999999999999999999999875543221
Q ss_pred eeecccCccccccccccc-cCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWIT-NNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSl 679 (679)
....|+..|+|||.+. +..++.++|||||
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 182 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSL 182 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHH
Confidence 2346899999999886 4568899999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=231.39 Aligned_cols=184 Identities=26% Similarity=0.323 Sum_probs=151.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCe-----e
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAH-----R 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~ 560 (679)
.|++.+.||+|+||.||+|+.. +++.||||.++... .....+.+|+.++++++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 3566788999999999999976 58999999886532 23467888999999995 6999999999987665 7
Q ss_pred eEEEeccCCCCHhHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccC
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEE-SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGL 638 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~ 638 (679)
+++|||+++ +|.+++...... ...+++..++.++.||++||.|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999986 898888654322 35689999999999999999999999 9999999999999998 88999999999
Q ss_pred CcccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
++........ .....+++.|+|||++.+ ..++.++|||||
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 198 (295)
T cd07837 158 GRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV 198 (295)
T ss_pred ceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence 9865433221 122356888999998865 457899999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=226.54 Aligned_cols=185 Identities=26% Similarity=0.381 Sum_probs=158.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|++.+.||.|++|+||+|... ++..+++|++... ....+.+.+|++.++.++|+||+++++.+.+++..++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 3667889999999999999965 5789999998642 234577899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..+.....
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 82 SGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred CCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999965432 24589999999999999999999999 999999999999999999999999999877654332
Q ss_pred e---eeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 L---VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. ......++..|+|||.+... .++.++|+|||
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 2 11334688999999998776 78999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=226.68 Aligned_cols=180 Identities=30% Similarity=0.422 Sum_probs=159.1
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+++.+.||+|++|.||+++... ++.|+||++.... .....+.+|++.+.+++|+||+++++++...+..++++||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 5667899999999999999875 8999999987643 346789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+++|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999653 458999999999999999999999 8 999999999999999999999999999987654433
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ....++..|+|||.+.+..++.++|||||
T Consensus 156 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 186 (264)
T cd06623 156 QC-NTFVGTVTYMSPERIQGESYSYAADIWSL 186 (264)
T ss_pred cc-cceeecccccCHhhhCCCCCCchhhHHHH
Confidence 21 24467899999999998889999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=233.41 Aligned_cols=178 Identities=25% Similarity=0.332 Sum_probs=152.2
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCH---------HHHHHHHHHHHhhc---CCCcceEEEEEEeCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGK---------KEFSAEVTTIGNVH---HLHLVKLKGFCIEGA 558 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~---------~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 558 (679)
|...+++|.|+||.|+.+.++. ...|+||.+.+...-. -..-.|+++|..|+ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4556789999999999999875 6789999886533211 22456999999997 999999999999999
Q ss_pred eeeEEEeccC-CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 559 HRLLAYEYLG-NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 559 ~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
.+||+||-.. +.+|.++|.. ...+++.++..|++||+.|+++||++ +|||||||-+||.++.+|-+||+|||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 9999999764 5688898854 44699999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCC-cccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSl 679 (679)
.+....... ...++||..|.|||++.|.+|- ..-|||+|
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 998765543 4567899999999999998874 66799986
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=233.49 Aligned_cols=184 Identities=22% Similarity=0.327 Sum_probs=152.0
Q ss_pred hhhhhhcCcccceEEEEEEeCC---CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 562 (679)
|++.++||+|++|.||+|.... ++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5667889999999999999754 7899999987522 2345678899999999999999999999988 78999
Q ss_pred EEeccCCCCHhHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC----CCcEEEeecc
Q 046493 563 AYEYLGNGSLDKWIFNSTEE-SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD----NFTAKVSDFG 637 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~DFg 637 (679)
||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 677766543322 23689999999999999999999999 9999999999999999 9999999999
Q ss_pred CCcccccCCce--eeecccCccccccccccccC-CCCcccceeeC
Q 046493 638 LAKLMNREESL--VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
++......... ......++..|+|||.+.+. .++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 202 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence 99876443221 12234678899999988764 57899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=226.58 Aligned_cols=179 Identities=27% Similarity=0.405 Sum_probs=154.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e 565 (679)
|++.+.||+|++|.||+|+.. +++.|++|.++.. ....+++.+|+.++++++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 566788999999999999974 5899999998642 334567889999999997 9999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... .+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988532 588999999999999999999999 9999999999999999999999999999876554
Q ss_pred CceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
... .....|+..|+|||.+.+. .++.++|||||
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSL 188 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHH
Confidence 322 2334688999999988654 57899999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-27 Score=230.28 Aligned_cols=187 Identities=27% Similarity=0.330 Sum_probs=160.3
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCC
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGA 558 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 558 (679)
+.+....++|..+||+|+||.|.++.-+. .+.+|||++++.. .+.+--+.|-++|+.. +-|.+++++.++++-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 45566678899999999999999999765 6789999997632 3344456777888776 5789999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
.+|+||||+.||+|--++++. ..+.+..+.-++..|+-||-+||++ +||.||||.+|||+|.+|.+||+|||+
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred heeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence 999999999999999888653 3478888999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++.---.. ....+..|||.|+|||++..++|+..+|.|||
T Consensus 497 cKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~ 536 (683)
T KOG0696|consen 497 CKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 536 (683)
T ss_pred ccccccCC-cceeeecCCCcccccceEEecccccchhHHHH
Confidence 98643322 23466899999999999999999999999996
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=228.15 Aligned_cols=182 Identities=26% Similarity=0.404 Sum_probs=153.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
|++.++||.|++|.||+|+.. +++.||||+++... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 566789999999999999986 48899999986532 234667889999999999999999999999999999999998
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 5 88888865432 34589999999999999999999999 999999999999999999999999999976543321
Q ss_pred eeecccCccccccccccccC-CCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
......++..|+|||.+.+. .++.++|||||
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV 187 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHH
Confidence 11334578899999988664 46889999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=239.11 Aligned_cols=183 Identities=29% Similarity=0.443 Sum_probs=162.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe-----CCeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE-----GAHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv 563 (679)
+.+|.+.||.|.+|.||+++.. +++.+|+|++.......++++.|.++++.. .|||++.+++++.. ++.++||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 3567889999999999999954 589999999988888889999999999998 59999999999874 5688999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
||||.+|+..+++.... +..+.|+.+..|++.++.||.+||.+ .++|||||-.|||++.++.+||.|||++..+.
T Consensus 100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 99999999999998765 66799999999999999999999999 99999999999999999999999999998776
Q ss_pred cCCceeeecccCccccccccccccC-----CCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNN-----PISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwSl 679 (679)
..... ..+..||+.|||||++.-. .|+.++|+|||
T Consensus 175 sT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsL 214 (953)
T KOG0587|consen 175 STVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSL 214 (953)
T ss_pred ccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhc
Confidence 65443 3567899999999998643 37789999997
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=229.39 Aligned_cols=181 Identities=27% Similarity=0.365 Sum_probs=152.3
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|+..+.||.|++|.||+|+.. +++.||||+++... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 456688999999999999976 48999999886432 23357889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
. ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 6 58988886533 34589999999999999999999999 999999999999999999999999999876543321
Q ss_pred eeeecccCccccccccccccCC-CCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
. .....+++.|+|||.+.+.. ++.++|||||
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 187 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHH
Confidence 1 22345688999999887654 6889999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=226.38 Aligned_cols=176 Identities=28% Similarity=0.450 Sum_probs=152.6
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
.+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 468999999999999964 58899999886432 3345688999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||.+......... ...
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-ccc
Confidence 999854 3488999999999999999999999 9999999999999999999999999988765433221 123
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..|++.|+|||.+.+..++.++|||||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~sl 201 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSL 201 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHH
Confidence 468899999999988889999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=227.36 Aligned_cols=176 Identities=27% Similarity=0.440 Sum_probs=152.2
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
..+||+|++|.||++... +++.||||++.... .....+.+|+.++++++|+||+++++.+..++..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 58999999986432 3456688999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......... ...
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc-ccc
Confidence 998743 2478999999999999999999999 9999999999999999999999999998765433211 133
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..+++.|+|||.+.+..++.++|+|||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~sl 202 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSL 202 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHH
Confidence 468899999999988888999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=221.08 Aligned_cols=180 Identities=29% Similarity=0.488 Sum_probs=158.7
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
|++.+.||+|++|.||++... +++.+++|++..... ..+.+.+|++++++++|+||+++++++..++..++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 455678999999999999986 588999999976433 567899999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 82 GSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999986532 4589999999999999999999998 999999999999999999999999999987665432
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....++..|+|||.+.+..++.++|||||
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 183 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSL 183 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHH
Confidence 234568899999999988889999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=222.70 Aligned_cols=184 Identities=29% Similarity=0.472 Sum_probs=160.5
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||.|++|.||++... ++..+++|++.... ...+.+.+|++++++++|+|++++++.+..++..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 556788999999999999976 48899999986532 34567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.........+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99999999976543346799999999999999999999999 999999999999999999999999999987655431
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......+++.|+|||.+.+..++.++|+|||
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 189 (258)
T cd08215 159 -LAKTVVGTPYYLSPELCQNKPYNYKSDIWSL 189 (258)
T ss_pred -eecceeeeecccChhHhccCCCCccccHHHH
Confidence 2233568889999999988889999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=224.62 Aligned_cols=173 Identities=25% Similarity=0.344 Sum_probs=142.7
Q ss_pred hcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHH---HHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 497 KLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTT---IGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.||+|+||.||+++.. +++.||+|.+.... .....+..|..+ ++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999975 48899999886422 112234445444 344579999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998854 34589999999999999999999999 999999999999999999999999999876543221
Q ss_pred eeecccCccccccccccccC-CCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
....|+..|+|||.+.+. .++.++|||||
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~ 182 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSL 182 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhH
Confidence 234689999999998754 68999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=225.26 Aligned_cols=175 Identities=27% Similarity=0.367 Sum_probs=151.6
Q ss_pred cCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||+|++|.||+++... ++.+++|.+.... ...+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 8999999986532 2456788999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc-----
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES----- 647 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~----- 647 (679)
.+++.+. ..+++..+..++.||++||+|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998653 2589999999999999999999999 999999999999999999999999999876543311
Q ss_pred --eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 --LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......++..|+|||.+.+...+.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 187 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSL 187 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHH
Confidence 11233567889999999988888999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=235.10 Aligned_cols=179 Identities=27% Similarity=0.297 Sum_probs=151.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------C
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------A 558 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 558 (679)
..+|++.+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 456777889999999999999975 5899999998642 22345677899999999999999999988643 3
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 56999999964 88887732 288899999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++....... .....+++.|+|||.+.+..++.++|||||
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 203 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence 987654322 233467889999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=227.96 Aligned_cols=178 Identities=30% Similarity=0.416 Sum_probs=150.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|.+.++||+|++|.||+|+.. +++.||+|++.... ...+++.+|+++++.++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777889999999999999975 48999999885422 22356889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||++ ++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5777766433 23589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
. ....+++.|+|||++. ...++.++|||||
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~ 200 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHH
Confidence 2 2345788999999874 3568899999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=227.69 Aligned_cols=181 Identities=25% Similarity=0.355 Sum_probs=153.4
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 565 (679)
|++.++||+|++|.||+|+..+ ++.+|+|++... ......+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 3456789999999999999764 889999999764 23345688999999999999999999999988 78999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++ +|.+++... ...+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888887543 24589999999999999999999999 9999999999999999999999999999877654
Q ss_pred CceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.........++..|+|||.+.+. .++.++|||||
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 188 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSV 188 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHH
Confidence 33223344578899999987653 57899999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=225.39 Aligned_cols=184 Identities=27% Similarity=0.421 Sum_probs=149.8
Q ss_pred hhhhhcCcccceEEEEEEeC----CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------e
Q 046493 493 NFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------H 559 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 559 (679)
.+.+.||+|+||.||+|.+. .++.||||+++... ...+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999853 36889999986532 23456889999999999999999999887543 2
Q ss_pred eeEEEeccCCCCHhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTE--ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
.++++||+++++|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 3688999999999988754321 123478999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.++........ ......+++.|++||.+.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~sl 201 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHH
Confidence 99866433221 1122345678999999988889999999996
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=224.94 Aligned_cols=182 Identities=29% Similarity=0.463 Sum_probs=155.7
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|.+.+.||+|++|.||++.... +..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+.+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 4567889999999999999764 889999998642 234567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCcccccCC
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREE 646 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~ 646 (679)
++++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999986532 33579999999999999999999999 999999999999999885 46999999998765432
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....|++.|+|||++.+..++.++|+|||
T Consensus 157 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 188 (257)
T cd08225 157 EL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSL 188 (257)
T ss_pred cc-ccccCCCccccCHHHHcCCCCCchhhHHHH
Confidence 21 233468899999999988889999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=225.21 Aligned_cols=182 Identities=30% Similarity=0.465 Sum_probs=158.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.++||+|++|.||+++.. +++.+++|.+.... ....++.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 566788999999999999865 57899999986532 33456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.+.......+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 99999999876444445689999999999999999999999 99999999999999999999999999998765542
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||.+.+..++.++|+|||
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl 187 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHH
Confidence 223467889999999999889999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=250.27 Aligned_cols=180 Identities=29% Similarity=0.445 Sum_probs=144.2
Q ss_pred hhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------------
Q 046493 493 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------------ 557 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------ 557 (679)
+..+.||+||||.||+++.+ ||+.+|||++.... .....+.+|++.+++|+|||||+++..+.+.
T Consensus 482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 33468999999999999976 79999999997643 3345688999999999999999998543210
Q ss_pred --------------------------------------------------------------------------------
Q 046493 558 -------------------------------------------------------------------------------- 557 (679)
Q Consensus 558 -------------------------------------------------------------------------------- 557 (679)
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence
Q ss_pred ---------------------------CeeeEEEeccCCCCHhHHhhccCCCCCCC-CHHHHHHHHHHHHHHHHHHhcCC
Q 046493 558 ---------------------------AHRLLAYEYLGNGSLDKWIFNSTEESRFL-SWNTRFNIALGMAKGLAYLHEEC 609 (679)
Q Consensus 558 ---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~i~~~L~yLH~~~ 609 (679)
..+||-||||+..+|.+++.++. .. .....++++++|++||+|+|++
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH~~- 716 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIHDQ- 716 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHHhC-
Confidence 11367789998878888775532 12 4677899999999999999999
Q ss_pred CCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc----c-------------CCceeeecccCccccccccccccCC---
Q 046493 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN----R-------------EESLVYTTLRGTRGYLAPEWITNNP--- 669 (679)
Q Consensus 610 ~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~~--- 669 (679)
+||||||||.||+++++..+||+|||+|.... . ......+..+||.-|+|||++.+..
T Consensus 717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 99999999999999999999999999998721 0 0011234578999999999997654
Q ss_pred CCcccceeeC
Q 046493 670 ISEKSDVYSY 679 (679)
Q Consensus 670 ~s~~sDvwSl 679 (679)
|+.|+|+|||
T Consensus 795 Yn~KiDmYSL 804 (1351)
T KOG1035|consen 795 YNSKIDMYSL 804 (1351)
T ss_pred ccchhhhHHH
Confidence 9999999996
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=210.55 Aligned_cols=179 Identities=25% Similarity=0.396 Sum_probs=148.9
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEeccccc--CHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
++...||+|..|+|++.+... |..+|||.+..... +.+.+.+.++++.+-+ .|.||+.+|+|..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 345679999999999999765 89999999976443 3456777888877765 8999999999999999999999984
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
- -++.++.+- .+++++..+-++...+++||.||.++ .+|+|||+||+|||+|+.|++||+|||.+-.+.+...
T Consensus 175 ~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 175 T-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred H-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 3 455555443 45688999999999999999999987 4999999999999999999999999999987765443
Q ss_pred eeecccCccccccccccccC---CCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNN---PISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSl 679 (679)
.+...|-+.|||||.+.-. .|+.++|||||
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 3556799999999998643 58889999997
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=227.81 Aligned_cols=186 Identities=28% Similarity=0.387 Sum_probs=153.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC----
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA---- 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 558 (679)
.....|++.+.||+|++|.||+|.... ++.||+|+++.. ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 344567788999999999999999864 889999998642 233456788999999999999999999987655
Q ss_pred ------eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 559 ------HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 559 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 777766443 23589999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
|+|||++...............++..|+|||.+.+. .++.++|||||
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 999999987654432222333567889999988654 57899999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=234.88 Aligned_cols=185 Identities=28% Similarity=0.454 Sum_probs=158.6
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC--C--cEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD--G--IQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
+....+.++||+|.||.|++|.+.. | ..||||.++... ....+|.+|+.+|.+|+|+|+++++|+..+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3444567889999999999999763 3 468999997643 356889999999999999999999999988 67789
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|+|.++.|+|.+.|++. ....+-......++.|||.||.||.++ ++|||||..+|+||-....+||+|||+.+.+
T Consensus 188 V~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999772 245577888899999999999999999 9999999999999999999999999999988
Q ss_pred ccCCcee-eec-ccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLV-YTT-LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~-~~~-~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+... ... ..-...|.|||.+....++.+||||+|
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmy 301 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMY 301 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhh
Confidence 7765542 111 234668999999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=220.32 Aligned_cols=180 Identities=30% Similarity=0.415 Sum_probs=157.7
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.+.||+|++|.||+++.. +++.|++|.+.... ...+.+.+|++++++++|+|++++++++.+++..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 566789999999999999876 47899999997644 34567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998653 4589999999999999999999999 999999999999999999999999999987655432
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....++..|+|||.+.+..++.++|||||
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~l 185 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSL 185 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHH
Confidence 2 233467889999999988888999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=226.75 Aligned_cols=182 Identities=25% Similarity=0.351 Sum_probs=149.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|++.++||+|++|.||+|+.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 3567789999999999999976 58899999886432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccccC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~ 645 (679)
++ ++|.+++.... ...+++..+..++.||+.||+|||++ +++|+||+|+||++++ ++.+||+|||++......
T Consensus 83 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 83 LD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 96 57877775432 23467888899999999999999999 9999999999999985 567999999999765432
Q ss_pred CceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.. ......+++.|+|||.+.+. .++.++|||||
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 190 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence 21 12334578899999988664 57899999996
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=254.78 Aligned_cols=178 Identities=31% Similarity=0.420 Sum_probs=151.8
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
..+||.|.||.||-+... +|+..|+|.++- .....+...+|+.++..++|||+|+++|+=.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 357999999999999965 489999998753 2334567889999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc---
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES--- 647 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~--- 647 (679)
+|.+.+... +..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1320 sLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999998653 3466777778889999999999999 999999999999999999999999999988765421
Q ss_pred eeeecccCccccccccccccCC---CCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNP---ISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwSl 679 (679)
.......||+.|||||++.+.. ...++|||||
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWsl 1427 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSL 1427 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcc
Confidence 1223468999999999997653 5678999996
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=228.56 Aligned_cols=181 Identities=28% Similarity=0.345 Sum_probs=150.1
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 564 (679)
.|++.+.||+|++|.||+|... +++.||+|+++... .....+.+|++++++++|+||+++++++.+. +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4667788999999999999976 48999999986422 1234567899999999999999999998765 4679999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++ +|.+++... ...+++.++..++.||++||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 88 e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 88 EYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred ecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99975 888888653 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.... .....+++.|+|||.+.+ ..++.++|||||
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 195 (309)
T cd07845 161 PAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAV 195 (309)
T ss_pred ccCC-CCcccccccccChhhhcCCCCcCchHHHHHH
Confidence 3221 123345788999999865 457899999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=189.86 Aligned_cols=107 Identities=36% Similarity=0.609 Sum_probs=92.6
Q ss_pred CcEEEeCCCeeEEEEEeCCCCc-eEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEEEeCCc-eeEEeccCC-C
Q 046493 47 GLFLISNNSVFGFGFYTALDVQ-FFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNG-EAWSANTSG-Q 123 (679)
Q Consensus 47 ~~~l~S~~g~F~lGFf~~~~~~-~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl~~~~~-~vWst~~~~-~ 123 (679)
+..|+|++|.|++|||++.... .+.++|+....+++||+|||+.|...+..+.|..||+|+|.+.++ .+|+|++.+ .
T Consensus 7 ~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~ 86 (116)
T cd00028 7 GQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVN 86 (116)
T ss_pred CCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccCCC
Confidence 4456999999999999987776 888888875547899999999985544558999999999998777 799999875 5
Q ss_pred ceeEEEEecCCCEEEEccCCceeeecCCCC
Q 046493 124 KVECMELQDSGNLVLLGVNGSILWQSFSHP 153 (679)
Q Consensus 124 ~~~~a~LldsGNLVl~~~~~~~lWQSFD~P 153 (679)
....|+|+|+|||||++.++.++|||||||
T Consensus 87 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 87 GNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=224.79 Aligned_cols=181 Identities=27% Similarity=0.369 Sum_probs=152.3
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|++.++||.|++|.||+|... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 356788999999999999975 58999999986432 23456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++.... ...+++..+..++.|+++||+|||++ +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68999886543 23589999999999999999999999 999999999999999999999999999976543321
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. .....++..|+|||++.+. .++.++|||||
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 186 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSI 186 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHH
Confidence 1 1233568899999988664 57889999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=221.12 Aligned_cols=172 Identities=30% Similarity=0.326 Sum_probs=144.5
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEeccccc----CHHHHHHHHHHH-HhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTTI-GNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+.||+|++|.||+|... +++.||||.++.... ....+..|..++ ...+|+||+++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999975 488999999865321 122344454443 445899999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 9999998643 3588999999999999999999999 9999999999999999999999999998754331
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....++..|+|||.+.+..++.++|||||
T Consensus 151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 179 (260)
T cd05611 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSL 179 (260)
T ss_pred -ccCCCCcCccChhhhcCCCCcchhhhHHH
Confidence 23467889999999988888999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=220.63 Aligned_cols=194 Identities=28% Similarity=0.370 Sum_probs=159.6
Q ss_pred CcCHHHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--------cCHHHHHHHHHHHHhhcCCCcceEE
Q 046493 481 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--------QGKKEFSAEVTTIGNVHHLHLVKLK 551 (679)
Q Consensus 481 ~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~ 551 (679)
.|.-.-+...+|-+...||+|+|+.||++.+- ..+.||||+-.... .-.+...+|.++-+.|.||.||+++
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 34445567788888999999999999999954 58899999764321 1224467899999999999999999
Q ss_pred EEEE-eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---C
Q 046493 552 GFCI-EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---D 627 (679)
Q Consensus 552 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~ 627 (679)
+++. +.+..|-|+||++|.+|+-||.. .+.+++.++..|+.||+.||.||.+. .++|||-||||.|||+. .
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence 9987 55678899999999999999965 45699999999999999999999996 67899999999999995 4
Q ss_pred CCcEEEeeccCCcccccCCce------eeecccCccccccccccccC----CCCcccceeeC
Q 046493 628 NFTAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNN----PISEKSDVYSY 679 (679)
Q Consensus 628 ~~~~kL~DFg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwSl 679 (679)
-|.+||+|||+++.+..+... ..+...||..|++||.+.-+ +++.|+||||.
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 578999999999998765332 12346799999999977432 47899999984
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=227.52 Aligned_cols=182 Identities=25% Similarity=0.326 Sum_probs=149.1
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC--------
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-------- 558 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 558 (679)
.|++.++||+|++|.||+++.. +++.||||++... ......+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4777889999999999999976 4899999988542 222345678999999999999999999987654
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..++||||+++ +|.+++... ...+++.++..++.||++||+|||++ +++|+||||+||++++++.+||+|||+
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999974 888877543 23589999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCce---eeecccCccccccccccccC-CCCcccceeeC
Q 046493 639 AKLMNREESL---VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+......... ......++..|+|||.+.+. .++.++|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 9866443221 11234578899999988765 47889999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=225.89 Aligned_cols=181 Identities=26% Similarity=0.311 Sum_probs=152.6
Q ss_pred hhhhhhcCcccceEEEEEEeC----CCcEEEEEEeccc-----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeee
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 561 (679)
|++.+.||+|++|.||+++.. +++.||||.++.. ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456788999999999999843 4788999998642 12345678999999999 5999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++... ..+++..+..++.|++++|.|||+. +++||||+|+||++++++.++|+|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998542 3588999999999999999999998 999999999999999999999999999886
Q ss_pred cccCCceeeecccCccccccccccccCC--CCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNP--ISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSl 679 (679)
.............++..|+|||.+.+.. ++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl 194 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHH
Confidence 5544322223346889999999987665 7889999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=214.12 Aligned_cols=173 Identities=26% Similarity=0.284 Sum_probs=147.8
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe----CCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE----GAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~ 569 (679)
++||-|-.|.|-.+..+ .++.+|+|++.+ ....++|+++--+. .|||||.+++++.. ...+++|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhc----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 67999999999999876 489999999875 33457888876555 59999999999864 3467899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---CCCcEEEeeccCCcccccCC
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~~~~ 646 (679)
|.|...+++.. ...+++.++-.|++||..|+.|||+. +|.||||||+|+|.. .+-.+||+|||+|+.-....
T Consensus 144 GeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 144 GELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred hHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 99999887654 45699999999999999999999999 999999999999996 45579999999999765433
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+.+-|+.|.|||++..++|+...|+||+
T Consensus 219 --~L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 219 --DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred --cccCCcccccccCHHHhCchhcCCCCCccch
Confidence 2356678999999999998999999999996
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=218.78 Aligned_cols=190 Identities=24% Similarity=0.343 Sum_probs=165.0
Q ss_pred CCcCHHHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcC--C----CcceEEE
Q 046493 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHH--L----HLVKLKG 552 (679)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~ 552 (679)
..+...|....+|.+.+.+|+|.||.|-++.+.. +..||||+++......+..+-|+++++++.+ | -++++.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 4567778888999999999999999999999765 7899999999877777888899999999942 2 3888889
Q ss_pred EEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-----
Q 046493 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD----- 627 (679)
Q Consensus 553 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~----- 627 (679)
++...++.+||+|.+ |.++.++|..+. ..+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 999999999999998 569999997654 55688999999999999999999999 9999999999999931
Q ss_pred ---------------CCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 628 ---------------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 628 ---------------~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+..+||+|||.|....... +..+.|..|.|||++.+-.++.++||||+
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceee
Confidence 3368999999998765544 45678999999999999999999999996
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=226.73 Aligned_cols=182 Identities=28% Similarity=0.449 Sum_probs=156.8
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 564 (679)
.|.+.+.||+|++|.||+++.. +++.|++|++... ....+.+.+|++++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 3567788999999999999976 5899999998652 233467888999999998 999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|++++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 82 EYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999653 3599999999999999999999999 999999999999999999999999999886544
Q ss_pred CCc-------------------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EES-------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .......++..|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl 208 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWAL 208 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHH
Confidence 321 11223457889999999988889999999985
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=226.68 Aligned_cols=185 Identities=25% Similarity=0.330 Sum_probs=155.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecc---cccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLES---IGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 562 (679)
+....|++.++||+||.+.||++...+.+.+|+|++.. +.+...-|.+|+..|.+|+ |.+|+++++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45667888999999999999999998888899988754 3344567999999999996 9999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||= ..+|..+|..... ....| .+..+..||+.|+.++|++ +|||.||||.|+|+- .|.+||+|||.|..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99986 4699999976432 22223 7788999999999999999 999999999999987 469999999999988
Q ss_pred ccCCce-eeecccCccccccccccccC-----------CCCcccceeeC
Q 046493 643 NREESL-VYTTLRGTRGYLAPEWITNN-----------PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwSl 679 (679)
..+... ....++||+.||+||.+... ++++++|||||
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSL 558 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSL 558 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhh
Confidence 766543 33558999999999988532 25689999996
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=225.65 Aligned_cols=178 Identities=29% Similarity=0.404 Sum_probs=150.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..+...+.||+|+||.||+++.. ++..+|+|++.... .....+.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 33566788999999999999975 58899999986422 22346888999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++ +|.+++... ...+++.++..++.|++.||.|||++ +|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 777776543 34589999999999999999999999 999999999999999999999999999875443
Q ss_pred CCceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
. ....+++.|+|||++. .+.++.++|||||
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl 210 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHH
Confidence 2 2346788999999874 4568899999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=219.52 Aligned_cols=172 Identities=24% Similarity=0.266 Sum_probs=142.8
Q ss_pred hhhhhh--cCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTK--LGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~--Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+++.+. ||+|+||.||+++.+ +++.+|+|.+........ |+.....+ +||||+++++.+...+..++||||+
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 344454 599999999999975 488899999865322211 22222223 6999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCcccccCC
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREE 646 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~ 646 (679)
++++|.+++... ..+++.++..++.||++||.|||+. +++||||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 164 (267)
T PHA03390 92 KDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence 999999998653 2689999999999999999999999 999999999999999988 99999999987654332
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...++..|+|||++.+..++.++|||||
T Consensus 165 -----~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 165 -----CYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred -----cCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 2357899999999998889999999996
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=228.67 Aligned_cols=183 Identities=27% Similarity=0.403 Sum_probs=151.5
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC--Cee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG--AHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 560 (679)
....|++.+.||+|+||.||+|.+. +++.+|||++... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3456788899999999999999976 4889999988542 23345677899999999 999999999998754 367
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5998888542 578899999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCc----eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 641 LMNREES----LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
....... .......++..|+|||.+.+ ..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 6644322 12233568899999998765 457889999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=219.16 Aligned_cols=181 Identities=31% Similarity=0.433 Sum_probs=158.1
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 565 (679)
|...+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++.+++++|+||+++++.+.+. +..++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 445678999999999999986 58999999986543 3467789999999999999999999999988 88999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 82 YVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998653 2689999999999999999999998 9999999999999999999999999999877654
Q ss_pred Cce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......++..|+|||.+.+...+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 189 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSL 189 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHH
Confidence 321 1234568899999999988889999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=223.69 Aligned_cols=183 Identities=30% Similarity=0.395 Sum_probs=148.4
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc--cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+++.++||+|+||.||++.... ++.+|+|++.... .....+.+|+.++.++. |+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 4456789999999999999764 8999999986532 34567889999999996 999999999999999999999998
Q ss_pred CCCCHhHHhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 568 GNGSLDKWIFN-STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 568 ~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+. +|.++... .......+++..+..++.|++.||+|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 64 66554321 111134689999999999999999999973 289999999999999999999999999997654332
Q ss_pred ceeeecccCccccccccccccC---CCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNN---PISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSl 679 (679)
. .....+++.|+|||++.+. .++.++|||||
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 196 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL 196 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHH
Confidence 1 1234678999999998776 68999999996
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=221.53 Aligned_cols=178 Identities=25% Similarity=0.346 Sum_probs=147.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeC--CeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEG--AHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 565 (679)
|++.++||+|++|.||+|+.. +++.||+|+++.. ........+|+.+++++. |+||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 356788999999999999975 5889999998653 222334557888999885 99999999999987 88999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 4887777543 24589999999999999999999999 9999999999999999 99999999999876443
Q ss_pred CceeeecccCccccccccccc-cCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWIT-NNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSl 679 (679)
.. .....++..|+|||.+. +..++.++|||||
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAV 185 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHH
Confidence 22 12345788999999764 4557889999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=226.55 Aligned_cols=179 Identities=22% Similarity=0.283 Sum_probs=145.9
Q ss_pred hhcCcc--cceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQG--GFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..||+| ++++||++++. +++.||+|++..... ..+.+++|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457776 89999999975 589999999864322 236688899999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987643 23488999999999999999999998 99999999999999999999999998654332211100
Q ss_pred ------eecccCccccccccccccC--CCCcccceeeC
Q 046493 650 ------YTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 650 ------~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
.....++..|+|||++.+. .++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence 0112346679999999764 47899999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=223.02 Aligned_cols=180 Identities=31% Similarity=0.461 Sum_probs=151.7
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccccc--CHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEecc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
|.+.+.||+|++|.||+|+..+ ++.|+||++..... ......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 3567889999999999999864 78999999865332 2334567999999999 999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+++|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789988886543 34689999999999999999999999 999999999999999999999999999986644322
Q ss_pred eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.....++..|+|||++.+ ..++.++|+|||
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~ 185 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhH
Confidence 233467889999998754 457899999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=221.05 Aligned_cols=180 Identities=26% Similarity=0.393 Sum_probs=150.6
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhh---cCCCcceEEEEEEeCCe-----
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNV---HHLHLVKLKGFCIEGAH----- 559 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 559 (679)
|++.+.||+|++|.||+|+... ++.+|+|+++... .....+.+|+.+++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 3456789999999999999875 8999999996422 1234566788877766 59999999999998776
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8988886533 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... ....++..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~ 192 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSV 192 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhH
Confidence 876544321 23457889999999998889999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=230.42 Aligned_cols=181 Identities=25% Similarity=0.403 Sum_probs=149.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 561 (679)
..|++.++||+|++|.||+|+.. +++.||||+++.. ......+.+|+.++++++|+||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 35677889999999999999865 5899999998642 223456788999999999999999999876543 579
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+++||+++ +|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 85 IVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999975 88777643 3589999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCce--eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 642 MNREESL--VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
....... ......|++.|+|||.+.+ ..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 196 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV 196 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence 5433211 1123467899999998754 468899999995
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=227.98 Aligned_cols=178 Identities=25% Similarity=0.312 Sum_probs=148.0
Q ss_pred hhhhcCcccceEEEEEEeC-CCcEEEEEEecccccC---------------HHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 494 FSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---------------KKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 494 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
+.+.||+|++|+||+|+.. +++.||||+++..... ...+.+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4567999999999999976 5899999988643221 12477899999999999999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
+..+++|||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence 99999999997 589988854 33589999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCC-------------ceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 638 LAKLMNREE-------------SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
++....... ........+++.|+|||.+.+. .++.++|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 998665111 0111223467889999998764 46899999996
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=222.40 Aligned_cols=184 Identities=26% Similarity=0.391 Sum_probs=151.9
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecc------cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES------IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+|.+.++||+|++|.||+++... +..+++|.++. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36678899999999999998754 44455555543 122334577899999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
+||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876444456799999999999999999999999 9999999999999975 569999999987764
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......+++.|+|||.+.+..++.++|+|||
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 191 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSL 191 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence 4322 1234567889999999988888999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=224.90 Aligned_cols=181 Identities=18% Similarity=0.169 Sum_probs=147.9
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.+.+.+|.|+++.|++++. +++.||||++... ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666655 6899999998653 23446789999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 648 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~- 648 (679)
++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999997543 23588999999999999999999999 9999999999999999999999999988755332110
Q ss_pred -----eeecccCccccccccccccC--CCCcccceeeC
Q 046493 649 -----VYTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 649 -----~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
......++..|+|||++.+. .++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~ 196 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence 11234577889999998763 57899999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=224.60 Aligned_cols=187 Identities=25% Similarity=0.263 Sum_probs=139.1
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccccC---H---------HHHHHHHHHHHhhcCCCcc
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQG---K---------KEFSAEVTTIGNVHHLHLV 548 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~---~---------~~~~~E~~~l~~l~h~niv 548 (679)
.++...+|++.++||+|+||.||+|...+ +..+|+|........ + .....+...+..++|++|+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34555678889999999999999999754 345666653321111 0 1112233445567899999
Q ss_pred eEEEEEEeCC----eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 046493 549 KLKGFCIEGA----HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVL 624 (679)
Q Consensus 549 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIl 624 (679)
++++++.... ..++++|++.. ++.+.+... ...++..+..++.|+++||+|||++ +|+||||||+|||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil 158 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM 158 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 9999876544 34678887743 666665332 2357888899999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCCcccccCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 625 LDDNFTAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 625 l~~~~~~kL~DFg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSl 219 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL 219 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHH
Confidence 999999999999999876432211 1123469999999999999999999999996
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=229.01 Aligned_cols=182 Identities=21% Similarity=0.356 Sum_probs=150.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 561 (679)
..|++.+.||+|++|.||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 45677788999999999999975 48999999986532 234567889999999999999999998763 34679
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+|+||+. ++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 589888854 33489999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCce---eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 642 MNREESL---VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
....... ......++..|+|||.+.+ ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 198 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence 5443211 1123468899999998865 458899999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=229.00 Aligned_cols=180 Identities=26% Similarity=0.402 Sum_probs=154.4
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 562 (679)
|++.+.||.|++|.||+|+... ++.|+||++... ....+.+.+|+++++.++|+||+++++++.+.+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 5677899999999999999765 899999998653 234567899999999999999999999998775 7899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+|||++ ++|.+++... ..+++..+..++.||++||+|||+. +|+||||||+||++++++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999998 4888888542 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCc--eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 643 NREES--LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
..... .......++..|+|||.+.+. .++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 193 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSV 193 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHH
Confidence 55431 112334678899999999887 78999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=222.14 Aligned_cols=179 Identities=29% Similarity=0.393 Sum_probs=153.3
Q ss_pred hhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
++.+.||+|++|.||++... +++.+++|+++.... ....+.+|++++++++|+||+++++++.+++..++++||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999975 588999999865332 35678889999999999999999999999999999999997
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+ +|.+++... ...+++..+..++.|+++||.|||++ +|+|+||||+||++++++.++|+|||.+....... .
T Consensus 82 ~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 82 T-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred C-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 5 888887553 24689999999999999999999999 99999999999999999999999999998765543 1
Q ss_pred eeecccCccccccccccccC-CCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
......++..|+|||.+.+. .++.++|||||
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl 185 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence 12334678899999998876 68999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=222.19 Aligned_cols=180 Identities=27% Similarity=0.392 Sum_probs=150.7
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
...+|...+.||+|++|.||+|+.. +++.+++|.+... .....++.+|++++++++|+|++++++++.+.+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3445666788999999999999975 4788999988642 1223567889999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
|+||+. ++|.+++... ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999997 5787776543 23588999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
... ....+++.|+|||.+. ...++.++|||||
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 200 (308)
T cd06634 166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (308)
T ss_pred cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHH
Confidence 432 2345788999999874 3457889999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=228.28 Aligned_cols=177 Identities=28% Similarity=0.365 Sum_probs=148.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------e
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------H 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 559 (679)
.+|.+.+.||+|++|.||++... +++.||||++.... .....+.+|++++++++||||+++++++..+. .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 45677789999999999999865 58999999985422 22356789999999999999999999987654 3
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 58999999 6799888743 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
....... ....+++.|+|||.+.+ ..++.++|+|||
T Consensus 166 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 202 (343)
T cd07880 166 RQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202 (343)
T ss_pred cccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence 8654322 23457889999998876 457899999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=242.21 Aligned_cols=193 Identities=26% Similarity=0.414 Sum_probs=161.4
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeCC--------CcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEE
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKG 552 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~ 552 (679)
..|+......+.+.||+|.||.|++|.... ...||||.++... .+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 334455555667799999999999998431 4579999997633 4467899999999999 5999999999
Q ss_pred EEEeCCeeeEEEeccCCCCHhHHhhccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 046493 553 FCIEGAHRLLAYEYLGNGSLDKWIFNST---E-------ES--RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKP 620 (679)
Q Consensus 553 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp 620 (679)
+|..++..++|+||++.|+|.++|+..+ . .. ..++....+.++.||+.|++||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 0 01 2388999999999999999999999 999999999
Q ss_pred CCeEeCCCCcEEEeeccCCcccccCCceeeeccc--CccccccccccccCCCCcccceeeC
Q 046493 621 ENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR--GTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 621 ~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+|||+.++..+||+|||+|+.............. -...|||||.+....|+.+||||||
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSf 507 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSF 507 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHH
Confidence 9999999999999999999976655444322222 2456999999999999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-26 Score=212.34 Aligned_cols=180 Identities=30% Similarity=0.409 Sum_probs=146.5
Q ss_pred hhhcCcccceEEEEEEeCC-CcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 495 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
...||.|+||+|++-.++. |+..|||+++... .+.++++.|.+...+- +.||||+++|.+..++..++.||.|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 3579999999999988754 9999999997633 4556788888875554 79999999999999999999999995 4
Q ss_pred CHhHHhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 571 SLDKWIFN-STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 571 sL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
+|+.+... .......+++...-+|..-.++||.||.+. ..|||||+||+|||++..|.+||+|||.+..+...-.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-- 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-- 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence 77654322 122244588888889999999999999987 4899999999999999999999999999986654322
Q ss_pred eecccCccccccccccccC--CCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
.+...|-..|||||.+... .|+-+||||||
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSL 255 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSL 255 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhh
Confidence 2445788999999998643 48899999997
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=214.75 Aligned_cols=174 Identities=32% Similarity=0.387 Sum_probs=151.8
Q ss_pred cCcccceEEEEEEeCC-CcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
||.|++|.||++...+ ++.+++|.++.... ....+..|++++++++|+||+++++.+.+++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999764 89999999865322 345788999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeec
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~ 652 (679)
.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 9998653 2589999999999999999999998 999999999999999999999999999987654321 1234
Q ss_pred ccCccccccccccccCCCCcccceeeC
Q 046493 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 653 ~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..++..|+|||.+.+...+.++|+|||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~sl 179 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSL 179 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHH
Confidence 567889999999988888999999986
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-26 Score=214.07 Aligned_cols=177 Identities=28% Similarity=0.413 Sum_probs=150.3
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eeeEEEe
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRLLAYE 565 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 565 (679)
.+.||-|+||.||.+.++ +|+.|++|++...- ...+.+.+|++++.-++|.|++..+++..-.+ +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 356999999999999976 59999999986532 23467889999999999999999998876543 5678899
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
.|. .+|...+-. ...++...+.-++.||++||+|||+. +|.||||||.|.|++.+...||+|||+++.-..+
T Consensus 138 LmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 985 488877743 45688889999999999999999999 9999999999999999999999999999987766
Q ss_pred CceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+....+..+-|..|.|||++.|. .|+.+.||||.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSV 244 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSV 244 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehh
Confidence 65555556678899999999986 58999999983
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=226.02 Aligned_cols=177 Identities=26% Similarity=0.382 Sum_probs=146.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ce
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 559 (679)
.+|.+.+.||+|+||.||++... +++.||+|+++... ...+.+.+|++++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 34666788999999999999864 58899999986532 2245678899999999999999999988643 34
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++++|++ +++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 97 ~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred EEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccc
Confidence 67888876 7799888743 2489999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+...... ....++..|+|||.+.+ ..++.++|||||
T Consensus 168 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 204 (345)
T cd07877 168 RHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204 (345)
T ss_pred ccccccc----cccccCCCccCHHHHhCccCCCchhhHHHH
Confidence 8653321 23467889999998866 468899999996
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=219.09 Aligned_cols=176 Identities=30% Similarity=0.417 Sum_probs=147.8
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+...++||+|++|.||+|+.. +++.|++|++.... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 444567999999999999975 48899999986422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+. ++|.+++... ...+++.++..++.||+.||.|||++ +++|+||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 5777776543 34589999999999999999999999 9999999999999999999999999998643221
Q ss_pred ceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
....|+..|+|||++. +..++.++|||||
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~sl 206 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHH
Confidence 2356888999999984 4568889999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=226.56 Aligned_cols=180 Identities=27% Similarity=0.396 Sum_probs=149.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-----Ceee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-----AHRL 561 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 561 (679)
+|.+.+.||+|++|+||+++.. +++.||||.++.. ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4667789999999999999975 4899999998642 23345677899999999999999999988654 3479
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+++||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 9999996 688888854 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
...... ......++..|+|||.+.+ ..++.++|||||
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (337)
T cd07858 158 TSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV 195 (337)
T ss_pred cCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHH
Confidence 644321 1233467889999998765 468899999996
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=226.05 Aligned_cols=175 Identities=29% Similarity=0.395 Sum_probs=145.8
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------ee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------HR 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 560 (679)
+|.+.+.||+|++|.||+|+.. +++.||||++... ......+.+|++++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 4566788999999999999965 5899999998642 223356789999999999999999999987543 45
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++|+||+.. +|..++ ...+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 96 ~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 96 YLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 899999964 777665 23588999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
...... ....++..|+|||.+.+ ..++.++|||||
T Consensus 166 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 201 (342)
T cd07879 166 HADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSV 201 (342)
T ss_pred CCCCCC----CCceeeecccChhhhcCccccCchHHHHHH
Confidence 653321 23457889999999876 458899999996
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=220.96 Aligned_cols=180 Identities=26% Similarity=0.421 Sum_probs=148.4
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc--cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.+++.+.||+|++|.||+|...+ ++.||||.++... ....++..|+.++.+.+ ||||+++++++.++...+++|||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 35677899999999999999875 8999999986532 23455677887777775 99999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
+++ +|.+++... ...+++..+..++.||++||+|||+ . +|+||||+|+||++++++.+||+|||++..+...
T Consensus 96 ~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 96 MST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred cCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 854 777766543 2368999999999999999999997 5 8999999999999999999999999999765433
Q ss_pred CceeeecccCccccccccccccCC----CCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSl 679 (679)
... ....++..|+|||.+.+.. ++.++|||||
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 204 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence 221 2345788999999987654 7889999996
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=223.52 Aligned_cols=177 Identities=27% Similarity=0.371 Sum_probs=148.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-CCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-GAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 564 (679)
..|++.+.||.|+||.||++... +++.||||++... ....+.+.+|++++++++||||+++++++.. .+..++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 34677789999999999999965 5899999988542 2234678899999999999999999999876 55788999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+.....
T Consensus 90 e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 90 ELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred ehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 998 4689888743 3478888999999999999999999 999999999999999999999999999875433
Q ss_pred CCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.. ....++..|+|||.+.+ ..++.++|||||
T Consensus 161 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 192 (328)
T cd07856 161 QM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192 (328)
T ss_pred Cc----CCCcccccccCceeeeccCCcCcHHHHHHH
Confidence 21 23457889999998766 568999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=212.95 Aligned_cols=164 Identities=24% Similarity=0.184 Sum_probs=140.0
Q ss_pred ccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHhHHhhcc
Q 046493 501 GGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS 579 (679)
Q Consensus 501 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 579 (679)
|.++.||++++. +++.+|+|+++... .+.+|...+....||||+++++++.+.+..+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999976 48899999987532 3345556666667999999999999999999999999999999998653
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecccCcccc
Q 046493 580 TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659 (679)
Q Consensus 580 ~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y 659 (679)
..+++..+..++.|+++||+|||++ +|+||||||+||++++++.++|+|||.+....... ....++..|
T Consensus 80 ----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 80 ----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3489999999999999999999999 99999999999999999999999999886554321 223457789
Q ss_pred ccccccccCCCCcccceeeC
Q 046493 660 LAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 660 ~aPE~~~~~~~s~~sDvwSl 679 (679)
+|||.+.+..++.++|||||
T Consensus 149 ~aPE~~~~~~~~~~~Dvwsl 168 (237)
T cd05576 149 CAPEVGGISEETEACDWWSL 168 (237)
T ss_pred cCCcccCCCCCCchhhHHHH
Confidence 99999988889999999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=219.40 Aligned_cols=179 Identities=30% Similarity=0.393 Sum_probs=153.2
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
++.+.||+|++|.||+|+... ++.+++|.+... ....+.+..|++++++++|+||+++++++.+.+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 456789999999999999765 899999998753 2334678889999999999999999999999999999999998
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||+|+||++++++.++|+|||.+........
T Consensus 82 -~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 -MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred -cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 58999996542 3589999999999999999999999 999999999999999999999999999987654322
Q ss_pred eeecccCccccccccccccC-CCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
......++..|+|||.+.+. .++.++|||||
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 185 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV 185 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHH
Confidence 12334567789999998776 78999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=223.12 Aligned_cols=180 Identities=26% Similarity=0.333 Sum_probs=146.7
Q ss_pred hhhhhhcCcccceEEEEEEeCC---CcEEEEEEecccc---cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC----Cee
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG---QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG----AHR 560 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 560 (679)
|++.+.||+|+||.||+++... +..||+|++.... ...+.+.+|+++++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 5667889999999999999753 6789999986422 2245678899999999 599999999976432 456
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++++||++ ++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 88899886 689888854 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCce---eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 641 LMNREESL---VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
........ ......|+..|+|||.+.+ ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl 196 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence 65432211 1123468999999998765 468999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=222.40 Aligned_cols=183 Identities=28% Similarity=0.393 Sum_probs=148.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-------
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------- 558 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 558 (679)
..|++.++||+|++|.||+|+.. +++.+|||++.... .....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45677889999999999999975 48899999885422 22346788999999999999999999876543
Q ss_pred -eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 559 -HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 559 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
..++|+||+++ +|...+... ...+++..+..++.|+++||+|||++ +|+|+||||+||++++++.+||+|||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999975 677666442 34599999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce----------eeecccCccccccccccccC-CCCcccceeeC
Q 046493 638 LAKLMNREESL----------VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+++........ ......+++.|+|||.+.+. .++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 213 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHH
Confidence 99865433211 11223568889999987654 57899999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=223.91 Aligned_cols=177 Identities=23% Similarity=0.344 Sum_probs=149.8
Q ss_pred hhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 495 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.+.||-|+||.|.+++-.| ...+|+|.|++. .......+.|-.||+.-..+-||+|+-.|.+++.+|+||||++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3569999999999998544 677899999763 23445678899999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc------
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN------ 643 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~------ 643 (679)
|++-.+|-+ ...+.+..+..++..+..|+++.|.. |+|||||||+|||||.+|.+||+|||+|.-+.
T Consensus 714 GDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 714 GDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999998854 34588888888999999999999998 99999999999999999999999999985321
Q ss_pred ---cCC-----c---------------------------eeeecccCccccccccccccCCCCcccceee
Q 046493 644 ---REE-----S---------------------------LVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678 (679)
Q Consensus 644 ---~~~-----~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS 678 (679)
... + ......+||+.|+|||++....++..+|.||
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 000 0 0011246999999999999999999999998
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=182.45 Aligned_cols=106 Identities=39% Similarity=0.657 Sum_probs=92.2
Q ss_pred CcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEEEeCCc-eeEEeccC-CCc
Q 046493 47 GLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNG-EAWSANTS-GQK 124 (679)
Q Consensus 47 ~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl~~~~~-~vWst~~~-~~~ 124 (679)
+..|+|++|.|++|||++....+..++|++...+++||+|||+.|+.++..+.+..||+|+|.+.++ .+|+|++. +..
T Consensus 7 ~~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~ 86 (114)
T smart00108 7 GQTLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANG 86 (114)
T ss_pred CCEEecCCCcEeeeccccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCCC
Confidence 4456999999999999987777888888875447899999999998766668999999999998877 79999986 555
Q ss_pred eeEEEEecCCCEEEEccCCceeeecCCC
Q 046493 125 VECMELQDSGNLVLLGVNGSILWQSFSH 152 (679)
Q Consensus 125 ~~~a~LldsGNLVl~~~~~~~lWQSFD~ 152 (679)
...|+|+|+|||||++..++++||||||
T Consensus 87 ~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 87 NYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 6789999999999999999999999997
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=237.53 Aligned_cols=181 Identities=23% Similarity=0.280 Sum_probs=151.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|.+.++||+|+||.||+|.+. +++.||||+++... .....+..|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4667789999999999999986 48999999986532 123668889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ..+++..++.++.||+.||+|||.+ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 y~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 85 YLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred CCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 99999999998542 3588999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
... .....+|+.|++||...... -...+++|++
T Consensus 158 ~~~-~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~ 191 (669)
T cd05610 158 ELN-MMDILTTPSMAKPKNDYSRTPGQVLSLISSL 191 (669)
T ss_pred ccc-ccccccCccccCccccccCCCCceeeeeeec
Confidence 322 23467899999999654432 2334566653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-25 Score=209.13 Aligned_cols=182 Identities=26% Similarity=0.395 Sum_probs=147.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEec--c-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEe--------C
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLE--S-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--------G 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~--~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 557 (679)
..|+-..+||+|.||.||+|+..+ ++.||+|++- . ...-.....+|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556789999999999999765 7888988652 2 22223456789999999999999999988863 2
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
...++|+.+++. +|.-.|.+. ...++..++.+++.+++.||.|+|.. .|+|||+||.|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999975 888887543 34589999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce---eeecccCccccccccccccC-CCCcccceee
Q 046493 638 LAKLMNREESL---VYTTLRGTRGYLAPEWITNN-PISEKSDVYS 678 (679)
Q Consensus 638 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS 678 (679)
+++.+...... .++..+-|..|++||.+.|. .++++.|||.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWg 214 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWG 214 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHh
Confidence 99876554332 23445669999999988775 5899999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=228.22 Aligned_cols=176 Identities=22% Similarity=0.258 Sum_probs=132.3
Q ss_pred HHhhhhhhhcCcccceEEEEEEe-----------------CCCcEEEEEEecccccC---------------HHHHHHHH
Q 046493 489 KATKNFSTKLGQGGFGSVYLGML-----------------PDGIQVAVKKLESIGQG---------------KKEFSAEV 536 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~---------------~~~~~~E~ 536 (679)
...|++.++||+|+||+||+|.+ .+++.||||++...... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 34567789999999999999964 23568999998643221 12234577
Q ss_pred HHHHhhcCCCc-----ceEEEEEEe--------CCeeeEEEeccCCCCHhHHhhccCC--------------------CC
Q 046493 537 TTIGNVHHLHL-----VKLKGFCIE--------GAHRLLAYEYLGNGSLDKWIFNSTE--------------------ES 583 (679)
Q Consensus 537 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~ 583 (679)
.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876654 677777753 3567999999999999999864211 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecccCcccccccc
Q 046493 584 RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663 (679)
Q Consensus 584 ~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE 663 (679)
..+++..+..++.|++++|.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2356778899999999999999999 9999999999999999999999999999765433222112234578999999
Q ss_pred cccc
Q 046493 664 WITN 667 (679)
Q Consensus 664 ~~~~ 667 (679)
.+..
T Consensus 381 ~l~~ 384 (507)
T PLN03224 381 ELVM 384 (507)
T ss_pred hhcC
Confidence 8754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=223.38 Aligned_cols=181 Identities=24% Similarity=0.329 Sum_probs=147.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC----------
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG---------- 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 557 (679)
.+|.+.+.||.|++|.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 45677889999999999999975 48899999886533 4456788999999999999999999876543
Q ss_pred ----CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEE
Q 046493 558 ----AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAK 632 (679)
Q Consensus 558 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k 632 (679)
...++|+||++ ++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 589888743 3488999999999999999999999 999999999999997 456789
Q ss_pred EeeccCCcccccCCce--eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESL--VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
|+|||+++........ ......++..|+|||.+.+ ..++.++|||||
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 9999999765432111 1122357889999997654 567889999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=207.70 Aligned_cols=180 Identities=23% Similarity=0.284 Sum_probs=154.3
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEe
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 565 (679)
+.+.++||+|++..|.+++++. .+.+|+|++++. ..+.+-.+.|-.+..+. +||.+|.++.+++++...++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 3567889999999999999765 788999998752 22233456666666665 69999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|++||+|--++++. +.++++.+..+...|..||.|||++ |||.||||.+|||+|.+|.+||+|+|+++.--.+
T Consensus 332 yv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999998877654 3589999999999999999999999 9999999999999999999999999999865443
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ...++..|||.|+|||++++..|...+|.|+|
T Consensus 405 g-d~tstfcgtpnyiapeilrgeeygfsvdwwal 437 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 437 (593)
T ss_pred C-cccccccCCCcccchhhhcccccCceehHHHH
Confidence 3 23467899999999999999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=215.36 Aligned_cols=166 Identities=22% Similarity=0.180 Sum_probs=129.0
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC--CCcEEEEEEeccc------ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESI------GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
......|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344566888899999999999999865 4777899987532 1124568999999999999999853322 2
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeEeCCCCcEEEeec
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDI-KPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~DF 636 (679)
+..++||||+++++|.... . .. ...++.|++++|.|||++ +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~-~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR-P-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHhC-c-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 4679999999999996321 0 11 146788999999999999 9999999 999999999999999999
Q ss_pred cCCcccccCCce-------eeecccCccccccccccccC
Q 046493 637 GLAKLMNREESL-------VYTTLRGTRGYLAPEWITNN 668 (679)
Q Consensus 637 g~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 668 (679)
|+|+........ ......+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999976553211 11345688899999998643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=222.07 Aligned_cols=176 Identities=26% Similarity=0.382 Sum_probs=148.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe------e
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH------R 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 560 (679)
.|++.+.||+|++|.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4667789999999999999986 4789999998642 2233567789999999999999999998876654 8
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 96 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence 9999998 5699998853 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
..... .....++..|+|||.+.+. .++.++|||||
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 202 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence 66433 1334678899999988653 67899999996
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-25 Score=220.99 Aligned_cols=178 Identities=26% Similarity=0.291 Sum_probs=157.2
Q ss_pred hhhhhcCcccceEEEEEEeCCCc-EEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGI-QVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~-~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+....||-|+||.|=+++.+..+ .+|+|++++. ....+.+..|-++|...+.|.||+++..+.++...|++||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 33467999999999999986543 4888888652 234566888999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
-||.|-..|++ +..++..++..++..+++|++|||.+ +||.|||||+|.+++.+|-+||.|||+|+.+.....
T Consensus 503 lGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 503 LGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred cCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999965 44588889999999999999999999 999999999999999999999999999998877653
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.-+++|||.|.|||++.++.++.++|.|||
T Consensus 576 --TwTFcGTpEYVAPEIILnKGHD~avDyWaL 605 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGHDRAVDYWAL 605 (732)
T ss_pred --eeeecCCcccccchhhhccCcchhhHHHHH
Confidence 357899999999999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=221.72 Aligned_cols=178 Identities=30% Similarity=0.397 Sum_probs=145.3
Q ss_pred hhhcCcccce-EEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFG-SVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
.+.+|.|+.| .||+|.. +++.||||++-. .-.....+|+..|+.- +|||||++++.-.+....||..|.|. .+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 3568899887 4799999 789999999853 2234567899999888 59999999999888999999999995 699
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---C--CcEEEeeccCCcccccCCc
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---N--FTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~DFg~a~~~~~~~~ 647 (679)
.+++.....+.........+.+..|+++||++||+. +||||||||+||||+. + .+++|+|||+++.+.....
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999976421111122255678899999999999998 9999999999999975 2 5789999999999876654
Q ss_pred e--eeecccCccccccccccccCCCCcccceeeC
Q 046493 648 L--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......||-+|+|||++....-+.++|||||
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFsl 700 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSL 700 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhc
Confidence 3 2345679999999999999888889999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=198.34 Aligned_cols=181 Identities=34% Similarity=0.500 Sum_probs=155.7
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.+.+.|++|+++.||++...+ ++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999999876 89999999976433 467889999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++..... .+++..+..++.+++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999865431 178999999999999999999999 99999999999999999999999999998776543111
Q ss_pred eecccCcccccccccc-ccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWI-TNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSl 679 (679)
.....++..|++||.+ ....++.++|||||
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~l 186 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSL 186 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHH
Confidence 2334678899999998 66678889999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=190.65 Aligned_cols=177 Identities=23% Similarity=0.400 Sum_probs=150.3
Q ss_pred HHhhhhhhhcCcccceEEEEEE-eCCCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCC--eeeEEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGA--HRLLAY 564 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~ 564 (679)
...|++.+++|+|-++.||.|. ..+.+.++||++++. ..+.+.+|+.+|+.|. ||||++++++..+.. ...||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 3458889999999999999999 446889999999853 3577899999999997 999999999998765 457999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN 643 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~ 643 (679)
||+.+.+...+. ..++...+..++.++++||.|+|+. ||.|||+||.|++||. .-.++|+|+|+|.++.
T Consensus 115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999998877654 3478888999999999999999999 9999999999999995 4579999999999887
Q ss_pred cCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.... .+..+.+..|.-||.+..- .|+..-|+|||
T Consensus 185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~ 219 (338)
T KOG0668|consen 185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 219 (338)
T ss_pred CCce--eeeeeehhhcCCchheeechhccccHHHHHH
Confidence 7543 3445667889999988654 57888999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-23 Score=226.93 Aligned_cols=171 Identities=21% Similarity=0.226 Sum_probs=120.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-----CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEE------EEeCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF------CIEGA 558 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~ 558 (679)
..|++.++||+|+||.||+|++.+ +..||||++...... +....| .+....+.++..++.. ..++.
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 456778999999999999999754 689999988643221 111111 1122222222222211 24566
Q ss_pred eeeEEEeccCCCCHhHHhhccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEE----------------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
..++|+||+++++|.+++...... ........+..++.||+.||+|||++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 789999999999999988643210 01122345668999999999999999 99999999999
Q ss_pred eEeCC-CCcEEEeeccCCcccccCCceeeecccCccccccccccc
Q 046493 623 VLLDD-NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666 (679)
Q Consensus 623 Ill~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 666 (679)
||+++ ++.+||+|||+++.+............+++.|+|||.+.
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99985 579999999999866544333334567899999999654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-23 Score=215.06 Aligned_cols=175 Identities=26% Similarity=0.342 Sum_probs=147.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++...+|.|+|+.|-.+... +++..+||++.+. ..+..+|+.++... +||||+++.+.+.+..+.++|||.+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 34667778999999999999865 4888999999764 23345677676666 6999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe-CCCCcEEEeeccCCcccccCC
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL-DDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~DFg~a~~~~~~~ 646 (679)
.++-|.+-+.... ....++..|+.+|+.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9988877664432 22377888999999999999999 99999999999999 68999999999999977665
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....+-|..|.|||++....+++++|||||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSL 499 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSL 499 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHH
Confidence 233456889999999999999999999996
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=197.88 Aligned_cols=169 Identities=31% Similarity=0.464 Sum_probs=148.6
Q ss_pred cceEEEEEEeCC-CcEEEEEEeccccc-C-HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHhHHhhc
Q 046493 502 GFGSVYLGMLPD-GIQVAVKKLESIGQ-G-KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN 578 (679)
Q Consensus 502 ~~g~Vy~~~~~~-~~~vavK~l~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 578 (679)
+||.||+|+..+ ++.+++|++..... . .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 89999999975332 2 57899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecccCccc
Q 046493 579 STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 658 (679)
Q Consensus 579 ~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~ 658 (679)
.. .+++..+..++.+++.+|.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 32 288999999999999999999999 99999999999999999999999999998765542 1234567889
Q ss_pred cccccccccCCCCcccceeeC
Q 046493 659 YLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 659 y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||.+.+..++.++|||||
T Consensus 152 ~~~pE~~~~~~~~~~~Di~sl 172 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSL 172 (244)
T ss_pred CCCHHHHccCCCCchhhHHHH
Confidence 999999988889999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=206.18 Aligned_cols=192 Identities=24% Similarity=0.274 Sum_probs=166.8
Q ss_pred CCcCHHHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcC------CCcceEEE
Q 046493 480 TRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHH------LHLVKLKG 552 (679)
Q Consensus 480 ~~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~ 552 (679)
..+.+.|+...+|++....|+|-|++|.+|.+.. |..||||+++..+.-.+.=+.|+++|++|+. -|+++++.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 4577899999999999999999999999999765 8899999999877667777899999999962 38999999
Q ss_pred EEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcE
Q 046493 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTA 631 (679)
Q Consensus 553 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ 631 (679)
.|...+++|||+|-+ ..+|.+.|..... ...|....+..++.|+..||..|... +|+|.||||+||||++. ..+
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 999999999999988 4699999976543 33478889999999999999999997 99999999999999965 467
Q ss_pred EEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||.|.....++- +...-+.-|.|||++.|.+|+...|+||.
T Consensus 577 KLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSv 621 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSV 621 (752)
T ss_pred eeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceee
Confidence 9999999988766542 33445678999999999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-23 Score=218.30 Aligned_cols=181 Identities=25% Similarity=0.368 Sum_probs=156.8
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.|++..++|+|.+|.||++++. .++..|+|.++.. .....-++.|+-+++..+||||+.+++-+...+..++.|||+.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4567788999999999999976 4899999998763 3455667889999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+|+|++.-+. ..++++.++..+.+..++||+|||+. +-+|||||-.||++++.|.+|++|||.+..+...-..
T Consensus 96 ggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 96 GGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred CCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999986544 45699999999999999999999999 9999999999999999999999999998776554322
Q ss_pred eeecccCcccccccccc---ccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWI---TNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwSl 679 (679)
...+.||+.|||||+. +.+.|..++|||+.
T Consensus 169 -rksfiGtpywmapEvaaverkggynqlcdiwa~ 201 (829)
T KOG0576|consen 169 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAL 201 (829)
T ss_pred -hhcccCCccccchhHHHHHhccccccccccccc
Confidence 2457899999999976 34568999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=188.20 Aligned_cols=175 Identities=39% Similarity=0.616 Sum_probs=152.3
Q ss_pred cCcccceEEEEEEeCC-CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHhH
Q 046493 498 LGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDK 574 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 574 (679)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 89999999976444 25789999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccccCCceeeecc
Q 046493 575 WIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTTL 653 (679)
Q Consensus 575 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~~~~~~~~~ 653 (679)
++.... ..+++..+..++.+++++|++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 986532 3589999999999999999999999 9999999999999999 89999999999987655421 12334
Q ss_pred cCccccccccccccC-CCCcccceeeC
Q 046493 654 RGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 654 ~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.+...|++||.+... .++.++|+|+|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~l 180 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSL 180 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHH
Confidence 578899999999877 78899999985
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-22 Score=199.99 Aligned_cols=141 Identities=31% Similarity=0.413 Sum_probs=122.3
Q ss_pred CCcCHHHHHH-HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhc-----C---CCcce
Q 046493 480 TRFSYDDLCK-ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVH-----H---LHLVK 549 (679)
Q Consensus 480 ~~~~~~~l~~-~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h---~niv~ 549 (679)
..+.+.|+.. .+|.+.++||-|.|++||++.+.. .+.||+|+.+....-.+....|+++|++++ | .+||+
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 4456667766 999999999999999999999754 789999999987777788899999999984 3 36999
Q ss_pred EEEEEEe----CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe
Q 046493 550 LKGFCIE----GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL 625 (679)
Q Consensus 550 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll 625 (679)
|++.|.. +.+.++|+|++ |.+|..+|.... .+.++...+.+|++||+.||.|||.+| +|||-||||+|||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999985 45889999999 568888887654 456899999999999999999999997 99999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-22 Score=195.81 Aligned_cols=189 Identities=22% Similarity=0.321 Sum_probs=152.0
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-C
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-A 558 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 558 (679)
.+.+.++...+-+|.||.||+|.+. +.+.|.+|.++... .....+..|.-++..+.|||+.++.+++.++ +
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3344445567899999999999654 34668888886633 3346688898899999999999999998865 4
Q ss_pred eeeEEEeccCCCCHhHHhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEe
Q 046493 559 HRLLAYEYLGNGSLDKWIFNS----TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 634 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 634 (679)
..++++.++.-|+|..||... ....+.++..+...++.|++.|++|||.+ ++||.||.++|++||+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 678999999999999999732 22345578888999999999999999999 99999999999999999999999
Q ss_pred eccCCcccccCCceee-ecccCccccccccccccCCCCcccceeeC
Q 046493 635 DFGLAKLMNREESLVY-TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|=.+++.+-....... ..--.+..||+||.+.+..|+.++|||||
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsf 484 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSF 484 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHH
Confidence 9999986654332211 11224678999999999999999999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=180.81 Aligned_cols=178 Identities=19% Similarity=0.337 Sum_probs=144.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEE-EEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGF-CIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e~ 566 (679)
..|.+.+.||+|.||.+-+++++. ...+++|-+........+|.+|...--.| .|.||+.-+++ |+..+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 347888999999999999999875 78899999887777788999999876666 58999987764 6677888899999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC--CCCcEEEeeccCCccccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a~~~~~ 644 (679)
++.|+|..-+.. ..+.+..-.+++.|+++||.|+|++ ++||||||.+||||- +..++||+|||..+..+.
T Consensus 104 aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999886633 3477888899999999999999999 999999999999994 445899999999876543
Q ss_pred CCceeeecccCccccccccccccC-----CCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNN-----PISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwSl 679 (679)
.- ....-+..|.|||..... ...+.+|||.|
T Consensus 176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wqf 211 (378)
T KOG1345|consen 176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQF 211 (378)
T ss_pred ee----hhhhhhcccCCcHHHhhccccceEecccccchhe
Confidence 22 222346689999976432 24678999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=180.35 Aligned_cols=140 Identities=14% Similarity=0.152 Sum_probs=109.2
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEeccccc---C-------HH-----------------HHHHHHHHHHhhcCCCc
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---G-------KK-----------------EFSAEVTTIGNVHHLHL 547 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~-------~~-----------------~~~~E~~~l~~l~h~ni 547 (679)
.+.||+|++|.||+|...+|+.||||+++.... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999988899999999965321 1 11 22349999999988876
Q ss_pred ceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeEeC
Q 046493 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL-HEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 548 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~Dlkp~NIll~ 626 (679)
.....+.. ...+|||||++++++...+.. ...++...+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 233899999998877654322 23588999999999999999999 688 999999999999998
Q ss_pred CCCcEEEeeccCCccccc
Q 046493 627 DNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~ 644 (679)
++.++|+|||+|.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=188.04 Aligned_cols=171 Identities=29% Similarity=0.362 Sum_probs=141.9
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------CeeeEEEe
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AHRLLAYE 565 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 565 (679)
+.++.|.- .|-.+.+. .+++||+|++.. .....+...+|+..+..++|+||++++.++.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45677776 45555443 488999998854 233446678899999999999999999998743 35689999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
+|. .+|.+.+. ..++-+.+..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 996 58888874 2378888999999999999999999 9999999999999999999999999999865544
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+..+.|..|.|||++.+..+.+.+||||.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSv 203 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhh
Confidence 34466788999999999999889999999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=175.77 Aligned_cols=141 Identities=15% Similarity=0.144 Sum_probs=111.8
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEecccccC---------------------------HHHHHHHHHHHHhhcCCCc
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG---------------------------KKEFSAEVTTIGNVHHLHL 547 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni 547 (679)
.+.||+|++|.||+|+..+|+.||||+++..... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999878999999998753210 1123578999999999987
Q ss_pred ceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeC
Q 046493 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 548 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~ 626 (679)
.....+... ..+|||||++++++...... ...++...+..++.|++.+|.+||+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 24899999998865433211 2347788999999999999999999 8 999999999999999
Q ss_pred CCCcEEEeeccCCcccccC
Q 046493 627 DNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~~ 645 (679)
++.++|+|||++......
T Consensus 153 -~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 -DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred -CCCEEEEEcccceecCCC
Confidence 789999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=187.31 Aligned_cols=178 Identities=25% Similarity=0.324 Sum_probs=146.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|...++||+|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++...+|+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 34566789999999999999854 36789999986533 3556899999999995 999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEEEeeccCCcccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~ 643 (679)
||++...-.++... ++..++..+++.++.||+++|.+ |||||||||+|+|.+ ..++-.|.|||+|....
T Consensus 115 p~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred cccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence 99999998888743 77889999999999999999999 999999999999998 45788999999997211
Q ss_pred cCC---------------------------------ce----------eeecccCccccccccccccC-CCCcccceee
Q 046493 644 REE---------------------------------SL----------VYTTLRGTRGYLAPEWITNN-PISEKSDVYS 678 (679)
Q Consensus 644 ~~~---------------------------------~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS 678 (679)
... .. ......||++|.|||++..- ..++++||||
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 000 00 00114599999999998654 4788999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-20 Score=178.01 Aligned_cols=166 Identities=13% Similarity=0.120 Sum_probs=130.9
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHH----------HHHHHHHHHhhcCCCcceEEEE
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKE----------FSAEVTTIGNVHHLHLVKLKGF 553 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~~~ 553 (679)
.+++.+.+|+..+.|+.|+||.||++.. ++..+|||.+.......+. +++|++.+.+++|++|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4677888899999999999999999766 6778999999753322222 5889999999999999999998
Q ss_pred EEeC--------CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe
Q 046493 554 CIEG--------AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL 625 (679)
Q Consensus 554 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll 625 (679)
+... ...+|+|||++|.+|.++.. +++ ....+++.+|..+|+. +++||||||+||++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 6643 35789999999999988731 222 2456999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 626 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 626 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++++ ++|+|||............ .++....+..++|+|||
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~l 208 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDL 208 (232)
T ss_pred eCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccce
Confidence 9988 9999999887654322111 13344456678999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=177.67 Aligned_cols=182 Identities=25% Similarity=0.329 Sum_probs=152.6
Q ss_pred HhhhhhhhcCcccceEEEEEE-eCCCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
-.|++.++||+|.||.++.|+ +-++++||||.-. ......+++.|.+..+.|. .++|+..+-+..++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 357889999999999999999 4479999999643 3445567889999999985 789999999999999999999998
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-----CCcEEEeeccCCccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-----NFTAKVSDFGLAKLM 642 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DFg~a~~~ 642 (679)
|.+|+++..-. ++.++.+++..++.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 67998877433 56799999999999999999999999 9999999999999963 346899999999988
Q ss_pred ccCCcee------eecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLV------YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+..... ....-||.+||+--...|.+.+.+.|+=||
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaL 222 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEAL 222 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHh
Confidence 7654321 233569999999998888888888887553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-20 Score=171.23 Aligned_cols=184 Identities=25% Similarity=0.352 Sum_probs=150.1
Q ss_pred HHHHhhhhhhhcCcccceEEEEEE-eCCCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 564 (679)
+....|.+.++||+|+||.+|.|. ..+|++||||.-+. ......+..|.++.+.|+ ...|+.+..+..+.++..+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 455678889999999999999999 45699999997654 233455778999999997 468889999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---CCCcEEEeeccCCcc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKL 641 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~ 641 (679)
|.+ |.+|++++.-. .+.++..+++.++.|++.-++|+|.+ ++|||||||+|.|+. ...++.|+|||+|+.
T Consensus 91 dLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 998 67999987543 44589999999999999999999999 999999999999996 345789999999998
Q ss_pred cccCCce------eeecccCccccccccccccCCCCcccceee
Q 046493 642 MNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYS 678 (679)
Q Consensus 642 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwS 678 (679)
+.+.... ......||.+|.+--...+...+.+.|+=|
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeS 206 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMES 206 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhh
Confidence 7554321 112356999999988777776777777644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=186.49 Aligned_cols=183 Identities=24% Similarity=0.288 Sum_probs=149.1
Q ss_pred hhhhhhhcCcccceEEEEEEeCCC--cEEEEEEecccc-cCHHHHHHHHHHHHhhcC----CCcceEEEEE-EeCCeeeE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDG--IQVAVKKLESIG-QGKKEFSAEVTTIGNVHH----LHLVKLKGFC-IEGAHRLL 562 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~--~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 562 (679)
.|.+.++||+|+||.||++..... ..+|+|...... .....+..|..++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 678889999999999999997653 478888765432 222278889999999873 6899999999 47778899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-----CcEEEeecc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-----FTAKVSDFG 637 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kL~DFg 637 (679)
||+.+ |.+|.++..... .+.++..++++|+.|++.+|.+||+. |++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 679999775543 46799999999999999999999999 99999999999999854 469999999
Q ss_pred CCc--ccccCCc---e---e-eecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAK--LMNREES---L---V-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~--~~~~~~~---~---~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++ ....... . . ....+||..|++++...+...+.+.|+||+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~ 223 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESL 223 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhH
Confidence 998 3322211 1 1 123569999999999999999999999985
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.9e-18 Score=161.46 Aligned_cols=134 Identities=19% Similarity=0.286 Sum_probs=104.1
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEeccc-ccCHHHHHHHHHHHHhh-----cCCCcceEEEEEEeCC---eee-EEEe
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTTIGNV-----HHLHLVKLKGFCIEGA---HRL-LAYE 565 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~e 565 (679)
+.||+|+++.||. +++....+||++... ....+.+.+|+++++++ .||||+++++++.++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 444333479987642 33457799999999999 5799999999999874 333 7899
Q ss_pred c--cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeEeCC----CCcEEEee-cc
Q 046493 566 Y--LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL-AYLHEECEVKIVHCDIKPENVLLDD----NFTAKVSD-FG 637 (679)
Q Consensus 566 ~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~D-Fg 637 (679)
| +++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+| ||
T Consensus 86 ~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 5579999999542 24544 35677888787 899999 9999999999999974 34899999 55
Q ss_pred CCcc
Q 046493 638 LAKL 641 (679)
Q Consensus 638 ~a~~ 641 (679)
....
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 4443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=164.61 Aligned_cols=142 Identities=15% Similarity=0.163 Sum_probs=111.7
Q ss_pred hhhhhhcCcccceEEEEEE--eCCCcEEEEEEeccccc-------------------------CHHHHHHHHHHHHhhcC
Q 046493 492 KNFSTKLGQGGFGSVYLGM--LPDGIQVAVKKLESIGQ-------------------------GKKEFSAEVTTIGNVHH 544 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~-------------------------~~~~~~~E~~~l~~l~h 544 (679)
|.+.+.||+|++|.||+|. ..+|+.||||+++.... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5677899999999999998 55799999999864221 01235689999999975
Q ss_pred C--CcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCC
Q 046493 545 L--HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK-IVHCDIKPE 621 (679)
Q Consensus 545 ~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-ivH~Dlkp~ 621 (679)
. .++++++. ...++||||+++.+|...+.. ...+...++..++.||+.+|++||++ + |+||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 3 34455543 235899999999888765422 22356667789999999999999999 9 999999999
Q ss_pred CeEeCCCCcEEEeeccCCcccccC
Q 046493 622 NVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 622 NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
||+++ +++++|+|||.+......
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCc
Confidence 99999 889999999999865554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-17 Score=171.24 Aligned_cols=182 Identities=36% Similarity=0.505 Sum_probs=152.5
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCC-CcceEEEEEEeCCeeeEEEec
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHL-HLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 566 (679)
|.+.+.||.|+|+.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +|+++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999986 7899999865322 367799999999999988 799999999877778999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCcccccC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNRE 645 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~ 645 (679)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++||||||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776543211 3688999999999999999999999 999999999999999988 7999999999865544
Q ss_pred Cce-----eeecccCcccccccccccc---CCCCcccceeeC
Q 046493 646 ESL-----VYTTLRGTRGYLAPEWITN---NPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSl 679 (679)
... ......|+..|+|||.+.+ ...+...|+||+
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 321 2355789999999999987 578889999964
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=154.21 Aligned_cols=131 Identities=19% Similarity=0.167 Sum_probs=107.0
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEecccccCHH-----HHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccC
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKK-----EFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
...|++|+||+|+.+.. ++.+++.+.+.....-.. .+++|+++|++|+ |+++++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999998777 678888888865443222 5889999999995 5889999886 44699999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeEeCCCCcEEEeeccCCccccc
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDI-KPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|.+|.+.+.. ....++.|++++|.++|++ ||+|||| ||+|||+++++.++|+|||++.....
T Consensus 82 G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 82 GAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred CccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9998654310 1135778999999999999 9999999 79999999999999999999986544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-17 Score=156.79 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=109.1
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc-----------------------CHHHHHHHHHHHHhhcCC--C
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-----------------------GKKEFSAEVTTIGNVHHL--H 546 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~E~~~l~~l~h~--n 546 (679)
+.+.+.||+|++|.||++..++++.||||+++.... .......|+.++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 666788999999999999988899999998754221 112357789999999887 4
Q ss_pred cceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 547 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
+++.++ ....+++|||+++++|..... ......++.++++++.++|+. +|+||||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 555544 245589999999999976542 023567889999999999998 999999999999999
Q ss_pred CCCcEEEeeccCCccccc
Q 046493 627 DNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~ 644 (679)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-17 Score=157.33 Aligned_cols=135 Identities=18% Similarity=0.304 Sum_probs=114.4
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.||+|++|.||+|+. .+..+++|+...... ....+.+|++++..++|++|+....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999998 677899997653211 123577899999999999988887777778888999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
++|++|.+++... .. .+..++.+++.+|.+||+. +++|+|++|+|||++ ++.++|+|||.+....
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988432 12 7889999999999999999 999999999999999 7899999999988643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-18 Score=199.18 Aligned_cols=132 Identities=19% Similarity=0.212 Sum_probs=99.1
Q ss_pred hhcC-CCcceEEEEE-------EeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 046493 541 NVHH-LHLVKLKGFC-------IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612 (679)
Q Consensus 541 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ 612 (679)
.++| +||.++++.+ .+.+..++++|++ +++|.++|... ...+++.+++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4555 5788888877 2334567788987 56999999643 34589999999999999999999999 9
Q ss_pred eeecCCCCCCeEeCCC-------------------CcEEEeeccCCcccccCCc---------------eeeecccCccc
Q 046493 613 IVHCDIKPENVLLDDN-------------------FTAKVSDFGLAKLMNREES---------------LVYTTLRGTRG 658 (679)
Q Consensus 613 ivH~Dlkp~NIll~~~-------------------~~~kL~DFg~a~~~~~~~~---------------~~~~~~~gt~~ 658 (679)
|+||||||+||||+.. +.+||+|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666653211000 00112357889
Q ss_pred cccccccccCCCCcccceeeC
Q 046493 659 YLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 659 y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||||++.+..++.++|||||
T Consensus 181 Y~APE~~~~~~~~~~sDVwSl 201 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRL 201 (793)
T ss_pred eEChhhhccCCCCchhhhhhH
Confidence 999999999999999999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=154.30 Aligned_cols=131 Identities=18% Similarity=0.308 Sum_probs=107.8
Q ss_pred hcCcccceEEEEEEeCCCcEEEEEEecccc--c-------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIG--Q-------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.||+|++|.||+|.. ++..|++|...... . ....+.+|++++..++|+++.....++.+.+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 67889999864321 1 1245778999999999887666555666777789999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998874321 0 7899999999999999 999999999999999 7899999999988643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=175.33 Aligned_cols=135 Identities=17% Similarity=0.224 Sum_probs=111.0
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEE-ecccc--------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKK-LESIG--------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~-l~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
...++||+|+||+||++.+.+. .+++|+ +.... ...+.+.+|++++++++|++++....++.+.+..++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 3467899999999999998544 344443 22211 1124688999999999999999888888887788999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++. ....++.|++++|.+||+. +++||||||+|||+ +++.++|+|||+++...
T Consensus 415 ~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 415 MEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999873 3567899999999999999 99999999999999 67899999999998754
Q ss_pred c
Q 046493 644 R 644 (679)
Q Consensus 644 ~ 644 (679)
.
T Consensus 479 ~ 479 (535)
T PRK09605 479 L 479 (535)
T ss_pred c
Confidence 3
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=138.06 Aligned_cols=107 Identities=13% Similarity=0.271 Sum_probs=77.7
Q ss_pred eeccCCCcccccceEEeeeccccccccccccccccceeeEEEeecCCCCceEEEEEecCCCcEEEEEecCCCcccccccc
Q 046493 202 WSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIK 281 (679)
Q Consensus 202 w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~w~~~~~ 281 (679)
||+|+|.+....+.+.+..... ..+.|...+.+..+++. ..+...+.|++++.+|.++++.|.+..+.|...|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~---~~~~fv~~~~e~~~t~~---~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~ 74 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSL---YNYSFVSNNEEVYYTYS---LSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWS 74 (110)
T ss_pred CCccccCCeEECCcccccccce---eEEEEEECCCeEEEEEe---cCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEE
Confidence 7788777776655443321111 11223333323333332 22445677899999999999999999999999999
Q ss_pred cCCCCCCcCCCCCCCccccC--CCcccCCCCCccC
Q 046493 282 IPQISCSVPEPCNPYFVCYF--DNWCQCPTSLRSQ 314 (679)
Q Consensus 282 ~p~~~Cd~~~~CG~~g~C~~--~~~C~C~~gf~~~ 314 (679)
+|.|+||+|+.||+||+|+. .+.|+||+||+|+
T Consensus 75 ~p~d~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~ 109 (110)
T PF00954_consen 75 APKDQCDVYGFCGPNGICNSNNSPKCSCLPGFEPK 109 (110)
T ss_pred ecccCCCCccccCCccEeCCCCCCceECCCCcCCC
Confidence 99999999999999999986 3579999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-16 Score=178.77 Aligned_cols=186 Identities=22% Similarity=0.258 Sum_probs=147.0
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCCeee
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 561 (679)
-++....+.+.+.||+|++|+||+|...+++.||+|+-+... ..+|.-=.+++.+|+ -+-|.++..+..-.+.-+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 345556677889999999999999998889999999876432 233333344455555 234555555556677789
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-------CCCcEEEe
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-------DNFTAKVS 634 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~kL~ 634 (679)
||+||.+.|+|.+++. ..+.+++.....++.|++.-++.||.. +|||+||||+|.||. +..-++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999996 355699999999999999999999999 999999999999994 23468999
Q ss_pred eccCCcccccCC-ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 635 DFGLAKLMNREE-SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||.+..+.--. ........+|-.+-.+|+..|.+++..+|.|.|
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl 889 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL 889 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence 999987654322 234566788999999999999999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.4e-16 Score=146.97 Aligned_cols=136 Identities=20% Similarity=0.226 Sum_probs=100.3
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEecccccCH---HH----------------------HHHHHHHHHhhcCC--Cc
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK---KE----------------------FSAEVTTIGNVHHL--HL 547 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~----------------------~~~E~~~l~~l~h~--ni 547 (679)
.+.||+|+||+||+|...+++.||||+++...... .. ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999886522111 11 13566666666544 35
Q ss_pred ceEEEEEEeCCeeeEEEeccCCCCHhHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEe
Q 046493 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKW-IFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLL 625 (679)
Q Consensus 548 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll 625 (679)
++.+++ ...++||||++++.+... +.... .. ..+..++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 555543 245899999998544321 11100 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCcEEEeeccCCccccc
Q 046493 626 DDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 626 ~~~~~~kL~DFg~a~~~~~ 644 (679)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.3e-15 Score=135.64 Aligned_cols=135 Identities=24% Similarity=0.214 Sum_probs=114.9
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcC--CCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH--LHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
.+.|++|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++.+....+..++++||+++..+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999999854 7899999866433 5678999999999986 5999999988888889999999998777
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
..+ +......++.+++++|++||.....+++|+||+|+||++++.+.++++|||.+...
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 542 55667788999999999999964447999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-14 Score=144.44 Aligned_cols=135 Identities=17% Similarity=0.198 Sum_probs=105.9
Q ss_pred hhcC-cccceEEEEEEeCCCcEEEEEEecccc--------------cCHHHHHHHHHHHHhhcCCCc--ceEEEEEEeCC
Q 046493 496 TKLG-QGGFGSVYLGMLPDGIQVAVKKLESIG--------------QGKKEFSAEVTTIGNVHHLHL--VKLKGFCIEGA 558 (679)
Q Consensus 496 ~~Lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 558 (679)
..|| .|+.|+||.+.. .+..++||++.... .....+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 899999999988 47789999874311 123457889999999998775 77777654432
Q ss_pred ----eeeEEEeccCC-CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEE
Q 046493 559 ----HRLLAYEYLGN-GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 633 (679)
Q Consensus 559 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL 633 (679)
..++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+. ||+||||||+|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 6999887432 24443 357899999999999 9999999999999999899999
Q ss_pred eeccCCcccc
Q 046493 634 SDFGLAKLMN 643 (679)
Q Consensus 634 ~DFg~a~~~~ 643 (679)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999988654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-16 Score=147.57 Aligned_cols=178 Identities=23% Similarity=0.398 Sum_probs=140.8
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.++..+|.+...|..|+|++ .|..+++|++.. .....++|..|.-.++.+.||||+.+++.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 35667899999999999999 566777788754 33445779999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
.|+|...|+... .-..+..++.+++.+|++|++|||+. .+-|.---|.+..++||++.+.+|+- +-+++.-+..
T Consensus 271 ~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe~-- 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEV-- 344 (448)
T ss_pred chHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeecc--
Confidence 999999997654 44578889999999999999999996 33455557899999999999888741 2222211111
Q ss_pred eeecccCccccccccccccCCCC---cccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPIS---EKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s---~~sDvwSl 679 (679)
...-.|.||+||.+..++-+ .++|+|||
T Consensus 345 ---gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred ---ccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 12346899999999877643 57899997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-15 Score=168.83 Aligned_cols=177 Identities=23% Similarity=0.289 Sum_probs=137.3
Q ss_pred hhhhcCcccceEEEEEEeCC-CcEEEEEEec----ccccCH---HHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 494 FSTKLGQGGFGSVYLGMLPD-GIQVAVKKLE----SIGQGK---KEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 494 ~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~----~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
..+.+|.|++|.|+...... .+..+.|..+ ...... ..+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 35679999999777766432 3333333322 211111 225567778888999999888887777766666699
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++ +|..++... ..+...++..++.|++.|+.|||+. ||.|||||++|+++..+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999888542 3588899999999999999999999 9999999999999999999999999999876543
Q ss_pred Cc---eeeecccCccccccccccccCCCCc-ccceee
Q 046493 646 ES---LVYTTLRGTRGYLAPEWITNNPISE-KSDVYS 678 (679)
Q Consensus 646 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~-~sDvwS 678 (679)
.. ......+|+..|+|||++.+..|.+ ..||||
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS 510 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS 510 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhh
Confidence 32 2334578999999999999999986 479998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-15 Score=160.36 Aligned_cols=169 Identities=30% Similarity=0.304 Sum_probs=139.9
Q ss_pred hcCcccceEEEEEEe----CCCcEEEEEEecccc---cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccC
Q 046493 497 KLGQGGFGSVYLGML----PDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.+|+|.+|.|++++- ..+.-+|+|.+++.. ........|..++...+ ||.+++++..++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998762 236778888775421 11225567888888887 9999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+|.|...+.. ...+.+.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-..+.
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999877744 33467777777888999999999999 999999999999999999999999999987655432
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+||..|||||++. .+...+|.|||
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~ 177 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSF 177 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhh
Confidence 27899999999998 56788999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=135.29 Aligned_cols=90 Identities=28% Similarity=0.313 Sum_probs=78.6
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
|+|.+++... ...+++.+++.++.||++||+|||++ + ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899998653 34599999999999999999999998 5 999999999999999 99998664432
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..|++.|||||++.+..++.++|||||
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSl 90 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSL 90 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHH
Confidence 258899999999999999999999996
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-14 Score=160.89 Aligned_cols=180 Identities=21% Similarity=0.288 Sum_probs=137.0
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecc--cccCHHHHHHHHHH--HHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLES--IGQGKKEFSAEVTT--IGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.+.+.+.||++.|=+|.+++++.|. |+||++-+ .....+.+.++++- ...++|||.+++..+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 3556788999999999999998887 99998844 23344555554444 4455899999998887777778899898
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc--cc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NR 644 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~--~~ 644 (679)
..+ +|.|.|. .+..+...+...|+.|++.||..+|.. +|+|||||.+||||+.-.-+.|+||..-+.. ..
T Consensus 103 vkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 854 8877773 356788889999999999999999999 9999999999999999999999999876532 12
Q ss_pred CCcee----eecccCccccccccccccC----------C-CCcccceeeC
Q 046493 645 EESLV----YTTLRGTRGYLAPEWITNN----------P-ISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~----~~~~~gt~~y~aPE~~~~~----------~-~s~~sDvwSl 679 (679)
+.... ..+...-..|+|||.+... + .+++-||||+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~ 224 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA 224 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence 21111 2233445579999987531 2 5678899884
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=5e-13 Score=143.94 Aligned_cols=140 Identities=20% Similarity=0.225 Sum_probs=99.8
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccC-----------------------------------------HHHHHH
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG-----------------------------------------KKEFSA 534 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~ 534 (679)
+.||.|++|+||+|++++|+.||||+.+..... +-++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998542100 012445
Q ss_pred HHHHHHhhc----CCCcceEEEEEE-eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 046493 535 EVTTIGNVH----HLHLVKLKGFCI-EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAK-GLAYLHEE 608 (679)
Q Consensus 535 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~yLH~~ 608 (679)
|.+.+.+++ |.+-+.+-.++. .....+|||||++|++|.++...... .. .+..++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC
Confidence 666555553 222233322332 23457999999999999887643211 12 23456666665 46788988
Q ss_pred CCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 609 ~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
+++|+|+||.||+++++++++|+|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-13 Score=135.14 Aligned_cols=177 Identities=23% Similarity=0.302 Sum_probs=113.2
Q ss_pred hhhcCcccceEEEEEEeCC-CcEEEEEEecc----cccCHHHHHHHHHHHHhhcC----------CCcceEEEEEE----
Q 046493 495 STKLGQGGFGSVYLGMLPD-GIQVAVKKLES----IGQGKKEFSAEVTTIGNVHH----------LHLVKLKGFCI---- 555 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~---- 555 (679)
.+.||.|+++.||.+++.+ ++++|||+... .....+++++|.-.+..+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4679999999999999876 89999998743 22344667777655555332 22332223222
Q ss_pred -----eC---C-----eeeEEEeccCCCCHhHHhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 046493 556 -----EG---A-----HRLLAYEYLGNGSLDKWIF---NSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK 619 (679)
Q Consensus 556 -----~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 619 (679)
.. . ..+++|+-+ .++|.+++. ........+....++.+..|+++.+++||.. |++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 11 1 236788887 458887753 2222222344556677889999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeccCCcccccCCceeeecccCcccccccccccc--------CCCCcccceeeC
Q 046493 620 PENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN--------NPISEKSDVYSY 679 (679)
Q Consensus 620 p~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwSl 679 (679)
|+|++++++|.++|+||+.....+... .....+..|.+||.... -.++.+.|.|+|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 999999999999999998776544321 11345678999997643 246888899974
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.3e-12 Score=120.21 Aligned_cols=131 Identities=19% Similarity=0.091 Sum_probs=98.4
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEeccCCCCHhH
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEYLGNGSLDK 574 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 574 (679)
+.|+.|.++.||+++.. +..+++|...........+.+|+++++.+.+.++ ++++.+. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999999974 7789999986543334457889999999975554 4455443 334589999999988754
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 575 WIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC--EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 575 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
.. . ....++.+++++|+.||+.. +..++|+|++|.||+++ ++.++++||+.+...
T Consensus 81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 20 0 11345678999999999982 12369999999999999 668999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.2e-12 Score=136.89 Aligned_cols=140 Identities=15% Similarity=0.197 Sum_probs=94.5
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccccc---------------------------C--------H------HHHH
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---------------------------G--------K------KEFS 533 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---------------------------~--------~------~~~~ 533 (679)
+.||+|++|+||+|++++ |+.||||+.++... . . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999988 99999999864210 0 0 1234
Q ss_pred HHHHHHHhhc----CCCcceEEEEEEe-CCeeeEEEeccCCCCHhHHh--hccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 046493 534 AEVTTIGNVH----HLHLVKLKGFCIE-GAHRLLAYEYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLH 606 (679)
Q Consensus 534 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH 606 (679)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++- .........+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4555555553 4444444444433 45678999999999998742 21111111233333444444443
Q ss_pred cCCCCCeeecCCCCCCeEeCCCC----cEEEeeccCCcccccC
Q 046493 607 EECEVKIVHCDIKPENVLLDDNF----TAKVSDFGLAKLMNRE 645 (679)
Q Consensus 607 ~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DFg~a~~~~~~ 645 (679)
.. |++|+|+||.||+++.++ +++++|||++..+...
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 35 999999999999999888 9999999999877553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-12 Score=137.58 Aligned_cols=135 Identities=30% Similarity=0.516 Sum_probs=112.4
Q ss_pred HHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecC
Q 046493 539 IGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI-VHCD 617 (679)
Q Consensus 539 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i-vH~D 617 (679)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ...+++.....++++|++||+|||.. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 46789999999999999999999999999999999999763 34589999999999999999999997 44 9999
Q ss_pred CCCCCeEeCCCCcEEEeeccCCcccccC-CceeeecccCccccccccccccCC-------CCcccceeeC
Q 046493 618 IKPENVLLDDNFTAKVSDFGLAKLMNRE-ESLVYTTLRGTRGYLAPEWITNNP-------ISEKSDVYSY 679 (679)
Q Consensus 618 lkp~NIll~~~~~~kL~DFg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDvwSl 679 (679)
|++.|+++|....+||+|||+....... .........-..-|.|||.+.+.. .+.+.|||||
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 9999999999999999999998876431 111112233456799999997641 4678999996
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.5e-12 Score=99.12 Aligned_cols=58 Identities=22% Similarity=0.503 Sum_probs=49.2
Q ss_pred CcceEEEecccccccccCCCCCCCCCChhHHHHhhccCCceeEEEeeC--CCceeEeeec-c
Q 046493 330 NSAKLFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFFEN--STKNCFLFDQ-I 388 (679)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~y~~--~~~~C~~~~~-l 388 (679)
..++|..+++ +++|+........++++++|++.||+||||+||+|.+ ++++|++|.+ |
T Consensus 3 ~~d~F~~l~~-~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L 63 (66)
T PF08276_consen 3 SGDGFLKLPN-MKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDL 63 (66)
T ss_pred CCCEEEEECC-eeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEe
Confidence 3578889887 9999987664445689999999999999999999986 5689999976 5
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-13 Score=141.89 Aligned_cols=114 Identities=26% Similarity=0.455 Sum_probs=98.9
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
+.+|.|+++...+|.+||.+.+. ....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 56899999999999999975442 3457788899999999999999 6 999999999999999999999999999
Q ss_pred CcccccCC-----ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREE-----SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ ....+...||..||+||.+.++.|+.++|||||
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaL 448 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYAL 448 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhH
Confidence 98766554 223456789999999999999999999999986
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.1e-11 Score=113.32 Aligned_cols=136 Identities=13% Similarity=0.114 Sum_probs=100.8
Q ss_pred hhcCcccceEEEEEEeCC-------CcEEEEEEecccc-----------------------cCHHHHH----HHHHHHHh
Q 046493 496 TKLGQGGFGSVYLGMLPD-------GIQVAVKKLESIG-----------------------QGKKEFS----AEVTTIGN 541 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-----------------------~~~~~~~----~E~~~l~~ 541 (679)
..|+.|--+.||.|...+ +..+|||+.+... ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4799999764210 0012233 79999999
Q ss_pred hc--CCCcceEEEEEEeCCeeeEEEeccCCCCHhH-HhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecC
Q 046493 542 VH--HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDK-WIFNSTEESRFLSWNTRFNIALGMAKGLAYL-HEECEVKIVHCD 617 (679)
Q Consensus 542 l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~D 617 (679)
+. .-++++.+++ ...+|||||+.+..+.. .+.+ ..++..+...+..+++.+|..| |.. ++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 96 3577777765 45689999998654422 1211 1245566778889999999999 787 999999
Q ss_pred CCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 618 IKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 618 lkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|++.||+++ ++.++|+|||.+.....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.9e-12 Score=125.04 Aligned_cols=127 Identities=24% Similarity=0.389 Sum_probs=93.3
Q ss_pred cCCCcceEEEEEEe---------------------------CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHH
Q 046493 543 HHLHLVKLKGFCIE---------------------------GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA 595 (679)
Q Consensus 543 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 595 (679)
+|||||++.++|.+ +...|+||..++ .+|.+|+-.. ..+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence 68888888877653 235689998885 4999998543 36677788899
Q ss_pred HHHHHHHHHHhcCCCCCeeecCCCCCCeEeC--CCC--cEEEeeccCCcccccCC-----ceeeecccCccccccccccc
Q 046493 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLD--DNF--TAKVSDFGLAKLMNREE-----SLVYTTLRGTRGYLAPEWIT 666 (679)
Q Consensus 596 ~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~DFg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 666 (679)
.|+++|+.|||.+ +|.|||+|++||||. +++ ...|+|||.+---.... ....-...|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 444 56899999875332211 01112345788899999876
Q ss_pred cCC-----C-Ccccceee
Q 046493 667 NNP-----I-SEKSDVYS 678 (679)
Q Consensus 667 ~~~-----~-s~~sDvwS 678 (679)
..+ . -.|+|.|+
T Consensus 425 a~PGp~avvny~kAD~WA 442 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWA 442 (598)
T ss_pred cCCCCceeeccchhhhhh
Confidence 432 1 24789886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.7e-12 Score=142.63 Aligned_cols=184 Identities=27% Similarity=0.332 Sum_probs=145.5
Q ss_pred hhhhhhhcCcccceEEEEEEeCC--CcEEEEEEecccc---cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD--GIQVAVKKLESIG---QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 564 (679)
.|++.+.||+|+++.|-...... ...+|+|.+.... ........|..+-+.+. |+|++++++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35666779999999998887643 4566777665433 22344555888878886 999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH-EECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLM 642 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~ 642 (679)
||..++++.+-+.... ....+...+..++.|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999988773211 224667778889999999999999 77 999999999999999999 9999999999887
Q ss_pred cc-C-CceeeecccC-ccccccccccccCC-CCcccceeeC
Q 046493 643 NR-E-ESLVYTTLRG-TRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 643 ~~-~-~~~~~~~~~g-t~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
.. . .........| ++.|+|||...+.. ..+..|+||.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~ 216 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSL 216 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccc
Confidence 76 2 2233345678 99999999998854 4578899984
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.7e-10 Score=103.67 Aligned_cols=132 Identities=19% Similarity=0.294 Sum_probs=102.4
Q ss_pred hcCcccceEEEEEEeCCCcEEEEEE-eccccc--------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 497 KLGQGGFGSVYLGMLPDGIQVAVKK-LESIGQ--------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~~~~vavK~-l~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+.+|+-+.++.+.+ -|.++++|. +++... ......+|++++.+++--.|.-..=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999977 344566663 332111 1244678999999997666655555666788889999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
+|..|.+++... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..-..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 999999888442 256788888889999999 999999999999998764 99999999986544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=113.39 Aligned_cols=142 Identities=21% Similarity=0.243 Sum_probs=111.6
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcC--CCcceEEEEEEeCC---eeeEEEeccC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ--GKKEFSAEVTTIGNVHH--LHLVKLKGFCIEGA---HRLLAYEYLG 568 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 568 (679)
+.|+.|..+.+|+++..+|+.+++|....... ....+..|+++++.+++ .++++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778999999765332 45678999999999975 45677888766542 5689999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC--------------------------------------- 609 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--------------------------------------- 609 (679)
+.++.+.+.. ..++...+..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 24677788888888888888888531
Q ss_pred --------------CCCeeecCCCCCCeEeCC--CCcEEEeeccCCccc
Q 046493 610 --------------EVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLM 642 (679)
Q Consensus 610 --------------~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~ 642 (679)
...++|+|++|.||++++ ++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 667899999988743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.8e-10 Score=102.92 Aligned_cols=142 Identities=19% Similarity=0.284 Sum_probs=107.5
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEE-eccc--------ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKK-LESI--------GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~-l~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|-+|+-+.|+++.. .|+..+||. ..+. ....+...+|++.+.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4578999999999998 677777773 3221 11235678899999999866666555567777778899999
Q ss_pred cCC-CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEEEeeccCCccc
Q 046493 567 LGN-GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAKLM 642 (679)
Q Consensus 567 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~~ 642 (679)
+++ .++.+++...... ....+....++.+|-+.+.-||.+ +|+|+||..+||++.+++ .+.|+|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 987 4788888664422 223333478899999999999999 999999999999997654 4589999998754
Q ss_pred c
Q 046493 643 N 643 (679)
Q Consensus 643 ~ 643 (679)
.
T Consensus 167 ~ 167 (229)
T KOG3087|consen 167 R 167 (229)
T ss_pred c
Confidence 3
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.2e-11 Score=97.18 Aligned_cols=73 Identities=23% Similarity=0.528 Sum_probs=53.2
Q ss_pred cceEEEecccccccccCCCCCCCCCChhHHHHhhccCCceeEEEeeCCCceeEeeec-ccccccccCCCccceeeeeec
Q 046493 331 SAKLFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQ-IGSLQRSQQGSTGYVSYMKIS 408 (679)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~y~~~~~~C~~~~~-l~~~~~~~~~~~~~~~~~kv~ 408 (679)
...|..+.. +++|+..+.. ...++++|++.||+||+|.||+|.+++++|++|.. + .+.......+...|+|++
T Consensus 11 ~~~f~~~~~-~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~--~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPD-VKLPDNASAI--TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLL--NNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCC-eeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEecee--cceEeecCCCcEEEEEeC
Confidence 356777775 8888765542 56789999999999999999999988899999976 3 121111223456888874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.9e-11 Score=134.57 Aligned_cols=144 Identities=26% Similarity=0.340 Sum_probs=99.2
Q ss_pred hhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 571 (679)
+.++.|..|++|.||.++++. .++.|+|+ .+.... .++ ++.....|.+| |+
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li---lRn---ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI---LRN---ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcc-cccchh---hhc---cccccCCccee---------------------ch
Confidence 345789999999999999865 56777743 221110 011 22222333332 44
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc----
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES---- 647 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~---- 647 (679)
-.+.+.. .+.++. +++.+++|||+. +|+|||+||+|.+|..-|.+|++|||+.+.......
T Consensus 138 c~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 138 CATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 4444432 122332 237899999999 999999999999999999999999999875422100
Q ss_pred ----------eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 ----------LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ----------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..-...+||+.|+|||++..+.|...+|+|++
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwam 244 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 244 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHH
Confidence 00123579999999999999999999999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.2e-10 Score=104.59 Aligned_cols=126 Identities=25% Similarity=0.298 Sum_probs=85.2
Q ss_pred EEEEEEeCCCcEEEEEEeccccc---------------------------CHHHHHHHHHHHHhhcCC--CcceEEEEEE
Q 046493 505 SVYLGMLPDGIQVAVKKLESIGQ---------------------------GKKEFSAEVTTIGNVHHL--HLVKLKGFCI 555 (679)
Q Consensus 505 ~Vy~~~~~~~~~vavK~l~~~~~---------------------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 555 (679)
.||.|...++..+|||..+.... .....++|.+.|.++... ++++++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998743100 013467899999999755 677777552
Q ss_pred eCCeeeEEEeccC--CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 556 EGAHRLLAYEYLG--NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY-LHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 556 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
...|||||++ |..+..+.... ++.+....++.+++..+.. +|.. +|+|+||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4479999998 65565543221 1234456677888886665 4677 99999999999999988 999
Q ss_pred EeeccCCccccc
Q 046493 633 VSDFGLAKLMNR 644 (679)
Q Consensus 633 L~DFg~a~~~~~ 644 (679)
|+|||.+.....
T Consensus 147 iIDf~qav~~~~ 158 (188)
T PF01163_consen 147 IIDFGQAVDSSH 158 (188)
T ss_dssp E--GTTEEETTS
T ss_pred EEecCcceecCC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=114.06 Aligned_cols=149 Identities=19% Similarity=0.325 Sum_probs=113.6
Q ss_pred HHHHHHHHHHHhhcCCCcceEEEEEEeCC-----eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 046493 530 KEFSAEVTTIGNVHHLHLVKLKGFCIEGA-----HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604 (679)
Q Consensus 530 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~y 604 (679)
+..+.-+..|-++-|.|||+++.|+.+.. +..++.|||..|+|..+|++.......+......+++.||+.||.|
T Consensus 112 ek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 112 EKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhh
Confidence 33444556677788999999999987643 4678999999999999999877777788899999999999999999
Q ss_pred HhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc---cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 605 LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+ |.+.|+|+++..+.|++..++-+||.--.-..... ...........+-++|.|||.=.....+.++|||+|
T Consensus 192 Lhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 192 LHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred hhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 999 57799999999999999999999885321111000 000000112346789999998766667788999986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.8e-09 Score=104.01 Aligned_cols=138 Identities=16% Similarity=0.059 Sum_probs=101.8
Q ss_pred cCcccceEEEEEEeCCCcEEEEEEecccc------------cCHHHHHHHHHHHHhhcC--CCcceEEEEEEe-----CC
Q 046493 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIG------------QGKKEFSAEVTTIGNVHH--LHLVKLKGFCIE-----GA 558 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~------------~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-----~~ 558 (679)
+-.-....|.+... +|+.+.||+..... .....+.+|.+.+.++.. -..++.+.+... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667766 67889999774322 111247899999999953 345556666653 23
Q ss_pred eeeEEEeccCCC-CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-------CCc
Q 046493 559 HRLLAYEYLGNG-SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-------NFT 630 (679)
Q Consensus 559 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~ 630 (679)
..+||+|++++. +|.+++.... ....+...+..++.+++..+.-||+. ||+|+|++++|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 468999999986 8999885322 22356677889999999999999999 9999999999999975 468
Q ss_pred EEEeeccCCcc
Q 046493 631 AKVSDFGLAKL 641 (679)
Q Consensus 631 ~kL~DFg~a~~ 641 (679)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.4e-10 Score=119.45 Aligned_cols=189 Identities=24% Similarity=0.297 Sum_probs=149.2
Q ss_pred CHHHHHHHhhhhhhhcCc--ccceEEEEEEe--C-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhc-CCCcceEEEE
Q 046493 483 SYDDLCKATKNFSTKLGQ--GGFGSVYLGML--P-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVH-HLHLVKLKGF 553 (679)
Q Consensus 483 ~~~~l~~~~~~~~~~Lg~--G~~g~Vy~~~~--~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 553 (679)
..++.......+.+.+|. |.+|.+|.+.. . ++..+|+|+-+. .......-.+|+...++++ |+|.++....
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 456667777788889999 99999999997 3 478899987432 1223334456777777775 9999999999
Q ss_pred EEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeEeCCC-
Q 046493 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAK----GLAYLHEECEVKIVHCDIKPENVLLDDN- 628 (679)
Q Consensus 554 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~- 628 (679)
+.+.+..++-+|++. .+|.++.... ...++...++.+..+... ||..+|.. .++|-|+||.||++.++
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence 999999999999985 6887776543 334777888888888888 99999999 99999999999999999
Q ss_pred CcEEEeeccCCcccccCCce-e---eecccCccccccccccccCCCCcccceeeC
Q 046493 629 FTAKVSDFGLAKLMNREESL-V---YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 629 ~~~kL~DFg~a~~~~~~~~~-~---~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...+++|||+...+....-. . .....|...|++||.+.+ .++..+|||||
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl 313 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSL 313 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcch
Confidence 89999999999887765421 1 112367888999998865 46888999886
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.4e-09 Score=113.74 Aligned_cols=122 Identities=16% Similarity=0.204 Sum_probs=102.4
Q ss_pred eCCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHH
Q 046493 511 LPDGIQVAVKKLESIGQ-GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWN 589 (679)
Q Consensus 511 ~~~~~~vavK~l~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 589 (679)
..++.+|.|..++.... ......+.++.++.+|||||+++++...+++..|||+|.+. .|..++.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 34688899998876433 23457788899999999999999999999999999999984 68777744 3466
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 590 TRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 590 ~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
.....+.||+.||.|||+.| +++|++|..+.|+|++.|..||++|.++....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 67778899999999999765 99999999999999999999999999886543
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-09 Score=86.07 Aligned_cols=65 Identities=18% Similarity=0.355 Sum_probs=46.7
Q ss_pred eEEEecccccccccCCCCCCCCCChhHHHHhhcc---CCceeEEEeeCCCceeEeeec-c-cccccccCCCccceeeee
Q 046493 333 KLFYLGERLDYFALGFVSPFPRYDLNTCKEACLH---NCSCSVLFFENSTKNCFLFDQ-I-GSLQRSQQGSTGYVSYMK 406 (679)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~y~~~~~~C~~~~~-l-~~~~~~~~~~~~~~~~~k 406 (679)
.|..+.. ++.|++.. .+++||++.|++ ||||+||+|.+.+++|.+|.+ + .++. ...+.+..+|+|
T Consensus 10 ~fl~~~~-~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~--~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIA-LKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVR--KEFSHGFDLYEN 79 (80)
T ss_pred eEEEeec-ccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHH--hccCCCceeEeE
Confidence 4444444 67766553 579999999999 999999999876678999987 5 2332 333345567776
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.7e-09 Score=99.60 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=101.8
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc-----------------------cCHHHHHHHHHHHHhhcCC--C
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----------------------QGKKEFSAEVTTIGNVHHL--H 546 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~~~~E~~~l~~l~h~--n 546 (679)
+.+..+||-|--+.||.|..+.|.++|||.-+... ......++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35668899999999999999999999999542110 0123467899999999755 7
Q ss_pred cceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 547 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
+++.+++ +...+||||++|-.|...- ++.+..-.++..|++-+.-+-.. ||||+|+++=||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777765 5668999999986664321 23334444555555555555555 999999999999999
Q ss_pred CCCcEEEeeccCCccccc
Q 046493 627 DNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~ 644 (679)
++|.+.++||-.+.....
T Consensus 237 ~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCCEEEEeCcccccCCC
Confidence 999999999988765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.3e-07 Score=88.03 Aligned_cols=139 Identities=16% Similarity=0.110 Sum_probs=105.6
Q ss_pred cCcccceEEEEEEeCCCcEEEEEEecc----c---ccCHHHHHHHHHHHHhhc--CCCcceEEEEEEeC----CeeeEEE
Q 046493 498 LGQGGFGSVYLGMLPDGIQVAVKKLES----I---GQGKKEFSAEVTTIGNVH--HLHLVKLKGFCIEG----AHRLLAY 564 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~~~~vavK~l~~----~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~~~lv~ 564 (679)
-+.||.+-|++..+ +|..+-+|+-.. . ......|.+|+..|.+|. ...+++........ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 35689999999887 445788887641 1 346788999999999996 33455555222221 2357999
Q ss_pred eccCC-CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc--EEEeeccCCcc
Q 046493 565 EYLGN-GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--AKVSDFGLAKL 641 (679)
Q Consensus 565 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~~ 641 (679)
|-+++ .+|.+++.+.. ..+.+...+..++.++++.+.-||+. ++.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97763 58999885532 23467888889999999999999999 9999999999999986667 99999987764
Q ss_pred c
Q 046493 642 M 642 (679)
Q Consensus 642 ~ 642 (679)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.7e-08 Score=106.83 Aligned_cols=142 Identities=15% Similarity=0.181 Sum_probs=91.5
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccC-----------------------------------------HHHHHH
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG-----------------------------------------KKEFSA 534 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~ 534 (679)
+.|+.++-|+||+|++++|+.||||+.++.-.. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 468899999999999999999999987542110 012344
Q ss_pred HHHHHHhhc----CCCcceEEEEEE-eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 046493 535 EVTTIGNVH----HLHLVKLKGFCI-EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609 (679)
Q Consensus 535 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 609 (679)
|...+.+++ +..=+++=.++. -.....|+|||++|-.+.+...-.. ...+...+.....++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence 555555542 222223333333 3567789999999999988743221 1234222222221111 1111123
Q ss_pred CCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 610 ~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
++.|.|.+|.||+++.++++.+.|||+...+...
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 8999999999999999999999999999876553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.9e-07 Score=90.55 Aligned_cols=109 Identities=17% Similarity=0.199 Sum_probs=88.2
Q ss_pred CHHHHHHHHHHHHhhc--CCCcceEEEEEEeCC----eeeEEEeccCCC-CHhHHhhccCCCCCCCCHHHHHHHHHHHHH
Q 046493 528 GKKEFSAEVTTIGNVH--HLHLVKLKGFCIEGA----HRLLAYEYLGNG-SLDKWIFNSTEESRFLSWNTRFNIALGMAK 600 (679)
Q Consensus 528 ~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 600 (679)
......+|.+.+.+|+ .-.+++.+++..... ..+||+|++++. +|.+++.... ..+......++.++++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHH
Confidence 3456788999988885 445677777776533 348999999874 8999886532 2566778899999999
Q ss_pred HHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEEEeeccCCcccc
Q 046493 601 GLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAKLMN 643 (679)
Q Consensus 601 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~~~ 643 (679)
.++-||+. ||+|+|+++.|||++.+. .+.|+||+.++...
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999 999999999999999887 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-08 Score=108.73 Aligned_cols=177 Identities=23% Similarity=0.284 Sum_probs=131.5
Q ss_pred hhhhhcCcccceEEEEEEeC--CCcEEEEEEeccccc---CHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEec
Q 046493 493 NFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.+..+|+.+.|+.|+..... ++..+++|.+.+.-. +...-..|+.+...+ .|.++++....+...++.++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 44578999999999987744 478899998755221 122234567776666 499999988888888888899999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcEEEeeccCCcccccC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~~~~ 645 (679)
++++++...+. ....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||....+.-.
T Consensus 348 ~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 348 CEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred hcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence 99998876652 133477888999999999999999998 99999999999999876 78899999998643222
Q ss_pred CceeeecccCcccc-ccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGY-LAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y-~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....+..| .+|+......+-.+.|++||
T Consensus 421 ~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl 452 (524)
T KOG0601|consen 421 SG---VFHHIDRLYPIAEILLEDYPHLSKADIFSL 452 (524)
T ss_pred cc---cccccccccccchhhccccccccccccccc
Confidence 11 111223334 35666666678889999886
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.9e-07 Score=95.09 Aligned_cols=140 Identities=14% Similarity=0.234 Sum_probs=110.4
Q ss_pred ceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeEEEeccCC-CCHhHH
Q 046493 503 FGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLLAYEYLGN-GSLDKW 575 (679)
Q Consensus 503 ~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 575 (679)
-.+.|++... ||..+++|++.... +.......-+++.+++.|+|+|++.+++.. +...++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577888854 79999999994322 223334566889999999999999998873 4577999999986 477776
Q ss_pred hhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 576 IFNSTE-----------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 576 l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
-+.... .+...++..++.++.|+..||.++|+. |+.-+-|.|.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 654322 234477899999999999999999999 999999999999999999999998887766544
Q ss_pred C
Q 046493 645 E 645 (679)
Q Consensus 645 ~ 645 (679)
+
T Consensus 446 d 446 (655)
T KOG3741|consen 446 D 446 (655)
T ss_pred C
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=2e-06 Score=84.50 Aligned_cols=142 Identities=18% Similarity=0.186 Sum_probs=88.0
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEEEEEEeCCeeeEEEeccCCCC-H
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLKGFCIEGAHRLLAYEYLGNGS-L 572 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gs-L 572 (679)
..|++|..+.||+. .+..+++|.... ........+|.++++.+..- .+++.+++..+.+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999983 245678888765 33456679999999999644 35788888888888889999999863 2
Q ss_pred hHHhh--------------c-----cCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhcC-CCCCeeecCCCC
Q 046493 573 DKWIF--------------N-----STEESRFLSWNTRF-NIAL----------GMAK-GLAYLHEE-CEVKIVHCDIKP 620 (679)
Q Consensus 573 ~~~l~--------------~-----~~~~~~~l~~~~~~-~i~~----------~i~~-~L~yLH~~-~~~~ivH~Dlkp 620 (679)
...+. + +............. ++.. .+.+ ...+|... ..+.++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 21110 0 00000001100000 0000 0111 11122211 134678999999
Q ss_pred CCeEeCCCCcEEEeeccCCccc
Q 046493 621 ENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 621 ~NIll~~~~~~kL~DFg~a~~~ 642 (679)
.||++++++ +.|+||+.+..-
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CcEEEcCCC-cEEEechhcCcC
Confidence 999999888 999999988653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3e-06 Score=81.56 Aligned_cols=138 Identities=19% Similarity=0.208 Sum_probs=97.3
Q ss_pred hcCcccceEEEEEEeCCCcEEEEEEecccccCH--------------------H-----HHHHHHHHHHhhc--CCCcce
Q 046493 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK--------------------K-----EFSAEVTTIGNVH--HLHLVK 549 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------------------~-----~~~~E~~~l~~l~--h~niv~ 549 (679)
.|.+|--+.||+|...++..+|||+++...... + -.++|+.-|.++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 477888899999998889999999886422111 1 1345777788874 556666
Q ss_pred EEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC
Q 046493 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629 (679)
Q Consensus 550 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 629 (679)
.+.+. +..|||||+....+ -...-....+..+++..+..++++.+.-|-.. .++||+||+.=|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence 66653 34799999965411 01111111233446777888888888888773 2999999999999999 78
Q ss_pred cEEEeeccCCcccccC
Q 046493 630 TAKVSDFGLAKLMNRE 645 (679)
Q Consensus 630 ~~kL~DFg~a~~~~~~ 645 (679)
.+.|+|++.|.....+
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999999866543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.4e-06 Score=81.43 Aligned_cols=141 Identities=15% Similarity=0.175 Sum_probs=94.2
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCH-H---------HHHHHHHHHHhhcCC---CcceEE
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK-K---------EFSAEVTTIGNVHHL---HLVKLK 551 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~---------~~~~E~~~l~~l~h~---niv~l~ 551 (679)
+++.+..+.+.+.+-......|.+... ++..+++|..+...... + ...+++..+.+++.. ....++
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 456666677777777777777777777 67889999875422211 1 123344445555332 233323
Q ss_pred EEEEe-----CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 552 GFCIE-----GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 552 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
.+... ....+++|||++|..|.++.. +++ .+...+.+++.-||+. |++|+|.+|.|++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 22221 234568999999988866531 222 2456677889999999 999999999999999
Q ss_pred CCCcEEEeeccCCccc
Q 046493 627 DNFTAKVSDFGLAKLM 642 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~ 642 (679)
++ .++++||+..+..
T Consensus 170 ~~-~i~iID~~~k~~~ 184 (229)
T PF06176_consen 170 NN-GIRIIDTQGKRMS 184 (229)
T ss_pred CC-cEEEEECcccccc
Confidence 65 5999999877643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=7e-06 Score=82.09 Aligned_cols=142 Identities=14% Similarity=0.057 Sum_probs=88.4
Q ss_pred cCcccc-eEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccCCCCHhHH
Q 046493 498 LGQGGF-GSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKW 575 (679)
Q Consensus 498 Lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 575 (679)
|..|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+++++++...++..++|||+++|.+|.+.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444444 789999874 4788889876532 445778999998884 45577888887777778999999999887643
Q ss_pred hh-------------------ccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----CCC
Q 046493 576 IF-------------------NSTEESRFLSWN--TRFNIAL--------------------GMAKGLAYLHE----ECE 610 (679)
Q Consensus 576 l~-------------------~~~~~~~~l~~~--~~~~i~~--------------------~i~~~L~yLH~----~~~ 610 (679)
.. .......++... ....... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 000000011100 0000000 01111222211 113
Q ss_pred CCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 611 ~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+.++|+|+.|.|||++++....|+||+.+...
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 46999999999999999877889999988644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.2e-06 Score=90.61 Aligned_cols=140 Identities=18% Similarity=0.194 Sum_probs=91.0
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccC--------------------------------------HHHHHHHHH
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG--------------------------------------KKEFSAEVT 537 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------------------------------------~~~~~~E~~ 537 (679)
+.|+..+.++|++|++++|+.||||+-++.-.. +-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 569999999999999999999999976542110 112444554
Q ss_pred HHHhh----cCCC------cceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 046493 538 TIGNV----HHLH------LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607 (679)
Q Consensus 538 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~ 607 (679)
...+. +|-+ |++++-. -...+.|+||||+|..+.+.-.-. ...++...+..-+.++..-+-+-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~qIf~-- 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQIFK-- 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHHHHh--
Confidence 44433 4555 3333322 234679999999998876653221 22255554443333332222222
Q ss_pred CCCCCeeecCCCCCCeEeCC----CCcEEEeeccCCcccccC
Q 046493 608 ECEVKIVHCDIKPENVLLDD----NFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 608 ~~~~~ivH~Dlkp~NIll~~----~~~~kL~DFg~a~~~~~~ 645 (679)
. |++|+|-+|.||+++. ++.+.+-|||+...+...
T Consensus 320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 8999999999999984 678999999998876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=6e-06 Score=81.80 Aligned_cols=145 Identities=17% Similarity=0.135 Sum_probs=86.7
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEEEEEEeC---CeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLKGFCIEG---AHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~g 570 (679)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+++++...... ...+++||++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468889999999999876 69999997654 4567788999999988633 356777655433 3468999999998
Q ss_pred CHhH----------------Hhh---ccCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc--
Q 046493 571 SLDK----------------WIF---NSTEESRFLSWNT---------RFNI------------ALGMAK-GLAYLHE-- 607 (679)
Q Consensus 571 sL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~~i~~-~L~yLH~-- 607 (679)
.+.. .+. ............. .... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 111 1100001111000 0000 111222 2333332
Q ss_pred --CCCCCeeecCCCCCCeEeC-CCCcEEEeeccCCccc
Q 046493 608 --ECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLM 642 (679)
Q Consensus 608 --~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~ 642 (679)
..+..++|+|+.|.||+++ +++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1234799999999999999 6667789999988643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-05 Score=91.77 Aligned_cols=148 Identities=18% Similarity=0.254 Sum_probs=93.1
Q ss_pred hhcCcccceEEEEEEeCCC---cEEEEEEecccc--cCHHHHHHHHHHHHhhc-CCCc--ceEEEEEEeC---CeeeEEE
Q 046493 496 TKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG--QGKKEFSAEVTTIGNVH-HLHL--VKLKGFCIEG---AHRLLAY 564 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~ 564 (679)
++++.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |+++ ++++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688899999999887553 467888765422 23457889999999995 6654 7888888764 4678999
Q ss_pred eccCCCCHhH--------------------Hh---hccCCC-------CCCCC--HHHHHHHH---------------HH
Q 046493 565 EYLGNGSLDK--------------------WI---FNSTEE-------SRFLS--WNTRFNIA---------------LG 597 (679)
Q Consensus 565 e~~~~gsL~~--------------------~l---~~~~~~-------~~~l~--~~~~~~i~---------------~~ 597 (679)
||++|..+.+ .| +..... +.+.. ..++..+. -.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9999865321 01 110000 00111 11111111 11
Q ss_pred HHHHHHHHhcCCC--------CCeeecCCCCCCeEeCCC-Cc-EEEeeccCCcccc
Q 046493 598 MAKGLAYLHEECE--------VKIVHCDIKPENVLLDDN-FT-AKVSDFGLAKLMN 643 (679)
Q Consensus 598 i~~~L~yLH~~~~--------~~ivH~Dlkp~NIll~~~-~~-~kL~DFg~a~~~~ 643 (679)
+.+.+.+|..+.+ +.+||+|+++.||+++.+ .. .-|.||+++..-.
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2334566644332 359999999999999853 33 5799999987543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-05 Score=69.82 Aligned_cols=84 Identities=25% Similarity=0.470 Sum_probs=57.8
Q ss_pred eEEeeCCcEEEEeCC--ceeEEeccCC--CceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCC
Q 046493 98 FVFEKNGNAYLQRGN--GEAWSANTSG--QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFP 173 (679)
Q Consensus 98 ~~~~~~g~lvl~~~~--~~vWst~~~~--~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~ 173 (679)
+.+..||++|+.... ..+|++++.. .....+.|.++|||||++.++.++|+|=. . +
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t---~---~-------------- 83 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT---T---G-------------- 83 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc---c---C--------------
Confidence 345578999998765 3799998753 23367889999999999998999999821 1 1
Q ss_pred CCCCceEEEEeecCceEEEEecccceeeeec
Q 046493 174 NSNNMSVYLEFKSGDLVLYAGYQTSQTYWSL 204 (679)
Q Consensus 174 ~~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~ 204 (679)
..+.+.+.|+.++ +++++. ....+.|.+
T Consensus 84 ~~~~~~~~L~ddG-nlvl~~--~~~~~~W~S 111 (114)
T smart00108 84 ANGNYVLVLLDDG-NLVIYD--SDGNFLWQS 111 (114)
T ss_pred CCCceEEEEeCCC-CEEEEC--CCCCEEeCC
Confidence 1234555565555 777762 233567765
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.4e-05 Score=69.65 Aligned_cols=84 Identities=26% Similarity=0.464 Sum_probs=58.2
Q ss_pred EEee-CCcEEEEeCC--ceeEEeccCC--CceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCC
Q 046493 99 VFEK-NGNAYLQRGN--GEAWSANTSG--QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFP 173 (679)
Q Consensus 99 ~~~~-~g~lvl~~~~--~~vWst~~~~--~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~ 173 (679)
.... ||+||+.... ..+|++++.. .....+.|.++|||||+|.++.++|||=-..
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~-------------------- 84 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR-------------------- 84 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC--------------------
Confidence 3455 8999998765 3689999753 3456789999999999999999999975221
Q ss_pred CCCCceEEEEeecCceEEEEecccceeeeecc
Q 046493 174 NSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 174 ~~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
..+.+.+.|+.++ +++++. ....+.|.+.
T Consensus 85 ~~~~~~~~L~ddG-nlvl~~--~~~~~~W~Sf 113 (116)
T cd00028 85 VNGNYVLVLLDDG-NLVLYD--SDGNFLWQSF 113 (116)
T ss_pred CCCceEEEEeCCC-CEEEEC--CCCCEEEcCC
Confidence 1234455555555 788773 2245678754
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.5e-05 Score=70.21 Aligned_cols=132 Identities=18% Similarity=0.237 Sum_probs=91.4
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcce-EEEEEEeCCeeeEEEeccCCCC
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVK-LKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gs 571 (679)
+..+.|++|.+|.||++.+ .+..+|+|+-+. ......++.|++++..++-.++.+ ++.|. ..++.|||+.|..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3457899999999999999 455888887654 445778999999999998766554 44442 2345699999988
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCCeEeCCCCcEEEeeccCCccccc
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK-PENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|.+.-.. .+.+. +..+++.---|-.. ||-|+.|. |..++|..+..+.|+||..|+.-..
T Consensus 99 L~~~~~~-------~~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 99 LGKLEIG-------GDRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhhhhc-------ccHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 8765421 12222 33444442233333 89999987 6666666566999999999985443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.4e-05 Score=77.78 Aligned_cols=75 Identities=11% Similarity=0.060 Sum_probs=57.9
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcC---CCcceEEEEEEeC---CeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH---LHLVKLKGFCIEG---AHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~~~~ 569 (679)
+.|+.|..+.||+....++ .+++|..+. ......+..|.+.++.|.. ..++++++++.++ +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 5699999999999987666 466777432 2245688999999999953 4788999888653 568999999998
Q ss_pred CCH
Q 046493 570 GSL 572 (679)
Q Consensus 570 gsL 572 (679)
.++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.5e-05 Score=75.69 Aligned_cols=106 Identities=25% Similarity=0.307 Sum_probs=83.1
Q ss_pred HHHHHHHHhhcC-CCcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 046493 533 SAEVTTIGNVHH-LHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611 (679)
Q Consensus 533 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~ 611 (679)
..|.-+++.+++ +++++++|+|- .+++.||.+.+++... ......-...+|..+.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 458888999976 69999999983 3789999987655321 00000112368999999999999999999996554
Q ss_pred CeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 612 ~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
.+...|++|+|+-+++++++|++|...+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 78999999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.9e-05 Score=71.45 Aligned_cols=131 Identities=18% Similarity=0.262 Sum_probs=94.2
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccc-----------------cCHHHHHHHHHHHHhhc------CCCcceEEE
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----------------QGKKEFSAEVTTIGNVH------HLHLVKLKG 552 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~~ 552 (679)
..||+|+.-.||. +++....+||++.... ...++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4699999999885 5566778889886543 23567788887777666 789999999
Q ss_pred EEEeCCeeeEEEeccCC------CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 553 FCIEGAHRLLAYEYLGN------GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 553 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
+.+++...-+|+|.+.. .+|.+++.+. .++. .. ...+-+-..||-+. .|+.+||+|+||++.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999998999987643 3678888432 2444 33 33334445667777 899999999999996
Q ss_pred CC---C-cEEEee-ccCCc
Q 046493 627 DN---F-TAKVSD-FGLAK 640 (679)
Q Consensus 627 ~~---~-~~kL~D-Fg~a~ 640 (679)
.. . .+.|+| ||...
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 32 2 577777 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.4e-06 Score=93.29 Aligned_cols=170 Identities=19% Similarity=0.086 Sum_probs=123.0
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-cceEEEEEEeCCeeeEEEeccCCC-
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH-LVKLKGFCIEGAHRLLAYEYLGNG- 570 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g- 570 (679)
++-+.+++++.+.+++.+....+....+.+.. ....+-++++|.+++||| .++.++-+..++...+.++++..+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeecc----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34456788899999988865444455665543 255677999999999999 677777677777888999999876
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+-..-... ....+...+...+.+.-+++|++||+. .-+|+| ||+..+ +..+..||+....+.+.. ..
T Consensus 321 s~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 321 SSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred cccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 22211111 011234444556677778999999987 568988 777665 688999999988776653 23
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+...+++.++|||+.....+..+.|+||+
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~ 416 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSL 416 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCC
Confidence 55679999999999998888888898874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.4e-05 Score=75.81 Aligned_cols=73 Identities=12% Similarity=0.121 Sum_probs=48.0
Q ss_pred hhcCcccce-EEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC---CcceEEEEEEeCC---eeeEEEeccC
Q 046493 496 TKLGQGGFG-SVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL---HLVKLKGFCIEGA---HRLLAYEYLG 568 (679)
Q Consensus 496 ~~Lg~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~e~~~ 568 (679)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.++++.+... -++++++.....+ ..+++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456766665 58875 23577786554 33456789999999988632 4555555544322 3478999999
Q ss_pred CCCHh
Q 046493 569 NGSLD 573 (679)
Q Consensus 569 ~gsL~ 573 (679)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.98 E-value=9.2e-05 Score=73.49 Aligned_cols=144 Identities=14% Similarity=0.067 Sum_probs=84.1
Q ss_pred hhcCcccceEEEEEEeCC--CcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-cceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 496 TKLGQGGFGSVYLGMLPD--GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH-LVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
+.|..|-...+|+....+ +..+++|+.........+..+|+.+++.+.... .+++++... ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998764 678999977543222233457999999885433 444544332 2479999999776
Q ss_pred hHH-------h----------hccCCCC-------CCCC-HHHHHHHH-------------------------HHHHHHH
Q 046493 573 DKW-------I----------FNSTEES-------RFLS-WNTRFNIA-------------------------LGMAKGL 602 (679)
Q Consensus 573 ~~~-------l----------~~~~~~~-------~~l~-~~~~~~i~-------------------------~~i~~~L 602 (679)
... + +...... .... +..+..+. .+.+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 321 1 1110000 0111 11211111 1111111
Q ss_pred H-HHhcC-CCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccc
Q 046493 603 A-YLHEE-CEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN 643 (679)
Q Consensus 603 ~-yLH~~-~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~ 643 (679)
. .+... .+..++|+|+.+.|||+++ ++.+.|+||..|....
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~ 203 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY 203 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence 1 11111 2347999999999999998 5789999999887543
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.1e-05 Score=61.25 Aligned_cols=51 Identities=27% Similarity=0.625 Sum_probs=37.1
Q ss_pred EEEecccccccccCCCCCCCCCChhHHHHhhcc-CCceeEEEeeCCCceeEeee
Q 046493 334 LFYLGERLDYFALGFVSPFPRYDLNTCKEACLH-NCSCSVLFFENSTKNCFLFD 386 (679)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~y~~~~~~C~~~~ 386 (679)
|..+++ +.+++.... .....++++|++.|++ +|+|.||.|.+.++.|.+|.
T Consensus 6 f~~~~~-~~l~~~~~~-~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~ 57 (78)
T smart00473 6 FVRLPN-TKLPGFSRI-VISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWS 57 (78)
T ss_pred eEEecC-ccCCCCcce-eEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEee
Confidence 444444 444433221 1235689999999999 99999999987678999998
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=2.1e-06 Score=96.75 Aligned_cols=178 Identities=20% Similarity=0.184 Sum_probs=119.1
Q ss_pred hhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 495 STKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.+-+-++.++.++.+.-.. +...++|..... ....+..+.+-.++-..+||-+++..--+.-....+|+++|+.+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 4467788888888776432 333333332211 11122233333333333455555544444456677999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc-----
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR----- 644 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~----- 644 (679)
++|...|+... ..+.+.+...+..+..+++|||.. .+.|+|++|.|+++..++..+++||+.......
T Consensus 889 ~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 889 GDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99988886532 355556666777889999999998 799999999999999999999999984322110
Q ss_pred ----------------CC---------ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 ----------------EE---------SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ----------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ........+|+.|.+||.+.+......+|+|+.
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 00 001123568999999999999999999999874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00024 Score=75.14 Aligned_cols=74 Identities=15% Similarity=0.126 Sum_probs=55.1
Q ss_pred hhcCcccceEEEEEEeCCC-cEEEEEEeccc--------ccCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCCeeeEE
Q 046493 496 TKLGQGGFGSVYLGMLPDG-IQVAVKKLESI--------GQGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~-~~vavK~l~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 563 (679)
+.||.|.+..||++...+| +.|+||.-... ....+....|.+.|+.+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999999876 58999985321 124566778888888763 3467778777 44567899
Q ss_pred EeccCCCC
Q 046493 564 YEYLGNGS 571 (679)
Q Consensus 564 ~e~~~~gs 571 (679)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00016 Score=72.79 Aligned_cols=139 Identities=14% Similarity=0.062 Sum_probs=80.9
Q ss_pred cCcccceEEEEEEeCCCcEEEEEEecccccCH-HHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEeccCCCCHhHH
Q 046493 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGK-KEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEYLGNGSLDKW 575 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~ 575 (679)
+..|-...+|+... +++.+++|......... -...+|.++++.+....+ ++++.... ..+|+||++|..+..-
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677788998874 57788898765422221 245789999999864433 44554432 3689999998766421
Q ss_pred -----------------hhccCCCCCCCCHHH-HHHHHHHH---------HHHHHHHhcC-----CCCCeeecCCCCCCe
Q 046493 576 -----------------IFNSTEESRFLSWNT-RFNIALGM---------AKGLAYLHEE-----CEVKIVHCDIKPENV 623 (679)
Q Consensus 576 -----------------l~~~~~~~~~l~~~~-~~~i~~~i---------~~~L~yLH~~-----~~~~ivH~Dlkp~NI 623 (679)
|+.......+++... ......++ ...+..+... .+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111111111222211 11111111 1112222111 124689999999999
Q ss_pred EeCCCCcEEEeeccCCccc
Q 046493 624 LLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~ 642 (679)
++++++ +.|+||+.+..-
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999876 789999988654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=3.3e-05 Score=84.08 Aligned_cols=83 Identities=30% Similarity=0.505 Sum_probs=65.5
Q ss_pred HHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee---e-----cccCccccccccccc
Q 046493 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY---T-----TLRGTRGYLAPEWIT 666 (679)
Q Consensus 595 ~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~---~-----~~~gt~~y~aPE~~~ 666 (679)
+.+++.||.|+|.. +++||++|.|++|.++..+..||+.|+.+........... . ...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999987 5999999999999999999999999998875544211111 1 123456899999999
Q ss_pred cCCCCcccceeeC
Q 046493 667 NNPISEKSDVYSY 679 (679)
Q Consensus 667 ~~~~s~~sDvwSl 679 (679)
+...+.++|+|||
T Consensus 183 ~~~~~~~sd~fSl 195 (700)
T KOG2137|consen 183 GTTNTPASDVFSL 195 (700)
T ss_pred cccccccccceee
Confidence 8888899999986
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00038 Score=72.02 Aligned_cols=143 Identities=20% Similarity=0.165 Sum_probs=86.8
Q ss_pred hcCcccceEEEEEEeCC-------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-cceEEEEEEeCCeeeEEEeccC
Q 046493 497 KLGQGGFGSVYLGMLPD-------GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH-LVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.|..|-...+|+....+ ++.+++|+.........+..+|.+++..+.... .+++++++. + .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence 45566667899988755 578999997654434456788999988885333 345555543 2 35899999
Q ss_pred CCCHhHHh-----------------hccCCC--C---CCCC--HHHHH--------------------------HHHHHH
Q 046493 569 NGSLDKWI-----------------FNSTEE--S---RFLS--WNTRF--------------------------NIALGM 598 (679)
Q Consensus 569 ~gsL~~~l-----------------~~~~~~--~---~~l~--~~~~~--------------------------~i~~~i 598 (679)
|..+.... +..... . .... +.... .+...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 87764311 111000 0 0010 11110 011222
Q ss_pred HHHHHHHhc------CCCCCeeecCCCCCCeEeCCC----CcEEEeeccCCcccc
Q 046493 599 AKGLAYLHE------ECEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLMN 643 (679)
Q Consensus 599 ~~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~~~ 643 (679)
.+.+..|.. ..+..++|+|+.|.||+++++ +.++|+||..|....
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~ 215 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY 215 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence 233344432 234579999999999999985 889999999987543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0004 Score=71.62 Aligned_cols=143 Identities=16% Similarity=0.154 Sum_probs=87.8
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEEEE------EEeCCeeeEEEecc
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLKGF------CIEGAHRLLAYEYL 567 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~ 567 (679)
+.|..|....+|+....+ ..+++|+... ........|++++..+++. .+++++.. ....+..++++|++
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 457778778999987644 5788898764 3456678899988888543 34555442 22345668999999
Q ss_pred CCCCHhH----Hh----------hcc----CC---CCCCCCHHHHH----------HHHHHHHHHHHHHhc----CCCCC
Q 046493 568 GNGSLDK----WI----------FNS----TE---ESRFLSWNTRF----------NIALGMAKGLAYLHE----ECEVK 612 (679)
Q Consensus 568 ~~gsL~~----~l----------~~~----~~---~~~~l~~~~~~----------~i~~~i~~~L~yLH~----~~~~~ 612 (679)
+|..+.. .. +.. .. ......|.... .....+..++.++.+ ..+.+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9877532 11 000 00 00111221110 011123344444443 22347
Q ss_pred eeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 613 ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
++|+|+.|.||++++++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999987778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00048 Score=65.15 Aligned_cols=124 Identities=26% Similarity=0.360 Sum_probs=89.4
Q ss_pred HhhhhhhhcCcccc-eEEEEEEeCCCcEEEEEEecc---c---------c----------cCHHHHHHHHHHHHhhc---
Q 046493 490 ATKNFSTKLGQGGF-GSVYLGMLPDGIQVAVKKLES---I---------G----------QGKKEFSAEVTTIGNVH--- 543 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~-g~Vy~~~~~~~~~vavK~l~~---~---------~----------~~~~~~~~E~~~l~~l~--- 543 (679)
...++.+.||.|.. |.||++++ +|+.+|+|..+. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56778899999999 99999999 778999998321 0 0 11134788999888885
Q ss_pred CCCc--ceEEEEEEeCC------------------eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 046493 544 HLHL--VKLKGFCIEGA------------------HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603 (679)
Q Consensus 544 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~ 603 (679)
+.++ ++.+|+..-.. ...||.||.+... .++ .+-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 4456 88898874220 1246677665422 122 234567778889
Q ss_pred HHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 604 yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99998 9999999999986 5689999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00099 Score=57.57 Aligned_cols=96 Identities=20% Similarity=0.307 Sum_probs=56.4
Q ss_pred EeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEe-CCCCCCCCCCceEEeeCCcEEEEeCCc-eeEEeccCCCceeEE
Q 046493 51 ISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTA-NRGLLIRDSDKFVFEKNGNAYLQRGNG-EAWSANTSGQKVECM 128 (679)
Q Consensus 51 ~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvA-Nr~~p~~~~~~~~~~~~g~lvl~~~~~-~vWst~~~~~~~~~a 128 (679)
.+.+|.+.|-|-..++ .+.+. ...++||.+ +...+......+.|..+|||||.+..+ .+|++... ...+.+
T Consensus 15 ~~~s~~~~L~l~~dGn-----Lvl~~-~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-ptdt~L 87 (114)
T PF01453_consen 15 TSSSGNYTLILQSDGN-----LVLYD-SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDY-PTDTLL 87 (114)
T ss_dssp EECETTEEEEEETTSE-----EEEEE-TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTS-SS-EEE
T ss_pred ccccccccceECCCCe-----EEEEc-CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCC-CccEEE
Confidence 3433666666654322 11222 235679999 433333223458999999999998766 69999532 234555
Q ss_pred EEec--CCCEEEEccCCceeeecCCCCc
Q 046493 129 ELQD--SGNLVLLGVNGSILWQSFSHPT 154 (679)
Q Consensus 129 ~Lld--sGNLVl~~~~~~~lWQSFD~PT 154 (679)
..++ .||++ ......+.|.|=+.|+
T Consensus 88 ~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 88 PGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEET--TSEEE-EESTSSEEEESS----
T ss_pred eccCcccCCCc-cccceEEeECCCCCCC
Confidence 5566 88888 6666778999988774
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0012 Score=68.77 Aligned_cols=143 Identities=14% Similarity=0.137 Sum_probs=81.4
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEEEE------EEeCCeeeEEEecc
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLKGF------CIEGAHRLLAYEYL 567 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~ 567 (679)
+.|..|....+|+....++ .+++|+.+ ....+....|++++..|... .+++.+.. ....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3466777789999887555 68889876 23345556677777776422 24444431 22355678999999
Q ss_pred CCCCHh-----------HHh---hccCC-------CCCCCCH-HHHHH------------HHHH-HHHHHHHHhc----C
Q 046493 568 GNGSLD-----------KWI---FNSTE-------ESRFLSW-NTRFN------------IALG-MAKGLAYLHE----E 608 (679)
Q Consensus 568 ~~gsL~-----------~~l---~~~~~-------~~~~l~~-~~~~~------------i~~~-i~~~L~yLH~----~ 608 (679)
+|..+. +.| +.... ....+.+ ..... .+.+ +...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 987542 111 11000 0001111 11110 1111 1112233321 1
Q ss_pred CCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 609 ~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
.+.+++|+|++|.||+++.+...-|+||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 345899999999999999765568999998863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00017 Score=71.83 Aligned_cols=134 Identities=13% Similarity=0.108 Sum_probs=94.7
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc-----------------c------CHHHHHHHHHHHHhhc-CC-C
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----------------Q------GKKEFSAEVTTIGNVH-HL-H 546 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------~------~~~~~~~E~~~l~~l~-h~-n 546 (679)
+.+.++||-|--+.||.+-..+|++.++|.-+... . ..-...+|+..|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 45678999999999999999999999998432100 0 1123567888888885 32 3
Q ss_pred cceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 547 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
+++.+++ +..++|||++.+-.|...- ...+..+ +...+..-+.-|..+ |+||+|..-=||+|+
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~-------~v~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVR-------HVEDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeee-------ecCChHH---HHHHHHHHHHHHHHc---CceecccchheeEEe
Confidence 5555544 5568999999988875532 1122333 334444445556666 999999999999999
Q ss_pred CCCcEEEeeccCCccc
Q 046493 627 DNFTAKVSDFGLAKLM 642 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~ 642 (679)
+++.++++||-.....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0025 Score=66.04 Aligned_cols=144 Identities=19% Similarity=0.224 Sum_probs=84.8
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEEEEE------EeCCeeeEEEecc
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLKGFC------IEGAHRLLAYEYL 567 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e~~ 567 (679)
+.++.|....+|+....++ .+++|+.... ....+...|++++..|... .+++++... ...+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4567777789999886545 5778877542 2345567788888887432 245554421 1245678999999
Q ss_pred CCCCHhH-----------Hh---hccCC----CC----CCCCHHHHH------------HHHHHHHHHHHHHhc----CC
Q 046493 568 GNGSLDK-----------WI---FNSTE----ES----RFLSWNTRF------------NIALGMAKGLAYLHE----EC 609 (679)
Q Consensus 568 ~~gsL~~-----------~l---~~~~~----~~----~~l~~~~~~------------~i~~~i~~~L~yLH~----~~ 609 (679)
+|..+.. .+ +.... .. ..-.|.... .....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8865421 01 11000 00 001111100 111223344555532 23
Q ss_pred CCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 610 ~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+.+++|+|+++.||++++++...|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 45899999999999999887778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00023 Score=56.17 Aligned_cols=34 Identities=24% Similarity=0.621 Sum_probs=30.8
Q ss_pred CCChhHHHHhhccCCceeEEEeeCCCceeEeeec
Q 046493 354 RYDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQ 387 (679)
Q Consensus 354 ~~~~~~C~~~Cl~nCsC~a~~y~~~~~~C~~~~~ 387 (679)
..+.++|++.|+.||+|.||.|....+.|+++..
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 4578999999999999999999987899999865
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00099 Score=67.64 Aligned_cols=72 Identities=19% Similarity=0.258 Sum_probs=49.4
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. -..+++++++....+..+|++||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999988 478899999876 334466889999988884 446889999988888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0023 Score=66.01 Aligned_cols=176 Identities=15% Similarity=0.131 Sum_probs=107.7
Q ss_pred hhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEE------EEeCC-eeeEEEe
Q 046493 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGF------CIEGA-HRLLAYE 565 (679)
Q Consensus 494 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv~e 565 (679)
..+.||+|+.+.+|-.-- -...+.|++.......+ ...+..|.+. .||-+-.-+.+ .-++. ..-++|+
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 357799999999985432 12234577754332221 1223333333 45533321111 01122 2457777
Q ss_pred ccCCCC-HhHHhhc--cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 566 YLGNGS-LDKWIFN--STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 566 ~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
.+++.. ...++.- .+..-....|...++.++.++.+.+-||+. |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 776642 2232221 112233478999999999999999999999 9999999999999999999999985433222
Q ss_pred ccCCceeeecccCccccccccccc-----cCCCCcccceee
Q 046493 643 NREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYS 678 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwS 678 (679)
.........+|...|.+||... +-.-+...|-|.
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FG 206 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFG 206 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchh
Confidence 1222344568999999999764 222345566553
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0026 Score=64.56 Aligned_cols=70 Identities=17% Similarity=0.106 Sum_probs=42.2
Q ss_pred cCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc-C-C-CcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-H-L-HLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
.++|-...|+.....+|+..++|.-+. ......+.+|.++++.++ | + -+++++.. + ...++|++++|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~--~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRVH--T--PELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceeee--c--CceEEEeccCCCcc
Confidence 445555677777656788999998753 223456789999999985 3 2 12333221 1 22456766666543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0052 Score=64.59 Aligned_cols=143 Identities=16% Similarity=0.166 Sum_probs=82.3
Q ss_pred hcCcccceEEEEEEeCC-----CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcc-eEEEEEEeCCeeeEEEeccCCC
Q 046493 497 KLGQGGFGSVYLGMLPD-----GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLV-KLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 570 (679)
.|..|-.-.+|++...+ ++.|++|+........-+..+|.++++.+...++. ++++.+.. . .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCC
Confidence 35556677888887532 36899998765332223347799999988644443 55555432 2 579999887
Q ss_pred CHhHH-----------------hhccCCCC-C-CCCHHHHHHHHHHH-----------------HHHHHH----Hhc-CC
Q 046493 571 SLDKW-----------------IFNSTEES-R-FLSWNTRFNIALGM-----------------AKGLAY----LHE-EC 609 (679)
Q Consensus 571 sL~~~-----------------l~~~~~~~-~-~l~~~~~~~i~~~i-----------------~~~L~y----LH~-~~ 609 (679)
+|..- ++...... . ...+..+.++..++ ...+.. +.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 01111001 1 11122222222111 111112 222 22
Q ss_pred CCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccc
Q 046493 610 EVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN 643 (679)
Q Consensus 610 ~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~ 643 (679)
+..++|+|+++.|||+++ ++.++|+||..+....
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 347899999999999986 4689999999887543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.008 Score=62.36 Aligned_cols=78 Identities=14% Similarity=0.098 Sum_probs=51.7
Q ss_pred hcCcccceEEEEEEeCCC-cEEEEEEecc--------cccCHHHHHHHHHHHHhhc--CC-CcceEEEEEEeCCeeeEEE
Q 046493 497 KLGQGGFGSVYLGMLPDG-IQVAVKKLES--------IGQGKKEFSAEVTTIGNVH--HL-HLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~~-~~vavK~l~~--------~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 564 (679)
.||.|....||++..+++ +.|+||.-.. -....+....|.+.|+... -| .+++++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 6899996532 1223455567777776663 34 45566554 555667999
Q ss_pred eccCCC-CHhHHh
Q 046493 565 EYLGNG-SLDKWI 576 (679)
Q Consensus 565 e~~~~g-sL~~~l 576 (679)
|+++.. .|++.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998643 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0056 Score=62.61 Aligned_cols=143 Identities=16% Similarity=0.231 Sum_probs=81.1
Q ss_pred cccceEEEEEEeCCCcEEEEEEecc---cccCHHHHHHHHHHHHhhcC--CCcceEEEEEEeCC--eeeEEEeccCCCCH
Q 046493 500 QGGFGSVYLGMLPDGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHH--LHLVKLKGFCIEGA--HRLLAYEYLGNGSL 572 (679)
Q Consensus 500 ~G~~g~Vy~~~~~~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL 572 (679)
.|..-.+|..... +++++++ ... .........+|+++|+.+.- .-+.+.++.|.++. ..+.||+|.+|..+
T Consensus 35 ~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 35 GGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred CCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 3333445555543 7778877 332 22334556788888888853 34556677777666 66999999988433
Q ss_pred hHHhhccC--------------------------C--------CCCCCCHHHHHHHH--------HHHHHHHHHHhcCC-
Q 046493 573 DKWIFNST--------------------------E--------ESRFLSWNTRFNIA--------LGMAKGLAYLHEEC- 609 (679)
Q Consensus 573 ~~~l~~~~--------------------------~--------~~~~l~~~~~~~i~--------~~i~~~L~yLH~~~- 609 (679)
.+.+.... . .++...+....+.+ -....-..+|+++.
T Consensus 113 ~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p 192 (321)
T COG3173 113 WSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRP 192 (321)
T ss_pred cCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCC
Confidence 22211000 0 00000011111000 01112233444332
Q ss_pred ----CCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 610 ----EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 610 ----~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
++.++|+|+++.||+++++..+-+.||+++..-..
T Consensus 193 ~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 193 PWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 25699999999999999998899999999976543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0085 Score=61.95 Aligned_cols=141 Identities=23% Similarity=0.300 Sum_probs=85.7
Q ss_pred cCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC------cceEEE----EEEeCCeeeEEEecc
Q 046493 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH------LVKLKG----FCIEGAHRLLAYEYL 567 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lv~e~~ 567 (679)
|.+ .-..+|+....+|+. ++|+.+.. ....++..|+..+..|.-.. |..+=| ........+-++||+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456789999877776 88988876 67788888999988884222 111111 111123678899999
Q ss_pred CCCCHhH-H----h----------h----c----cCCCCCCCCHHH-------------HHHHHHHHHHHHHHHhcCC--
Q 046493 568 GNGSLDK-W----I----------F----N----STEESRFLSWNT-------------RFNIALGMAKGLAYLHEEC-- 609 (679)
Q Consensus 568 ~~gsL~~-~----l----------~----~----~~~~~~~l~~~~-------------~~~i~~~i~~~L~yLH~~~-- 609 (679)
+|..+.. . + + . +........|.. ......++...+..+.+..
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988872 1 1 0 0 111111122320 0112233344444444322
Q ss_pred --CCC---eeecCCCCCCeEeCCCCc-EEEeeccCCcc
Q 046493 610 --EVK---IVHCDIKPENVLLDDNFT-AKVSDFGLAKL 641 (679)
Q Consensus 610 --~~~---ivH~Dlkp~NIll~~~~~-~kL~DFg~a~~ 641 (679)
+.. +||+|+.|.||+++++.. +.++||+-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 223 999999999999998875 89999998763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.014 Score=61.77 Aligned_cols=78 Identities=19% Similarity=0.185 Sum_probs=53.0
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecc-----cc---cCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCCeeeEEE
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLES-----IG---QGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 564 (679)
+.||.|....||+.... +..++||+-.. .. .....-..|.+.|+.+. ..++++++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 56899999999998874 56799997642 11 13344455666666654 357888988876 4457899
Q ss_pred eccCC--CCHhHHh
Q 046493 565 EYLGN--GSLDKWI 576 (679)
Q Consensus 565 e~~~~--gsL~~~l 576 (679)
|++++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99977 3454433
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0074 Score=61.57 Aligned_cols=141 Identities=17% Similarity=0.226 Sum_probs=97.1
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccc----------cC-------------HH----HHHHHHHHHHhhcCCCcc
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIG----------QG-------------KK----EFSAEVTTIGNVHHLHLV 548 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~----------~~-------------~~----~~~~E~~~l~~l~h~niv 548 (679)
.-|..|--+.||.+.-.+|..+|||+++.+- .+ .+ -...|++-|++|+...|+
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3577888899999999999999999875320 00 11 134688888888755543
Q ss_pred eEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC
Q 046493 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN 628 (679)
Q Consensus 549 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 628 (679)
-.--+.. ....|||+|+....... ..-....++...+..+-.|++.-+.-|-+.| ++||.||.-=|+|+. +
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 2211111 12379999996432211 0111234777788888889999999888886 899999999999887 5
Q ss_pred CcEEEeeccCCcccccC
Q 046493 629 FTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 629 ~~~kL~DFg~a~~~~~~ 645 (679)
|.+.|+|-+.+.....+
T Consensus 301 G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CEEEEEEccccccCCCh
Confidence 58999999888755443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.036 Score=57.84 Aligned_cols=139 Identities=15% Similarity=0.150 Sum_probs=80.4
Q ss_pred ccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEE---E--EEEeCCeeeEEEeccCCCCHh
Q 046493 501 GGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLK---G--FCIEGAHRLLAYEYLGNGSLD 573 (679)
Q Consensus 501 G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~gsL~ 573 (679)
+.-..||+....++..+++|..+.......++..|++.+..|... .++... | ....++..+.++++++|....
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~~ 115 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAPE 115 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCCC
Confidence 345679999987888999998875555677788899988877422 223221 1 122345678899999876432
Q ss_pred -----------HHh---hccCC-----CCCCCCHHH-----H-----------------HHHHHHHHHHHHH-Hhc-CCC
Q 046493 574 -----------KWI---FNSTE-----ESRFLSWNT-----R-----------------FNIALGMAKGLAY-LHE-ECE 610 (679)
Q Consensus 574 -----------~~l---~~~~~-----~~~~l~~~~-----~-----------------~~i~~~i~~~L~y-LH~-~~~ 610 (679)
..+ +.... .....+... + ..++.++...++- +.. ..+
T Consensus 116 ~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 195 (325)
T PRK11768 116 LDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGDVR 195 (325)
T ss_pred CCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 111 11000 011112110 0 0112222211111 111 234
Q ss_pred CCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 611 ~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
.+++|+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4789999999999995 4 578999998864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.017 Score=60.46 Aligned_cols=144 Identities=14% Similarity=0.168 Sum_probs=81.2
Q ss_pred hhcCcccceEEEEEEeCC----CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEeccCCC
Q 046493 496 TKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+.|..|-...+|+....+ +..|++|+........-+..+|..+++.+...++ +++++++. ++ +|.||+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 345556667788887543 2478999875533323345689999999875555 45565552 22 589999877
Q ss_pred CHhHH-------h----------hccCCCC-C-CCCHHHHHHHHHH----------------------H---HHHHHHHh
Q 046493 571 SLDKW-------I----------FNSTEES-R-FLSWNTRFNIALG----------------------M---AKGLAYLH 606 (679)
Q Consensus 571 sL~~~-------l----------~~~~~~~-~-~l~~~~~~~i~~~----------------------i---~~~L~yLH 606 (679)
.|..- + +...... . +.-+..+.++..+ + +..+..+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 1 1111000 0 1112222222211 1 11122222
Q ss_pred c--CCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccc
Q 046493 607 E--ECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMN 643 (679)
Q Consensus 607 ~--~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~ 643 (679)
+ ..+.-++|+|+.+.|||+++ ++.++++||+.|..-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 1 11234799999999999975 5789999999887543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.00074 Score=77.72 Aligned_cols=67 Identities=19% Similarity=0.271 Sum_probs=50.6
Q ss_pred eeecCCCCC-CeEeCCCCcEEEeeccCCcccccCCc-eeeecccCccccccccccccCCCCcccceeeC
Q 046493 613 IVHCDIKPE-NVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 613 ivH~Dlkp~-NIll~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
-.|++.+|. |++++.....++.|||.++....... .......||+.|+|||++.+..++.++|||||
T Consensus 498 ~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSl 566 (669)
T cd05610 498 TPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWAL 566 (669)
T ss_pred CCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHH
Confidence 345666666 66777777788999999887654322 12234579999999999999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 679 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-113
Identities = 100/219 (45%), Positives = 135/219 (61%), Gaps = 4/219 (1%)
Query: 465 DLEEDNFLEKISGMPTRFSYDDLCKATKNFST--KLGQGGFGSVYLGMLPDGIQVAVKKL 522
D+ + E G RFS +L A+ NFS LG+GGFG VY G L DG VAVK+L
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 523 -ESIGQG-KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNST 580
E QG + +F EV I H +L++L+GFC+ RLL Y Y+ NGS+ +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 581 EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640
E L W R IALG A+GLAYLH+ C+ KI+H D+K N+LLD+ F A V DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
LM+ +++ V T +RGT G++APE+++ SEK+DV+ Y
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 221
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 3e-93
Identities = 83/226 (36%), Positives = 123/226 (54%), Gaps = 20/226 (8%)
Query: 468 EDNFLEKISGMPTRFSYDDLCKATKNFST--------KLGQGGFGSVYLGMLPDGIQVAV 519
E+ LE FS+ +L T NF K+G+GGFG VY G + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 520 KKLESI-----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDK 574
KKL ++ + K++F E+ + H +LV+L GF +G L Y Y+ NGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 575 WIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 634
+ + + LSW+ R IA G A G+ +LHE +H DIK N+LLD+ FTAK+S
Sbjct: 120 RLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175
Query: 635 DFGLAKLM-NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
DFGLA+ ++++ + + GT Y+APE + I+ KSD+YS+
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSF 220
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 3e-93
Identities = 83/203 (40%), Positives = 122/203 (60%), Gaps = 7/203 (3%)
Query: 481 RFSYDDLCKATKNFSTK--LGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVT 537
R DL +AT NF K +G G FG VY G+L DG +VA+K+ QG +EF E+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 538 TIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALG 597
T+ H HLV L GFC E +L Y+Y+ NG+L + ++ S + +SW R I +G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM-NREESLVYTTLRGT 656
A+GL YLH I+H D+K N+LLD+NF K++DFG++K +++ + T ++GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 657 RGYLAPEWITNNPISEKSDVYSY 679
GY+ PE+ ++EKSDVYS+
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSF 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-60
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 482 FSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTI 539
++L + +G FG V+ VAVK + + EV ++
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 540 GNVHHLHLVKLKGFCIEGAH----RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA 595
+ H ++++ G G L + GSL ++ + +SWN +IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIA 127
Query: 596 LGMAKGLAYLHEE-------CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
MA+GLAYLHE+ + I H DIK +NVLL +N TA ++DFGLA +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 649 VYTTLR-GTRGYLAPEWI-----TNNPISEKSDVYSY 679
T + GTR Y+APE + + D+Y+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-55
Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 12/232 (5%)
Query: 451 HHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM 510
HH+ ++ + E F + G + DL N K+G G FG+V+
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAE 57
Query: 511 LPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567
G VAVK L + + EF EV + + H ++V G + + + EYL
Sbjct: 58 W-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD 627
GSL + + S L R ++A +AKG+ YLH IVH ++K N+L+D
Sbjct: 117 SRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK 174
Query: 628 NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
+T KV DFGL++L + GT ++APE + + P +EKSDVYS+
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G FG V VA+K++ES +K F E+ + V+H ++VKL G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
C+ L EY GSL + + E + + + L ++G+AYLH +
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 614 VHCDIKPENVLLDDNFT-AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
+H D+KP N+LL T K+ DFG A + T +G+ ++APE + SE
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 673 KSDVYSY 679
K DV+S+
Sbjct: 183 KCDVFSW 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-50
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKL-----ESIGQGKKEFSAEVTTIGNVHHLHLV 548
+G GGFG VY G +VAVK E I Q + E + H +++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L+G C++ + L E+ G L++ + + + + N A+ +A+G+ YLH+E
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 609 CEVKIVHCDIKPENVLLD--------DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
V I+H D+K N+L+ N K++DFGLA+ +R + G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWM 181
Query: 661 APEWITNNPISEKSDVYSY 679
APE I + S+ SDV+SY
Sbjct: 182 APEVIRASMFSKGSDVWSY 200
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-48
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 494 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKL--------ESIGQGKKEFSAEVTTIGNVHH 544
+ ++G+GGFG V+ G + D VA+K L + + +EF EV + N++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 545 LHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
++VKL G + E++ G L + + ++ + W+ + + L +A G+ Y
Sbjct: 83 PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 605 LHEECEVKIVHCDIKPENVLLD-----DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+ IVH D++ N+ L AKV+DFGL+ ++ + L G +
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQW 192
Query: 660 LAPEWIT--NNPISEKSDVYSY 679
+APE I +EK+D YS+
Sbjct: 193 MAPETIGAEEESYTEKADTYSF 214
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 37/227 (16%)
Query: 482 FSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAE--VT 537
+ + N +G+G +G+VY G L D VAVK ++ F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF--ANRQNFINEKNIY 59
Query: 538 TIGNVHHLHLVKLKGFCIEG-----AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF 592
+ + H ++ + LL EY NGSL K++ T W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSC 114
Query: 593 NIALGMAKGLAYLHEE------CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-- 644
+A + +GLAYLH E + I H D+ NVL+ ++ T +SDFGL+ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 645 -----EESLVYTTLRGTRGYLAPEWITN-------NPISEKSDVYSY 679
EE + GT Y+APE + ++ D+Y+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-47
Identities = 43/204 (21%), Positives = 83/204 (40%), Gaps = 23/204 (11%)
Query: 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTTIG 540
+ L NF TKL + G ++ G G + VK L + + ++F+ E +
Sbjct: 9 FKQL-----NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 541 NVHHLHLVKLKGFCIEGAHRLLAY--EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM 598
H +++ + G C ++ GSL + T + + + AL M
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDM 120
Query: 599 AKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 658
A+G+A+LH E I + +V++D++ TA++S + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 659 YLAPEWITNNP---ISEKSDVYSY 679
++APE + P +D++S+
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSF 197
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-45
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKKLESIGQ-GKKEFSAEVTTIGNVHHLHLVKLKGFC 554
LG+G FG G + +K+L + ++ F EV + + H +++K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ EY+ G+L I + W+ R + A +A G+AYLH I+
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-------------TTLRGTRGYLA 661
H D+ N L+ +N V+DFGLA+LM E++ T+ G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 662 PEWITNNPISEKSDVYSY 679
PE I EK DV+S+
Sbjct: 191 PEMINGRSYDEKVDVFSF 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 16/190 (8%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G G FG+VY G VAVK L Q + F EV + H++++ G+
Sbjct: 31 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ ++ SL + +IA A+G+ YLH + I
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-EESLVYTTLRGTRGYLAPEWITN---NP 669
+H D+K N+ L ++ T K+ DFGLA +R S + L G+ ++APE I NP
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 670 ISEKSDVYSY 679
S +SDVY++
Sbjct: 202 YSFQSDVYAF 211
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 24/204 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G+G +G V++G G +VAVK + + E+ + H +++
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 554 CIEGAHRLLAY----EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE- 608
I+G +Y NGSL ++ ++T L + +A GL +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 609 ----CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY---TTLRGTRGYLA 661
+ I H D+K +N+L+ N T ++D GLA + + V T GT+ Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 662 PE------WITNNPISEKSDVYSY 679
PE + +D+YS+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSF 238
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 28/206 (13%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAE--VTTIGNVHHLHLVKLK 551
+G+G +G V+ G G VAVK S + +K + E + + H +++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 552 GFCIEGAHRLLAY----EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
+ H Y GSL ++ +T L + I L +A GLA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 608 E-----CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY---TTLRGTRGY 659
E + I H D+K +N+L+ N ++D GLA + ++ + + GT+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 660 LAPEWITNNPI------SEKSDVYSY 679
+APE + ++ D++++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAF 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 50/202 (24%), Positives = 77/202 (38%), Gaps = 25/202 (12%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G+G FG VY G +VA++ + K F EV H ++V
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G C+ H + +L + + L N IA + KG+ YLH +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR----EESLVYTTLRGTRGYLAPEWIT 666
I+H D+K +NV D+ ++DFGL + G +LAPE I
Sbjct: 150 -GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 667 N---------NPISEKSDVYSY 679
P S+ SDV++
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFAL 229
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G FG V+ G G +VAVK S + AE+ + H +++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 554 CIEGAHRLLAY----EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE- 608
+ +Y +GSL ++ ++ +AL A GLA+LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 609 ----CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES---LVYTTLRGTRGYLA 661
+ I H D+K +N+L+ N T ++D GLA + + GT+ Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 662 PE------WITNNPISEKSDVYSY 679
PE + + +++D+Y+
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAM 243
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 16/190 (8%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
++G+G FG V+ G L D VAVK K +F E + H ++V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
C + + E + G ++ E L T + A G+ YL +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY----LAPEWITNNP 669
+H D+ N L+ + K+SDFG+++ Y G R APE +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291
Query: 670 ISEKSDVYSY 679
S +SDV+S+
Sbjct: 292 YSSESDVWSF 301
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLGQG FG V++G +VA+K L+ + F E + + H LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
E + EY+ GSL F E ++L ++A +A G+AY+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
VH D++ N+L+ +N KV+DFGLA+L+ E YT +G + + APE
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 358
Query: 671 SEKSDVYSY 679
+ KSDV+S+
Sbjct: 359 TIKSDVWSF 367
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 27/199 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
+G GGFG V+ DG +K+ + ++ EV + + H+++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 556 EGAHRLLAY----------------EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMA 599
+ E+ G+L++WI L + +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQIT 132
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
KG+ Y+H + K+++ D+KP N+ L D K+ DFGL + + T +GT Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRY 187
Query: 660 LAPEWITNNPISEKSDVYS 678
++PE I++ ++ D+Y+
Sbjct: 188 MSPEQISSQDYGKEVDLYA 206
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLGQG FG V++G +VA+K L+ + F E + + H LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
E + EY+ GSL F E ++L ++A +A G+AY+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPI 670
VH D++ N+L+ +N KV+DFGLA+L+ E YT +G + + APE
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 441
Query: 671 SEKSDVYSY 679
+ KSDV+S+
Sbjct: 442 TIKSDVWSF 450
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
KLG G FG V++ +VAVK ++ + F AE + + H LVKL
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ + E++ GSL F ++E + + +A+G+A++ +
Sbjct: 252 VTK-EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWITNNPI 670
+H D++ N+L+ + K++DFGLA+++ E YT G + + APE I
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSF 362
Query: 671 SEKSDVYSY 679
+ KSDV+S+
Sbjct: 363 TIKSDVWSF 371
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-34
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 12/190 (6%)
Query: 494 FSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
KLG G +G VY G+ + VAVK L+ +EF E + + H +LV+L G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
C + E++ G+L + + +S +A ++ + YL ++
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNP 669
+H ++ N L+ +N KV+DFGL++LM + YT G + + APE + N
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNK 395
Query: 670 ISEKSDVYSY 679
S KSDV+++
Sbjct: 396 FSIKSDVWAF 405
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 9/187 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQG----KKEFSAEVTTIGNVHHLHLVKLK 551
K+G+G F VY L DG+ VA+KK++ + + E+ + ++H +++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
IE + E G L + I + ++ R + T + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--- 155
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+++H DIKP NV + K+ D GL + + + + ++ + GT Y++PE I N +
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 672 EKSDVYS 678
KSD++S
Sbjct: 215 FKSDIWS 221
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 497 KLGQGGFGSVYLGMLP-----DGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG+G FG V L G QVAVK L ES G + E+ + N++H ++VK
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 550 LKGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
KG C E L E+L +GSL +++ + + ++ + A+ + KG+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGS 144
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 664
+ VH D+ NVL++ K+ DFGL K + ++ YT + APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVFWYAPEC 200
Query: 665 ITNNPISEKSDVYSY 679
+ + SDV+S+
Sbjct: 201 LMQSKFYIASDVWSF 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
LG+GGFG V+ D A+K+ L + +++ EV + + H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 554 CIEGAHRLLAY------------EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKG 601
+E + +L W+ N + +I L +A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHIFLQIAEA 130
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-----------VY 650
+ +LH + ++H D+KP N+ + KV DFGL M+++E +
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 651 TTLRGTRGYLAPEWITNNPISEKSDVYS 678
T GT+ Y++PE I N S K D++S
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+LG G FG V LG VAVK ++ + EF E T+ + H LVK G C +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ NG L ++ + L + + + +G+A+L + +H
Sbjct: 75 EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D+ N L+D + KVSDFG+ + + ++ Y + GT+ + APE S K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 674 SDVYSY 679
SDV+++
Sbjct: 186 SDVWAF 191
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 54/186 (29%), Positives = 96/186 (51%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
++G G FG V+LG + +VA+K + +++F E + + H LV+L G C+E
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
A L E++ +G L ++ + T + L + +G+AYL E ++H
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CVIHR 128
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D+ N L+ +N KVSDFG+ + + ++ YT+ GT+ + +PE + + S K
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 674 SDVYSY 679
SDV+S+
Sbjct: 186 SDVWSF 191
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 497 KLGQGGFGSVYLGMLP-----DGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG+G FGSV + G VAVKKL S + ++F E+ + ++ H ++VK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 551 KGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
KG C R L EYL GSL ++ E + + KG+ YL +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 133
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWI 665
+ +H D+ N+L+++ K+ DFGL K++ +++ + + APE +
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPIFWYAPESL 189
Query: 666 TNNPISEKSDVYSY 679
T + S SDV+S+
Sbjct: 190 TESKFSVASDVWSF 203
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 497 KLGQGGFGSVYLGMLP-----DGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG+G FGSV + G VAVKKL S + ++F E+ + ++ H ++VK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 551 KGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
KG C R L EYL GSL ++ E + + KG+ YL +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK 164
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWI 665
+ +H D+ N+L+++ K+ DFGL K++ +++ Y + APE +
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFWYAPESL 220
Query: 666 TNNPISEKSDVYSY 679
T + S SDV+S+
Sbjct: 221 TESKFSVASDVWSF 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 52/187 (27%), Positives = 76/187 (40%), Gaps = 15/187 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTTIGNV-HHLHLVKLK 551
+LG G +G V+ DG AVK+ S +G K+ + AEV + V H V+L+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
EG L E G SL + L + LA+LH +
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ--- 176
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+VH D+KP N+ L K+ DFGL + + G Y+APE +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPE-LLQGSYG 233
Query: 672 EKSDVYS 678
+DV+S
Sbjct: 234 TAADVFS 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 9/190 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLKG 552
+G G +G DG + K+L+ + E EV + + H ++V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 553 -FCIEGAHRLLAY-EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
L EY G L I T+E ++L + + L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 611 V--KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
++H D+KP NV LD K+ DFGLA+++N + S T GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSPEQMNRM 191
Query: 669 PISEKSDVYS 678
+EKSD++S
Sbjct: 192 SYNEKSDIWS 201
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 497 KLGQGGFGSVYLGMLP-----DGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG+G FGSV L G VAVK+L S +++F E+ + +H +VK
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 551 KGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
+G + L EYL +G L ++ L + + + KG+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSR 146
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG---YLAPEWI 665
+ VH D+ N+L++ K++DFGLAKL+ ++ Y + + APE +
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPESL 202
Query: 666 TNNPISEKSDVYSY 679
++N S +SDV+S+
Sbjct: 203 SDNIFSRQSDVWSF 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 496 TKLGQGGFGSVYLGMLPDG---IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG G FGSV G+ I VA+K L + +E E + + + ++V+L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G C A L+ E G G L K++ + + + + ++ G+ YL E
Sbjct: 76 IGVCQAEALMLVM-EMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 667
VH D+ NVLL + AK+SDFGL+K + ++S YT + + APE I
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINF 187
Query: 668 NPISEKSDVYSY 679
S +SDV+SY
Sbjct: 188 RKFSSRSDVWSY 199
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
LGQG FG V D A+KK+ + +EV + +++H ++V+ +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 556 EGAHRLLAY-------------EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
E + + EY NG+L I E+ + + + + + L
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEAL 129
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY------------ 650
+Y+H + I+H D+KP N+ +D++ K+ DFGLAK ++R ++
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 651 -TTLRGTRGYLAPEWITNNPI-SEKSDVYS 678
T+ GT Y+A E + +EK D+YS
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 497 KLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G G G V G L + VA+K L + +++F +E + +G H ++++L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+G G ++ EY+ NGSLD ++ + + + G+ G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG------TRGYLAPEW 664
VH D+ NVL+D N KVSDFGL++++ + YTT G T APE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEA 225
Query: 665 ITNNPISEKSDVYSY 679
I S SDV+S+
Sbjct: 226 IAFRTFSSASDVWSF 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+LG G FG V++G +VAVK L+ F AE + + H LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ NGSL F T L+ N ++A +A+G+A++ E +H
Sbjct: 80 E-PIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-----APEWITNNPIS 671
D++ N+L+ D + K++DFGLA+L+ E YT G + APE I +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK--FPIKWTAPEAINYGTFT 188
Query: 672 EKSDVYSY 679
KSDV+S+
Sbjct: 189 IKSDVWSF 196
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+LG G FG V G VA+K ++ + EF E + N+ H LV+L G C +
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ NG L ++ + + + + YL + + +H
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISEK 673
D+ N L++D KVSDFGL++ + +E YT+ G++ + PE + + S K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 674 SDVYSY 679
SD++++
Sbjct: 202 SDIWAF 207
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 10/186 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA---EVTTIGNVHHLHLVKLKG 552
K+G+G FG L DG Q +K++ KE EV + N+ H ++V+ +
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
E + +Y G L K I + ++ + + + + L ++H+ K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
I+H DIK +N+ L + T ++ DFG+A+++N L + GT YL+PE N P +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204
Query: 673 KSDVYS 678
KSD+++
Sbjct: 205 KSDIWA 210
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 497 KLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
+G G FG VY GML + VA+K L + + +F E +G H ++++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L+G + ++ EY+ NG+LDK++ E S + G+A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANM- 166
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG------TRGYLAPE 663
VH D+ N+L++ N KVSDFGL++++ + YTT G T APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 664 WITNNPISEKSDVYSY 679
I+ + SDV+S+
Sbjct: 221 AISYRKFTSASDVWSF 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 22/234 (9%)
Query: 453 NKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM-L 511
+ +L + E + + L P + Y + + ++G+G FG V+
Sbjct: 22 SGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP-RVGRGSFGEVHRMKDK 80
Query: 512 PDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGS 571
G Q AVKK+ + + E E+ + +V L G EG + E L GS
Sbjct: 81 QTGFQCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 572 LDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN- 628
L + I E R L +GL YLH +I+H D+K +NVLL +
Sbjct: 137 LGQLIKQMGCLPEDRAL------YYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDG 187
Query: 629 FTAKVSDFGLAKLMNREESLVYT----TLRGTRGYLAPEWITNNPISEKSDVYS 678
A + DFG A + + + GT ++APE + P K D++S
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 497 KLGQGGFGSVYLGML-PDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG G FG+VY G+ P+G I VA+K+L + + KE E + +V + H+ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L G C+ L + + G L ++ + + N + +AKG+ YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 666
++VH D+ NVL+ K++DFGLAKL+ EE G + ++A E I
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 667 NNPISEKSDVYSY 679
+ + +SDV+SY
Sbjct: 193 HRIYTHQSDVWSY 205
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 497 KLGQGGFGSVYLGML-----PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG+G FG V L G VAVK L ++ Q + + E+ + ++H H++K
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 550 LKGFCIEGAHR--LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
KG C + L EY+ GSL ++ + A + +G+AYLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 664
+ +H D+ NVLLD++ K+ DFGLAK + Y + APE
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPEC 208
Query: 665 ITNNPISEKSDVYSY 679
+ SDV+S+
Sbjct: 209 LKEYKFYYASDVWSF 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 59/192 (30%), Positives = 92/192 (47%), Gaps = 16/192 (8%)
Query: 496 TKLGQGGFGSVYLGMLPDG---IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG G FGSV G+ I VA+K L + +E E + + + ++V+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G C A L+ E G G L K++ EE + + + ++ G+ YL E+
Sbjct: 402 IGVCQAEALMLVM-EMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK-- 455
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 667
VH ++ NVLL + AK+SDFGL+K + ++S YT + + APE I
Sbjct: 456 -NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINF 513
Query: 668 NPISEKSDVYSY 679
S +SDV+SY
Sbjct: 514 RKFSSRSDVWSY 525
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG-----IQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLH 546
LG G FG+V+ G+ I V +K + +S Q + + + IG++ H H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+V+L G C + +L+ +YL GSL + L N + +AKG+ YL
Sbjct: 77 IVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE 132
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPE 663
E +VH ++ NVLL +V+DFG+A L+ ++ + ++A E
Sbjct: 133 EH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWMALE 187
Query: 664 WITNNPISEKSDVYSY 679
I + +SDV+SY
Sbjct: 188 SIHFGKYTHQSDVWSY 203
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 18/192 (9%)
Query: 497 KLGQGGFGSVYLGMLPDG---IQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG G FG+V G VAVK L + K E AE + + + ++V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G C + L+ E G L+K++ +++R + + ++ G+ YL E
Sbjct: 84 IGICEAESWMLVM-EMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 667
VH D+ NVLL AK+SDFGL+K + +E+ Y + + APE I
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINY 194
Query: 668 NPISEKSDVYSY 679
S KSDV+S+
Sbjct: 195 YKFSSKSDVWSF 206
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 22/195 (11%)
Query: 497 KLGQGGFGSVYLGMLP----DGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G G FG V G L I VA+K L + +++F E + +G H ++++L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+G + ++ EY+ NGSLD ++ + + + G+A G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG------TRGYLAPEW 664
VH D+ N+L++ N KVSDFGL +++ + YTT G T +PE
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEA 221
Query: 665 ITNNPISEKSDVYSY 679
I + SDV+SY
Sbjct: 222 IAYRKFTSASDVWSY 236
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 497 KLGQGGFGSVYLGMLPDG-IQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
KLG G +G VY G+ + VAVK L+ +EF E + + H +LV+L G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
+ E++ G+L + + +S +A ++ + YL ++ +H
Sbjct: 80 REPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITNNPISE 672
D+ N L+ +N KV+DFGL++LM + YT G + + APE + N S
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 673 KSDVYSY 679
KSDV+++
Sbjct: 192 KSDVWAF 198
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 62/261 (23%), Positives = 103/261 (39%), Gaps = 38/261 (14%)
Query: 448 GLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDD---LCKATKNFSTKLGQGGFG 504
G+ + K+K + + +E PT+ Y++ + F LG G FG
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFG 60
Query: 505 SVYLGMLPD------GIQVAVKKL--ESIGQGKKEFSAEV---TTIGNVHHLHLVKLKGF 553
V ++VAVK L + K+ +E+ + +G H ++V L G
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHENIVNLLGA 118
Query: 554 CIEGAHRLLAYEYLGNGSL----------DKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
C G L+ EY G L + + S + + +A+G+A
Sbjct: 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL--- 660
+L + +H D+ NVLL + AK+ DFGLA+ + + Y L
Sbjct: 179 FLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS--NYI--VKGNARLPVK 231
Query: 661 --APEWITNNPISEKSDVYSY 679
APE I + + +SDV+SY
Sbjct: 232 WMAPESIFDCVYTVQSDVWSY 252
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLH 546
+F+ +G+G FG VY G L D I AVK L + +F E + + H +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 547 LVKLKGFCIEGAH-RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
++ L G C+ L+ Y+ +G L +I N T + L +AKG+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYL 144
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL----- 660
+ K VH D+ N +LD+ FT KV+DFGLA+ M +E Y+ T L
Sbjct: 145 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY--YSVHNKTGAKLPVKWM 199
Query: 661 APEWITNNPISEKSDVYSY 679
A E + + KSDV+S+
Sbjct: 200 ALESLQTQKFTTKSDVWSF 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-30
Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 22/192 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G FG V LG G +VAVK +++ + F AE + + + H +LV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 554 CIEGAHRLLAY---EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+E L Y EY+ GSL + + L + +L + + + YL
Sbjct: 255 IVEEKGGL--YIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 667
VH D+ NVL+ ++ AKVSDFGL +E +T + + APE +
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLT----KEA---SSTQDTGKLPVKWTAPEALRE 360
Query: 668 NPISEKSDVYSY 679
S KSDV+S+
Sbjct: 361 KKFSTKSDVWSF 372
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 497 KLGQGGFGSVYLGML-PDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG G FG+VY G+ P+G I VA+K+L + + KE E + +V + H+ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L G C+ L + + G L ++ + + N + +AKG+ YL +
Sbjct: 82 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWIT 666
++VH D+ NVL+ K++DFGLAKL+ EE G + ++A E I
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 667 NNPISEKSDVYSY 679
+ + +SDV+SY
Sbjct: 193 HRIYTHQSDVWSY 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDG----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLH 546
+F+ +G+G FG VY G L D I AVK L + +F E + + H +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 547 LVKLKGFCIEGAH-RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
++ L G C+ L+ Y+ +G L +I N T + L +AKG+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFL 208
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL----- 660
K VH D+ N +LD+ FT KV+DFGLA+ M +E T L
Sbjct: 209 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWM 263
Query: 661 APEWITNNPISEKSDVYSY 679
A E + + KSDV+S+
Sbjct: 264 ALESLQTQKFTTKSDVWSF 282
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG----IQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHL 547
+G+G FG VY G D IQ A+K + Q + F E + ++H ++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 548 VKLKGFCIEGA-HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+ L G + + Y+ +G L ++I R + + L +A+G+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL------ 660
E+ K VH D+ N +LD++FT KV+DFGLA+ + E Y +++ R
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE---YYSVQQHRHARLPVKWT 195
Query: 661 APEWITNNPISEKSDVYSY 679
A E + + KSDV+S+
Sbjct: 196 ALESLQTYRFTTKSDVWSF 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 19/194 (9%)
Query: 497 KLGQGGFGSVYLGML--PDG--IQVAVKKL----ESIGQGKKEFSAEVTTIGNVHHLHLV 548
KLG G FG V G P G + VAVK L S + +F EV + ++ H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
+L G + +++ E GSL + T A+ +A+G+ YL +
Sbjct: 85 RLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESK 140
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWI 665
+ +H D+ N+LL K+ DFGL + + + + Y + + APE +
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESL 196
Query: 666 TNNPISEKSDVYSY 679
S SD + +
Sbjct: 197 KTRTFSHASDTWMF 210
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 497 KLGQGGFGSVYLGMLPDG----IQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVK 549
LG+G FGSV G L ++VAVK ++ + +EF +E + + H ++++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 550 LKGFCIEGAHRLLAY-----EYLGNGSLDKWIFNS--TEESRFLSWNTRFNIALGMAKGL 602
L G CIE + + + ++ G L ++ S + + T + +A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-- 660
YL +H D+ N +L D+ T V+DFGL+K + + Y +G +
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD--YYR--QGRIAKMPV 213
Query: 661 ---APEWITNNPISEKSDVYSY 679
A E + + + KSDV+++
Sbjct: 214 KWIAIESLADRVYTSKSDVWAF 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 19/195 (9%)
Query: 494 FSTKLGQGGFGSVYLGML----PDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHL 547
+ LG+G FG VY G+ + I VAVK K + K++F +E + N+ H H+
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
VKL G E + E G L ++ + L T +L + K +AYL
Sbjct: 76 VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLES 131
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEW 664
VH DI N+L+ K+ DFGL++ + E+ Y TR +++PE
Sbjct: 132 I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPES 185
Query: 665 ITNNPISEKSDVYSY 679
I + SDV+ +
Sbjct: 186 INFRRFTTASDVWMF 200
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNV--HHLHLVKLK 551
++G GG V+ + A+K E+ Q + E+ + + H +++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ I + + E GN L+ W+ ++ + + R + M + + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY-TTLRGTRGYLAPEWITNNP- 669
IVH D+KP N L+ D K+ DFG+A M + + V + GT Y+ PE I +
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 670 ----------ISEKSDVYS 678
IS KSDV+S
Sbjct: 206 SRENGKSKSKISPKSDVWS 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 43/230 (18%)
Query: 476 SGMPTRFS--YDDLCKATKNFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEF 532
GM +R++ + +L K +G G FGSV+ + DG A+K+ + G +
Sbjct: 3 MGMKSRYTTEFHELEK--------IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE 54
Query: 533 SA---EVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSW 588
EV + H H+V+ E H L+ EY GSL I + +
Sbjct: 55 QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-------------------F 629
++ L + +GL Y+H +VH DIKP N+ +
Sbjct: 115 AELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 630 TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WITNNPISEKSDVYS 678
K+ D G ++ + G +LA E N K+D+++
Sbjct: 172 MFKIGDLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFA 216
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 22/192 (11%)
Query: 494 FSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G FG V LG G +VAVK +++ + F AE + + + H +LV+L G
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 554 CIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+E L + EY+ GSL + + L + +L + + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-----APEWITN 667
VH D+ NVL+ ++ AKVSDFGL +E +T + L APE +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT----KEA---SSTQDTGK--LPVKWTAPEALRE 188
Query: 668 NPISEKSDVYSY 679
S KSDV+S+
Sbjct: 189 KKFSTKSDVWSF 200
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 19/192 (9%)
Query: 497 KLGQGGFGSVYLGMLPDG----IQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G+G FG V+ G+ + VA+K K + +++F E T+ H H+VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G E + E G L ++ L + A ++ LAYL +
Sbjct: 82 IGVITENPV-WIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK-- 135
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 667
+ VH DI NVL+ N K+ DFGL++ M Y + ++APE I
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINF 191
Query: 668 NPISEKSDVYSY 679
+ SDV+ +
Sbjct: 192 RRFTSASDVWMF 203
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 30/209 (14%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLH 546
+LG+G FG V+L + + VAVK L E+ +++F E + + H H
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSL-----------DKWIFNSTEESRFLSWNTRFNIA 595
+V+ G C EG L+ +EY+ +G L L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 655
+A G+ YL + VH D+ N L+ K+ DFG+++ + + Y G
Sbjct: 165 SQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYR-VG 217
Query: 656 TRGYL-----APEWITNNPISEKSDVYSY 679
R L PE I + +SDV+S+
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSF 246
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 26/199 (13%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNV--HHLHLVKLK 551
++G GG V+ + A+K E+ Q + E+ + + H +++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ I + + E GN L+ W+ ++ + + R + M + + +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWITNNP- 669
IVH D+KP N L+ D K+ DFG+A M + S+V + GT Y+ PE I +
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 670 ----------ISEKSDVYS 678
IS KSDV+S
Sbjct: 187 SRENGKSKSKISPKSDVWS 205
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 20/199 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
KLG+GGF V L L DG A+K++ Q ++E E +H ++++L +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 555 IE----GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ L + G+L I ++ FL+ + + LG+ +GL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT--------TLRGTRGYLAP 662
H D+KP N+LL D + D G R T Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 663 EWI---TNNPISEKSDVYS 678
E ++ I E++DV+S
Sbjct: 213 ELFSVQSHCVIDERTDVWS 231
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 27/203 (13%)
Query: 497 KLGQGGFGSVYLGMLPDG----IQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG+G FGSV L ++VAVK L +EF E + H H+ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 550 LKGFCIEGAHRLLAY------EYLGNGSLDKWIFNS--TEESRFLSWNTRFNIALGMAKG 601
L G + + ++ +G L ++ S E L T + +A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL- 660
+ YL +H D+ N +L ++ T V+DFGL++ + + Y +G L
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD--YYR--QGCASKLP 202
Query: 661 ----APEWITNNPISEKSDVYSY 679
A E + +N + SDV+++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAF 225
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 47/193 (24%), Positives = 85/193 (44%), Gaps = 22/193 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE---FSAEVTTIGNVHHLHLVKLKG 552
++G+G F +VY G+ ++VA +L+ K E F E + + H ++V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 553 FCI---EGAHRLLAY-EYLGNGSLDKWI--FNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+G ++ E + +G+L ++ F + SW + + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILKGLQFLH 146
Query: 607 EECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
I+H D+K +N+ + + K+ D GLA L + + GT ++APE
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 202
Query: 666 TNNPISEKSDVYS 678
E DVY+
Sbjct: 203 EEK-YDESVDVYA 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 26/199 (13%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKE---FSAEVTTIGNVHH--LHLVKLK 551
++G GG V+ + A+K + + + E+ + + +++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ I + + E GN L+ W+ ++ + + R + M + + +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWITNNP- 669
IVH D+KP N L+ D K+ DFG+A M + S+V + G Y+ PE I +
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 670 ----------ISEKSDVYS 678
IS KSDV+S
Sbjct: 234 SRENGKSKSKISPKSDVWS 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 26/205 (12%)
Query: 494 FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHL 545
LG G FG VY G + P +QVAVK L Q + +F E I +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS---TEESRFLSWNTRFNIALGMAKGL 602
++V+ G ++ R + E + G L ++ + + L+ ++A +A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 603 AYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
YL E +H DI N LL AK+ DFG+A+ + R Y +G
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYR-KGGCAM 206
Query: 660 L-----APEWITNNPISEKSDVYSY 679
L PE + K+D +S+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSF 231
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 17/188 (9%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+GGF + A K L Q +K S E++ ++ H H+V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G E + + E SL + R+ + G YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+++H D+K N+ L+++ K+ DFGLA + + GT Y+APE ++
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH 218
Query: 671 SEKSDVYS 678
S + DV+S
Sbjct: 219 SFEVDVWS 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 32/226 (14%), Positives = 65/226 (28%), Gaps = 53/226 (23%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK--------KLESIGQGKKE----------------- 531
LGQ + G V +I Q K+E
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 532 ------FSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG--NGSLDKWIFNSTEES 583
F ++ + V+L + R Y + + + + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 584 RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643
+ L + R + L + + LA LH +VH ++P +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 644 REESLVYTTLRGTRGYLAPEWITNN-----------PISEKSDVYS 678
+RG+ PE ++ D ++
Sbjct: 258 A-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLH 546
+LG+G FG V+L + + VAVK L + +K+F E + N+ H H
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSL------------DKWIFNSTEESRFLSWNTRFNI 594
+VK G C +G ++ +EY+ +G L + L + +I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 654
A +A G+ YL + VH D+ N L+ N K+ DFG+++ + + Y
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYR-V 191
Query: 655 GTRGYL-----APEWITNNPISEKSDVYSY 679
G L PE I + +SDV+S+
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSF 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+G F VY + G++VA+K + G ++ EV + H +++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
E ++ + L E NG +++++ F R + + G+ YLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QIITGMLYLHSH-- 131
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
I+H D+ N+LL N K++DFGLA + YT GT Y++PE T +
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAH 189
Query: 671 SEKSDVYS 678
+SDV+S
Sbjct: 190 GLESDVWS 197
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 17/188 (9%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+GGF + A K L Q +K S E++ ++ H H+V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G E + + E SL + R+ + G YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARY-YLRQIVLGCQYLHRN-- 134
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+++H D+K N+ L+++ K+ DFGLA + + GT Y+APE ++
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH 192
Query: 671 SEKSDVYS 678
S + DV+S
Sbjct: 193 SFEVDVWS 200
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHL 545
S +LGQG FG VY G+ +VA+K + + + + EF E + + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI------FNSTEESRFLSWNTRFNIALGMA 599
H+V+L G +G L+ E + G L ++ + S + +A +A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
G+AYL+ K VH D+ N ++ ++FT K+ DFG+ + + + Y +G +G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--YYR--KGGKGL 201
Query: 660 L-----APEWITNNPISEKSDVYSY 679
L +PE + + + SDV+S+
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSF 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 26/202 (12%)
Query: 497 KLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLV 548
LG G FG VY G + +QVAVK L Q + +F E I +H ++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS---TEESRFLSWNTRFNIALGMAKGLAYL 605
+ G ++ R + E + G L ++ + + L+ ++A +A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 606 HEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL-- 660
E +H DI N LL AK+ DFG+A+ + R Y +G L
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYR-KGGCAMLPV 250
Query: 661 ---APEWITNNPISEKSDVYSY 679
PE + K+D +S+
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSF 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 10/186 (5%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK-KEFSAEVTTIGNVHHLHLVKLKGFCI 555
LG+G +G VY G L + +++A+K++ + E+ ++ H ++V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
E + E + GSL + + + + +GL YLH+ +IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDN---QIVH 145
Query: 616 CDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI--SE 672
DIK +NVL++ + K+SDFG +K + T GT Y+APE I P +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 673 KSDVYS 678
+D++S
Sbjct: 205 AADIWS 210
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 497 KLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLV 548
LG+G FG V VAVK L + ++ +E + V+H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSL--------------------DKWIFNSTEESRFLSW 588
KL G C + LL EY GSL + R L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
+ A +++G+ YL E +K+VH D+ N+L+ + K+SDFGL++ + E+
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-- 204
Query: 649 VYTTLRGTRGYL-----APEWITNNPISEKSDVYSY 679
Y + ++G + A E + ++ + +SDV+S+
Sbjct: 205 SYV--KRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 52/211 (24%), Positives = 81/211 (38%), Gaps = 32/211 (15%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHL 545
F +LG+ FG VY G L VA+K L ++ G ++EF E + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDK------------WIFNSTEESRFLSWNTRFN 593
++V L G + + + Y +G L + + L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 594 IALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTL 653
+ +A G+ YL +VH D+ NVL+ D K+SD GL + + + Y
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD--YYKL- 186
Query: 654 RGTRGYL-----APEWITNNPISEKSDVYSY 679
L APE I S SD++SY
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 216
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 494 FSTKLGQGGFGSVYLGMLPD--------GIQVAVKKL--ESIGQGKKEFSAEVTTIGNV- 542
LG+G FG V + + VAVK L ++ + + +E+ + +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNGSL------------DKWIFNSTEESRFLSWNT 590
H +++ L G C + + EY G+L + + +++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 591 RFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650
+ +A+G+ YL + K +H D+ NVL+ +N K++DFGLA+ +N + Y
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YY 213
Query: 651 TTLRGTRGYL-----APEWITNNPISEKSDVYSY 679
+ T G L APE + + + +SDV+S+
Sbjct: 214 K--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 51/192 (26%), Positives = 80/192 (41%), Gaps = 19/192 (9%)
Query: 497 KLGQGGFGSVYLGMLPDG----IQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G+G FG V+ G+ + VA+K K + +++F E T+ H H+VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G E + E G L ++ L + A ++ LAYL
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES--- 509
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR---GYLAPEWITN 667
+ VH DI NVL+ N K+ DFGL++ M Y + ++APE I
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINF 566
Query: 668 NPISEKSDVYSY 679
+ SDV+ +
Sbjct: 567 RRFTSASDVWMF 578
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 494 FSTKLGQGGFGSVYLGML--------PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNV- 542
LG+G FG V + + + VAVK L ++ + + +E+ + +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNGSL------------DKWIFNSTEESRFLSWNT 590
H +++ L G C + + EY G+L + + +++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 591 RFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650
+ +A+G+ YL + K +H D+ NVL+ +N K++DFGLA+ +N + Y
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YY 259
Query: 651 TTLRGTRGYL-----APEWITNNPISEKSDVYSY 679
+ T G L APE + + + +SDV+S+
Sbjct: 260 K--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 42/254 (16%), Positives = 82/254 (32%), Gaps = 30/254 (11%)
Query: 450 WHHNKRKRLTKFSQEDLEE-DNFLEKISGMPTRFSYDDLCKATKNFSTK--LGQGGFGSV 506
W +L + + N E +P + +K LG+G F V
Sbjct: 22 WDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQV 81
Query: 507 YLGM------LPDGIQVAVKKLESIGQGKKEFSAEVTT---IGNVHHLHLVKLKGFCIEG 557
Y + + +K + EF + +K +
Sbjct: 82 YEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139
Query: 558 AHRLLAYEYLGNGSL-DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+L E G+L + + + + A+ M + +H+ +I+H
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHG 196
Query: 617 DIKPENVLL-----------DDNFTAKVSDFGLAKLMNR-EESLVYTTLRGTRGYLAPEW 664
DIKP+N +L D + + D G + M + ++T T G+ E
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM 256
Query: 665 ITNNPISEKSDVYS 678
++N P + + D +
Sbjct: 257 LSNKPWNYQIDYFG 270
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 63/190 (33%), Positives = 94/190 (49%), Gaps = 18/190 (9%)
Query: 497 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKEFSA----EVTTIGNVHHLHLVK 549
KLG GG +VYL D I +VA+K + + K+E EV + H ++V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ E L EY+ +L ++I E LS +T N + G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNN 668
+IVH DIKP+N+L+D N T K+ DFG+AK ++ E SL T + GT Y +PE
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 669 PISEKSDVYS 678
E +D+YS
Sbjct: 188 ATDECTDIYS 197
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG---IQVAVKKL--ESIGQGKKEFSAEVTTIGNV-HHLHL 547
F +G+G FG V + + A+K++ + ++F+ E+ + + HH ++
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSL------------DKWIFNSTEESRFLSWNTRFNIA 595
+ L G C + LA EY +G+L D + + LS + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 655
+A+G+ YL ++ + +H D+ N+L+ +N+ AK++DFGL+ R + VY +
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS----RGQE-VYV--KK 198
Query: 656 TRGYL-----APEWITNNPISEKSDVYSY 679
T G L A E + + + SDV+SY
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSY 227
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 34/213 (15%)
Query: 494 FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNV-HH 544
LG+G FG V VAVK L + + +E+ + ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 545 LHLVKLKGFC-IEGAHRLLAYEYLGNGSL------------DKWIFNSTEESRFLSWNTR 591
L++V L G C G ++ E+ G+L + FL+
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 592 FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
+ +AKG+ +L K +H D+ N+LL + K+ DFGLA+ + ++ Y
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--DYV 205
Query: 652 TLRGTRGYL-----APEWITNNPISEKSDVYSY 679
R L APE I + + +SDV+S+
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+G FG+VYL +A+K +LE G + EV ++ H ++++L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G+ A R+ L EY G++ + + + S+F T I +A L+Y H +
Sbjct: 76 GY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITE-LANALSYCHSK-- 128
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+++H DIKPEN+LL K++DFG + S T L GT YL PE I
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 671 SEKSDVYS 678
EK D++S
Sbjct: 185 DEKVDLWS 192
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 46/210 (21%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSA---EVTT-IGNVHHLHLV 548
LG G G+V G VAVK++ E+ + H +++
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVI 72
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWI---FNSTEESRFLSWNTRFNIALGMAKGLAYL 605
+ +A E +L + S E + ++ +A G+A+L
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 606 HEECEVKIVHCDIKPENVLLD-------------DNFTAKVSDFGLAKLMNREESLVYTT 652
H KI+H D+KP+N+L+ +N +SDFGL K ++ +S T
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 653 LR---GTRGYLAPEWITNNPISEKSDVYSY 679
L GT G+ APE + + + +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTR 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 39/216 (18%)
Query: 494 FSTKLGQGGFGSVYLGMLPD------GIQVAVKKL--ESIGQGKKEFSAEV---TTIGNV 542
F LG G FG V + VAVK L + ++ +E+ + +GN
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNGSL--------------DKWIFNSTEESRFLSW 588
H+++V L G C G L+ EY G L ++ L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
+ + +AKG+A+L + +H D+ N+LL K+ DFGLA+ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-- 199
Query: 649 VYTTLRGTRGYL-----APEWITNNPISEKSDVYSY 679
Y L APE I N + +SDV+SY
Sbjct: 200 NYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 25/191 (13%)
Query: 497 KLGQGGFGSVYLG--MLPDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKG 552
+ GG G +YL +G V +K L G + + AE + V H +V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 553 FCIEGAH--RLLAY---EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
F + Y EY+G SL + + L L + L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
+ +V+ D+KPEN++L + K+ D G +N L GT G+ APE +
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----GTPGFQAPEIVRT 251
Query: 668 NPISEKSDVYS 678
P + +D+Y+
Sbjct: 252 GP-TVATDIYT 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 40/219 (18%)
Query: 494 FSTKLGQGGFGSVYLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHL 545
+ +G+G FG V+ P VAVK L E+ + +F E + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSL--------------------DKWIFNSTEESRF 585
++VKL G C G L +EY+ G L S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 586 LSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645
LS + IA +A G+AYL E K VH D+ N L+ +N K++DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 646 ESLVYTTLRGTRGYL-----APEWITNNPISEKSDVYSY 679
+ Y + PE I N + +SDV++Y
Sbjct: 228 D--YYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 19/188 (10%)
Query: 498 LGQGGFGSVYLG-MLPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+G FG+VYL + +A+K +LE G + E+ ++ H +++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ R+ L E+ G L K + + RF + + +A L Y HE
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEE-LADALHYCHER-- 133
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
K++H DIKPEN+L+ K++DFG + SL T+ GT YL PE I
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPPEMIEGKTH 189
Query: 671 SEKSDVYS 678
EK D++
Sbjct: 190 DEKVDLWC 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 28/220 (12%), Positives = 59/220 (26%), Gaps = 42/220 (19%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKL--------ESIGQGKKEFSAE------------- 535
LGQ + G V +I Q K+E
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 536 ----------VTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG--NGSLDKWIFNSTEES 583
+ + V+L + R Y + + + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 584 RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643
+ L + R + L + + LA LH +VH ++P +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 644 REESLVYTTLRGTRGYLAPEWITNNP-----ISEKSDVYS 678
A + ++ D ++
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 38/233 (16%)
Query: 460 KFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAV 519
Q+D +E+ + + + S+ LG G G++ + D VAV
Sbjct: 6 SLEQDDGDEETSVVIVG----KISF--------CPKDVLGHGAEGTIVYRGMFDNRDVAV 53
Query: 520 KKLESIGQGKKEFSA---EVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKW 575
K++ + FS EV + H ++++ + + +A E +L ++
Sbjct: 54 KRIL-----PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY 107
Query: 576 IFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL-----DDNFT 630
+ ++ + GLA+LH IVH D+KP N+L+
Sbjct: 108 V---EQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIK 161
Query: 631 AKVSDFGLAKLMNREESLVY--TTLRGTRGYLAPEWI---TNNPISEKSDVYS 678
A +SDFGL K + + + GT G++APE + + D++S
Sbjct: 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 60/268 (22%), Positives = 99/268 (36%), Gaps = 47/268 (17%)
Query: 450 WHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKN---FSTKLGQGGFGSV 506
+ + + ++ + + E + YD + + F LG G FG V
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61
Query: 507 YLGMLPDG------IQVAVKKL--ESIGQGKKEFSAEV---TTIGNVHHLHLVKLKGFCI 555
IQVAVK L ++ ++ +E+ T +G+ H ++V L G C
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACT 119
Query: 556 EGAHRLLAYEYLGNGSL-------------------DKWIFNSTEESRFLSWNTRFNIAL 596
L +EY G L ++ E+ L++ A
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 597 GMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGT 656
+AKG+ +L + VH D+ NVL+ K+ DFGLA+ + + Y
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS--NYV--VRG 232
Query: 657 RGYL-----APEWITNNPISEKSDVYSY 679
L APE + + KSDV+SY
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSY 260
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 42/206 (20%), Positives = 86/206 (41%), Gaps = 33/206 (16%)
Query: 494 FSTKLGQGGFGSVYLGML--------PDGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHH 544
F+ LGQG F ++ G+ +V +K L ++ + F + + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 545 LHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
HLV G C+ G +L E++ GSLD ++ + ++ + +A +A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHF 128
Query: 605 LHEECEVKIVHCDIKPENVLLD--------DNFTAKVSDFGLAKLMNREESLVYTT--LR 654
L E ++H ++ +N+LL + K+SD G++ + ++ +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIP 182
Query: 655 GTRGYLAPEWITNNPI-SEKSDVYSY 679
PE I N + +D +S+
Sbjct: 183 WV----PPECIENPKNLNLATDKWSF 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 39/213 (18%)
Query: 497 KLGQGGFGSVYLGMLPD--------GIQVAVKKL--ESIGQGKKEFSAEV---TTIGNVH 543
LG+G FG V L +VAVK L ++ + + +E+ IG
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-- 133
Query: 544 HLHLVKLKGFCIEGAHRLLAYEYLGNGSL------------DKWIFNSTEESRFLSWNTR 591
H +++ L G C + + EY G+L + S LS
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 592 FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651
+ A +A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ ++ + Y
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID--YYK 248
Query: 652 TLRGTRGYL-----APEWITNNPISEKSDVYSY 679
+ T G L APE + + + +SDV+S+
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKL--- 550
+LG GGFG V + G QVA+K + E + ++ + E+ + ++H ++V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 551 ---KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
LLA EY G L K++ N E L + ++ L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 608 ECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
+I+H D+KPEN++L K+ D G AK +++ E T GT YLAPE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAPEL 194
Query: 665 ITNNPISEKSDVYS 678
+ + D +S
Sbjct: 195 LEQKKYTVTVDYWS 208
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 34/208 (16%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLE-SIGQGKKEFSA-----------------EVTT 538
L QG F + L D A+KK E S+ + K++F+ E+
Sbjct: 38 TLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 539 IGNVHHLHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWI-----FNSTEESRFLSWNTRF 592
I ++ + + + +G I + + YEY+ N S+ K+ + +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 593 NIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT 652
I + +Y+H E I H D+KP N+L+D N K+SDFG ++ M
Sbjct: 156 -IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209
Query: 653 LRGTRGYLAPEWITNNPI--SEKSDVYS 678
RGT ++ PE+ +N K D++S
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWS 237
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 23/199 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE--SIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
LGQG +V+ G G A+K S + E + ++H ++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 554 --CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
H++L E+ GSL + + L + + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 612 KIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
IVH +IKP N++ D K++DFG A+ + +E +L GT YL P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYER 189
Query: 668 NPI--------SEKSDVYS 678
+ D++S
Sbjct: 190 AVLRKDHQKKYGATVDLWS 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 25/200 (12%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE--SIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
LGQG +V+ G G A+K S + E + ++H ++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 554 CIEGAHRLLAY---EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
E E+ GSL + + L + + + G+ +L E
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 611 VKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
IVH +IKP N++ D K++DFG A+ + +E +L GT YL P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMYE 188
Query: 667 NNPI--------SEKSDVYS 678
+ D++S
Sbjct: 189 RAVLRKDHQKKYGATVDLWS 208
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNV-HHLHLVKLKGF 553
L +GGF VY + G + A+K+L S + + EV + + H ++V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 554 CIEGAHR--------LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
G LL E ++ E LS +T I + + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-----------TLR 654
H + I+H D+K EN+LL + T K+ DFG A ++ ++ T
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 655 GTRGYLAPEWI---TNNPISEKSDVYS 678
T Y PE I +N PI EK D+++
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWA 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 49/200 (24%), Positives = 78/200 (39%), Gaps = 32/200 (16%)
Query: 497 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKEFSA----EVTTIGNVHHLHLVK 549
LG GG V+L D VAVK L + F E ++H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 550 LKGFCI------EGAHRLLAY---EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAK 600
+ E L Y EY+ +L + ++ + +
Sbjct: 77 -----VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQ 127
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT--LRGTRG 658
L + H+ I+H D+KP N+++ KV DFG+A+ + + V T + GT
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 659 YLAPEWITNNPISEKSDVYS 678
YL+PE + + +SDVYS
Sbjct: 185 YLSPEQARGDSVDARSDVYS 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 18/190 (9%)
Query: 497 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIGQGKKEFSA----EVTTIGNVHHLHLVK 549
+G+GG G VY D + VA+K + F E T G + H+V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ F + + L + L+ I + L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNN 668
H D+KPEN+L+ + A + DFG+A +E L GT Y+APE + +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 669 PISEKSDVYS 678
+ ++D+Y+
Sbjct: 211 HATYRADIYA 220
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 20/216 (9%), Positives = 48/216 (22%), Gaps = 42/216 (19%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
L G V+L + A+K E+ + + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 553 FC----------IEG----------------AHRLLAYEYLG--NGSLDKWIFNSTEESR 584
++ A+ LL L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 585 FLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644
+ + + A L + +VH P+N+ + + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL----W 242
Query: 645 EESLVYTTLRGTRGYLAPEWIT--NNPISEKSDVYS 678
+ Y E++ + + +
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 16/193 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK-----KLESI-GQGKKEFSAEVTTIGNVHHLHLVK 549
+G+G F V + G Q AVK K S G ++ E + + H H+V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 550 LKGFCIEGAHRLLAYEYLGNGSL-DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L + +E++ L + I + S + + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 609 CEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
I+H D+KP VLL +++ K+ FG+A + E LV GT ++APE +
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 205
Query: 666 TNNPISEKSDVYS 678
P + DV+
Sbjct: 206 KREPYGKPVDVWG 218
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 58/250 (23%), Positives = 103/250 (41%), Gaps = 37/250 (14%)
Query: 456 KRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTK-----------LGQGGFG 504
+ + K + L ++ + F + DL ++ K LG G G
Sbjct: 90 ELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACG 149
Query: 505 SVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----EVTTIGNVHHLHLVKLKGFC 554
V L +VA++ K + + + E+ + ++H ++K+K F
Sbjct: 150 EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF- 208
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ + E + G L F+ ++ L T M + YLHE I+
Sbjct: 209 FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GII 261
Query: 615 HCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN--- 668
H D+KPENVLL +++ K++DFG +K++ E+ + TL GT YLAPE + +
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 669 PISEKSDVYS 678
+ D +S
Sbjct: 320 GYNRAVDCWS 329
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKK--LESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+LG G G V+ P G+ +A K LE + + E+ + + ++V G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLAYLHE 607
+ E++ GSLD+ L R +++ + KGL YL E
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ----------VLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
+ KI+H D+KP N+L++ K+ DFG++ + +S+ + + GTR Y++PE +
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQG 204
Query: 668 NPISEKSDVYS 678
S +SD++S
Sbjct: 205 THYSVQSDIWS 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKGFC 554
LG G F V+L G A+K ++ + E+ + + H ++V L+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
H L + + G L I E + + + + + YLHE IV
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDAS-LVIQQVLSAVKYLHEN---GIV 128
Query: 615 HCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
H D+KPEN+L ++N ++DFGL+K+ + +T GT GY+APE + P S
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYS 185
Query: 672 EKSDVYS 678
+ D +S
Sbjct: 186 KAVDCWS 192
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 26/235 (11%)
Query: 451 HHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 509
H + R+ L F+ G Y KLG G +G V L
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKG-HLSEMYQ--------RVKKLGSGAYGEVLLCR 57
Query: 510 MLPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566
++ A+K K + EV + + H +++KL F + + L E
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL- 625
G L F+ + I + G+ YLH+ IVH D+KPEN+LL
Sbjct: 118 YKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLE 170
Query: 626 --DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ + K+ DFGL+ + ++ + GT Y+APE + EK DV+S
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWS 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 31/194 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKGFC 554
K+G+G G V L G QVAVK ++ Q ++E EV + + H ++V++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLAYLHEE 608
+ G + E+L G+L + R N + + + LAYLH +
Sbjct: 112 LVGEELWVLMEFLQGGALTD-----------IVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 664
++H DIK +++LL + K+SDFG ++K + + +SLV GT ++APE
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEV 212
Query: 665 ITNNPISEKSDVYS 678
I+ + + + D++S
Sbjct: 213 ISRSLYATEVDIWS 226
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 16/189 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
+LG+G F V + G++ A K + + ++ E + H ++V+L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
E + L ++ + G L F F S + + + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSN---G 125
Query: 613 IVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
IVH ++KPEN+LL K++DFGLA + +S + GT GYL+PE + +P
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 670 ISEKSDVYS 678
S+ D+++
Sbjct: 184 YSKPVDIWA 192
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 17/210 (8%)
Query: 476 SGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG-MLPDGIQVAVK---KLESIGQGKKE 531
S + N LG+G FG V + AVK K + +
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 532 FSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTR 591
EV + + H +++KL + + + E G L F+ + + S +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDA 123
Query: 592 FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESL 648
I + G+ Y+H+ IVH D+KPEN+LL + + K+ DFGL+ +++
Sbjct: 124 ARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNT 178
Query: 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
GT Y+APE + EK DV+S
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWS 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 31/194 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKGFC 554
K+GQG G+VY M + G +VA++++ Q KKE E+ + + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLAYLHEE 608
+ G + EYL GSL + T + + + L +LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 664
+++H DIK +N+LL + + K++DFG + ++ ++V GT ++APE
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEV 187
Query: 665 ITNNPISEKSDVYS 678
+T K D++S
Sbjct: 188 VTRKAYGPKVDIWS 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 27/193 (13%)
Query: 489 KATKNFSTK------LGQGGFGSVYLGM-LPDGIQVAVK----------KLESIGQGKKE 531
+T F LG+G V + P + AVK E + + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 532 FSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNT 590
EV + V H ++++LK L ++ + G L F+ E LS
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 591 RFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650
I + + + LH+ IVH D+KPEN+LLDD+ K++DFG + ++ E
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KL 180
Query: 651 TTLRGTRGYLAPE 663
+ GT YLAPE
Sbjct: 181 REVCGTPSYLAPE 193
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 56/235 (23%), Positives = 90/235 (38%), Gaps = 39/235 (16%)
Query: 451 HHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 509
HH+ R + Q E Y+ LG+G FG V
Sbjct: 5 HHHSSGRENLYFQGTFAER--------------YN--------IVCMLGKGSFGEVLKCK 42
Query: 510 MLPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566
+ AVK K + + EV + + H +++KL + + + E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL- 625
G L F+ + + S + I + G+ Y+H+ IVH D+KPEN+LL
Sbjct: 103 YTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLE 155
Query: 626 --DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ + K+ DFGL+ + + GT Y+APE + EK DV+S
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGTYDEKCDVWS 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 13/216 (6%)
Query: 469 DNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG-MLPDGIQVAVKKLE--SI 525
+ SG + + F KLG G FG V+L G++ +K +
Sbjct: 2 HHHHHHSSGRENLYFQGTI-DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 526 GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRF 585
++ AE+ + ++ H +++K+ + + + E G L + I ++ +
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120
Query: 586 LSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLM 642
LS + M LAY H + +VH D+KPEN+L + K+ DFGLA+L
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ T GT Y+APE + ++ K D++S
Sbjct: 178 --KSDEHSTNAAGTALYMAPE-VFKRDVTFKCDIWS 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 18/194 (9%)
Query: 493 NFSTKLGQGGFGSVYLG-MLPDGIQVAVKKLE----SIGQGKKEFSAEVTTIGNVHHLHL 547
LG+G FG V L G + AVK + K+ EV + + H ++
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
+KL F + + L E G L F+ + S I + G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 608 ECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
KIVH D+KPEN+LL + ++ DFGL+ + + GT Y+APE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE- 198
Query: 665 ITNNPISEKSDVYS 678
+ + EK DV+S
Sbjct: 199 VLHGTYDEKCDVWS 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 493 NFSTKLGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----EVTTIGNV 542
S LG G G V L +VA+K K + + + E+ + +
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
+H ++K+K F + + E + G L F+ ++ L T M +
Sbjct: 73 NHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 603 AYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
YLHE I+H D+KPENVLL +++ K++DFG +K++ E+ + TL GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTY 182
Query: 660 LAPEWITNN---PISEKSDVYS 678
LAPE + + + D +S
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWS 204
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 37/246 (15%)
Query: 451 HHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG- 509
HH+ + F + ++ K G SY KLG G +G V L
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEG-KIGESYF--------KVRKLGSGAYGEVLLCK 56
Query: 510 MLPDGIQVAVK-----KLESIGQGKKEFSA---------EVTTIGNVHHLHLVKLKGFCI 555
+ A+K + + + E++ + ++ H +++KL
Sbjct: 57 EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
+ + L E+ G L F NI + G+ YLH+ IVH
Sbjct: 117 DKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVH 169
Query: 616 CDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
DIKPEN+LL + K+ DFGL+ +++ L GT Y+APE + +E
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNE 226
Query: 673 KSDVYS 678
K DV+S
Sbjct: 227 KCDVWS 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 21/194 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTTIGNVHHLHLV 548
+LG G F V G++ A K + G ++E EV+ + V H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L +L E + G L F+ + LS + + G+ YLH +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 609 CEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
KI H D+KPEN++L K+ DFGLA + + + GT ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 665 ITNNPISEKSDVYS 678
+ P+ ++D++S
Sbjct: 190 VNYEPLGLEADMWS 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 16/189 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
+LG+G F V + G++ A K + + ++ E + H ++V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
E + L ++ + G L F F S + + + +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHSN---G 148
Query: 613 IVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
IVH ++KPEN+LL K++DFGLA + +S + GT GYL+PE + +P
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 670 ISEKSDVYS 678
S+ D+++
Sbjct: 207 YSKPVDIWA 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 15/191 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTI-GNVHHLHLVKLKG 552
+LG+G +G V +P G +AVK+ Q +K ++ V V G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ E + SLDK+ ++ + + + IA+ + K L +LH + +
Sbjct: 74 ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGL-AKLMNREESLVYTTLRGTRGYLAPEWITNNPI- 670
++H D+KP NVL++ K+ DFG+ L++ + G + Y+APE I
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELNQ 187
Query: 671 ---SEKSDVYS 678
S KSD++S
Sbjct: 188 KGYSVKSDIWS 198
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 448 GLWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFST------KLGQG 501
G HH+ + + + +++ + + ++ + + +LG G
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62
Query: 502 GFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559
FG V+ + G K + K E++ + +HH L+ L +
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122
Query: 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK 619
+L E+L G L I E +S N +GL ++HE IVH DIK
Sbjct: 123 MVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIK 176
Query: 620 PENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVY 677
PEN++ + + K+ DFGLA +N +E + T + APE + P+ +D++
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 678 S 678
+
Sbjct: 235 A 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 21/194 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTTIGNVHHLHLV 548
+LG G F V G++ A K + G ++E EV+ + V H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L +L E + G L F+ + LS + + G+ YLH +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 609 CEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
KI H D+KPEN++L K+ DFGLA + + + GT ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 665 ITNNPISEKSDVYS 678
+ P+ ++D++S
Sbjct: 190 VNYEPLGLEADMWS 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 21/194 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTTIGNVHHLHLV 548
+LG G F V G + A K G ++E EV + + H +++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L +L E + G L F+ E L+ + + G+ YLH +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 609 CEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
+I H D+KPEN++L N K+ DFG+A + + GT ++APE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 665 ITNNPISEKSDVYS 678
+ P+ ++D++S
Sbjct: 183 VNYEPLGLEADMWS 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 17/192 (8%)
Query: 493 NFSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIG-NVHHLHLVKL 550
+G G + + ++ AVK I + K++ + E+ + H +++ L
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPTEEIEILLRYGQHPNIITL 81
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
K +G + + E + G L + +F S + + K + YLH +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHAQ-- 135
Query: 611 VKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
+VH D+KP N+L + + ++ DFG AK + E L+ T T ++APE +
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLE 193
Query: 667 NNPISEKSDVYS 678
D++S
Sbjct: 194 RQGYDAACDIWS 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 17/188 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTTIGNV-HHLHLVKLKGF 553
LG+G F + AVK I + + E+T + H ++VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ H L E L G L F ++ + S I + ++++H+ +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GV 127
Query: 614 VHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
VH D+KPEN+L +DN K+ DFG A+L ++ T T Y APE + N
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 671 SEKSDVYS 678
E D++S
Sbjct: 187 DESCDLWS 194
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-22
Identities = 43/189 (22%), Positives = 82/189 (43%), Gaps = 15/189 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
+LG+G F V + + G + A + + ++ E + H ++V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
E H L ++ + G L F + S + + + + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQM---G 130
Query: 613 IVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+VH ++KPEN+LL K++DFGLA + E+ + GT GYL+PE + +P
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDP 189
Query: 670 ISEKSDVYS 678
+ D+++
Sbjct: 190 YGKPVDLWA 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 21/128 (16%)
Query: 565 EYLGNGSLDKWI---FNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPE 621
+ +L W+ + + + + I + +A+ + +LH + ++H D+KP
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLH----IFIQIAEAVEFLHSK---GLMHRDLKPS 193
Query: 622 NVLLDDNFTAKVSDFGLAKLMNREESL-----------VYTTLRGTRGYLAPEWITNNPI 670
N+ + KV DFGL M+++E +T GT+ Y++PE I N
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 671 SEKSDVYS 678
S K D++S
Sbjct: 254 SHKVDIFS 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK---------KLESIGQGKKEFSAEVTTIGNVH-HL 545
+G+G V + G + AVK E + + ++ E + V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
H++ L + L ++ + G L F+ E LS +I + + +++L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFL 216
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-- 663
H IVH D+KPEN+LLDDN ++SDFG + + E L GT GYLAPE
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEIL 271
Query: 664 ----WITNNPISEKSDVYS 678
T+ ++ D+++
Sbjct: 272 KCSMDETHPGYGKEVDLWA 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 33/199 (16%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK---KLESIGQGKKEFSAEVTTIGNV-HHLHLVKLK 551
+LG+G F V + G + A K K + E E+ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 552 GFCIEGAHRLLAYEYLGNGSL-----DKWIFNSTEESRFLSWNTRFNIALGMAK----GL 602
+ +L EY G + + +E + + K G+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-----------VIRLIKQILEGV 144
Query: 603 AYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
YLH+ IVH D+KP+N+LL K+ DFG+++ + + + GT Y
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEY 199
Query: 660 LAPEWITNNPISEKSDVYS 678
LAPE + +PI+ +D+++
Sbjct: 200 LAPEILNYDPITTATDMWN 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 23/195 (11%)
Query: 493 NFSTKLGQGGFGSVYLG-MLPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLH 546
+G+G +G V + I+ A K +E F E+ + ++ H +
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPN 67
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+++L + L E G L F R + I + +AY H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 607 EECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+ + H D+KPEN L + K+ DFGLA + + T GT Y++P+
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQ 178
Query: 664 WITNNPISEKSDVYS 678
+ + D +S
Sbjct: 179 -VLEGLYGPECDEWS 192
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK-------KLESIGQGKKEFSAEVTTIGNVHHLHLV 548
+LG G F V G+Q A K K G +++ EV+ + + H +++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L +L E + G L F+ E L+ + G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 609 CEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
+I H D+KPEN++L K+ DFGLA ++ + + GT ++APE
Sbjct: 134 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEI 188
Query: 665 ITNNPISEKSDVYS 678
+ P+ ++D++S
Sbjct: 189 VNYEPLGLEADMWS 202
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 26/197 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTI-GNVHHLHLVKLKG 552
++G+G +GSV + P G +AVK+ + +K+ ++ + + ++V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN------IALGMAKGLAYLH 606
+ E + S DK+ + + + I L K L +L
Sbjct: 89 ALFREGDCWICMELMS-TSFDKFY-----KYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGL-AKLMNREESLVYTTLRGTRGYLAPEWI 665
E +KI+H DIKP N+LLD + K+ DFG+ +L++ S+ T G R Y+APE I
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERI 197
Query: 666 TNNPI----SEKSDVYS 678
+ +SDV+S
Sbjct: 198 DPSASRQGYDVRSDVWS 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 14/187 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
LG G FG V+ G+++A K +++ G + K+E E++ + + H +L++L
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA- 154
Query: 555 IEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
E + + L EY+ G L I +ES L+ + +G+ ++H+ I
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICEGIRHMHQM---YI 208
Query: 614 VHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+H D+KPEN+L + K+ DFGLA+ E L GT +LAPE + + +S
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVS 266
Query: 672 EKSDVYS 678
+D++S
Sbjct: 267 FPTDMWS 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 36/185 (19%), Positives = 78/185 (42%), Gaps = 11/185 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
LG+G FG V+ + K ++ G + E++ + H +++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
++ +E++ + + I + L+ + + + L +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 616 CDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
DI+PEN++ ++ K+ +FG A+ + + + L Y APE ++ +S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 674 SDVYS 678
+D++S
Sbjct: 184 TDMWS 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 12/185 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
K+G+G FG V+ G+ VA+K LE ++ E+T + ++ K G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
++ + EYLG GS + + ++ I + KGL YLH E K
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYLHSE---KK 140
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
+H DIK NVLL ++ K++DFG+A + + T GT ++APE I + K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSK 199
Query: 674 SDVYS 678
+D++S
Sbjct: 200 ADIWS 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 52/200 (26%), Positives = 77/200 (38%), Gaps = 33/200 (16%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----------KLESIGQGKKEFSAEVTTIGNVHHL 545
LG+GGFG+V+ G L D +QVA+K L E + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGS--LDKWIFN---STEESRFLSWNTRFNIALGMAK 600
+++L + +L E D SR +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ--------VVA 150
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+ + H +VH DIK EN+L+D AK+ DFG L++ E YT GTR Y
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVY 204
Query: 660 LAPEWITNNP-ISEKSDVYS 678
PEWI+ + + + V+S
Sbjct: 205 SPPEWISRHQYHALPATVWS 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 496 TKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
KLG+G +GSVY + G VA+K++ + +E E++ + H+VK G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 555 IEGAHRLLAYEYLGNGSLD---KWIFNSTEESRFLSWNTRFNIAL---GMAKGLAYLHEE 608
+ + EY G GS+ + + E IA KGL YLH
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---------IATILQSTLKGLEYLHFM 144
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 664
+ +H DIK N+LL+ AK++DFG L M + +++ GT ++APE
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEV 196
Query: 665 ITNNPISEKSDVYS 678
I + +D++S
Sbjct: 197 IQEIGYNCVADIWS 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
+LG+G VY A+K L KK E+ + + H +++KLK
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
L E + G L I E+ + + + + + +AYLHE IVH
Sbjct: 119 TPTEISLVLELVTGGELFDRI---VEKGYYSERDAA-DAVKQILEAVAYLHEN---GIVH 171
Query: 616 CDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
D+KPEN+L + K++DFGL+K++ E ++ T+ GT GY APE +
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRGCAYGP 229
Query: 673 KSDVYS 678
+ D++S
Sbjct: 230 EVDMWS 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 29/198 (14%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+G +G V + + AVK KL I G+ E+ + + H ++++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 552 GFCIEGAHRLLAY---EYLGNGSLDKWIFNSTEESRFLSWNTR--FN--IALGMAKGLAY 604
+ + Y EY G + + +S E RF F I GL Y
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID-----GLEY 124
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN--REESLVYTTLRGTRGYLAP 662
LH + IVH DIKP N+LL T K+S G+A+ ++ + T+ +G+ + P
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPP 180
Query: 663 EWITNNPISE--KSDVYS 678
E K D++S
Sbjct: 181 EIANGLDTFSGFKVDIWS 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 13/231 (5%)
Query: 452 HNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGM- 510
R + T S D + ++ P +D + + +LG G FG V+
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV-LDHYDIHEELGTGAFGVVHRVTE 178
Query: 511 LPDGIQVAVKKLE-SIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569
G A K + K+ E+ T+ + H LV L + ++ YE++
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629
G L + + +E +S + + KGL ++HE VH D+KPEN++
Sbjct: 239 GELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKR 292
Query: 630 TA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ K+ DFGL ++ ++S+ GT + APE P+ +D++S
Sbjct: 293 SNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 31/198 (15%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA--EVTTIGNVHHL--HL 547
LG GGFGSVY G+ + D + VA+K ++ G+ EV + V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 548 VKLKGFCIEGAHRLLAYEY-LGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKGL 602
++L + +L E L +I E +R W + + +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ--------VLEAV 162
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLA 661
+ H ++H DIK EN+L+D N K+ DFG L+ VYT GTR Y
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 216
Query: 662 PEWITNNP-ISEKSDVYS 678
PEWI + + V+S
Sbjct: 217 PEWIRYHRYHGRSAAVWS 234
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 62/197 (31%), Positives = 90/197 (45%), Gaps = 34/197 (17%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK------KLESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG+G +G V L + VAVK ++ KKE + ++H ++VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 551 KGFCIEGAHRLLAYEYLGNGSL-DKWIFN---STEESRFLSWNTRFN--IALGMAKGLAY 604
G EG + L EY G L D+ + +++ F+ +A G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF-----FHQLMA-----GVVY 120
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAP 662
LH I H DIKPEN+LLD+ K+SDFGLA + N E L+ GT Y+AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 663 EWITNNP-ISEKSDVYS 678
E + +E DV+S
Sbjct: 177 ELLKRREFHAEPVDVWS 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 54/232 (23%), Positives = 82/232 (35%), Gaps = 53/232 (22%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKE-FSAEVTTIGNVHHLHLVK 549
+GQG +G V + + A+K K+ I E EV + +HH ++ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 550 LKGFCIEGAHRLLAYEYLGNGSL-DKWIFNSTEESRFLSWNTRFNIALG----------- 597
L + + L E G L DK + + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 598 ------------------------MAKGLAYLHEECEVKIVHCDIKPENVLL--DDNFTA 631
+ L YLH + I H DIKPEN L + +F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 632 KVSDFGLAKLMNR---EESLVYTTLRGTRGYLAPEWI--TNNPISEKSDVYS 678
K+ DFGL+K + E TT GT ++APE + TN K D +S
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 45/193 (23%), Positives = 81/193 (41%), Gaps = 21/193 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTIGN-VHHLHLVKLKG 552
++G G G V+ G +AVK+ + K ++ + ++V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 553 FCIEGAHRLLAYEYLGNGSLD--KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
I +A E +G + K + E R L + + + K L YL E+
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-RILG-----KMTVAIVKALYYLKEK-- 143
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
++H D+KP N+LLD+ K+ DFG++ + + G Y+APE I
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 671 SE-----KSDVYS 678
++ ++DV+S
Sbjct: 202 TKPDYDIRADVWS 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 34/199 (17%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKGFC 554
+LG G FG VY G A K +E+ + + E + E+ + H ++VKL G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 555 IEGAHRLLAYEYLGNGSLD---KWIFNSTEESRFLSWNTRFNIAL---GMAKGLAYLHEE 608
+ E+ G++D + E + I + M + L +LH +
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---------IQVVCRQMLEALNFLHSK 136
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPEW 664
+I+H D+K NVL+ +++DFG K + + +S + GT ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188
Query: 665 ITNNPISE-----KSDVYS 678
+ + + K+D++S
Sbjct: 189 VMCETMKDTPYDYKADIWS 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 33/199 (16%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----EVTTIGNVHHLHL 547
LG G FG V+ + +V VK K+ + E+ + V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 548 VKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALG------MAK 600
+K+ E L E G+G LD +F F+ + R + L +
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSG-LD--LFA------FIDRHPRLDEPLASYIFRQLVS 141
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYL 660
+ YL + I+H DIK EN+++ ++FT K+ DFG A + R + T GT Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYC 196
Query: 661 APEWITNNP-ISEKSDVYS 678
APE + NP + +++S
Sbjct: 197 APEVLMGNPYRGPELEMWS 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 27/199 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVK----- 549
+G G +G VY G + G A+K ++ G ++E E+ + HH ++
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 550 LKGFCIEGAHRL-LAYEYLGNGSL-DKWIFNSTEESRFLSWNTRFNIAL---GMAKGLAY 604
+K +L L E+ G GS+ D + +T+ + IA + +GL++
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTL----KEEWIAYICREILRGLSH 144
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH+ K++H DIK +NVLL +N K+ DFG++ ++R T GT ++APE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEV 200
Query: 665 ITNNPISE-----KSDVYS 678
I + + KSD++S
Sbjct: 201 IACDENPDATYDFKSDLWS 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 62/197 (31%), Positives = 90/197 (45%), Gaps = 34/197 (17%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK------KLESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
LG+G +G V L + VAVK ++ KKE + ++H ++VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 551 KGFCIEGAHRLLAYEYLGNGSL-DKWIFN---STEESRFLSWNTRFN--IALGMAKGLAY 604
G EG + L EY G L D+ + +++ F+ +A G+ Y
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF-----FHQLMA-----GVVY 120
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAP 662
LH I H DIKPEN+LLD+ K+SDFGLA + N E L+ GT Y+AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 663 EWITNNP-ISEKSDVYS 678
E + +E DV+S
Sbjct: 177 ELLKRREFHAEPVDVWS 193
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-20
Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
LG+GGFG V+ + ++ A KKL + + + K A E + VH +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTE-ESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ E L L + G + I+N E F F A + GL +LH+
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQR-- 308
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
I++ D+KPENVLLDD+ ++SD GLA + ++ GT G++APE +
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT-KGYAGTPGFMAPELLLGEE 365
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 30/195 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLK 551
++G G FG+VY + + VA+KK+ G+ E EV + + H + ++ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 552 GFCIEGAHRLLAYEYLGNGSLD--KWIFNSTEESRFLSWNTRFNIAL---GMAKGLAYLH 606
G + L EY + D + +E IA G +GLAYLH
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE---------IAAVTHGALQGLAYLH 171
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
++H D+K N+LL + K+ DFG A +M S V GT ++APE I
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223
Query: 667 N---NPISEKSDVYS 678
K DV+S
Sbjct: 224 AMDEGQYDGKVDVWS 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 57/178 (32%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFSA--EVTTIGNVHHLHLVKLKG 552
LG+GGFG V + ++ A KKL + I + K E A E + V+ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ E L L + G L I++ ++ F F A + GL LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAA-EICCGLEDLHRE--- 305
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+IV+ D+KPEN+LLDD+ ++SD GLA + +++ GT GY+APE + N
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKNER 361
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 17/186 (9%)
Query: 498 LGQGGFGSVYLG-MLPDGIQVAVKKL--ESIGQGKKE--FSAEVTTIGNVHHLHLVKLKG 552
LG+G F +V L L + A+K L I + K + E + + H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 553 FCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYLHEECE 610
F + +L Y NG L K+I + F TRF A + A L YLH +
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSA--LEYLHGK-- 149
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-TLRGTRGYLAPEWITNNP 669
I+H D+KPEN+LL+++ +++DFG AK+++ E + GT Y++PE +T
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 670 ISEKSD 675
+ SD
Sbjct: 209 ACKSSD 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 30/194 (15%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
+G+G F V L + G +VA+K +L K EV + ++H ++VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNHPNIVKL- 79
Query: 552 GF-CIEGAHRL-LAYEYLGNGSL-DKWIFN---STEESRFLSWNTRFNIALGMAKGLAYL 605
F IE L L EY G + D + + +E+R + + Y
Sbjct: 80 -FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------IVSAVQYC 130
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
H++ IVH D+K EN+LLD + K++DFG + L G Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELF 185
Query: 666 TNNP-ISEKSDVYS 678
+ DV+S
Sbjct: 186 QGKKYDGPEVDVWS 199
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 50/218 (22%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSA----------------- 534
+G+G +G V L D A+K KL +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 535 -----EVTTIGNVHHLHLVKLKGFCIEGAHRLLAY---EYLGNGSLDKWIFN---STEES 583
E+ + + H ++VKL ++ + Y E + G + + S +++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 584 RFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643
RF + + KG+ YLH + KI+H DIKP N+L+ ++ K++DFG++
Sbjct: 140 RFYFQD--------LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 644 REESLVYTTLRGTRGYLAPEWITNNPIS---EKSDVYS 678
++L+ T GT ++APE ++ + DV++
Sbjct: 189 GSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWA 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 19/196 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+G G V P +VA+K LE E E+ + HH ++V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFN---IAL---GMAKGLAYLHE 607
+ L + L GS+ I ++ + + IA + +GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLRGTRGYLAPE 663
+H D+K N+LL ++ + +++DFG LA + + V T GT ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 664 WIT-NNPISEKSDVYS 678
+ K+D++S
Sbjct: 197 VMEQVRGYDFKADIWS 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 25/229 (10%)
Query: 449 LWHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYL 508
+ + + KF + D K + + +D + +G+GGFG VY
Sbjct: 153 ICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDF-----SVHRIIGRGGFGEVYG 207
Query: 509 GMLPDGIQV-AVKKLE--SIGQGKKEFSAEV-----TTIGNVHHLHLVKLKGFCIEGAHR 560
D ++ A+K L+ I + E A + + +V + + +
Sbjct: 208 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDK 266
Query: 561 L-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK 619
L + + G L + F + RF A + GL ++H +V+ D+K
Sbjct: 267 LSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAA-EIILGLEHMHNR---FVVYRDLK 319
Query: 620 PENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
P N+LLD++ ++SD GLA ++++ GT GY+APE +
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 365
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 21/189 (11%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+G G FG L VAVK +E + E+ ++ H ++V+ K +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 557 GAHRLLAYEYLGNGSLDKWIFN----STEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
H + EY G L + I N S +E+RF + G++Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ--------LLSGVSYCHSM---Q 136
Query: 613 IVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP- 669
I H D+K EN LLD + K+ DFG +K S +T+ GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAPEVLLRQEY 194
Query: 670 ISEKSDVYS 678
+ +DV+S
Sbjct: 195 DGKIADVWS 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 45/196 (22%), Positives = 71/196 (36%), Gaps = 31/196 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
LG G G V G + A+K L + ++E G H+V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG---GPHIVCILDVYE 92
Query: 556 EGAHRLLAY----EYLGNGSL-----DKWIFNSTE-ESRFLSWNTRFNIALGMAKGLAYL 605
H E + G L ++ TE E+ I + + +L
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--------EIMRDIGTAIQFL 144
Query: 606 HEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 662
H I H D+KPEN+L + + K++DFG AK + T T Y+AP
Sbjct: 145 HSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAP 198
Query: 663 EWITNNPISEKSDVYS 678
E + + D++S
Sbjct: 199 EVLGPEKYDKSCDMWS 214
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 38/203 (18%), Positives = 69/203 (33%), Gaps = 33/203 (16%)
Query: 497 KLGQG--GFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFS---AEVTTIGNVHHLHLVKL 550
+G+G +V L P G V V+++ + + E+ +H ++V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 551 KGFCIEGAHRLLAYEYLGNGSLD---KWIFNST-EESRFLSWNTRFNIAL---GMAKGLA 603
+ I + ++ GS F E IA G+ K L
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKALD 142
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG----LAKLMNREESLVYTTLR--GTR 657
Y+H VH +K ++L+ + +S + R+ +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 658 GYLAPEWITNNPI--SEKSDVYS 678
+L+PE + N KSD+YS
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYS 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 60/193 (31%), Positives = 87/193 (45%), Gaps = 27/193 (13%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG G FG V +G G +VAVK K+ S+ K E+ + H H++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77
Query: 552 GFCIEGAHRL-LAYEYLGNGSL-DKWIFN---STEESRFLSWNTRFNIALGMAKGLAYLH 606
I + EY+ G L D + E+R L + + Y H
Sbjct: 78 Q-VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ--------ILSAVDYCH 128
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
+VH D+KPENVLLD + AK++DFGL+ +M+ E L T G+ Y APE I+
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 183
Query: 667 NNP-ISEKSDVYS 678
+ D++S
Sbjct: 184 GRLYAGPEVDIWS 196
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 52/200 (26%), Positives = 74/200 (37%), Gaps = 32/200 (16%)
Query: 494 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLK 551
S LG G G V + A+K L+ + EV H+V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIV 121
Query: 552 GFC----IEGAHRLLAYEYLGNGSL-----DKWIFNSTE-ESRFLSWNTRFNIALGMAKG 601
L+ E L G L D+ TE E+ I + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 173
Query: 602 LAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRG 658
+ YLH I H D+KPEN+L N K++DFG AK SL TT T
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPY 228
Query: 659 YLAPEWITNNPISEKSDVYS 678
Y+APE + + D++S
Sbjct: 229 YVAPEVLGPEKYDKSCDMWS 248
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 19/178 (10%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554
LG+G V + L + AVK +E G + EV + H ++++L F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
E L +E + GS+ + + R + + +A L +LH + I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 615 HCDIKPENVLL---DDNFTAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPE 663
H D+KPEN+L + K+ DF L + T G+ Y+APE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 15/222 (6%)
Query: 463 QEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQV-AVKK 521
+D +FL+ + R L + +G+G F V + + QV A+K
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 522 L--ESIGQGKKE---FSAEVTTIGNVHHLHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKW 575
+ + + + E F E + N + +L F + + L L EY G L
Sbjct: 94 MNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTL 151
Query: 576 IFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635
+ S R + RF +A + + +H + VH DIKP+N+LLD +++D
Sbjct: 152 L--SKFGERIPAEMARFYLA-EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVY 677
FG + + ++ GT YL+PE + + Y
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 17/184 (9%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKE---FSAEVTTIGNVHHLHLVKLK 551
+G+G FG V + L + +V A+K L + + + E F E + N + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLH 140
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYLHEEC 609
+ + + L L +Y G L + S E R RF +A + +A + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVIA--IDSVHQ-- 193
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+ VH DIKP+N+L+D N +++DFG + + ++ + GT Y++PE +
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 670 ISEK 673
+
Sbjct: 253 GGKG 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 63/193 (32%), Positives = 90/193 (46%), Gaps = 27/193 (13%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG G FG V +G G +VAVK K+ S+ K E+ + H H++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82
Query: 552 GFCIEGAHRL-LAYEYLGNGSL-DKWIFN---STEESRFLSWNTRFNIALGMAKGLAYLH 606
I + + EY+ G L D N +ESR L + G+ Y H
Sbjct: 83 QV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ--------ILSGVDYCH 133
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
+VH D+KPENVLLD + AK++DFGL+ +M+ E L T G+ Y APE I+
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 188
Query: 667 NNP-ISEKSDVYS 678
+ D++S
Sbjct: 189 GRLYAGPEVDIWS 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 58/193 (30%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVK-----KLESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+G FG V L +VA+K L+ + E++ + + H H++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 552 GFCIEGAHRL-LAYEYLGNGSL-DKWIFN---STEESRFLSWNTRFNIALGMAKGLAYLH 606
I + + EY G G L D + + +E R + + Y H
Sbjct: 76 DV-ITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQ--------IICAIEYCH 125
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
KIVH D+KPEN+LLDDN K++DFGL+ +M L T G+ Y APE I
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVIN 180
Query: 667 NNP-ISEKSDVYS 678
+ DV+S
Sbjct: 181 GKLYAGPEVDVWS 193
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 20/180 (11%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNVHHLHLVKLK 551
+G+G FG V + D ++ A+K + + + + E E+ + + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYLHEEC 609
+ + + + + L G L ++ + F + I L MA L YL +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKEETVKLFICELVMA--LDYLQNQ- 134
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+I+H D+KP+N+LLD++ ++DF +A ++ RE + TT+ GT+ Y+APE ++
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRK 190
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 15/213 (7%)
Query: 463 QEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQV-AVKK 521
+++ DNFL + + + +G+G FG V L +V A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 522 L--ESIGQGKKE--FSAEVTTIGNVHHLHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWI 576
L + + F E + + +V+L + + L + EY+ G L
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL---- 156
Query: 577 FNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636
N RF A + L +H + +H D+KP+N+LLD + K++DF
Sbjct: 157 VNLMSNYDVPEKWARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
G MN+E + T GT Y++PE + +
Sbjct: 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 16/176 (9%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+G G FG V+ L + +VA+KK + Q K+ + E+ + V H ++V LK F
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 557 GAHRL------LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ L EY+ ++ + + + + + + + LAY+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---S 159
Query: 611 VKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
+ I H DIKP+N+LLD + K+ DFG AK++ E + +R Y APE I
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELI 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 59/179 (32%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNVHHLHLVKLK 551
LG+G FG V L + A+K L E I K E + E + N H L LK
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ + RL EY G L F+ + E F RF A + L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN 269
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+V+ D+K EN++LD + K++DFGL K ++ T GT YLAPE + +N
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 325
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 31/204 (15%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG----QGKKEF-------SAEVTTIGNVHH 544
KLG G F +V+L + + VA+K + + E A+ T ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 545 LHLVKLKGF----CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAK 600
H++KL G H ++ +E LG +L I E + I+ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKY-EHRGIPLIYVK-QISKQLLL 142
Query: 601 GLAYLHEECEVKIVHCDIKPENVLLDD------NFTAKVSDFGLAKLMNREESLVYTTLR 654
GL Y+H C I+H DIKPENVL++ K++D G A + +++
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQ 197
Query: 655 GTRGYLAPEWITNNPISEKSDVYS 678
TR Y +PE + P +D++S
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWS 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 19/178 (10%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
+G G FG VY L G VA+KK + Q K+ + E+ + + H ++V+L+ F
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 556 EGAHRL------LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ L +Y+ ++ + + + + L + + LAY+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 173
Query: 610 EVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWI 665
I H DIKP+N+LLD D K+ DFG AK + R E V Y +R Y APE I
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELI 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 498 LGQGGFGSVYL---GMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNVHHLHLV 548
LG+GG+G V+ + ++ A+K L I + K+ + AE + V H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 549 KLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
L + + +L L EYL G L E F+ F +A ++ L +LH+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLA-EISMALGHLHQ 139
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667
+ I++ D+KPEN++L+ K++DFGL K + ++ +T GT Y+APE +
Sbjct: 140 K---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMR 195
Query: 668 NP 669
+
Sbjct: 196 SG 197
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 22/180 (12%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNVHHLHLVKLK 551
LG G FG V+L + A+K L E + + K+ E + V H ++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYLHEEC 609
+ A ++ + +Y+ G L + RF + +F A + +A L YLH +
Sbjct: 73 -GTFQDAQQIFMIMDYIEGGEL---FSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSK- 125
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
I++ D+KPEN+LLD N K++DFG AK V TL GT Y+APE ++ P
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTKP 179
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 59/179 (32%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNVHHLHLVKLK 551
LG+G FG V L + A+K L E I K E + E + N H L LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ + RL EY G L F+ + E F RF A + L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSR-- 124
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+V+ DIK EN++LD + K++DFGL K + T GT YLAPE + +N
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLEDND 181
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 58/186 (31%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 498 LGQGGFGSVYL---GMLPDGIQV-AVKKLESIGQGKKEF---SAEVTTIG------NVHH 544
LGQG FG V+L D Q+ A+K L KK V T V+H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL------KKATLKVRDRVRTKMERDILVEVNH 85
Query: 545 LHLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
+VKL + + +L L ++L G L ++E F + +F +A +A L
Sbjct: 86 PFIVKLH-YAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLA-ELALALD 140
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+LH I++ D+KPEN+LLD+ K++DFGL+K E Y+ GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 196
Query: 664 WITNNP 669
+
Sbjct: 197 VVNRRG 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 15/151 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH-LHLVKLKGFC 554
++G+G FG ++ G L + QVA+K E + E T + + + F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
EG H +L + LG SL+ + + R S T A M + +HE+ +V
Sbjct: 76 QEGLHNVLVIDLLGP-SLED-LLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 615 HCDIKPENVLLDDNFTAK-----VSDFGLAK 640
+ DIKP+N L+ + V DFG+ K
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 498 LGQGGFGSVYL---GMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNV-HHLHL 547
LG G +G V+L D ++ A+K L +I Q K E + ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 548 VKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYL 605
V L + + +L L +Y+ G L + ++ RF + + + +A L +L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVLA--LEHL 175
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
H+ I++ DIK EN+LLD N ++DFGL+K +E+ GT Y+AP+ +
Sbjct: 176 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 666 TNNP 669
Sbjct: 233 RGGD 236
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 22/180 (12%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKL--ESIGQGKKEFS---AEVTTIGNVHHLHLVKLK 551
LG G FG V L + A+K L + + + K+ E + V+ LVKL+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA-LGMAKGLAYLHEEC 609
F + L + EY+ G + + RF + RF A + + YLH
Sbjct: 108 -FSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL- 160
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+++ D+KPEN+L+D +V+DFG AK TL GT LAPE I +
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKG 214
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 3e-14
Identities = 99/628 (15%), Positives = 176/628 (28%), Gaps = 198/628 (31%)
Query: 126 ECMELQDSGNLVL--------LG----VNGS--ILWQSFSHPTDTLLPGQQFVEGMRLKS 171
+C ++QD +L + V+G+ + W S + + Q+FVE + +
Sbjct: 34 DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV---QKFVEEVLRIN 90
Query: 172 FP-NSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWN 230
+ + + S +Y Q + Y ND++ V AK + VS
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYI-EQRDRLY----NDNQ-----VFAKYN----VSRLQP 136
Query: 231 FYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQISCSVP 290
+ +R+ALL A I G G +GK +
Sbjct: 137 YLKLRQALL--------ELRPAKNVLIDGVLG--------SGK------------TWVAL 168
Query: 291 EPCNPY-FVCYFDN---W-----CQCPTSLRSQLN--CRPPVASTCNVSMNSAKLFYLGE 339
+ C Y C D W C P ++ L + + S +S+ +
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 340 RLDYFALGFVS--PFPR--------YDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQIG 389
+ + P+ + N SC +L +T+ + D +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWN---AFNLSCKILL---TTRFKQVTDFLS 282
Query: 390 SLQRSQQGSTGYVSYMKISSG---NE-------VLNSK----SRESDGGKPIVLIVVIVV 435
+ + ++S S +E L+ + RE P
Sbjct: 283 AATTT------HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR------- 329
Query: 436 ATILVIASLLYAGL-----WHHNKRKRLTKF---SQEDLEEDNFLEKISGMPTRFSYDDL 487
+ +IA + GL W H +LT S LE + R +D L
Sbjct: 330 --LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY---------RKMFDRL 378
Query: 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVT--------- 537
+ P + L I K V
Sbjct: 379 ---------------------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417
Query: 538 -------TIGNVHHLHLVKLKGFCIEGA-HRLLAYEYLGNGSLDKWIFNSTEESRFLSWN 589
TI + ++L E A HR + Y + D ++ +
Sbjct: 418 EKQPKESTIS-IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476
Query: 590 TRFNIALGMAKGLAYLH-EECEVKIVHCDIKPE--NVLLDDNF-TAKVSDFGLAKLMNRE 645
+ + H + E H + V LD F K+ A +
Sbjct: 477 ------------IGH-HLKNIE----HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 646 ESLVYTTLRGTRGYLAPEWITNNPISEK 673
L+ + Y+ N+P E+
Sbjct: 520 ILNTLQQLKFYKPYICD----NDPKYER 543
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 73/525 (13%), Positives = 148/525 (28%), Gaps = 170/525 (32%)
Query: 128 MELQDSGNLVLLGVNGS----------------------ILWQSFSH---PTDTLLPGQQ 162
+EL+ + N+++ GV GS I W + + P L Q+
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK 204
Query: 163 FVEGMRLKSFPNSNNM-SVYLEFKSG-----DLVLYAGYQTS-------QTYWSL-ANDS 208
+ + S++ ++ L S L+ Y+ Q + A +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264
Query: 209 R-KT-----NTSVAAKVHSA-----SLVSNAWNFY-DIRKALLWQFIFSENNDENATWAA 256
K V + +A SL ++ D K+LL +
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL------------LKYL- 311
Query: 257 ILGSNGEITFSNLRNGKAATSEAIKI-PQISCSVPEPCNPYFVCYFDNWCQCPTSLRSQL 315
+ +L E + P+ + E + +DNW +
Sbjct: 312 ------DCRPQDLP------REVLTTNPRRLSIIAESIRD-GLATWDNW--------KHV 350
Query: 316 NCRPPVASTCNVSMNSAKLFYLGERLDYFALGFVSPFPRYDLNTCKEACLHNCSCSVLFF 375
NC + + S+N + + D ++ FP + L S+++F
Sbjct: 351 NC-DKLTTIIESSLNVLEPAEYRKMFDRLSV-----FP-PSAHI-PTILL-----SLIWF 397
Query: 376 ENSTKNCFLFDQIGSLQRS----QQGSTGYVSY------MKISSGNE------VLNS--- 416
+ + + L + +Q +S +K+ NE +++
Sbjct: 398 DVIKSDVMVVVN--KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNI 455
Query: 417 -KSRESDGGKPIVLIVVIVVATILVIASLLYAGLWHHNKRKRLTKFSQEDLEEDNFLEKI 475
K+ +SD P + Y+ + HH L E +
Sbjct: 456 PKTFDSDDLIP------------PYLDQYFYSHIGHH-----LKNIEHP--ERMTLFRMV 496
Query: 476 SGMPTRFSYDDLCKATKNF-STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSA 534
+ D F K+ G + + +Q I ++
Sbjct: 497 --------FLDF-----RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543
Query: 535 EVTTIGNV-----HHLH------LVKL-----KGFCIEGAHRLLA 563
V I + +L L+++ E AH+ +
Sbjct: 544 LVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 62/233 (26%), Positives = 93/233 (39%), Gaps = 33/233 (14%)
Query: 450 WHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLG 509
+ K + TK +E +G R D NF LG+G FG V L
Sbjct: 306 FERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDF-----NFLMVLGKGSFGKVMLS 360
Query: 510 MLPDGIQV-AVKKLESIGQGKKEF---SAEVTTI--------GNVHHLHLVKLKGFCIEG 557
++ AVK L KK+ +V L +L C +
Sbjct: 361 ERKGTDELYAVKIL------KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQT 413
Query: 558 AHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
RL EY+ G L +++ + RF + F A +A GL +L + I++
Sbjct: 414 MDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSK---GIIYR 466
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
D+K +NV+LD K++DFG+ K N + + T GT Y+APE I P
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQP 518
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 35/217 (16%), Positives = 74/217 (34%), Gaps = 36/217 (16%)
Query: 450 WHHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNF--STKLGQGGFGSVY 507
HH+ + ++ L + + +PT D + + + + G +Y
Sbjct: 3 HHHHHSSGVDLGTEN-LYFQSMTTSLEALPTGTVLTDKSG--RQWKLKSFQTRDNQGILY 59
Query: 508 LGM---------LPDGIQVAVKKLES------------IGQGKKEFSAEVTTIGNVHHLH 546
P + ++ KL++ K + + + L
Sbjct: 60 EAAPTSTLTCDSGPQKQKFSL-KLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118
Query: 547 LVKLKGF-CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
+ GF + +R L LG SL + + + S + +A + L +L
Sbjct: 119 IPTCMGFGVHQDKYRFLVLPSLGR-SLQS-ALDVSPKHVL-SERSVLQVACRLLDALEFL 175
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKV--SDFGLAK 640
H E + VH ++ EN+ +D ++V + +G A
Sbjct: 176 H---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 15/151 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH-LHLVKLKGFC 554
K+G G FG + LG L VA+K LE + + E + + ++ F
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
G + + E LG SL+ +F+ R S T IA+ + + Y+H + ++
Sbjct: 75 PCGKYNAMVLELLGP-SLED-LFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 615 HCDIKPENVLLDDNFTAKVS-----DFGLAK 640
+ D+KPEN L+ DF LAK
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 60/185 (32%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEFSAEVTTIG-----------NVHHL 545
+G+G FG V L AVK L +K+ + NV H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL------QKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 546 HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
LV L F + A +L +Y+ G L ++ E FL RF A +A L Y
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAA-EIASALGY 154
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH IV+ D+KPEN+LLD ++DFGL K N E + +T GT YLAPE
Sbjct: 155 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEV 210
Query: 665 ITNNP 669
+ P
Sbjct: 211 LHKQP 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 19/189 (10%), Positives = 47/189 (24%), Gaps = 46/189 (24%)
Query: 497 KLGQGGFGSVYLGMLPDGI---QVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVK 549
G + + D QVA+ ++ G +E + + + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
+ A L+ E++ GSL + ++ S +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTS-PSPVGAIRAMQSLAAAADAAHRA- 148
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
+ P V + + ++ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------ 179
Query: 670 ISEKSDVYS 678
+ + D+
Sbjct: 180 -NPQDDIRG 187
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA--EVTTIGNVHHLHLVKLK 551
K+G+G +G V+ G VA+KK K A E+ + + H +LV L
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKHPNLVNLL 68
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
L +EY + ++ + R + + +I + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH--- 121
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+H D+KPEN+L+ + K+ DFG A+L+ Y TR Y +PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPE 172
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 29/108 (26%), Positives = 48/108 (44%), Gaps = 12/108 (11%)
Query: 577 FNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636
FL+ + +AKG+ +L K +H D+ N+LL + K+ DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDF 237
Query: 637 GLAKLMNREESLVYTTLRGTRGYL-----APEWITNNPISEKSDVYSY 679
GLA+ + ++ Y R L APE I + + +SDV+S+
Sbjct: 238 GLARDIYKDP--DYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSF 281
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 33/164 (20%), Positives = 60/164 (36%), Gaps = 21/164 (12%)
Query: 494 FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNV-HH 544
LG+G FG V VAVK L + + +E+ + ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 545 LHLVKLKGFCIEGAHRLLA-YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
L++V L G C + L+ E+ G+L ++ + R KG
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGAR 134
Query: 604 YLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647
+ + V + D+K + + ++ S F K ++ E
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 41/166 (24%), Positives = 64/166 (38%), Gaps = 30/166 (18%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVK--KLESIGQG-------------KKEFSAEVTTIG 540
K+G GGFG +YL + A K+E G KK+ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 541 NVHHLHLVKLKGF----CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIAL 596
+ +L + G ++R + E LG L K I ++ +T + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQK-ISG---QNGTFKKSTVLQLGI 158
Query: 597 GMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV--SDFGLAK 640
M L Y+HE VH DIK N+LL +V +D+GL+
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEF--SA--EVTTIGNVHHLHLVK 549
LG+G F +VY VA+KK L + K +A E+ + + H +++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L ++ L ++++ L+ I ++ S L+ + L +GL YLH+
Sbjct: 77 LLDAFGHKSNISLVFDFM-ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH- 131
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I+H D+KP N+LLD+N K++DFGLAK + YT TR Y APE
Sbjct: 132 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPE 182
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 53/239 (22%), Positives = 94/239 (39%), Gaps = 35/239 (14%)
Query: 451 HHNKRKRLTKFSQEDLEEDNFLEKISGMPTRFSYDDLCKATKNFSTK-------LGQGGF 503
HH+ ++ + I + + KA+ + + +G+G +
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65
Query: 504 GSVYLGMLPDGIQV-AVKKLESIGQGKKEF---SAEVTTI--------GNVHHLHLVKLK 551
V L L ++ A++ + KKE ++ + +H LV L
Sbjct: 66 AKVLLVRLKKTDRIYAMRVV------KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 552 GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
C + RL EY+ G L +F+ + + + RF A ++ L YLHE
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNYLHER-- 172
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
I++ D+K +NVLLD K++D+G+ K +T GT Y+APE +
Sbjct: 173 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGED 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF---SAEVTTI--------GNVHHL 545
+G+G + V L L ++ A+K + KKE ++ + +H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVV------KKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 546 HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
LV L C + RL EY+ G L +F+ + + + RF A ++ L Y
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSA-EISLALNY 125
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LHE I++ D+K +NVLLD K++D+G+ K +T GT Y+APE
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEI 181
Query: 665 ITNNP 669
+
Sbjct: 182 LRGED 186
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 31/168 (18%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFS------------AEVTTIGNVHH 544
+GQGGFG +YL + V + + A+ I
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 545 LHLVKLKGFC----------IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNI 594
+K G ++R + + G+ L K I+ + ++ S T +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEAN--AKRFSRKTVLQL 157
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV--SDFGLAK 640
+L + L Y+HE VH DIK N+LL+ +V D+GLA
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEV---TTIGNVHHLHLVKLKG 552
K+G G FG +YLG + G +VA+K E + + E + + ++
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGV--GIPTIRW 72
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
EG + ++ E LG SL+ +FN SR S T +A M + Y+H +
Sbjct: 73 CGAEGDYNVMVMELLGP-SLED-LFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--- 125
Query: 613 IVHCDIKPENVLL---DDNFTAKVSDFGLAK 640
+H D+KP+N L+ + DFGLAK
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 50/185 (27%), Positives = 74/185 (40%), Gaps = 28/185 (15%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF---SAEVTTI--------GNVHHL 545
LG+G FG V+L Q A+K L KK+ +V H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL------KKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 546 HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
L + + L EYL G L +++ +F F A + GL +
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA-EIILGLQF 133
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH + IV+ D+K +N+LLD + K++DFG+ K N T GT Y+APE
Sbjct: 134 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYIAPEI 189
Query: 665 ITNNP 669
+
Sbjct: 190 LLGQK 194
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLV 548
K+G+G +G VY G VA+KK L++ + E +A E++ + ++H ++V
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIV 65
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLD-KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
KL L +E+L D K +++ + + + + +GLA+ H
Sbjct: 66 KLLDVIHTENKLYLVFEFL---HQDLKKFMDASALTGIPLPLIK-SYLFQLLQGLAFCHS 121
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+++H D+KP+N+L++ K++DFGLA+ YT T Y APE
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPE 173
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 488 CKATKNFS--TKLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSAEVTTI--- 539
AT + ++G G +G+VY G VA+K + + G G ++T+
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP--ISTVREV 62
Query: 540 ------GNVHHLHLVKLKGFCIEGAHRL-----LAYEYLGNGSLDKWIFNSTEESRFLSW 588
H ++V+L C L +E++ + L ++ L
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPA 119
Query: 589 NTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648
T ++ +GL +LH IVH D+KPEN+L+ T K++DFGLA++ + + +
Sbjct: 120 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--M 174
Query: 649 VYTTLRGTRGYLAPE 663
T + T Y APE
Sbjct: 175 ALTPVVVTLWYRAPE 189
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 19/174 (10%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLVK 549
K+G+G +G VY G VA+K+ L++ + E +A E++ + +HH ++V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDA----EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L L +E++ L K + ++ + + +G+A+ H+
Sbjct: 84 LIDVIHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIK-IYLYQLLRGVAHCHQH- 138
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+I+H D+KP+N+L++ + K++DFGLA+ YT T Y AP+
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPD 189
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF---SAEVTTI--------GNVHHL 545
LG+G FG V L ++ AVK L KK+ +V
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL------KKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 546 HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
L +L C + RL EY+ G L +++ + RF + F A +A GL +
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAA-EIAIGLFF 136
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
L + I++ D+K +NV+LD K++DFG+ K N + + T GT Y+APE
Sbjct: 137 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEI 192
Query: 665 ITNNP 669
I P
Sbjct: 193 IAYQP 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 20/177 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE---FSA--EVTTIGNVHHLHLVKL 550
KLG G + +VY G+ G+ VA+K+ + +E +A E++ + + H ++V+L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKE---VKLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 551 KGFCIEGAHRLLAYEYLGNGSLD-KWIFNSTEESRFLSWNTRFNIALGMA---KGLAYLH 606
L +E++ D K +S + +GLA+ H
Sbjct: 69 YDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
E KI+H D+KP+N+L++ K+ DFGLA+ + +++ T Y AP+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPD 178
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 40/161 (24%), Positives = 59/161 (36%), Gaps = 28/161 (17%)
Query: 494 FSTKLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
S LG G G V + A+K L+ + ++E H+V++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVD 78
Query: 553 FC----IEGAHRLLAYEYLGNGSL-----DKWIFNSTE-ESRFLSWNTRFNIALGMAKGL 602
L+ E L G L D+ TE E+ I + + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAI 130
Query: 603 AYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAK 640
YLH I H D+KPEN+L N K++DFG AK
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL---------HL 547
+G+G FG V VA+K + + K+ I + HL ++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 548 VKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKGLAYL 605
+ + H + +E L +L + ++++F ++ A + + L L
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NL----YELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
H+ +I+HCD+KPEN+LL + KV DFG + ++ VYT ++ +R Y APE
Sbjct: 217 HKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQ-SRFYRAPE 269
Query: 664 WITNNPISEKSDVYS 678
I D++S
Sbjct: 270 VILGARYGMPIDMWS 284
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 498 LGQGGFGSVYLGMLPDGIQV-AVKKLESIGQGKKEF---SAEVT-TIG-------NVHHL 545
LG+G FG V L + + + AVK L KK+ +V T+ +H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL------KKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 546 HLVKLKGFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
L +L C + RL E++ G L +F+ + RF RF A + L +
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAA-EIISALMF 139
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH++ I++ D+K +NVLLD K++DFG+ K + T GT Y+APE
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPEI 195
Query: 665 ITNNP 669
+
Sbjct: 196 LQEML 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 48/195 (24%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLV 548
K+GQG FG V+ G +VA+KK +E+ +KE +A E+ + + H ++V
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALREIKILQLLKHENVV 79
Query: 549 KLKGFCIEGAHRL--------LAYEYLGN---GSLDKWIFNSTEESRFLSWNTRFNIA-- 595
L C A L +++ + G L + +F ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------------NVLVKFTLSEI 126
Query: 596 ----LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN---REESL 648
+ GL Y+H KI+H D+K NVL+ + K++DFGLA+ + +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 649 VYTTLRGTRGYLAPE 663
YT T Y PE
Sbjct: 184 RYTNRVVTLWYRPPE 198
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFC 554
K+G G FG +YLG + +VA+K E++ + E + + ++ F
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+EG + +L + LG SL+ +FN SR LS T +A M + ++H + +
Sbjct: 73 VEGDYNVLVMDLLGP-SLED-LFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 615 HCDIKPENVLLDDNFTAK---VSDFGLAK 640
H DIKP+N L+ A + DFGLAK
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLV 548
K+G+G +G+V+ VA+K+ L+ E SA E+ + + H ++V
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICLLKELKHKNIV 64
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
+L L +E+ + L K+ + + + + KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFC-DQDLKKYF--DSCNGDLDPEIVK-SFLFQLLKGLGFCHSR 120
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
++H D+KP+N+L++ N K+++FGLA+ Y+ T Y P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPD 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKK--LESIGQGKKEFSA--EVTTIGNVHHLHLVKLK 551
+G+G +G V G VA+KK + K A E+ + + H +LV L
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNLL 90
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
C + L +E++ + ++ + L + + G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFV-DHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSH--- 143
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I+H DIKPEN+L+ + K+ DFG A+ + VY TR Y APE
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPE 194
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLV 548
KLG+G + +VY G VA+K+ LE +E +A EV+ + ++ H ++V
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLE-----HEEGAPCTAIREVSLLKDLKHANIV 63
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L L +EYL + L +++ + N + + +GLAY H +
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVK-LFLFQLLRGLAYCHRQ 119
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
K++H D+KP+N+L+++ K++DFGLA+ + + Y T Y P+
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVVTLWYRPPD 170
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 21/193 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESI----GQGKKEFS--AEVTTIGNVHHLHLVK 549
+G+G FG V + VA+K +++ Q + E + ++V
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKGLAYLHE 607
LK + H L +E L +L ++ + F + A M L +L
Sbjct: 121 LKRHFMFRNHLCLVFEMLSY-NL----YDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 608 ECEVKIVHCDIKPENVLLDDNFTA--KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
E+ I+HCD+KPEN+LL + + K+ DFG + + + +Y ++ +R Y +PE +
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQ-SRFYRSPEVL 230
Query: 666 TNNPISEKSDVYS 678
P D++S
Sbjct: 231 LGMPYDLAIDMWS 243
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLVK 549
K+G+G +G VY G A+KK LE + E + E++ + + H ++VK
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK----EDEGIPSTTIREISILKELKHSNIVK 64
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L +L +E+L + L K + E S + + L + G+AY H+
Sbjct: 65 LYDVIHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAK-SFLLQLLNGIAYCHDR- 119
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+++H D+KP+N+L++ K++DFGLA+ YT T Y AP+
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPD 170
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 37/190 (19%)
Query: 497 KLGQGGFGSVYLGML-PDGIQVAVKK-LESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
GQG FG+V LG G+ VA+KK ++ +E + + +HH ++V+L+ +
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 555 IEGAHR-------LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALG---------- 597
R + EY+ R R +A
Sbjct: 89 YTLGERDRRDIYLNVVMEYVP-----------DTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLV-YTTLRG 655
+ + + LH V + H DIKP NVL++ + T K+ DFG AK ++ E V Y
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--- 193
Query: 656 TRGYLAPEWI 665
+R Y APE I
Sbjct: 194 SRYYRAPELI 203
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 54/244 (22%), Positives = 90/244 (36%), Gaps = 71/244 (29%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVT-----TIGNVHHL---HL 547
KLG G F +V+L + VA+K ++S + E+ + + +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 548 VKLKG-FCIEGA---HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA 603
V+L F I G H + +E LG+ L KWI S + I + +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKK-IIQQVLQGLD 160
Query: 604 YLHEECEVKIVHCDIKPENVLL-------------------------------------- 625
YLH +C +I+H DIKPEN+LL
Sbjct: 161 YLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 626 -----------DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 674
+ K++D G A +++ +T TR Y + E + + + +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 675 DVYS 678
D++S
Sbjct: 275 DIWS 278
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 462 SQEDLEEDNFLEKISGMPTRFSYDDL--CKATKNFS--TKLGQGGFGSVYLGM-LPDGIQ 516
+ LE + P S + + TKLG+G +G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 517 VAVKK--LESIGQGKKE---FSA--EVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569
VA+K+ LE ++E +A EV+ + + H ++++LK L +EY
Sbjct: 62 VAIKRIRLEH----EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-E 116
Query: 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629
L K++ +++ +S + + G+ + H + +H D+KP+N+LL +
Sbjct: 117 NDLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSD 169
Query: 630 TA-----KVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
+ K+ DFGLA+ +T T Y PE
Sbjct: 170 ASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPE 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 31/188 (16%)
Query: 497 KLGQGGFGSVYLGM---LPDGIQVAVKKLESIGQGKKEFSA--EVTTIGNVHHLHLVKLK 551
K+G+G +G VY D A+K++E G SA E+ + + H +++ L+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQ 84
Query: 552 GFCIEGAHRL--LAYEYLGNGSLD-KWIFNSTEESRFLSWNTRFNIALG------MAKGL 602
+ A R L ++Y D I S+ + + + G+
Sbjct: 85 KVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTA----KVSDFGLAKLMNREESLVYTTLRG--- 655
YLH ++H D+KP N+L+ K++D G A+L N L
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVV 197
Query: 656 TRGYLAPE 663
T Y APE
Sbjct: 198 TFWYRAPE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 46/199 (23%), Positives = 96/199 (48%), Gaps = 33/199 (16%)
Query: 485 DDLCKATKNFS--TKLGQGGFGSVYLG--MLPDGIQVAVKK--LESIGQGKKEFSAEVTT 538
D LC+A + + ++G+G +G V+ + G VA+K+ +++ +G ++T
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-----MPLST 58
Query: 539 I---------GNVHHLHLVKLK----GFCIEGAHRL-LAYEYLGNGSLDKWIFNSTEESR 584
I H ++V+L + +L L +E++ + L ++
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEP 115
Query: 585 FLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644
+ T ++ + +GL +LH ++VH D+KP+N+L+ + K++DFGLA++ +
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 645 EESLVYTTLRGTRGYLAPE 663
+ + T++ T Y APE
Sbjct: 173 Q--MALTSVVVTLWYRAPE 189
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 42/209 (20%), Positives = 77/209 (36%), Gaps = 49/209 (23%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
LG G FG V + G + A+KK + Q + + E+ + + H++++KL +
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEES---------------------------RFLSW 588
+ N+ + + L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 589 NTRFNIALG----------MAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFG 637
R ++ + + + ++H + I H DIKP+N+L++ + T K+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 638 LAKLMNREESLV-YTTLRGTRGYLAPEWI 665
AK + E V Y +R Y APE +
Sbjct: 188 SAKKLIPSEPSVAYIC---SRFYRAPELM 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 28/81 (34%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M G+ +LH I+H D+KP N+++ + T K+ DFGLA+ + T TR
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTR 190
Query: 658 GYLAPEWITNNPISEKSDVYS 678
Y APE I E D++S
Sbjct: 191 YYRAPEVILGMGYKENVDIWS 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 5/79 (6%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
G+ +LH I+H D+KP N+++ + T K+ DFGLA+ + T TR Y
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 229
Query: 660 LAPEWITNNPISEKSDVYS 678
APE I E D++S
Sbjct: 230 RAPEVILGMGYKENVDIWS 248
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 55/218 (25%)
Query: 497 KLGQGGFGSVY--LGMLPDGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHL----- 545
LG+G FG V L QVA+K + ++G + E I + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-------INVLKKIKEKDK 78
Query: 546 ----HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMA 599
V + + H +A+E LG + +++ +E+ F + ++A +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFL----KENNFQPYPLPHVRHMAYQLC 133
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTA-------------------KVSDFGLAK 640
L +LHE ++ H D+KPEN+L ++ +V+DFG A
Sbjct: 134 HALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ T + TR Y PE I ++ DV+S
Sbjct: 191 FDHEH---HTTIVA-TRHYRPPEVILELGWAQPCDVWS 224
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 9e-10
Identities = 38/221 (17%), Positives = 66/221 (29%), Gaps = 51/221 (23%)
Query: 479 PTRFSYDDLCKATKNFST--KLGQGGFGSVYLGMLPDGIQVAVKKL---------ESIGQ 527
P FS+ C T+ K+G+G FG V+ + D VA+K + S +
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 528 GKKEFSAEVTTIGNVHHLH---------LVKLKGFCI----EGAHRLLAYEYLG--NGSL 572
+E E+ + L + L L A+++ GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 573 DKWIFNSTEESRFL-------------------SWNTRFNIALGMAKGLAYLHEECEVKI 613
+ ++ F+ S T +I + LA +
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RF 183
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 654
H D+ NVLL K+ K + ++
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554
KLG+G + V+ + + + +V VK L+ + KK+ E+ + N+ +++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIV 100
Query: 555 IEGAHRLLAY--EYLGNGSLDKWIFN-STEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ R A E++ N + + + RF + + K L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKALDYCHSM--- 149
Query: 612 KIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE 663
I+H D+KP NV++D ++ ++ D+GLA+ + + Y +R + PE
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPE 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 8/82 (9%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M KGL Y+H I+H D+KP N+ ++++ K+ DFGLA R+ T TR
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGYVVTR 189
Query: 658 GYLAPEWITNNPI-SEKSDVYS 678
Y APE I N ++ D++S
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWS 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 59/223 (26%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHL------ 545
K+G G FG V L + + AVK + +I K E + +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-------ADILKKIQNDDIN 94
Query: 546 --HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMAKG 601
++VK G + H L +E LG SL + I + + ++ + + K
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEII----TRNNYNGFHIEDIKLYCIEILKA 149
Query: 602 LAYLHEECEVKIVHCDIKPENVLLDDNFTA-------------------------KVSDF 636
L YL + + + H D+KPEN+LLDD + K+ DF
Sbjct: 150 LNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
G A + + + TR Y APE I N SD++S+
Sbjct: 207 GCATFKSDY---HGSIIN-TRQYRAPEVILNLGWDVSSDMWSF 245
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 24/64 (37%), Positives = 31/64 (48%), Gaps = 5/64 (7%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
GL LHE +VH D+ P N+LL DN + DF LA+ + + T R Y
Sbjct: 145 LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWY 199
Query: 660 LAPE 663
APE
Sbjct: 200 RAPE 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 598 MAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTR 657
M KGL Y+H +VH D+KP N+ ++++ K+ DFGLA R T TR
Sbjct: 135 MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTGYVVTR 187
Query: 658 GYLAPEWITNNPI-SEKSDVYS 678
Y APE I + ++ D++S
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWS 209
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-09
Identities = 26/142 (18%), Positives = 55/142 (38%), Gaps = 35/142 (24%)
Query: 76 HISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVECME-LQDSG 134
+SS ++T + L + S + + + + N L W++NT G C L ++G
Sbjct: 3 SLSSPNSLFTGHS-LEVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNG 61
Query: 135 NLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAG 194
NLV+ + ++WQ+ K+ ++ + L+ + ++V+Y
Sbjct: 62 NLVIYDQSNRVIWQT--------------------KTNGKEDHYVLVLQ-QDRNVVIY-- 98
Query: 195 YQTSQTYWSLANDSRKTNTSVA 216
W+ T + A
Sbjct: 99 ---GPVVWA-------TGSGPA 110
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 8/80 (10%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGY 659
+GL Y+H I+H D+KP N+ ++++ K+ DFGLA R + T TR Y
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMTGYVATRWY 195
Query: 660 LAPEWITNNPI-SEKSDVYS 678
APE + N ++ D++S
Sbjct: 196 RAPEIMLNWMHYNQTVDIWS 215
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 5/66 (7%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTR 657
+GL Y+H ++H D+KP N+LL+ K+ DFGLA++ + + + T TR
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 658 GYLAPE 663
Y APE
Sbjct: 196 WYRAPE 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 55/218 (25%)
Query: 497 KLGQGGFGSVY--LGMLPDGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHL----- 545
LG+G FG V + G VAVK ++++ + E I + HL
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-------IQVLEHLNTTDP 73
Query: 546 ----HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRF--NIALGMA 599
V++ + H + +E LG S +I +E+ FL + +A +
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFI----KENGFLPFRLDHIRKMAYQIC 128
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTA-------------------KVSDFGLAK 640
K + +LH K+ H D+KPEN+L + KV DFG A
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYS 678
+ T + TR Y APE I S+ DV+S
Sbjct: 186 YDDEH---HSTLVS-TRHYRAPEVILALGWSQPCDVWS 219
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 14/73 (19%), Positives = 31/73 (42%), Gaps = 2/73 (2%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVECM-ELQDSGNLVLL 139
+ VW + + +GN + G+ W++NT+ Q LQ N+V+
Sbjct: 38 RAVWASGTNGKASGC-VLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY 96
Query: 140 GVNGSILWQSFSH 152
+ + +W + ++
Sbjct: 97 DNSNNAIWATHTN 109
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 6e-04
Identities = 14/59 (23%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPT 154
F+ + + N L N W++ T+G+ C +++Q+ GNLV+ + +I + +
Sbjct: 22 LFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQN 80
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 17/54 (31%), Positives = 25/54 (46%), Gaps = 1/54 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQS 149
+F+ + + N L N W+ NT G C LQ G LV++ +WQS
Sbjct: 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQS 86
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 15/71 (21%), Positives = 27/71 (38%), Gaps = 6/71 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGNLVL 138
+W N G L + V + +G + W + +G+ + LQ N+V+
Sbjct: 49 NPIWATNTGGLGNGC-RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 139 LGVNGSILWQS 149
G LW +
Sbjct: 108 ---YGDALWAT 115
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 12/73 (16%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG---- 655
+ + LH ++H D+KP N+L++ N KV DFGLA++++ +
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 656 -----TRGYLAPE 663
TR Y APE
Sbjct: 180 VEFVATRWYRAPE 192
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 91 LIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVE--CMELQDSGNLVLLGVNGSILWQ 148
L + F+ +++ N L + W++NT + LQ GN V+ G LW
Sbjct: 16 LDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWA 75
Query: 149 SFSH 152
S S
Sbjct: 76 SHSV 79
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-07
Identities = 19/77 (24%), Positives = 39/77 (50%), Gaps = 5/77 (6%)
Query: 78 SSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVEC-MELQDSGN 135
+ VW +N G+L + K V + +GN + G + W++++ + LQ+ GN
Sbjct: 35 DHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGN 94
Query: 136 LVLLGVNGSILWQSFSH 152
+V+ GS +W + ++
Sbjct: 95 VVIY---GSDIWSTGTY 108
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 26/85 (30%), Positives = 36/85 (42%), Gaps = 24/85 (28%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG---- 655
G ++HE I+H D+KP N LL+ + + KV DFGLA+ +N E+
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 656 -----------------TRGYLAPE 663
TR Y APE
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPE 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 36/191 (18%), Positives = 72/191 (37%), Gaps = 27/191 (14%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSA-----EVTTIGNVHHLHLVKL 550
+G G +G V + VA+KK+ + + E+ + ++H H+VK+
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE--DLIDCKRILREIAILNRLNHDHVVKV 117
Query: 551 KG-FCIEGAHRL----LAYEYLG---NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGL 602
+ + + E ++ + + L +N + G+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN--------LLVGV 169
Query: 603 AYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAP 662
Y+H I+H D+KP N L++ + + KV DFGLA+ ++ E+ R
Sbjct: 170 KYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 663 EWITNNPISEK 673
+ + K
Sbjct: 227 LVTFPHTKNLK 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNRE--ESLVYTTLRGT 656
+GL Y+H ++H D+KP N+ ++ ++ K+ DFGLA++M+ + T
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 657 RGYLAPE 663
+ Y +P
Sbjct: 188 KWYRSPR 194
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 1/57 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
F+ +++ N L + W+ NT G C + +Q GNLV+ + +W S +
Sbjct: 22 VFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTG 78
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 18/74 (24%), Positives = 32/74 (43%), Gaps = 6/74 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVECM-ELQDSGNLVL 138
K +W N G L R + +GN + W++NT G+ + LQ N+V+
Sbjct: 38 KPIWATNTGGLDRRC-HLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVI 96
Query: 139 LGVNGSILWQSFSH 152
G+ W + ++
Sbjct: 97 Y---GTARWATGTN 107
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 23/84 (27%), Positives = 33/84 (39%), Gaps = 23/84 (27%)
Query: 600 KGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG---- 655
K + YLH ++H D+KP N+LL+ KV+DFGL++ +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 656 ----------------TRGYLAPE 663
TR Y APE
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPE 200
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-07
Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 1/57 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
+ N + + W++NT + C + L GNLV+ N + +W S
Sbjct: 23 TLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW 79
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-07
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 91 LIRDSDKFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQS 149
L + + V + + N L G W +NT G C + L G L++ + +W S
Sbjct: 21 LTAKNHQLVMQGDCNLVL-YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSS 79
Query: 150 FSH 152
S
Sbjct: 80 RSS 82
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-06
Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 4/60 (6%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPTD 155
V + + N L GN W +NT+ +C + L D G LV+ +GS +W+S +
Sbjct: 24 DLVMQDDCNLVLYNGN---WQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVK 80
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 2e-06
Identities = 31/180 (17%), Positives = 61/180 (33%), Gaps = 13/180 (7%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSHPTD- 155
+F + + N L + W++NT+G LQ G LV+L +I W S + +
Sbjct: 29 RFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIG 88
Query: 156 ----TLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKT 211
L P + ++N + +G+ +LY+ +L
Sbjct: 89 NYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ 148
Query: 212 NTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDENATWAAILGSNGEITFSNLRN 271
+ S+ ++ R +W + + A+L NG + +N
Sbjct: 149 L-----SPYRLSMETDCNLVLFDRDDRVWS---TNTAGKGTGCRAVLQPNGRMDVLTNQN 200
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 5e-06
Identities = 15/60 (25%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPTD 155
+ E + N L + WS NT+G+ C LQ +G + +L +W S + +
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA 212
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 13/56 (23%), Positives = 20/56 (35%), Gaps = 3/56 (5%)
Query: 97 KFVFEKNGN--AYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQS 149
V + N W + TSG+ C M L SG L + + ++ S
Sbjct: 27 SLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVS 82
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 16/80 (20%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 72 LVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVEC-ME 129
LV+ S +VW + + +G + + +NT GQ+ + +
Sbjct: 36 LVLTKGSKTNIVWESGTSGRGQHC-FMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLI 94
Query: 130 LQDSGNLVLLGVNGSILWQS 149
LQ +G V+ G +W +
Sbjct: 95 LQINGQAVVY---GPAVWST 111
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.6 bits (109), Expect = 1e-05
Identities = 15/82 (18%), Positives = 34/82 (41%), Gaps = 5/82 (6%)
Query: 73 VVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVECMELQ 131
+V + + W A + + + VF+ +GN + W ++T G + LQ
Sbjct: 176 LVAYGPNGAATWNAGTQ--GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQ 233
Query: 132 DSGNLVLLGVNGSILWQSFSHP 153
+G++ + ++ +W F
Sbjct: 234 ANGSIAI--LDEKPVWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.2 bits (95), Expect = 6e-04
Identities = 21/59 (35%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 95 SDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSH 152
+ K VF+ +GN NG A W+A T G+ Q GNLV+ G ++LW S +
Sbjct: 165 ASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG 223
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 4e-04
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 3/58 (5%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNG-SILWQSFSH 152
FV + + N L + +NT G+ V+C + L + G L + N + +W
Sbjct: 23 AFVMQGDCNLVL-YNEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS 79
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 679 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.79 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.77 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.75 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.65 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.52 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.5 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.48 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.48 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.43 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.4 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.09 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.08 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.07 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.97 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.95 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.82 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.49 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.22 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.43 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.76 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 93.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.49 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.13 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.04 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.92 Aligned_cols=193 Identities=26% Similarity=0.414 Sum_probs=165.4
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
+.|+...+++|.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 33445566788899999999999999963 4678999999753 334678999999999999999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
+++..+||||||++|+|.++|..... ....+++.++++|+.||++||+|||++ +||||||||+||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NI 176 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNV 176 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccce
Confidence 99999999999999999999965321 134589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||++++.+||+|||+++........ ......||+.|||||++.++.++.++|||||
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 9999999999999999876544322 2244679999999999999999999999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.75 Aligned_cols=188 Identities=29% Similarity=0.527 Sum_probs=161.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
...+.+.++||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345677899999999999999864 3778999999763 334578999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 562 LAYEYLGNGSLDKWIFNST---------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
|||||+++|+|.++|.... .....+++.++++|+.||++||+|||++ +||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997542 2235699999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCceee-ecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVY-TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+|+.......... ....||+.|||||++.+..++.++|||||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~ 216 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 216 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHH
Confidence 999999987655433222 23568999999999999999999999996
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.66 Aligned_cols=183 Identities=27% Similarity=0.426 Sum_probs=156.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.++||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++|+|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 5788899999999999999975 59999999996533 2346789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.++|.... ...+++.+++.++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 105 ~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 105 CEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999997543 44589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....+||+.|||||++.+..|+.++|||||
T Consensus 180 ~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl 211 (350)
T 4b9d_A 180 E-LARACIGTPYYLSPEICENKPYNNKSDIWAL 211 (350)
T ss_dssp H-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred c-cccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence 2 1234679999999999999999999999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.13 Aligned_cols=180 Identities=26% Similarity=0.418 Sum_probs=162.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.|++.++||+|+||+||+|+.. +|+.||||+++. .....+.+.+|+++|++++|||||++++++.+++..||||||++
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 4777889999999999999976 599999999965 33445678999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+|+|.+++.+ ..+++.++..++.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+......
T Consensus 155 gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 155 GGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 9999999864 2489999999999999999999999 9999999999999999999999999999977654332
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....+||+.|||||++.+..|+.++|||||
T Consensus 227 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 256 (346)
T 4fih_A 227 -RKSLVGTPYWMAPELISRLPYGPEVDIWSL 256 (346)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred -ccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 355789999999999999999999999996
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.66 Aligned_cols=182 Identities=27% Similarity=0.412 Sum_probs=163.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||+||+|+.. +++.||||++++ .....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4888999999999999999975 489999999964 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++.+ ...+++.++..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+...
T Consensus 113 y~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 113 YAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999965 34599999999999999999999999 9999999999999999999999999999987544
Q ss_pred Cc-eeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......+||+.|||||++.+..|+.++|||||
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 220 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 220 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence 32 23356789999999999999999999999996
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.48 Aligned_cols=187 Identities=27% Similarity=0.486 Sum_probs=154.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
..+.+.++||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34466789999999999999864 3788999999763 3345789999999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcE
Q 046493 563 AYEYLGNGSLDKWIFNSTE-----------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 631 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 631 (679)
||||+++|+|.++|+.... ...++++.+++.|+.||++||+|||++ +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976432 134699999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||+++........ ......||+.|||||++.+..++.++|||||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~ 246 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccch
Confidence 99999999876544322 2244679999999999999999999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.97 Aligned_cols=181 Identities=26% Similarity=0.417 Sum_probs=162.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.++||+|+||.||+|+.. +|+.||||++... ....+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 34778899999999999999976 4999999999653 344567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++|+|.+++.. ..+++.++..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999854 2489999999999999999999999 999999999999999999999999999997765433
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....+||+.|||||++.+..|+.++|||||
T Consensus 303 ~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 333 (423)
T 4fie_A 303 R-RKSLVGTPYWMAPELISRLPYGPEVDIWSL 333 (423)
T ss_dssp C-BCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred c-ccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 2 355789999999999999999999999996
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=334.28 Aligned_cols=183 Identities=31% Similarity=0.508 Sum_probs=151.6
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
....+.+.++||+|+||+||+|++.+ .||||+++... ...++|.+|++++++++|||||++++++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 33445678899999999999999753 69999987532 334679999999999999999999998864 5689999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.++|... ...+++.+++.|+.||++||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999654 34599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-eeeecccCcccccccccccc---CCCCcccceeeC
Q 046493 645 EES-LVYTTLRGTRGYLAPEWITN---NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSl 679 (679)
... .......||+.|||||++.+ .+|+.++|||||
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~ 223 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSY 223 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhH
Confidence 332 22345689999999999864 358999999996
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=326.83 Aligned_cols=177 Identities=24% Similarity=0.440 Sum_probs=153.2
Q ss_pred hhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLLA 563 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 563 (679)
+++.++||+|+||+||+|++.. ++.||||++.... ...+.|.+|++++++++|||||++++++.+ ++..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3567789999999999999764 8999999996532 234678999999999999999999999875 3457999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeC-CCCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLD-DNFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DFg~a~ 640 (679)
|||+++|+|.+++.+ ...+++..+..++.||++||+|||++ + ||||||||+||||+ +++.+||+|||+|+
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999965 34699999999999999999999998 6 99999999999998 47999999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ....+||+.|||||++.+ +|+.++|||||
T Consensus 181 ~~~~~~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSl 215 (290)
T 3fpq_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAF 215 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred eCCCCc---cCCcccCccccCHHHcCC-CCCcHHHHHHH
Confidence 654332 245689999999999875 69999999996
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.97 Aligned_cols=178 Identities=29% Similarity=0.353 Sum_probs=154.1
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.+++.++||+|+||.||+|++. +|+.||||+++.... ..+|++++++++|||||++++++.+++..||||||+++
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 3566788999999999999976 489999999975332 24799999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCcccccCCce
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~~~~~ 648 (679)
|+|.++|.+. ..+++.++..++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+......
T Consensus 135 g~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 135 GSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999653 4599999999999999999999999 999999999999999887 6999999999977543221
Q ss_pred ----eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 ----VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+||+.|||||++.+.+|+.++|||||
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 242 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence 1223579999999999999999999999996
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=321.76 Aligned_cols=180 Identities=28% Similarity=0.455 Sum_probs=146.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 35888999999999999999975 5999999999642 233567899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999865 34599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
... .....||+.|||||++.+..+ +.++|||||
T Consensus 165 ~~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl 198 (275)
T 3hyh_A 165 GNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred CCc--cCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence 332 245689999999999998886 579999996
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.95 Aligned_cols=181 Identities=27% Similarity=0.330 Sum_probs=153.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC----CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
.|++.+.||+|+||+||+|+.. .++.||||+++.. ......+.+|++++++++|||||++++++.+++..|||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5888999999999999999863 3789999999652 22344688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++|+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 105 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp ECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999653 4599999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .....||+.|||||++.+..|+.++|||||
T Consensus 178 ~~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 212 (304)
T 3ubd_A 178 DHEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSF 212 (304)
T ss_dssp ---CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred CCCcc-ccccccCcccCCHHHhccCCCCCCCcccch
Confidence 43322 245689999999999999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=326.90 Aligned_cols=185 Identities=25% Similarity=0.410 Sum_probs=148.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC---------
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA--------- 558 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 558 (679)
.|++.+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4677899999999999999975 58999999986532 23467899999999999999999999987654
Q ss_pred ---eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEee
Q 046493 559 ---HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635 (679)
Q Consensus 559 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 635 (679)
..|+||||+++|+|.+++..... ....++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999975432 23356778899999999999999999 999999999999999999999999
Q ss_pred ccCCcccccCCce-----------eeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESL-----------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|+........ ..+..+||+.|||||++.+.+|+.++|||||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 9999877553221 1233579999999999999999999999996
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.14 Aligned_cols=183 Identities=27% Similarity=0.377 Sum_probs=151.2
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC----eeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA----HRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 566 (679)
++.+.++||+|+||+||+|++ +|+.||||+++........++.|+..+.+++|||||++++++.+++ ..+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456778999999999999998 6899999999764433344455677778899999999999998764 57999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+++|+|.++|... .++++.+.+++.|+++||+|||+++ .++||||||||+||||++++.+||+|||+|+.
T Consensus 83 ~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 83 HEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999653 4899999999999999999999762 35899999999999999999999999999987
Q ss_pred cccCCcee---eecccCccccccccccccC------CCCcccceeeC
Q 046493 642 MNREESLV---YTTLRGTRGYLAPEWITNN------PISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSl 679 (679)
........ .....||+.|||||++.+. .++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 65543321 2245799999999999764 36789999996
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=313.25 Aligned_cols=223 Identities=21% Similarity=0.271 Sum_probs=160.1
Q ss_pred cccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCC-----CCceEEe
Q 046493 27 HIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRD-----SDKFVFE 101 (679)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~-----~~~~~~~ 101 (679)
+.|+|.+|++++. +..|+||+|+||||||++ ++.| + |+ +.+ |||+||||+|+.+ ++.|+|+
T Consensus 13 ~~~~l~~g~~l~~-------~~~l~S~~g~F~lgf~~~-~~~~-l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~ 78 (276)
T 3m7h_A 13 GTSVLPAYQTLSA-------GQYLLSPNQRFKLLLQGD-GNLV-I---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLA 78 (276)
T ss_dssp TSSEECTTEEBCT-------TCEEECTTSSEEEEECTT-SCEE-E---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSE
T ss_pred cCCEecCCCEecC-------CCEEEcCCCcEEEEEECC-CCeE-E---EC-CCC-eEEECCCCCCcCCcccccceEEEEe
Confidence 3599999965544 455699999999999943 3333 3 45 667 9999999999987 3459999
Q ss_pred eCCcEEE--EeCCc-eeEEeccCC------CceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCc----cCCCce
Q 046493 102 KNGNAYL--QRGNG-EAWSANTSG------QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQ----FVEGMR 168 (679)
Q Consensus 102 ~~g~lvl--~~~~~-~vWst~~~~------~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqk----l~~~~~ 168 (679)
.||+||| .++++ +||+|+++. ..++.|+|+|+|||||+| +.+|||| ||||||||||| |..|.+
T Consensus 79 ~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~ 154 (276)
T 3m7h_A 79 FYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSE 154 (276)
T ss_dssp EEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEE
T ss_pred CCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCcc
Confidence 9999999 67666 799999764 346789999999999998 7899999 99999999999 778888
Q ss_pred eec--CCCCCCceEEEEeecCceEEEEecccceeeeeccCCCcccccceEEeeeccccccccccccccccceeeEEEeec
Q 046493 169 LKS--FPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSE 246 (679)
Q Consensus 169 l~S--~~~~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (679)
|+| +|++|.|++.++.++ +++++ .....+||+++.+.... ....... .+.+.++..+...++. ..
T Consensus 155 L~S~~dps~G~fsl~l~~dG-nlvLy--~~~~~~yW~Sgt~~~~~--~~l~l~~-----dGnLvl~d~~~~~vWs---S~ 221 (276)
T 3m7h_A 155 LVQGVVYGAGASKLVFQGDG-NLVAY--GPNGAATWNAGTQGKGA--VRAVFQG-----DGNLVVYGAGNAVLWH---SH 221 (276)
T ss_dssp ECTTCEEEETTEEEEECTTS-CEEEE--CTTSSEEEECCCTTTTC--CEEEECT-----TSCEEEECTTSCEEEE---CS
T ss_pred cccCCCCCCceEEEeecCCc-eEEEE--eCCCeEEEECCCCCCcc--EEEEEcC-----CCeEEEEeCCCcEEEE---ec
Confidence 877 677899999998766 66664 33468999988554321 1111111 1222233222112221 11
Q ss_pred CCCCceEEEEEecCCCcEEEEEecCCCcccccccccCC
Q 046493 247 NNDENATWAAILGSNGEITFSNLRNGKAATSEAIKIPQ 284 (679)
Q Consensus 247 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~w~~~~~~p~ 284 (679)
..+. ..++++++.+|++++|.| ...|..++.+|.
T Consensus 222 t~~~-~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 222 TGGH-ASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CTTC-TTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred CCCC-CCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 1122 236788999999999998 357888887776
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.45 Aligned_cols=192 Identities=25% Similarity=0.403 Sum_probs=163.8
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcC-CCcceEEEEEE
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHH-LHLVKLKGFCI 555 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h-~niv~l~~~~~ 555 (679)
.|+....+++.++||+|+||+||+|++.. ++.||||+++... ...++|.+|++++++++| ||||+++++|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 35667788899999999999999998642 3689999997633 334679999999999965 89999999997
Q ss_pred eC-CeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 556 EG-AHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 556 ~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
+. +..+||||||++|+|.++|+.... ....+++..++.++.||++||+|||++ +||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 64 568999999999999999975432 134589999999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~ 273 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeeh
Confidence 99999999999999999977554332 2344678999999999999999999999996
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.01 Aligned_cols=181 Identities=24% Similarity=0.384 Sum_probs=154.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEe------CCee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIE------GAHR 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 560 (679)
+|++.++||+|+||+||+|++. +|+.||||+++.... ..+.+.+|+++|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 5788899999999999999975 599999999975332 33567899999999999999999999764 3578
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
||||||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 135 ~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 99999996 689999854 34699999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCC---ceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 641 LMNREE---SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.+.... .......+||+.|||||++.+. .++.++||||+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 764432 1123457899999999998875 46899999995
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=322.91 Aligned_cols=179 Identities=25% Similarity=0.335 Sum_probs=155.0
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHH---HHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAE---VTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
.|++.+.||+|+||.||+|+... |+.||||++++. ........+| +.+++.++|||||++++++.+.+..||
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 36788999999999999999764 999999999642 2333444444 556667789999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||++||+|.++|... ..+++..+..++.||+.||+|||++ +||||||||+||||+++|.+||+|||+|+..
T Consensus 270 VmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999653 4599999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.... ....+||+.|||||++.+ ..|+.++|||||
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSL 377 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSL 377 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHH
Confidence 5543 245689999999999964 579999999996
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=307.04 Aligned_cols=179 Identities=27% Similarity=0.356 Sum_probs=153.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.++||+|+||+||+|+.+ .++.||||++... .....+.+|+++++++ +||||+++++++.++++.++||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 45888999999999999999853 3688999998654 3456788999999998 6999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcEEEeeccCCcccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLMN 643 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~~ 643 (679)
||+++++|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 100 E~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 100 PYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp ECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred eCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999982 389999999999999999999999 99999999999999876 799999999998654
Q ss_pred cCCc---------------------------eeeecccCccccccccccccCC-CCcccceeeC
Q 046493 644 REES---------------------------LVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
.... ......+||+.|||||++.+.+ ++.++||||+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 3211 0123357999999999998764 8999999995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.65 Aligned_cols=181 Identities=26% Similarity=0.407 Sum_probs=161.7
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.|++.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 5788899999999999999976 48999999986533 345678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC--CcEEEeeccCCcccccCC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN--FTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DFg~a~~~~~~~ 646 (679)
+|+|.++|... ...+++.++..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 238 gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 238 GGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998543 34589999999999999999999999 99999999999999854 899999999999876544
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....||+.|||||++.+..|+.++|||||
T Consensus 312 ~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSl 342 (573)
T 3uto_A 312 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342 (573)
T ss_dssp E--EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred c--eeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence 3 345689999999999999999999999995
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=279.41 Aligned_cols=181 Identities=26% Similarity=0.411 Sum_probs=161.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+|++.++||+|+||+||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 45777899999999999999964 589999999865 3345677899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999643 489999999999999999999999 999999999999999999999999999987655433
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....||+.|+|||++.+..++.++|||||
T Consensus 172 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 202 (297)
T 3fxz_A 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (297)
T ss_dssp C-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred c-cCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence 2 245679999999999999999999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=280.66 Aligned_cols=184 Identities=29% Similarity=0.459 Sum_probs=159.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|.+.++||+|+||+||+|++. +++.||+|++.. .....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45677889999999999999976 489999998865 3345577999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ...+++.+++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999764 34589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ee-------------eecccCccccccccccccCCCCcccceeeC
Q 046493 648 LV-------------YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~-------------~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 11 114579999999999999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=283.41 Aligned_cols=182 Identities=27% Similarity=0.336 Sum_probs=160.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||+||+++.. +++.||||+++. .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 35677899999999999999976 489999999965 2345677899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998653 4589999999999999999999999 999999999999999999999999999986433
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......||+.|+|||++.+..++.++|||||
T Consensus 158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 191 (337)
T 1o6l_A 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred CCC-cccccccChhhCChhhhcCCCCCchhhcccc
Confidence 222 2245679999999999999999999999996
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=278.34 Aligned_cols=186 Identities=27% Similarity=0.436 Sum_probs=167.0
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
...+|++.+.||+|+||.||+|+..++..||||+++......+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 44567888999999999999999988889999999887777888999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999654 33589999999999999999999999 999999999999999999999999999987765544
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......+|+.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence 33344567788999999999889999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=295.00 Aligned_cols=184 Identities=22% Similarity=0.275 Sum_probs=161.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.++||+|+||+||+|+... ++.||||+++.. ......+.+|..++.+++||||+++++++.+++..++||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 456777899999999999999875 789999999642 223344889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 154 Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999653 34599999999999999999999999 999999999999999999999999999987765
Q ss_pred CCceeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
..........||+.|+|||++. ...++.++|||||
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl 267 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence 5444444568999999999987 4568999999996
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=287.62 Aligned_cols=200 Identities=46% Similarity=0.787 Sum_probs=173.3
Q ss_pred CCcCHHHHHHH--hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 480 TRFSYDDLCKA--TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 480 ~~~~~~~l~~~--~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
..+++.++... .|++.+.||+|+||.||+|+..+++.||||++.... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 44666665544 456678999999999999998889999999997532 23346899999999999999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEee
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 635 (679)
+.+..++||||+++++|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|||+++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987665566799999999999999999999998777999999999999999999999999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++..............||+.|+|||++.+..++.++|||||
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 221 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 221 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHH
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhH
Confidence 99999876555444455679999999999998889999999996
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=277.94 Aligned_cols=184 Identities=28% Similarity=0.499 Sum_probs=164.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..|++.+.||+|+||.||+|+..+++.||+|++.......+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 45777899999999999999998899999999988777788899999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 90 ~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 90 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999653 34589999999999999999999999 99999999999999999999999999998765443222
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSF 193 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence 234567888999999998999999999996
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=279.46 Aligned_cols=191 Identities=26% Similarity=0.388 Sum_probs=165.6
Q ss_pred CCcCHHHHHHHhh------------hhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCC
Q 046493 480 TRFSYDDLCKATK------------NFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHL 545 (679)
Q Consensus 480 ~~~~~~~l~~~~~------------~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~ 545 (679)
..++++++..+.. +..++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3467777766653 34468999999999999986 5999999999653 34567789999999999999
Q ss_pred CcceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe
Q 046493 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL 625 (679)
Q Consensus 546 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll 625 (679)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999853 3489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 626 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 626 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 227 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSL 227 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHH
Confidence 99999999999999876554322 244679999999999999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=293.25 Aligned_cols=182 Identities=24% Similarity=0.282 Sum_probs=160.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.++||+|+||+||+|+... ++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 356777899999999999999864 889999998642 233455889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 149 E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999998642 489999999999999999999999 999999999999999999999999999987765
Q ss_pred CCceeeecccCccccccccccccCC----CCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNP----ISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSl 679 (679)
..........||+.|+|||++.+.. ++.++|||||
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSl 259 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHH
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecc
Confidence 5443345678999999999998765 7889999996
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=285.89 Aligned_cols=189 Identities=23% Similarity=0.350 Sum_probs=164.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc------ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI------GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
+....|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999975 4899999998532 2246789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc---EEEeec
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDF 636 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DF 636 (679)
.++||||+++++|.+++.........+++..+..++.||++||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999988865433345689999999999999999999999 9999999999999986654 999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++........ ......||+.|+|||++.+..++.++|||||
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHH
Confidence 99987665432 2244679999999999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=278.66 Aligned_cols=184 Identities=31% Similarity=0.444 Sum_probs=155.6
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
..+|++.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 456788899999999999999975 48999999985422 2236788999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999653 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...........||+.|+|||++.+..++.++|||||
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 198 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence 543333344679999999999999999999999996
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=282.24 Aligned_cols=180 Identities=24% Similarity=0.377 Sum_probs=159.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 4677899999999999999974 69999999996533 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 96 ASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999653 3589999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeecccCccccccccccccCCCC-cccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSl 679 (679)
. .....||+.|+|||++.+..+. .++|||||
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 200 (328)
T 3fe3_A 169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSL 200 (328)
T ss_dssp G--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred c--cccccCCcceeCcccccCCCcCCchhhhhhh
Confidence 2 2456799999999999988765 79999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=281.21 Aligned_cols=186 Identities=40% Similarity=0.751 Sum_probs=163.2
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
.|++.+.||+|+||.||+|++.+++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 35667889999999999999888999999998653 34457899999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 648 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~- 648 (679)
++|.+++.........+++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999976554445699999999999999999999999 9999999999999999999999999999865433221
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......||+.|+|||++.+..++.++|||||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 2233568999999999998899999999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=279.96 Aligned_cols=182 Identities=21% Similarity=0.319 Sum_probs=162.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.+|++.+.||+|+||.||+++... ++.||+|.++........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 357788999999999999999764 8899999997665566778999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC--CCcEEEeeccCCcccccCC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 85 GLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999543 34589999999999999999999999 9999999999999987 7899999999998775543
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....||+.|+|||++.+..++.++|||||
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence 2 345678999999999999889999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=277.84 Aligned_cols=179 Identities=28% Similarity=0.408 Sum_probs=160.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 34677899999999999999976 5899999999652 245577889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999987544
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ....||+.|+|||++.+..++.++|||||
T Consensus 159 ~~----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (318)
T 1fot_A 159 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSF 189 (318)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred cc----ccccCCccccCHhHhcCCCCCcccchhhh
Confidence 22 34579999999999999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.96 Aligned_cols=186 Identities=24% Similarity=0.404 Sum_probs=157.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC--------
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-------- 558 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 558 (679)
..|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45778899999999999999986 6899999998642 334577999999999999999999999987644
Q ss_pred -------------------------------------------------eeeEEEeccCCCCHhHHhhccCCCCCCCCHH
Q 046493 559 -------------------------------------------------HRLLAYEYLGNGSLDKWIFNSTEESRFLSWN 589 (679)
Q Consensus 559 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 589 (679)
..++||||+++++|.+++..... ....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence 27899999999999999976543 3446778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-----------eeecccCccc
Q 046493 590 TRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-----------VYTTLRGTRG 658 (679)
Q Consensus 590 ~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-----------~~~~~~gt~~ 658 (679)
.++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 9999999999999999999999999999877654211 1233569999
Q ss_pred cccccccccCCCCcccceeeC
Q 046493 659 YLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 659 y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||++.+..++.++|||||
T Consensus 242 y~aPE~~~~~~~~~~~Di~sl 262 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSL 262 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHH
Confidence 999999999999999999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=276.06 Aligned_cols=187 Identities=25% Similarity=0.420 Sum_probs=163.5
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+...+|++.+.||+|+||.||+++..++..||||+++......+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 44556788899999999999999998888999999988777788899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999653 23599999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........+|+.|+|||++.+..++.++|||||
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 207 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence 222233457788999999998899999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=289.99 Aligned_cols=184 Identities=20% Similarity=0.248 Sum_probs=160.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+++.. +++.||||++++.. ...+.+.+|.+++.+++||||+++++++.+.+..++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45677789999999999999986 58999999996421 23345889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 141 E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999653 23589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCceeeecccCccccccccccc-------cCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWIT-------NNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvwSl 679 (679)
..........||+.|+|||++. +..++.++|||||
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSl 256 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHH
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHH
Confidence 5443334568999999999987 3568999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=285.25 Aligned_cols=185 Identities=26% Similarity=0.315 Sum_probs=156.8
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 560 (679)
+.-..|++.+.||+|+||.||+|+... ++.||||+++.. ....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 344567888999999999999999764 899999999652 23456788999999998 699999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999999653 4599999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... ......||+.|+|||++.+..++.++|||||
T Consensus 173 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 210 (353)
T 3txo_A 173 EGICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHH
T ss_pred ecccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcc
Confidence 6433322 2345679999999999999899999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.34 Aligned_cols=182 Identities=24% Similarity=0.305 Sum_probs=158.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 563 (679)
..|++.++||+|+||.||+|+... ++.||||+++... ...+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 357788999999999999999765 7899999997532 2234578899999887 899999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999998653 3599999999999999999999999 99999999999999999999999999998643
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+..++.++|||||
T Consensus 205 ~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~Diwsl 239 (396)
T 4dc2_A 205 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239 (396)
T ss_dssp CTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cCCC-ccccccCCcccCCchhhcCCCCChHHHHHHH
Confidence 3222 2345689999999999999999999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.84 Aligned_cols=183 Identities=25% Similarity=0.340 Sum_probs=160.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 562 (679)
...|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+..|.+++.++ +||||+++++++.+.+..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 345778899999999999999986 4899999999753 34566788999999987 89999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999653 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......||+.|+|||++.+..++.++|||||
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (345)
T 1xjd_A 169 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 204 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHH
Confidence 33222 2345689999999999999999999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=281.30 Aligned_cols=181 Identities=27% Similarity=0.429 Sum_probs=160.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..|++.+.||+|+||.||+++.. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 45778899999999999999976 489999999865321 3578999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC----cEEEeecc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDFG 637 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DFg 637 (679)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|||
T Consensus 92 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999954 34599999999999999999999999 999999999999998777 79999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++........ .....||+.|+|||++.+..++.++|||||
T Consensus 165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 204 (361)
T ss_dssp SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHH
Confidence 9987655332 245679999999999999899999999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.87 Aligned_cols=187 Identities=19% Similarity=0.256 Sum_probs=160.5
Q ss_pred HHHhhhhhhhcCcccceEEEEEE------eCCCcEEEEEEecccccCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCC
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGM------LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGA 558 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 558 (679)
....|.+.++||+|+||+||+|. ...++.||||+++. ....++..|++++++++ |+||+++++++.+.+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 34567788999999999999994 34588999999975 34667888998888886 999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC----------
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTE-ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---------- 627 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---------- 627 (679)
..++||||+++|+|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999975322 245699999999999999999999999 9999999999999998
Q ss_pred -CCcEEEeeccCCcccccC-CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 628 -NFTAKVSDFGLAKLMNRE-ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 628 -~~~~kL~DFg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 271 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHH
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHH
Confidence 899999999999765432 2223455789999999999999999999999996
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=275.09 Aligned_cols=183 Identities=25% Similarity=0.418 Sum_probs=161.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
....|++.+.||+|+||.||+++.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456888999999999999999976 48999999986522 146789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC----cEEEee
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSD 635 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~D 635 (679)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999954 34589999999999999999999999 999999999999999887 899999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 203 (326)
T 2y0a_A 162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 203 (326)
T ss_dssp CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHH
Confidence 999987654332 244579999999999999899999999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.70 Aligned_cols=189 Identities=25% Similarity=0.448 Sum_probs=161.1
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC--------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
....|++.+.||+|+||.||+|+.. ++..||||+++... ...+.+.+|+++++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3456788899999999999999852 35679999997533 2346789999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVL 624 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIl 624 (679)
.+..++||||+++|+|.+++..... ....+++.+++.++.||++||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999976432 123589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 625 LDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 625 l~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 999999999999999876543321 1233467889999999999999999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=281.36 Aligned_cols=181 Identities=25% Similarity=0.372 Sum_probs=160.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+++... ++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 457888999999999999999764 889999998642 345577899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999965 34599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCcccccccccccc---CCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++.+ ..++.++|||||
T Consensus 168 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSl 203 (384)
T 4fr4_A 168 ETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL 203 (384)
T ss_dssp TCC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHH
T ss_pred CCc--eeccCCCccccCCeeeccCCCCCCCccceeech
Confidence 332 345689999999999864 458999999996
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=298.72 Aligned_cols=189 Identities=26% Similarity=0.453 Sum_probs=167.4
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
++....+++.++||+|+||.||+|++.. +..||||+++......+++.+|++++++++||||+++++++.+.+..++||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4455667888999999999999999875 889999999876667889999999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999997643 34589999999999999999999999 999999999999999999999999999987755
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..........+++.|+|||++.+..++.++|||||
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 405 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 405 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhH
Confidence 43332233456789999999998899999999996
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=278.90 Aligned_cols=187 Identities=34% Similarity=0.523 Sum_probs=152.7
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+....|++.++||+|+||+||+|+. +++.||||++..... ..+++.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3445678889999999999999988 688999999875432 235688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
|||+++++|.+++..... ...+++..++.++.||++||+|||++ + |+||||||+||++++++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999965321 23489999999999999999999999 8 99999999999999999999999999986
Q ss_pred cccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......||+.|+|||++.+..++.++|||||
T Consensus 189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (309)
T 3p86_A 189 KASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred cccccc-ccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence 544321 1234679999999999999999999999996
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=296.73 Aligned_cols=188 Identities=24% Similarity=0.437 Sum_probs=164.3
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++....+++.++||+|+||.||+|++.++..||||+++......+++.+|++++++++||||+++++++. .+..++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4455667888999999999999999988899999999876677889999999999999999999999986 667899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999996532 23588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........+++.|+|||++.+..++.++|||||
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 371 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence 2222233456789999999998899999999996
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=279.40 Aligned_cols=181 Identities=24% Similarity=0.308 Sum_probs=158.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.|++.+.||+|+||.||+|+... ++.||||+++... ...+.+.+|..+++++ +||||+++++++.+.+..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 46778999999999999999864 8999999997532 2235578899999988 8999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999986433
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......||+.|+|||++.+..++.++|||||
T Consensus 163 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 196 (345)
T 3a8x_A 163 PGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred CCC-cccccCCCccccCccccCCCCCChHHhHHHH
Confidence 222 2345689999999999999999999999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=279.60 Aligned_cols=179 Identities=27% Similarity=0.308 Sum_probs=160.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45777899999999999999976 5899999998642 244577889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ....||+.|+|||++.+..++.++|||||
T Consensus 194 ~~----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 224 (350)
T 1rdq_E 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred Cc----ccccCCccccCHHHhcCCCCCCcCCEecc
Confidence 32 34578999999999999999999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=280.95 Aligned_cols=188 Identities=28% Similarity=0.496 Sum_probs=159.3
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
++...+|++.+.||+|+||.||+|++. .+..||||+++.. ....+.+.+|++++++++||||+++++++.+++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 345567888899999999999999975 3556999999753 2345678999999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred cEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999653 34589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+........ ......+|+.|+|||++.+..++.++|||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 240 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHH
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHH
Confidence 877554322 1223456788999999998899999999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=276.32 Aligned_cols=190 Identities=27% Similarity=0.446 Sum_probs=169.4
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
.++....|++.+.||+|+||.||+|+... ++.||+|++.......+.+.+|++++++++||||+++++++.+++..++|
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 34556678888999999999999999865 88999999987666678899999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999997643 34589999999999999999999999 99999999999999999999999999998776
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...........+++.|+|||++.+..++.++|||||
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence 555444444567889999999999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=277.14 Aligned_cols=183 Identities=27% Similarity=0.356 Sum_probs=151.3
Q ss_pred HHhhhhhhhcCcccceEEEEEEe----CCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESIG-----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
...|++.+.||+|+||.||+++. .+++.||+|+++... .....+.+|++++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35678889999999999999997 368999999997532 234567889999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999653 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+....... ......||+.|+|||++.+..++.++|||||
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSL 207 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence 86443322 2244679999999999999899999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=279.18 Aligned_cols=184 Identities=27% Similarity=0.442 Sum_probs=161.1
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
.....|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567889999999999999999976 489999999965332 34568899999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEEEeeccCC
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLA 639 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a 639 (679)
||||+++++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999998854 34589999999999999999999999 999999999999998654 5999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ .....||+.|+|||++.+..++.++|||||
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 216 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHH
Confidence 87654332 244679999999999999899999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=279.74 Aligned_cols=183 Identities=26% Similarity=0.315 Sum_probs=160.8
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 562 (679)
...|++.+.||+|+||.||+|+... ++.||||+++.. ....+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3457788999999999999999875 789999999652 34557788999999988 79999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999653 3589999999999999999999999 9999999999999999999999999999864
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......||+.|+|||++.+..++.++|||||
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 207 (353)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHH
T ss_pred ccCCc-ccccccCCccccChhhhcCCCcCCcccccch
Confidence 33222 2345679999999999999999999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=273.93 Aligned_cols=182 Identities=25% Similarity=0.339 Sum_probs=156.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.+|++.++||+|+||+||+|+..+++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 4577889999999999999999889999999996532 2246788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++ +|.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 101 MEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 985 888887653 34589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
. ......||+.|+|||++.+ ..++.++|||||
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 206 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHH
Confidence 2 2244578999999999876 468999999995
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-32 Score=294.31 Aligned_cols=188 Identities=29% Similarity=0.484 Sum_probs=158.3
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++....+++.++||+|+||.||+|++.++..||||+++......+++.+|++++++++||||+++++++.+ +..++|||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34456678889999999999999999888889999998766667889999999999999999999999876 67899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999996432 34589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........+++.|+|||++.+..++.++|||||
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 367 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence 3322234457889999999998899999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=290.24 Aligned_cols=186 Identities=27% Similarity=0.369 Sum_probs=163.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34566688999999999999986 4899999999642 244577899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999976554455799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....||+.|+|||++.+..++.++|||||
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl 375 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcc
Confidence 4322 234589999999999999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=285.14 Aligned_cols=184 Identities=23% Similarity=0.380 Sum_probs=159.7
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
....|++.++||+|+||.||+|... +++.+|+|++.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3566888999999999999999975 58999999986533 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---CCCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~ 640 (679)
|||+++++|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999998653 4599999999999999999999999 999999999999998 56789999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ .....||+.|+|||++.+..++.++|||||
T Consensus 162 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 199 (444)
T 3soa_A 162 EVEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199 (444)
T ss_dssp CCCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred EecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHH
Confidence 76554322 244679999999999999999999999995
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=269.51 Aligned_cols=184 Identities=28% Similarity=0.486 Sum_probs=163.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..|++.+.||+|+||.||+++..+++.||+|++.......+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 45677889999999999999998889999999987766778899999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++..........
T Consensus 88 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 88 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999654 24589999999999999999999999 99999999999999999999999999998765432222
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||++.+..++.++|||||
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSF 191 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhh
Confidence 233457889999999998899999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=290.57 Aligned_cols=183 Identities=30% Similarity=0.361 Sum_probs=162.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34677789999999999999986 5899999999642 345567889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 264 Ey~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999997543 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++.+..++.++|||||
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSL 371 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHH
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHH
Confidence 432 244689999999999999899999999996
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=271.88 Aligned_cols=186 Identities=30% Similarity=0.494 Sum_probs=163.1
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
...+|++.+.||+|+||.||+|+..++..||||+++......+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34567888999999999999999988889999999876667888999999999999999999999986 45689999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999996432 23589999999999999999999999 999999999999999999999999999987765443
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......+++.|+|||++.+..++.++|||||
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 196 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence 33334567889999999998889999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=269.30 Aligned_cols=181 Identities=22% Similarity=0.331 Sum_probs=155.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.++||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 4677889999999999999986 48999999996532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++ +|.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 83 CDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 986 565555432 34599999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
. ......||+.|+|||++.+.. ++.++|||||
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 188 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHH
Confidence 2 224457899999999998766 7999999996
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=275.00 Aligned_cols=179 Identities=29% Similarity=0.445 Sum_probs=157.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 4778899999999999999974 5899999998642 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+ +|+|.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 90 ~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 90 YA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 99 67898888653 3599999999999999999999999 9999999999999999999999999999876554
Q ss_pred CceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
.. .....||+.|+|||++.+..+ ++++|||||
T Consensus 162 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp BT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred cc--cccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 32 244579999999999988876 789999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.84 Aligned_cols=187 Identities=28% Similarity=0.506 Sum_probs=149.7
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
+....|++.+.||+|+||.||+|++. ++..||||+++... ...+++.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 33456778899999999999999975 47789999997532 3346799999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++++|.+++... ...+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999653 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceee--ecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVY--TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.......... ....+++.|+|||++.+..++.++|||||
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~Sl 236 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHH
Confidence 7655432211 12345778999999999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=275.31 Aligned_cols=182 Identities=30% Similarity=0.415 Sum_probs=156.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4677899999999999999976 58999999986422 33466889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 88 SGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp TTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999854 34599999999999999999999999 999999999999999999999999999987653322
Q ss_pred e-eeecccCccccccccccccCCC-CcccceeeC
Q 046493 648 L-VYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 648 ~-~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
. ......||+.|+|||++.+..+ +.++|||||
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHH
Confidence 1 2235679999999999988775 778999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=279.62 Aligned_cols=182 Identities=30% Similarity=0.399 Sum_probs=151.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHH-HHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTT-IGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
..|++.+.||+|+||.||+++... ++.||||+++... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 457888999999999999999864 8899999996532 233456667766 5678999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999653 3589999999999999999999999 99999999999999999999999999998643
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+..++.++|||||
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHH
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHH
Confidence 3222 2345689999999999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=268.87 Aligned_cols=187 Identities=26% Similarity=0.395 Sum_probs=155.5
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc------cCHHHHHHHHHHHHhhc---CCCcceEEEEE
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG------QGKKEFSAEVTTIGNVH---HLHLVKLKGFC 554 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 554 (679)
.++...+|++.++||+|+||+||+|+.. +++.||||+++... .....+.+|++++++++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3455678899999999999999999974 58999999986422 22356778888887775 99999999999
Q ss_pred EeCC-----eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC
Q 046493 555 IEGA-----HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF 629 (679)
Q Consensus 555 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 629 (679)
.+.. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 8765 5789999997 59999997643 33489999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 630 TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 630 ~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 158 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp CEEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred CEEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHH
Confidence 999999999987654332 245678999999999999999999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=269.72 Aligned_cols=181 Identities=27% Similarity=0.354 Sum_probs=153.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+|++.++||+|+||+||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 467788999999999999999779999999986532 23477889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++ +|.+++... ...+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 83 DQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp SE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred CC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 85 999988653 24589999999999999999999999 999999999999999999999999999987643322
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
......||+.|+|||++.+. .++.++|||||
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 187 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHH
Confidence 12345789999999998764 58999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=269.30 Aligned_cols=181 Identities=25% Similarity=0.403 Sum_probs=152.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---------------------------CHHHHHHHHHHHHh
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------------------------GKKEFSAEVTTIGN 541 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~E~~~l~~ 541 (679)
..|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 35778899999999999999975 489999999864321 12568899999999
Q ss_pred hcCCCcceEEEEEEe--CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 046493 542 VHHLHLVKLKGFCIE--GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK 619 (679)
Q Consensus 542 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 619 (679)
++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||++||+|||++ +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999987 568899999999999988652 34599999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeccCCcccccCCceeeecccCccccccccccccCC---CCcccceeeC
Q 046493 620 PENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP---ISEKSDVYSY 679 (679)
Q Consensus 620 p~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwSl 679 (679)
|+|||++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 226 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence 99999999999999999999876554322 34567999999999998765 3788999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.15 Aligned_cols=187 Identities=27% Similarity=0.322 Sum_probs=156.4
Q ss_pred CHHHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccC---HHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 483 SYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 483 ~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
...++....|++.++||+|+||+||+|++. +++.||||++...... ......|+..+.++ +||||+++++++.++
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345677788999999999999999999987 5899999998653322 23455566666555 899999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
+..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999 66999888654 34599999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++........ .....||+.|+|||++.+ .++.++|||||
T Consensus 203 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 241 (311)
T 3p1a_A 203 LLVELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSL 241 (311)
T ss_dssp TCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred eeeecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHH
Confidence 9987654332 234569999999999876 78999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.19 Aligned_cols=185 Identities=26% Similarity=0.413 Sum_probs=146.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 35777899999999999999975 4899999998653 23457788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 567 LGNGSLDKWIFNST--EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 567 ~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
++ ++|.+++.... .....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 59999886532 1224589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
... ......||+.|+|||++.+. .++.++|||||
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 195 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC 195 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHH
Confidence 322 12345789999999999764 68999999996
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=275.13 Aligned_cols=188 Identities=29% Similarity=0.491 Sum_probs=156.0
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe-----CCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-- 557 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 557 (679)
++...+|++.++||+|+||.||+|++ .+++.||||++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34456788899999999999999984 258899999997533 3346789999999999999999999998654
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 45899999999999999997642 3489999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++........ ......++..|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHH
Confidence 99876543321 1233457788999999999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.54 Aligned_cols=184 Identities=27% Similarity=0.369 Sum_probs=159.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC--eeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA--HRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 564 (679)
.+|.+.++||+|+||+||+|+... ++.||||+++.. ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 457788999999999999999865 899999999753 344677889999999999999999999998765 779999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe----CCCCcEEEeeccCCc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAK 640 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a~ 640 (679)
||+++++|.+++..... ...+++..++.++.||++||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999976432 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred ccccCCceeeecccCccccccccccc--------cCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWIT--------NNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDvwSl 679 (679)
....... .....||+.|+|||++. +..++.++|||||
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 7655432 23457999999999986 5678999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=277.40 Aligned_cols=181 Identities=28% Similarity=0.368 Sum_probs=151.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.+|++.++||+|+||.||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 45788899999999999999986 58999999998766666789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc--EEEeeccCCcccccCC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--AKVSDFGLAKLMNREE 646 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~~~~~~~ 646 (679)
+++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 100 GGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp SCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999998653 3599999999999999999999999 9999999999999987765 9999999997543322
Q ss_pred ceeeecccCccccccccccccCCCCcc-cceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEK-SDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwSl 679 (679)
. .....||+.|+|||++.+..++.+ +|||||
T Consensus 173 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 204 (361)
T 3uc3_A 173 Q--PKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred C--CCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence 1 234579999999999988887655 899996
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=280.47 Aligned_cols=191 Identities=27% Similarity=0.425 Sum_probs=163.2
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC--------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 554 (679)
++...+|.+.++||+|+||.||+|+.. .+..||||+++... ...+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 455567888999999999999999852 24679999997633 2346788999999999 899999999999
Q ss_pred EeCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 555 IEGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 555 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
.+++..++||||+++++|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999976432 124589999999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 99999999999999999876543321 2233567889999999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=277.85 Aligned_cols=188 Identities=28% Similarity=0.346 Sum_probs=165.0
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-----CCCcceEEEEEE
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-----HLHLVKLKGFCI 555 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~ 555 (679)
+...++....|++.++||+|+||+||+|+.. +++.||||+++......+.+..|++++++++ ||||+++++++.
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 4444566778899999999999999999975 5899999999865555677888999999996 999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC--------
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-------- 627 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------- 627 (679)
..+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence 999999999999 899999997643 33589999999999999999999999 9999999999999975
Q ss_pred -----------------CCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 628 -----------------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 628 -----------------~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 7899999999998654432 34578999999999999999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=277.42 Aligned_cols=182 Identities=27% Similarity=0.390 Sum_probs=160.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 45788899999999999999976 48999999986532 34567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC--CCcEEEeeccCCcccccC
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~~~~ 645 (679)
++++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998643 33589999999999999999999999 9999999999999974 578999999999877654
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....||+.|+|||++.+..++.++|||||
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 236 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAI 236 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeH
Confidence 33 234579999999999999999999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=297.32 Aligned_cols=188 Identities=29% Similarity=0.484 Sum_probs=163.8
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
++....+++.++||+|+||.||+|++.++..||||+++......+++.+|++++++++||||+++++++.+ +..+||||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34556678889999999999999999888889999998766667889999999999999999999999876 67899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.++|.... ...+++.+++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999996432 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.........++..|+|||++.+..++.++|||||
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 450 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence 2222223456789999999998899999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=272.08 Aligned_cols=181 Identities=25% Similarity=0.402 Sum_probs=151.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHh--hcCCCcceEEEEEEeC----Ceee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGN--VHHLHLVKLKGFCIEG----AHRL 561 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 561 (679)
....|++.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.+. ...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 345678889999999999999998 7899999999753 34556667776666 7999999999997653 4578
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeEeCCCCcEEE
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH--------EECEVKIVHCDIKPENVLLDDNFTAKV 633 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kL 633 (679)
+||||+++++|.+++.. ..+++..++.++.||++||+||| ++ +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999943 35899999999999999999999 77 9999999999999999999999
Q ss_pred eeccCCcccccCCcee---eecccCccccccccccccC------CCCcccceeeC
Q 046493 634 SDFGLAKLMNREESLV---YTTLRGTRGYLAPEWITNN------PISEKSDVYSY 679 (679)
Q Consensus 634 ~DFg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSl 679 (679)
+|||+++......... .....||+.|+|||++.+. .++.++|||||
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 9999998765543322 2234799999999999876 45579999996
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=275.73 Aligned_cols=184 Identities=32% Similarity=0.444 Sum_probs=156.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC----eeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA----HRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 565 (679)
..|++.++||+|+||.||+|+.. ++.||||+++..........+|+.++++++||||+++++++.+.. ..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 45778899999999999999984 799999999766555666778999999999999999999998754 4699999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------CCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC-------EVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
|+++++|.+++... .+++..++.++.||++||+|||+.+ ..+|+||||||+|||+++++.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999653 3899999999999999999999852 23899999999999999999999999999
Q ss_pred CcccccCCce-eeecccCccccccccccccC-----CCCcccceeeC
Q 046493 639 AKLMNREESL-VYTTLRGTRGYLAPEWITNN-----PISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwSl 679 (679)
++........ ......||+.|+|||++.+. .++.++|||||
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 9876554322 12335799999999999873 45678999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=287.20 Aligned_cols=182 Identities=27% Similarity=0.333 Sum_probs=150.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.++||+|+||.||+|+.. +++.||||+++.. ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 45778899999999999999975 4899999999642 233456788999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
||+++++|.+++... ..+++..+..++.||+.||+|||+ + +|+||||||+||||+.++.+||+|||+++...
T Consensus 228 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 228 EYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred eeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998653 358999999999999999999998 8 99999999999999999999999999998644
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+..++.++|||||
T Consensus 301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 335 (446)
T 4ejn_A 301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred CCCc-ccccccCCccccCHhhcCCCCCCCccchhhh
Confidence 3322 2345689999999999999999999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=283.70 Aligned_cols=180 Identities=31% Similarity=0.480 Sum_probs=156.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC-eeeEEEecc
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-HRLLAYEYL 567 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 567 (679)
...+++.++||+|+||.||+|+. .++.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 34567788999999999999998 47899999997643 5678999999999999999999999988765 789999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++|+|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp TTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999997643 33479999999999999999999999 99999999999999999999999999998543321
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....+++.|+|||++.+..++.++|||||
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 372 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSF 372 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 23367889999999999999999999996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=281.46 Aligned_cols=193 Identities=26% Similarity=0.430 Sum_probs=161.4
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEE
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 554 (679)
-.++...+|++.++||+|+||.||+|++ .+++.||||+++... ...+.+.+|+++++++ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 3445567788899999999999999983 236899999997633 2345789999999999 799999999999
Q ss_pred EeCCe-eeEEEeccCCCCHhHHhhccCCC---------------------------------------------------
Q 046493 555 IEGAH-RLLAYEYLGNGSLDKWIFNSTEE--------------------------------------------------- 582 (679)
Q Consensus 555 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 582 (679)
.+.+. .++||||+++|+|.+++......
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 87654 89999999999999999764321
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc-eee
Q 046493 583 -----------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES-LVY 650 (679)
Q Consensus 583 -----------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~-~~~ 650 (679)
...+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 12288999999999999999999999 999999999999999999999999999987644332 223
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 281 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSF 281 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhH
Confidence 44678999999999999999999999996
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=283.07 Aligned_cols=187 Identities=25% Similarity=0.371 Sum_probs=159.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+....+.+.++||+|+||.||+|+.. +++.||||+++... ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 33456778899999999999999986 58999999987532 2234688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999653 33589999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCceee-ecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVY-TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... ....+++.|+|||++.+..++.++|||||
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 301 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHH
Confidence 3321111 11235778999999998889999999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=270.33 Aligned_cols=174 Identities=28% Similarity=0.382 Sum_probs=136.8
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccCCCCHh
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLGNGSLD 573 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 573 (679)
++||+|+||.||+|+.. +++.||||++.. .....+.+|++++++++ ||||+++++++.+++..++||||+++++|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG--GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh--hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999986 489999999964 34567889999999997 999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEEEeeccCCcccccCCceee
Q 046493 574 KWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 574 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 95 ~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 95 ERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 999653 4599999999999999999999999 999999999999997665 899999999986654332 22
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 195 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSL 195 (325)
T ss_dssp -----------------CCCCHHHHHHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHH
Confidence 44578999999999999999999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=282.60 Aligned_cols=190 Identities=26% Similarity=0.423 Sum_probs=160.2
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
+....|++.++||+|+||.||+|++. +++.||||+++.. ......+.+|+.++++++||||+++++++.+.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34566788899999999999999953 3678999999653 334457889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEE
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAK 632 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~k 632 (679)
..++||||+++++|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999976432 224589999999999999999999999 999999999999999555 599
Q ss_pred EeeccCCcccccCCc-eeeecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+++....... .......+|+.|+|||++.+..++.++|||||
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 272 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHH
Confidence 999999986533221 11234567999999999999999999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=271.00 Aligned_cols=192 Identities=29% Similarity=0.463 Sum_probs=163.0
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEe-----CCCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEE
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 554 (679)
....++....|++.++||+|+||.||+|++ .+++.||||+++.. ....+.+.+|++++++++||||+++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 444455566788899999999999999983 35899999999753 34457899999999999999999999999
Q ss_pred EeC--CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 555 IEG--AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 555 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
.+. +..++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence 876 6689999999999999999654 23589999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||++......... ......+|..|+|||++.+..++.++|||||
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 215 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence 9999999877654432 2234568889999999999899999999996
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=276.76 Aligned_cols=189 Identities=29% Similarity=0.474 Sum_probs=160.4
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
....|++.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3456778899999999999999974 34889999997532 234678999999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEE--------------------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK 619 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 619 (679)
.++||||+++++|.+++...... ...+++.+++.++.||++||.|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999764311 25689999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeccCCcccccCCc-eeeecccCccccccccccccCCCCcccceeeC
Q 046493 620 PENVLLDDNFTAKVSDFGLAKLMNREES-LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 620 p~NIll~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+||++++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 9999999999999999999987644322 12234568899999999999899999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=261.60 Aligned_cols=181 Identities=23% Similarity=0.364 Sum_probs=160.0
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..+|++.++||+|+||.||+|+... +..||+|++.. .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4568888999999999999999765 78999999865 345567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe---CCCCcEEEeeccCCcccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~ 643 (679)
+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988653 3589999999999999999999999 99999999999999 788999999999998765
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....||+.|+|||++.+. ++.++|||||
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~sl 193 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSA 193 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHH
T ss_pred Cccc--hhccCCCCCccChHHhccc-CCchhhehhH
Confidence 4432 2445799999999998764 8999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.08 Aligned_cols=180 Identities=28% Similarity=0.398 Sum_probs=143.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
..|++.+.||+|+||.||+|+... ++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 457788999999999999999864 7899999997533 45678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCcccccC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~~~~~~ 645 (679)
+++|.+++.. ...+++.++..++.||++||.|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 132 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 132 GGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp SCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999854 34589999999999999999999999 9999999999999975 889999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....||+.|+|||++.+..++.++|||||
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 236 (349)
T 2w4o_A 205 VL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHH
T ss_pred cc--cccccCCCCccCHHHhcCCCCCcccchHHH
Confidence 21 234678999999999999899999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.28 Aligned_cols=182 Identities=23% Similarity=0.269 Sum_probs=158.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+++++++ +||||+++++++.+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 35677899999999999999964 58999999986532 234688999999999 8999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc-----EEEeeccCCccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-----AKVSDFGLAKLM 642 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~DFg~a~~~ 642 (679)
+++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++..
T Consensus 88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 88 -GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred -CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 89999999754 34699999999999999999999999 9999999999999998887 999999999876
Q ss_pred ccCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......||+.|+|||++.+..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 203 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL 203 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence 543321 1234679999999999999999999999996
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=265.45 Aligned_cols=185 Identities=28% Similarity=0.423 Sum_probs=156.5
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
...|.+.++||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 456888999999999999999975 4899999998653 3456889999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe---CCCCcEEEeeccCCccc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~ 642 (679)
|+++++|.+++.........+++..+..++.||++||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865433346699999999999999999999999 99999999999999 45678999999999876
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .....||+.|+|||++. ..++.++|||||
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~sl 211 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSA 211 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHH
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehH
Confidence 54332 24457899999999886 468999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.42 Aligned_cols=177 Identities=29% Similarity=0.431 Sum_probs=151.4
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
.+.||+|+||.||+|+.. +++.||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999975 58999999997633 4457799999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe--CCCCcEEEeeccCCcccccCCceee
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL--DDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||+ ++++.+||+|||+++....... .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9988653 34589999999999999999999999 99999999999999 6778999999999987655432 2
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 274 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence 34579999999999998899999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=268.07 Aligned_cols=183 Identities=26% Similarity=0.427 Sum_probs=161.9
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
....|++.+.||+|+||.||+|+.. +++.||||+++... ...+++.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567888999999999999999976 48999999986522 136789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC----cEEEee
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSD 635 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~D 635 (679)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||++++++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999964 34589999999999999999999999 999999999999999887 799999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||++........ .....||+.|+|||++.+..++.++|||||
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 204 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHH
Confidence 999987655332 234579999999999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=275.72 Aligned_cols=185 Identities=19% Similarity=0.213 Sum_probs=159.5
Q ss_pred HhhhhhhhcCcc--cceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQG--GFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
.+|++.++||+| +||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 457888999999 99999999986 58999999997533 2335688899999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+....
T Consensus 105 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999997643 34589999999999999999999999 99999999999999999999999999987553
Q ss_pred cCCce------eeecccCcccccccccccc--CCCCcccceeeC
Q 046493 644 REESL------VYTTLRGTRGYLAPEWITN--NPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSl 679 (679)
..... ......||+.|+|||++.+ ..++.++|||||
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 32211 1122478999999999987 578999999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.58 Aligned_cols=177 Identities=19% Similarity=0.228 Sum_probs=150.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---------cCHHHHHHHHHHHHhhc---------CCCcc
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---------QGKKEFSAEVTTIGNVH---------HLHLV 548 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~---------h~niv 548 (679)
+...+|++.++||+|+||+||+|+. +++.||||+++... ...+.+.+|++++++++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4456789999999999999999998 78999999996532 22378899999999986 88888
Q ss_pred eEEEEEE------------------------------eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHH
Q 046493 549 KLKGFCI------------------------------EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGM 598 (679)
Q Consensus 549 ~l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i 598 (679)
++.+++. +.+..++||||+++|++.+.+.+ ..+++..+..++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 8777643 26788999999999976666532 458999999999999
Q ss_pred HHHHHHHh-cCCCCCeeecCCCCCCeEeCCCC--------------------cEEEeeccCCcccccCCceeeecccCcc
Q 046493 599 AKGLAYLH-EECEVKIVHCDIKPENVLLDDNF--------------------TAKVSDFGLAKLMNREESLVYTTLRGTR 657 (679)
Q Consensus 599 ~~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DFg~a~~~~~~~~~~~~~~~gt~ 657 (679)
+.||+||| ++ +|+||||||+||||+.++ .+||+|||+|+..... ...||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 88 999999999999999887 8999999999876542 236899
Q ss_pred ccccccccccCCCCcccceeeC
Q 046493 658 GYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 658 ~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.|+|||++.+.. +.++|||||
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl 262 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRL 262 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhh
Confidence 999999998876 899999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=269.75 Aligned_cols=185 Identities=26% Similarity=0.384 Sum_probs=146.9
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
...+|++.+.||+|+||.||+|+... +..||+|+++... ...+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 44578888999999999999999743 4579999987532 23467899999999999999999999974 56789
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++... ...+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999653 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.............+++.|+|||++.+..++.++|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 203 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHH
Confidence 75543333334567889999999998899999999996
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-31 Score=273.40 Aligned_cols=189 Identities=30% Similarity=0.448 Sum_probs=161.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
....|.+.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3456788899999999999999862 35889999997532 234678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTE--------------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIK 619 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 619 (679)
.++||||+++++|.+++..... ....+++..++.++.||++||+|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976432 123489999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 620 PENVLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 620 p~NIll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+||++++++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999999999999999998765543321 233467889999999999889999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=271.68 Aligned_cols=183 Identities=26% Similarity=0.381 Sum_probs=159.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
...+|++.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567888899999999999999965 589999999865321 234577899999999999999999999999
Q ss_pred CeeeEEEeccCCC-CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeec
Q 046493 558 AHRLLAYEYLGNG-SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 558 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 636 (679)
+..++||||+.+| +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999776 999998653 3599999999999999999999999 9999999999999999999999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
|++........ .....||+.|+|||++.+..+ +.++|||||
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 216 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSL 216 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhH
Confidence 99987655432 234579999999999988876 789999996
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=281.63 Aligned_cols=181 Identities=30% Similarity=0.455 Sum_probs=160.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34778899999999999999976 5899999999642 234567899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999954 34599999999999999999999999 999999999999999999999999999987655
Q ss_pred CCceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
... .....||+.|+|||++.+..+ +.++|||||
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 202 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSS 202 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence 332 245679999999999988765 689999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=264.61 Aligned_cols=187 Identities=25% Similarity=0.469 Sum_probs=162.4
Q ss_pred CHHHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-----
Q 046493 483 SYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----- 556 (679)
Q Consensus 483 ~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 556 (679)
+.++.....|++.+.||+|+||.||+|+.. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 345566778889999999999999999986 68999999997532 357789999999999999999999865
Q ss_pred -----------CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe
Q 046493 557 -----------GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL 625 (679)
Q Consensus 557 -----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll 625 (679)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFL 155 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEE
Confidence 445799999999999999997543 34689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 626 DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 626 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++++.+||+|||++........ .....|++.|+|||++.+..++.++|||||
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHH
T ss_pred cCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHH
Confidence 9999999999999987655432 234568999999999999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-31 Score=273.25 Aligned_cols=183 Identities=24% Similarity=0.351 Sum_probs=150.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe----e
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH----R 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 560 (679)
.+|++.+.||+|+||.||+++.. +++.||||+++.... ....+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 46788899999999999999974 589999999975322 23568899999999999999999999887654 3
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++++|.+++... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999653 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ ......||+.|+|||++.+..++.++|||||
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 205 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHH
Confidence 76543221 1233568999999999999999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=274.64 Aligned_cols=191 Identities=29% Similarity=0.447 Sum_probs=160.9
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEeccc--ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESI--GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
++....|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34556778889999999999999996 23578999999753 23457799999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTEE-------------------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCD 617 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~D 617 (679)
.+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||++ +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999764321 13489999999999999999999999 999999
Q ss_pred CCCCCeEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 618 IKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 618 lkp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 9999999999999999999999876554332 2234567889999999999899999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=264.24 Aligned_cols=194 Identities=41% Similarity=0.704 Sum_probs=167.0
Q ss_pred CCcCHHHHHHHhhhhh--------hhcCcccceEEEEEEeCCCcEEEEEEeccc-----ccCHHHHHHHHHHHHhhcCCC
Q 046493 480 TRFSYDDLCKATKNFS--------TKLGQGGFGSVYLGMLPDGIQVAVKKLESI-----GQGKKEFSAEVTTIGNVHHLH 546 (679)
Q Consensus 480 ~~~~~~~l~~~~~~~~--------~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h~n 546 (679)
..+++.++.+.+.++. ++||+|+||.||+|+. +++.||||++... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 5688899998887765 4599999999999997 6889999998642 223567899999999999999
Q ss_pred cceEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 547 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
|+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.||++||+|||++ +|+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999865332 34689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 627 DNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++.+||+|||++......... ......||+.|+|||++.+ .++.++|||||
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~sl 220 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSF 220 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHH
Confidence 9999999999999876543322 2234578999999998875 48899999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=261.36 Aligned_cols=183 Identities=24% Similarity=0.431 Sum_probs=158.6
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
....|++.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4567888999999999999999986 48999999986422 236789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC----cEEEee
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSD 635 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~D 635 (679)
.++||||+++++|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||++++++ .+||+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999965 23589999999999999999999999 999999999999998877 899999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||++........ .....|++.|+|||++.+..++.++|||||
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (283)
T 3bhy_A 156 FGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 197 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhH
Confidence 999987654322 234568999999999999899999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=275.25 Aligned_cols=183 Identities=24% Similarity=0.293 Sum_probs=157.8
Q ss_pred HhhhhhhhcCcccceEEEEEEe----CCCcEEEEEEeccc-----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESI-----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 559 (679)
..|++.++||+|+||.||+++. .+++.||||+++.. ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4578889999999999999997 36899999998642 23446678899999999 69999999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++++|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999653 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccC--CCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
+..............||+.|+|||++.+. .++.++|||||
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence 87654433333456799999999999863 47899999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=263.32 Aligned_cols=183 Identities=26% Similarity=0.400 Sum_probs=157.8
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 563 (679)
...|++.+.||+|+||.||+|+.. +++.||||+++.. .....++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 466888899999999999999986 5899999998752 23456788999999999 899999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC---------------
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN--------------- 628 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--------------- 628 (679)
|||+++++|.+++.........+++..++.++.||++||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976543335689999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeeccCCcccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 629 ----FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 629 ----~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 479999999998765433 23589999999999876 56689999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=261.13 Aligned_cols=182 Identities=27% Similarity=0.420 Sum_probs=139.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 4677889999999999999974 6899999998642 2334778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 92 MCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp CCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred cCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999653 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++.+..++.++|||||
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (278)
T 3cok_A 166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSL 198 (278)
T ss_dssp ---------------------------CTHHHHH
T ss_pred CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence 221 234568999999999999889999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=272.56 Aligned_cols=188 Identities=26% Similarity=0.330 Sum_probs=154.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc------ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI------GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..+|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 466888999999999999999975 4889999998642 234577999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCC------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 046493 562 LAYEYLGNGSLDKWIFNSTEE------------------------------------SRFLSWNTRFNIALGMAKGLAYL 605 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~L~yL 605 (679)
+||||+++++|.+++...... ...+++..+..++.||++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521100 11246778889999999999999
Q ss_pred hcCCCCCeeecCCCCCCeEeCCCC--cEEEeeccCCcccccCCc---eeeecccCcccccccccccc--CCCCcccceee
Q 046493 606 HEECEVKIVHCDIKPENVLLDDNF--TAKVSDFGLAKLMNREES---LVYTTLRGTRGYLAPEWITN--NPISEKSDVYS 678 (679)
Q Consensus 606 H~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DFg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS 678 (679)
|++ +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999 999999999999998776 899999999987644221 12345679999999999875 57899999999
Q ss_pred C
Q 046493 679 Y 679 (679)
Q Consensus 679 l 679 (679)
|
T Consensus 262 l 262 (345)
T 3hko_A 262 A 262 (345)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-31 Score=269.71 Aligned_cols=182 Identities=24% Similarity=0.440 Sum_probs=158.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-C-------cEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-G-------IQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~-------~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
+...+|.+.+.||+|+||.||+|+... + ..||+|++... ....+.+.+|++++++++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 344567888999999999999999653 3 57999999653 34567899999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc-------
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT------- 630 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~------- 630 (679)
+..++||||+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 9999999999999999999764 23489999999999999999999999 9999999999999998877
Q ss_pred -EEEeeccCCcccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 631 -AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 631 -~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+||+|||++...... ....+++.|+|||++.+ ..++.++|||||
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 999999999765432 23457889999999987 678999999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=293.28 Aligned_cols=184 Identities=26% Similarity=0.308 Sum_probs=160.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 561 (679)
.-..|++.++||+|+||.||+|+... ++.||||+++.. ....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34457778899999999999999764 889999999642 34456788899999988 7999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999753 3599999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......||+.|+|||++.+..++.++|||||
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSl 528 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHH
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEech
Confidence 433322 2345689999999999999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-31 Score=276.15 Aligned_cols=191 Identities=29% Similarity=0.458 Sum_probs=161.4
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
++....|++.+.||+|+||.||+|+... ...||+|.+.... ...+.+.+|+++++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4455667888999999999999999643 2489999997633 2346789999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTE----------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~ 626 (679)
++..++||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 9999999999999999999965321 123589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 627 DNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 9999999999999876544322 2233457889999999999899999999996
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=269.96 Aligned_cols=190 Identities=28% Similarity=0.468 Sum_probs=162.7
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+...+|++.+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+++++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 4456778889999999999999985 246899999997533 2346789999999999 899999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTE--------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
+..++||||+++++|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999976432 123589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++++++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 99999999999999998776544322 233457889999999999899999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=265.73 Aligned_cols=183 Identities=22% Similarity=0.308 Sum_probs=149.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45788899999999999999976 588999999975322 2367889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..........|++.|+|||++.+..++.++|||||
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 221 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYAL 221 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHH
Confidence 43333345678999999999999899999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=272.16 Aligned_cols=186 Identities=30% Similarity=0.451 Sum_probs=153.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-Cc----EEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
+...+|++.++||+|+||+||+|++.. ++ +||+|.++. .....+++.+|++++++++||||+++++++.+++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 344567888999999999999999643 43 468888754 2345678999999999999999999999998765
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++|+||+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 67899999999999999764 34589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+........ ......+|+.|+|||++.+..++.++|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence 876554332 2233457889999999999999999999996
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=261.26 Aligned_cols=181 Identities=27% Similarity=0.454 Sum_probs=158.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
..|++.++||+|+||.||+|.... ++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457788999999999999999764 89999999865332 34668899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc---EEEeeccCCccc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFGLAKLM 642 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DFg~a~~~ 642 (679)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||++...
T Consensus 86 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 86 LVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888653 4589999999999999999999999 9999999999999986655 999999999876
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .....||+.|+|||++.+..++.++|||||
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence 54432 234679999999999999999999999995
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=261.26 Aligned_cols=180 Identities=28% Similarity=0.417 Sum_probs=155.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+... ++.||||++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 346778899999999999999765 789999998542 234567899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999998653 3589999999999999999999999 999999999999999999999999999865443
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....|++.|+|||++.+..++.++|||||
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (279)
T 3fdn_A 162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred cc---ccccCCCCCccCHhHhccCCCCccchhHhH
Confidence 32 234578999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=270.41 Aligned_cols=191 Identities=25% Similarity=0.455 Sum_probs=161.7
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC--------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP--------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 554 (679)
++...+|++.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445567888999999999999999863 46789999997533 2346788999999999 899999999999
Q ss_pred EeCCeeeEEEeccCCCCHhHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEE------------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 555 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
.+.+..++||||+++++|.+++...... ...+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 9999999999999999999999764321 23489999999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 999999999999999998765543221 233457889999999998889999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=273.94 Aligned_cols=184 Identities=26% Similarity=0.376 Sum_probs=146.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCC--e
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGA--H 559 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 559 (679)
....+|++.++||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.++++++ ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34567888899999999999999975 58999999986532 33456788999999997 999999999998654 6
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 589998864 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCC--------------------ceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREE--------------------SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+...... ........||+.|+|||++.+ ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 217 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHH
Confidence 8653311 111234579999999999987 578999999996
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=264.43 Aligned_cols=181 Identities=25% Similarity=0.367 Sum_probs=151.9
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.++||+|+||.||+|+... ++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 46778999999999999999864 899999998654332 45678999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 84 CDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988754 34589999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.. .....||+.|+|||++.+ ..++.++|||||
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 189 (311)
T 4agu_A 157 DY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAI 189 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHH
T ss_pred cc-cCCCcCCccccChHHHhcCCCCCcchhhHHH
Confidence 22 234578999999999876 568999999996
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=249.03 Aligned_cols=208 Identities=16% Similarity=0.211 Sum_probs=139.6
Q ss_pred cccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcE
Q 046493 27 HIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNA 106 (679)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~l 106 (679)
+.++|.+|++++. +..| ++|.|+|||+.+++ +.+ +. .+|+||+|||+.| ..+.|.|+.||||
T Consensus 7 ~~~~i~~g~~L~~-------g~~l--~~g~f~l~f~~~gn----l~l-y~--~~~~vW~an~~~~--~~~~l~l~~dGnL 68 (236)
T 1dlp_A 7 LSHEGSHPQTLHA-------AQSL--ELSSFRFTMQSDCN----LVL-FD--SDVRVWASNTAGA--TGCRAVLQSDGLL 68 (236)
T ss_dssp SSSSSCSCSCCCT-------TCEE--CSTTEEEEECTTSC----EEE-EE--SSSEEECCCCCSC--SCCBCCBCSSSCB
T ss_pred ccceeCCCCEECC-------CCEE--EcCCEEEEECCCCc----EEE-EE--CCEEEEECCCCCC--CCeEEEEcCCCcE
Confidence 3589999977655 3444 59999999986543 122 33 2799999999988 3456999999999
Q ss_pred EEEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeecCCCCcccc----------CCCCccCCC-ceeec--
Q 046493 107 YLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTL----------LPGQQFVEG-MRLKS-- 171 (679)
Q Consensus 107 vl~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTl----------Lpgqkl~~~-~~l~S-- 171 (679)
||.+.++ ++|+|++.. .....|+|+|+|||||++. ++||||||||||+ +||||+..+ ++|++
T Consensus 69 vl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~ 145 (236)
T 1dlp_A 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQ 145 (236)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSC
T ss_pred EEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCc
Confidence 9999877 689998763 3345899999999999954 8999999998555 777766543 46766
Q ss_pred CCCCCCceEEEEeecCceEEEEecccceeeeeccCCCcccccceEEeeeccccccccccccccccceeeEEEeecCCCCc
Q 046493 172 FPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSRKTNTSVAAKVHSASLVSNAWNFYDIRKALLWQFIFSENNDEN 251 (679)
Q Consensus 172 ~~~~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (679)
++++|.|++.++.++ +++++ +...+||+++.+... ......+..++. +.++..+...+++...... .
T Consensus 146 d~s~G~~~l~l~~dG-~LvL~---~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-----l~ly~~~~~~vw~s~~~~~--~- 212 (236)
T 1dlp_A 146 SLQLSPYRLSMETDC-NLVLF---DRDDRVWSTNTAGKG-TGCRAVLQPNGR-----MDVLTNQNIAVWTSGNSRS--A- 212 (236)
T ss_dssp CCBCSSCEEEEETTT-EEEEE---BTTBCCSCCCCCSSC-SSCEEEEETTTE-----EEEEETTTEEEEECCCCCS--S-
T ss_pred EeecCcEEEEECCCC-cEEEE---cCCEeEEeCCCcCCC-CceEEEECCCCc-----EEEEeCCCcEEEEeCCCCC--C-
Confidence 677899999998776 66554 345689998865432 112222222221 1112212122332211111 1
Q ss_pred eEEEEEecCCCcEEEEE
Q 046493 252 ATWAAILGSNGEITFSN 268 (679)
Q Consensus 252 ~~~~~~~~~~g~~~~~~ 268 (679)
..++++++.+|.+++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 34678889999998874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=281.86 Aligned_cols=178 Identities=26% Similarity=0.291 Sum_probs=147.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ce
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 559 (679)
.+|++.++||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 34777899999999999999976 48999999996532 3346788999999999999999999999754 35
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++ +|.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 142 ~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 6999999976 4666662 2389999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+...... ......||+.|+|||++.+..++.++|||||
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 249 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence 8765432 2345689999999999999999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=281.39 Aligned_cols=182 Identities=26% Similarity=0.371 Sum_probs=142.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-----Cee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-----AHR 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 560 (679)
.+|++.++||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++||||+++++++... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 45788899999999999999976 58999999986532 2346788999999999999999999999543 568
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||++ ++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999985 689998854 34599999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCc--------------------------eeeecccCcccccccccc-ccCCCCcccceeeC
Q 046493 641 LMNREES--------------------------LVYTTLRGTRGYLAPEWI-TNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSl 679 (679)
....... ......+||+.|+|||++ .+..++.++|||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 7643221 112345789999999976 55679999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=273.67 Aligned_cols=177 Identities=27% Similarity=0.312 Sum_probs=144.9
Q ss_pred hhhh-hhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe----CCeeeEEE
Q 046493 492 KNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE----GAHRLLAY 564 (679)
Q Consensus 492 ~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~ 564 (679)
|.+. +.||+|+||+||+++.. +++.||||+++. ...+.+|++++.++ +||||+++++++.. .+..++||
T Consensus 63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 3443 68999999999999976 489999999864 34577888887554 89999999999876 56789999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCcc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKL 641 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~~ 641 (679)
||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 139 E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp ECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999997642 34589999999999999999999999 9999999999999997 78999999999986
Q ss_pred cccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....||+.|+|||++.+..++.++|||||
T Consensus 214 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 249 (400)
T 1nxk_A 214 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred cCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence 654322 245678999999999999999999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=264.82 Aligned_cols=192 Identities=24% Similarity=0.391 Sum_probs=162.6
Q ss_pred CcCHHHHHHHhhhhh-hhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhc-CCCcceEEEEE
Q 046493 481 RFSYDDLCKATKNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVH-HLHLVKLKGFC 554 (679)
Q Consensus 481 ~~~~~~l~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 554 (679)
.+...+.....|.+. ++||+|+||.||+|+.. +++.||||+++.. .....++.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 456666777778777 88999999999999976 4899999998652 234678999999999995 69999999999
Q ss_pred EeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcE
Q 046493 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTA 631 (679)
Q Consensus 555 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ 631 (679)
.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999985432 35699999999999999999999999 9999999999999997 7899
Q ss_pred EEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNI 219 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHH
Confidence 9999999987654332 234579999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=262.98 Aligned_cols=178 Identities=31% Similarity=0.529 Sum_probs=145.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+. .++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 3567788999999999999998 48899999986532 23467899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eeecCCCCCCeEeCC--------CCcEEE
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK---IVHCDIKPENVLLDD--------NFTAKV 633 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~---ivH~Dlkp~NIll~~--------~~~~kL 633 (679)
||+++++|.+++.. ..+++..++.++.|+++||+|||++ + |+||||||+||++++ ++.+||
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp ECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999842 3589999999999999999999999 7 999999999999986 778999
Q ss_pred eeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 634 SDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 634 ~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+|||++........ ....||+.|+|||.+.+..++.++|||||
T Consensus 158 ~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (271)
T 3dtc_A 158 TDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSY 200 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred ccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHH
Confidence 99999986654332 24568999999999999899999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=268.77 Aligned_cols=180 Identities=23% Similarity=0.393 Sum_probs=155.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEec
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
...|++.+.||+|+||.||+++.. +++.||||+++.... ...+|++++.++ +||||+++++++.+++..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 456888899999999999999986 489999999975432 245788888888 799999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC----CcEEEeeccCCccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLM 642 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~~ 642 (679)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998653 4589999999999999999999999 99999999999998543 35999999999876
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 206 (342)
T 2qr7_A 171 RAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSL 206 (342)
T ss_dssp BCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeH
Confidence 554322 244678999999999988889999999996
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=260.42 Aligned_cols=182 Identities=25% Similarity=0.337 Sum_probs=159.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+|.+.+.||+|+||.||+++..+ ++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 457778999999999999999865 8899999986532 23467889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++.++..++.||++||+|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988653 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....|++.|+|||++.+..++.++|||||
T Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 201 (294)
T 2rku_A 168 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201 (294)
T ss_dssp TTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred Cccc-cccccCCCCcCCcchhccCCCCchhhHHHH
Confidence 3221 234578999999999999889999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=266.26 Aligned_cols=182 Identities=25% Similarity=0.337 Sum_probs=160.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+|.+.+.||+|+||.||+++..+ ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 457778999999999999999865 7899999986532 23467889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988653 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....|++.|+|||++.+..++.++|||||
T Consensus 194 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (335)
T 2owb_A 194 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227 (335)
T ss_dssp TTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred Cccc-ccccCCCccccCHHHhccCCCCchhhHHHH
Confidence 3221 234578999999999999899999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=269.05 Aligned_cols=189 Identities=25% Similarity=0.414 Sum_probs=145.6
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCCC----cEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPDG----IQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
...+|++.+.||+|+||.||+|++... ..||||+++.. ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 445678889999999999999997643 27999998653 33457789999999999999999999999887655
Q ss_pred ------eEEEeccCCCCHhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 561 ------LLAYEYLGNGSLDKWIFNSTE--ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 561 ------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
++||||+++++|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 999999999999999965332 223589999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+++........ ......+++.|+|||.+.+..++.++|||||
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhH
Confidence 9999999876543322 1223457889999999999999999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=262.42 Aligned_cols=185 Identities=28% Similarity=0.408 Sum_probs=153.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-----------
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----------- 556 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------- 556 (679)
...|++.+.||+|+||.||+|+.. +++.||||+++......+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 356788899999999999999975 58999999997655556788999999999999999999999865
Q ss_pred --CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEe
Q 046493 557 --GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVS 634 (679)
Q Consensus 557 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 634 (679)
.+..++||||+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 35678999999999999999753 34578899999999999999999999 99999999999999999999999
Q ss_pred eccCCcccccCC-------------ceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 635 DFGLAKLMNREE-------------SLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
|||++....... ........|++.|+|||++.+. .++.++|||||
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 999998764321 1112345689999999999865 68999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=267.70 Aligned_cols=179 Identities=28% Similarity=0.420 Sum_probs=155.1
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
...|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345777889999999999999964 689999999865322 235688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||++ |+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 5888877543 34589999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
.. ....||+.|+|||++. +..++.++|||||
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 239 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence 32 2357899999999984 5678999999996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=258.52 Aligned_cols=180 Identities=26% Similarity=0.386 Sum_probs=159.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+... ++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 457788999999999999999764 789999998542 234577899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999976544
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. .....|++.|+|||++.+..++.++|||||
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhH
Confidence 32 234578999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=261.55 Aligned_cols=182 Identities=28% Similarity=0.443 Sum_probs=158.0
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
...+|.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567888899999999999999976 58999999997533 344678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe---CCCCcEEEeeccCCccc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~ 642 (679)
|+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||++ ++++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999998653 3589999999999999999999999 99999999999999 78899999999999765
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....|++.|+|||++.+..++.++|||||
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHH
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHH
Confidence 4322 233568999999999999999999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=260.82 Aligned_cols=183 Identities=24% Similarity=0.296 Sum_probs=158.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEe-CCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEec
Q 046493 489 KATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..+|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 44578889999999999999996 458999999986432 345688999999999 799999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc-----EEEeeccCCcc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-----AKVSDFGLAKL 641 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~DFg~a~~ 641 (679)
+ +++|.+++... ...+++..+..++.||++||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 99999999754 23599999999999999999999999 9999999999999987776 99999999987
Q ss_pred cccCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... ......||+.|+|||++.+..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 204 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence 6554321 1234579999999999999999999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=260.18 Aligned_cols=181 Identities=29% Similarity=0.412 Sum_probs=160.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 34677889999999999999975 5899999998653 34567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999853 3589999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ......|++.|+|||++.+..++.++|||||
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 205 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHH
Confidence 2 1244578999999999999999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=267.77 Aligned_cols=181 Identities=25% Similarity=0.378 Sum_probs=150.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcC--CCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHH--LHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||++...+++.||||++..... ..+.+.+|++++++++| |||+++++++.+++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 45778899999999999999998899999999865332 33678899999999986 99999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
| +.+++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 89 e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp C-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred e-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9 5578999999653 4589999999999999999999999 999999999999997 57899999999987654
Q ss_pred CCce-eeecccCcccccccccccc-----------CCCCcccceeeC
Q 046493 645 EESL-VYTTLRGTRGYLAPEWITN-----------NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+ ..++.++|||||
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 4322 2234679999999999865 678999999996
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=263.88 Aligned_cols=186 Identities=26% Similarity=0.454 Sum_probs=150.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 35788899999999999999974 5899999998742 223467889999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++.........+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999975433355689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....|++.|+|||++.+..++.++|||||
T Consensus 189 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 222 (310)
T 2wqm_A 189 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSL 222 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred CCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence 3221 234568999999999999899999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=276.42 Aligned_cols=182 Identities=28% Similarity=0.412 Sum_probs=152.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-----Cee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-----AHR 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 560 (679)
.+|++.+.||+|+||.||+|+... ++.||||+++... ...+.+.+|++++++++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 357788999999999999999764 8899999997532 2346788999999999999999999999876 578
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||++ ++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 106 ~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 99999997 599999854 34599999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCce---------------------eeecccCcccccccccc-ccCCCCcccceeeC
Q 046493 641 LMNREESL---------------------VYTTLRGTRGYLAPEWI-TNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSl 679 (679)
........ ......||+.|+|||++ .+..++.++|||||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 76543211 12456799999999986 55679999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=256.60 Aligned_cols=184 Identities=30% Similarity=0.403 Sum_probs=159.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
...|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356788899999999999999986 5899999998643 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998853 34589999999999999999999999 9999999999999999999999999999876443
Q ss_pred Cce-eeecccCccccccccccccCCC-CcccceeeC
Q 046493 646 ESL-VYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 646 ~~~-~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
... ......|++.|+|||++.+..+ +.++|||||
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 194 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHH
Confidence 221 2234678999999999988765 778999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=277.74 Aligned_cols=182 Identities=27% Similarity=0.394 Sum_probs=158.8
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc---cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES---IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
...+|++.++||+|+||+||+|+.. +++.||||++.. .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567899999999999999999976 589999999854 234567899999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---CCCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~ 640 (679)
|||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999988653 3589999999999999999999999 999999999999995 45679999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .....||+.|+|||++.+ .++.++|||||
T Consensus 173 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 208 (486)
T 3mwu_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSA 208 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHH
T ss_pred ECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHH
Confidence 7654432 244679999999999976 58999999995
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=266.65 Aligned_cols=181 Identities=31% Similarity=0.484 Sum_probs=148.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..|++.+.||+|+||.||+++. .++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 4567788999999999999998 4788999999643 34577899999999999999999999876 447899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc-EEEeeccCCcccccCCce
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT-AKVSDFGLAKLMNREESL 648 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~DFg~a~~~~~~~~~ 648 (679)
++|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999976432 235789999999999999999999932229999999999999988876 7999999997654322
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 189 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence 33468999999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=261.31 Aligned_cols=186 Identities=29% Similarity=0.408 Sum_probs=157.0
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
+.....|++.+.||+|+||.||+|+... ++.||||++... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3455668888999999999999999864 899999999753 34577899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ...+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999998642 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....|++.|+|||++.+..++.++|||||
T Consensus 178 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (314)
T 3com_A 178 TMAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211 (314)
T ss_dssp TBSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred hccc-cCccCCCCCccChhhcCCCCCCccccHHHH
Confidence 3221 234578999999999999899999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=270.46 Aligned_cols=187 Identities=24% Similarity=0.292 Sum_probs=152.1
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecccccC------------HHHHHHHHHHHHhhcCCCc
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLESIGQG------------KKEFSAEVTTIGNVHHLHL 547 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~h~ni 547 (679)
++....|++.++||+|+||.||+|++.. ++.||||++...... ...+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 3444578889999999999999999764 478999998653211 1223345556677789999
Q ss_pred ceEEEEEEeC----CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 548 VKLKGFCIEG----AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 548 v~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
+++++++.+. ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni 183 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL 183 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence 9999999875 4579999999 99999999653 34599999999999999999999999 999999999999
Q ss_pred EeC--CCCcEEEeeccCCcccccCCcee------eecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLD--DNFTAKVSDFGLAKLMNREESLV------YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~--~~~~~kL~DFg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++ .++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 247 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEIL 247 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHH
Confidence 998 88999999999998765432211 123459999999999999999999999996
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=268.22 Aligned_cols=183 Identities=31% Similarity=0.470 Sum_probs=152.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-Cc----EEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
..|++.+.||+|+||.||+|++.. ++ +||+|.+... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 356778899999999999999653 44 3888887542 233456788999999999999999999986 556889
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999654 34588999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......+++.|+|||++.+..++.++|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence 554322 2244567889999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=274.44 Aligned_cols=184 Identities=27% Similarity=0.399 Sum_probs=147.6
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---------cCHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---------QGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
+.....|.+.++||+|+||.||+|.... ++.||||++.... .....+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3445678889999999999999999764 8999999986422 11234789999999999999999999975
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---cEE
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---TAK 632 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~k 632 (679)
.+..++||||+++++|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 4567999999999999998854 34589999999999999999999999 999999999999997544 599
Q ss_pred EeeccCCcccccCCceeeecccCcccccccccccc---CCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSl 679 (679)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 99999998765432 2245679999999999864 567889999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=262.93 Aligned_cols=182 Identities=25% Similarity=0.347 Sum_probs=150.6
Q ss_pred hhhhh-hhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|++. +.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 45553 67999999999999965 5899999999653 34567899999999995 799999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc---EEEeeccCCcccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFGLAKLMN 643 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DFg~a~~~~ 643 (679)
+++++|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++. +||+|||++....
T Consensus 93 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 93 MRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred CCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999653 3589999999999999999999999 9999999999999998776 9999999998654
Q ss_pred cCCc------eeeecccCcccccccccccc-----CCCCcccceeeC
Q 046493 644 REES------LVYTTLRGTRGYLAPEWITN-----NPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSl 679 (679)
.... .......||+.|+|||++.+ ..++.++|||||
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 212 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence 3211 11123469999999999875 458899999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=257.62 Aligned_cols=179 Identities=31% Similarity=0.536 Sum_probs=152.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc--C------HHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ--G------KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
..+|++.+.||+|+||.||+|++. +++.||||++..... . .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 456788899999999999999975 589999999854221 1 167899999999999999999999986655
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeCCCCc-----EE
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFT-----AK 632 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k 632 (679)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999988654 34699999999999999999999999 8 999999999999988776 99
Q ss_pred EeeccCCcccccCCceeeecccCccccccccccc--cCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT--NNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwSl 679 (679)
|+|||+++..... .....||+.|+|||++. ...++.++|||||
T Consensus 170 l~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl 214 (287)
T 4f0f_A 170 VADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214 (287)
T ss_dssp ECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred eCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence 9999999854432 24567999999999984 4557899999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=274.42 Aligned_cols=184 Identities=27% Similarity=0.369 Sum_probs=158.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC--eeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA--HRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 564 (679)
.+|.+.++||+|+||.||+|++.. ++.||||+++.. ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 457788999999999999999865 899999999753 244677889999999999999999999998765 679999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe----CCCCcEEEeeccCCc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSDFGLAK 640 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DFg~a~ 640 (679)
||+++++|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999965432 23389999999999999999999999 99999999999999 778889999999998
Q ss_pred ccccCCceeeecccCcccccccccccc--------CCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITN--------NPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwSl 679 (679)
....... .....||+.|+|||++.+ ..++.++|||||
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 7655432 234579999999999865 467889999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=267.82 Aligned_cols=185 Identities=30% Similarity=0.489 Sum_probs=159.0
Q ss_pred HHhhhhhhhcCcccceEEEEEEe-----CCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEE--eCCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCI--EGAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 560 (679)
..+|++.++||+|+||.||++++ .+++.||||++.... ...+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35678889999999999999984 358899999997633 33466899999999999999999999987 45568
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 89999999999999997542 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ ......+|+.|+|||++.+..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 216 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHH
Confidence 77544332 1233568888999999999889999999996
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.83 Aligned_cols=190 Identities=26% Similarity=0.411 Sum_probs=154.8
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHh--hcCCCcceEEEEEEeC--
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGN--VHHLHLVKLKGFCIEG-- 557 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~-- 557 (679)
....+....+|++.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 4456667788999999999999999999984 8999999986533 3444555555554 4899999999999987
Q ss_pred --CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEeCCCCc
Q 046493 558 --AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFT 630 (679)
Q Consensus 558 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~ 630 (679)
...++||||+++++|.+++... .+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 6889999999999999999543 4899999999999999999999752 338999999999999999999
Q ss_pred EEEeeccCCcccccCCcee---eecccCccccccccccccCCCCcc------cceeeC
Q 046493 631 AKVSDFGLAKLMNREESLV---YTTLRGTRGYLAPEWITNNPISEK------SDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------sDvwSl 679 (679)
+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 9999999998765433221 124579999999999987766654 999996
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=262.44 Aligned_cols=180 Identities=31% Similarity=0.467 Sum_probs=155.4
Q ss_pred hhhhhhcCcccceEEEEEEeC-----CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-----DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLL 562 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 562 (679)
+++.++||+|+||+||++... +++.||||+++... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999998743 57899999997643 3346789999999999999999999999884 57899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999543 389999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......+++.|+|||++.+..++.++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 223 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHH
Confidence 654322 1234567889999999999889999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=267.42 Aligned_cols=191 Identities=26% Similarity=0.443 Sum_probs=161.4
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
++...+|++.+.||+|+||.||+|+.. .++.||||++.... .....+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344567888899999999999999864 36889999997533 2345688999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcE
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTE------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 631 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 631 (679)
+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence 999999999999999999965321 124578999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||+++......... .....+|+.|+|||++.+..++.++|||||
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 999999998765433221 123456889999999999899999999996
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=264.54 Aligned_cols=182 Identities=27% Similarity=0.417 Sum_probs=158.1
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---------CHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---------GKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
...|++.+.||+|++|.||+|++. +|+.||||+++.... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 456777899999999999999986 599999999865321 135678899999999 799999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999642 4589999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCceeeecccCcccccccccccc------CCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITN------NPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwSl 679 (679)
++........ .....||+.|+|||++.+ ..++.++|||||
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence 9987655432 244679999999999864 357889999996
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=267.89 Aligned_cols=191 Identities=26% Similarity=0.444 Sum_probs=161.0
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEeccccc--CHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIGQ--GKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
++...+|++.+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+++++++ +||||+++++++.+
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34566788889999999999999984 2468999999976332 345788999999999 79999999999887
Q ss_pred CC-eeeEEEeccCCCCHhHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 557 GA-HRLLAYEYLGNGSLDKWIFNSTEE------------SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 557 ~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
.+ ..++||||+++++|.+++...... ...+++..++.++.||++||.|||++ +|+||||||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni 179 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 179 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence 55 589999999999999999765421 12378999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHH
Confidence 9999999999999999876544332 2234567899999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=262.18 Aligned_cols=186 Identities=27% Similarity=0.426 Sum_probs=156.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 563 (679)
..|++.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 35677889999999999999986 58999999996532 234668899999999999999999998864 5678999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK-----IVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
|||+++++|.+++.........+++..++.++.||+.||+|||++ + |+||||||+||++++++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999976544445699999999999999999999998 7 99999999999999999999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+......... .....|++.|+|||++.+..++.++|||||
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 163 ARILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp HHHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred heeecccccc-ccccCCCccccChHHhccCCCCchhhHHHH
Confidence 9876543221 133568999999999999899999999996
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-30 Score=260.02 Aligned_cols=184 Identities=29% Similarity=0.424 Sum_probs=153.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
...|++.+.||+|+||.||+|+... +..||||.++... ...+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3457788999999999999998643 3469999987532 345678999999999999999999999765 45689
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999654 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
............+++.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF 200 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHH
Confidence 6544333344567889999999998899999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=266.51 Aligned_cols=181 Identities=25% Similarity=0.368 Sum_probs=147.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.+|++.++||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 46788899999999999999965 58999999996532 223567899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe-----CCCCcEEEeeccCCc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL-----DDNFTAKVSDFGLAK 640 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll-----~~~~~~kL~DFg~a~ 640 (679)
|+++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++
T Consensus 114 ~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 114 YAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp CCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred cCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9985 999998653 3489999999999999999999999 99999999999999 455669999999998
Q ss_pred ccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
....... ......||+.|+|||++.+. .++.++|||||
T Consensus 186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 224 (329)
T 3gbz_A 186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSI 224 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHH
Confidence 7654322 22445689999999999875 48999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=277.02 Aligned_cols=182 Identities=28% Similarity=0.407 Sum_probs=155.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
....|++.++||+|+||+||+|+.. ++..||||+++.. ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567888999999999999999986 5889999998653 33457789999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC---CcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DFg~a~ 640 (679)
|||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999988653 3589999999999999999999999 99999999999999764 459999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .....||+.|+|||++. ..++.++|||||
T Consensus 188 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~Diwsl 223 (494)
T 3lij_A 188 VFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223 (494)
T ss_dssp ECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred ECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHH
Confidence 7655432 24467999999999986 468999999995
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=262.00 Aligned_cols=183 Identities=33% Similarity=0.535 Sum_probs=153.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEE-eCCeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCI-EGAHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv 563 (679)
+|++.++||+|+||.||+|+..+ ...||+|.++... ...+.+.+|++++++++||||+++++++. +++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 46777899999999999999643 2368999987533 23467889999999999999999999865 45678999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 106 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999653 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCce---eeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESL---VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......+|+.|+|||.+.+..++.++|||||
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 218 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHH
Confidence 43321 1233567889999999999999999999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=267.77 Aligned_cols=188 Identities=27% Similarity=0.481 Sum_probs=155.9
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC-CcE--EEEEEecc--cccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQ--VAVKKLES--IGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~--vavK~l~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 560 (679)
+....|++.+.||+|+||.||+|+... +.. ||||+++. .....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 334567888999999999999999753 554 49998865 233456789999999999 899999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC
Q 046493 561 LLAYEYLGNGSLDKWIFNST------------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN 628 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 628 (679)
++||||+++++|.+++.... .....+++..++.++.||++||+|||++ +|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999997643 2234699999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 629 FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 629 ~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.+||+|||+++....... .....+++.|+|||++.+..++.++|||||
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp GCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred CeEEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHH
Confidence 9999999999974432211 133457889999999998889999999996
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=262.75 Aligned_cols=184 Identities=30% Similarity=0.464 Sum_probs=153.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe------CCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE------GAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~ 561 (679)
..|++.+.||+|+||.||+|+.. +++.||||++.......+.+.+|+++++++ +||||+++++++.. .+..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 45677899999999999999975 589999999977666678899999999999 79999999999987 46789
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 9999999999999997643 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCceeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
....... .....|++.|+|||++. +..++.++|||||
T Consensus 179 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 220 (326)
T 2x7f_A 179 LDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHH
T ss_pred cCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHH
Confidence 6543221 23457899999999987 5568899999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=259.21 Aligned_cols=182 Identities=30% Similarity=0.479 Sum_probs=155.4
Q ss_pred hhhhhh-hcCcccceEEEEEEeC---CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFST-KLGQGGFGSVYLGMLP---DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+.+.+ .||+|+||.||+|.+. +++.||||+++... ...+.+.+|++++++++||||+++++++ +.+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344554 8999999999999864 47889999997632 3456789999999999999999999999 556789999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ...+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp ECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999643 34589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .....+|+.|+|||++.+..++.++|||||
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 199 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 199 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHH
Confidence 43321 123456889999999998889999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.05 Aligned_cols=182 Identities=27% Similarity=0.422 Sum_probs=152.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.+|++.+.||+|+||.||+|+... ++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 357788999999999999999865 899999998653322 3557899999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999888644 23589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
.. ......||+.|+|||++.+. .++.++|||||
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 211 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence 22 22445789999999999875 68999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=272.26 Aligned_cols=185 Identities=24% Similarity=0.366 Sum_probs=159.9
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
++....|++.++||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 445567888899999999999999986 4899999998753 2334678999999999999999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++... ..+++..+..++.|++.||+|||++. +|+||||||+||+++.++.+||+|||++...
T Consensus 109 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999999653 35899999999999999999999831 7999999999999999999999999999765
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....||+.|+|||++.+..++.++|||||
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 216 (360)
T 3eqc_A 183 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216 (360)
T ss_dssp HHHC-------CCCCTTCCHHHHTTCCCSHHHHHHHH
T ss_pred cccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHH
Confidence 4322 234578999999999999999999999996
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=277.34 Aligned_cols=181 Identities=29% Similarity=0.433 Sum_probs=155.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc--------------cCHHHHHHHHHHHHhhcCCCcceEEEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG--------------QGKKEFSAEVTTIGNVHHLHLVKLKGF 553 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 553 (679)
...|.+.++||+|+||+||+|+... ++.||||++.... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3557888999999999999999764 8899999986532 335678999999999999999999999
Q ss_pred EEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC---c
Q 046493 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF---T 630 (679)
Q Consensus 554 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~ 630 (679)
+.+.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988653 4599999999999999999999999 999999999999998776 6
Q ss_pred EEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 631 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+||+|||++........ .....||+.|+|||++.+ .++.++|||||
T Consensus 188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 233 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSC 233 (504)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHH
T ss_pred EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHH
Confidence 99999999987655432 244679999999999874 68999999995
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=272.58 Aligned_cols=182 Identities=24% Similarity=0.310 Sum_probs=158.7
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhh------cCCCcceEEEEEEeCCee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNV------HHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 560 (679)
...+|++.++||+|+||.||+|+... ++.||||+++........+.+|+++++.+ +|+||+++++++...+..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 34568888999999999999998764 89999999987555567788899998888 467999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc--EEEeeccC
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT--AKVSDFGL 638 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~ 638 (679)
++||||++ ++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 69999887643 34589999999999999999999999 9999999999999999887 99999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+....... ....||+.|+|||++.+..++.++|||||
T Consensus 249 a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 285 (429)
T 3kvw_A 249 SCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSL 285 (429)
T ss_dssp CEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred ceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhH
Confidence 97654322 34578999999999999999999999996
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=268.06 Aligned_cols=186 Identities=28% Similarity=0.482 Sum_probs=151.6
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC-----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD-----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
....+.+.+.||+|+||.||+|+... +..||||+++... .....+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 33456677899999999999998643 2469999997532 2345688999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999653 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... .....+|+.|+|||++.+..++.++|||||
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 236 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHH
Confidence 765433221 122346789999999999899999999996
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=263.81 Aligned_cols=183 Identities=25% Similarity=0.335 Sum_probs=154.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe--------C
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--------G 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 557 (679)
.+|++.++||+|+||.||+|+.. +++.||||++.... .....+.+|++++++++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 46788899999999999999985 58999999985422 334678899999999999999999999987 3
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
+..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999985 777777543 23599999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCc---eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 638 LAKLMNREES---LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+++....... .......||+.|+|||++.+ ..++.++|||||
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 9987653221 12244578999999999876 458999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=269.72 Aligned_cols=181 Identities=25% Similarity=0.377 Sum_probs=151.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhc--CCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVH--HLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 564 (679)
..|++.+.||+|+||.||++...+++.||||++.... ...+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4578889999999999999998889999999986533 23467899999999996 599999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
| +.+++|.+++... ..+++.++..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5678999999753 3589999999999999999999999 999999999999996 57999999999987654
Q ss_pred CCce-eeecccCcccccccccccc-----------CCCCcccceeeC
Q 046493 645 EESL-VYTTLRGTRGYLAPEWITN-----------NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+ ..++.++|||||
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 4322 2244679999999999865 368899999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=278.26 Aligned_cols=183 Identities=30% Similarity=0.408 Sum_probs=161.3
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
+...+|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45667899999999999999999986 5899999998542 345678999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe---CCCCcEEEeeccC
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGL 638 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~ 638 (679)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999998865 34589999999999999999999999 99999999999999 5678999999999
Q ss_pred CcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++....... .....||+.|+|||++.+ .++.++|||||
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl 213 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWST 213 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHH
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHH
Confidence 987654432 244579999999999876 68999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=264.16 Aligned_cols=188 Identities=26% Similarity=0.380 Sum_probs=161.1
Q ss_pred CcCHHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHh--hcCCCcceEEEEEEeCC
Q 046493 481 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGN--VHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 481 ~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 558 (679)
.+...+....+|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3445677788999999999999999999998 5899999999643 35667888888887 78999999999998876
Q ss_pred ----eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeEeC
Q 046493 559 ----HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH--------EECEVKIVHCDIKPENVLLD 626 (679)
Q Consensus 559 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivH~Dlkp~NIll~ 626 (679)
..++||||+++++|.+++... .+++..++.++.||+.||+||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 789999999999999999643 4899999999999999999999 77 999999999999999
Q ss_pred CCCcEEEeeccCCcccccCCce---eeecccCccccccccccccC------CCCcccceeeC
Q 046493 627 DNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLAPEWITNN------PISEKSDVYSY 679 (679)
Q Consensus 627 ~~~~~kL~DFg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSl 679 (679)
+++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 9999999999999876654432 12345799999999999775 23478999996
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=255.90 Aligned_cols=177 Identities=24% Similarity=0.435 Sum_probs=152.5
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLLA 563 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 563 (679)
|++.++||+|+||.||+|... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 567788999999999999975 48899999986533 234668899999999999999999999875 3567999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeC-CCCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLD-DNFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DFg~a~ 640 (679)
|||+++++|.+++... ..+++..++.++.||+.||.|||++ + |+||||||+||+++ +++.+||+|||++.
T Consensus 108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999653 4589999999999999999999998 7 99999999999998 78999999999997
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....||+.|+|||++.+ .++.++|||||
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~sl 215 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAF 215 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred cccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHH
Confidence 654432 234578999999998875 58999999996
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=263.37 Aligned_cols=192 Identities=25% Similarity=0.444 Sum_probs=149.8
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
-.+....|.+.+.||+|+||.||+|+... ++.||||+++.... ..+.+.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34455678888999999999999998642 45899999875332 336688999999999999999999999876
Q ss_pred Ce-----eeEEEeccCCCCHhHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc
Q 046493 558 AH-----RLLAYEYLGNGSLDKWIFNST--EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT 630 (679)
Q Consensus 558 ~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 630 (679)
+. .++||||+++++|.+++.... .....+++..++.++.||++||.|||++ +|+||||||+||++++++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 53 499999999999999985432 2345699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 631 AKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 235 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHH
Confidence 999999999876543321 1233467889999999999999999999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=263.90 Aligned_cols=189 Identities=29% Similarity=0.485 Sum_probs=147.7
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
....|+...+|++.++||+|+||.||+|+... .||||+++.... ..+.+.+|++++++++||||++++++. ..+
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 34446677788999999999999999998643 599999865332 346789999999999999999999965 556
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred ccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence 689999999999999999643 34589999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCc-eeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 639 AKLMNREES-LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
+........ .......||+.|+|||++. +..++.++|||||
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 211 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence 986554221 2223457899999999986 5678899999996
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=266.62 Aligned_cols=183 Identities=27% Similarity=0.351 Sum_probs=152.4
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..+|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 356788899999999999999976 489999999864221 1246789999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++ +|.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999986 888888543 34588999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
...... ......||+.|+|||++.+. .++.++|||||
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 199 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 199 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhH
Confidence 654332 22446789999999998764 48999999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=271.27 Aligned_cols=182 Identities=32% Similarity=0.525 Sum_probs=144.8
Q ss_pred hhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEe-CCeeeEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-GAHRLLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 564 (679)
+++.+.||+|+||.||+|+..+ +..||||.++... ...+.+.+|+.++++++||||+++++++.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 5567889999999999999642 2468999986532 345779999999999999999999998764 45789999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 171 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999653 34588999999999999999999999 999999999999999999999999999986644
Q ss_pred CCce---eeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESL---VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......+++.|+|||++.+..++.++|||||
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 282 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence 3221 1123457889999999999999999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=268.12 Aligned_cols=177 Identities=28% Similarity=0.372 Sum_probs=147.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------e
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------H 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 559 (679)
.+|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 34677889999999999999975 589999999965322 2456889999999999999999999998763 4
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 59999999 7899999864 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+..... .....+|+.|+|||++.+ ..++.++|||||
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 212 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 212 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHH
Confidence 875443 234578999999999887 679999999995
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=266.05 Aligned_cols=181 Identities=25% Similarity=0.393 Sum_probs=148.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG--KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+|.+.++||+|+||.||+|+.. +++.||||+++..... ...+.+|++++++++||||+++++++.+++..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 4677889999999999999986 5899999998653221 124567999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+ ++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 83 D-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp S-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 7 5899888654 34589999999999999999999999 999999999999999999999999999986543322
Q ss_pred eeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
......||+.|+|||++.+ ..++.++|||||
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 187 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV 187 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHH
Confidence 2234578999999999876 568999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=270.93 Aligned_cols=182 Identities=24% Similarity=0.325 Sum_probs=151.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC----------
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG---------- 557 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 557 (679)
..+|++.+.||+|+||.||+|+.. +++.||||++..... ...+|++++++++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 346788899999999999999974 589999999865322 234799999999999999999998543
Q ss_pred ----------------------------CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 046493 558 ----------------------------AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609 (679)
Q Consensus 558 ----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~ 609 (679)
...++||||++ ++|.+.+.........+++..+..++.||++||+|||++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34789999998 588888765333356799999999999999999999999
Q ss_pred CCCeeecCCCCCCeEeC-CCCcEEEeeccCCcccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 610 EVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 610 ~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+|+||||||+|||++ +++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999999999999997 688999999999987654432 2345789999999998775 48999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=255.51 Aligned_cols=181 Identities=29% Similarity=0.434 Sum_probs=151.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 45777899999999999999986 5899999998642 234567899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++++|.+++... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
... .....+++.|+|||++.+..+ +.++|||||
T Consensus 164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 197 (276)
T 2h6d_A 164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHH
T ss_pred Ccc--eecccCCccccCHHHHcCCCCCCccchHHHH
Confidence 322 234568999999999988765 689999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=263.25 Aligned_cols=188 Identities=27% Similarity=0.390 Sum_probs=156.0
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 562 (679)
..+|++.+.||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 456788899999999999999974 6899999988642 3445678999999999999999999999873 347789
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++.........+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999976544456799999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCce--------eeecccCccccccccccccCC---CCcccceeeC
Q 046493 643 NREESL--------VYTTLRGTRGYLAPEWITNNP---ISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwSl 679 (679)
...... ......||+.|+|||++.+.. ++.++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 232 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHH
Confidence 432110 012245799999999987654 6889999996
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=269.36 Aligned_cols=190 Identities=23% Similarity=0.267 Sum_probs=153.7
Q ss_pred cCHHHHHHHhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEeccccc------------CHHHHHHHHHHHHhhcCC
Q 046493 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESIGQ------------GKKEFSAEVTTIGNVHHL 545 (679)
Q Consensus 482 ~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~E~~~l~~l~h~ 545 (679)
..+.++...+|++.+.||+|+||.||+|+.. .+..+|||++..... ....+.+|+..++.++||
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (345)
T 2v62_A 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYL 108 (345)
T ss_dssp CEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCC
T ss_pred CeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccccc
Confidence 3345566678899999999999999999976 468899999865321 123466788889999999
Q ss_pred CcceEEEEEEe----CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 046493 546 HLVKLKGFCIE----GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPE 621 (679)
Q Consensus 546 niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~ 621 (679)
||+++++++.+ ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 180 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA 180 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred CcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence 99999999988 67889999999 99999998653 2699999999999999999999999 9999999999
Q ss_pred CeEeCCCC--cEEEeeccCCcccccCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 622 NVLLDDNF--TAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 622 NIll~~~~--~~kL~DFg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 99998877 9999999999876543211 1133579999999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=259.13 Aligned_cols=176 Identities=23% Similarity=0.372 Sum_probs=154.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEe--CCeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIE--GAHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e 565 (679)
..|++.++||+|+||.||+|+.. +++.||||+++. ...+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 56788899999999999999864 589999999974 34678999999999997 9999999999998 567899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCccccc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNR 644 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~ 644 (679)
|+++++|.+++. .+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999873 288999999999999999999999 999999999999999776 899999999987654
Q ss_pred CCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
... .....+++.|+|||++.+ ..++.++|||||
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 217 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHH
Confidence 432 244578999999999877 668999999996
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=264.57 Aligned_cols=184 Identities=28% Similarity=0.385 Sum_probs=159.9
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe-C-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC------cceEEEEEEeC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML-P-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH------LVKLKGFCIEG 557 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 557 (679)
++...+|++.++||+|+||.||+|.. . +++.||||+++......+.+.+|++++++++|++ ++++++++.+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 34455788899999999999999987 3 5889999999865555678899999999997664 99999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC----------
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---------- 627 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---------- 627 (679)
+..++||||+ +++|.+++.... ...+++..+..++.||++||+|||++ +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 889999987643 34589999999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 628 ---------NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 628 ---------~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 220 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSI 220 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHH
T ss_pred cccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHH
Confidence 6689999999998654332 34578999999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=271.83 Aligned_cols=190 Identities=29% Similarity=0.385 Sum_probs=160.8
Q ss_pred CcCHHHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc--------CCCcceEE
Q 046493 481 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH--------HLHLVKLK 551 (679)
Q Consensus 481 ~~~~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~ 551 (679)
.+...++...+|++.++||+|+||+||+|+.. +++.||||+++......+.+.+|++++++++ |+||++++
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 35556666788999999999999999999975 4889999999865555678899999999996 78899999
Q ss_pred EEEE----eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC
Q 046493 552 GFCI----EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD 627 (679)
Q Consensus 552 ~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 627 (679)
+++. +....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+||||+.
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 9988 456789999999 556666665432 345999999999999999999999853 8999999999999997
Q ss_pred CC-------------------------------------------------cEEEeeccCCcccccCCceeeecccCccc
Q 046493 628 NF-------------------------------------------------TAKVSDFGLAKLMNREESLVYTTLRGTRG 658 (679)
Q Consensus 628 ~~-------------------------------------------------~~kL~DFg~a~~~~~~~~~~~~~~~gt~~ 658 (679)
++ .+||+|||++....... ....||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~ 258 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQ 258 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCc
Confidence 75 79999999998765432 34578999
Q ss_pred cccccccccCCCCcccceeeC
Q 046493 659 YLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 659 y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||++.+..++.++|||||
T Consensus 259 y~aPE~~~~~~~~~~~Diwsl 279 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWST 279 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHH
T ss_pred ccCChhhcCCCCCcHHHHHHH
Confidence 999999999999999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=255.66 Aligned_cols=178 Identities=24% Similarity=0.402 Sum_probs=153.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC--CeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG--AHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 564 (679)
.+|++.+.||+|+||.||+|++ +++.||||+++... ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4567789999999999999998 48899999997533 2346789999999999999999999999887 7789999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||+++++|.+++.... ...+++..++.++.||++||+|||++ + |+||||||+||++++++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999997643 33589999999999999999999998 8 999999999999999999999999887653
Q ss_pred ccCCceeeecccCccccccccccccCCCCc---ccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISE---KSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDvwSl 679 (679)
.. ....||+.|+|||++.+..++. ++|||||
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 32 2346899999999998765544 7999996
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=259.10 Aligned_cols=180 Identities=31% Similarity=0.481 Sum_probs=149.0
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-CeeeEEEecc
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-AHRLLAYEYL 567 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 567 (679)
...|++.+.||+|+||.||+++. .++.||||+++.. ...+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34677889999999999999998 5889999999754 3567789999999999999999999997654 4789999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++.... ...+++..++.++.|+++||+|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999996532 23488999999999999999999999 99999999999999999999999999998654332
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....+++.|+|||++.+..++.++|||||
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 23457889999999998899999999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=264.75 Aligned_cols=187 Identities=28% Similarity=0.482 Sum_probs=158.8
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEe-----CCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC--
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGML-----PDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA-- 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 558 (679)
+....|++.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3445678889999999999999984 358999999997633 34567999999999999999999999987654
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..++||||+++++|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6799999999999999997642 3589999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 639 AKLMNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.......... .....++..|+|||++.+..++.++|||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 98776543321 123457788999999998889999999996
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=259.14 Aligned_cols=182 Identities=31% Similarity=0.450 Sum_probs=154.6
Q ss_pred hhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee-eEEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR-LLAY 564 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ 564 (679)
+++.++||+|+||.||+|+..+ +..||+|+++... ...+.+.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4455889999999999998543 2379999987533 2346788999999999999999999999876655 9999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+.+++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999653 34589999999999999999999999 999999999999999999999999999986644
Q ss_pred CCc---eeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EES---LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .......+++.|+|||.+.+..++.++|||||
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 321 11234567899999999999999999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=265.35 Aligned_cols=181 Identities=27% Similarity=0.413 Sum_probs=158.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccC------------------HHHHHHHHHHHHhhcCCCcceEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG------------------KKEFSAEVTTIGNVHHLHLVKLK 551 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~------------------~~~~~~E~~~l~~l~h~niv~l~ 551 (679)
..|++.+.||+|+||.||+|+. +++.||||++...... .+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4578889999999999999999 9999999998642211 17899999999999999999999
Q ss_pred EEEEeCCeeeEEEeccCCCCHhHH------hhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeE
Q 046493 552 GFCIEGAHRLLAYEYLGNGSLDKW------IFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVL 624 (679)
Q Consensus 552 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIl 624 (679)
+++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ + +|+||||||+||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 999999999999999999999998 4332 14569999999999999999999999 8 9999999999999
Q ss_pred eCCCCcEEEeeccCCcccccCCceeeecccCccccccccccccC-CCCc-ccceeeC
Q 046493 625 LDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PISE-KSDVYSY 679 (679)
Q Consensus 625 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDvwSl 679 (679)
++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 238 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence 999999999999999876443 23456799999999999887 5666 9999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=266.41 Aligned_cols=191 Identities=26% Similarity=0.436 Sum_probs=157.1
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
++....|++.+.||+|+||.||+|+.. +++.||||++... .....++.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 445567888999999999999999842 4778999999643 23456788999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcE
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTA 631 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ 631 (679)
+..++||||+++++|.+++..... ....+++..++.++.||++||.|||++ +|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999976532 124589999999999999999999999 9999999999999984 4469
Q ss_pred EEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||++......... ......+++.|+|||++.+..++.++|||||
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 231 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence 99999999865433221 1234567899999999998899999999996
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=255.16 Aligned_cols=181 Identities=27% Similarity=0.389 Sum_probs=157.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----------cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----------QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEG 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 557 (679)
..|++.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++ ||||+++++++.++
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 45777899999999999999986 48999999986432 12356789999999996 99999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999653 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCceeeecccCccccccccccc------cCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWIT------NNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwSl 679 (679)
++........ .....+++.|+|||++. ...++.++|||||
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 215 (298)
T 1phk_A 170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215 (298)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhH
Confidence 9987654332 24457899999999885 4468899999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=266.74 Aligned_cols=178 Identities=26% Similarity=0.285 Sum_probs=144.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------e
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------H 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 559 (679)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 35777899999999999999975 48999999996532 23456889999999999999999999998665 6
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++ +|.+++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7999999975 7888873 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+...... ......||+.|+|||++.+..++.++|||||
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 8665432 2234678999999999999999999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=263.16 Aligned_cols=184 Identities=29% Similarity=0.453 Sum_probs=149.5
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC-Cc----EEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..+|++.++||+|+||.||+|++.. ++ +|++|.+.. .....+.+.+|++++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3457788999999999999999643 44 467887754 3345688999999999999999999999998765 78
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+|+||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999764 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... ......+|+.|+|||++.+..++.++|||||
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHH
Confidence 6543322 1233457889999999999999999999996
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=260.70 Aligned_cols=184 Identities=28% Similarity=0.391 Sum_probs=153.6
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc---------cCHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG---------QGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
......|.+.+.||+|+||.||+|+... ++.||||++.... .....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 3456778999999999999999999764 8899999986422 12245889999999999999999999987
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc---EE
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AK 632 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~k 632 (679)
.++ .++||||+++++|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||+++.++. +|
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred CCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence 655 7999999999999998854 34589999999999999999999999 9999999999999987654 99
Q ss_pred EeeccCCcccccCCceeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
|+|||+++....... .....||+.|+|||++. ...++.++|||||
T Consensus 158 l~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 205 (322)
T 2ycf_A 158 ITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205 (322)
T ss_dssp ECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHH
T ss_pred EccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHH
Confidence 999999987654321 23456899999999974 4568899999996
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=283.02 Aligned_cols=176 Identities=31% Similarity=0.488 Sum_probs=148.6
Q ss_pred hcCcccceEEEEEEeC---CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCC
Q 046493 497 KLGQGGFGSVYLGMLP---DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 571 (679)
+||+|+||.||+|.+. ++..||||+++.. ....+++.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4678999999763 3456889999999999999999999999976 56899999999999
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee--
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-- 649 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~-- 649 (679)
|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999653 34589999999999999999999999 99999999999999999999999999998765433221
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+++.|+|||++.+..++.++|||||
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSl 525 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSY 525 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHH
Confidence 122345689999999999999999999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=259.84 Aligned_cols=183 Identities=25% Similarity=0.400 Sum_probs=153.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.+.||+|+||.||+|+... ++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 457888999999999999999864 899999998653 345678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++++|.+++... ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 99 PGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 999999998653 24589999999999999999999999 999999999999999999999999998764322211
Q ss_pred eeeecccCcccccccccc-----ccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWI-----TNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvwSl 679 (679)
......|++.|+|||++ .+..++.++|||||
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 208 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 208 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence 11335689999999998 35678999999996
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=266.21 Aligned_cols=184 Identities=28% Similarity=0.405 Sum_probs=146.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe-----CCeeeEEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE-----GAHRLLAY 564 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~ 564 (679)
..|++.+.||+|+||.||+|+. +++.||||++............|+..+..++||||+++++.+.. ....++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 4567789999999999999987 78999999997543322223344444556899999999986543 23568999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC------EVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
||+++++|.+++... ..++..+..++.||++||+|||+++ ..+|+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 999999999999653 2588999999999999999999863 23899999999999999999999999999
Q ss_pred CcccccCCc-------eeeecccCcccccccccccc-------CCCCcccceeeC
Q 046493 639 AKLMNREES-------LVYTTLRGTRGYLAPEWITN-------NPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSl 679 (679)
++....... .......||+.|+|||++.+ ..++.++|||||
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 987654321 11224569999999999987 456789999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=269.64 Aligned_cols=182 Identities=18% Similarity=0.195 Sum_probs=155.4
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeCC---------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcce---------
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLPD---------GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVK--------- 549 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 549 (679)
....|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 35678889999999999999999764 789999998753 45889999999999999887
Q ss_pred ------EEEEEEe-CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 550 ------LKGFCIE-GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 550 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67889999999 999999997642 35699999999999999999999999 99999999999
Q ss_pred eEeCCCC--cEEEeeccCCcccccCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNF--TAKVSDFGLAKLMNREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~--~~kL~DFg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 254 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSL 254 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHH
Confidence 9999998 9999999999876543221 1133579999999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=270.39 Aligned_cols=180 Identities=28% Similarity=0.367 Sum_probs=147.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------CeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 563 (679)
.|++.+.||+|+||.||+|++. +++.||||++.... ....+|++++++++||||+++++++... ...++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 4677889999999999999986 48999999986532 2234799999999999999999998642 235799
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-CcEEEeeccCCccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-FTAKVSDFGLAKLM 642 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DFg~a~~~ 642 (679)
|||+++ +|.+.+.........+++..+..++.||++||+|||++ +|+||||||+||||+.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 66666654323345699999999999999999999999 99999999999999955 67899999999876
Q ss_pred ccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
..... .....||+.|+|||++.+. .++.++|||||
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 243 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence 54332 2345789999999998765 68999999996
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=256.23 Aligned_cols=182 Identities=31% Similarity=0.462 Sum_probs=153.2
Q ss_pred Hhhhhhh-hcCcccceEEEEEEeC---CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 490 ATKNFST-KLGQGGFGSVYLGMLP---DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 490 ~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
.+|.+.+ .||+|+||.||+|.+. .++.||||+++... ...+++.+|++++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 8999999999999642 36889999997532 2256799999999999999999999999 6677899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++++|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999653 3589999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .....+++.|+|||.+.+..++.++|||||
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 206 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHH
Confidence 5544322 122456789999999998889999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=283.63 Aligned_cols=176 Identities=32% Similarity=0.470 Sum_probs=148.0
Q ss_pred hhcCcccceEEEEEEeC---CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLP---DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
++||+|+||.||+|.+. .++.||||+++... ...+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 36789999997633 235789999999999999999999999864 557899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce-
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL- 648 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~- 648 (679)
++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 34589999999999999999999999 9999999999999999999999999999876544321
Q ss_pred -eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 -VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 -~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......+|+.|+|||++.+..++.++|||||
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSl 558 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 558 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHH
Confidence 1223456789999999999999999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-29 Score=262.42 Aligned_cols=186 Identities=26% Similarity=0.331 Sum_probs=144.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe-------
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH------- 559 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 559 (679)
.-.+|++.+.||+|+||.||+|+.. +++.||||++...........+|++.++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 3456778899999999999999985 48999999987655555667788999999999999999999976443
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCCeEeCC-CCcEEEeec
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH--EECEVKIVHCDIKPENVLLDD-NFTAKVSDF 636 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DF 636 (679)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 7899999986 555554432233556899999999999999999999 87 9999999999999996 899999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
|+++....... .....||+.|+|||++.+.. ++.++|||||
T Consensus 177 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 177 GSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp TTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred CCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 99987655432 23457899999999987654 8999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-30 Score=273.39 Aligned_cols=181 Identities=18% Similarity=0.191 Sum_probs=147.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHH---HHHHhhcCCCcceEE-------EEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEV---TTIGNVHHLHLVKLK-------GFC 554 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~ 554 (679)
..|++.+.||+|+||+||+|+.. +++.||||++.. .....+.+.+|+ +++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 34677889999999999999974 589999999863 223457789999 455556899999998 666
Q ss_pred EeCCe-----------------eeEEEeccCCCCHhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 046493 555 IEGAH-----------------RLLAYEYLGNGSLDKWIFNSTE---ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614 (679)
Q Consensus 555 ~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iv 614 (679)
.+.+. .++||||+ +|+|.+++..... ....+++..++.++.||++||+|||++ +|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 65532 78999999 5799999975321 112344688899999999999999999 999
Q ss_pred ecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecccCccccccccccccC-----------CCCcccceeeC
Q 046493 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-----------PISEKSDVYSY 679 (679)
Q Consensus 615 H~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwSl 679 (679)
||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999986433 2345567 999999999887 89999999996
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-29 Score=253.92 Aligned_cols=180 Identities=28% Similarity=0.404 Sum_probs=152.0
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
...||+|+||.||+|+.. +++.||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 347999999999999975 5889999998653 33457789999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeeccCCcccccCCceeee
Q 046493 573 DKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYT 651 (679)
Q Consensus 573 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg~a~~~~~~~~~~~~ 651 (679)
.+++..... ...+++..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||++........ ...
T Consensus 107 ~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 181 (295)
T 2clq_A 107 SALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTE 181 (295)
T ss_dssp HHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------C
T ss_pred HHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccc
Confidence 999976432 33467899999999999999999999 9999999999999987 89999999999987654322 123
Q ss_pred cccCccccccccccccCC--CCcccceeeC
Q 046493 652 TLRGTRGYLAPEWITNNP--ISEKSDVYSY 679 (679)
Q Consensus 652 ~~~gt~~y~aPE~~~~~~--~s~~sDvwSl 679 (679)
...|++.|+|||++.+.. ++.++|||||
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 211 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHH
Confidence 457899999999997654 7899999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=264.14 Aligned_cols=181 Identities=25% Similarity=0.364 Sum_probs=146.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccC------------HHHHHHHHHHHHhhcCCCcceEEEEEEeC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQG------------KKEFSAEVTTIGNVHHLHLVKLKGFCIEG 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 557 (679)
..|++.+.||+|+||.||+|...+++.||||++...... .+.+.+|++++++++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 456778999999999999999888999999998542211 26789999999999999999999998643
Q ss_pred -----CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 558 -----AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 558 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
...++||||++ ++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEE
Confidence 35799999998 5888887643 34589999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
|+|||+++....... .....+|+.|+|||++.+ ..++.++|||||
T Consensus 175 l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 220 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHH
T ss_pred EEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhH
Confidence 999999985544322 234578999999999877 678999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=257.56 Aligned_cols=186 Identities=25% Similarity=0.350 Sum_probs=142.5
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
...|++.++||+|+||.||+++.. +++.||||+++..... .+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 456788899999999999999975 5899999999753222 223444555578889999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||++ ++|.+++.........+++..++.++.||+.||+|||++ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 488888765433356799999999999999999999984 2899999999999999999999999999987654
Q ss_pred CCceeeecccCcccccccccc----ccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWI----TNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++ .+..++.++|||||
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl 199 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence 332 2334789999999996 55678999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=266.80 Aligned_cols=184 Identities=22% Similarity=0.368 Sum_probs=139.2
Q ss_pred hhhh-hhhcCcccceEEEEEEeC---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeEEE
Q 046493 491 TKNF-STKLGQGGFGSVYLGMLP---DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLLAY 564 (679)
Q Consensus 491 ~~~~-~~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 564 (679)
.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.+ ....++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 3455 457999999999999965 47899999997543 34568899999999999999999999965 66889999
Q ss_pred eccCCCCHhHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe----CCCCcEEEee
Q 046493 565 EYLGNGSLDKWIFNST-----EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL----DDNFTAKVSD 635 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 635 (679)
||+++ +|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99974 8887775321 1123489999999999999999999999 99999999999999 6788999999
Q ss_pred ccCCcccccCCc--eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 636 FGLAKLMNREES--LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
||+++....... .......||+.|+|||++.+. .++.++|||||
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 222 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence 999987654322 122446789999999999874 58999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-29 Score=253.87 Aligned_cols=183 Identities=26% Similarity=0.340 Sum_probs=151.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEE-EeCCeeeEEEec
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC-IEGAHRLLAYEY 566 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~ 566 (679)
..+|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++|++++..+..+ .+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 456888899999999999999974 58999999875432 234578999999999988777666655 667788999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe---CCCCcEEEeeccCCcccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~ 643 (679)
+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 89999998643 23599999999999999999999999 99999999999999 788999999999998765
Q ss_pred cCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......||+.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHH
Confidence 54321 1234578999999999999999999999996
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=267.54 Aligned_cols=177 Identities=11% Similarity=0.071 Sum_probs=136.0
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhh--cCCCcceEE-------EEEEeC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNV--HHLHLVKLK-------GFCIEG 557 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~ 557 (679)
|.+.++||+|+||.||+|++. +++.||||++.... ...+.+++|+++++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 667889999999999999976 58999999997633 2345677886655555 599988755 455433
Q ss_pred -----------------CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCee
Q 046493 558 -----------------AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTR------FNIALGMAKGLAYLHEECEVKIV 614 (679)
Q Consensus 558 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~yLH~~~~~~iv 614 (679)
...++||||++ ++|.+++.... ..+.+..+ +.++.||++||+|||++ +|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33799999999 89999997642 23455555 78889999999999999 999
Q ss_pred ecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecccCcccccccccccc--CCCCcccceeeC
Q 046493 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN--NPISEKSDVYSY 679 (679)
Q Consensus 615 H~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSl 679 (679)
||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 99999999999999999999999998664321 24567799999999987 679999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=264.61 Aligned_cols=177 Identities=26% Similarity=0.381 Sum_probs=135.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------Ce
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 559 (679)
.+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 35677899999999999999965 58999999996532 2346688999999999999999999998754 56
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++|+|++ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 79999999 6799988853 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
+..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 216 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHH
Confidence 865432 234578999999999877 678999999996
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=257.36 Aligned_cols=182 Identities=24% Similarity=0.388 Sum_probs=154.0
Q ss_pred HhhhhhhhcCcccceEEEEEEeC--CCcEEEEEEecccc---cCHHHHHHHHHHHHhh---cCCCcceEEEEEE-----e
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIG---QGKKEFSAEVTTIGNV---HHLHLVKLKGFCI-----E 556 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 556 (679)
..|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+|+.+++++ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 45778899999999999999973 58899999986422 2234567788887777 8999999999987 4
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeec
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 636 (679)
....++||||++ ++|.+++.... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 567899999998 59999987643 33589999999999999999999999 9999999999999999999999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 165 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 165 GLARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp CSCCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred cccccccCCCC--ccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 99987654322 234578999999999999899999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-29 Score=266.18 Aligned_cols=181 Identities=27% Similarity=0.332 Sum_probs=148.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe------eeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH------RLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv 563 (679)
.+|++.+.||+|+||.||+|+...+..||+|++..... ...+|++++++++||||+++++++...+. .++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 35778899999999999999998777799998854322 22479999999999999999999975443 7899
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEEEeeccCCccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLM 642 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DFg~a~~~ 642 (679)
|||++++.+. .+.........+++..+..++.||++||+|||++ +|+||||||+||||+ .++.+||+|||+++..
T Consensus 117 ~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999875443 3332222245699999999999999999999999 999999999999999 7999999999999876
Q ss_pred ccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
..... .....+|+.|+|||++.+. .++.++|||||
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 54432 2345789999999998765 58999999995
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=253.37 Aligned_cols=184 Identities=24% Similarity=0.326 Sum_probs=153.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc-----ccCHHHHHHHHHHHHhhcCCCcceEEEEEE--eCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI-----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCI--EGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 561 (679)
.+|++.+.||+|+||.||++... +++.||||+++.. ....+.+.+|++++++++||||+++++++. +.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 35778899999999999999975 4889999999653 234577999999999999999999999985 455789
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||++++ |.+++.... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 999999876 777776543 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCc-eeeecccCccccccccccccCC--CCcccceeeC
Q 046493 642 MNREES-LVYTTLRGTRGYLAPEWITNNP--ISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSl 679 (679)
...... .......|++.|+|||++.+.. ++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 199 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA 199 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHH
Confidence 654322 2234467899999999997654 3789999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-29 Score=259.67 Aligned_cols=187 Identities=28% Similarity=0.360 Sum_probs=142.3
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhc-CCCcceEEEEEE--------e
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVH-HLHLVKLKGFCI--------E 556 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~ 556 (679)
...+|++.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3446788899999999999999975 58999999885432 34567889999999996 999999999995 3
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeCCCCcEEEe
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLDDNFTAKVS 634 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~ 634 (679)
....+++|||++ |+|.+++..... ...+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 345789999996 699998865322 34599999999999999999999998 8 9999999999999999999999
Q ss_pred eccCCcccccCCcee-----------eecccCcccccccccc---ccCCCCcccceeeC
Q 046493 635 DFGLAKLMNREESLV-----------YTTLRGTRGYLAPEWI---TNNPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~~sDvwSl 679 (679)
|||+++......... .....||+.|+|||++ .+..++.++|||||
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence 999998765432211 1134589999999998 56678999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=261.34 Aligned_cols=181 Identities=23% Similarity=0.377 Sum_probs=153.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-----Ceee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-----AHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 561 (679)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 35788899999999999999976 58899999997533 2336788999999999999999999999765 3679
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 9999997 599998854 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCcee--eecccCcccccccccccc-CCCCcccceeeC
Q 046493 642 MNREESLV--YTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
........ .....||+.|+|||++.+ ..++.++|||||
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 218 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHH
Confidence 65433221 234579999999998754 458999999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=250.72 Aligned_cols=185 Identities=27% Similarity=0.387 Sum_probs=160.0
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
......+|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4556678899999999999999999986 5899999998642 34567899999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC---CcEEEeecc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN---FTAKVSDFG 637 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DFg 637 (679)
++|+||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.+ +.+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 9999999999999988653 3589999999999999999999999 99999999999999754 479999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++........ .....+++.|+|||++.+ .++.++|||||
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~sl 208 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSA 208 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHH
T ss_pred cceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhH
Confidence 9987654332 133458899999999876 48999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=260.22 Aligned_cols=190 Identities=23% Similarity=0.370 Sum_probs=142.1
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+....|++.+.||+|+||.||+|+.. +++.||||++... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 33456778899999999999999965 5899999998643 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhcc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 564 YEYLGNGSLDKWIFNS----TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
|||+++++|.+++... ......+++..+..++.||++||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 11234589999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCce----eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 640 KLMNREESL----VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
......... ......||+.|+|||++.+ ..++.++|||||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 213 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHH
Confidence 766443211 1234578999999999876 568999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=261.86 Aligned_cols=175 Identities=29% Similarity=0.386 Sum_probs=148.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee------
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR------ 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------ 560 (679)
+|.+.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 4677889999999999999976 489999999975332 246788999999999999999999999877655
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||++ ++|.+++ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 123 ~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp EEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 5888877 33489999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 228 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHH
Confidence 65433 234578999999999887 678999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=251.52 Aligned_cols=182 Identities=26% Similarity=0.348 Sum_probs=153.7
Q ss_pred HhhhhhhhcCcccceEEEEEEe-CCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEE-EeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGML-PDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC-IEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~ 567 (679)
.+|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++++++|++++..+..+ .+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3567789999999999999997 468999999986533 335688999999999988766666555 5677889999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---CCCcEEEeeccCCccccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~~ 644 (679)
+++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++.....
T Consensus 88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 88 -GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 89999999643 23599999999999999999999999 999999999999994 888999999999987665
Q ss_pred CCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHH
Confidence 4321 1234579999999999999999999999996
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-29 Score=282.29 Aligned_cols=187 Identities=26% Similarity=0.386 Sum_probs=155.4
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH 559 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 559 (679)
++...+|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445667888999999999999999743 4679999986532 23467899999999999999999999985 466
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.++||||+++++|.+++... ...+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 89999999999999999653 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+..............+|+.|+|||++.+..++.++|||||
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 578 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHH
Confidence 8775544333334567889999999998899999999996
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=260.77 Aligned_cols=186 Identities=26% Similarity=0.395 Sum_probs=158.9
Q ss_pred HHHHHHHhhhhhhhcCcccceEEEEEEeCC-C-cEEEEEEecccccCHHHHHHHHHHHHhhcCCC------cceEEEEEE
Q 046493 484 YDDLCKATKNFSTKLGQGGFGSVYLGMLPD-G-IQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH------LVKLKGFCI 555 (679)
Q Consensus 484 ~~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~ 555 (679)
..+....+|++.+.||+|+||.||+|+... + +.||||+++......+.+.+|++++++++|++ ++.+++++.
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 344456678899999999999999999753 4 78999999865555678889999999998766 999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe----------
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---------- 625 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---------- 625 (679)
..+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEEC
T ss_pred eCCeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccc
Confidence 999999999999 567777775532 34589999999999999999999999 99999999999999
Q ss_pred ---------CCCCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 626 ---------DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 626 ---------~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 225 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSI 225 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHH
Confidence 567899999999998654332 34578999999999999999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=260.28 Aligned_cols=183 Identities=27% Similarity=0.345 Sum_probs=156.2
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-CC-----CcceEEEEEEeCCeee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HL-----HLVKLKGFCIEGAHRL 561 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~ 561 (679)
..+|++.+.||+|+||+||+|+.. +++.||||+++.......++..|+++++.++ |+ +|+++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 456888899999999999999976 4889999999865555677888999999885 55 4999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC--CCCcEEEeeccCC
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLA 639 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a 639 (679)
+||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 133 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999996 59999997643 24589999999999999999999952 12899999999999994 5788999999999
Q ss_pred cccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+...... ....||+.|+|||++.+..++.++|||||
T Consensus 209 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 209 CQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp EETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred eeccccc----ccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 8765432 34578999999999999999999999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-29 Score=253.41 Aligned_cols=184 Identities=26% Similarity=0.400 Sum_probs=147.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC--CC--cEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP--DG--IQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~--~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
...|++.+.||+|+||+||+|++. ++ ..||||+++.. ....+.+.+|++++++++||||+++++++.+++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 456788899999999999999853 23 36899988642 233467899999999999999999999998765 7
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++|+||+++++|.+++... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999754 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
......... .....+++.|+|||++.+..++.++|||||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 210 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHH
Confidence 775543321 223467889999999998889999999996
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=285.14 Aligned_cols=179 Identities=27% Similarity=0.436 Sum_probs=152.4
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeC--CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe-
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLP--DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH- 559 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 559 (679)
.++...+|++.+.||+|+||.||++++. +++.||||++.... .....+.+|++++++++||||+++++++.+.+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3444567889999999999999999975 58999999986532 234568899999999999999999999987665
Q ss_pred ----eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEee
Q 046493 560 ----RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635 (679)
Q Consensus 560 ----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 635 (679)
.+|||||+++++|.+++. ..+++.+++.++.||++||.|||++ +|+||||||+|||++++ .+||+|
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp SCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEe
Confidence 699999999999988773 2589999999999999999999999 99999999999999986 999999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+++..... ....||+.|+|||++.+.. +.++|||||
T Consensus 225 FG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~sl 262 (681)
T 2pzi_A 225 LGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTV 262 (681)
T ss_dssp CTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHH
T ss_pred cccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhh
Confidence 9999876543 3457999999999987754 899999996
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=258.05 Aligned_cols=181 Identities=24% Similarity=0.355 Sum_probs=151.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-----Ceee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-----AHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 561 (679)
..|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 35677899999999999999976 48999999996532 2345678999999999999999999998764 6789
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 9999997 589998854 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCce---------eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 642 MNREESL---------VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
....... ......||+.|+|||++.+ ..++.++|||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 6543211 1123468999999998764 678999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=257.62 Aligned_cols=175 Identities=29% Similarity=0.374 Sum_probs=147.8
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCe------e
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAH------R 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 560 (679)
+|.+.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4667789999999999999975 489999999965332 24568899999999999999999999987654 4
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 105 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp EEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 99999997 58888772 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
..... .....+|+.|+|||++.+ ..++.++|||||
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 210 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence 65432 234578999999999877 678999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=253.80 Aligned_cols=181 Identities=25% Similarity=0.344 Sum_probs=145.7
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEE------------
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCI------------ 555 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------ 555 (679)
.+|++.+.||+|+||.||+|+... ++.||||++.... ...+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 456778999999999999999875 8999999986532 34567899999999999999999999874
Q ss_pred --eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEE
Q 046493 556 --EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAK 632 (679)
Q Consensus 556 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k 632 (679)
+.+..++||||++ ++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+||+++ +++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 599999843 3589999999999999999999999 999999999999997 567999
Q ss_pred EeeccCCcccccCCce--eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESL--VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
|+|||+++........ ......+++.|+|||++.+ ..++.++|||||
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 211 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence 9999999876543211 1234567999999998865 678999999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=256.46 Aligned_cols=182 Identities=27% Similarity=0.394 Sum_probs=156.2
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhc--CCCcceEEEEEEeC
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTTIGNVH--HLHLVKLKGFCIEG 557 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 557 (679)
...+|++.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.++++++ |+||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4456788899999999999999965 589999999865321 2245778999999996 59999999999999
Q ss_pred CeeeEEEeccCC-CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCcEEEee
Q 046493 558 AHRLLAYEYLGN-GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSD 635 (679)
Q Consensus 558 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~D 635 (679)
+..++|+|++.+ ++|.+++.. ...+++..++.++.||++||+|||++ +|+||||||+|||++ +++.+||+|
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999986 899999865 24589999999999999999999999 999999999999999 789999999
Q ss_pred ccCCcccccCCceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 636 FGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 636 Fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
||+++...... .....||+.|+|||++.+..+ +.++|||||
T Consensus 194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 235 (320)
T 3a99_A 194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235 (320)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence 99998765432 234578999999999987765 688999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=263.37 Aligned_cols=182 Identities=26% Similarity=0.340 Sum_probs=154.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcC-CCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH-LHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
..|++.++||+|+||.||+|+.. +++.||||++.... ...++.+|+++++.++| ++|..+..++.+.+..+|||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 45778899999999999999974 58999999876533 23457899999999986 56667777778888999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEe---CCCCcEEEeeccCCccccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLL---DDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DFg~a~~~~~ 644 (679)
+++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||| ++++.+||+|||+++....
T Consensus 86 -g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 86 -GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 89999999653 33599999999999999999999999 99999999999999 5889999999999987665
Q ss_pred CCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... ......||+.|+|||++.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSl 199 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESL 199 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHH
Confidence 4321 1224679999999999999999999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=264.00 Aligned_cols=182 Identities=24% Similarity=0.297 Sum_probs=141.6
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
+...+.||+|+||+||.+...+++.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++ +
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 4445789999999998777668999999998643 345678999999987 89999999999999999999999996 6
Q ss_pred CHhHHhhccCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC-------------CcEEEe
Q 046493 571 SLDKWIFNSTEESRF---LSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN-------------FTAKVS 634 (679)
Q Consensus 571 sL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kL~ 634 (679)
+|.+++......... .++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999764322111 23345678999999999999999 99999999999999654 489999
Q ss_pred eccCCcccccCCce---eeecccCcccccccccccc-------CCCCcccceeeC
Q 046493 635 DFGLAKLMNREESL---VYTTLRGTRGYLAPEWITN-------NPISEKSDVYSY 679 (679)
Q Consensus 635 DFg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSl 679 (679)
|||+++........ ......||+.|+|||++.+ ..++.++|||||
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSl 225 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM 225 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhH
Confidence 99999987654322 1234579999999999976 568999999996
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=260.20 Aligned_cols=184 Identities=28% Similarity=0.371 Sum_probs=157.6
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-----------CCCcceEEEEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-----------HLHLVKLKGFC 554 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 554 (679)
+...+|++.+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++++++ ||||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34567888999999999999999974 5899999999865555677899999999886 89999999999
Q ss_pred EeCC----eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC----
Q 046493 555 IEGA----HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---- 626 (679)
Q Consensus 555 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---- 626 (679)
...+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 8654 789999999 889999997643 345899999999999999999999952 899999999999994
Q ss_pred --CCCcEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 627 --DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 627 --~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 221 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWST 221 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred CcCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHH
Confidence 44589999999998765432 34578999999999999999999999996
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=250.52 Aligned_cols=184 Identities=26% Similarity=0.375 Sum_probs=150.8
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc---cCHHHHHHHHHHHHhhc--CCCcceEEEEEEeCCeee
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG---QGKKEFSAEVTTIGNVH--HLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 561 (679)
+....|++.+.||+|+||.||+++..+++.||||++.... ...+.+.+|++++++++ ||||+++++++.+++..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 3445678889999999999999999889999999986532 23467899999999997 599999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||| +.+++|.+++... ..+++..+..++.||++||.|||++ +|+||||||+||++++ +.+||+|||+++.
T Consensus 105 lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence 9999 5678999999653 3589999999999999999999999 9999999999999964 8999999999987
Q ss_pred cccCCce-eeecccCcccccccccccc-----------CCCCcccceeeC
Q 046493 642 MNREESL-VYTTLRGTRGYLAPEWITN-----------NPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwSl 679 (679)
....... ......|++.|+|||++.+ ..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 6543322 1234578999999999875 468889999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=253.16 Aligned_cols=179 Identities=24% Similarity=0.278 Sum_probs=131.1
Q ss_pred Hhhhhh-hhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeEE
Q 046493 490 ATKNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLLA 563 (679)
Q Consensus 490 ~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 563 (679)
..|.+. +.||+|+||.||+|+.. +++.||||++.... ....+....++.++||||+++++++.. +...++|
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 456664 46999999999999987 58999999986532 222233334566799999999999976 4457999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~ 640 (679)
|||+++++|.+++.... ...+++.+++.++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||+++
T Consensus 105 ~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 105 MECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999997643 34699999999999999999999999 9999999999999986 4559999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....+|+.|+|||++.+..++.++|||||
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 215 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHH
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence 655332 234578999999999988889999999996
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=253.78 Aligned_cols=185 Identities=29% Similarity=0.404 Sum_probs=149.2
Q ss_pred HHHHHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhh----cCCCcceEEE
Q 046493 485 DDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ-------GKKEFSAEVTTIGNV----HHLHLVKLKG 552 (679)
Q Consensus 485 ~~l~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~~ 552 (679)
.+....+|++.+.||+|+||.||+|+.. +++.||||+++.... ....+.+|++++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4556677899999999999999999975 588999999965322 223456799999999 8999999999
Q ss_pred EEEeCCeeeEEEec-cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC-CCCc
Q 046493 553 FCIEGAHRLLAYEY-LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFT 630 (679)
Q Consensus 553 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~ 630 (679)
++.+.+..++|+|+ +++++|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||+++ +++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 7899999999653 3589999999999999999999999 999999999999999 8899
Q ss_pred EEEeeccCCcccccCCceeeecccCccccccccccccCCCC-cccceeeC
Q 046493 631 AKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS-EKSDVYSY 679 (679)
Q Consensus 631 ~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSl 679 (679)
+||+|||++....... .....|++.|+|||++.+..+. .++|||||
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 225 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSL 225 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHH
Confidence 9999999998765433 2345689999999999877664 58999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=271.03 Aligned_cols=184 Identities=29% Similarity=0.446 Sum_probs=157.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEe------CCee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE------GAHR 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 560 (679)
.+|++.++||+|+||.||+|... +++.||||+++.. ....+.+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56889999999999999999975 4899999998653 2335678899999999999999999998765 6678
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCc---EEEeecc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFT---AKVSDFG 637 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DFg 637 (679)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999976432 33588999999999999999999999 9999999999999997664 9999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
++........ .....||+.|+|||++.+..++.++|||||
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL 209 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHH
Confidence 9987655432 244679999999999999999999999996
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-28 Score=259.97 Aligned_cols=180 Identities=24% Similarity=0.308 Sum_probs=142.1
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+|++.+.||+|+||+|+.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 4666789999999997655556899999999965322 2356899999999 79999999999999999999999996
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-----CCcEEEeeccCCccccc
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-----NFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DFg~a~~~~~ 644 (679)
++|.+++.... ....+..+..++.||++||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 59999997543 2244556678999999999999999 9999999999999953 33688999999987654
Q ss_pred CCc--eeeecccCccccccccccc---cCCCCcccceeeC
Q 046493 645 EES--LVYTTLRGTRGYLAPEWIT---NNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSl 679 (679)
... .......||+.|+|||++. +..++.++|||||
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSl 215 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHH
Confidence 322 1223467999999999997 4567889999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-28 Score=252.80 Aligned_cols=182 Identities=28% Similarity=0.408 Sum_probs=148.9
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
...|++.+.||+|+||.||+|+... .+|+|+++.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3456788999999999999999854 4999998642 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||+++ ++.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999653 34589999999999999999999999 999999999999998 679999999998765322
Q ss_pred Cc----eeeecccCcccccccccccc---------CCCCcccceeeC
Q 046493 646 ES----LVYTTLRGTRGYLAPEWITN---------NPISEKSDVYSY 679 (679)
Q Consensus 646 ~~----~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDvwSl 679 (679)
.. .......|++.|+|||++.+ ..++.++|||||
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 11 11233468999999999874 357889999996
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-28 Score=267.85 Aligned_cols=171 Identities=18% Similarity=0.073 Sum_probs=123.9
Q ss_pred hcCcccceEEEEEEe-CCCcEEEEEEecccc-----------cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEE
Q 046493 497 KLGQGGFGSVYLGML-PDGIQVAVKKLESIG-----------QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 563 (679)
..+.|+.|.+..++. --|+.++||.+.... ...++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456666666665542 248889999985421 2236799999999999 699999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||++|++|.++|.+. .+++.. +|+.||+.||+|||++ |||||||||+||||++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999653 346654 5889999999999999 99999999999999999999999999998765
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ....+||+.|||||++.+. +..++|+||+
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~ 424 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSA 424 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC--------------
T ss_pred CCCcc-ccCceechhhccHHHhCCC-CCCccccccc
Confidence 54322 2456899999999999864 5677899984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=248.39 Aligned_cols=185 Identities=27% Similarity=0.372 Sum_probs=133.4
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHH-HHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVT-TIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
..|++.+.||+|+||.||+|+.. +++.||||+++... ....++..|+. +++.++||||+++++++.+++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 34667789999999999999985 58999999996532 22344556665 6777899999999999999999999999
Q ss_pred ccCCCCHhHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 566 YLGNGSLDKWIFNST-EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|+++ +|.+++.... .....+++..+..++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 8887775311 1235689999999999999999999984 2899999999999999999999999999987654
Q ss_pred CCceeeecccCcccccccccc----ccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWI----TNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++ .+..++.++|||||
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~sl 215 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL 215 (327)
T ss_dssp -----------------------------CCSHHHHHHH
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHH
Confidence 322 2334689999999998 45678999999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=245.27 Aligned_cols=181 Identities=23% Similarity=0.344 Sum_probs=133.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
..|++.+.||+|+||.||+|+.. +++.||||++...... .+.+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 34677789999999999999986 5899999999753322 2334445556788899999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|+ ++.+..+.... ...+++..+..++.||++||.|||+ . +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 45555554332 3458999999999999999999998 5 899999999999999999999999999976654
Q ss_pred CCceeeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
... .....+++.|+|||++. +..++.++|||||
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 215 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHH
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhH
Confidence 322 23456899999999984 4568899999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=235.12 Aligned_cols=146 Identities=12% Similarity=0.022 Sum_probs=127.8
Q ss_pred cCHHH-HHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCcceEEEEEE
Q 046493 482 FSYDD-LCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQG----KKEFSAEVTTIGNVHHLHLVKLKGFCI 555 (679)
Q Consensus 482 ~~~~~-l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~ 555 (679)
+...+ +...+|++.+.||+|+||.||+|+... ++.||||++...... .+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 34444 566778999999999999999999865 899999999764322 367899999999999999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEee
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSD 635 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 635 (679)
+++..++||||+++++|.+++.. .....++.+++.||++||+|||++ +|+||||||+|||+++++.+||++
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECS
T ss_pred ECCcEEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEe
Confidence 99999999999999999999843 145667899999999999999999 999999999999999999999984
Q ss_pred c
Q 046493 636 F 636 (679)
Q Consensus 636 F 636 (679)
+
T Consensus 173 ~ 173 (286)
T 3uqc_A 173 P 173 (286)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-26 Score=245.52 Aligned_cols=179 Identities=17% Similarity=0.167 Sum_probs=136.2
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcC-CCc---------ceEE-----
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIGNVHH-LHL---------VKLK----- 551 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h-~ni---------v~l~----- 551 (679)
+.+.+.||+|+||.||+|++. +++.||||+++.. ....+.+++|+.+++.++| +|. +...
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 345678999999999999965 5899999998732 2235779999999999987 221 1111
Q ss_pred -------EEEEe-----CCeeeEEEeccCCCCHhHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 046493 552 -------GFCIE-----GAHRLLAYEYLGNGSLDKWIFNS---TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616 (679)
Q Consensus 552 -------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~ 616 (679)
.+... ....+++|+++ +++|.+++... ......+++..++.++.||++||+|||++ +|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 11111 12346777765 57999888421 22244588889999999999999999999 99999
Q ss_pred CCCCCCeEeCCCCcEEEeeccCCcccccCCceeeecccCcccccccccc----------ccCCCCcccceeeC
Q 046493 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI----------TNNPISEKSDVYSY 679 (679)
Q Consensus 617 Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDvwSl 679 (679)
||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999999999999865443 344567 999999999 55568899999996
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-26 Score=250.99 Aligned_cols=166 Identities=17% Similarity=0.232 Sum_probs=132.7
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.+.||+|+||.||+++. .++.+++|+...... ..+.+.+|++++++++||||+++..++.+.+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 56899999999999965 578899998643211 12457899999999999999977667678888899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++.. +..++.||++||+|||++ +|+||||||+|||+++ .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999843 568999999999999999 9999999999999998 9999999999987654
Q ss_pred Ccee------eecccCcccccccccccc--CCCCcccceee
Q 046493 646 ESLV------YTTLRGTRGYLAPEWITN--NPISEKSDVYS 678 (679)
Q Consensus 646 ~~~~------~~~~~gt~~y~aPE~~~~--~~~s~~sDvwS 678 (679)
.... .....||+.|||||++.+ ..|+..+|+||
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws 523 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWE 523 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHH
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence 3221 134679999999999986 55777889886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-25 Score=226.18 Aligned_cols=156 Identities=25% Similarity=0.318 Sum_probs=132.9
Q ss_pred hhhh-hhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHH-HhhcCCCcceEEEEEEe----CCeeeEEE
Q 046493 492 KNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTI-GNVHHLHLVKLKGFCIE----GAHRLLAY 564 (679)
Q Consensus 492 ~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~ 564 (679)
|.+. +.||+|+||.||++... +++.||||+++. ...+.+|++++ +.++||||+++++++.+ ....++||
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 4444 67999999999999975 589999999864 34577889888 55589999999999987 67789999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCcc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKL 641 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~~ 641 (679)
||+++++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++..
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp CCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999997643 34699999999999999999999999 9999999999999998 78999999999864
Q ss_pred cccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. +..++.++|||||
T Consensus 170 ~~-----------------------~~~~~~~~Diwsl 184 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSL 184 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHH
T ss_pred cc-----------------------cccCCchhhHHHH
Confidence 32 2346678888885
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.6e-23 Score=208.78 Aligned_cols=142 Identities=13% Similarity=0.059 Sum_probs=115.0
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc-------------------CHHHHHHHHHHHHhhcCCCcceEEEE
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-------------------GKKEFSAEVTTIGNVHHLHLVKLKGF 553 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~ 553 (679)
.+.+.||+|+||.||+|+..+++.||||.++.... ....+.+|++++++++ | +++.++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 34588999999999999997799999999864221 2456889999999999 4 555555
Q ss_pred EEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEE
Q 046493 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 633 (679)
Q Consensus 554 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL 633 (679)
+. .+..++||||+++++|.+ +.. .....++.||++||.|||++ +|+||||||+|||++ ++.+||
T Consensus 170 ~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 170 YA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp EE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred Ee-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence 43 356699999999999988 411 12457999999999999999 999999999999999 999999
Q ss_pred eeccCCcccccCCceeeecccCcccccccccccc
Q 046493 634 SDFGLAKLMNREESLVYTTLRGTRGYLAPEWITN 667 (679)
Q Consensus 634 ~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 667 (679)
+|||+++. +..++|||++..
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHHH
Confidence 99999963 335788888753
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.8e-19 Score=148.07 Aligned_cols=103 Identities=18% Similarity=0.301 Sum_probs=81.4
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
.|+|.+|+.+.+ ++ .|.| |.|.|.|...++ +.++. ..++||+|||+.|..+++.|.|+.|||||
T Consensus 1 kn~L~~g~~L~~------g~-~L~s--g~y~l~~q~DgN----Lvly~---~~~~vW~ant~~~~~~~~~L~l~~dGnLv 64 (105)
T 4h3o_A 1 RNILDNNEGLYA------GQ-SLDV--EPYHFIMQDDCN----LVLYD---HSTSTWASNTEIGGKSGCSAVLQSDGNFV 64 (105)
T ss_dssp CCEECTTEEECT------TC-EEEE--TTEEEEECTTSC----EEEEE---TTEEEEECCCCCTTCCSCEEEECTTSCEE
T ss_pred CCCcCCCCEEcC------CC-EEEE--CCEEEEECCCCe----EEEEE---CCEEEEEecCCCCCCccEEEEEeCCccEE
Confidence 378889966655 34 4477 889999976544 33332 56899999999998876779999999999
Q ss_pred EEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeec
Q 046493 108 LQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (679)
Q Consensus 108 l~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQS 149 (679)
|.+.++ .+|+|+++. .....|+|+|+|||||++ +.+|||
T Consensus 65 L~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~---~~~W~S 105 (105)
T 4h3o_A 65 VYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYG---SDIWST 105 (105)
T ss_dssp EECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC---CcEecC
Confidence 999888 699999763 455689999999999996 369998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=149.26 Aligned_cols=107 Identities=22% Similarity=0.356 Sum_probs=83.7
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEE
Q 046493 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYL 108 (679)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl 108 (679)
|+|.+|+++.+ ++ .|+ ++|.|+|+|+..++ .++++ ..++||+||++.|.. +..+.|..||||||
T Consensus 2 d~l~~g~~L~~------g~-~l~-~~~~~~l~~~~dGn-----lvl~~--~~~~vW~sn~~~~~~-~~~l~l~~dGNLVl 65 (110)
T 3a0c_A 2 NSLSSPNSLFT------GH-SLE-VGPSYRLIMQGDCN-----FVLYD--SGKPVWASNTGGLGS-GCRLTLHNNGNLVI 65 (110)
T ss_dssp CEEETTCEECT------TC-EEE-ETTTEEEEECTTSC-----EEEEE--TTEEEEECCCTTSCS-SCEEEECTTSCEEE
T ss_pred CEeCCCCEECC------CC-EEE-ECCCEEEEEcCCCc-----EEEEE--CCEEEEECCCCCCCC-cEEEEEeCCCCEEE
Confidence 78888866544 34 458 89999999987654 24444 479999999987632 34588999999999
Q ss_pred EeCCc-eeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCc
Q 046493 109 QRGNG-EAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPT 154 (679)
Q Consensus 109 ~~~~~-~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PT 154 (679)
.+.++ .+|+|++... ....++|+|+|||||++. .+||||+||.
T Consensus 66 ~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 66 YDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred ECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 98766 6999987643 345899999999999974 8999999983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-19 Score=178.25 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=107.3
Q ss_pred hhhhhhcCcccceEEEEEEe-CCCcE--EEEEEecccccC-------------------------HHHHHHHHHHHHhhc
Q 046493 492 KNFSTKLGQGGFGSVYLGML-PDGIQ--VAVKKLESIGQG-------------------------KKEFSAEVTTIGNVH 543 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~E~~~l~~l~ 543 (679)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34667899999999999998 67888 999987542111 135789999999999
Q ss_pred CCCc--ceEEEEEEeCCeeeEEEeccCC-C----CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeee
Q 046493 544 HLHL--VKLKGFCIEGAHRLLAYEYLGN-G----SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH-EECEVKIVH 615 (679)
Q Consensus 544 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH 615 (679)
|+++ +.++.. +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8754 444443 356899999942 3 67665422 224467789999999999999 88 9999
Q ss_pred cCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 616 ~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
|||||+|||+++ .++|+|||+|.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999998 999999999986643
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-18 Score=149.43 Aligned_cols=104 Identities=20% Similarity=0.295 Sum_probs=82.0
Q ss_pred ccccCCCccccceeeecCCCcEEE--eCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCc
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLI--SNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGN 105 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~--S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~ 105 (679)
.++|.+|+++.+ ++ .|+ |++|.|+|+|+++++ .++++. +++||+|||+.|- .+..+.|..|||
T Consensus 8 ~~~l~~g~~L~~------g~-~l~~~S~~g~~~L~~~~dgn-----lvly~~--~~~vW~sn~~~~~-~~~~l~l~~dGN 72 (119)
T 1b2p_A 8 QPDDNHPQILHA------TE-SLEILFGTHVYRFIMQTDCN-----LVLYDN--NNPIWATNTGGLG-NGCRAVLQPDGV 72 (119)
T ss_dssp CSSSCCCCEEET------TC-EEEEEETTEEEEEEECTTSC-----EEEEET--TEEEEECCCTTSC-SSCEEEECTTSC
T ss_pred CcccCCCCEEcC------CC-EEEEeCCCCCEEEEEecCCC-----EEEEEC--CEEEEeCCCccCC-CceEEEEccCCE
Confidence 488999966544 44 458 999999999998654 234543 8999999998762 234589999999
Q ss_pred EEEEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeec
Q 046493 106 AYLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (679)
Q Consensus 106 lvl~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQS 149 (679)
|||.+.++ .+|+|++.. .....++|+|+|||||++ .++|||
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99998776 699998753 345689999999999998 389998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=6.3e-18 Score=145.96 Aligned_cols=108 Identities=16% Similarity=0.310 Sum_probs=83.5
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
.|+|.+|+++.+ ++. |+ +|.|+|+|++.++ . . +++ ..++||+|||+.|.. +..+.|..+||||
T Consensus 2 ~dtl~~gq~L~~------g~~-L~--~g~~~L~~~~dgn--l--v-ly~--~~~~vW~sn~~~~~~-~~~l~l~~~GnLv 64 (115)
T 2dpf_A 2 DNVLLSGQTLHA------DHS-LQ--AGAYTLTIQNKCN--L--V-KYQ--NGRQIWASNTDRRGS-GCRLTLLSDGNLV 64 (115)
T ss_dssp CCEEETTCEEET------TEE-EE--ETTEEEEECTTSC--E--E-EEE--TTEEEEECSCTTSCS-SCEEEECTTSCEE
T ss_pred CCEeCCCCEECC------CCE-EE--CCCEEEEEcCCCc--E--E-EEe--CCEEEEeCCCCCCCC-ceEEEECCCCcEE
Confidence 378999976655 333 46 7999999976543 1 2 233 588999999998842 3458999999999
Q ss_pred EEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeecCCCCcc
Q 046493 108 LQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTD 155 (679)
Q Consensus 108 l~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTD 155 (679)
|.+.++ .+|+|++.. .....|+|+|+|||||++. ++||||.++..
T Consensus 65 l~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 65 IYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred EECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 998766 699998763 3456899999999999964 89999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=143.34 Aligned_cols=109 Identities=17% Similarity=0.339 Sum_probs=82.6
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
+|+|.+|+++.+ ++++ ++|.|+|+|+.+++ .++++. +++||+||++.+- .+..+.|..+||||
T Consensus 1 tdtl~~gq~L~~------g~~L---~~~~~~L~~~~dgn-----lvl~~~--~~~vW~sn~~~~~-~~~~l~l~~~GNLv 63 (112)
T 1xd5_A 1 SDRLNSGHQLDT------GGSL---AEGGYLFIIQNDCN-----LVLYDN--NRAVWASGTNGKA-SGCVLKMQNDGNLV 63 (112)
T ss_dssp CCEEETTEEECT------TCEE---EETTEEEEECTTSC-----EEEEET--TEEEEECCCTTSC-SSEEEEECTTSCEE
T ss_pred CCCCCCCCEECC------CCEE---eCCCEEEEEcCCCc-----EEEEEC--CEEEEeCCCcCCC-CCEEEEEeCCCCEE
Confidence 478999976655 3433 48999999998765 223443 7899999997531 12348899999999
Q ss_pred EEeCCceeEEeccCC-CceeEEEEecCCCEEEEccCCceeeecCCCC
Q 046493 108 LQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHP 153 (679)
Q Consensus 108 l~~~~~~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQSFD~P 153 (679)
|.+.+..+|+|++.. .....++|+++|||||++..+.++||||++.
T Consensus 64 l~d~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred EEcCCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 999333799998653 3346799999999999987788999999985
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-17 Score=171.67 Aligned_cols=137 Identities=10% Similarity=0.064 Sum_probs=101.3
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc---------------CHHH--------HHHHHHHHHhhcCCCcc
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ---------------GKKE--------FSAEVTTIGNVHHLHLV 548 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------------~~~~--------~~~E~~~l~~l~h~niv 548 (679)
|++.+.||+|++|.||+|...+|+.||||+++.... .... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 667789999999999999998999999998753110 0111 23567777777655443
Q ss_pred eEEEEEEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC
Q 046493 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN 628 (679)
Q Consensus 549 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 628 (679)
...-+.. ...+|||||+++++|.++.. ......++.||+.+|.+||+. +||||||||.|||++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 2211111 22379999999988866531 112456889999999999999 99999999999999877
Q ss_pred C----------cEEEeeccCCcccc
Q 046493 629 F----------TAKVSDFGLAKLMN 643 (679)
Q Consensus 629 ~----------~~kL~DFg~a~~~~ 643 (679)
+ .+.|+||+.+....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999887544
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4.6e-16 Score=132.77 Aligned_cols=102 Identities=25% Similarity=0.439 Sum_probs=76.9
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEE
Q 046493 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYL 108 (679)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl 108 (679)
++|.||+.+.+ +..|+ +|.|+|+|...++ +.+ +.. .++||+||++.+- .+..+.|..||||||
T Consensus 2 ntL~~gq~L~~-------g~~L~--~g~~~L~~q~dGn----Lvl-y~~--~~~vW~snt~~~~-~~~~l~l~~dGNLvl 64 (109)
T 3dzw_A 2 NILYSGETLSP-------GEFLN--NGRYVFIMQEDCN----LVL-YDV--DKPIWATNTGGLD-RRCHLSMQSDGNLVV 64 (109)
T ss_dssp CEEETTEEECT-------TCEEE--ETTEEEEECTTSC----EEE-EET--TEEEEECCCTTSS-SSCEEEECTTSCEEE
T ss_pred CCcCCCCEeCC-------CCEEE--CCCEEEEEcCCCc----EEE-EeC--CEEEEECCcccCC-CCEEEEEeCCCCEEE
Confidence 68889966555 33334 7999999987554 222 332 6899999998752 234588999999999
Q ss_pred EeCCc-eeEEeccCCCc-eeEEEEecCCCEEEEccCCceeeecC
Q 046493 109 QRGNG-EAWSANTSGQK-VECMELQDSGNLVLLGVNGSILWQSF 150 (679)
Q Consensus 109 ~~~~~-~vWst~~~~~~-~~~a~LldsGNLVl~~~~~~~lWQSF 150 (679)
.+.++ .+|+|++.+.. ...|+|+|+|||||+++ .+|||=
T Consensus 65 ~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 65 YSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred ECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 98776 79999876433 46799999999999984 899983
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.52 E-value=6.9e-14 Score=119.87 Aligned_cols=104 Identities=16% Similarity=0.237 Sum_probs=76.8
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
.|+|.+|+++.+ ++.+ . +|.|.|-|...++ +.+ +.....++||++|+..+-. ...+.|..|||||
T Consensus 6 ~~tL~~gq~L~~------g~~L-~--~g~~~L~~q~dGN----LvL-~~~~~~~~vWssnt~~~~~-~~~l~l~~dGNLV 70 (113)
T 3mez_B 6 RNVLFSSQVMYD------NAQL-A--TRDYSLVMRDDCN----LVL-TKGSKTNIVWESGTSGRGQ-HCFMRLGHSGELD 70 (113)
T ss_dssp SSEEETTCEEET------TCEE-E--ETTEEEEECTTSC----EEE-EETTTTEEEEECCCTTSCS-SCEEEECTTSCEE
T ss_pred CCEeCCCCEECC------CCEe-E--cCCEEEEEcCCCE----EEE-EECCCCEEEEECCcccCCc-CEEEEEeCCCcEE
Confidence 589999977655 3443 4 4788888865433 222 3322468999999986532 3458899999999
Q ss_pred EEeCCc-eeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeec
Q 046493 108 LQRGNG-EAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQS 149 (679)
Q Consensus 108 l~~~~~-~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQS 149 (679)
|.+.++ .+|++++... ....|+|+|+|||||++ ..+|+|
T Consensus 71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 998776 6999987533 34689999999999997 689997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.50 E-value=5e-14 Score=120.01 Aligned_cols=101 Identities=18% Similarity=0.162 Sum_probs=72.7
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
+|+|.+|+++.+ +..|+| |.|+|-|-. .++ +.+ +.. ++||++|++..- .+..+.|..|||||
T Consensus 6 ~dtL~~gq~L~~-------g~~L~s--g~~~L~~q~-dGn---Lvl-~~~---~~vW~snt~~~~-~~~~l~l~~dGNLv 67 (110)
T 3r0e_B 6 NNLLFSGQVLYG-------DGRLTA--KNHQLVMQG-DCN---LVL-YGG---KYGWQSNTHGNG-EHCFLRLNHKGELI 67 (110)
T ss_dssp TTEEETTCEEET-------TEEEEC--SSCEEEECT-TSC---EEE-ECS---SSCEECCCTTSS-SSCEEEECTTSCEE
T ss_pred cCEECCCCEecC-------CCEEEe--CCEEEEEcC-CCe---EEE-ECC---eEEEECCCcCCC-cCEEEEEeCCCcEE
Confidence 599999976655 334476 558885533 222 222 222 589999997521 12358899999999
Q ss_pred EEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeec
Q 046493 108 LQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (679)
Q Consensus 108 l~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQS 149 (679)
|.+.++ .+|++++.. .....|+|+|+|||||++ ..+|+|
T Consensus 68 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 68 IKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 998776 699998753 334689999999999997 489997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.2e-14 Score=119.64 Aligned_cols=85 Identities=20% Similarity=0.481 Sum_probs=66.8
Q ss_pred CceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCC
Q 046493 96 DKFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPN 174 (679)
Q Consensus 96 ~~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~ 174 (679)
..|.+..||||||.+.+..||++++... ....|+|+|+|||||+|.++.++||||..| +
T Consensus 22 ~~l~~~~dGnlvl~~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~--------------------~ 81 (110)
T 3a0c_A 22 YRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNG--------------------K 81 (110)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------------S
T ss_pred EEEEEcCCCcEEEEECCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCCCC--------------------C
Confidence 4488899999999986557999997633 346899999999999999899999999544 3
Q ss_pred CCCceEEEEeecCceEEEEecccceeeeeccC
Q 046493 175 SNNMSVYLEFKSGDLVLYAGYQTSQTYWSLAN 206 (679)
Q Consensus 175 ~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~ 206 (679)
+|.|++.++.++ +++++. . .||+++.
T Consensus 82 ~g~~~l~l~~dG-nlvl~~---~--~~W~S~~ 107 (110)
T 3a0c_A 82 EDHYVLVLQQDR-NVVIYG---P--VVWATGS 107 (110)
T ss_dssp SSCCEEEECTTS-CEEEEC---S--EEEECSC
T ss_pred CCCEEEEEeCCc-cEEEEC---C--CEecCCC
Confidence 467888887665 677752 2 7999764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.48 E-value=9.8e-14 Score=119.05 Aligned_cols=88 Identities=22% Similarity=0.504 Sum_probs=68.8
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNS 175 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~ 175 (679)
.|.+..||+|+|.+.+..+|++++.+. ....|+|+|+|||||+| ++.++||||++| ++
T Consensus 22 ~L~~~~dgnlvl~~~~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~--------------------~~ 80 (112)
T 1xd5_A 22 LFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNR--------------------QN 80 (112)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCCC--------------------SC
T ss_pred EEEEcCCCcEEEEECCEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCccC--------------------CC
Confidence 488889999999987557999997642 34689999999999999 788999999765 34
Q ss_pred CCceEEEEeecCceEEEEecccceeeeeccCCC
Q 046493 176 NNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDS 208 (679)
Q Consensus 176 g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~~~ 208 (679)
|.|++.++.++ +++++ .....+||+++.+.
T Consensus 81 g~~~l~l~~dG-nlvl~--~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 81 GNYYLILQRDR-NVVIY--DNSNNAIWATHTNV 110 (112)
T ss_dssp CCCEEEECTTS-CEEEE--CTTSCEEEECCCCC
T ss_pred CCEEEEEeCCC-cEEEE--CCCCceEEECCCcc
Confidence 67888887665 67776 23467899987543
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=115.33 Aligned_cols=105 Identities=18% Similarity=0.353 Sum_probs=76.3
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
.|+|.||+.+.+. +++ .+|.|.|.|...++ +.+ +. .+|.+|+..+- .+..+.|..|||||
T Consensus 3 ~dtL~~gq~L~~g------~~L---~~g~~~L~~q~dGN----Lvl-~~-----~~Wssnt~~~~-~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 3 TNYLLSGQTLDTE------GHL---KNGDFDLVMQDDCN----LVL-YN-----GNWQSNTANNG-RDCKLTLTDYGELV 62 (109)
T ss_dssp CSEEETTCEECTT------CEE---EETTEEEEECTTSC----EEE-ET-----TTEECCCTTSC-SSCEEEECTTSCEE
T ss_pred cCCcCCCCCcCCC------CEe---ECCCEEEEEecCCe----EEE-Ee-----CeEEcCCCCCC-CcEEEEEcCCCeEE
Confidence 5899999776553 332 46999998865443 111 11 16999987642 23458899999999
Q ss_pred EEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeecCCCCccccCCC
Q 046493 108 LQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPG 160 (679)
Q Consensus 108 l~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpg 160 (679)
|.+.++ .+|++++.+ .....|+|+|+|||||++ ..+|+| .|.+||
T Consensus 63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 998776 699998764 334689999999999997 689998 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=114.02 Aligned_cols=84 Identities=24% Similarity=0.449 Sum_probs=66.4
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNS 175 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~ 175 (679)
.|.+..||+|+|.+.+.+||++++... ....|+|+|+|||||+|.++.++||||+.| ++
T Consensus 33 ~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~--------------------~~ 92 (119)
T 1b2p_A 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAG--------------------KA 92 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCCC--------------------CS
T ss_pred EEEEecCCCEEEEECCEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCCCC--------------------CC
Confidence 377888999999987557999997633 346899999999999999899999999554 35
Q ss_pred CCceEEEEeecCceEEEEecccceeeeeccC
Q 046493 176 NNMSVYLEFKSGDLVLYAGYQTSQTYWSLAN 206 (679)
Q Consensus 176 g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~ 206 (679)
|.|++.++.++ +++++. ..||+++.
T Consensus 93 g~~~l~l~~~G-nlvl~~-----~~~W~Sg~ 117 (119)
T 1b2p_A 93 GHYVLVLQPDR-NVVIYG-----DALWATQT 117 (119)
T ss_dssp SCEEEEECTTS-CEEEEE-----SEEEECCC
T ss_pred CCEEEEEECCC-cEEEEC-----ccEeCCCC
Confidence 67888887665 677762 38999763
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=111.94 Aligned_cols=88 Identities=20% Similarity=0.380 Sum_probs=68.1
Q ss_pred CceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCC
Q 046493 96 DKFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPN 174 (679)
Q Consensus 96 ~~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~ 174 (679)
..|.+..||+|+|.+....+|++++... ....++|+++|||||+|.++.++|||||+| +
T Consensus 22 ~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~--------------------~ 81 (115)
T 2dpf_A 22 YTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG--------------------D 81 (115)
T ss_dssp EEEEECTTSCEEEEETTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------------S
T ss_pred EEEEEcCCCcEEEEeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC--------------------C
Confidence 3477888999999885447999997533 346899999999999998889999999985 3
Q ss_pred CCCceEEEEeecCceEEEEecccceeeeeccCCCc
Q 046493 175 SNNMSVYLEFKSGDLVLYAGYQTSQTYWSLANDSR 209 (679)
Q Consensus 175 ~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~~~~ 209 (679)
++.|++.++.++ +++++ +. .||+++.+..
T Consensus 82 ~g~~~l~l~~dG-nlvl~---~~--~~W~S~~~~~ 110 (115)
T 2dpf_A 82 NGKYALVLQKDG-RFVIY---GP--VLWSLGPNGC 110 (115)
T ss_dssp SSCCEEEECTTS-CEEEE---CS--EEECSSTTCB
T ss_pred CCCEEEEEeCCC-eEEEE---CC--CEEECCCCCC
Confidence 456777777665 67765 22 7999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.4e-12 Score=127.08 Aligned_cols=141 Identities=13% Similarity=0.008 Sum_probs=111.5
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEecccc-cCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
|++...++.|+.+.||++... ++.+++|+..... .....+.+|+++++.+. |..++++++++.+.+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 455677888888999999864 6899999986521 33456899999999995 77889999999998899999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC---------------------------------------- 609 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------------------------------------- 609 (679)
.+|.+.+. +......++.+++++|+.||+..
T Consensus 95 ~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 95 VLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred eehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99987641 11223478889999999999810
Q ss_pred ----------------CCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 610 ----------------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 610 ----------------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+..++|+|++|.||+++++..+.|+||+.+...
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 135899999999999987656679999988643
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=5.9e-12 Score=107.33 Aligned_cols=101 Identities=13% Similarity=0.156 Sum_probs=72.8
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
+|+|.+|+.+.+. +.+ .+|.|.|-|...++ +.+ +. ... ||.+|+..+.. ...+.|..|||||
T Consensus 2 ~~~l~~gq~L~~g------~~L---~~g~~~L~~q~dGn----Lvl-~~--~~~-vW~snt~~~~~-~~~l~l~~dGNLV 63 (111)
T 3mez_A 2 NNVLLTGDVIHTD------NQL---SYESAAFVMQGDCN----LVL-YN--EAG-GFQSNTHGRGV-DCTLRLNNRGQLE 63 (111)
T ss_dssp TTEEETTCEECTT------CEE---EETTEEEEECTTSC----EEE-EC--SSC-CEECCCTTSCS-SCEEEECTTSCEE
T ss_pred cCEeCCCCEeCCC------CEE---ecCCEEEEEccCCe----EEE-EC--CCC-EEECCcccCCc-CEEEEEcCCCcEE
Confidence 5889999776663 332 36889998854333 122 22 223 99999986622 3458899999999
Q ss_pred EEeCCc-e-eEEeccC---CCceeEEEEecCCCEEEEccCCceeeec
Q 046493 108 LQRGNG-E-AWSANTS---GQKVECMELQDSGNLVLLGVNGSILWQS 149 (679)
Q Consensus 108 l~~~~~-~-vWst~~~---~~~~~~a~LldsGNLVl~~~~~~~lWQS 149 (679)
|.+.++ . +|+|++. ......|+|+|+|||||++ ..+|+|
T Consensus 64 l~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 64 IHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp EECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 998866 4 9999853 2234679999999999997 789997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=4.6e-11 Score=119.35 Aligned_cols=130 Identities=15% Similarity=0.045 Sum_probs=99.5
Q ss_pred CcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC--cceEEEEEEeCCeeeEEEeccCCCCHhHHh
Q 046493 499 GQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH--LVKLKGFCIEGAHRLLAYEYLGNGSLDKWI 576 (679)
Q Consensus 499 g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 576 (679)
+.|..+.||++...+|+.+++|..... ....+.+|+++++.+++.+ +++++++..+++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 355569999998877888999997653 2355789999999996544 567899888888889999999998884 2
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 046493 577 FNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC----------------------------------------------- 609 (679)
Q Consensus 577 ~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------------------- 609 (679)
.. .+ ...++.++++.|..||+..
T Consensus 105 ~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 SH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp SC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred Cc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11 11 2356778888888888742
Q ss_pred --------CCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 610 --------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 610 --------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+..++|+|++|.||+++++..+.|+||+.+...
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.9e-10 Score=120.77 Aligned_cols=140 Identities=16% Similarity=0.182 Sum_probs=107.5
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEec--ccc--cCHHHHHHHHHHHHhhc--CCCcceEEEEEEeC---CeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLE--SIG--QGKKEFSAEVTTIGNVH--HLHLVKLKGFCIEG---AHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 566 (679)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+++++.++ +..+++++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568899999999998754 678889876 322 23456889999999997 45688999988776 457999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC------------------------------------- 609 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------- 609 (679)
++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9998875421 223778888999999999999999721
Q ss_pred ------------------CCCeeecCCCCCCeEeCCCCc--EEEeeccCCccc
Q 046493 610 ------------------EVKIVHCDIKPENVLLDDNFT--AKVSDFGLAKLM 642 (679)
Q Consensus 610 ------------------~~~ivH~Dlkp~NIll~~~~~--~kL~DFg~a~~~ 642 (679)
+..++|+|++|.||++++++. +.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999998753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=4.7e-10 Score=111.87 Aligned_cols=116 Identities=20% Similarity=0.333 Sum_probs=80.2
Q ss_pred ccccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCC--CCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeC
Q 046493 26 QHIGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTAL--DVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKN 103 (679)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~--~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~ 103 (679)
-.+|+|.||+.+.. -+..++. |.| +.+++.|+|+.. +... +.++. ...+++|.+++..+- ...+.+..+
T Consensus 134 ~ptdtlLpg~~~~~--~l~~g~~-L~S-~~dps~G~fsl~l~~dGn-lvLy~--~~~~~yW~Sgt~~~~--~~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSL--LLAPGSE-LVQ-GVVYGAGASKLVFQGDGN-LVAYG--PNGAATWNAGTQGKG--AVRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCE--EECSSEE-ECT-TCEEEETTEEEEECTTSC-EEEEC--TTSSEEEECCCTTTT--CCEEEECTT
T ss_pred cccccccccccccc--ccccCcc-ccc-CCCCCCceEEEeecCCce-EEEEe--CCCeEEEECCCCCCc--cEEEEEcCC
Confidence 45799999976211 1333333 444 456666666531 1222 22222 135799999998762 245888899
Q ss_pred CcEEEEeCCc-eeEEeccCCCceeEEEEecCCCEEEEccCCceeeecCCC
Q 046493 104 GNAYLQRGNG-EAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (679)
Q Consensus 104 g~lvl~~~~~-~vWst~~~~~~~~~a~LldsGNLVl~~~~~~~lWQSFD~ 152 (679)
|+|++.+.++ .+|++++.+.....|+|+++|||||++. +.+||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 9999998877 7999987654557899999999999986 689999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.08 E-value=2.1e-10 Score=97.64 Aligned_cols=84 Identities=21% Similarity=0.360 Sum_probs=63.9
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCc-eeeecCCCCccccCCCCccCCCceeecCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGS-ILWQSFSHPTDTLLPGQQFVEGMRLKSFPN 174 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~-~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~ 174 (679)
.|.+..||||||.+.++ +|++++.+. ....|+|+|+|||||++.++. ++|||.-+ +...
T Consensus 23 ~L~~q~dGnLvl~~~~~-vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------~~~~ 83 (111)
T 3mez_A 23 AFVMQGDCNLVLYNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------VNTV 83 (111)
T ss_dssp EEEECTTSCEEEECSSC-CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------------CCCC
T ss_pred EEEEccCCeEEEECCCC-EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------------cCCC
Confidence 38889999999998888 999997643 346899999999999998776 59999832 0112
Q ss_pred CCCceEEEEeecCceEEEEecccceeeeecc
Q 046493 175 SNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 175 ~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
.+.+.+.++.++ ++++|. ..+|.++
T Consensus 84 ~~~~~l~Lq~dG-Nlvly~-----~~~W~s~ 108 (111)
T 3mez_A 84 RGNYAATLGPDQ-HVTIYG-----PAIWSTP 108 (111)
T ss_dssp SSCCEEEECTTS-CEEEEC-----SEEEECC
T ss_pred CcCEEEEECCCC-eEEEec-----cCEEccC
Confidence 356677777666 888872 6789865
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.07 E-value=3.9e-10 Score=96.43 Aligned_cols=91 Identities=23% Similarity=0.386 Sum_probs=65.5
Q ss_pred CCCCCCCC-ceEEeeCCcEEEEeCC-c-eeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccC
Q 046493 89 GLLIRDSD-KFVFEKNGNAYLQRGN-G-EAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFV 164 (679)
Q Consensus 89 ~~p~~~~~-~~~~~~~g~lvl~~~~-~-~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~ 164 (679)
+.|+.+.. .|.+..||||||.+.+ + .+|++++... ....|+|+|+|||||+|.+++++|||=.+-
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~----------- 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG----------- 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC-----------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC-----------
Confidence 34454333 3889999999999873 4 7999997643 346899999999999999889999984321
Q ss_pred CCceeecCCCCCCceEEEEeecCceEEEEecccceeeeecc
Q 046493 165 EGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 165 ~~~~l~S~~~~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
..+.+.+.++.++ ++++|. ...|.++
T Consensus 87 ---------~~~~~~~~L~~dG-nlvly~-----~~~W~s~ 112 (113)
T 3mez_B 87 ---------QEGDYVLILQING-QAVVYG-----PAVWSTA 112 (113)
T ss_dssp ---------SSSCCEEEECTTS-CEEEEC-----SEEEESC
T ss_pred ---------CCCCEEEEEcCCc-eEEEec-----CCEecCC
Confidence 1234666666555 788872 4778765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.5e-09 Score=92.20 Aligned_cols=84 Identities=23% Similarity=0.452 Sum_probs=62.2
Q ss_pred CceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCC
Q 046493 96 DKFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPN 174 (679)
Q Consensus 96 ~~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~ 174 (679)
..|.+..||||||.+.+..+|++++.+. ....++|+|+|||||+|.++.++|||.... .
T Consensus 21 ~~L~~q~dGnLvly~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~--------------------~ 80 (109)
T 3dzw_A 21 YVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG--------------------E 80 (109)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC--------------------S
T ss_pred EEEEEcCCCcEEEEeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC--------------------C
Confidence 3488889999999988668999997643 346899999999999998889999986432 1
Q ss_pred CCCceEEEEeecCceEEEEecccceeeeecc
Q 046493 175 SNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 175 ~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
.+.+.+.++.++ ++++|. ...|.++
T Consensus 81 ~~~~~~~L~ddG-Nlvly~-----~~~W~s~ 105 (109)
T 3dzw_A 81 NGNYVCVLQKDR-NVVIYG-----TARWATG 105 (109)
T ss_dssp SSCEEEEECTTS-CEEEEE-----SCCCCCC
T ss_pred CCCEEEEEeCCC-EEEEEC-----CCEEeCC
Confidence 133455555554 788873 2678765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.7e-09 Score=91.89 Aligned_cols=83 Identities=20% Similarity=0.360 Sum_probs=61.8
Q ss_pred CceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCC
Q 046493 96 DKFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPN 174 (679)
Q Consensus 96 ~~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~ 174 (679)
..|.+..||||||.+. ..+|++++.+. ....++|+|+|||||+|.++.++|||-.+- .
T Consensus 26 ~~L~~q~dGnLvl~~~-~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~--------------------~ 84 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG-KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS--------------------K 84 (110)
T ss_dssp CEEEECTTSCEEEECS-SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------------S
T ss_pred EEEEEcCCCeEEEECC-eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC--------------------C
Confidence 3488899999999876 57999997643 235899999999999999889999996421 1
Q ss_pred CCCceEEEEeecCceEEEEecccceeeeecc
Q 046493 175 SNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 175 ~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
.+.+.+.++.++ ++++|. ...|.++
T Consensus 85 ~~~~~~~L~~dG-Nlvly~-----~~~W~t~ 109 (110)
T 3r0e_B 85 QGEYVLILQDDG-FGVIYG-----PAIFETS 109 (110)
T ss_dssp SSCCEEEECTTS-CEEEEC-----SEEEESC
T ss_pred CCCEEEEEcCCc-cEEEec-----CCEecCC
Confidence 234566666555 788872 3678764
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.1e-08 Score=86.71 Aligned_cols=81 Identities=23% Similarity=0.451 Sum_probs=60.6
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNS 175 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~ 175 (679)
.|.+..||||||.+. +|+|++.+. ....++|+++|||||+|.++.++|+|-... ..
T Consensus 24 ~L~~q~dGNLvl~~~---~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~--------------------~~ 80 (109)
T 3r0e_A 24 DLVMQDDCNLVLYNG---NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQS--------------------VK 80 (109)
T ss_dssp EEEECTTSCEEEETT---TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCCC--------------------SS
T ss_pred EEEEecCCeEEEEeC---eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCcC--------------------CC
Confidence 388889999999874 799998643 346899999999999999889999863210 12
Q ss_pred CCceEEEEeecCceEEEEecccceeeeeccC
Q 046493 176 NNMSVYLEFKSGDLVLYAGYQTSQTYWSLAN 206 (679)
Q Consensus 176 g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~ 206 (679)
+.+.+.++.++ ++++|. ...|.++.
T Consensus 81 ~~~~~~L~~dG-Nlvly~-----~~~W~s~t 105 (109)
T 3r0e_A 81 GNYAAVVHPDG-RLVVFG-----PSVFKIDP 105 (109)
T ss_dssp SCCEEEEETTT-EEEEEC-----SEEEEECT
T ss_pred cCEEEEEcCCC-eEEEEe-----cCEECCCC
Confidence 44666777655 888872 57898764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.79 E-value=1.9e-08 Score=84.46 Aligned_cols=54 Identities=30% Similarity=0.554 Sum_probs=46.5
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccC--CCceeEEEEecCCCEEEEccCCceeeecC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTS--GQKVECMELQDSGNLVLLGVNGSILWQSF 150 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~--~~~~~~a~LldsGNLVl~~~~~~~lWQSF 150 (679)
.|.+..||||||.+.+..||++++. ......++|.++|||||+|.+++++|+|-
T Consensus 22 ~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~ 77 (105)
T 4h3o_A 22 HFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH 77 (105)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred EEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec
Confidence 4788899999999987789999875 23446799999999999999999999983
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.57 E-value=8.2e-08 Score=98.05 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=100.1
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCC--cceEEEEEEeCC---eeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLH--LVKLKGFCIEGA---HRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~ 569 (679)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +++++......+ ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 347889999999854 46888986532 33567899999999884 333 455655544333 34899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE----------------------------------------- 608 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------------------------------------- 608 (679)
.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 88865432 2367778888888888888888861
Q ss_pred --------------CCCCeeecCCCCCCeEeCC--CCcEEEeeccCCccc
Q 046493 609 --------------CEVKIVHCDIKPENVLLDD--NFTAKVSDFGLAKLM 642 (679)
Q Consensus 609 --------------~~~~ivH~Dlkp~NIll~~--~~~~kL~DFg~a~~~ 642 (679)
.++.++|+|++|.||++++ ...+.|+||+.+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999998 456789999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=4.4e-07 Score=90.84 Aligned_cols=136 Identities=15% Similarity=0.133 Sum_probs=98.6
Q ss_pred cCcccce-EEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccCCCCHhH
Q 046493 498 LGQGGFG-SVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDK 574 (679)
Q Consensus 498 Lg~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 574 (679)
+..|..+ .||+.... ++..+++|+-... ...++.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4444444 68988765 4678999986532 3566889999999885 4457889999999999999999999988876
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 046493 575 WIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC--------------------------------------------- 609 (679)
Q Consensus 575 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--------------------------------------------- 609 (679)
..... ......+..++++.|.-||...
T Consensus 110 ~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 110 VLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 54221 1122345566666666666421
Q ss_pred ----------CCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 610 ----------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 610 ----------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
++.++|+|+.+.|||+++++.+-|+||+.+....
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 1237999999999999987777899999987543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=6.1e-07 Score=91.58 Aligned_cols=137 Identities=18% Similarity=0.196 Sum_probs=96.1
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC---CcceEEEEEE-eCCeeeEEEeccCCCC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL---HLVKLKGFCI-EGAHRLLAYEYLGNGS 571 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gs 571 (679)
+.++.|....||+. +..+++|+-.. ......+.+|.++++.+++. .+++.+.+.. ..+..++|||+++|.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 34777888899987 56788888532 22346789999999999752 4677777775 3456789999999988
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE------------------------------------------- 608 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------------- 608 (679)
|.+... ..++..+...++.++++.|+.||+.
T Consensus 100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 876321 1234555555555565555555542
Q ss_pred --------------CCCCeeecCCCCCCeEeCC---CCc-EEEeeccCCcccc
Q 046493 609 --------------CEVKIVHCDIKPENVLLDD---NFT-AKVSDFGLAKLMN 643 (679)
Q Consensus 609 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DFg~a~~~~ 643 (679)
.++.++|+|++|.||++++ ++. ..|+||+.+....
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2235799999999999997 455 4899999887543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=3.9e-07 Score=89.04 Aligned_cols=83 Identities=22% Similarity=0.392 Sum_probs=62.5
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNS 175 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~ 175 (679)
.+.+..+|+|+|.+.+..+|++++.+. ....++|.++||||+++.++..+||||.+. +.
T Consensus 153 ~l~l~~dG~LvL~~~~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~--------------------~~ 212 (236)
T 1dlp_A 153 RLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSR--------------------SA 212 (236)
T ss_dssp EEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCC--------------------SS
T ss_pred EEEECCCCcEEEEcCCEeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCCC--------------------CC
Confidence 478889999999987767899987532 346789999999999998888999999542 23
Q ss_pred CCceEEEEeecCceEEEEecccceeeeecc
Q 046493 176 NNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 176 g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
+.+++.++.++ .+++|. ..||.++
T Consensus 213 ~~~rl~Ld~dG-~l~ly~-----~~~W~sg 236 (236)
T 1dlp_A 213 GRYVFVLQPDR-NLAIYG-----GALWTTG 236 (236)
T ss_dssp SCCEEEECSSS-CEEEEC-----CCCCBC-
T ss_pred CCEEEEEcCCC-cEEEeC-----CCCccCC
Confidence 55677777665 667662 3788754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.4e-06 Score=90.93 Aligned_cols=79 Identities=6% Similarity=0.035 Sum_probs=57.6
Q ss_pred hhc-CcccceEEEEEEeC-------CCcEEEEEEecccc---c-CHHHHHHHHHHHHhhc-C--CCcceEEEEEEeC---
Q 046493 496 TKL-GQGGFGSVYLGMLP-------DGIQVAVKKLESIG---Q-GKKEFSAEVTTIGNVH-H--LHLVKLKGFCIEG--- 557 (679)
Q Consensus 496 ~~L-g~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 557 (679)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+++++.++ + ..+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998864 26788999875432 1 2356788999999885 3 3678888887665
Q ss_pred CeeeEEEeccCCCCHhH
Q 046493 558 AHRLLAYEYLGNGSLDK 574 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~ 574 (679)
+..++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=2.1e-05 Score=83.29 Aligned_cols=73 Identities=10% Similarity=0.032 Sum_probs=50.0
Q ss_pred hhcCcccceEEEEEEeC-CCcEEEEEEecccc--------cCHHHHHHHHHHHHhhcC--C-CcceEEEEEEeCCeeeEE
Q 046493 496 TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--------QGKKEFSAEVTTIGNVHH--L-HLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~lv 563 (679)
+.||.|..+.||++... +++.++||...... ...+.+..|.++++.+.. + .+++++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999864 46889999864321 123456789999988853 3 34456544 45566899
Q ss_pred EeccCCC
Q 046493 564 YEYLGNG 570 (679)
Q Consensus 564 ~e~~~~g 570 (679)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=3e-05 Score=80.15 Aligned_cols=141 Identities=13% Similarity=0.189 Sum_probs=83.0
Q ss_pred hcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc--CCCcceEEE------EEEeCCeeeEEEeccC
Q 046493 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH--HLHLVKLKG------FCIEGAHRLLAYEYLG 568 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~~~ 568 (679)
.|+.|....||+....++ .+++|+... ...++..|+++++.|. .-.+++++. +....+..+++|||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 465667889999987554 589998875 2344556677666664 223444443 1234667899999999
Q ss_pred CCCHh-----------HH---hhccCC----C------CCCCCHHHH-------------------------------HH
Q 046493 569 NGSLD-----------KW---IFNSTE----E------SRFLSWNTR-------------------------------FN 593 (679)
Q Consensus 569 ~gsL~-----------~~---l~~~~~----~------~~~l~~~~~-------------------------------~~ 593 (679)
|..+. .. ++.... . .....|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 01 111000 0 001122211 11
Q ss_pred HHHHHHHHHHHHhc----------CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 594 IALGMAKGLAYLHE----------ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 594 i~~~i~~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+..++.+++.+|++ ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11234446666663 0234899999999999998888999999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=5.7e-05 Score=76.75 Aligned_cols=138 Identities=20% Similarity=0.181 Sum_probs=93.2
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc---CCCcceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH---HLHLVKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+++++.+....+..++|||++++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4588999999999987 5678889987542 3567889999999884 36788999998888889999999998765
Q ss_pred hH--------H---hhccCC-C--C---------------CCCCHHHHH---HHH----------------HHHHHHH-H
Q 046493 573 DK--------W---IFNSTE-E--S---------------RFLSWNTRF---NIA----------------LGMAKGL-A 603 (679)
Q Consensus 573 ~~--------~---l~~~~~-~--~---------------~~l~~~~~~---~i~----------------~~i~~~L-~ 603 (679)
.. . |+.... . + -.-+|.... ++. .++++.+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1 121111 0 0 012444321 111 1122222 2
Q ss_pred HHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 604 YLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 604 yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
.|.. ..++.++|+|+.+.||+++.++ +.|+|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2346899999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=4.7e-05 Score=76.72 Aligned_cols=73 Identities=22% Similarity=0.254 Sum_probs=54.7
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcC---CCcceEEEEEEeCCeeeEEEeccCCCC
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHH---LHLVKLKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gs 571 (679)
+.+|.|..+.||+.++.||+.+++|+..... .....+..|++.|+.|.. --+++++++ + ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 5689999999999999999999999875432 334568899999998842 235566654 2 3478999998765
Q ss_pred H
Q 046493 572 L 572 (679)
Q Consensus 572 L 572 (679)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00023 Score=75.83 Aligned_cols=71 Identities=15% Similarity=0.223 Sum_probs=45.7
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecc-------c-c--cCHHHHHHHHHHHHh-hcCCCcceEEEEEEeCCeeeEEE
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLES-------I-G--QGKKEFSAEVTTIGN-VHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~-------~-~--~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
+.|+.|....||++.. +++.++||.... . . .....++.|+..+.. ..+..+++++.+. .+..++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 4688899999999975 567899994321 1 1 123344444443322 2234677777765 56679999
Q ss_pred ecc-CC
Q 046493 565 EYL-GN 569 (679)
Q Consensus 565 e~~-~~ 569 (679)
|++ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00015 Score=73.49 Aligned_cols=140 Identities=11% Similarity=0.058 Sum_probs=77.0
Q ss_pred hhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEecc-CCCCH
Q 046493 495 STKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEYL-GNGSL 572 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL 572 (679)
.+.|+.|....+|+. ..+++|+............+|+.+++.+....+ ++++.+ +.+.-++++||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 356888989999998 568889876432212234578888888753333 466654 344457899999 66555
Q ss_pred hHH--------h----------hccCC-CCCCCCH-HHHHHHHH--------------HHHHHH----HHHhc-CCCCCe
Q 046493 573 DKW--------I----------FNSTE-ESRFLSW-NTRFNIAL--------------GMAKGL----AYLHE-ECEVKI 613 (679)
Q Consensus 573 ~~~--------l----------~~~~~-~~~~l~~-~~~~~i~~--------------~i~~~L----~yLH~-~~~~~i 613 (679)
... + +.... ....... .....+.. .+.+.+ ..|.. ..+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 320 0 11000 0000111 11111100 011111 11111 223468
Q ss_pred eecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 614 vH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+|+|+.+.||+ .+++.+.|+||..+...
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 99999999999 55667899999988653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00079 Score=68.91 Aligned_cols=142 Identities=12% Similarity=0.051 Sum_probs=84.9
Q ss_pred cCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CcceEEEE-----EEeCCeeeEEEeccCCC
Q 046493 498 LGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHL--HLVKLKGF-----CIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 498 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~g 570 (679)
++ |....||+....+|+.+++|...........+..|..+++.+... .+++++.. ....+..++++|+++|.
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 55 777899998877787899999875444567788899988888522 24455443 12245567899999885
Q ss_pred CHh-----HH---------hhc----cCC-CCCCCCHHHH----------------------HHHHHHHHHHHHHHhc-C
Q 046493 571 SLD-----KW---------IFN----STE-ESRFLSWNTR----------------------FNIALGMAKGLAYLHE-E 608 (679)
Q Consensus 571 sL~-----~~---------l~~----~~~-~~~~l~~~~~----------------------~~i~~~i~~~L~yLH~-~ 608 (679)
.+. .+ ++. ... .....++... ...+.+++..+.-+.. .
T Consensus 113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 192 (328)
T 1zyl_A 113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 192 (328)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 432 11 111 000 0111222111 1112222222222211 1
Q ss_pred CCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 609 ~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
.+..++|+|+++.||+++ + .+.|+||+.+...
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234789999999999999 4 8999999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00036 Score=72.83 Aligned_cols=143 Identities=17% Similarity=0.145 Sum_probs=85.0
Q ss_pred hhcCcccceEEEEEEeCC--------CcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.|..|-...+|++...+ ++.+++|+..........+.+|.++++.|. +.-.+++++++.+ -+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 356677778899998742 478999987443335667789999999885 3334667666543 289999
Q ss_pred cCCCCHhHH-h----------------hccC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 046493 567 LGNGSLDKW-I----------------FNST-EESRFLS--WNTRFNIALGMAK-------------------GLAYLH- 606 (679)
Q Consensus 567 ~~~gsL~~~-l----------------~~~~-~~~~~l~--~~~~~~i~~~i~~-------------------~L~yLH- 606 (679)
++|.+|..- + +... ...+... +.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998665311 0 1110 0011122 3444444443321 122222
Q ss_pred ---c-CCCCCeeecCCCCCCeEeCCC----CcEEEeeccCCccc
Q 046493 607 ---E-ECEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLM 642 (679)
Q Consensus 607 ---~-~~~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~~ 642 (679)
. ..+..++|+|+.+.||+++++ +.+.|+||..+...
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 1 123478999999999999876 78999999998743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00024 Score=72.70 Aligned_cols=144 Identities=13% Similarity=0.127 Sum_probs=81.3
Q ss_pred hhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC--cceEEEE------EEeCCeeeEEEecc
Q 046493 496 TKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH--LVKLKGF------CIEGAHRLLAYEYL 567 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~ 567 (679)
+.|+.|....+|+....++ .+++|..... .....+..|+.+++.|.... +++++.. ....+..++++|++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3467788889999987655 6888988652 12345667888888775222 3444421 12345678999999
Q ss_pred CCCCHhH----H----------hhccC----CCC-CCC---CHHHHHH------------HHHHHHHHHHHHhc----CC
Q 046493 568 GNGSLDK----W----------IFNST----EES-RFL---SWNTRFN------------IALGMAKGLAYLHE----EC 609 (679)
Q Consensus 568 ~~gsL~~----~----------l~~~~----~~~-~~l---~~~~~~~------------i~~~i~~~L~yLH~----~~ 609 (679)
+|..+.. . ++... ... ... .|..... +...+.+.++.+++ ..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9865421 0 11100 000 001 1221100 00113344555542 12
Q ss_pred CCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 610 ~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34799999999999999876668999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00041 Score=74.00 Aligned_cols=72 Identities=19% Similarity=0.208 Sum_probs=50.3
Q ss_pred hhcCcccceEEEEEEeCC--------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 566 (679)
+.|+.|....+|++...+ ++.+++|+.... .....+..|..+++.|...++ +++++.+. + .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 457788889999998753 578999988432 222566689999998853333 66776543 2 389999
Q ss_pred cCCCCH
Q 046493 567 LGNGSL 572 (679)
Q Consensus 567 ~~~gsL 572 (679)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0011 Score=68.13 Aligned_cols=143 Identities=18% Similarity=0.091 Sum_probs=76.4
Q ss_pred hcCcccceE-EEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcC--CCcceEEEEEEeCCeeeEEEeccCCCCHh
Q 046493 497 KLGQGGFGS-VYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH--LHLVKLKGFCIEGAHRLLAYEYLGNGSLD 573 (679)
Q Consensus 497 ~Lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 573 (679)
.|+.|.... +|+....++..+++|...... ..++..|+++++.+.. -.+++++.+..+. -+++||++++..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 455554444 667766446778888654322 1335667787777742 3466777764333 37899999877765
Q ss_pred HHhhccC---------------------CC-CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---cC
Q 046493 574 KWIFNST---------------------EE-SRFLSWNTRF-------N-------------IALGMAKGLAYLH---EE 608 (679)
Q Consensus 574 ~~l~~~~---------------------~~-~~~l~~~~~~-------~-------------i~~~i~~~L~yLH---~~ 608 (679)
+++.... .. ...++..... . ....+...+..|. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4442110 00 0112211100 0 0001111222221 11
Q ss_pred CCCCeeecCCCCCCeEeCCC----CcEEEeeccCCcccc
Q 046493 609 CEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLMN 643 (679)
Q Consensus 609 ~~~~ivH~Dlkp~NIll~~~----~~~kL~DFg~a~~~~ 643 (679)
.+..++|||+.+.||+++.+ +.+.|+||+.+..-.
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 23489999999999999874 689999999887543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0015 Score=70.02 Aligned_cols=73 Identities=8% Similarity=-0.078 Sum_probs=48.5
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEeccCCCCH
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEYLGNGSL 572 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 572 (679)
+.|+.|-...+|++...+ +..+++|+.........+..+|..+++.|...++ +++++++. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457788889999999865 5788999875422222223689999999964444 56777652 2 259999987555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00067 Score=70.83 Aligned_cols=73 Identities=11% Similarity=-0.001 Sum_probs=45.5
Q ss_pred hhcCcccceEEEEEEeCC---------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-cceEEEEEEeCCeeeEEEe
Q 046493 496 TKLGQGGFGSVYLGMLPD---------GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH-LVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 565 (679)
+.|+.|....+|+....+ ++.+++|+.........+...|.++++.+...+ .+++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457778888999998754 268889987543222223467888888885333 45676543 2 368999
Q ss_pred ccCCCCH
Q 046493 566 YLGNGSL 572 (679)
Q Consensus 566 ~~~~gsL 572 (679)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9988644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0035 Score=64.44 Aligned_cols=68 Identities=10% Similarity=0.052 Sum_probs=44.9
Q ss_pred CcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcC---CCcceEEEE------EEeCCeeeEEEeccCC
Q 046493 499 GQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH---LHLVKLKGF------CIEGAHRLLAYEYLGN 569 (679)
Q Consensus 499 g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~e~~~~ 569 (679)
|.|....||+....++ .+++|+...... ..|+..++.|.. |++++.+.. ....+..+++|||++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 3344679999998777 899998765332 456666666632 224555432 2335677899999998
Q ss_pred CCH
Q 046493 570 GSL 572 (679)
Q Consensus 570 gsL 572 (679)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.76 E-value=0.034 Score=58.68 Aligned_cols=73 Identities=5% Similarity=-0.043 Sum_probs=49.1
Q ss_pred hhcCcccceEEEEEEeCC--------CcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.|..|-...+|+....+ ++.+++|+.........+..+|.++++.+. +.-.+++++.+ . -++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456677788999998753 578999987543222223468999988885 33345666533 2 3789999
Q ss_pred cCCCCH
Q 046493 567 LGNGSL 572 (679)
Q Consensus 567 ~~~gsL 572 (679)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998764
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=93.93 E-value=0.06 Score=41.70 Aligned_cols=35 Identities=17% Similarity=0.414 Sum_probs=31.8
Q ss_pred CCCChhHHHHhhccCCceeEEEeeCCCceeEeeec
Q 046493 353 PRYDLNTCKEACLHNCSCSVLFFENSTKNCFLFDQ 387 (679)
Q Consensus 353 ~~~~~~~C~~~Cl~nCsC~a~~y~~~~~~C~~~~~ 387 (679)
..+++++|+..|+.+=.|.||.|+.....|+++.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 35689999999999999999999988899999976
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.49 E-value=0.17 Score=53.04 Aligned_cols=31 Identities=23% Similarity=0.335 Sum_probs=26.2
Q ss_pred CeeecCCCCCCeEe------CCCCcEEEeeccCCccc
Q 046493 612 KIVHCDIKPENVLL------DDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 612 ~ivH~Dlkp~NIll------~~~~~~kL~DFg~a~~~ 642 (679)
.++|+|+.+.|||+ +++..++++||..|..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 46799999999999 45678999999998753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.13 E-value=2.1 Score=39.95 Aligned_cols=86 Identities=10% Similarity=0.128 Sum_probs=63.1
Q ss_pred cCCCcceEEEEEEeCCeeeEEEeccCC-CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 046493 543 HHLHLVKLKGFCIEGAHRLLAYEYLGN-GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPE 621 (679)
Q Consensus 543 ~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~ 621 (679)
.||+.+.. .+-.+++...+.++.-+. .+... -+..+...+++++.+|+....+++. -+|--|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~--------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN--------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG--------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH--------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 58888866 566666766666665432 22222 2347889999999999998866664 478899999
Q ss_pred CeEeCCCCcEEEeeccCCccc
Q 046493 622 NVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 622 NIll~~~~~~kL~DFg~a~~~ 642 (679)
||+++.++.++|.-.|+-..+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV 129 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB
T ss_pred eEEEcCCCCEEEEEccCccCC
Confidence 999999999999988865433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.04 E-value=3.7 Score=38.46 Aligned_cols=85 Identities=9% Similarity=0.115 Sum_probs=60.9
Q ss_pred cCCCcceEEEEEEeCCeeeEEEeccCCC-CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCC
Q 046493 543 HHLHLVKLKGFCIEGAHRLLAYEYLGNG-SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLA-YLHEECEVKIVHCDIKP 620 (679)
Q Consensus 543 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~~~ivH~Dlkp 620 (679)
.||++ -..+-.+++...+.++.-+++ +... + +.++...+++++.+|+.... +++. -+|--|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 57877 334446677776767655332 3332 2 23788899999998888776 5554 57888999
Q ss_pred CCeEeCCCCcEEEeeccCCccc
Q 046493 621 ENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 621 ~NIll~~~~~~kL~DFg~a~~~ 642 (679)
+||+++.++.++|.-.|+-..+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB
T ss_pred ceEEEeCCCcEEEEEcCCcccC
Confidence 9999999999999988865443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 679 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-10 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-05 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-04 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.001 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 8e-53
Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 6/183 (3%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+LG G FG V++G +VAVK L+ F AE + + H LV+L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ NGSL ++ L+ N ++A +A+G+A++ E +H
Sbjct: 80 E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 676
D++ N+L+ D + K++DFGLA+L+ E + + APE I + KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 677 YSY 679
+S+
Sbjct: 194 WSF 196
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 6/187 (3%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
F +LG G FG V G VA+K ++ + EF E + N+ H LV+L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
C + + EY+ NG L ++ + + + + YL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
+H D+ N L++D KVSDFGL++ + +E + + PE + + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 673 KSDVYSY 679
KSD++++
Sbjct: 181 KSDIWAF 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-52
Identities = 53/187 (28%), Positives = 96/187 (51%), Gaps = 6/187 (3%)
Query: 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
F ++G G FG V+LG + +VA+K + +++F E + + H LV+L G
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
C+E A L +E++ +G L ++ + + T + L + +G+AYL E C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
++H D+ N L+ +N KVSDFG+ + + ++ T + + +PE + + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 673 KSDVYSY 679
KSDV+S+
Sbjct: 182 KSDVWSF 188
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-51
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 12/188 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
++G G FG+VY G + V + + + Q + F EV + H++++ G+
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
+ ++ SL + +IA A+G+ YLH + I+H
Sbjct: 75 AP-QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREE-SLVYTTLRGTRGYLAPEWIT---NNPIS 671
D+K N+ L ++ T K+ DFGLA + +R S + L G+ ++APE I NP S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 672 EKSDVYSY 679
+SDVY++
Sbjct: 188 FQSDVYAF 195
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
+LG G G V+ P G+ +A K + E + + E+ + + ++V G
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ E++ GSLD+ + +++ + +++ + KGL YL E+ KI
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 126
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
+H D+KP N+L++ K+ DFG++ + + + GTR Y++PE + S +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQ 183
Query: 674 SDVYSY 679
SD++S
Sbjct: 184 SDIWSM 189
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-50
Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 6/183 (3%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
KLGQG FG V++G +VA+K L+ + F E + + H LV+L E
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHC 616
+ EY+ GSL ++ E ++L ++A +A G+AY+ VH
Sbjct: 84 E-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 137
Query: 617 DIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDV 676
D++ N+L+ +N KV+DFGLA+L+ E + + APE + KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 677 YSY 679
+S+
Sbjct: 198 WSF 200
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (440), Expect = 9e-50
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 482 FSYDDLCKATKNFST-----------KLGQGGFGSVYLGMLP----DGIQVAVKKLES-- 524
F+++D +A + F+ +G G FG V G L I VA+K L+S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 525 IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESR 584
+ +++F +E + +G H +++ L+G + ++ E++ NGSLD ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 585 FLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644
+ + G+A G+ YL + VH D+ N+L++ N KVSDFGL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 645 EESLVYTT----LRGTRGYLAPEWITNNPISEKSDVYSY 679
+ S T + + APE I + SDV+SY
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY 219
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 7e-49
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 9/191 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
+G G +G DG + K+L K+ +EV + + H ++V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 553 FCIEGAHRLL--AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE--E 608
I+ + L EY G L I T+E ++L + + L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN 668
++H D+KP NV LD K+ DFGLA+++N + S GT Y++PE +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRM 189
Query: 669 PISEKSDVYSY 679
+EKSD++S
Sbjct: 190 SYNEKSDIWSL 200
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 6e-48
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 479 PTRFSYDDLCKATKNFS--TKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAE 535
P+ +YD + + KLG G +G VY G+ + VAVK L+ +EF E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 536 VTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA 595
+ + H +LV+L G C + E++ G+L ++ + +S +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMA 121
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 655
++ + YL ++ +H D+ N L+ +N KV+DFGL++LM + + +
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 656 TRGYLAPEWITNNPISEKSDVYSY 679
+ APE + N S KSDV+++
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAF 202
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-47
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 478 MPTRFSYDDLCKATKNFST--KLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKK 530
+ F DD K FS ++G G FG+VY + + VA+KK+ + + +
Sbjct: 4 VAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 531 EFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNT 590
+ EV + + H + ++ +G + L EY + D + + L
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVE 116
Query: 591 RFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650
+ G +GLAYLH ++H D+K N+LL + K+ DFG A +M
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168
Query: 651 TTLRGTRGYLAPEWI---TNNPISEKSDVYSY 679
+ GT ++APE I K DV+S
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 56/184 (30%), Positives = 90/184 (48%), Gaps = 12/184 (6%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+G+G FG V LG G +VAVK +++ + F AE + + + H +LV+L G +E
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 557 GAHRL-LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
L + EY+ GSL ++ + L + +L + + + YL VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126
Query: 616 CDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSD 675
D+ NVL+ ++ AKVSDFGL K + + T + + APE + S KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSD 182
Query: 676 VYSY 679
V+S+
Sbjct: 183 VWSF 186
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-46
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 496 TKLGQGGFGSVYLGML---PDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG G FGSV G+ I VA+K L + +E E + + + ++V+L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G C + +L E G G L K++ EE + + + ++ G+ YL E+
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY--TTLRGTRGYLAPEWITNN 668
VH D+ NVLL + AK+SDFGL+K + ++S + + + APE I
Sbjct: 129 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 669 PISEKSDVYSY 679
S +SDV+SY
Sbjct: 188 KFSSRSDVWSY 198
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-46
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 14/190 (7%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
+LG G FG VY + + A K +++ + +++ E+ + + H ++VKL
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ + E+ G++D + R L+ + + L YLH+ KI+
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-----TNNP 669
H D+K N+L + K++DFG++ R + GT ++APE + + P
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 670 ISEKSDVYSY 679
K+DV+S
Sbjct: 192 YDYKADVWSL 201
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-45
Identities = 43/195 (22%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 494 FSTKLGQGGFGSVYLGMLPD-GIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
F ++G+G F +VY G+ + ++VA +L + ++ F E + + H ++V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 550 LKGFCIEGA----HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
+L E + +G+L ++ + + + + KGL +L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 606 HEECEVKIVHCDIKPENVLLDD-NFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
H I+H D+K +N+ + + K+ D GLA L + + GT ++APE
Sbjct: 129 HTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM 184
Query: 665 ITNNPISEKSDVYSY 679
E DVY++
Sbjct: 185 Y-EEKYDESVDVYAF 198
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-45
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 11/185 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE-FSAEVTTIGNVHHLHLVKLKGFC 554
K+GQG G+VY M + G +VA++++ Q KKE E+ + + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ G + EYL GSL + + + + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 615 HCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKS 674
H DIK +N+LL + + K++DFG + E+S +T+ GT ++APE +T K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 675 DVYSY 679
D++S
Sbjct: 198 DIWSL 202
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-44
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 481 RFSYDDLCKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAE 535
+++ +D LG+G FG+VYL +A+K L + + E
Sbjct: 2 QWALEDF-----EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 56
Query: 536 VTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIA 595
V ++ H ++++L G+ + L EY G++ + + ++
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYI 112
Query: 596 LGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRG 655
+A L+Y H + +++H DIKPEN+LL K++DFG + TTL G
Sbjct: 113 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCG 166
Query: 656 TRGYLAPEWITNNPISEKSDVYSY 679
T YL PE I EK D++S
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSL 190
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 5e-44
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 482 FSYDDLCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKL--ESIGQGKKEFS 533
+ +++ + +G+G FG V+ P VAVK L E+ + +F
Sbjct: 10 YPRNNI-----EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 534 AEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN--------------- 578
E + + ++VKL G C G L +EY+ G L++++ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 579 -----STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 633
S+ LS + IA +A G+AYL E K VH D+ N L+ +N K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 634 SDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
+DFGL++ + + ++ PE I N + +SDV++Y
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-44
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE 556
+G+G FG V+ G G +VAVK S + AE+ + H +++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 557 G----AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC--- 609
L +Y +GSL ++ T ++ +AL A GLA+LH E
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 610 --EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE---SLVYTTLRGTRGYLAPEW 664
+ I H D+K +N+L+ N T ++D GLA + + GT+ Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 665 ITNN------PISEKSDVYSY 679
+ ++ +++D+Y+
Sbjct: 184 LDDSINMKHFESFKRADIYAM 204
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 52/222 (23%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 479 PTRF---SYDDLCKATKNFSTKLGQGGFGSVYLGMLPDG---IQVAVKKLESIG--QGKK 530
PT + ++D+ F +G+G FG V + + A+K+++ +
Sbjct: 1 PTIYPVLDWNDI-----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 531 EFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS---------- 579
+F+ E+ + + HH +++ L G C + LA EY +G+L ++ S
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 580 --TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637
+ LS + A +A+G+ YL ++ + +H D+ N+L+ +N+ AK++DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 172
Query: 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
L++ T R ++A E + + + SDV+SY
Sbjct: 173 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 16/191 (8%)
Query: 497 KLGQGGFGSVYLGMLPD---GIQVAVKKLE---SIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+LG G FG+V G VAVK L+ + K E AE + + + ++V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G C E +L E G L+K++ ++R + + ++ G+ YL E
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES-- 126
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT--LRGTRGYLAPEWITNN 668
VH D+ NVLL AK+SDFGL+K + +E+ + + APE I
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 669 PISEKSDVYSY 679
S KSDV+S+
Sbjct: 186 KFSSKSDVWSF 196
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 35/233 (15%)
Query: 479 PTRFSYDDLCKATKN---FSTKLGQGGFGSVYLGMLPD------GIQVAVKKL--ESIGQ 527
+ YD + + F LG G FG V IQVAVK L ++
Sbjct: 23 FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82
Query: 528 GKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN-------- 578
++ +E+ + + H ++V L G C L +EY G L ++ +
Sbjct: 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 579 -----------STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD 627
E+ L++ A +AKG+ +L + VH D+ NVL+
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTH 199
Query: 628 NFTAKVSDFGLAK-LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
K+ DFGLA+ +M+ +V R ++APE + + KSDV+SY
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-43
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 30/228 (13%)
Query: 479 PTRFSYDDLCKATKN---FSTKLGQGGFGSVYLGML------PDGIQVAVKKL--ESIGQ 527
PT+ YD + +N F LG G FG V + VAVK L +
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 528 GKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNS------- 579
++ +E+ + + +H+++V L G C G L+ EY G L ++
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 580 -------TEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632
++ L + + +AKG+A+L + +H D+ N+LL K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITK 185
Query: 633 VSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNNPISEKSDVYSY 679
+ DFGLA+ + + + V R ++APE I N + +SDV+SY
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-43
Identities = 56/188 (29%), Positives = 81/188 (43%), Gaps = 12/188 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
LG+G +G V L + VAVK + + + E+ ++H ++VK G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
EG + L EY G L I E + + G+ YLH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNR-EESLVYTTLRGTRGYLAPEWITNNPI-S 671
H DIKPEN+LLD+ K+SDFGLA + + + GT Y+APE + +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 672 EKSDVYSY 679
E DV+S
Sbjct: 185 EPVDVWSC 192
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 493 NFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLH 546
+F+ +G+G FG VY G L D I AVK L I +F E + + H +
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 547 LVKLKGFCIEG-AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
++ L G C+ L+ Y+ +G L +I N E+ + L +AKG+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGM--- 143
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY---TTLRGTRGYLAP 662
K VH D+ N +LD+ FT KV+DFGLA+ M +E T + ++A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 663 EWITNNPISEKSDVYSY 679
E + + KSDV+S+
Sbjct: 204 ESLQTQKFTTKSDVWSF 220
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (388), Expect = 6e-42
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 12/187 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL-ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
+LG G FG V+ G A K + K+ E+ T+ + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ ++ YE++ G L + + + E +S + + KGL ++HE V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 615 HCDIKPENVLL--DDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
H D+KPEN++ + K+ DFGL ++ ++S GT + APE P+
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGY 204
Query: 673 KSDVYSY 679
+D++S
Sbjct: 205 YTDMWSV 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-41
Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 15/191 (7%)
Query: 498 LGQGGFGSVYLGMLPDG-----IQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKL 550
+G G FG VY GML + VA+K L + + +F E +G H ++++L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+G + ++ EY+ NG+LDK++ E+ S + G+A G+ YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN- 130
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT--LRGTRGYLAPEWITNN 668
VH D+ N+L++ N KVSDFGL++++ + YTT + + APE I+
Sbjct: 131 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 669 PISEKSDVYSY 679
+ SDV+S+
Sbjct: 189 KFTSASDVWSF 199
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 55/191 (28%), Positives = 93/191 (48%), Gaps = 15/191 (7%)
Query: 497 KLGQGGFGSVYLGMLPD-----GIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG G FG+VY G+ I VA+K+L + + KE E + +V + H+ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L G C+ +L+ + + G L ++ E + N + +AKG+ YL +
Sbjct: 76 LLGICLTSTVQLI-TQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTT-LRGTRGYLAPEWITNN 668
++VH D+ NVL+ K++DFGLAKL+ EE + + ++A E I +
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 669 PISEKSDVYSY 679
+ +SDV+SY
Sbjct: 189 IYTHQSDVWSY 199
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 13/189 (6%)
Query: 497 KLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKL 550
+G+G FG V+ G+ + VA+K ++ +++F E T+ H H+VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
G E + E G L ++ L + A ++ LAYL +
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
+ VH DI NVL+ N K+ DFGL++ M + + ++APE I
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 671 SEKSDVYSY 679
+ SDV+ +
Sbjct: 187 TSASDVWMF 195
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 17/193 (8%)
Query: 497 KLGQGGFGSVYLGMLP----DGIQVAVKKLE----SIGQGKKEFSAEVTTIGNVHHLHLV 548
KLG G FG V G + VAVK L+ S + +F EV + ++ H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
+L G + +++ E GSL + T A+ +A+G+ YL +
Sbjct: 75 RLYGVVLTPPMKMV-TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAPEWIT 666
+H D+ N+LL K+ DFGL + + N + ++ + + APE +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 667 NNPISEKSDVYSY 679
S SD + +
Sbjct: 188 TRTFSHASDTWMF 200
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 13/188 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG+G F +V L L + A+K LE + E + + H VKL
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ Y NG L K+I + L YLH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPI 670
I+H D+KPEN+LL+++ +++DFG AK+++ E + GT Y++PE +T
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 671 SEKSDVYS 678
+ SD+++
Sbjct: 188 CKSSDLWA 195
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 143 bits (362), Expect = 2e-38
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE-SIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC 554
+LG G FG V+ + G K + K E++ + +HH L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
+ +L E+L G L I E +S N +GL ++HE IV
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 615 HCDIKPENVLLD--DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
H DIKPEN++ + + K+ DFGLA +N +E + TT T + APE + P+
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 673 KSDVYS 678
+D+++
Sbjct: 208 YTDMWA 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 479 PTRFSYDDLCKATK--------NFSTKLGQGGFGSVYLGML------PDGIQVAVKKL-- 522
P FS D+ + S +LGQG FG VY G+ +VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 523 ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN---- 578
+ + + EF E + + + H+V+L G +G L+ E + G L ++ +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 579 --STEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636
+ S + +A +A G+AYL+ K VH D+ N ++ ++FT K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 637 GLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679
G+ + + + +++PE + + + SDV+S+
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 9e-38
Identities = 37/186 (19%), Positives = 79/186 (42%), Gaps = 11/186 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
LG+G FG V+ + K ++ G + E++ + H +++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 556 EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVH 615
++ +E++ + + I + L+ + + + L +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 616 CDIKPENVLLD--DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
DI+PEN++ + T K+ +FG A+ + ++ + L Y APE ++ +S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 674 SDVYSY 679
+D++S
Sbjct: 184 TDMWSL 189
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 497 KLGQGGFGSVYLGMLP--------DGIQVAVKKL--ESIGQGKKEFSAEVTTIGNV-HHL 545
LG+G FG V L +VAVK L ++ + + +E+ + + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFN------------STEESRFLSWNTRFN 593
+++ L G C + + EY G+L +++ S LS +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 594 IALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT-T 652
A +A+G+ YL + K +H D+ NVL+ ++ K++DFGLA+ ++ + T
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 653 LRGTRGYLAPEWITNNPISEKSDVYSY 679
R ++APE + + + +SDV+S+
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSF 223
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 5e-37
Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 9/186 (4%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL--ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
LG G F V L VA+K + +++ + E+ + + H ++V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
G H L + + G L I E F + + + + YLH+ V
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
LD++ +SDFGL+K+ + V +T GT GY+APE + P S+
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 674 SDVYSY 679
D +S
Sbjct: 190 VDCWSI 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 497 KLGQGGFGSVYLGM------LPDGIQVAVKKL--ESIGQGKKEFSAEVTTIG-NVHHLHL 547
LG+G FG V VAVK L + + +E+ + HHL++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 548 VKLKGFCIE-GAHRLLAYEYLGNGSLDKWIFNSTEE------------SRFLSWNTRFNI 594
V L G C + G ++ E+ G+L ++ + E FL+
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV-YTTL 653
+ +AKG+ +L K +H D+ N+LL + K+ DFGLA+ + ++ V
Sbjct: 140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 654 RGTRGYLAPEWITNNPISEKSDVYSY 679
R ++APE I + + +SDV+S+
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSF 222
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (340), Expect = 4e-36
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 27/201 (13%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL----------ESIGQGKKEFSAEVTTIGNVH-H 544
LG+G V + P + AVK + E + + ++ EV + V H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 545 LHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
++++LK L ++ + G L ++ E LS I + + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
LH+ IVH D+KPEN+LLDD+ K++DFG + ++ E + GT YLAPE
Sbjct: 126 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEI 180
Query: 665 IT------NNPISEKSDVYSY 679
I + ++ D++S
Sbjct: 181 IECSMNDNHPGYGKEVDMWST 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-34
Identities = 41/188 (21%), Positives = 82/188 (43%), Gaps = 10/188 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK--KEFSAEVTTIGNVHHLHLVKLKGF 553
+G+G +G V + ++VA+KK+ + E+ + H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+ YL + ++ + LS + + +GL Y+H +
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLM--NREESLVYTTLRGTRGYLAPEWITNN-PI 670
+H D+KP N+LL+ K+ DFGLA++ + + + T TR Y APE + N+
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 671 SEKSDVYS 678
++ D++S
Sbjct: 191 TKSIDIWS 198
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (332), Expect = 1e-34
Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG G FG V+L +G A+K L+ + + + E + V H ++++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
G + + +Y+ G L + S ++ + L L
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSK 123
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
I++ D+KPEN+LLD N K++DFG AK + TL GT Y+APE ++ P +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYN 179
Query: 672 EKSDVYSY 679
+ D +S+
Sbjct: 180 KSIDWWSF 187
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (332), Expect = 3e-34
Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 19/192 (9%)
Query: 497 KLGQGGFGSVYLGMLPD-GIQVAVKKLE----SIGQGKKEFSAEVTTI---GNVHHLHLV 548
+G+GGFG VY D G A+K L+ + QG+ E + +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
+ + + G L + + S A + GL ++H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 609 CEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TN 667
+V+ D+KP N+LLD++ ++SD GLA ++++ GT GY+APE +
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 668 NPISEKSDVYSY 679
+D +S
Sbjct: 181 VAYDSSADWFSL 192
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 46/190 (24%), Positives = 73/190 (38%), Gaps = 18/190 (9%)
Query: 498 LGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFC-- 554
LG G G V + A+K L+ + ++E H+V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDVYEN 76
Query: 555 --IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L+ E L G L I + +++ + I + + + YLH
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSI---N 131
Query: 613 IVHCDIKPENVLLD---DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP 669
I H D+KPEN+L N K++DFG AK S TT T Y+APE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEK 189
Query: 670 ISEKSDVYSY 679
+ D++S
Sbjct: 190 YDKSCDMWSL 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 14/189 (7%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTTIG-NVHHLHLVKL 550
LG+G FG V+L A+K L+ + + E + H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 551 KGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECE 610
+ EYL G L I + + A + GL +LH +
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK-- 122
Query: 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPI 670
IV+ D+K +N+LLD + K++DFG+ K ++ T GT Y+APE +
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKY 180
Query: 671 SEKSDVYSY 679
+ D +S+
Sbjct: 181 NHSVDWWSF 189
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 45/205 (21%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 487 LCKATKNFS--TKLGQGGFGSVYLG--MLPDGIQVAVKKL------ESIGQGKKEFSAEV 536
LC+A + + ++G+G +G V+ + G VA+K++ E + A +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 537 TTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI--FNSTEESRFLSWNTRFNI 594
+ H ++V+L C L +D+ + + + T ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 595 ALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLR 654
+ +GL +LH ++VH D+KP+N+L+ + K++DFGLA++ + + + T++
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 176
Query: 655 GTRGYLAPEWITNNPISEKSDVYSY 679
T Y APE + + + D++S
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSV 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 129 bits (324), Expect = 5e-34
Identities = 46/193 (23%), Positives = 75/193 (38%), Gaps = 18/193 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL----ESIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG GG V+L L VAVK L F E ++H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 552 GFCIE----GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE 607
G + EY+ +L + ++ + + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 129
Query: 608 ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV--YTTLRGTRGYLAPEWI 665
I+H D+KP N+++ KV DFG+A+ + + V + GT YL+PE
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 666 TNNPISEKSDVYS 678
+ + +SDVYS
Sbjct: 187 RGDSVDARSDVYS 199
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 47/195 (24%), Positives = 73/195 (37%), Gaps = 21/195 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL-------ESIGQGKKEFSAEVTTIGNVHHLH-- 546
LG GGFGSVY G+ + D + VA+K + EV + V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 547 LVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
+++L + +L E E L + + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHC- 126
Query: 607 EECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI 665
++H DIK EN+L+D + K+ DFG L+ YT GTR Y PEWI
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 666 TNNP-ISEKSDVYSY 679
+ + V+S
Sbjct: 182 RYHRYHGRSAAVWSL 196
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (320), Expect = 2e-33
Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 10/186 (5%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKGF 553
K+G+G +G VY G A+KK+ + E++ + + H ++VKL
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKI 613
+L +E+L L T + L + G+AY H+ ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 614 VHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEK 673
+H D+KP+N+L++ K++DFGLA+ + + + S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 674 SDVYSY 679
D++S
Sbjct: 182 IDIWSV 187
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 479 PTRFSYDDLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVT 537
P SY D +G G FG VY L D G VA+KK+ Q K+ + E+
Sbjct: 17 PQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQ 65
Query: 538 TIGNVHHLHLVKLKGFCIEGA------HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTR 591
+ + H ++V+L+ F + L +Y+ + + + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 592 FNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVY 650
+ + LAY+H I H DIKP+N+LLD D K+ DFG AK + R E
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--N 179
Query: 651 TTLRGTRGYLAPEWITNN-PISEKSDVYS 678
+ +R Y APE I + DV+S
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWS 208
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 3e-33
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 19/194 (9%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554
K+G G FG +YLG + G +VA+K + + E + + + ++
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
EG + ++ E LG D + F SR S T +A M + Y+H + +
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 615 HCDIKPENVL---LDDNFTAKVSDFGLAKLMNREESLVY------TTLRGTRGYLAPEWI 665
H D+KP+N L + DFGLAK + + L GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 666 TNNPISEKSDVYSY 679
S + D+ S
Sbjct: 186 LGIEQSRRDDLESL 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (317), Expect = 6e-33
Identities = 45/196 (22%), Positives = 72/196 (36%), Gaps = 21/196 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554
++G+G FG ++ G L + QVA+K + E T + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 555 IEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIV 614
EG H +L + LG D R S T A M + +HE+ +V
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 615 HCDIKPENVLLDDNF-----TAKVSDFGLAKLMNREES------LVYTTLRGTRGYLAPE 663
+ DIKP+N L+ V DFG+ K + L GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 664 WITNNPISEKSDVYSY 679
S + D+ +
Sbjct: 184 THLGREQSRRDDLEAL 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL------ESIGQGKKEFSAEVTTIGNVHHLHLVK 549
LG+G F +VY VA+KK+ E+ + E+ + + H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 550 LKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC 609
L ++ L ++++ NS L+ + L +GL YLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 610 EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWI-TNN 668
I+H D+KP N+LLD+N K++DFGLAK + YT TR Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 669 PISEKSDVYSY 679
D+++
Sbjct: 177 MYGVGVDMWAV 187
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 7e-32
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 12/188 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
K+G+G +G VY G VA+KK+ E++ + ++H ++VKL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L +E+L F + + + +GLA+ H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNP-IS 671
++H D+KP+N+L++ K++DFGLA+ YT T Y APE + S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYS 181
Query: 672 EKSDVYSY 679
D++S
Sbjct: 182 TAVDIWSL 189
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL-------ESIGQGKKEFSAEVTTIGNVHHLHLV 548
+LG G F V G+Q A K + G +++ EV+ + + H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 549 KLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEE 608
L +L E + G L ++ E L+ + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 609 CEVKIVHCDIKPENVLLDDN----FTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEW 664
I H D+KPEN++L D K+ DFGLA ++ + + GT ++APE
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEI 187
Query: 665 ITNNPISEKSDVYS 678
+ P+ ++D++S
Sbjct: 188 VNYEPLGLEADMWS 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 2e-29
Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLE----SIGQGKKEFSAEVTTIGNVHHLHLVKLK 551
LG G FG V L G A+K L+ + + E + V+ LVKL+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
+ ++ + EY+ G + + S A + YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL--- 160
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+++ D+KPEN+L+D +V+DFG AK + TL GT LAPE I + +
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYN 216
Query: 672 EKSDVYS 678
+ D ++
Sbjct: 217 KAVDWWA 223
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 12/187 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTTIGNVHHLHLVKLKG 552
+G G +G+V + G +VA+KKL Q + K E+ + ++ H +++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
++ + L + + M KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--- 141
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PIS 671
I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE I N +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 197
Query: 672 EKSDVYS 678
+ D++S
Sbjct: 198 QTVDIWS 204
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 51/188 (27%), Positives = 71/188 (37%), Gaps = 13/188 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKE----FSAEVTTIGNVHHLHLVKLK 551
LG+G FG V L G A+K L K+ E + N H L LK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 552 GFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEV 611
EY G L + R + + L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 612 KIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPIS 671
+V+ DIK EN++LD + K++DFGL K + + + T GT YLAPE + +N
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYG 183
Query: 672 EKSDVYSY 679
D +
Sbjct: 184 RAVDWWGL 191
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 23/198 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKL---ESIGQGKKEFSAEVTTIGNVHHLHLVKLKG 552
K+GQG FG V+ G +VA+KK+ E+ + + H ++V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 553 FCIEGAHR--------LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAY 604
C A L +++ + + + + + + GL Y
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYY 132
Query: 605 LHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL---VYTTLRGTRGYLA 661
+ KI+H D+K NVL+ + K++DFGLA+ + ++ YT T Y
Sbjct: 133 I---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 662 PEWITN-NPISEKSDVYS 678
PE + D++
Sbjct: 190 PELLLGERDYGPPIDLWG 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-27
Identities = 34/187 (18%), Positives = 70/187 (37%), Gaps = 11/187 (5%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTTIGNVHHLHLVKLKG 552
K+G+G +G+V+ VA+K++ + E+ + + H ++V+L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
L +E+ + + L + + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISE 672
++H D+KP+N+L++ N K+++FGLA+ + S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 673 KSDVYSY 679
D++S
Sbjct: 182 SIDMWSA 188
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 47/192 (24%), Positives = 71/192 (36%), Gaps = 22/192 (11%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGK---KEFSAEVTTIGNVHHLHLVKLKG 552
+G G G V VA+KKL Q + K E+ + V+H +++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 553 FCI------EGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLH 606
E L E + E + M G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------RMSYLLYQMLCGIKHLH 136
Query: 607 EECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWIT 666
I+H D+KP N+++ + T K+ DFGLA+ + T TR Y APE I
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL 191
Query: 667 NNPISEKSDVYS 678
E D++S
Sbjct: 192 GMGYKENVDIWS 203
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (279), Expect = 2e-27
Identities = 41/189 (21%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFC 554
KLG+G + V+ + + + +V VK L+ + KK+ E+ + N+ +++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIV 99
Query: 555 IEGAHRLLA--YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ R A +E++ N + + L+ + K L Y H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 613 IVHCDIKPENVLLD-DNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPE-WITNNPI 670
I+H D+KP NV++D ++ ++ D+GLA+ + + Y +R + PE +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMY 207
Query: 671 SEKSDVYSY 679
D++S
Sbjct: 208 DYSLDMWSL 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-26
Identities = 44/219 (20%), Positives = 83/219 (37%), Gaps = 24/219 (10%)
Query: 473 EKISGMPTRFSYDDLCKATKNFSTKLGQGGFGSVYLGML----PDGIQVAVKKLESI--- 525
++G + ++ LG G +G V+L G A+K L+
Sbjct: 12 ANLTGHAEKVGIENF-----ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 526 --GQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEE 582
+ + E + ++ LV L L +Y+ G L +
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-- 124
Query: 583 SRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642
T + + + + + L ++ I++ DIK EN+LLD N ++DFGL+K
Sbjct: 125 -----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 643 NREESLVYTTLRGTRGYLAPEWI--TNNPISEKSDVYSY 679
+E+ GT Y+AP+ + ++ + D +S
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 9e-25
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 12/187 (6%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQG---KKEFSAEVTTIGNVHHLHLVKLKG 552
+G G +GSV G++VAVKKL Q K E+ + ++ H +++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 553 FCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK 612
+ L N+ + + L+ + + + +GL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--- 141
Query: 613 IVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNN-PIS 671
I+H D+KP N+ ++++ K+ DFGLA+ + E T TR Y APE + N +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYN 197
Query: 672 EKSDVYS 678
+ D++S
Sbjct: 198 QTVDIWS 204
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 4e-24
Identities = 46/198 (23%), Positives = 75/198 (37%), Gaps = 17/198 (8%)
Query: 497 KLGQGGFGSVYLGM-LPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCI 555
KLG G F +V+L + + VA+K + + E+ + V+ K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 556 EGAHRLLAYEYLGNGSLDKWI------------FNSTEESRFLSWNTRFNIALGMAKGLA 603
+LL + + + E R + I+ + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 604 YLHEECEVKIVHCDIKPENVLLD-DNFTAKVSDFGLAKLMN-REESLVYTTLRGTRGYLA 661
Y+H C I+H DIKPENVL++ + + +A L N YT TR Y +
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 662 PEWITNNPISEKSDVYSY 679
PE + P +D++S
Sbjct: 198 PEVLLGAPWGCGADIWST 215
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 28/165 (16%), Positives = 50/165 (30%), Gaps = 22/165 (13%)
Query: 497 KLGQGGFGSVYLGMLPDGIQVAVKKLES-----------IGQGKKEFSAEVTTIGNVHHL 545
+G+G +V+ + VK + G FS
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 546 HLVKLKGFCIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYL 605
L KL+G + Y + GN L + I + + + + +A
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAKF 119
Query: 606 HEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650
+ IVH D+ NVL+ + + DF + + E
Sbjct: 120 YHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREI 160
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 59.2 bits (143), Expect = 2e-11
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 1/70 (1%)
Query: 84 WTANRGLLIRDSD-KFVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVN 142
T + + S +F + + N L + W++NT+G LQ G LV+L
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQ 74
Query: 143 GSILWQSFSH 152
+I W S +
Sbjct: 75 NTIRWSSGTK 84
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.9 bits (137), Expect = 2e-10
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 4/89 (4%)
Query: 77 ISSAKVVWTANRGLLIRDSD-KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSG 134
+ T + ++ S + E + N L + WS NT+G+ C LQ +G
Sbjct: 17 QGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNG 76
Query: 135 NLVLLGVNGSILWQSFS--HPTDTLLPGQ 161
+ +L +W S + + Q
Sbjct: 77 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQ 105
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 55.7 bits (134), Expect = 3e-10
Identities = 22/95 (23%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 60 GFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSA 118
Y + + LV+ + VW +N G+L + K V + +GN + G + W++
Sbjct: 19 EPYHFIMQEDCNLVLYD--HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS 76
Query: 119 NTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
++ + LQ+ GN+V+ GS +W + ++
Sbjct: 77 HSVRGNGNYVLVLQEDGNVVIY---GSDIWSTGTY 108
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 51.0 bits (121), Expect = 2e-08
Identities = 11/76 (14%), Positives = 29/76 (38%), Gaps = 2/76 (2%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEAWSA-NTSGQKVECMELQDSGNLVLL 139
+ VW + + +GN + G+ W++ + LQ N+V+
Sbjct: 38 RAVWASGTNGKASGC-VLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY 96
Query: 140 GVNGSILWQSFSHPTD 155
+ + +W + ++ +
Sbjct: 97 DNSNNAIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.7 bits (100), Expect = 1e-05
Identities = 17/57 (29%), Positives = 25/57 (43%), Gaps = 1/57 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSH 152
+F+ + + N L N W+ NT G C LQ G LV++ +WQS
Sbjct: 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA 89
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 38.1 bits (88), Expect = 4e-04
Identities = 20/74 (27%), Positives = 34/74 (45%), Gaps = 6/74 (8%)
Query: 81 KVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNGEA-WSANTSGQKVECM-ELQDSGNLVL 138
K +W N G L R + +GN + + + W++NT GQ + LQ N+V+
Sbjct: 38 KPIWATNTGGLSRSC-FLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI 96
Query: 139 LGVNGSILWQSFSH 152
G + W + +H
Sbjct: 97 YG---TDRWATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 36.5 bits (84), Expect = 0.001
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 97 KFVFEKNGNAYLQRGNGEAWSANTSGQKVEC-MELQDSGNLVLLGVNGSILWQSFSHPT 154
F+ +++ N L + W+ NT G C + +Q GNLV+ + +W S +
Sbjct: 22 VFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQ 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 679 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.98 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.98 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.75 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.71 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.61 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.53 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.44 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.06 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.88 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.81 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.81 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.72 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.16 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.81 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.14 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 81.82 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-40 Score=331.87 Aligned_cols=189 Identities=27% Similarity=0.457 Sum_probs=170.6
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEeCC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGMLPD-GIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
|+....+++.++||+|+||+||+|++.+ ++.||||+++......+++.+|++++++++|||||++++++.+++..++||
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 4555677888999999999999999864 889999999877777889999999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 93 E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999997643 45689999999999999999999999 999999999999999999999999999998766
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..........|++.|+|||++.+..++.++|||||
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~ 202 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhH
Confidence 55444445568999999999999999999999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-40 Score=326.96 Aligned_cols=183 Identities=28% Similarity=0.500 Sum_probs=155.2
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNG 570 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 570 (679)
.+++.++||+|+||+||+|++.+++.||||+++......+++.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 35678899999999999999988899999999887777889999999999999999999999999999999999999999
Q ss_pred CHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceee
Q 046493 571 SLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVY 650 (679)
Q Consensus 571 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~ 650 (679)
+|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 86 ~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 86 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp BHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred cHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999998654 34589999999999999999999999 999999999999999999999999999987765544333
Q ss_pred ecccCccccccccccccCCCCcccceeeC
Q 046493 651 TTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 651 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....||+.|+|||++.+..++.++|||||
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~ 188 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSF 188 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCchhhhcch
Confidence 44678999999999999999999999996
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=329.09 Aligned_cols=187 Identities=29% Similarity=0.499 Sum_probs=166.4
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+....+++.++||+|+||+||+|++++++.||||+++......++|.+|++++++++|||||++++++.+ +..++||||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 3345678889999999999999999888999999998877778899999999999999999999998754 567999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.+++.... ...+++..+++|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999875432 34589999999999999999999999 99999999999999999999999999999876655
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~ 196 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence 444455678999999999999899999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=321.49 Aligned_cols=180 Identities=26% Similarity=0.411 Sum_probs=161.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+|++.++||+|+||+||+|+.. +|+.||||+++. .....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 5788899999999999999975 599999999865 33456789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+|+|.+++.+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 101 gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 9999998754 2489999999999999999999999 9999999999999999999999999999977554322
Q ss_pred eeecccCccccccccccccCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+.+++.++|||||
T Consensus 173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 202 (293)
T d1yhwa1 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (293)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred -ccccccCCCccChhhhcCCCCCchhceehH
Confidence 345679999999999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=317.37 Aligned_cols=179 Identities=28% Similarity=0.421 Sum_probs=161.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||+||+|+.. +++.||||++.. .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4788899999999999999986 489999999864 23456778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 87 y~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 87 YAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred ecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999653 4599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....||+.|||||++.+..++.++|||||
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 190 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSL 190 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhH
Confidence 3 245679999999999999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=321.11 Aligned_cols=182 Identities=30% Similarity=0.411 Sum_probs=158.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 4778899999999999999975 5899999998653 233466899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
++|+|.+++.. ...+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 86 ~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 86 SGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp TTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999854 34699999999999999999999999 999999999999999999999999999997754432
Q ss_pred e-eeecccCccccccccccccCCC-CcccceeeC
Q 046493 648 L-VYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 648 ~-~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
. .....+||+.|||||++.+..+ +.++|||||
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSl 192 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHh
Confidence 2 2345689999999999988876 578999996
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=313.95 Aligned_cols=182 Identities=26% Similarity=0.434 Sum_probs=166.2
Q ss_pred hhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCCCC
Q 046493 492 KNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGNGS 571 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 571 (679)
+++.++||+|+||+||+|+.++++.||||+++......+++.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 46788999999999999999888899999998877778899999999999999999999999999999999999999999
Q ss_pred HhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCceeee
Q 046493 572 LDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLVYT 651 (679)
Q Consensus 572 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~~~ 651 (679)
|.+++... ...+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 86 l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 86 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred HHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99997654 34589999999999999999999999 9999999999999999999999999999877665444444
Q ss_pred cccCccccccccccccCCCCcccceeeC
Q 046493 652 TLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 652 ~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...||+.|+|||++.+..++.++|||||
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~ 187 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAF 187 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence 5678999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=321.22 Aligned_cols=188 Identities=26% Similarity=0.412 Sum_probs=149.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEe--CCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIE--GAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 564 (679)
.|++.+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++||||+++++++.+ ++..++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 4778899999999999999975 589999999965332 34568899999999999999999999875 45679999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC--EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||+++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+||||++++.+||+|||+|+..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 999999999999765444567999999999999999999999861 113999999999999999999999999999987
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....||+.|||||++.+..++.++|||||
T Consensus 165 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 165 NHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred ccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 654322 245689999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-39 Score=329.51 Aligned_cols=182 Identities=24% Similarity=0.361 Sum_probs=160.5
Q ss_pred HHHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 488 CKATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 488 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
....|++.++||+|+||+||+|+.. +++.||+|+++.. ....+.+.+|++++++++|||||++++++.++++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3456788899999999999999975 5899999998653 233567899999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
||+++|+|.+++.+. ..+++..+..++.||++||.|||+ + +|+||||||+||||++++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999653 359999999999999999999996 5 79999999999999999999999999998765
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++.+.+++.++|||||
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSl 189 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHH
T ss_pred CCc---cccccCCccccCchHHcCCCCCcHHHHHHH
Confidence 432 245689999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-38 Score=316.33 Aligned_cols=182 Identities=27% Similarity=0.412 Sum_probs=159.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||+||+|+.. +++.||||+++. .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4788899999999999999975 589999999864 23455779999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 89 y~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 89 YAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998865 34599999999999999999999999 9999999999999999999999999999977544
Q ss_pred Cce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......||+.|+|||++.+..++.++|||||
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehh
Confidence 322 2345679999999999999999999999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=320.03 Aligned_cols=184 Identities=30% Similarity=0.485 Sum_probs=157.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
..+++.++||+|+||+||+|++++++.||||+++......+.|.+|+.++++++|||||++++++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 4678899999999999999999888899999998877778899999999999999999999999854 567899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
|+|..++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.........
T Consensus 96 g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999886543 34599999999999999999999999 99999999999999999999999999998775544433
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~ 200 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSF 200 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcc
Confidence 345678999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=318.62 Aligned_cols=182 Identities=25% Similarity=0.392 Sum_probs=159.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc-cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES-IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.|++.++||+|+||+||+|+.. +++.||||+++. .....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3777899999999999999976 489999999965 33445778999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCce
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESL 648 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~ 648 (679)
+|+|.+++.+. ...+++.++..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 93 ~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 93 GGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 99999998653 34599999999999999999999999 999999999999999999999999999986544321
Q ss_pred eeecccCccccccccccc-----cCCCCcccceeeC
Q 046493 649 VYTTLRGTRGYLAPEWIT-----NNPISEKSDVYSY 679 (679)
Q Consensus 649 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSl 679 (679)
......||+.|+|||++. +..++.++|||||
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl 201 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence 123467999999999984 4568999999996
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-38 Score=316.42 Aligned_cols=182 Identities=29% Similarity=0.494 Sum_probs=150.7
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
...|++.++||+|+||+||+|+.+ ..||||+++.. ....+.|++|++++++++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 345677889999999999999874 36999998642 3345789999999999999999999998754 56899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++... ...+++..++.++.||++||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999654 34599999999999999999999999 9999999999999999999999999999876543
Q ss_pred Cc-eeeecccCccccccccccccC---CCCcccceeeC
Q 046493 646 ES-LVYTTLRGTRGYLAPEWITNN---PISEKSDVYSY 679 (679)
Q Consensus 646 ~~-~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSl 679 (679)
.. .......||+.|||||++.+. +++.++|||||
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~ 195 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhh
Confidence 32 223456799999999998643 58999999996
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-38 Score=318.13 Aligned_cols=183 Identities=30% Similarity=0.498 Sum_probs=146.9
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-C---cEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-G---IQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.+++.++||+|+||+||+|++.. + ..||||++... ....++|.+|++++++++|||||++++++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34556789999999999999753 2 36899988653 234467999999999999999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++... ...+++.+++.++.||++||+|||++ +|+||||||+||||++++.+||+|||+++....
T Consensus 107 Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999988653 34589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCcee----eecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLV----YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... .....||+.|||||.+.+..++.++|||||
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~ 219 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY 219 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccc
Confidence 43221 112457899999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-37 Score=308.94 Aligned_cols=177 Identities=24% Similarity=0.435 Sum_probs=152.6
Q ss_pred hhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEe----CCeeeEE
Q 046493 492 KNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIE----GAHRLLA 563 (679)
Q Consensus 492 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 563 (679)
+++.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999976 48899999986533 234568899999999999999999999875 3467899
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeEeC-CCCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVK--IVHCDIKPENVLLD-DNFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DFg~a~ 640 (679)
|||+++|+|.+++.+. ..+++..+..++.||++||+|||++ + |+||||||+||||+ +++.+||+|||+|+
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999999653 4589999999999999999999998 7 99999999999996 57899999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....||+.|||||++.+ +++.++|||||
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSl 198 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAF 198 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhH
Confidence 654432 245689999999999875 59999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-37 Score=316.79 Aligned_cols=181 Identities=28% Similarity=0.452 Sum_probs=144.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
..|++.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45788899999999999999976 4899999998653 23345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC---CCCcEEEeeccCCcccc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD---DNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DFg~a~~~~ 643 (679)
+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999965 34699999999999999999999999 999999999999994 57899999999998765
Q ss_pred cCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....||+.|||||++.+..++.++|||||
T Consensus 162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSl 195 (307)
T d1a06a_ 162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred CCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence 4332 245679999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-37 Score=315.49 Aligned_cols=181 Identities=28% Similarity=0.338 Sum_probs=162.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.+.||+|+||.||+|+.. +++.||||++++ .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 4778899999999999999975 599999999964 23456778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+.....
T Consensus 86 y~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 86 YANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999998653 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl 191 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccch
Confidence 32 2345689999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-37 Score=313.12 Aligned_cols=178 Identities=29% Similarity=0.412 Sum_probs=160.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||+||+|+.. +|+.||||+++. .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 3778899999999999999975 589999999964 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++|+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 85 YIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred ecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998865 34588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....||+.|||||++.+..++.++|||||
T Consensus 158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSl 187 (316)
T d1fota_ 158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSF 187 (316)
T ss_dssp B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred c----ccccCcccccCHHHHcCCCCCchhhcccc
Confidence 2 34689999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.2e-37 Score=317.65 Aligned_cols=181 Identities=26% Similarity=0.407 Sum_probs=161.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
+|++.++||+|+||.||+|+.. +|+.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 6888999999999999999975 58999999996533 345678999999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC--CCCcEEEeeccCCcccccCC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a~~~~~~~ 646 (679)
+|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 107 gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 107 GGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp SCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998543 34599999999999999999999999 999999999999996 46789999999999876544
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....||+.|||||++.+..++.++|||||
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl 211 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhh
Confidence 3 245689999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-37 Score=311.30 Aligned_cols=179 Identities=27% Similarity=0.410 Sum_probs=156.6
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
+..|+..++||+|+||+||+|+.. +++.||||+++.... ..+.+.+|++++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345788899999999999999975 588999999865332 235688999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+++|+|..++.. ...+++.++..++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+...
T Consensus 94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999999876644 34699999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCceeeecccCcccccccccccc---CCCCcccceeeC
Q 046493 644 REESLVYTTLRGTRGYLAPEWITN---NPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSl 679 (679)
.. ....||+.|||||++.+ .+++.++|||||
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSl 200 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHH
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhH
Confidence 43 34579999999999864 358999999996
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=309.05 Aligned_cols=176 Identities=32% Similarity=0.467 Sum_probs=150.1
Q ss_pred hhcCcccceEEEEEEeCC---CcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 496 TKLGQGGFGSVYLGMLPD---GIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
++||+|+||+||+|.+.+ ++.||||+++... ...+++.+|++++++++||||++++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 5689999996532 234679999999999999999999999865 457899999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999998653 4599999999999999999999999 99999999999999999999999999998776543322
Q ss_pred --eecccCccccccccccccCCCCcccceeeC
Q 046493 650 --YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 --~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....||+.|||||++.+..++.++|||||
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 196 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 196 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccc
Confidence 223578999999999999999999999996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-37 Score=309.44 Aligned_cols=180 Identities=31% Similarity=0.480 Sum_probs=154.4
Q ss_pred hhhh-hcCcccceEEEEEEeC---CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 493 NFST-KLGQGGFGSVYLGMLP---DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 493 ~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.+.+ +||+|+||+||+|.+. ++..||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 3445 4999999999999864 35679999997532 335679999999999999999999999865 567899999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+++|+|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 90 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 90 AGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp CTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred CCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999998543 34599999999999999999999999 99999999999999999999999999999876544
Q ss_pred cee--eecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... .....||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~ 198 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 198 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcc
Confidence 322 233568999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-36 Score=314.97 Aligned_cols=181 Identities=27% Similarity=0.393 Sum_probs=161.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 568 (679)
.|++.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5888999999999999999975 59999999986533 345678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeC--CCCcEEEeeccCCcccccCC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLD--DNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DFg~a~~~~~~~ 646 (679)
+|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|+......
T Consensus 110 gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 110 GGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887543 34599999999999999999999999 999999999999998 67899999999999876554
Q ss_pred ceeeecccCccccccccccccCCCCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. .....||+.|+|||++.+..++.++|||||
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (352)
T d1koba_ 184 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAI 214 (352)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred c--eeeccCcccccCHHHHcCCCCCCccchHHH
Confidence 3 245679999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=306.38 Aligned_cols=181 Identities=25% Similarity=0.421 Sum_probs=160.8
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-------cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46888999999999999999975 58999999985421 23578999999999999999999999999999999
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC----cEEEeecc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF----TAKVSDFG 637 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DFg 637 (679)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999653 3599999999999999999999999 999999999999998776 59999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+++....... .....||+.|+|||++.+..++.++|||||
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSl 202 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhh
Confidence 9987755432 245678999999999999999999999996
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-37 Score=315.69 Aligned_cols=190 Identities=29% Similarity=0.447 Sum_probs=160.2
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC------CcEEEEEEecc--cccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD------GIQVAVKKLES--IGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+....+++.++||+|+||+||+|+... ...||||++.. .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 444567888999999999999999643 23699999864 234456789999999999 899999999999999
Q ss_pred CeeeEEEeccCCCCHhHHhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTE-------------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDI 618 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl 618 (679)
+..++||||+++|+|.++|..... ....+++..++.++.||++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999976432 123589999999999999999999999 9999999
Q ss_pred CCCCeEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 619 KPENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 619 kp~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 999999999999999999999876655433 2234568999999999999999999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=310.79 Aligned_cols=183 Identities=29% Similarity=0.494 Sum_probs=150.7
Q ss_pred hhhhhhhcCcccceEEEEEEeCCC-----cEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDG-----IQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~-----~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
.+++.+.||+|+||+||+|+++.. ..||||+++... ....+|.+|++++++++|||||++++++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 345678899999999999997542 479999996532 3345789999999999999999999999999999999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
|||+.+++|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 88 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 88 TEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999987654 34599999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCce--eeecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESL--VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
..... ......||+.|||||++.++.++.++|||||
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~ 199 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCccccccc
Confidence 44322 1233568999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-36 Score=310.64 Aligned_cols=178 Identities=27% Similarity=0.310 Sum_probs=161.1
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecc----cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEe
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLES----IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYE 565 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 565 (679)
.|++.++||+|+||.||+|+.. +|+.||||++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 6788899999999999999975 599999999864 23445778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 122 ~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999998653 3599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
. ....||+.|||||++.+..++.++|||||
T Consensus 195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 224 (350)
T d1rdqe_ 195 T----WTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp B----CCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred c----ccccCccccCCHHHHcCCCCCccccccch
Confidence 2 34679999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=304.25 Aligned_cols=181 Identities=21% Similarity=0.320 Sum_probs=161.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEeccCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYLGN 569 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 569 (679)
+|++.++||+|+||+||+|+.. +++.||||+++........+.+|++++++++||||+++++++.+++..|+||||+++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 4788899999999999999976 588999999987666667789999999999999999999999999999999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCC--CcEEEeeccCCcccccCCc
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDN--FTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DFg~a~~~~~~~~ 647 (679)
++|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 86 g~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999999643 33589999999999999999999999 99999999999999854 5899999999987654432
Q ss_pred eeeecccCccccccccccccCCCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.....+|+.|+|||.+.+..++.++|||||
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSl 189 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred --ccccccccccccchhccCCCCCchhhcccH
Confidence 345678999999999999999999999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=302.93 Aligned_cols=184 Identities=26% Similarity=0.390 Sum_probs=147.1
Q ss_pred HHhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
...|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4567888999999999999998643 3578999986532 33467999999999999999999999985 467899
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.+++... ...+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999987654 34589999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
............||+.|+|||++.+..++.++|||||
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl 195 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccc
Confidence 6554444455678999999999999999999999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-35 Score=302.02 Aligned_cols=181 Identities=25% Similarity=0.348 Sum_probs=158.8
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHHHHHHH-hhcCCCcceEEEEEEeCCeeeEEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAEVTTIG-NVHHLHLVKLKGFCIEGAHRLLAY 564 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~ 564 (679)
.|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 4678899999999999999986 4899999999642 344566777777765 689999999999999999999999
Q ss_pred eccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccccc
Q 046493 565 EYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNR 644 (679)
Q Consensus 565 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~ 644 (679)
||+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999653 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......||+.|+|||++.+..++.++|||||
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 189 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence 432 2345689999999999999999999999996
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-36 Score=299.23 Aligned_cols=178 Identities=31% Similarity=0.489 Sum_probs=149.1
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-CeeeEEEeccCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-AHRLLAYEYLGN 569 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~ 569 (679)
.+++.++||+|+||.||+|++ .|+.||||+++.. ...+++.+|++++++++||||+++++++.++ +..++||||+++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 456788999999999999999 5788999999753 4467899999999999999999999998654 567999999999
Q ss_pred CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCcee
Q 046493 570 GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREESLV 649 (679)
Q Consensus 570 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~~~ 649 (679)
|+|.++|.... ...+++..+++++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 86 GSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp EEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999996532 33589999999999999999999999 99999999999999999999999999998654432
Q ss_pred eecccCccccccccccccCCCCcccceeeC
Q 046493 650 YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 650 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....+++.|+|||++.+..++.++|||||
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSf 186 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSF 186 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhH
Confidence 34568899999999999999999999996
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-35 Score=305.92 Aligned_cols=179 Identities=25% Similarity=0.326 Sum_probs=153.9
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc----ccCHHHHHHH---HHHHHhhcCCCcceEEEEEEeCCeeeE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI----GQGKKEFSAE---VTTIGNVHHLHLVKLKGFCIEGAHRLL 562 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~l 562 (679)
.|++.+.||+|+||.||+|+.. +|+.||||++... ......+.+| +++++.++||||+++++++.+++..++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 4678899999999999999976 4899999998542 2233444555 566667789999999999999999999
Q ss_pred EEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 563 AYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 563 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
||||+++|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 85 vmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999653 4588999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
.... .....||+.|+|||++.+ ..++.++|||||
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSl 192 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSL 192 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHH
Confidence 5543 244679999999999864 568999999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-36 Score=304.30 Aligned_cols=188 Identities=29% Similarity=0.484 Sum_probs=160.0
Q ss_pred HHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCee
Q 046493 489 KATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHR 560 (679)
Q Consensus 489 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 560 (679)
...+++.++||+|+||+||+|+.. +++.||||+++... ...+++.+|++++++++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 345678899999999999999863 35789999997533 2356799999999999999999999999999999
Q ss_pred eEEEeccCCCCHhHHhhccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 046493 561 LLAYEYLGNGSLDKWIFNSTE--------------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKP 620 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp 620 (679)
+++|||+++|+|.++++.... ....+++..++.|+.||++||+|||++ +||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence 999999999999999964321 123489999999999999999999999 999999999
Q ss_pred CCeEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 621 ENVLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 621 ~NIll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
+||||+.++.+||+|||+++........ ......|++.|+|||.+.+..++.++|||||
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 9999999999999999999876544322 2234678999999999999999999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9e-35 Score=292.07 Aligned_cols=180 Identities=27% Similarity=0.381 Sum_probs=157.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc----------CHHHHHHHHHHHHhhc-CCCcceEEEEEEeCC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ----------GKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGA 558 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 558 (679)
.|++.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 5778899999999999999975 589999999865321 1235789999999997 999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccC
Q 046493 559 HRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGL 638 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~ 638 (679)
..+|||||+++|+|.++|.. ...+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999965 34599999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCceeeecccCcccccccccccc------CCCCcccceeeC
Q 046493 639 AKLMNREESLVYTTLRGTRGYLAPEWITN------NPISEKSDVYSY 679 (679)
Q Consensus 639 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwSl 679 (679)
++....... .....||+.|+|||++.+ ..++.++|||||
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl 201 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence 998765432 245679999999999863 346889999995
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=302.96 Aligned_cols=190 Identities=26% Similarity=0.424 Sum_probs=151.1
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEeC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEG 557 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 557 (679)
+....|++.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|...+.++ +|+||+++++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 44567888999999999999999953 24689999997532 3346678888888887 689999999998765
Q ss_pred C-eeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeE
Q 046493 558 A-HRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVL 624 (679)
Q Consensus 558 ~-~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIl 624 (679)
+ ..++||||+++|+|.+++..... ....+++.+++.++.||++||+|||++ +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 4 67999999999999999975432 133589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 625 LDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 625 l~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 222 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeeh
Confidence 999999999999999876544332 2234679999999999999999999999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4e-35 Score=295.89 Aligned_cols=183 Identities=23% Similarity=0.336 Sum_probs=151.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC----ee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG----QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA----HR 560 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 560 (679)
.+|++.+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 45788899999999999999975 59999999996532 22356899999999999999999999998654 37
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
|+||||+++++|.+++... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++..+|+|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 8999999999999988653 4599999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCc--eeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREES--LVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .......||+.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl 200 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccc
Confidence 6544322 12344679999999999999999999999996
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=301.20 Aligned_cols=182 Identities=30% Similarity=0.455 Sum_probs=153.0
Q ss_pred hhhhhhhcCcccceEEEEEEeCC-Cc----EEEEEEecc--cccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPD-GI----QVAVKKLES--IGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 563 (679)
.|++.++||+|+||+||+|++.. |+ +||+|+++. .....+++.+|++++++++|||||+++++|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 36778999999999999999653 43 689998864 334567899999999999999999999999875 45788
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
+||+.+++|.+++... ...+++..+++++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988654 34699999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 644 REESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... .....||+.|+|||++.++.++.++|||||
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~ 199 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhH
Confidence 544332 233568999999999999999999999996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-35 Score=300.34 Aligned_cols=178 Identities=26% Similarity=0.311 Sum_probs=153.3
Q ss_pred hhhhh-hhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCcceEEEEEEe----CCeeeEE
Q 046493 491 TKNFS-TKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE----GAHRLLA 563 (679)
Q Consensus 491 ~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv 563 (679)
.|++. +.||+|+||+||+|+.. +++.||||+++. ...+.+|++++.++ +||||+++++++.+ +...++|
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 46665 45999999999999974 589999999864 35578899987665 89999999999876 4568999
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAK 640 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~ 640 (679)
|||+++|+|.++|.... ...+++.++..++.||+.||+|||++ +|+||||||+|||+++ .+.+||+|||+|+
T Consensus 88 mEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 99999999999997532 34699999999999999999999999 9999999999999985 5679999999998
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .....||+.|+|||++.+..++.++|||||
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 7665433 245679999999999999999999999996
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-35 Score=297.19 Aligned_cols=183 Identities=27% Similarity=0.367 Sum_probs=149.8
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC----eeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA----HRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 566 (679)
++.+.++||+|+||+||+|++ +|+.||||+++.........+.|+..+.+++||||+++++++.+.+ ..++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 455678899999999999997 6899999999764433333445666667889999999999998754 57899999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC-----EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+++|+|.++|++. .+++..+++++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+++.
T Consensus 83 ~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 83 HEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999653 4899999999999999999999631 23999999999999999999999999999998
Q ss_pred cccCCce---eeecccCccccccccccccCC------CCcccceeeC
Q 046493 642 MNREESL---VYTTLRGTRGYLAPEWITNNP------ISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDvwSl 679 (679)
....... ......||+.|+|||++.+.. ++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 7654332 223467999999999987643 5778999996
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-35 Score=297.74 Aligned_cols=185 Identities=27% Similarity=0.492 Sum_probs=155.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC-Cc--EEEEEEecc--cccCHHHHHHHHHHHHhh-cCCCcceEEEEEEeCCeeeEE
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD-GI--QVAVKKLES--IGQGKKEFSAEVTTIGNV-HHLHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~l~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 563 (679)
..+++.++||+|+||+||+|++.+ +. .||||+++. .....+++.+|+++++++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 345678899999999999999754 43 578888754 233456799999999999 799999999999999999999
Q ss_pred EeccCCCCHhHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcE
Q 046493 564 YEYLGNGSLDKWIFNST------------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTA 631 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 631 (679)
|||+++|+|.++|+... .....+++..+++++.||++||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997541 2345699999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 632 KVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 632 kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
||+|||+++....... .....||..|+|||.+.+..++.++|||||
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf 212 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehh
Confidence 9999999986543322 234568999999999999999999999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-35 Score=298.99 Aligned_cols=191 Identities=28% Similarity=0.470 Sum_probs=164.5
Q ss_pred HHHHHhhhhhhhcCcccceEEEEEEe------CCCcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEEe
Q 046493 486 DLCKATKNFSTKLGQGGFGSVYLGML------PDGIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCIE 556 (679)
Q Consensus 486 ~l~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 556 (679)
|+....+++.++||+|+||.||+|++ .+++.||||+++... ....++.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 45556788899999999999999985 236789999997533 3445789999999999 69999999999999
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTE--------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPEN 622 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~N 622 (679)
++..++||||+++|+|.++++.... ....+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999975431 233589999999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 623 VLLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 623 Ill~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 99999999999999999977654332 2344678999999999999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=296.04 Aligned_cols=177 Identities=28% Similarity=0.330 Sum_probs=149.9
Q ss_pred hhhcCcccceEEEEEEeC-CCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 495 STKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ------GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 495 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.++||+|+||+||+|++. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 367999999999999975 489999999864321 1246889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
+++++..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877766532 44589999999999999999999999 999999999999999999999999999987655432
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. .....||+.|+|||++.+. .++.++|||||
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 187 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAV 187 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhc
Confidence 2 2346799999999988654 57999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=295.38 Aligned_cols=181 Identities=33% Similarity=0.532 Sum_probs=154.7
Q ss_pred hhhhhcCcccceEEEEEEeCCC----cEEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC-CeeeEEEe
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDG----IQVAVKKLESI--GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-AHRLLAYE 565 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 565 (679)
++.++||+|+||+||+|++.++ ..||||+++.. ....++|.+|++++++++||||+++++++.+. +..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999997542 36899999752 23447799999999999999999999998764 57899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccC
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~ 645 (679)
|+++++|.+++... ...+++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++.....
T Consensus 110 ~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999998654 34578899999999999999999999 9999999999999999999999999999876554
Q ss_pred Ccee---eecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESLV---YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.... .....||+.|+|||.+.+..++.++|||||
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf 220 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhh
Confidence 3221 123568999999999999999999999996
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=295.02 Aligned_cols=190 Identities=27% Similarity=0.423 Sum_probs=157.9
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeCC--------CcEEEEEEecccc--cCHHHHHHHHHHHHhh-cCCCcceEEEEEE
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIG--QGKKEFSAEVTTIGNV-HHLHLVKLKGFCI 555 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 555 (679)
+....|++.++||+|+||.||+|+... +..||||+++... ....++.+|...+.++ +||||++++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 344577888999999999999998532 2479999996633 3447788999999998 7999999999999
Q ss_pred eCCeeeEEEeccCCCCHhHHhhccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 046493 556 EGAHRLLAYEYLGNGSLDKWIFNSTE------------ESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENV 623 (679)
Q Consensus 556 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NI 623 (679)
+++..++||||+++|+|.++|..... ....+++.+++.++.||+.||+|||++ +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975432 234589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeccCCcccccCCce-eeecccCccccccccccccCCCCcccceeeC
Q 046493 624 LLDDNFTAKVSDFGLAKLMNREESL-VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 624 ll~~~~~~kL~DFg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|++.++.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~ 223 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHh
Confidence 9999999999999999877654332 2234678999999999999999999999996
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=290.86 Aligned_cols=183 Identities=25% Similarity=0.385 Sum_probs=147.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeCC----CcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeee
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLPD----GIQVAVKKLESI----GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRL 561 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 561 (679)
..|++.+.||+|+||+||+|+... ...||||+++.. ....++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 346788999999999999998532 247899988642 2234679999999999999999999999965 4678
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+||||+++++|.+++... ...+++..++.++.||++||.|||++ +|+||||||+||+|+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988654 34599999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCcee--eecccCccccccccccccCCCCcccceeeC
Q 046493 642 MNREESLV--YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
........ .....|+..|+|||++.+..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~ 200 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 200 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhh
Confidence 75543322 233567889999999999999999999996
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=296.41 Aligned_cols=190 Identities=26% Similarity=0.441 Sum_probs=162.0
Q ss_pred HHHHhhhhhhhcCcccceEEEEEEeC------CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC
Q 046493 487 LCKATKNFSTKLGQGGFGSVYLGMLP------DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA 558 (679)
Q Consensus 487 l~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 558 (679)
+....+++.++||+|+||+||+|++. +++.||||+++... .....+.+|++++++++||||+++++++..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33456678899999999999999863 25789999997533 23356899999999999999999999999999
Q ss_pred eeeEEEeccCCCCHhHHhhccC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEE
Q 046493 559 HRLLAYEYLGNGSLDKWIFNST------EESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAK 632 (679)
Q Consensus 559 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 632 (679)
..++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||++ +|+||||||+||||++++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence 9999999999999999986432 1223578999999999999999999999 999999999999999999999
Q ss_pred EeeccCCcccccCCcee-eecccCccccccccccccCCCCcccceeeC
Q 046493 633 VSDFGLAKLMNREESLV-YTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 633 L~DFg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+|||+++......... .....||+.|+|||.+.+..++.++|||||
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~ 221 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence 99999998775543322 233468999999999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-34 Score=290.23 Aligned_cols=182 Identities=26% Similarity=0.369 Sum_probs=153.3
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
.|++.++||+|+||+||+|++. +++.||||+++... ...+.+.+|++++++++||||+++++++.++++.++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 4677889999999999999975 58999999996532 2357789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+.++ +.+++.... ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 83 ~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 83 LHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred cCCc-hhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9764 444443322 44699999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
. ......||+.|+|||++.... ++.++|||||
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSl 189 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHH
T ss_pred c-cceeecccceeeehhhhccccCCCcccccccc
Confidence 2 224457999999999887765 5789999996
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=288.85 Aligned_cols=180 Identities=28% Similarity=0.390 Sum_probs=153.3
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc-------cCHHHHHHHHHHHHhhc--CCCcceEEEEEEeCCe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG-------QGKKEFSAEVTTIGNVH--HLHLVKLKGFCIEGAH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 559 (679)
.+|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46788899999999999999975 58999999986422 11234678999999996 8999999999999999
Q ss_pred eeEEEeccCC-CCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-CCcEEEeecc
Q 046493 560 RLLAYEYLGN-GSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-NFTAKVSDFG 637 (679)
Q Consensus 560 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DFg 637 (679)
.++||||+.+ +++.+++.. ...+++.++..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 577787754 34599999999999999999999999 9999999999999985 5799999999
Q ss_pred CCcccccCCceeeecccCccccccccccccCCC-CcccceeeC
Q 046493 638 LAKLMNREESLVYTTLRGTRGYLAPEWITNNPI-SEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSl 679 (679)
+|+...... .+...||+.|+|||++.+..+ +.++|||||
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl 196 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence 998754432 245689999999999988765 567899996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.98 E-value=1.3e-33 Score=286.41 Aligned_cols=181 Identities=25% Similarity=0.326 Sum_probs=154.0
Q ss_pred hhhhhhhcCcccceEEEEEEeCCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEecc
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
+|++.++||+|+||+||+|++++++.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 46778999999999999999988999999999653 233578999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCCc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREES 647 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~~ 647 (679)
.++.+..+... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+........
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 83 DQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp SEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred hhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 88777666533 35699999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeecccCccccccccccccC-CCCcccceeeC
Q 046493 648 LVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 648 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
. .....+++.|+|||.+.+. .++.++|||||
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~~Diwsl 187 (286)
T d1ob3a_ 156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred c-cceecccchhhhHHHHhCCCCCCcceeehhc
Confidence 2 2345689999999998765 56899999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.1e-33 Score=286.48 Aligned_cols=182 Identities=23% Similarity=0.351 Sum_probs=151.2
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-C-CcEEEEEEecccc---cCHHHHHHHHHHHHhh---cCCCcceEEEEEEe-----
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-D-GIQVAVKKLESIG---QGKKEFSAEVTTIGNV---HHLHLVKLKGFCIE----- 556 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 556 (679)
.+|++.++||+|+||+||+|++. + ++.||||+++... .....+.+|+.+++.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 46788899999999999999974 4 6779999986422 2234566788877776 79999999999864
Q ss_pred CCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeec
Q 046493 557 GAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDF 636 (679)
Q Consensus 557 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DF 636 (679)
....+++|||++++.+....... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 34678999999987776544332 44589999999999999999999999 9999999999999999999999999
Q ss_pred cCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 637 GLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 637 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
|+++....... .....||+.|+|||++.+.+++.++|||||
T Consensus 161 g~~~~~~~~~~--~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 161 GLARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp CSCCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred hhhhhhccccc--CCCcccChhhcCcchhcCCCCChhehhhch
Confidence 99986554332 245689999999999999999999999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=6.2e-33 Score=281.75 Aligned_cols=182 Identities=24% Similarity=0.298 Sum_probs=156.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcC-CCcceEEEEEEeCCeeeEEEecc
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHH-LHLVKLKGFCIEGAHRLLAYEYL 567 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~ 567 (679)
.+|++.++||+|+||+||+|++. +++.||||+++... ..+.+++|++.++.++| +|++.+++++.++...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 46788999999999999999975 58999999885432 34457889999999975 89999999999999999999999
Q ss_pred CCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC-----CCcEEEeeccCCccc
Q 046493 568 GNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD-----NFTAKVSDFGLAKLM 642 (679)
Q Consensus 568 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DFg~a~~~ 642 (679)
+++|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 -~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 68999988654 34589999999999999999999999 9999999999999974 578999999999876
Q ss_pred ccCCce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 643 NREESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
...... ......||+.|||||++.+..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSl 199 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHh
Confidence 543211 1234679999999999999999999999996
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-32 Score=283.99 Aligned_cols=181 Identities=23% Similarity=0.368 Sum_probs=149.1
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCC----eeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG--QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA----HRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 563 (679)
+|++.++||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 4778899999999999999964 69999999997533 23457889999999999999999999997653 23455
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMN 643 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~ 643 (679)
+||+.+++|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||++++.+||+|||+++...
T Consensus 89 ~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 6667799999999643 489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCce--eeecccCcccccccccccc-CCCCcccceeeC
Q 046493 644 REESL--VYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 644 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
..... ......||+.|+|||++.. ..++.++||||+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl 199 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence 44322 1244679999999999854 457899999995
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=5e-32 Score=280.23 Aligned_cols=176 Identities=23% Similarity=0.372 Sum_probs=152.1
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeC--CeeeEEEe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEG--AHRLLAYE 565 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 565 (679)
.+|++.++||+|+||+||+|+.. +++.||||+++. ...+.+.+|+++|++++ ||||+++++++... ...++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 36888999999999999999975 589999999974 34577899999999995 99999999999854 46899999
Q ss_pred ccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCccccc
Q 046493 566 YLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLMNR 644 (679)
Q Consensus 566 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~~~ 644 (679)
|+++++|..+. +.+++..+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999997754 3489999999999999999999999 999999999999998654 699999999987655
Q ss_pred CCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 645 EESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 645 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
... .....+|+.|+|||.+.+. .++.++|||||
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhh
Confidence 432 2456789999999998765 47999999995
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-32 Score=279.04 Aligned_cols=183 Identities=23% Similarity=0.302 Sum_probs=150.5
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCcceEEEEEEe--------C
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESI---GQGKKEFSAEVTTIGNVHHLHLVKLKGFCIE--------G 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 557 (679)
.+|++.++||+|+||+||+|++. +|+.||||++... ....+.+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 56788899999999999999975 6999999998542 2345678899999999999999999999865 3
Q ss_pred CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeecc
Q 046493 558 AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFG 637 (679)
Q Consensus 558 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg 637 (679)
+..++||||++++.+..+... ...+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 467899999988776654422 44689999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccCCce---eeecccCccccccccccccC-CCCcccceeeC
Q 046493 638 LAKLMNREESL---VYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 638 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
+++........ ......||+.|+|||++.+. .++.++|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl 208 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence 99876543221 12335799999999998765 68999999996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-32 Score=284.28 Aligned_cols=180 Identities=28% Similarity=0.358 Sum_probs=147.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCcceEEEEEEeC------CeeeEE
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHLVKLKGFCIEG------AHRLLA 563 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 563 (679)
+|+..++||+|+||+||+|++. +++.||||+++.... ...+|++++++++||||+++++++... .+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4666788999999999999986 489999999965332 234799999999999999999998643 346899
Q ss_pred EeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCC-cEEEeeccCCccc
Q 046493 564 YEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNF-TAKVSDFGLAKLM 642 (679)
Q Consensus 564 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DFg~a~~~ 642 (679)
|||++++.+.. +.........+++.++..++.||++||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998654443 332222345699999999999999999999999 999999999999999775 8999999999876
Q ss_pred ccCCceeeecccCcccccccccccc-CCCCcccceeeC
Q 046493 643 NREESLVYTTLRGTRGYLAPEWITN-NPISEKSDVYSY 679 (679)
Q Consensus 643 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSl 679 (679)
..... .....||+.|+|||.+.+ ..++.++|||||
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSl 209 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSA 209 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeeccc
Confidence 55432 244679999999998765 468999999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-32 Score=283.62 Aligned_cols=176 Identities=28% Similarity=0.363 Sum_probs=146.2
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeCC------ee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEGA------HR 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 560 (679)
+|++.++||+|+||+||+|++. +++.||||+++.... ..+.+.+|+++|++++|||||++++++...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 5778899999999999999975 499999999975332 2456889999999999999999999998655 46
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
++||||+ +.+|..++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 99 ~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 9999999 5678777643 3499999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCceeeecccCccccccccccccC-CCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNN-PISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSl 679 (679)
...... +...||+.|+|||++.+. .++.++|||||
T Consensus 170 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 170 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred ccCCcc----ccccccccccCHHHHcCCCCCCccchhhcc
Confidence 765432 456799999999998764 56899999995
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=272.51 Aligned_cols=181 Identities=21% Similarity=0.291 Sum_probs=157.5
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCcceEEEEEEeCCeeeEEEec
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIG---QGKKEFSAEVTTIGNVHHLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+|++.++||+|+||+||+|++. +++.||||+++... .....+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 4777899999999999999975 58999999986432 3357789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcccccCC
Q 046493 567 LGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLMNREE 646 (679)
Q Consensus 567 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~~~~~ 646 (679)
+.+++|..++.. .+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 83 ~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 83 CDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred cccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998887754 34588999999999999999999999 99999999999999999999999999998765543
Q ss_pred ceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 647 SLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 647 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
.. .....+++.|+|||++.+.. ++.++|||||
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSl 188 (292)
T d1unla_ 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred cc-ceeeccccchhhhhHhccCCCCCchhhcccc
Confidence 22 23456788999999987665 6899999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-32 Score=278.77 Aligned_cols=183 Identities=24% Similarity=0.291 Sum_probs=157.6
Q ss_pred HhhhhhhhcCcccceEEEEEEeC----CCcEEEEEEeccc-----ccCHHHHHHHHHHHHhhcC-CCcceEEEEEEeCCe
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP----DGIQVAVKKLESI-----GQGKKEFSAEVTTIGNVHH-LHLVKLKGFCIEGAH 559 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~-----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 559 (679)
..|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 34888999999999999999852 3789999998642 2345678899999999976 899999999999999
Q ss_pred eeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCC
Q 046493 560 RLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLA 639 (679)
Q Consensus 560 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a 639 (679)
.+++|||+.+++|.+++... ..+.+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998654 3478899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCceeeecccCccccccccccccC--CCCcccceeeC
Q 046493 640 KLMNREESLVYTTLRGTRGYLAPEWITNN--PISEKSDVYSY 679 (679)
Q Consensus 640 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSl 679 (679)
+..............|++.|+|||.+.+. .++.++|||||
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl 218 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence 87765544434557899999999998765 46889999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.1e-31 Score=271.78 Aligned_cols=181 Identities=26% Similarity=0.319 Sum_probs=149.0
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc-ceEEEEEEeCCeeeEEEeccC
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL-VKLKGFCIEGAHRLLAYEYLG 568 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 568 (679)
+|++.++||+|+||.||+|++. +++.||||++.... ..+++..|++++++++|+|+ +.+..+..+++..++||||++
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 5788899999999999999975 58999999886533 33457899999999987665 555566677888999999995
Q ss_pred CCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCC---CCcEEEeeccCCcccccC
Q 046493 569 NGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDD---NFTAKVSDFGLAKLMNRE 645 (679)
Q Consensus 569 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DFg~a~~~~~~ 645 (679)
++|.+.+... ...+++..+..++.|+++||+|||++ +|+||||||+|||++. +..+||+|||+|+.....
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 87 -PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 5666665443 34599999999999999999999999 9999999999999863 557999999999987543
Q ss_pred Cce------eeecccCccccccccccccCCCCcccceeeC
Q 046493 646 ESL------VYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 646 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
... ......||+.|||||++.+.+++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 199 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEec
Confidence 321 1234679999999999999999999999996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-31 Score=276.45 Aligned_cols=177 Identities=27% Similarity=0.280 Sum_probs=141.4
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEe------CCee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIE------GAHR 560 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 560 (679)
+|++.++||+|+||+||+|++. +|+.||||+++.... ....+.+|+.++++++||||+++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4777899999999999999976 599999999975332 23568899999999999999999999964 3678
Q ss_pred eEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCc
Q 046493 561 LLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAK 640 (679)
Q Consensus 561 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~ 640 (679)
|+||||+.++.+. .+ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++
T Consensus 98 ~iv~Ey~~~~l~~-~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 98 YLVMELMDANLCQ-VI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEECCSEEHHH-HH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeccchHHHH-hh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 9999999765554 44 23489999999999999999999999 99999999999999999999999999988
Q ss_pred ccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 641 LMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 641 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
....... .....+|+.|+|||++.+..+++++||||+
T Consensus 168 ~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl 204 (355)
T d2b1pa1 168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccc--cccccccccccChhhhcCCCCCCCcccccc
Confidence 6654332 345678999999999999999999999995
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.2e-31 Score=274.44 Aligned_cols=177 Identities=27% Similarity=0.372 Sum_probs=147.6
Q ss_pred hhhhhhhcCcccceEEEEEEeC-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCcceEEEEEEeC-----Ceee
Q 046493 491 TKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQ---GKKEFSAEVTTIGNVHHLHLVKLKGFCIEG-----AHRL 561 (679)
Q Consensus 491 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 561 (679)
+|++.++||+|+||+||+|+.. +++.||||+++.... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4778899999999999999975 599999999975433 335688999999999999999999998643 3446
Q ss_pred EEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 562 LAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 562 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
+++||+.+++|.+++.. +.+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++..
T Consensus 99 ~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp EEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 77788889999999843 3499999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCceeeecccCccccccccccccCC-CCcccceeeC
Q 046493 642 MNREESLVYTTLRGTRGYLAPEWITNNP-ISEKSDVYSY 679 (679)
Q Consensus 642 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSl 679 (679)
..... ....|++.|+|||.+.+.. ++.++|||||
T Consensus 171 ~~~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 171 TDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp CTGGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred cCccc----ccccccccccCchhhcCCccCCcccchhhh
Confidence 54432 3457899999999877654 6889999996
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.93 E-value=2.7e-27 Score=248.04 Aligned_cols=182 Identities=26% Similarity=0.279 Sum_probs=146.9
Q ss_pred HhhhhhhhcCcccceEEEEEEeC-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-----------CCCcceEEEEEEeC
Q 046493 490 ATKNFSTKLGQGGFGSVYLGMLP-DGIQVAVKKLESIGQGKKEFSAEVTTIGNVH-----------HLHLVKLKGFCIEG 557 (679)
Q Consensus 490 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 557 (679)
.+|++.++||+|+||+||+|+.. +|+.||||+++......+.+.+|++++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 46899999999999999999975 5999999999875555677889999988875 47899999988653
Q ss_pred --CeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeEeCCCC-----
Q 046493 558 --AHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE-ECEVKIVHCDIKPENVLLDDNF----- 629 (679)
Q Consensus 558 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~----- 629 (679)
...+++++++..+......... .....+++..+..++.||++||+|||+ . +|+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 4556667666554433222221 124568999999999999999999998 6 899999999999998654
Q ss_pred -cEEEeeccCCcccccCCceeeecccCccccccccccccCCCCcccceeeC
Q 046493 630 -TAKVSDFGLAKLMNREESLVYTTLRGTRGYLAPEWITNNPISEKSDVYSY 679 (679)
Q Consensus 630 -~~kL~DFg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSl 679 (679)
.++|+|||.+....... ....||+.|+|||++.+..++.++|||||
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 215 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWST 215 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccch
Confidence 49999999998654432 44679999999999999999999999995
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.8e-23 Score=197.55 Aligned_cols=158 Identities=15% Similarity=0.137 Sum_probs=118.5
Q ss_pred hhhhhcCcccceEEEEEEeCCCcEEEEEEeccccc-------------------CHHHHHHHHHHHHhhcCCCcceEEEE
Q 046493 493 NFSTKLGQGGFGSVYLGMLPDGIQVAVKKLESIGQ-------------------GKKEFSAEVTTIGNVHHLHLVKLKGF 553 (679)
Q Consensus 493 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~ 553 (679)
.+.++||+|+||+||+|++.+|+.||||+++.... ......+|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35688999999999999998899999998753110 01234568889999999999998765
Q ss_pred EEeCCeeeEEEeccCCCCHhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeEeCCCCcEEE
Q 046493 554 CIEGAHRLLAYEYLGNGSLDKWIFNSTEESRFLSWNTRFNIALGMAKGLAYLHEECEVKIVHCDIKPENVLLDDNFTAKV 633 (679)
Q Consensus 554 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL 633 (679)
. ..+++|||+++..+.+ ++...+..++.|++++|+|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998765533 33444578999999999999999 99999999999999965 5899
Q ss_pred eeccCCcccccCCceeeecccCcccccc------ccccccCCCCcccceeeC
Q 046493 634 SDFGLAKLMNREESLVYTTLRGTRGYLA------PEWITNNPISEKSDVYSY 679 (679)
Q Consensus 634 ~DFg~a~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~~sDvwSl 679 (679)
+|||+|.....+... .|.. .|.+ .+.|+.++|+||.
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~ 185 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSA 185 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHH
Confidence 999999765433221 1111 1112 3467889999983
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=7.3e-20 Score=155.19 Aligned_cols=111 Identities=17% Similarity=0.315 Sum_probs=88.7
Q ss_pred ccccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEE
Q 046493 28 IGKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAY 107 (679)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lv 107 (679)
+|+|.||+++.+ +..|+ +|.|+|+|...++ +.++. ..++||.||++.|.. ...+.+..||+|+
T Consensus 1 tDtL~~gq~L~~-------g~~l~--~g~~~l~~q~DGN----Lvly~---~~~~vW~s~~~~~~~-~~~l~l~~dGnLv 63 (112)
T d1xd5a_ 1 SDRLNSGHQLDT-------GGSLA--EGGYLFIIQNDCN----LVLYD---NNRAVWASGTNGKAS-GCVLKMQNDGNLV 63 (112)
T ss_dssp CCEEETTEEECT-------TCEEE--ETTEEEEECTTSC----EEEEE---TTEEEEECCCTTSCS-SEEEEECTTSCEE
T ss_pred CCEecCCCEecC-------CCEEE--ECCEEEEEcCCCC----EEEEc---CCcEEEEccCccCCC-CcEEEEeccccEE
Confidence 489999977666 44445 4999999987554 33332 578999999988754 2458899999999
Q ss_pred EEeCCceeEEeccCC-CceeEEEEecCCCEEEEccCCceeeecCCCCcc
Q 046493 108 LQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTD 155 (679)
Q Consensus 108 l~~~~~~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTD 155 (679)
|.+.++.+|+++++. .....|+|+|+|||||++.+++++|||+.+|++
T Consensus 64 l~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EEecCCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 999877888887653 345689999999999999999999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.75 E-value=4.3e-18 Score=142.62 Aligned_cols=105 Identities=25% Similarity=0.422 Sum_probs=83.3
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEE
Q 046493 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYL 108 (679)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl 108 (679)
|+|.||+++.+ +..|. +|.|.|+|...++ +.++ . ..++||+||++.|......+.|..||+|||
T Consensus 2 ~~L~~g~~L~~-------g~~l~--~g~~~l~~q~dgn----Lvl~-~--~~~~vW~ant~~~~~~~~~l~l~~dGnLvl 65 (109)
T d1kj1a_ 2 NLLTNGEGLYA-------GQSLD--VEPYHFIMQEDCN----LVLY-D--HSTSVWASNTGILGKKGCKAVLQSDGNFVV 65 (109)
T ss_dssp CEEETTCEEET-------TCEEE--ETTEEEEECTTSC----EEEE-E--TTEEEEECCCCCTTCCCCEEEECTTSCEEE
T ss_pred CCccCCCEEeC-------CCEEE--eCCEEEEecCCCe----EEEE-e--CCEEEEEeCCCCCCceeEEEEEcCCceEEE
Confidence 78899977766 44444 4889999976544 2232 2 568999999999988666799999999999
Q ss_pred EeCCc-eeEEeccC-CCceeEEEEecCCCEEEEccCCceeeecCCC
Q 046493 109 QRGNG-EAWSANTS-GQKVECMELQDSGNLVLLGVNGSILWQSFSH 152 (679)
Q Consensus 109 ~~~~~-~vWst~~~-~~~~~~a~LldsGNLVl~~~~~~~lWQSFD~ 152 (679)
.+.++ ++|+|+++ +.....|+|+|+|||||++ ..+|||+-|
T Consensus 66 ~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~---~~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---SDIWSTGTY 108 (109)
T ss_dssp ECSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC---CEEEECCCC
T ss_pred EeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC---CCEecCCCc
Confidence 99888 69999876 4455689999999999996 369999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.71 E-value=1.4e-17 Score=139.36 Aligned_cols=104 Identities=29% Similarity=0.426 Sum_probs=80.6
Q ss_pred cccCCCccccceeeecCCCcEEEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEE
Q 046493 29 GKLYPGFEATQMEWINNNGLFLISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYL 108 (679)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl 108 (679)
|+|.+|++|.+ +..|. +|.|.|+|...++ +.++. ..++||+||++.|-. ...+.+..+|+|+|
T Consensus 2 ~~L~~g~~L~~-------G~~l~--ng~~~l~~q~DGN----Lvly~---~~~~vW~s~~~~~~~-~~~l~l~~~Gnlvl 64 (108)
T d1jpca_ 2 NILYSGETLST-------GEFLN--YGSFVFIMQEDCN----LVLYD---VDKPIWATNTGGLSR-SCFLSMQTDGNLVV 64 (108)
T ss_dssp CEEETTEEECT-------TCEEE--ETTEEEEECTTSC----EEEEE---TTEEEEECCCTTSCS-SCEEEECTTSCEEE
T ss_pred CCccCCCEecC-------CCEEE--cCCEEEEECCCCe----EEEEe---CCceeeEeCCCCCCC-ccEEEEeccceEEE
Confidence 78889977665 44443 6999999997665 33332 468999999988743 34588999999999
Q ss_pred EeCCc-eeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCC
Q 046493 109 QRGNG-EAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSH 152 (679)
Q Consensus 109 ~~~~~-~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~ 152 (679)
.+.++ .+|+|++... ....|+|+|+|||||++. .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 99888 6999987543 345789999999999964 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.61 E-value=3.9e-16 Score=132.67 Aligned_cols=96 Identities=20% Similarity=0.259 Sum_probs=78.3
Q ss_pred EeeCCeEEEEeCCCCCCCCCC-ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCC
Q 046493 76 HISSAKVVWTANRGLLIRDSD-KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHP 153 (679)
Q Consensus 76 ~~~~~tvVWvANr~~p~~~~~-~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~P 153 (679)
.+++++.+|++|++.|+.... .|.+..||||+|.+.+..+|++++.+. ....|+|+|+|||||+|.++.++|||+..
T Consensus 16 ~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~- 94 (120)
T d1dlpa2 16 TQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS- 94 (120)
T ss_dssp C--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC-
T ss_pred CCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCC-
Confidence 455788999999999998655 499999999999998878999987643 45689999999999999999999999852
Q ss_pred ccccCCCCccCCCceeecCCCCCCceEEEEeecCceEEE
Q 046493 154 TDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLY 192 (679)
Q Consensus 154 TDTlLpgqkl~~~~~l~S~~~~g~~s~~~~~~~~~~~~~ 192 (679)
.+.++|.+.|+.++ ++++|
T Consensus 95 -------------------~~~~~~~l~Lq~DG-nlvlY 113 (120)
T d1dlpa2 95 -------------------RSAGRYVFVLQPDR-NLAIY 113 (120)
T ss_dssp -------------------CSSSCCEEEECSSS-CEEEE
T ss_pred -------------------CCCCcEEEEECCCC-cEEEe
Confidence 23466777777776 77777
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.53 E-value=7.4e-16 Score=129.48 Aligned_cols=107 Identities=21% Similarity=0.316 Sum_probs=86.5
Q ss_pred EEEee-CCeEEEEeCCCCCCCCCCc-eEEeeCCcEEEEeCCceeEEeccCCCceeEEEEecCCCEEEEccCCceeeecCC
Q 046493 74 VIHIS-SAKVVWTANRGLLIRDSDK-FVFEKNGNAYLQRGNGEAWSANTSGQKVECMELQDSGNLVLLGVNGSILWQSFS 151 (679)
Q Consensus 74 ~~~~~-~~tvVWvANr~~p~~~~~~-~~~~~~g~lvl~~~~~~vWst~~~~~~~~~a~LldsGNLVl~~~~~~~lWQSFD 151 (679)
||..+ ..+..|+.+.+.++.+... |.+..||||||.+++..+|++++.+..+..|.|+|+|||||+|.+++++|||+.
T Consensus 4 ~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t 83 (115)
T d1dlpa1 4 LFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGT 83 (115)
T ss_dssp CBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCC
T ss_pred EEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcCC
Confidence 34333 5667799999999976553 889999999999977789999987667788999999999999999999999984
Q ss_pred CCccccCCCCccCCCceeecCCCCCCceEEEEeecCceEEEEecccceeeeeccC
Q 046493 152 HPTDTLLPGQQFVEGMRLKSFPNSNNMSVYLEFKSGDLVLYAGYQTSQTYWSLAN 206 (679)
Q Consensus 152 ~PTDTlLpgqkl~~~~~l~S~~~~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~ 206 (679)
. .+.|.|.+.|+.++ ++++| ...+|.++.
T Consensus 84 ~--------------------~~~g~y~l~Lq~DG-NlvlY-----~~~~Wssgt 112 (115)
T d1dlpa1 84 K--------------------GSIGNYVLVLQPDR-TVTIY-----GPGLWDSGT 112 (115)
T ss_dssp C--------------------CCSSCCEEEECSSS-CEEEE-----CSEEEECSC
T ss_pred C--------------------CCCCCEEEEECCCC-cEEEe-----CCCeecCCC
Confidence 3 24677888888776 77776 347998763
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.44 E-value=3.4e-13 Score=113.80 Aligned_cols=91 Identities=21% Similarity=0.427 Sum_probs=71.3
Q ss_pred EEeCCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEEEeCCc-eeEEeccCC-CceeE
Q 046493 50 LISNNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNG-EAWSANTSG-QKVEC 127 (679)
Q Consensus 50 l~S~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl~~~~~-~vWst~~~~-~~~~~ 127 (679)
+.+..|.|.|.|...++ +.+ + ...++||.||+..|.. ...+.+..||+|+|.+.++ .+|++++.+ .....
T Consensus 25 ~~~~~~~y~l~mQ~DGN----LVL-y--~~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~~ 96 (119)
T d1b2pa_ 25 ILFGTHVYRFIMQTDCN----LVL-Y--DNNNPIWATNTGGLGN-GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYV 96 (119)
T ss_dssp EEETTEEEEEEECTTSC----EEE-E--ETTEEEEECCCTTSCS-SCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEE
T ss_pred EecCCceEEEEECCCCc----EEE-E--ECCeEEEEecCCCCCc-ceEEEEEeCCCEEEECCCCcEEEECCCcCCCCceE
Confidence 37789999999987655 222 2 2467999999987643 2458899999999999988 689998764 34457
Q ss_pred EEEecCCCEEEEccCCceeeecCC
Q 046493 128 MELQDSGNLVLLGVNGSILWQSFS 151 (679)
Q Consensus 128 a~LldsGNLVl~~~~~~~lWQSFD 151 (679)
|+|+|+|||||++ ..+|||-.
T Consensus 97 l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 97 LVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEECTTSCEEEEE---SEEEECCC
T ss_pred EEEcCCCCEEEEC---CCEeccCC
Confidence 8999999999995 57999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.06 E-value=1e-10 Score=97.64 Aligned_cols=87 Identities=23% Similarity=0.350 Sum_probs=64.4
Q ss_pred CCCeeEEEEEeCCCCceEEEEEEEeeCCeEEEEeCCCCCCCCCCceEEeeCCcEEEEeCCc-eeEEeccCC-CceeEEEE
Q 046493 53 NNSVFGFGFYTALDVQFFLLVVIHISSAKVVWTANRGLLIRDSDKFVFEKNGNAYLQRGNG-EAWSANTSG-QKVECMEL 130 (679)
Q Consensus 53 ~~g~F~lGFf~~~~~~~~~~~~~~~~~~tvVWvANr~~p~~~~~~~~~~~~g~lvl~~~~~-~vWst~~~~-~~~~~a~L 130 (679)
.+|.|.|.|...++ +.++. ..++||.+|...+ ....+.|..+|||||.+.++ .+|++++.. .....++|
T Consensus 24 ~~g~~~l~~q~DGN----LvL~~---~~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~L 94 (115)
T d1dlpa1 24 ELSSFRFTMQSDCN----LVLFD---SDVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVL 94 (115)
T ss_dssp CSTTEEEEECTTSC----EEEEE---SSSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEE
T ss_pred EcCCEEEEECCCCe----EEEEc---CCeeEEEcccCCC--CceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEEEE
Confidence 46778888876554 33332 4578999997532 23458899999999998877 699998763 44457999
Q ss_pred ecCCCEEEEccCCceeeecCC
Q 046493 131 QDSGNLVLLGVNGSILWQSFS 151 (679)
Q Consensus 131 ldsGNLVl~~~~~~~lWQSFD 151 (679)
+++|||||++ ..+|+|-.
T Consensus 95 q~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 95 QPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CSSSCEEEEC---SEEEECSC
T ss_pred CCCCcEEEeC---CCeecCCC
Confidence 9999999994 47999853
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.88 E-value=3.2e-09 Score=89.00 Aligned_cols=82 Identities=24% Similarity=0.447 Sum_probs=63.0
Q ss_pred eEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCCC
Q 046493 98 FVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNSN 176 (679)
Q Consensus 98 ~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~g 176 (679)
|.+..||||||.+++..+|++++.+. ....++|.++|||||+|.++.++|+|.-. -+.+
T Consensus 34 l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t~--------------------~~~~ 93 (119)
T d1b2pa_ 34 FIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA--------------------GKAG 93 (119)
T ss_dssp EEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCC--------------------CCSS
T ss_pred EEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCCc--------------------CCCC
Confidence 67889999999998878999997643 35789999999999999999999997421 1234
Q ss_pred CceEEEEeecCceEEEEecccceeeeecc
Q 046493 177 NMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 177 ~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
.+.+.|+.++ ++++| ..+.|.++
T Consensus 94 ~~~l~Lq~DG-NlvlY-----g~~~W~S~ 116 (119)
T d1b2pa_ 94 HYVLVLQPDR-NVVIY-----GDALWATQ 116 (119)
T ss_dssp CEEEEECTTS-CEEEE-----ESEEEECC
T ss_pred ceEEEEcCCC-CEEEE-----CCCEeccC
Confidence 5666666555 78887 23678765
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.81 E-value=8.4e-09 Score=85.16 Aligned_cols=83 Identities=28% Similarity=0.486 Sum_probs=61.9
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCC--CceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSG--QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPN 174 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~--~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~ 174 (679)
.|.+..||||||...+..||++++.. .....+.|.++|||||+++++.++|+|=-. ..
T Consensus 22 ~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~--------------------~~ 81 (109)
T d1kj1a_ 22 HFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSV--------------------RG 81 (109)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECCCC--------------------CC
T ss_pred EEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEeeE--------------------CC
Confidence 47788999999998777899998753 345679999999999999999999998210 12
Q ss_pred CCCceEEEEeecCceEEEEecccceeeeecc
Q 046493 175 SNNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 175 ~g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
.+.+.+.|+.++ ++++| ....|.++
T Consensus 82 ~~~~~l~L~ddG-Nlvly-----~~~~W~S~ 106 (109)
T d1kj1a_ 82 NGNYVLVLQEDG-NVVIY-----GSDIWSTG 106 (109)
T ss_dssp SSCCEEEECTTS-CEEEE-----CCEEEECC
T ss_pred CCCEEEEEeCCC-cEEEE-----CCCEecCC
Confidence 345666666555 78877 23578754
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.81 E-value=6.6e-09 Score=85.79 Aligned_cols=83 Identities=24% Similarity=0.480 Sum_probs=61.8
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCCC-ceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSGQ-KVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNS 175 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~~-~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~ 175 (679)
.|.+..||||||.+.+..||++++.+. ..+.++|.++|||||++.++.++|+|= |. ...
T Consensus 22 ~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~---t~-----------------~~~ 81 (108)
T d1jpca_ 22 VFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASN---TG-----------------GQN 81 (108)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC---CC-----------------CSC
T ss_pred EEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEcc---cc-----------------CCC
Confidence 478889999999998778999987643 346799999999999999999999971 11 123
Q ss_pred CCceEEEEeecCceEEEEecccceeeeecc
Q 046493 176 NNMSVYLEFKSGDLVLYAGYQTSQTYWSLA 205 (679)
Q Consensus 176 g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~ 205 (679)
+.+.+.|+.++ ++++| ....|.++
T Consensus 82 ~~~~l~L~ddG-NlVly-----~~~~W~S~ 105 (108)
T d1jpca_ 82 GNYVCILQKDR-NVVIY-----GTDRWATG 105 (108)
T ss_dssp SCEEEEECTTS-CEEEE-----ECCCCCCC
T ss_pred CcEEEEEcCCC-CEEEe-----CCCcccCC
Confidence 45555666554 88887 22467654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.72 E-value=2e-08 Score=84.26 Aligned_cols=66 Identities=23% Similarity=0.450 Sum_probs=50.0
Q ss_pred CCeEEEEeCCCCCCCCC-CceEEeeCCcEEEEeCCc-eeEEeccCC-CceeEEEEecCCCEEEEccCCceeeec
Q 046493 79 SAKVVWTANRGLLIRDS-DKFVFEKNGNAYLQRGNG-EAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQS 149 (679)
Q Consensus 79 ~~tvVWvANr~~p~~~~-~~~~~~~~g~lvl~~~~~-~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQS 149 (679)
...+||.+|-.. ... ..+.|..+|||||.+.++ .+|++++.. .....+.|.++|||||++ ..+|.|
T Consensus 52 ~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 52 RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 346789988542 222 348899999999998887 689998753 344578999999999994 468875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=1.6e-07 Score=91.12 Aligned_cols=134 Identities=14% Similarity=0.050 Sum_probs=94.7
Q ss_pred CcccceEEEEEEeCCCcEEEEEEeccc-ccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEeccCCCCHhHHh
Q 046493 499 GQGGFGSVYLGMLPDGIQVAVKKLESI-GQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDKWI 576 (679)
Q Consensus 499 g~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 576 (679)
+.++.+.||+... +++.+++|+.... ......+.+|...+..+. +--+++++.+..+++..++|||+++|.++.+..
T Consensus 23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 3344578999875 5667788887543 334456788999988885 445788898888889999999999998886543
Q ss_pred hccCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 046493 577 FNSTEESRFLSWNTRFNIALGMAKGLAYLHEEC----------------------------------------------- 609 (679)
Q Consensus 577 ~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------------------- 609 (679)
... .....++.++++.|+.||+..
T Consensus 102 ~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T d1j7la_ 102 EDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp TTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred ccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence 211 112334555566666666421
Q ss_pred ---------CCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 610 ---------EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 610 ---------~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
...++|+|+.|.|||+++++.+.|+||+.+...
T Consensus 173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123799999999999998766779999988753
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.49 E-value=3.2e-07 Score=76.06 Aligned_cols=86 Identities=22% Similarity=0.499 Sum_probs=61.0
Q ss_pred ceEEeeCCcEEEEeCCceeEEeccCC-CceeEEEEecCCCEEEEccCCceeeecCCCCccccCCCCccCCCceeecCCCC
Q 046493 97 KFVFEKNGNAYLQRGNGEAWSANTSG-QKVECMELQDSGNLVLLGVNGSILWQSFSHPTDTLLPGQQFVEGMRLKSFPNS 175 (679)
Q Consensus 97 ~~~~~~~g~lvl~~~~~~vWst~~~~-~~~~~a~LldsGNLVl~~~~~~~lWQSFD~PTDTlLpgqkl~~~~~l~S~~~~ 175 (679)
.|.+..||||||...+..||++++.+ ...+.++|..+|||||++. +..+|.|=.. ...
T Consensus 22 ~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s~t~--------------------~~~ 80 (112)
T d1xd5a_ 22 LFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWASNTN--------------------RQN 80 (112)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEECCCC--------------------CSC
T ss_pred EEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEEeec--------------------cCC
Confidence 47888999999999877899998764 3456799999999999986 4566765210 123
Q ss_pred CCceEEEEeecCceEEEEecccceeeeeccC
Q 046493 176 NNMSVYLEFKSGDLVLYAGYQTSQTYWSLAN 206 (679)
Q Consensus 176 g~~s~~~~~~~~~~~~~~~~~~~~~yw~~~~ 206 (679)
+.+.+.|+.++ ++++|. ....+.|.++.
T Consensus 81 ~~~~l~L~ddG-Nlvly~--~~~~~~W~S~t 108 (112)
T d1xd5a_ 81 GNYYLILQRDR-NVVIYD--NSNNAIWATHT 108 (112)
T ss_dssp CCCEEEECTTS-CEEEEC--TTSCEEEECCC
T ss_pred CceEEEEcCCC-CEEEEC--CCCcEEecCCC
Confidence 44566666555 788873 23457888763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=2.7e-06 Score=81.69 Aligned_cols=131 Identities=15% Similarity=0.067 Sum_probs=88.0
Q ss_pred cCccc-ceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhc--CCCcceEEEEEEeCCeeeEEEeccCCCCHhH
Q 046493 498 LGQGG-FGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVH--HLHLVKLKGFCIEGAHRLLAYEYLGNGSLDK 574 (679)
Q Consensus 498 Lg~G~-~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 574 (679)
+..|. ...||+....++..+++|...... ...+..|.+.++.+. ...+++++.+..+++..++|||+++|.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 34444 367999998778889999865432 334678888888774 3346788888888888999999999876643
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 046493 575 WIFNSTEESRFLSWNTRFNIALGMAKGLAYLHE----------------------------------------------- 607 (679)
Q Consensus 575 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~----------------------------------------------- 607 (679)
.. ... ...+.++.+.|+-||+
T Consensus 96 ~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 96 SH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp SC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 11 111 1112223333333332
Q ss_pred ----CC----CCCeeecCCCCCCeEeCCCCcEEEeeccCCccc
Q 046493 608 ----EC----EVKIVHCDIKPENVLLDDNFTAKVSDFGLAKLM 642 (679)
Q Consensus 608 ----~~----~~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~~ 642 (679)
.. ++.++|+|+.|.|||++++..+.|+||+.+...
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 11 124799999999999998766789999988653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=8.4e-05 Score=75.84 Aligned_cols=74 Identities=11% Similarity=0.060 Sum_probs=49.4
Q ss_pred hhcCcccceEEEEEEeCC-CcEEEEEEeccc--------ccCHHHHHHHHHHHHhhc-C--CCcceEEEEEEeCCeeeEE
Q 046493 496 TKLGQGGFGSVYLGMLPD-GIQVAVKKLESI--------GQGKKEFSAEVTTIGNVH-H--LHLVKLKGFCIEGAHRLLA 563 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 563 (679)
+.||.|....||++...+ ++.++||.-... .........|.+.++.+. + ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999999765 678999975321 112344567888887773 2 346666654 55667899
Q ss_pred EeccCCCC
Q 046493 564 YEYLGNGS 571 (679)
Q Consensus 564 ~e~~~~gs 571 (679)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.56 E-value=9.8e-05 Score=73.30 Aligned_cols=136 Identities=12% Similarity=0.075 Sum_probs=83.1
Q ss_pred eEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCc--ceEEE-----EEEeCCeeeEEEeccCCCCHh---
Q 046493 504 GSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLHL--VKLKG-----FCIEGAHRLLAYEYLGNGSLD--- 573 (679)
Q Consensus 504 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~--- 573 (679)
-.||+++.++|+.+++|+.+......+++..|++.+..|....+ +..+. .....+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 57999999999999999998766678889999999988853322 21111 223456678899998775432
Q ss_pred --HH------h---h----ccC-CCCCCCCH-------------------H---HHHHHHHHHHHHHHHH-hcCCCCCee
Q 046493 574 --KW------I---F----NST-EESRFLSW-------------------N---TRFNIALGMAKGLAYL-HEECEVKIV 614 (679)
Q Consensus 574 --~~------l---~----~~~-~~~~~l~~-------------------~---~~~~i~~~i~~~L~yL-H~~~~~~iv 614 (679)
.+ + + ... ......+. . .....+.++...+.-+ .+..+.++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 11 0 0 000 00111111 1 1122333333333322 223345799
Q ss_pred ecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 615 HCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 615 H~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
|+|+.+.|||++++ ..++||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999743 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.04 E-value=0.00087 Score=68.11 Aligned_cols=72 Identities=17% Similarity=0.134 Sum_probs=50.6
Q ss_pred hhcCcccceEEEEEEeCC--------CcEEEEEEecccccCHHHHHHHHHHHHhhc-CCCcceEEEEEEeCCeeeEEEec
Q 046493 496 TKLGQGGFGSVYLGMLPD--------GIQVAVKKLESIGQGKKEFSAEVTTIGNVH-HLHLVKLKGFCIEGAHRLLAYEY 566 (679)
Q Consensus 496 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 566 (679)
+.|+.|-.-.+|++..++ .+.|++++.-. ........+|.++++.+. +.-.+++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 467788888999998754 35677776653 334556778999999885 4444577777642 689999
Q ss_pred cCCCCH
Q 046493 567 LGNGSL 572 (679)
Q Consensus 567 ~~~gsL 572 (679)
+++..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.16 E-value=0.0082 Score=58.44 Aligned_cols=143 Identities=12% Similarity=-0.016 Sum_probs=75.2
Q ss_pred hcCcccceEEEEEEeCCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC--cceEEE------EEEeCCeeeEEEeccC
Q 046493 497 KLGQGGFGSVYLGMLPDGIQVAVKKLESIGQGKKEFSAEVTTIGNVHHLH--LVKLKG------FCIEGAHRLLAYEYLG 568 (679)
Q Consensus 497 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e~~~ 568 (679)
.|..|---+.|+.+..+|+ +++|+.+.. ...+++..|++++..|.+.+ ++..+. +.........++++..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3556767888999986654 889988653 23455667787877775322 221111 1122345566666665
Q ss_pred CCCHhHH-----------h---hc----c--CCCCCC-----------------CCHHHHHHHHHHHHHHHHHHhc-CCC
Q 046493 569 NGSLDKW-----------I---FN----S--TEESRF-----------------LSWNTRFNIALGMAKGLAYLHE-ECE 610 (679)
Q Consensus 569 ~gsL~~~-----------l---~~----~--~~~~~~-----------------l~~~~~~~i~~~i~~~L~yLH~-~~~ 610 (679)
+...... + +. . ...... .........+..+...+.-.+. ..+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 5433110 0 00 0 000000 0011112222233333333332 234
Q ss_pred CCeeecCCCCCCeEeCCCCcEEEeeccCCcc
Q 046493 611 VKIVHCDIKPENVLLDDNFTAKVSDFGLAKL 641 (679)
Q Consensus 611 ~~ivH~Dlkp~NIll~~~~~~kL~DFg~a~~ 641 (679)
.++||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 5899999999999999887778999998863
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.81 E-value=0.072 Score=31.60 Aligned_cols=29 Identities=28% Similarity=0.607 Sum_probs=23.0
Q ss_pred CCCCcCCCCCCCccccC--CC-cccCCCCCccC
Q 046493 285 ISCSVPEPCNPYFVCYF--DN-WCQCPTSLRSQ 314 (679)
Q Consensus 285 ~~Cd~~~~CG~~g~C~~--~~-~C~C~~gf~~~ 314 (679)
|.|.+-..|| +|.|+. .. .|.|-.||+|.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 4799999998 588965 23 59999999874
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.14 E-value=0.21 Score=31.73 Aligned_cols=29 Identities=28% Similarity=0.544 Sum_probs=22.4
Q ss_pred CCCCc-CCCCCCCccccCCC---cccCCCCCcc
Q 046493 285 ISCSV-PEPCNPYFVCYFDN---WCQCPTSLRS 313 (679)
Q Consensus 285 ~~Cd~-~~~CG~~g~C~~~~---~C~C~~gf~~ 313 (679)
|.|.. ...|..+|.|.... .|.|++||.-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 36875 57899999997533 6999999963
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.82 E-value=0.53 Score=35.49 Aligned_cols=33 Identities=24% Similarity=0.726 Sum_probs=28.0
Q ss_pred CChhHHHHhhccC----CceeEEEeeCCCceeEeeec
Q 046493 355 YDLNTCKEACLHN----CSCSVLFFENSTKNCFLFDQ 387 (679)
Q Consensus 355 ~~~~~C~~~Cl~n----CsC~a~~y~~~~~~C~~~~~ 387 (679)
.+.++|.+.|+++ =.|.+|.|....+.|.+...
T Consensus 30 ~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls~~ 66 (91)
T d2qj2a1 30 NTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPF 66 (91)
T ss_dssp SCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEESS
T ss_pred CCHHHHHHHHHccCCCCceEEeEEEECCCCeEEEccc
Confidence 3799999999884 46999999988899998754
|